000005|N05AX0801|Risperdal|töflur|0,5|mg|20|stk|1|þpakki||N05AX08|01.04.2000||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|1366|2694|lyfalmen|V1070|1792|00|20|0|2|Vistor hf|Janssen-Cilag AB|Risperídón||1366||1366|2694 000018|G01AF0501|Pevaryl|krem/sti|0| |15|g|1|sett|krem+3 stílar|G01AF05|01.05.1978||L|A|2|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||00|15|0|4|Vistor hf|Janssen-Cilag AB|Ekónazól||||| 000020|J07AL0201|Prevenar|stl|0| |0,5|ml|1|hgl||J07AL02|01.10.2002||R|K|2|0|0|0|0|WLV|0|0|0|100|USD|6403|9530|lyfalmen|||02|0|0|0|Icepharma hf|Wyeth Lederle Vaccines SA|Hreinsuð pneumococca poly­sakkaríð mótefnavakar (cojugated)||6403||6403|9530 000054|B03XA0103|NeoRecormon|stl|4000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|45740|58814|lyfsjukr|||00|2|0|24|Icepharma hf|Roche|Epóetín||45740||45740|58814 000055|B03XA0103|NeoRecormon|sts|60000|ae/rörly|1|ml|1|rörlyk|+leysir|B03XA01|01.11.2003||R|K|2|0|1|0|1|ROC|0|0|0|100|DKK|123240|155301|lyfsjukr|||00|1|0|60|Icepharma hf|Roche|Epóetín||123240||123240|155301 000145|B03XA0103|NeoRecormon|stl|6000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|68536|87195|lyfsjukr|||00|2|0|36|Icepharma hf|Roche|Epóetín||68536||68536|87195 000159|N05AH0302|Zyprexa Velotab|munndr.t|5|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|10410|14967|lyfalmen|||00|28|0|14|Icepharma hf|Eli Lilly Nederland -|Olanzapín||10410||10410|14967 000166|A07FA0201|Precosa|hylki|250|mg|20|stk|1|glas||A07FA02|01.12.1998||R|A|3|0|0|0|0|LAO|0|0|0|100|SEK|1544|2936|lyfalmen|||00|20|0|5|Vistor hf|Laboratories Biocodex|Saccharomyces boulardii||1544||1544|2936 000182|A07FA0201|Precosa|hylki|250|mg|50|stk|1|glas||A07FA02|01.12.1998||R|A|3|0|0|0|0|LAO|0|0|0|100|SEK|3563|5676|lyfalmen|||00|50|0|12|Vistor hf|Laboratories Biocodex|Saccharomyces boulardii||3563||3563|5676 000184|N05AH0302|Zyprexa Velotab|munndr.t|15|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|30972|40745|lyfalmen|||00|28|0|42|Icepharma hf|Eli Lilly Nederland -|Olanzapín||30972||30972|40745 000193|N05AH0302|Zyprexa Velotab|munnltfl|20|mg|28|stk|1|þpakki||N05AH03|01.12.2003||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|40280|52334|lyfalmen|||00|28|0|56|Icepharma hf|Eli Lilly Nederland -|Olanzapín||40280||40280|52334 000198|N05AH0302|Zyprexa Velotab|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|20264|27414|lyfalmen|V0813|26911|00|28|0|28|Icepharma hf|Eli Lilly Nederland -|Olanzapín||20264||20264|27414 000211|J07AL0201|Prevenar|stl|0| |0,5|ml|1|spr|áfyllt sprauta|J07AL02|01.04.2006||R|K|2|0|0|0|0|WLV|0|0|0|100|USD|9312|13477|lyfalmen|||02|0|0|0|Icepharma hf|Wyeth Lederle Vaccines SA|Hreinsuð pneumococca poly­sakkaríð mótefnavakar (cojugated)||9312||9312|13477 000223|G02CX0101|Tractocile|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.12.2006||R|K|2|0|1|0|1|FER|0|0|0|100|DKK|5930|8490|lyfsjukr|||00|1|0|0|Vistor hf|Ferring|Atosíban||5930||5930|8490 000225|QM01AC0601|Metacam|mixtúra|1,5|mg/ml|100|ml|1|fl||QM01AC06|01.05.2004||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|7619|14684|vetalmen|||00|100|0|0|Vistor hf|Boehringer Ingelheim|||7619||7619|14684 000237|G02CX0101|Tractocile|irþ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.12.2006||R|K|2|0|1|0|1|FER|0|0|0|100|DKK|17662|23857|lyfsjukr|||00|5|0|0|Vistor hf|Ferring|Atosíban||17662||17662|23857 000240|D07AC1301|Elocon|áburður|1|mg/g|50|ml|1|glas||D07AC13|01.04.1994|30.04.2009|R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1729|3187|lyfalmen|||20|50|0|50|Vistor hf|Schering-Plough|Mómetasón||1729||1729|3187 000290|G03GA0601|Puregon|stl|300|ae/rörly|0,36|ml|1|pakki||G03GA06|01.02.2002||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|20292|27449|lyfalmen|||00|0|0|1|Vistor hf|N.V. Organon|Follitrópín beta||20292||20292|27449 000315|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|30|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|5389|7716|lyfsjukr|||00|3000|0|3|Icepharma hf|Fresenius Kabi|Elektrólýtar||5389||5389|7716 000316|G03GA0601|Puregon|stl|600|ae/rörly|0,72|ml|1|pakki||G03GA06|01.02.2002||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|40251|52297|lyfalmen|||00|1|0|6|Vistor hf|N.V. Organon|Follitrópín beta||40251||40251|52297 000373|N02CC0402|Maxalt Smelt|munnltfl|10|mg|6|stk|1|þpakki||N02CC04|01.03.1999||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|5687|8558|lyfalmen|||00|6|0|6|Icepharma hf|M.S.D.|Rizatriptan||5687||5687|8558 000390|J01CR0202|Augmentin|sts|600|mg/hgl|10|hgl|1|pakki|500+100 mg|J01CR02|01.01.2000||R|A|2|0|0|0|1|GSK|0|0|0|100|IKR|2534|3628|lyfsjukr|||00|10|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2534||2534|3628 000402|J01CR0202|Augmentin|sts|1200|mg/hgl|5|hgl|1|pakki|1000+200 mg|J01CR02|01.01.2000||R|A|2|0|0|0|1|GSK|0|0|0|100|IKR|2175|3114|lyfsjukr|||00|5|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||2175||2175|3114 000448|D07AC1301|Elocon|húðlausn|0,1|%|100|ml|1|glas||D07AC13|01.03.2009||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|3194|5175|lyfalmen|||0|100|0|100|Vistor hf|Schering-Plough|Mómetasón||||3194|5175 000530|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|20|spr|án nála|J07BF03|01.06.2005||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|28062|37122|lyfalmen|||02|10|0|0|Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||28062||28062|37122 000548|S01GX0801|Zaditen|augndr|0,25|mg/ml|5|ml|1|glas||S01GX08|01.07.2001||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1964|3506|lyfalmen|||06|5|0|0|Vistor hf|Novartis Healthcare A/S-|Ketotifen||1964||1964|3506 000552|G04BE0105|Caverject Dual|sts|20|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|5210|7911|lyfalmen|||23|2|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprostadíl||5210||5210|7911 000555|N03AX1101|Topimax|hylki|15|mg|60|stk|1|plglas||N03AX11|01.05.2001||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|4058|6347|lyfalmen|||00|60|0|3|Vistor hf|Janssen-Cilag AB|Tópíramat||4058||4058|6347 000565|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|20|sk-hyl||S01GX08|01.07.2001||L|A|2|0|0|0|0|NOH|0|0|0|100|IKR|||lyflausa|||00|8|0|0|Vistor hf|Novartis Healthcare A/S-|Ketotifen||||| 000573|S01GX0801|Zaditen|augndr|0,25|mg/ml|0,4|ml|60|sk-hyl||S01GX08|01.07.2001||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|5580|8413|lyfalmen|||00|24|0|0|Vistor hf|Novartis Healthcare A/S-|Ketotifen||5580||5580|8413 000641|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|100|ml|10|fl||B05BA02|01.04.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|14997|20539|lyfsjukr|||00|1000|0|1|Icepharma hf|Fresenius Kabi|Fitusambönd||14997||14997|20539 000646|C08CA0101|Norvasc|töflur|10|mg|30|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|4593|7073|lyfalmen|||00|30|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Amlódipín||||4593|7073 000770|V08BA0104|E-Z paste|pasta|60|%|1|lbs|1|pakki|til inntöku|V08BA01|01.01.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|2590|3708|lyfsjukr|||00|1|1|0|Parlogis hf|Parlogis - óskráð lyf|Baríumsúlfat||2590||2590|3708 000784|G04BE0105|Caverject Dual|sts|10|mcg/lykj|2|lykjur|1|pakki|2ja hólfa lykja|G04BE01|01.03.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|3799|5996|lyfalmen|||23|2|0|1|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprostadíl||3799||3799|5996 000801|R06AA0201|Benylan|mixtúra|2,8|mg/ml|125|ml|1|glas||R06AA02|01.05.1999||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|125|0|2|Vistor hf|McNeil Denmark ApS|Dífenhýdramín||||| 000815|R06AA0201|Benylan|mixtúra|1,4|mg/ml|125|ml|1|glas||R06AA02|01.06.2001||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|125|0|1|Vistor hf|McNeil Denmark ApS|Dífenhýdramín||||| 000879|L03AB0702|Rebif|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.01.2001||R|K|2|0|1|0|1|SEN|0|0|0|100|SEK|162673|204395|lyfsjukr|||00|6|0|123|Gróco ehf|Serono Nordic|Interferón beta-1a||162673||162673|204395 000891|M05BA0101|Didronate|töflur|200|mg|60|stk|1|þpakki||M05BA01|01.04.1996||R|A|4|0|0|E|0|PGA|0|0|0|100|DKK|13973|19581|lyfalmen|||00|60|0|30|Sofus Consulting AB|Procter & Gamble-|Etídrónsýra||13973||13973|19581 000957|H01AC0101|Genotropin|sts|0| |5|mg|1|hgl|+ leysir 1 ml|H01AC01|01.05.2001||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|34175|44415|lyfsjukr|||02|5|0|7|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sómatrópín||34175||34175|44415 001167|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|1|spr||H01CC01|01.05.2001||R|A|2|0|1|0|1|ORG|0|0|0|100|DKK|6339|9076|lyfsjukr|||02|0|0|1|Vistor hf|N.V. Organon|Ganirelix||6339||6339|9076 001194|M01AH0101|Celebra|hylki|200|mg|10|stk|1|þpakki||M01AH01|01.03.2003||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|1720|3175|lyfalmen|||00|10|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Celekoxíb||1720||1720|3175 001225|C10AA0501|Zarator|töflur|80|mg|30|stk|1|þpakki||C10AA05|01.06.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|11868|16946|lyfalmen|||00|30|0|240|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||11868||11868|16946 001239|C10AA0501|Zarator|töflur|80|mg|100|stk|1|þpakki||C10AA05|01.06.2002||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|23911|31954|lyfalmen|||00|100|0|800|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||23911||23911|31954 001291|C07AB0206|Seloken ZOC|forðatfl|23,75|mg|100|stk|1|plglas||C07AB02|01.05.2006||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2264|3913|lyfalmen|||43|100|0|16|Vistor hf|AstraZeneca A/S DK|Metóprólól||2264||2264|3913 001324|C09CA0201|Teveten|töflur|600|mg|98|stk|1|þpakki||C09CA02|01.08.2001||R|A|3|0|0|B|0|SOP|0|0|0|100|XEU|11798|16851|lyfalmen|||00|98|0|98|Icepharma hf|Solvay Pharmaceuticals|Eprosartan||11798||11798|16851 001337|V08CA0901|Gadovist|stl|1|mmol/ml|30|ml|10|hgl||V08CA09|01.12.2003||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|397957|497324|lyfsjukr|||02|300|0|0|Icepharma hf|Bayer Schering Pharma AG|Gadóbútról||397957||397957|497324 001346|C09CA0201|Teveten|töflur|400|mg|56|stk|1|þpakki||C09CA02|01.10.2001||R|A|3|0|0|B|0|SOP|0|0|0|100|XEU|4672|7181|lyfalmen|||00|56|0|37|Icepharma hf|Solvay Pharmaceuticals|Eprosartan||4672||4672|7181 001386|C10AA0102|Sivacor|töflur|10|mg|28|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|1400|2740|lyfalmen|||00|28|0|19|Actavis Group hf|Actavis hf|Simvastatín||1400||1400|2740 001399|H01CC0101|Orgalutran|stl|0,5|mg/ml|0,5|ml|5|spr||H01CC01|01.05.2001||R|A|2|0|1|0|1|ORG|0|0|0|100|DKK|32553|42396|lyfsjukr|||02|2|0|5|Vistor hf|N.V. Organon|Ganirelix||32553||32553|42396 001400|C10AA0102|Sivacor|töflur|10|mg|98|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|868|2018|lyfalmen|||00|98|0|65|Actavis Group hf|Actavis hf|Simvastatín||868||868|2018 001409|C10AA0102|Sivacor|töflur|20|mg|28|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|928|2100|lyfalmen|||00|28|0|37|Actavis Group hf|Actavis hf|Simvastatín||928||928|2100 001422|C10AA0102|Sivacor|töflur|20|mg|98|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1050|2265|lyfalmen|||00|98|0|131|Actavis Group hf|Actavis hf|Simvastatín||1050||1050|2265 001431|C10AA0102|Sivacor|töflur|40|mg|28|stk|1|glas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|2700|4504|lyfalmen|||00|28|0|75|Actavis Group hf|Actavis hf|Simvastatín||2700||2700|4504 001442|C10AA0102|Sivacor|töflur|40|mg|98|stk|1|plglas||C10AA01|01.03.2000||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|1630|3052|lyfalmen|V0367|3052|00|98|0|261|Actavis Group hf|Actavis hf|Simvastatín||1630||1630|3052 001490|A10AD0502|NovoMix 30 Penfill|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.08.2002||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|6682|9908|lyfalmen|||02|15|0|38|Vistor hf|Novo-Nordisk|Insulín aspart||6682||6682|9908 001512|C04AD0301|Trental|forðatfl|400|mg|100|stk|1|þpakki||C04AD03|01.05.2002||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|4454|6885|lyfalmen|||10|100|0|40|Vistor hf|Sanofi-aventis Norge AS|Pentoxífýllín||4454||4454|6885 001517|N06AB0308|Fluoxetin Actavis|hylki|20|mg|30|stk|1|þpakki||N06AB03|01.03.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|883|2039|lyfalmen|||10|30|0|30|Actavis Group hf|Actavis hf|Flúoxetín||883||883|2039 001528|N06AB0308|Fluoxetin Actavis|hylki|20|mg|100|stk|1|þpakki||N06AB03|01.03.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2456|4173|lyfalmen|||10|100|0|100|Actavis Group hf|Actavis hf|Flúoxetín||2456||2456|4173 001588|B05BA1014|Kabiven|irl|900|kcal|1026|ml|4|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|26848|35293|lyfsjukr|||00|4104|0|0|Icepharma hf|Fresenius Kabi|Blöndur||26848||26848|35293 001599|B03AC0201|Venofer|stl|20|mg/ml|5|ml|5|hgl||B03AC02|01.07.2005||R|A|3|0|0|E|0|SKY|0|0|1|100|CHF|14475|20206|lyfalmen|V0011|18630|00|25|0|5|Icepharma hf|SkyPharma PLC|Járnoxíð (sykurflétta)||14475||14475|20206 001605|B05BA1014|Kabiven|irl|1400|kcal|1540|ml|4|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|36386|47168|lyfsjukr|||00|6160|0|6|Icepharma hf|Fresenius Kabi|Blöndur||36386||36386|47168 001622|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|2|pokar||B05BA10|01.08.2003||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|24690|32607|lyfsjukr|||00|5132|0|5|Icepharma hf|Fresenius Kabi|Blöndur||24690||24690|32607 001685|B05AA0108|Albuminativ 200 g/l|irl|200|mg/ml|50|ml|1|hgl||B05AA01|01.03.1981||R|A|5|0|0|0|1|OCT|0|0|0|100|DKK|6934|9928|lyfsjukr|||02|50|0|0|Vistor hf|Octapharma AB|Albúmín||6934||6934|9928 001693|B05AA0108|Albuminativ 200 g/l|irl|200|mg/ml|100|ml|1|hgl||B05AA01|01.03.1981||R|A|5|0|0|0|1|OCT|0|0|0|100|DKK|11074|15655|lyfsjukr|||02|100|0|0|Vistor hf|Octapharma AB|Albúmín||11074||11074|15655 001792|N02BA0109|Alka-Seltzer|freyðit|324|mg|20|stk|1|pakki||N02BA01|01.08.2004||L|A|3|0|0|0|0|BAS|0|0|1|100|IKR|||lyflausa|||00|20|0|2|Vistor hf|Bayer A/S|Acetýlsalicýlsýra||||| 001874|G02AB0101|Methergin|stl|0,2|mg/ml|1|ml|10|lykjur||G02AB01|01.11.2001||R|K|3|0|0|0|1|NOH|0|0|0|100|DKK|1299|1860|lyfsjukr|||02|10|0|10|Vistor hf|Novartis Healthcare A/S-|Metýlergómetrín||1299||1299|1860 001878|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|3|glös||S01EC04|01.11.2001||R|A|2|0|0|*|0|ALC|0|0|0|100|USD|4082|6380|lyfalmen|||06|15|0|75|K.Pétursson hf|Alcon|Brinzólamíð||4082||4082|6380 001889|A02BC0501|Nexium|sh-tfl|20|mg|7|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|1014|2216|lyfalmen|||00|7|0|5|Vistor hf|AstraZeneca A/S DK|Esómeprazól||1014||1014|2216 001894|J05AR0401|Trizivir|filmhtfl|750|mg|60|stk|1|glas|300+150+300 mg|J05AR04|01.08.2003||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|75501|95866|lyfsjukr|||00|60|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|Zídóvúdín, lamívúdín og abacavír||75501||75501|95866 001954|N05AX0802|Rison|töflur|1|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|2358|4040|lyfalmen|V0791|4040|00|60|0|12|Actavis Group hf|Actavis hf|Risperídón||2358||2358|4040 001957|N05AX0802|Rison|töflur|4|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|12969|18331|lyfalmen|V0795|18331|00|60|0|48|Actavis Group hf|Actavis hf|Risperídón||12969||12969|18331 001962|N01BX0401|Capsina|krem|0,75|mg/g|45|g|1|túpa||N01BX04|01.06.1998||R|A|3|0|0|0|0|BIG|0|0|0|100|SEK|4330|6716|lyfalmen|||00|45|0|45|Icepharma hf|Bioglan AB|Capsaicin||4330||4330|6716 001965|N05AX0802|Rison|töflur|2|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|5475|8270|lyfalmen|V0793|8270|00|60|0|24|Actavis Group hf|Actavis hf|Risperídón||5475||5475|8270 001974|J01CA0801|Selexid|töflur|200|mg|100|stk|1|glas||J01CA08|01.10.1990||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|9023|13085|lyfalmen|V0456|12970|43|100|0|33|Vistor hf|LEO Pharma A/S|Pívmecillínam||9023||9023|13085 001980|A02BC0501|Nexium|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|3801|5999|lyfalmen|V0084|5910|00|28|0|19|Vistor hf|AstraZeneca A/S DK|Esómeprazól||3801||3801|5999 001986|N05AX0802|Rison|töflur|3|mg|60|stk|1|glas||N05AX08|01.05.2000||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|8009|11709|lyfalmen|V0794|11709|00|60|0|36|Actavis Group hf|Actavis hf|Risperídón||8009||8009|11709 001991|A02BC0501|Nexium|sh-tfl|20|mg|56|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|7515|11039|lyfalmen|||0|56|0|37|Vistor hf|AstraZeneca A/S DK|Esómeprazól||7515||7515|11039 002011|A02BC0501|Nexium|sh-tfl|40|mg|7|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|1338|2656|lyfalmen|||00|7|0|9|Vistor hf|AstraZeneca A/S DK|Esómeprazól||1338||1338|2656 002033|A02BC0501|Nexium|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|5009|7638|lyfalmen|V0085|7529|00|28|0|37|Vistor hf|AstraZeneca A/S DK|Esómeprazól||5009||5009|7638 002071|A07EC0204|Asacol|sh-tfl|400|mg|100|stk|1|þpakki||A07EC02|01.01.2000||R|A|2|0|0|B|0|TIL|0|0|0|100|SEK|4587|7065|lyfalmen|||00|100|0|27|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||4587||4587|7065 002169|B05BA1010|Kabiven Peripheral|irþ|0| |2400|ml|2|pokar|3ja hólfa poki |B05BA10|01.02.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|21439|28559|lyfsjukr|||00|4800|0|5|Icepharma hf|Fresenius Kabi|Blöndur||21439||21439|28559 002180|A02BC0501|Nexium|sh-tfl|20|mg|50|stk|1|þpakki|stakskammtar|A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|6123|9150|lyfalmen|||00|50|0|33|Vistor hf|AstraZeneca A/S DK|Esómeprazól||6123||6123|9150 002186|B05BA1010|Kabiven Peripheral|irþ|0| |1920|ml|2|pokar|3ja hólfa poki|B05BA10|01.02.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|19175|25740|lyfsjukr|||00|3840|0|4|Icepharma hf|Fresenius Kabi|Blöndur||19175||19175|25740 002194|B05BA1010|Kabiven Peripheral|irþ|0| |1440|ml|4|pokar|3ja hólfa poki|B05BA10|01.02.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|31378|40933|lyfsjukr|||00|5760|0|6|Icepharma hf|Fresenius Kabi|Blöndur||31378||31378|40933 002197|A02BC0501|Nexium|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|13281|18720|lyfalmen|V0087|18389|00|100|0|67|Vistor hf|AstraZeneca A/S DK|Esómeprazól||13281||13281|18720 002205|A02BC0501|Nexium|sh-tfl|40|mg|50|stk|1|veski|stakskammtar|A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|7989|11682|lyfalmen|||00|50|0|67|Vistor hf|AstraZeneca A/S DK|Esómeprazól||7989||7989|11682 002208|A10AB0504|NovoRapid|stl|100|ae/ml|10|ml|1|hgl||A10AB05|01.04.2006||R|A|2|0|0|*|0|NON|0|0|0|100|DKK|3915|6153|lyfalmen|||02|10|0|25|Vistor hf|Novo-Nordisk|Insúlín aspart||3915||3915|6153 002219|A02BC0501|Nexium|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.11.2000||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|17854|24413|lyfalmen|V0089|24060|00|100|0|133|Vistor hf|AstraZeneca A/S DK|Esómeprazól||17854||17854|24413 002237|D05AX0201|Daivonex|smyrsli|50|mcg/g|60|g|1|túpa||D05AX02|01.06.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|4164|6491|lyfalmen|||00|60|0|0|Vistor hf|LEO Pharma A/S|Kalcípótríól||4164||4164|6491 002263|D05AX0201|Daivonex|smyrsli|50|mcg/g|120|g|1|túpa||D05AX02|01.06.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|6809|10081|lyfalmen|||00|120|0|0|Vistor hf|LEO Pharma A/S|Kalcípótríól||6809||6809|10081 002265|D05AX0201|Daivonex|krem|50|mcg/g|120|g|1|túpa||D05AX02|01.06.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|7135|10523|lyfalmen|||00|120|0|120|Vistor hf|LEO Pharma A/S|Kalcípótríól||7135||7135|10523 002276|D05AX0201|Daivonex|krem|50|mcg/g|60|g|1|túpa||D05AX02|01.06.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|4153|6476|lyfalmen|||00|60|0|60|Vistor hf|LEO Pharma A/S|Kalcípótríól||4153||4153|6476 002312|D01AE1501|Lamisil|hlaup|10|mg/g|15|g|1|túpa||D01AE15|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|15|0|15|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín||||| 002328|R03DC0301|Singulair|tuggutfl|4|mg|98|stk|1|þpakki||R03DC03|01.08.2002||R|A|2|0|0|B|0|MSD|0|0|0|100|XEU|20993|28321|lyfalmen|||00|98|0|39|Icepharma hf|M.S.D.|Montelúkast||20993||20993|28321 002342|B02BD0204|Helixate NexGen|sts|1000|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAH|0|0|0|100|SEK|97853|123694|lyfsjukr|||00|1|0|2|ZLB Behring AB|Bayer HealthCare AG-|Storkuþáttur VIII||97853||97853|123694 002356|B02BD0204|Helixate NexGen|sts|500|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAH|0|0|0|100|SEK|49153|63063|lyfsjukr|||00|1|0|1|ZLB Behring AB|Bayer HealthCare AG-|Storkuþáttur VIII||49153||49153|63063 002367|B02BD0204|Helixate NexGen|sts|250|ae/hgl|1|hgl|1|pakki|+leysir og bl.sett|B02BD02|01.12.2003||R|K|1,9|0|0|0|1|BAH|0|0|0|100|SEK|28175|36945|lyfsjukr|||00|1|0|0|ZLB Behring AB|Bayer HealthCare AG-|Storkuþáttur VIII||28175||28175|36945 002391|G03AA1201|Yasmin|töflur|0||63|stk|1|þpakki|3+0,03 mg|G03AA12|01.02.2001||R|A|3|0|0|0|0|BAP|0|0|0|100|SEK|2628|4407|lyfalmen|||00|63|0|84|Icepharma hf|Bayer Schering Pharma AG|Dróspírenón og östrógen||||2628|4407 002405|C09AA0206|Enalapril Merck NM|töflur|2,5|mg|50|stk|1|þpakki||C09AA02|01.10.2007||R|A||0|0|B|0|PCO|0|0|0|100|IKR|510|1532|lyfalmen|||00|50|1|12|Distica|Distica - óskráð lyf|Enalapríl||510||510|1532 002413|G03AA1204|Yasmin 28|töflur|0| |84|stk|1|þpakki|3+0,03 mg|G03AA12|01.10.2007||R|A|3|0|0|0|0|BAP|0|0|0|100|SEK|2628|4407|lyfalmen|||00|84|0|0|Icepharma hf|Bayer Schering Pharma AG|Dróspírenón og östrógen||2628||2628|4407 002487|R06AX1304|Loritin|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.10.2000||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|10|0|10|Actavis Group hf|Actavis hf|Lóratadín||||| 002499|R06AX1304|Loritin|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.10.2000||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|30|Actavis Group hf|Actavis hf|Lóratadín||||| 002510|R06AX1304|Loritin|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.10.2000||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|2079|3662|lyfalmen|V0984|3662|00|100|0|100|Actavis Group hf|Actavis hf|Lóratadín||2079||2079|3662 002616|S01LA0101|Visudyne|irs|15|mg/hgl|1|hgl|1|pakki||S01LA01|01.12.2000||R|A|4|0|1|0|1|NOO|0|0|0|100|DKK|198550|249062|lyfsjukr|||00|1|0|0|Vistor hf|Novartis Ophthalmics Europe Ltd.|Verteporfin||198550||198550|249062 002659|QP52AA0101|Droncit vet.|sts|57|mg/ml|10|ml|1|hgl|lausn|QP52AA01|01.03.2009||R|A|4|0|0|0|0|BAN|0|0|0|100|DKK|2882|4987|vetorma|||0|10|0|0|Vistor hf|Bayer Animal Health GmbH|||||2882|4987 002754|N07BA0107|Nicotinell Mint|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.06.2002||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|204|0|7|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 002830|S01ED0106|Timosan Depot|augngel|1|mg/g|5|g|1|glas||S01ED01|01.08.2000||R|A|1,5|0|0|*|0|SAO|0|0|0|100|XEU|1374|2705|lyfalmen|||07|5|0|25|Icepharma hf|Santen Oy|Tímólól||1374||1374|2705 002853|M03AX0101|Botox|sts|100|ae/hgl|1|hgl|1|pakki||M03AX01|01.07.1994||R|K|3|0|1|0|1|ALL|0|0|0|100|SEK|28791|37712|lyfsjukr|||02|1|0|0|Vistor hf|Allergan|Clostridium botulinum toxín-A||28791||28791|37712 002966|G03GA0502|Gonal-f|sts|1050|ae|1|hgl|1|pakki|á 1,75 ml + leysir |G03GA05|01.02.2002||R|A|1|0|1|E|0|SEN|0|0|0|100|SEK|62923|80524|lyfalmen|||00|1|0|14|Gróco ehf|Serono Nordic|Follitrópín alfa||62923||62923|80524 003023|C09DA0104|Cozaar Comp Forte|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.06.2007||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|16173|15220|lyfalmen|V0193|15220|00|98|0|196|Icepharma hf|M.S.D.|Lósartan og þvagræsilyf||10596||10596|15220 003078|N03AX1401|Keppra|filmhtfl|250|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|13474|18960|lyfalmen|||00|100|0|12|Vistor hf|U.C.B|Levetíracetam||13474||13474|18960 003099|L01DB0104|Myocet|irl|50|mg|2|sett|1|pakki||L01DB01|01.07.2006||R|K|1,5|0|1|0|1|ZEP|0|0|0|100|DKK|279230|349509|lyfsjukr|||02|2|0|0|Icepharma hf|Zeneus Pharma Limited-|Doxórúbicín||279230||279230|349509 003112|N03AX1401|Keppra|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|19858|26908|lyfalmen|V1710|26413|00|100|0|25|Vistor hf|U.C.B|Levetíracetam||19858||19858|26908 003158|N03AX1401|Keppra|filmhtfl|1000|mg|100|stk|1|þpakki||N03AX14|01.10.2005||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|45238|58506|lyfalmen|||00|100|0|50|Vistor hf|U.C.B|Levetíracetam||45238||45238|58506 003164|L01CA0401|Navelbine|hylki|20|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|K|3|0|1|*|0|PFP|0|0|0|100|SEK|8457|12317|lyfalmen|||00|1|0|0|Vistor hf|Pierre Fabre Pharma|Vínorelbín||8457||8457|12317 003175|L01CA0401|Navelbine|hylki|30|mg|1|stk|1|pakki|mjúkt|L01CA04|01.05.2007||R|K|3|0|1|*|0|PFP|0|0|0|100|SEK|12616|17892|lyfalmen|||00|1|0|0|Vistor hf|Pierre Fabre Pharma|Vínorelbín||12616||12616|17892 003195|B03XA0201|Aranesp|stl|10|mcg/spr|0,4|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|18807|25282|lyfsjukr|||00|2|0|9|Vistor hf|Amgen|Darbepóetín alfa||18807||18807|25282 003208|B03XA0201|Aranesp|stl|15|mcg/spr|0,375|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|28018|36750|lyfsjukr|||00|2|0|13|Vistor hf|Amgen|Darbepóetín alfa||28018||28018|36750 003230|B03XA0201|Aranesp|stl|20|mcg/spr|0,5|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|31664|41289|lyfsjukr|||00|2|0|18|Vistor hf|Amgen|Darbepóetín alfa||31664||31664|41289 003238|J07AM0101|Tetavax|stl|40|ae|0,5|ml|1|lykja||J07AM01|01.03.2006||R|K||0|0|0|0|LDR|0|0|1|100|IKR|557|1596|lyfalmen|||00|0|1|0|Parlogis hf|Parlogis - óskráð lyf|||557||557|1596 003252|B03XA0201|Aranesp|stl|30|mcg/spr|0,3|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|47012|60397|lyfsjukr|||00|1|0|27|Vistor hf|Amgen|Darbepóetín alfa||47012||47012|60397 003274|B03XA0201|Aranesp|stl|40|mcg/spr|0,4|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|61684|78664|lyfsjukr|||00|2|0|36|Vistor hf|Amgen|Darbepóetín alfa||61684||61684|78664 003296|B03XA0201|Aranesp|stl|50|mcg/spr|0,5|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|75937|96409|lyfsjukr|||00|2|0|44|Vistor hf|Amgen|Darbepóetín alfa||75937||75937|96409 003298|V08CA0901|Gadovist|stl|1|mmol/ml|15|ml|10|hgl|lausn|V08CA09|01.04.2007||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|197605|247886|lyfsjukr|||02|150|0|0|Icepharma hf|Bayer Schering Pharma AG|Gadóbútról||197605||197605|247886 003310|R03AK0701|Symbicort Turbuhaler|innúðadu|164,5|mcg/sk|120|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|7754|11363|lyfalmen|V0990|11310|0|120|0|30|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||7754||7754|11363 003318|B03XA0201|Aranesp|stl|60|mcg/spr|0,3|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|92864|117483|lyfsjukr|||00|1|0|53|Vistor hf|Amgen|Darbepóetín alfa||92864||92864|117483 003325|R03AK0702|Symbicort mite Turbuhaler|innúðadu|84,5|mcg/sk|120|sk|1|pakki|80+4,5 mcg/sk|R03AK07|01.08.2002||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|7086|10456|lyfalmen|||00|120|0|15|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||7086||7086|10456 003340|B03XA0201|Aranesp|stl|80|mcg/spr|0,4|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|138167|173885|lyfsjukr|||00|2|0|71|Vistor hf|Amgen|Darbepóetín alfa||138167||138167|173885 003353|L04AA1001|Rapamune|töflur|1|mg|100|stk|1|þpakki||L04AA10|01.04.2004||R|A|1,5|0|1|*|0|WTE|0|0|0|100|USD|66209|84615|lyfalmen|||00|100|0|33|Icepharma hf|Wyeth Europe|Sirolimus||66209||66209|84615 003355|D01AE1501|Lamisil|úðalausn|10|mg/g|15|ml|1|fl|úðalausn á húð|D01AE15|01.04.2002||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|15|0|15|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín||||| 003362|B03XA0201|Aranesp|stl|100|mcg/spr|0,5|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|147711|185768|lyfsjukr|||00|2|0|89|Vistor hf|Amgen|Darbepóetín alfa||147711||147711|185768 003386|B03XA0201|Aranesp|stl|150|mcg/spr|0,3|ml|4|spr|áfylltar sprautur|B03XA02|01.12.2001||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|221177|277233|lyfsjukr|||00|1|0|133|Vistor hf|Amgen|Darbepóetín alfa||221177||221177|277233 003395|B03XA0201|Aranesp|stl|300|mcg/spr|0,6|ml|1|spr|áfyllt sprauta|B03XA02|01.12.2003||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|110667|139648|lyfsjukr|||00|1|0|67|Vistor hf|Amgen|Darbepóetín alfa||110667||110667|139648 003423|A10BG0301|Actos|töflur|15|mg|28|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|XEU|4171|6501|lyfalmen|||00|28|0|14|Eli Lilly Danmark A/S|Takeda Europe -|Píóglítazón||4171||4171|6501 003455|A02BB0101|Cytotec|töflur|0,2|mg|60|stk|1|þpakki||A02BB01|01.08.2002||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|3582|5701|lyfalmen|||00|60|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Mísóprostól||3582||3582|5701 003800|A10BG0301|Actos|töflur|15|mg|98|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|XEU|14367|20072|lyfalmen|||00|98|0|49|Eli Lilly Danmark A/S|Takeda Europe -|Píóglítazón||14367||14367|20072 003809|A10BG0301|Actos|töflur|30|mg|28|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|XEU|6413|9543|lyfalmen|||00|28|0|28|Eli Lilly Danmark A/S|Takeda Europe -|Píóglítazón||6413||6413|9543 003831|A10BG0301|Actos|töflur|30|mg|98|stk|1|þpakki||A10BG03|01.12.2000||R|A|3|0|0|*|0|TKE|0|0|0|100|XEU|21440|28878|lyfalmen|||00|98|0|98|Eli Lilly Danmark A/S|Takeda Europe -|Píóglítazón||||21440|28878 003869|R01BA5202|Clarinase|forðatfl|10|mg|10|stk|1|pakki|þp 10+240 mg|R01BA52|01.09.1998||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|885|2041|lyfalmen|||00|10|0|10|Vistor hf|Schering-Plough|Pseudóefedrín í blöndum||885||885|2041 003927|N06AB0602|Sertral|töflur|50|mg|28|stk|1|glas||N06AB06|01.11.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1170|2428|lyfalmen|V0931|2428|00|28|0|28|Actavis Group hf|Actavis hf|Sertralín||1170||1170|2428 003939|M01AB0505|Voltaren|sh-tfl|50|mg|20|stk|1|þpakki||M01AB05|01.03.1984||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|646|1717|lyfalmen|||67|20|0|10|Vistor hf|Novartis Healthcare A/S-|Díklófenak||646||646|1717 003950|N06AB0602|Sertral|töflur|50|mg|98|stk|1|glas||N06AB06|01.11.2000||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|4068|6361|lyfalmen|V0933|6361|00|98|0|98|Actavis Group hf|Actavis hf|Sertralín||4068||4068|6361 003974|J05AE0601|Kaletra|mixtúra|100|mg/ml|60|ml|1|glas|80 + 20 mg/ml|J05AE06|01.08.2003||R|A|2|0|1|0|1|ABL|0|0|0|100|DKK|95343|120570|lyfsjukr|||00|60|0|8|Vistor hf|Abbott Laboratories A/S|Lopinavír||95343||95343|120570 003988|M01AB0505|Voltaren|sh-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.1984||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|2721|4533|lyfalmen|V0608|2001|67|100|0|50|Vistor hf|Novartis Healthcare A/S-|Díklófenak||2721||2721|4533 004002|L04AD0101|Sandimmun|irþ|50|mg/ml|5|ml|10|lykjur||L04AD01|01.10.1985||R|A|4|0|0|0|1|NOH|0|0|0|100|DKK|33624|43729|lyfsjukr|||00|50|0|10|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||33624||33624|43729 004014|N03AF0201|Trileptal|mixtúra|60|mg/ml|250|ml|1|fl||N03AF02|01.01.2002||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|8031|11739|lyfalmen|||00|250|0|15|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||8031||8031|11739 004028|A07DA0301|Imodium|mixtúra|0,2|mg/ml|100|ml|1|fl||A07DA03|01.01.1990||L|A|5|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||00|100|0|2|Vistor hf|Janssen-Cilag AB|Lóperamíð||||| 004050|R03AK0601|Seretide|innúðal|75|mcg/sk|120|skammtar|1|pakki|25+50 mcg/sk|R03AK06|01.10.2002||R|A|1|0|0|B|0|GSK|0|0|0|100|GBP|3906|6141|lyfalmen|||23|120|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||3906||3906|6141 004086|N06AB0601|Zoloft|töflur|25|mg|7|stk|1|þpakki||N06AB06|01.05.2003||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|601|1656|lyfalmen|||00|7|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sertralín||601||601|1656 004111|N05CD0102|Dalmadorm medium|hylki|15|mg|30|stk|1|þpakki||N05CD01|01.12.2000||R|A|5|0|0|0|0|VAL|0|0|1|100|DKK|1075|2299|lyfalmen|||10|30|0|15|Icepharma hf|Valeant Pharmaceuticals B.V.|Flúrazepam||1075||1075|2299 004259|N05AE0401|Zeldox|hylki|40|mg|14|stk|1|þpakki|hart hylki|N05AE04|01.03.2003||R|A|4|0|0|0|0|PFI|0|1|0|100|DKK|6276|9357|lyfalmen|||00|14|0|7|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ziprasidon||6276||6276|9357 004282|R03AK0601|Seretide|innúðal|150|mcg/sk|120|skammtar|1|pakki|25+125 mcg/sk|R03AK06|01.10.2002||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|5699|8574|lyfalmen|||23|120|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||5699||5699|8574 004293|R03AK0601|Seretide|innúðal|275|mcg/sk|120|skammtar|1|pakki|25+250 mcg/sk|R03AK06|01.10.2002||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|7932|11604|lyfalmen|||23|120|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||7932||7932|11604 004298|R06AX2701|Aerius|töflur|5|mg|10|stk|1|þpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|761|1873|lyfalmen|||00|10|0|10|Vistor hf|Schering-Plough|Deslóratadín||761||761|1873 004301|N06AX1101|Remeron|mixtúra|15|mg/ml|66|ml|1|fl|lausn|N06AX11|01.01.2003||R|A|2|0|0|B|0|ORG|0|1|0|100|DKK|6015|9003|lyfalmen|||00|66|0|33|Vistor hf|N.V. Organon|Mirtazapín||6015||6015|9003 004352|J02AC0301|Vfend|irs|200|mg|1|hgl|1|pakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|24673|32585|lyfsjukr|||00|1|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Voricónazól||24673||24673|32585 004370|R06AX2701|Aerius|töflur|5|mg|30|stk|1|þpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|2197|3822|lyfalmen|V1901|3763|00|30|0|30|Vistor hf|Schering-Plough|Deslóratadín||2197||2197|3822 004374|A04AA0101|Zofran|töflur|4|mg|10|stk|1|glas||A04AA01|01.01.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|7938|11613|lyfalmen|||0|10|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||7938||7938|11613 004378|R06AX2701|Aerius|töflur|5|mg|100|stk|1|þpakki||R06AX27|01.05.2001||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|5155|7836|lyfalmen|V1902|7696|00|100|0|100|Vistor hf|Schering-Plough|Deslóratadín||||5155|7836 004388|QJ51RC2501|Benestermycin, vet.|spenalyf|0| |5|ml|20|spr||QJ51RC25|01.12.1978||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|4634|8998|vetalmen|||16|100|0|0|Vistor hf|Boehringer Ingelheim|||4634||4634|8998 004455|N02AX0208|Zytram|forðatfl|75|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|3295|5312|lyfalmen|||00|56|0|14|Icepharma hf|Norpharma |Tramadól||3295||3295|5312 004465|C01DA0801|Sorbangil|töflur|5|mg|100|stk|1|þpakki||C01DA08|01.06.1980||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|618|1679|lyfalmen|||00|100|0|8|Vistor hf|Recip AB|Ísósorbíð dínítrat||618||618|1679 004468|J07BC0203|Vaqta|bóluefni|25|ein|0,5|ml|1|spr|áfyllt spr. án nálar|J07BC02|01.03.2001||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|3238|5235|lyfalmen|||51|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3238||3238|5235 004478|N02AX0208|Zytram|forðatfl|100|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|4395|6805|lyfalmen|||00|56|0|19|Icepharma hf|Norpharma |Tramadól||4395||4395|6805 004487|L01BC0301|Uft|hylki|324|mg|21|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKG|0|0|0|100|DKK|33328|43361|lyfsjukr|||00|21|0|0|Merck AB|Merck KgaA (M)|Tegafur||33328||33328|43361 004489|N02AX0208|Zytram|forðatfl|150|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|6207|9264|lyfalmen|||00|56|0|28|Icepharma hf|Norpharma |Tramadól||6207||6207|9264 004500|N02AX0208|Zytram|forðatfl|200|mg|56|stk|1|glas||N02AX02|01.01.2001||R|A|3|0|0|E|0|NOP|0|0|1|100|DKK|8261|12051|lyfalmen|||00|56|0|37|Icepharma hf|Norpharma |Tramadól||8261||8261|12051 004502|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|0,5|ml|1|dæla|einnota dæla|J07BC01|01.01.1990||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|1888|3402|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsaðir mótefna­vakar||1888||1888|3402 004532|L01BC0301|Uft|hylki|324|mg|35|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKG|0|0|0|100|DKK|55546|71022|lyfsjukr|||00|35|0|0|Merck AB|Merck KgaA (M)|Tegafur||55546||55546|71022 004543|L01BC0301|Uft|hylki|324|mg|42|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKG|0|0|0|100|DKK|66655|84853|lyfsjukr|||00|42|0|0|Merck AB|Merck KgaA (M)|Tegafur||66655||66655|84853 004565|L01BC0301|Uft|hylki|324|mg|28|stk|1|þpakki|100 + 224 mg|L01BC03|01.05.2001||R|A|2|0|1|0|1|MKG|0|0|0|100|DKK|44437|57192|lyfsjukr|||00|28|0|0|Merck AB|Merck KgaA (M)|Tegafur||44437||44437|57192 004586|A10BB1201|Amaryl|töflur|4|mg|90|stk|1|þpakki||A10BB12|01.06.2005||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|7266|10701|lyfalmen|||00|90|0|180|Vistor hf|Aventis Pharma |Glímepíríð||7266||7266|10701 004589|N06AB0402|Oropram|töflur|20|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2556|4309|lyfalmen|V0926|4309|00|100|0|100|Actavis Group hf|Actavis hf|Cítalópram||2556||2556|4309 004611|H01AC0104|Saizen|sts|8|mg/hgl|1|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|A|3|0|1|0|1|EME|0|0|0|100|SEK|36892|47798|lyfsjukr|||00|1|0|4|MedFarm ehf|E. Merck AB|Sómatrópín||36892||36892|47798 004612|D06BX0105|Metronidazol Actavis|krem|10|mg/g|25|g|1|túpa||D06BX01|01.07.1987||R|A|2|0|0|0|0|AGT|0|0|1|100|DKK|1949|3485|lyfalmen|||20|25|0|25|Actavis Group hf|Actavis Group hf|Metrónídazól||1949||1949|3485 004613|J07BC0101|Engerix-B|bóluefni|20|mcg/ml|1|ml|1|dæla|einnotadæl|J07BC01|01.01.1990||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|2447|4161|lyfalmen|||00|1|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-B, hreinsaðir mótefna­vakar||2447||2447|4161 004623|J07BC0203|Vaqta|bóluefni|50|ein|1|ml|1|spr|áfyllt spr. án nálar|J07BC02|01.03.2001||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|4837|7404|lyfalmen|||51|1|0|0|Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||4837||4837|7404 004625|N06AB0402|Oropram|töflur|40|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1836|3332|lyfalmen|V0927|3332|00|28|0|56|Actavis Group hf|Actavis hf|Cítalópram||1836||1836|3332 004636|N06AB0402|Oropram|töflur|40|mg|56|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|5188|7881|lyfalmen|V0929|7881|00|56|0|112|Actavis Group hf|Actavis hf|Cítalópram||5188||5188|7881 004645|N06AB0402|Oropram|töflur|40|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|5614|8459|lyfalmen|V0930|8459|00|100|0|200|Actavis Group hf|Actavis hf|Cítalópram||5614||5614|8459 004656|N06AB0402|Oropram|töflur|10|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|776|1893|lyfalmen|V0921|1893|00|28|0|14|Actavis Group hf|Actavis hf|Cítalópram||776||776|1893 004667|N06AB0402|Oropram|töflur|10|mg|100|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2703|4508|lyfalmen|V0922|4508|00|100|0|50|Actavis Group hf|Actavis hf|Cítalópram||2703||2703|4508 004678|N06AB0402|Oropram|töflur|20|mg|28|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1269|2562|lyfalmen|V0923|2562|00|28|0|28|Actavis Group hf|Actavis hf|Cítalópram||1269||1269|2562 004687|A02AA0403|Magnesia "medic"|filmhtfl|500|mg|100|stk|1|glas||A02AA04|01.02.2006||L|A|3|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||00|100|0|0|Vistor hf|Medic Team|Magnesíum hýdroxíð|||||1629 004688|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|7|spr||L04AC03|01.07.2002||R|K|2|0|1|0|1|BIA|0|0|0|100|DKK|43365|55857|lyfsjukr|||00|5|0|7|Vistor hf|Biovitrum AB (publ)|Anakinra||43365||43365|55857 004691|N06AB0402|Oropram|töflur|20|mg|56|stk|1|glas||N06AB04|01.01.2001||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1778|3253|lyfalmen|V0925|3253|00|56|0|56|Actavis Group hf|Actavis hf|Cítalópram||1778||1778|3253 004696|R05DA0901|Dexomet|mixtúra|3|mg/ml|150|ml|1|glas||R05DA09|01.06.2001||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|150|0|5|Actavis Group hf|Actavis hf|Dextrómetorfan||||| 004699|L04AC0301|Kineret|stl|100|mg/spr|0,67|ml|28|spr||L04AC03|01.04.2007||R|K|2|0|1|0|1|BIA|0|0|0|100|DKK|166952|209723|lyfsjukr|||00|19|0|28|Vistor hf|Biovitrum AB (publ)|Anakinra||166952||166952|209723 004733|H01AC0104|Saizen|sts|8|mg/hgl|5|hgl|1|pakki|+ leysir f.click easy|H01AC01|01.05.2002||R|A|3|0|1|0|1|EME|0|0|0|100|SEK|184465|231526|lyfsjukr|||00|5|0|20|MedFarm ehf|E. Merck AB|Sómatrópín||184465||184465|231526 004746|A10AE0401|Lantus [OptiPen]|stl|100|ein/ml|3|ml|5|rörlyk|fyrir OptiPen|A10AE04|01.06.2004||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|9698|14001|lyfalmen|||00|15|0|38|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||9698||9698|14001 004811|J01XD0105|Metronidazol Actavis|irl|5|mg/ml|100|ml|10|poki||J01XD01|01.04.1990||R|A|2|0|0|0|1|AGT|0|0|0|100|DKK|11046|15620|lyfsjukr|||00|1000|0|3|Actavis Group hf|Actavis Group hf|Metrónídazól||11046||11046|15620 004822|J01XD0105|Metronidazol Actavis|irl|5|mg/ml|200|ml|10|poki||J01XD01|01.04.1990||R|A|2|0|0|0|1|AGT|0|0|0|100|DKK|20575|27483|lyfsjukr|||00|2000|0|7|Actavis Group hf|Actavis Group hf|Metrónídazól||20575||20575|27483 004834|N03AX1201|Neurontin|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|8932|9379|lyfalmen|V0714|7740|0|100|0|17|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gabapentín||6292||6292|9379 004845|N03AX1201|Neurontin|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|11701|12307|lyfalmen|V0715|10260|10|100|0|22|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gabapentín||8450||8450|12307 004855|P01AB0105|Metronidazol Actavis|töflur|250|mg|24|stk|1|þpakki||P01AB01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|659|1735|lyfalmen|||41|24|0|3|Actavis Group hf|Actavis Group hf|Metrónídazól||659||659|1735 004863|R03DX0501|Xolair|sts|150|mg|2|ml|1|hgl|+ leysir, lausn|R03DX05|01.01.2006||R|A|4|0|1|0|1|NOE|0|0|0|100|XEU|69975|88986|lyfsjukr|||00|2|0|9|Vistor hf|Novartis Europharm Ltd|Omalizúmab||69975||69975|88986 004880|J01FA1001|Zitromax|irs|500|mg/hgl|1|hgl|1|pakki||J01FA10|01.05.2003||R|A|3|0|0|0|1|PFI|0|0|0|100|DKK|5496|7869|lyfsjukr|||00|1|0|1|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Azitrómýcín||5496||5496|7869 004888|P01AB0105|Metronidazol Actavis|töflur|500|mg|8|stk|1|glas||P01AB01|01.03.1981||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|390|1370|lyfalmen|||41|8|0|2|Actavis Group hf|Actavis Group hf|Metrónídazól||390||390|1370 004921|P01AB0105|Metronidazol Actavis|töflur|500|mg|14|stk|1|glas||P01AB01|01.01.1988||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|666|1744|lyfalmen|||41|14|0|4|Actavis Group hf|Actavis Group hf|Metrónídazól||666||666|1744 004976|P01AB0105|Metronidazol Actavis|töflur|500|mg|30|stk|1|glas||P01AB01|01.01.1988||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|1260|2550|lyfalmen|||41|30|0|8|Actavis Group hf|Actavis Group hf|Metrónídazól||1260||1260|2550 005048|N07BA0107|Nicotinell Mint|munnstfl|2|mg|36|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|36|0|2|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 005059|N07BA0107|Nicotinell Mint|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|96|0|6|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 005070|N07BA0107|Nicotinell Mint|munnstfl|2|mg|204|stk|1|pakki||N07BA01|01.04.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|204|0|14|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 005085|J07AJ5205|Boostrix|stl|0| |0,5|ml|1|spr|áfyllt, dreifa|J07AJ52|01.01.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|1647|3075|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Kíghósti, í blöndum með öðrum toxóíðum||1647||1647|3075 005089|J07AL0103|Pneumovax|stl|0||0,5|ml|1|hgl|lausn|J07AL01|01.11.2008||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|2351|4031|lyfalmen|||00|1|0|0|Icepharma hf|Sanofi Pasteur MSD|Hreinsuð pneumococca poly­sakkaríð mótefnavakar||||2351|4031 005108|G04CA0201|Omnic|forðahlk|0,4|mg|90|stk|1|þpakki||G04CA02|01.08.1998||R|A|4|0|0|E|0|YAM|0|0|0|100|XEU|10408|9302|lyfalmen|V0437|6694|00|90|0|90|Vistor hf|Yamanouchi Europe|Tamsúlósín||6235||6235|9302 005178|J01CF0102|Staklox|hylki|250|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|754|1864|lyfalmen|||10|30|0|4|Actavis Group hf|Actavis hf|Díkloxacillín||754||754|1864 005189|J01CF0102|Staklox|hylki|500|mg|20|stk|1|þpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|763|1876|lyfalmen|||10|20|0|5|Actavis Group hf|Actavis hf|Díkloxacillín||763||763|1876 005200|J01CF0102|Staklox|hylki|500|mg|30|stk|1|þpakki||J01CF01|01.05.2001||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1076|2301|lyfalmen|||10|30|0|8|Actavis Group hf|Actavis hf|Díkloxacillín||1076||1076|2301 005241|R03AK0701|Symbicort Turbuhaler|innúðadu|164,5|mcg/sk|360|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.05.2001||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|23261|31145|lyfalmen|||00|360|0|90|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||23261||23261|31145 005296|N05AH0401|Seroquel|filmhtfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2002||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|42134|54642|lyfalmen|||00|100|0|75|Vistor hf|AstraZeneca UK Ltd|Quetíapín||42134||42134|54642 005303|N02CC0303|Zomig Nasal|nefúði|5|mg/sk|5|mg|2|stauk||N02CC03|01.02.2003||R|A|2,5|0|0|E|0|ASZ|0|0|0|100|SEK|2779|4612|lyfalmen|||00|10|0|4|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||2779||2779|4612 005330|D08AG0201|Betadine|áburður|100|mg/ml|500|ml|1|fl|sprittl.|D08AG02|01.09.1982||L|A|3|0|0|0|0|NAP|0|0|0|100|IKR|||lyflausa|||00|500|0|500|Icepharma hf|Napp|Joð/pólývídón||||| 005336|R01AA0704|Otrivin ukonserveret|nefúði|0,5|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.07.2003||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|6|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín||||| 005355|S01AA1301|Fucithalmic|augndr|10|mg/g|0,2|g|12|sk-hyl|2 mg/sk|S01AA13|01.04.1992||R|A|2|0|0|E|0|LEP|0|0|1|100|DKK|1142|2390|lyfalmen|||00|2|0|0|Vistor hf|LEO Pharma A/S|Fúsidínsýra||1142||1142|2390 005363|L02AE0301|Zoladex|vefjalyf|10,8|mg|1|stk|1|glas|+ dæla|L02AE03|01.04.1996||R|A|3|0|1|*|0|ASZ|0|0|0|100|SEK|58095|74513|lyfalmen|||00|1|0|84|Vistor hf|AstraZeneca UK Ltd|Góserelín||58095||58095|74513 005380|L01XD0301|Metvix|krem|160|mg/g|2|g|1|túpa||L01XD03|01.04.2004||R|K|1|0|1|*|0|PHO|0|0|0|100|NOK|38842|50543|lyfalmen|||00|2|0|0|Icepharma hf|PhotoCure ASA|Metýlamínólevúlínat||38842||38842|50543 005390|R03BB0101|Atrovent|innúðal|20|mcg/sk|200|skammtar|1|stauk||R03BB01|01.08.2004||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|1508|2887|lyfalmen|||24|200|0|33|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||1508||1508|2887 005503|N05AH0301|Zyprexa|húðuðtfl|15|mg|28|stk|1|þpakki||N05AH03|01.06.2002||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|30006|16601|lyfalmen|V0815|16601|00|28|0|42|Icepharma hf|Eli Lilly Nederland -|Olanzapín||11614||11614|16601 005507|M05BA0403|Fosamax vikutafla 70 mg|töflur|70|mg|4|stk|1|þpakki||M05BA04|01.08.2001||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|5382|8144|lyfalmen|||00|4|0|28|Icepharma hf|M.S.D.|Alendrónsýra||5382||5382|8144 005526|N05AH0301|Zyprexa|húðuðtfl|20|mg|28|stk|1|þpakki||N05AH03|01.12.2003||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|38163|49698|lyfalmen|||00|28|0|56|Icepharma hf|Eli Lilly Nederland -|Olanzapín||38163||38163|49698 005538|G03AA0702|Microgyn|töflur|0| |63|stk|1|þpakki||G03AA07|01.06.1977||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|1020|2225|lyfalmen|||23|63|0|84|Icepharma hf|Bayer Schering Pharma AG|Levónorgestrel og östrógen||1020||1020|2225 005565|M05BA0403|Fosamax vikutafla 70 mg|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.08.2001||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|14927|20769|lyfalmen|V0718|12241|00|12|0|84|Icepharma hf|M.S.D.|Alendrónsýra||14927||14927|20769 005576|R05CA1002|Tussol|mixtúra|0| |150|ml|1|glas||R05CA10|01.10.2001||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||01|150|0|0|Actavis Group hf|Actavis hf|Blöndur||||| 005588|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.01.2003||R|A|2|0|0|B|0|BII|0|0|0|100|DKK|6944|10264|lyfalmen|V2110|10262|00|30|0|30|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||6944||6944|10264 005600|R03BB0401|Spiriva|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.01.2003||R|A|2|0|0|B|0|BII|0|0|0|100|DKK|7313|10764|lyfalmen|V0985|10614|0|30|0|30|Vistor hf|Boehringer Ingelheim International|Tíótrópíumbrómíð||7313||7313|10764 005606|J07AH0703|NeisVac-C|bóluefni|0| |0,5|ml|1|spr|áfyllt sprauta|J07AH07|01.09.2001||R|K|3,5|0|0|0|0|BAX|0|0|0|100|USD|4103|6408|lyfalmen|||00|0|0|0|Icepharma hf|Baxter|Hreinsuð meningókokka C, poly­sakkaríð mótefnavakar||4103||4103|6408 005624|A10BB0902|Diamicron Uno|töflur|30|mg|30|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|1621|3040|lyfalmen|||00|30|0|6|Icepharma hf|Servier|Glíklazíð||1621||1621|3040 005641|A10BB0902|Diamicron Uno|töflur|30|mg|60|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|2825|4674|lyfalmen|||00|60|0|11|Icepharma hf|Servier|Glíklazíð||2825||2825|4674 005672|A10BB0902|Diamicron Uno|töflur|30|mg|180|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|7501|11020|lyfalmen|||00|180|0|34|Icepharma hf|Servier|Glíklazíð||7501||7501|11020 005674|A10BB0902|Diamicron Uno|töflur|30|mg|90|stk|1|þpakki||A10BB09|01.04.2002||R|A|3|0|0|*|0|SEV|0|0|0|100|DKK|4122|6434|lyfalmen|||00|90|0|17|Icepharma hf|Servier|Glíklazíð||4122||4122|6434 005689|B01AC0601|Hjartamagnyl|töflur|75|mg|100|stk|1|plglas||B01AC06|01.06.2007||L|A|2|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||00|100|0|100|Actavis Group hf|Actavis hf|Asetýlsalicýlsýra||||| 005747|G03CA0317|Aerodiol|nefúði|150|mcg/sk|180|skammtar|1|pakki|60 skammtar x 3|G03CA03|01.01.2003||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|6240|9308|lyfalmen|||00|180|0|90|Icepharma hf|Servier|Estradíól||6240||6240|9308 005757|N06AB1001|Cipralex|töflur|5|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|2414|4116|lyfalmen|||00|28|0|14|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||2414||2414|4116 005766|H01CC0201|Cetrotide|sts|0,25|mg/hgl|1|hgl|1|pakki|+ leysir 3 ml|H01CC02|01.09.2001||R|A|2|0|1|0|1|SEN|0|0|0|100|SEK|4401|6301|lyfsjukr|||00|1|0|0|Gróco ehf|Serono Nordic|Cetrorelix||4401||4401|6301 005782|L01BB0501|Fludara|filmhtfl|10|mg|15|stk|1|þpakki||L01BB05|01.11.2002||R|A|3|0|1|0|1|BAP|0|0|0|100|SEK|67219|85555|lyfsjukr|||00|15|0|0|Icepharma hf|Bayer Schering Pharma AG|Flúdarabín||67219||67219|85555 005787|H01CC0201|Cetrotide|sts|0,25|mg/hgl|7|hgl|1|pakki|+ leysir 3 ml|H01CC02|01.09.2001||R|A|2|0|1|0|1|SEN|0|0|0|100|SEK|34508|44830|lyfsjukr|||00|7|0|0|Gróco ehf|Serono Nordic|Cetrorelix||34508||34508|44830 005789|H01CC0201|Cetrotide|sts|3|mg/hgl|1|hgl|1|pakki|+ leysir 3 ml|H01CC02|01.09.2001||R|A|2|0|1|0|1|SEN|0|0|0|100|SEK|34508|44830|lyfsjukr|||00|1|0|0|Gróco ehf|Serono Nordic|Cetrorelix||34508||34508|44830 005790|N06AB1001|Cipralex|töflur|5|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|7388|10866|lyfalmen|||00|100|0|50|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||7388||7388|10866 005812|N06AB1001|Cipralex|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|3285|5298|lyfalmen|V0939|5210|00|28|0|28|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||3285||3285|5298 005822|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|5|l|1|fl||QP54AA01|01.08.2001||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|16775|29030|vetorma|||16|5|0|0|Vistor hf|Merial (MSD)|||16775||16775|29030 005823|N06AB1001|Cipralex|töflur|10|mg|56|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|6511|9676|lyfalmen|||00|56|0|56|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||6511||6511|9676 005836|L01BB0501|Fludara|filmhtfl|10|mg|20|stk|1|þpakki||L01BB05|01.11.2002||R|A|3|0|1|0|1|BAP|0|0|0|100|SEK|74945|95174|lyfsjukr|||00|20|0|0|Icepharma hf|Bayer Schering Pharma AG|Flúdarabín||74945||74945|95174 005845|N06AB1001|Cipralex|töflur|10|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|11534|16493|lyfalmen|||00|100|0|100|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||11534||11534|16493 005867|N06AB1001|Cipralex|töflur|15|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|5744|8635|lyfalmen|||00|28|0|42|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||5744||5744|8635 005872|C09DA0701|MicardisPlus|töflur|52,5|mg|28|stk|1|þpakki|40 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|B|0|BII|0|0|0|100|DKK|3187|5165|lyfalmen|||00|28|0|28|Vistor hf|Boehringer Ingelheim International |||3187||3187|5165 005884|P01BC0201|Lariam|töflur|250|mg|8|stk|1|þpakki||P01BC02|01.01.1993||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|3026|4947|lyfalmen|||59|8|0|2|Icepharma hf|Roche|Meflókvín||3026||3026|4947 005885|N05AH0301|Zyprexa|sts|10|mg|1|hgl|1|pakki||N05AH03|01.02.2004||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|896|2056|lyfalmen|||00|1|0|1|Icepharma hf|Eli Lilly Nederland -|Olanzapín||896||896|2056 005894|C09DA0701|MicardisPlus|töflur|52,5|mg|98|stk|1|þpakki|40 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|B|0|BII|0|0|0|100|DKK|10430|14994|lyfalmen|||00|98|0|98|Vistor hf|Boehringer Ingelheim International |||10430||10430|14994 005902|N06AB1001|Cipralex|töflur|15|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|21909|29462|lyfalmen|||00|100|0|150|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||21909||21909|29462 005910|C09CA0301|Diovan|töflur|80|mg|28|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|3732|5905|lyfalmen|||00|28|0|28|Vistor hf|Novartis Healthcare A/S-|Valsartan||3732||3732|5905 005922|N06AB1001|Cipralex|töflur|20|mg|28|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|7021|10368|lyfalmen|V1039|10178|00|28|0|56|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||7021||7021|10368 005932|C09CA0301|Diovan|töflur|80|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|10143|12430|lyfalmen|V1110|9971|00|98|0|98|Vistor hf|Novartis Healthcare A/S-|Valsartan||8540||8540|12430 005933|N06AB1001|Cipralex|töflur|20|mg|56|stk|1|þpakki||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|14264|19944|lyfalmen|||00|56|0|112|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||14264||14264|19944 005954|C09CA0301|Diovan|töflur|160|mg|28|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|4758|7297|lyfalmen|||00|28|0|56|Vistor hf|Novartis Healthcare A/S-|Valsartan||4758||4758|7297 005976|C09CA0301|Diovan|töflur|160|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.01.2001||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|14331|17572|lyfalmen|V1111|14055|00|98|0|196|Vistor hf|Novartis Healthcare A/S-|Valsartan||12359||12359|17572 006000|R07AA0201|Curosurf|innö.guf|80|mg/ml|1,5|ml|1|hgl||R07AA02|01.01.1995||R|K|1,5|0|1|0|1|NYG|0|0|0|100|DKK|86408|109445|lyfsjukr|||00|2|0|1|Gróco ehf|Nycomed Danmark A/S|Náttúrulegir fosfólípíðar||86408||86408|109445 006024|A10AD0501|NovoMix 30 FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|í lyfjapenna|A10AD05|01.07.2002||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|6382|9501|lyfalmen|||02|15|0|38|Vistor hf|Novo-Nordisk|Insulín aspart||6382||6382|9501 006026|L01XA0208|Carboplatin Mayne|irþ|10|mg/ml|60|ml|1|hgl||L01XA02|01.04.2007||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|31910|41595|lyfsjukr|||00|60|0|0|Icepharma hf|Mayne Pharma Plc|Karbóplatín||31910||31910|41595 006079|J02AX0403|Cancidas|irþ|70|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|K|2|0|1|0|1|MSD|0|0|0|100|XEU|125592|158230|lyfsjukr|||00|1|0|1|Icepharma hf|M.S.D.|Caspofungin||125592||125592|158230 006102|A10AB0501|NovoRapid FlexPen|stl|100|ein/ml|3|ml|5|rörlyk|einnota pennar|A10AB05|01.12.2001||R|A|2,5|0|0|*|0|NON|0|0|0|100|DKK|6244|9314|lyfalmen|||02|15|0|38|Vistor hf|Novo-Nordisk|Insúlín aspart||6244||6244|9314 006111|R07AA0201|Curosurf|innö.guf|80|mg/ml|3|ml|1|hgl||R07AA02|01.01.1995||R|K|1,5|0|1|0|1|NYG|0|0|0|100|DKK|172938|217175|lyfsjukr|||00|3|0|2|Gróco ehf|Nycomed Danmark A/S|Náttúrulegir fosfólípíðar||172938||172938|217175 006115|J02AX0403|Cancidas|irþ|50|mg/hgl|1|hgl|1|pakki||J02AX04|01.02.2002||R|K|2|0|1|0|1|MSD|0|0|0|100|XEU|87585|110911|lyfsjukr|||00|1|0|1|Icepharma hf|M.S.D.|Caspofungin||87585||87585|110911 006172|S01XA2007|Simplex|augnsm|0| |4|g|1|túpa|paraf+vasel án ullarf.|S01XA20|01.07.2003||R|A||0|0|E|0|LDR|0|0|0|100|IKR|972|2159|lyfalmen|||00|4|1|0|Parlogis hf|Parlogis - óskráð lyf|Gervitár og aðrar óvirkar sam­setningar||972||972|2159 006178|A10AE0402|Lantus [Optiset]|stl|100|ein/ml|3|ml|5|pennar||A10AE04|01.11.2005||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|8596|12506|lyfalmen|||00|15|0|38|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||8596||8596|12506 006212|J01MA0202|Ciproxin|irl|2|mg/ml|100|ml|12|pokar||J01MA02|01.12.2001||R|A|3|0|0|0|1|BHC|0|0|0|100|SEK|36827|47717|lyfsjukr|||00|1200|0|0|Vistor hf|Bayer HealthCare AG|Cíprófloxacín||36827||36827|47717 006226|J01MA0202|Ciproxin|irl|2|mg/ml|200|ml|12|pokar||J01MA02|01.12.2001||R|A|3|0|0|0|1|BHC|0|0|0|100|SEK|63318|80698|lyfsjukr|||00|2400|0|0|Vistor hf|Bayer HealthCare AG|Cíprófloxacín||63318||63318|80698 006346|N03AG0101|Depakine|sh-tfl|500|mg|40|stk|1|glas||N03AG01|01.04.1986||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|2430|4138|lyfalmen|||43|40|0|13|Vistor hf|Sanofi-aventis Norge AS|Valpróínsýra||2430||2430|4138 006443|QM01AC0601|Metacam|stl|20|mg/ml|50|ml|1|hgl||QM01AC06|01.05.2004||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|8942|17204|vetalmen|||00|50|0|0|Vistor hf|Boehringer Ingelheim|||8942||8942|17204 006579|D05AX5201|Daivobet|smyrsli|0| |60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2002||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|9493|13723|lyfalmen|V0391|13475|00|60|0|0|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||9493||9493|13723 006637|D05AX5201|Daivobet|smyrsli|0| |120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.04.2002||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|14094|19732|lyfalmen|V2001|19381|00|120|0|0|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||14094||14094|19732 006650|A04AA0301|Navoban|stl|1|mg/ml|5|ml|10|lykjur||A04AA03|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|DKK|35553|46448|lyfalmen|||02|50|0|10|Vistor hf|Novartis Healthcare A/S-|Trópísetrón||35553||35553|46448 006681|N02BE0109|Panodil Hot|skammtar|500|mg|10|skammtar|1|pakki||N02BE01|01.05.2003||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|10|0|2|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||||| 006785|G03AC0303|NorLevo|töflur|750|mcg|2|stk|1|þpakki||G03AC03|01.01.2005||L|A|3|0|0|0|0|LHP|0|0|0|100|IKR|||lyflausa|||23|2|0|0|Gróco ehf|Laboratoire HRA Pharma|Levonorgestrel||||| 006825|A04AA0301|Navoban|hylki|5|mg|5|stk|1|þpakki||A04AA03|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|DKK|15751|21795|lyfalmen|||10|5|0|5|Vistor hf|Novartis Healthcare A/S-|Trópísetrón||15751||15751|21795 006928|C09CA0101|Cozaar|töflur|100|mg|98|stk|1|þpakki||C09CA01|01.05.2002||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|17741|24273|lyfalmen|||00|98|0|196|Icepharma hf|M.S.D.|Lósartan||17741||17741|24273 007099|C10AA0701|Crestor|filmhtfl|10|mg|28|stk|1|þpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|3764|5948|lyfalmen|||00|28|0|28|Vistor hf|AstraZeneca A/S DK|||3764||3764|5948 007104|N05AA0201|Nozinan|töflur|5|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|736|1839|lyfalmen|||00|100|0|2|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||736||736|1839 007123|V03AE0201|Renagel|filmhtfl|800|mg|180|stk|1|glas||V03AE02|01.01.2004||R|A|2|0|0|0|0|GZE|0|0|0|100|XEU|31152|40969|lyfalmen|||00|180|0|22|Vistor hf|Genzyme Europe B.V.|Sevelamer||31152||31152|40969 007126|QJ01CE9002|Mamyzin vet.|sts|10|millj ae|20|hgl|1|pakki|+ leysir|QJ01CE90|01.12.2002||R|A|3|0|0|0|0|BID|0|0|0|100|DKK|24547|46930|vetalmen|||27|20|0|0|Vistor hf|Boehringer Ingelheim Danmark|||24547||24547|46930 007133|C10AA0701|Crestor|filmhtfl|10|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|11974|17090|lyfalmen|||00|98|0|98|Vistor hf|AstraZeneca A/S DK|||11974||11974|17090 007138|N05AA0201|Nozinan|töflur|25|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|1838|3335|lyfalmen|||00|100|0|8|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||1838||1838|3335 007144|C10AA0701|Crestor|filmhtfl|20|mg|28|stk|1|þpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|5639|8493|lyfalmen|||00|28|0|56|Vistor hf|AstraZeneca A/S DK|||5639||5639|8493 007155|C10AA0701|Crestor|filmhtfl|20|mg|98|stk|1|þpakki||C10AA07|01.06.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|17944|24525|lyfalmen|||00|98|0|196|Vistor hf|AstraZeneca A/S DK|||17944||17944|24525 007161|N05AA0201|Nozinan|töflur|100|mg|100|stk|1|glas||N05AA02|01.10.1995||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|5945|8908|lyfalmen|||00|100|0|33|Vistor hf|Sanofi-aventis Norge AS|Levómeprómazín||5945||5945|8908 007166|C10AA0701|Crestor|filmhtfl|40|mg|28|stk|1|þpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|7486|10999|lyfalmen|||00|28|0|112|Vistor hf|AstraZeneca A/S DK|||7486||7486|10999 007186|C10AA0701|Crestor|filmhtfl|40|mg|98|stk|1|þpakki||C10AA07|01.07.2003||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|26201|34805|lyfalmen|||00|98|0|392|Vistor hf|AstraZeneca A/S DK|||26201||26201|34805 007223|B01AX0001|Ceprotin|sts|500|ae/hgl|1|hgl|1|pakki|+ 5 ml leysir|B01AX00|01.02.2002||R|K|2|0|1|0|1|BAX|0|0|0|100|SEK|149310|187758|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter|||149310||149310|187758 007268|B01AX0001|Ceprotin|sts|1000|ae/hgl|1|hgl|1|pakki|+ 10 ml leysir|B01AX00|01.02.2002||R|K|2|0|1|0|1|BAX|0|0|0|100|SEK|263750|330236|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter|||263750||263750|330236 007278|C08CA0302|Lomir Retard|forðahlk|2,5|mg|30|stk|1|þpakki||C08CA03|01.04.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|2139|3743|lyfalmen|||10|30|0|15|Vistor hf|Novartis Healthcare A/S-|Ísradipín||2139||2139|3743 007292|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|1|glös||S01EE03|01.04.2005||R|A|2|0|0|*|0|ALL|0|0|0|100|SEK|2636|4418|lyfalmen|||00|3|0|30|Vistor hf|Allergan|Bimatóprost||2636||2636|4418 007297|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.04.2002||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|14|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 007337|H01CB0302|Ipstyl Autogel|stl|60|mg/spr|1|spr|1|pakki|einnota sprauta|H01CB03|01.03.2002||R|K|2|0|1|0|1|INP|0|0|0|100|DKK|151578|190582|lyfsjukr|||00|1|0|20|Icepharma hf|Institut Produits Synthése (IPSEN) AB|Lanreótíð||151578||151578|190582 007360|H01CB0302|Ipstyl Autogel|stl|120|mg/spr|1|spr|1|pakki|einnota sprauta|H01CB03|01.03.2002||R|K|2|0|1|0|1|INP|0|0|0|100|DKK|233280|292301|lyfsjukr|||00|1|0|40|Icepharma hf|Institut Produits Synthése (IPSEN) AB|Lanreótíð||233280||233280|292301 007363|H01CB0302|Ipstyl Autogel|stl|90|mg/spr|1|spr|1|pakki|einnota sprauta|H01CB03|01.03.2002||R|K|2|0|1|0|1|INP|0|0|0|100|DKK|202814|254371|lyfsjukr|||00|1|0|30|Icepharma hf|Institut Produits Synthése (IPSEN) AB|Lanreótíð||202814||202814|254371 007375|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.04.2002||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 007378|J01XX0801|Zyvoxid|irl|2|mg/ml|300|ml|10|pokar||J01XX08|01.12.2001||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|132341|166632|lyfsjukr|||00|3000|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Linezolíd||132341||132341|166632 007385|A02BA0205|Zantac|töflur|150|mg|20|stk|1|þpakki||A02BA02|01.09.1983||L|A|5|0|0|0|0|GSK|0|0|0|100|IKR|||lyflausa|||00|20|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín||||| 007424|J01XX0801|Zyvoxid|töflur|600|mg|30|stk|1|þpakki||J01XX08|01.12.2001||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|333414|416968|lyfsjukr|||00|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Linezolíd||333414||333414|416968 007434|S01ED5106|Xalcom|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.12.2001||R|K|2|0|0|*|0|PFI|0|0|0|100|DKK|3591|5714|lyfalmen|V0988|5616|06|2|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Tímólól í blöndum||3591||3591|5714 007448|B05XC04|Cernevit|sts|0| |5|ml|10|hgl||B05XC|01.05.2002||R|A|3|0|0|0|1|CPS|0|0|0|100|SEK|7100|10165|lyfsjukr|||02|50|0|0|Icepharma hf|Clintec parenteral SA|||7100||7100|10165 007449|V03AB0001|Fomepizole OPi|irþ|5|mg/ml|20|ml|5|hgl||V03AB00|01.09.2003||R|A|2|0|0|0|1|OPO|0|0|0|100|XEU|122468|154340|lyfsjukr|||00|100|0|0|Swedish Orphan International AB|OPi Orphan Pharma international (S)|||122468||122468|154340 007462|N01AB0801|Sevorane|innönd.l|0| |250|ml|1|plastf||N01AB08|01.03.2002||R|A|3|0|0|0|1|ABS|0|0|0|100|DKK|26104|34367|lyfsjukr|||00|250|0|0|Vistor hf|Abbott Scandinavia AB|Sevóflúran||26104||26104|34367 007494|QP52AA0101|Droncit vet.|hlaup|9|%|6,67|g|1|dæla|til inntöku|QP52AA01|01.04.2002||L|A|2|0|0|0|0|BAN|0|0|0|0|DKK|||vetorma|||16|7|0|0|Vistor hf|Bayer Animal Health GmbH||||||3456 007505|G04BD0702|Detrusitol Retard|forðahlk|1,4|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|6981|10314|lyfalmen|||00|30|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Tólteródín||6981||6981|10314 007516|R03BA0701|Asmanex Twisthaler|innúðadu|200|mcg|60|skammtar|1|pakki||R03BA07|01.04.2003||R|A|2|0|0|B|0|SPL|0|0|0|100|DKK|5028|7664|lyfalmen|||00|60|0|30|Vistor hf|Schering-Plough Europe|Mometasón||5028||5028|7664 007534|C09CA0601|Atacand|töflur|16|mg|28|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3004|4917|lyfalmen|||00|28|0|56|Vistor hf|AstraZeneca A/S DK|Candesartan||3004||3004|4917 007538|R03BA0701|Asmanex Twisthaler|innúðadu|400|mcg|30|skammtar|1|pakki||R03BA07|01.04.2003||R|A|2|0|0|B|0|SPL|0|0|0|100|DKK|5028|7664|lyfalmen|||00|30|0|30|Vistor hf|Schering-Plough Europe|Mometasón||5028||5028|7664 007540|N02BE0111|Perfalgan|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.08.2003||R|A|2|0|0|0|1|BRS|0|0|0|100|DKK|9229|13214|lyfsjukr|||00|1200|0|4|Vistor hf|Bristol-Myers Squibb|Paracetamól||9229||9229|13214 007541|J07BL0101|Stamaril|bóluefni|0| |0,5|ml|10|lykjur|+leysir|J07BL01|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|21813|29342|lyfalmen|||02|5|0|0|Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluð veira||21813||21813|29342 007549|R03BA0701|Asmanex Twisthaler|innúðadu|400|mcg|60|skammtar|1|pakki||R03BA07|01.03.2003||R|A|2|0|0|B|0|SPL|0|0|0|100|DKK|9801|14141|lyfalmen|||00|60|0|60|Vistor hf|Schering-Plough Europe|Mometasón||9801||9801|14141 007559|C09CA0601|Atacand|töflur|16|mg|98|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|9560|13814|lyfalmen|||00|98|0|196|Vistor hf|AstraZeneca A/S DK|Candesartan||9560||9560|13814 007575|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|0| |1000|ml|9|plpok|Exel umbúðir|B05BB02|01.04.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|2566|3674|lyfsjukr|||02|9000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||2566||2566|3674 007609|C09CA0601|Atacand|töflur|4|mg|28|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2289|3947|lyfalmen|||00|28|0|14|Vistor hf|AstraZeneca A/S DK|Candesartan||2289||2289|3947 007657|QH02AB0602|Prednisolonacetat, vet."Intervet"|stl|10|mg/ml|50|ml|1|hgl||QH02AB06|01.05.1998|31.03.2009|R|A|5|0|0|0|0|INI|1|0|0|100|DKK|1773|3499|vetalmen|||58|50|0|0|Icepharma hf|Intervet International B.V.|||1773||1773|3499 007760|G04BD0702|Detrusitol Retard|forðahlk|2,8|mg|30|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|7772|11387|lyfalmen|||00|30|0|21|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Tólteródín||7772||7772|11387 007769|G04BD0702|Detrusitol Retard|forðahlk|2,8|mg|100|stk|1|plglas||G04BD07|01.01.2001||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|23602|31569|lyfalmen|||00|100|0|70|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Tólteródín||23602||23602|31569 007778|N05AX0802|Rison|töflur|0,5|mg|60|stk|1|glas||N05AX08|01.10.2001||R|A|3|0|0|*|0|ACA|0|1|0|100|IKR|1728|3185|lyfalmen|V1075|3185|00|60|0|6|Actavis Group hf|Actavis hf|Risperídón||1728||1728|3185 007852|G02BB0101|NuvaRing|sk-hring|0| |3|stk|1|pakki|með forðaverkun|G02BB01|01.11.2002||R|A|3,3|0|0|0|0|ORG|0|0|0|100|DKK|4127|6441|lyfalmen|||00|3|0|84|Vistor hf|N.V. Organon|Skeiðarinnleg með progestógeni og östrógeni||4127||4127|6441 007878|V07AB0001|Sterilt vatten Baxter Viaflo|leysir|0| |50|ml|50|pokar|leysir f.stungulyf|V07AB00|01.08.2005||L|A|1,5|0|0|0|0|BAM|0|0|0|100|IKR|||lyflausa|||00|2500|0|0|Icepharma hf|Baxter Medical AB|||||| 007889|V07AB0002|Sterilt Vand "Baxter" Viaflo|leysir|0| |100|ml|50|pokar|leysir f.stungulyf|V07AB00|01.02.2006||L|A|1,5|0|0|0|0|BAX|0|0|0|100|IKR|||lyflausa|||00|5000|0|0|Icepharma hf|Baxter|||||| 007920|S01EX0601|Travatan|augndr|40|mcg/ml|2,5|ml|1|glas||S01EX06|01.02.2004||R|A|3|0|0|*|0|ALC|0|0|0|100|USD|2593|4359|lyfalmen|||00|2|0|0|K.Pétursson hf|Alcon|||2593||2593|4359 007921|S01GX0901|Opatanol|augndr|1|mg/ml|5|ml|1|glas||S01GX09|01.05.2004||R|A|3|0|0|0|0|ALC|0|0|0|100|USD|1304|2610|lyfalmen|||00|5|0|0|K.Pétursson hf|Alcon|Ólópatadín||1304||1304|2610 007978|B01AD1001|Xigris|irs|20|mg|1|hgl|1|pakki|lausn|B01AD10|01.11.2002||R|K|3|0|1|0|1|ELD|0|0|0|100|XEU|161617|203081|lyfsjukr|||00|1|0|0|Icepharma hf|Eli Lilly Nederland -|Drotrecogin alfa (virkjað)||161617||161617|203081 007986|D07AA0208|Mildison Lipid|krem|10|mg/g|15|g|1|túpa|feitt|D07AA02|01.01.1990||L|A|3|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||20|15|0|15|Vistor hf|Astellas Pharma A/S|Hýdrókortisón||||| 007995|R07AX0101|INOmax|innö.gas|400|ppm|10|l|1|gashyl||R07AX01|01.01.2004||R|A|2|0|1|0|1|AGA|0|0|0|100|XEU|22573|29971|lyfsjukr|||00|10|0|0|Ísaga ehf|AGA AB|Nituroxíð||22573||22573|29971 007997|H02AB0104|Betapred|lausnart|0,5|mg|30|stk|1|glas||H02AB01|01.09.1998||R|A||0|0|E|0|LVE|0|0|1|100|IKR|729|1830|lyfalmen|||00|30|1|10|Lyfjaver ehf|Lyfjaver - óskráð lyf|Betametasón||729||729|1830 008010|B01AD1001|Xigris|irs|5|mg|1|hgl|1|pakki|lausn|B01AD10|01.11.2002||R|K|3|0|1|0|1|ELD|0|0|0|100|XEU|40723|52568|lyfsjukr|||00|1|0|0|Icepharma hf|Eli Lilly Nederland -|Drotrecogin alfa (virkjað)||40723||40723|52568 008023|A10BA0201|Glucophage|töflur|1000|mg|30|stk|1|þpakki||A10BA02|01.01.2002||R|A|3|0|0|*|0|MCK|0|0|0|100|XEU|672|1752|lyfalmen|||00|30|0|15|Icepharma hf|Merck Santé s.a.s.|Metformín||672||672|1752 008028|J05AH0201|Tamiflu|mixtduft|12|mg/ml|1|stk|1|fl|750 mg í flösku|J05AH02|01.11.2002||R|A|2|0|0|0|0|RRL|0|0|0|100|DKK|3594|5718|lyfalmen|||00|1|0|5|Icepharma hf|Roche Registration Limited|Oseltamivír||3594||3594|5718 008058|B05BA1011|Oliclinomel N4 550E|irl|0| |1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|24160|31947|lyfsjukr|||00|6000|0|0|Icepharma hf|Baxter Medical AB|Blöndur||24160||24160|31947 008069|B05BA1011|Oliclinomel N4 550E|irl|0| |2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|30201|39468|lyfsjukr|||00|8000|0|0|Icepharma hf|Baxter Medical AB|Blöndur||30201||30201|39468 008086|D07AC0101|Betnovat|krem|1|mg/g|30|g|1|túpa||D07AC01|01.01.1985|30.04.2009|R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|378|1353|lyfalmen|||20|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||378||378|1353 008097|N02CC0402|Maxalt Smelt|munnltfl|5|mg|6|stk|1|þpakki||N02CC04|01.03.2003||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|6839|10121|lyfalmen|||00|6|0|3|Icepharma hf|M.S.D.|Rizatriptan||6839||6839|10121 008101|L03AB1001|PegIntron|sts|50|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|93806|118656|lyfsjukr|||00|4|0|27|Vistor hf|Schering-Plough|Peginterferón alfa 2b||93806||93806|118656 008102|D07AC0101|Betnovat|krem|1|mg/g|100|g|1|túpa||D07AC01|01.07.1995|30.04.2009|R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|1198|2466|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||1198||1198|2466 008108|L03AB1001|PegIntron|sts|100|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|188588|236660|lyfsjukr|||00|4|0|53|Vistor hf|Schering-Plough|Peginterferón alfa 2b||188588||188588|236660 008131|L03AB1001|PegIntron|sts|80|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|136756|172129|lyfsjukr|||00|4|0|43|Vistor hf|Schering-Plough|Peginterferón alfa 2b||136756||136756|172129 008134|L03AB1001|PegIntron|sts|120|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.08.2003||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|201298|252484|lyfsjukr|||00|4|0|64|Vistor hf|Schering-Plough|Peginterferón alfa 2b||201298||201298|252484 008145|L03AB1001|PegIntron|sts|150|mcg|4|stk|1|pakki|fjölskammta pennar|L03AB10|01.12.2002||R|K|3|0|1|0|1|SCP|0|0|0|100|DKK|234995|294436|lyfsjukr|||00|4|0|80|Vistor hf|Schering-Plough|Peginterferón alfa 2b||234995||234995|294436 008194|D07AA0208|Mildison Lipid|krem|10|mg/g|30|g|1|túpa|feitt|D07AA02|01.01.1990||L|A|3|0|0|0|0|ASP|0|0|1|100|IKR|||lyflausa|||20|30|0|30|Vistor hf|Astellas Pharma A/S|Hýdrókortisón||||| 008196|D07AA0208|Mildison Lipid|krem|10|mg/g|100|g|1|túpa|feitt|D07AA02|01.01.1990||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|2062|3639|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|Hýdrókortisón||2062||2062|3639 008197|R06AX2701|Aerius|saft|0,5|mg/ml|120|ml|1|fl||R06AX27|01.10.2002||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|1178|2439|lyfalmen|||00|120|0|12|Vistor hf|Schering-Plough|Deslóratadín||1178||1178|2439 008219|D07AC0101|Betnovat|áburður|1|mg/ml|20|ml|1|glas||D07AC01|01.12.1980||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|267|1203|lyfalmen|||20|20|0|20|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||267||267|1203 008223|B05BA1013|Oliclinomel N6 900E|irl|0| |1000|ml|6|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|31817|41480|lyfsjukr|||00|6000|0|0|Icepharma hf|Baxter Medical AB|Blöndur||31817||31817|41480 008234|B05BA1013|Oliclinomel N6 900E|irl|0| |1500|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|24844|32798|lyfsjukr|||00|6000|0|0|Icepharma hf|Baxter Medical AB|Blöndur||24844||24844|32798 008243|D07AC0101|Betnovat|áburður|1|mg/g|30|ml|1|glas|í hársvörð|D07AC01|01.01.1985||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|438|1435|lyfalmen|||33|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||438||438|1435 008245|B05BA1013|Oliclinomel N6 900E|irl|0| |2000|ml|4|plpok|fleyti|B05BA10|01.06.2002||R|A|2|0|0|0|1|BAM|0|0|0|100|SEK|31135|40631|lyfsjukr|||00|8000|0|0|Icepharma hf|Baxter Medical AB|Blöndur||31135||31135|40631 008300|C09CA0601|Atacand|töflur|4|mg|98|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|7756|11366|lyfalmen|||00|98|0|49|Vistor hf|AstraZeneca A/S DK|Candesartan||7756||7756|11366 008301|N02AX0209|Tramol-L|forðatfl|100|mg|20|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|1194|2461|lyfalmen|V0733|2461|00|20|0|7|Actavis Group hf|Actavis hf|Tramadól||1194||1194|2461 008318|C09CA0601|Atacand|töflur|8|mg|28|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2458|4176|lyfalmen|||00|28|0|28|Vistor hf|AstraZeneca A/S DK|Candesartan||2458||2458|4176 008326|D07AC0101|Betnovat|áburður|1|mg/g|100|ml|1|glas|í hársvörð|D07AC01|01.07.1988||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|1306|2613|lyfalmen|||33|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||1306||1306|2613 008334|C09CA0601|Atacand|töflur|8|mg|98|stk|1|þpakki||C09CA06|01.02.1998||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|7824|11458|lyfalmen|||00|98|0|98|Vistor hf|AstraZeneca A/S DK|Candesartan||7824||7824|11458 008338|N02AX0209|Tramol-L|forðatfl|100|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|4673|7182|lyfalmen|V0734|7182|00|100|0|33|Actavis Group hf|Actavis hf|Tramadól||4673||4673|7182 008360|N02AX0209|Tramol-L|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|7172|10573|lyfalmen|V0736|10573|00|100|0|50|Actavis Group hf|Actavis hf|Tramadól||7172||7172|10573 008368|N02AX0209|Tramol-L|forðatfl|200|mg|100|stk|1|þpakki||N02AX02|01.04.2002||R|A|3|0|0|E|0|ACA|0|0|1|100|XEU|9444|13656|lyfalmen|V0738|13656|00|100|0|67|Actavis Group hf|Actavis hf|Tramadól||9444||9444|13656 008370|V04CJ0101|Thyrogen|sts|0,9|mg/hgl|2|hgl|1|pakki|lausn|V04CJ01|01.01.2006||R|K|3|0|1|0|1|GEZ|0|0|0|100|XEU|209905|263199|lyfsjukr|||02|2|0|0|Vistor hf|Genzyme BV|Thýrótrópín||209905||209905|263199 008383|D07AC0101|Betnovat|smyrsli|1|mg/g|30|g|1|túpa||D07AC01|01.01.1985|30.04.2009|R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|378|1353|lyfalmen|||20|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||378||378|1353 008396|H03AA0104|Euthyrox|töflur|50|mcg|100|stk|1|þpakki||H03AA01|01.05.2002||R|A|3|0|0|B|0|MAC|0|0|0|100|XEU|790|1912|lyfalmen|V0431|1912|00|100|0|33|Actavis Group PTC ehf|Merck KgaA (A) |Levótýroxínnatríum||790||790|1912 008435|H03AA0104|Euthyrox|töflur|100|mcg|100|stk|1|þpakki||H03AA01|01.05.2002||R|A|3|0|0|B|0|MAC|0|0|0|100|XEU|667|1746|lyfalmen|V0430|1746|00|100|0|67|Actavis Group PTC ehf|Merck KgaA (A) |Levótýroxínnatríum||667||667|1746 008466|D07AC0101|Betnovat|smyrsli|1|mg/g|100|g|1|túpa||D07AC01|01.07.1995|30.04.2009|R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|1198|2466|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Betametasón||1198||1198|2466 008484|QP52AC1303|Zerofen, vet.|mixtúra|10|%|1000|ml|1|plbrús||QP52AC13|01.11.2001||R|A|3|0|0|0|0|CHP|1|0|0|100|USD|5027|8699|vetorma|||00|1000|0|0|Icepharma hf|Chanelle Pharmaceuticals |||5027||5027|8699 008497|QN05CM9203|Chanazine, vet.|stl|10|%|50|ml|1|hgl||QN05CM92|01.11.2001||R|A|5|0|0|0|0|CHP|1|0|0|100|XEU|11066|21250|vetalmen|||00|50|0|0|Icepharma hf|Chanelle Pharmaceuticals |||11066||11066|21250 008498|R06AX2201|Kestine|töflur|10|mg|10|stk|1|þpakki||R06AX22|01.04.1998||L|A|3|0|0|0|0|ALF|0|0|1|100|IKR|||lyflausa|||00|10|0|10|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||||| 008523|R06AX2201|Kestine|töflur|10|mg|100|stk|1|þpakki||R06AX22|01.04.1998||R|A|3|0|0|E|0|ALF|0|0|1|100|NOK|4620|7110|lyfalmen|||00|100|0|100|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||4620||4620|7110 008534|R06AX2201|Kestine|töflur|10|mg|30|stk|1|þpakki||R06AX22|01.04.1998||L|A|3|0|0|0|0|ALF|0|0|1|100|IKR|||lyflausa|||00|30|0|30|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||||| 008545|G03FB0506|NovoFem|filmhtfl|0| |84|stk|1|skífup|1+1mg|G03FB05|01.06.2002||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|2931|4818|lyfalmen|||23|84|0|84|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||2931||2931|4818 008745|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|2|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 008767|L03AB1101|Pegasys|stl|135|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|133296|167821|lyfsjukr|||00|2|0|0|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||133296||133296|167821 008768|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 008782|L03AB1101|Pegasys|stl|180|mcg/spr|0,5|ml|4|spr|áfyllt sprauta|L03AB11|01.11.2002||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|138947|174857|lyfsjukr|||00|2|0|28|Icepharma hf|Roche Registration Limited|Peginterferón alfa 2a||138947||138947|174857 008785|QP52AC1303|Zerofen, vet.|mixtúra|10|%|500|ml|1|plbrús||QP52AC13|01.11.2001||R|A|3|0|0|0|0|CHP|1|0|0|100|USD|2575|4456|vetorma|||00|500|0|0|Icepharma hf|Chanelle Pharmaceuticals |||2575||2575|4456 008831|D11AX1501|Elidel|krem|1|%|15|g|1|túpa||D11AX15|01.11.2002||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|3121|5076|lyfalmen|||00|15|0|15|Vistor hf|Novartis Healthcare A/S-|Pímekrólímus||3121||3121|5076 008888|C09DA0601|Atacand Plus|töflur|28,5|mg|28|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.01.2001||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3004|4917|lyfalmen|||00|28|0|56|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||3004||3004|4917 008904|D10AF0101|Dalacin|lausn|10|mg/ml|60|ml|1|glas|Áburður, lausn|D10AF01|01.01.1994||R|A|2,5|0|0|0|0|PFI|0|0|0|100|DKK|2321|3990|lyfalmen|||20|60|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||2321||2321|3990 008927|G04BE0801|Cialis|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|6133|9163|lyfalmen|V1350|8998|00|4|0|8|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||6133|9163 008938|H02AB0104|Betapred|stl|4|mg/ml|1|ml|5|lykjur||H02AB01|01.07.2004||R|A||0|0|0|0|LVE|0|0|1|100|IKR|950|2130|lyfalmen|||02|5|1|13|Lyfjaver ehf|Lyfjaver - óskráð lyf|Betametasón||950||950|2130 008950|G04BE0801|Cialis|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|12083|17228|lyfalmen|V1351|16909|00|8|0|16|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||12083|17228 009065|D11AX1501|Elidel|krem|1|%|30|g|1|túpa||D11AX15|01.11.2002||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|5266|7987|lyfalmen|||00|30|0|30|Vistor hf|Novartis Healthcare A/S-|Pímekrólímus||5266||5266|7987 009079|D11AX1501|Elidel|krem|1|%|100|g|1|túpa||D11AX15|01.11.2002||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|16346|22536|lyfalmen|||00|100|0|100|Vistor hf|Novartis Healthcare A/S-|Pímekrólímus||16346||16346|22536 009192|M01AH0401|Dynastat|sts|40|mg/hgl|5|hgl|1|pakki|+leysir 2ml/lykju |M01AH04|01.06.2002||R|A|3|0|0|0|0|PFL|0|0|1|100|DKK|7451|10952|lyfalmen|||03|5|0|5|Vistor hf|Pfizer Limited|Parekoxíb||7451||7451|10952 009214|M01AH0401|Dynastat|sts|40|mg/hgl|10|hgl|1|pakki||M01AH04|01.06.2002||R|A|3|0|0|0|0|PFL|0|0|1|100|DKK|14144|19794|lyfalmen|||03|10|0|10|Vistor hf|Pfizer Limited|Parekoxíb||14144||14144|19794 009278|J02AC0301|Vfend|töflur|50|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|61805|78815|lyfsjukr|||00|30|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Voricónazól||61805||61805|78815 009282|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|A|3|0|0|0|0|FRP|0|0|0|100|DKK|||lyfalmen|||02|400|0|0|Icepharma hf|Fresenius Kabi||||||1678 009285|D11AX1401|Protopic|smyrsli|0,03|%|30|g|1|túpa||D11AX14|01.07.2003||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|5631|8482|lyfalmen|||00|30|0|0|Vistor hf|Astellas Pharma A/S|Takrólímus||5631||5631|8482 009340|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|0| |20|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|400|0|0|Icepharma hf|Fresenius Kabi|||||| 009409|G03CA0316|Vivelle Dot|forðapl|37,5|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1381|2714|lyfalmen|||23|8|0|21|Vistor hf|Novartis Healthcare A/S-|Estradíól||1381||1381|2714 009443|G03CA0316|Vivelle Dot|forðapl|50|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1484|2854|lyfalmen|||23|8|0|28|Vistor hf|Novartis Healthcare A/S-|Estradíól||1484||1484|2854 009465|G03CA0316|Vivelle Dot|forðapl|75|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1749|3214|lyfalmen|||23|8|0|42|Vistor hf|Novartis Healthcare A/S-|Estradíól||1749||1749|3214 009489|G03CA0316|Vivelle Dot|forðapl|100|mcg/sólh|8|stk|1|pakki||G03CA03|01.07.2002||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|2012|3571|lyfalmen|||23|8|0|56|Vistor hf|Novartis Healthcare A/S-|Estradíól||2012||2012|3571 009522|N02BE0101|Panodil|eþ-stil|500|mg|10|stk|1|pakki||N02BE01|01.11.1981||L|A|5|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||04|10|0|2|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||||| 009609|J02AC0301|Vfend|töflur|200|mg|30|stk|1|þpakki||J02AC03|01.11.2002||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|246882|309236|lyfsjukr|||00|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Voricónazól||246882||246882|309236 009649|D11AX1401|Protopic|smyrsli|0,1|%|30|g|1|túpa||D11AX14|01.07.2003||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|6254|9327|lyfalmen|||00|30|0|0|Vistor hf|Astellas Pharma A/S|Takrólímus||6254||6254|9327 009672|J05AB0102|Zovir|töflur|400|mg|55|stk|1|þpakki||J05AB01|01.09.2003||R|A|5|0|0|E|0|GSK|0|0|1|100|GBP|9487|13715|lyfalmen|||00|55|0|6|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||9487||9487|13715 009679|J05AF0701|Viread|filmhtfl|245|mg|30|stk|1|glas||J05AF07|01.04.2003||R|A|3|0|1|0|1|GIS|0|0|0|100|DKK|71315|90655|lyfsjukr|||00|30|0|30|Gilead Sience Sweden AB|Gilead Science International ltd.|Tenófóvír dísóproxíl||71315||71315|90655 009688|C09DA0601|Atacand Plus|töflur|28,5|mg|98|stk|1|þpakki|16 + 12,5 mg|C09DA06|01.01.2001||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|9558|13811|lyfalmen|||00|98|0|196|Vistor hf|AstraZeneca A/S DK|Candesartan og þvagræsilyf||9558||9558|13811 009830|B03XA0103|NeoRecormon|stl|20000|ae/spr|0,6|ml|1|spr||B03XA01|01.05.2006||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|41899|54032|lyfsjukr|||00|1|0|20|Icepharma hf|Roche|Epóetín||41899||41899|54032 009881|A10BD0201|Glucovance|filmhtfl|502,5|mg|30|stk|1|þpakki|500+2,5 mg|A10BD02|01.03.2003||R|A|3|0|0|*|0|MCK|0|0|0|100|XEU|853|1998|lyfalmen|||00|30|0|15|Icepharma hf|Merck Santé s.a.s.|Metformin og súlfónamíð||853||853|1998 009900|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk|sjálfs|N01BB03|01.03.1984||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|6672|9895|lyfalmen|||02|180|0|0|Vistor hf|Dentsply Limited|Mepívakaín||6672||6672|9895 009905|N01BB5402|Citanest Dental Octapressin|stl|0| |1,8|ml|100|rörlyk||N01BB54|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|6549|9728|lyfalmen|||00|180|0|0|Vistor hf|Dentsply Limited|||6549||6549|9728 009911|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml|N01BB52|01.12.1983||R|S|2|0|0|0|0|DPL|0|0|1|100|XEU|7762|11374|lyfalmen|||17|180|0|0|Vistor hf|Dentsply Limited|||7762||7762|11374 009913|N06AX1102|Remeron Smelt|munndr.t|15|mg|6|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|557|1596|lyfalmen|||00|6|0|3|Vistor hf|N.V. Organon|Mirtazapín||557||557|1596 009942|N01BB5402|Citanest Dental Octapressin|stl|0| |1,8|ml|100|rörlyk|sjálfsog|N01BB54|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|7067|10431|lyfalmen|||00|180|0|0|Vistor hf|Dentsply Limited|||7067||7067|10431 009945|N01BB5204|Xylocain Dental adrenalin|stl|20|mg/ml|1,8|ml|100|rörlyk|20mg+12.5mcg/ml-sjálfsog|N01BB52|01.12.1983||R|S|2|0|0|0|0|DPL|0|0|1|100|XEU|7791|11413|lyfalmen|||17|180|0|0|Vistor hf|Dentsply Limited|||7791||7791|11413 009947|N01BB0303|Carbocain dental|stl|30|mg/ml|1,8|ml|100|rörlyk||N01BB03|01.12.1983||R|A|3|0|0|0|0|DPL|0|0|1|100|XEU|5993|8973|lyfalmen|||02|180|0|0|Vistor hf|Dentsply Limited|Mepívakaín||5993||5993|8973 010002|N06AX1102|Remeron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|2364|4048|lyfalmen|V1151|2902|00|30|0|15|Vistor hf|N.V. Organon|Mirtazapín||2364||2364|4048 010035|N06AX1102|Remeron Smelt|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|4195|6533|lyfalmen|V1152|4188|00|30|0|30|Vistor hf|N.V. Organon|Mirtazapín||4195||4195|6533 010057|N06AX1102|Remeron Smelt|munndr.t|45|mg|30|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|8959|12998|lyfalmen|||00|30|0|45|Vistor hf|N.V. Organon|Mirtazapín||8959||8959|12998 010070|L03AA1301|Neulasta|stl|6|mg/spr|0,6|ml|1|spr|áfyllt sprauta, lausn|L03AA13|01.12.2003||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|190910|239550|lyfsjukr|||00|1|0|20|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||190910||190910|239550 010102|G03GA0502|Gonal-f|sts|75|ae|1|hgl|1|pakki|(5,5 mcg) + leysir|G03GA05|01.04.2003||R|A|1|0|1|E|0|SEE|0|0|0|100|SEK|4507|6957|lyfalmen|||00|1|0|1|Gróco ehf|Serono Europe|Follitrópín alfa||4507||4507|6957 010135|A10BD0201|Glucovance|filmhtfl|505|mg|30|stk|1|þpakki|500+5 mg|A10BD02|01.03.2003||R|A|3|0|0|*|0|MCK|0|0|0|100|XEU|1222|2499|lyfalmen|||00|30|0|15|Icepharma hf|Merck Santé s.a.s.|Metformin og súlfónamíð||1222||1222|2499 010159|G03GA0502|Gonal-f|sts|75|ae|10|hgl|1|pakki|(5,5 mcg) + leysir |G03GA05|01.04.2003||R|A|1|0|1|E|0|SEE|0|0|0|100|SEK|46300|59828|lyfalmen|||00|10|0|10|Gróco ehf|Serono Europe|Follitrópín alfa||46300||46300|59828 010164|G03GA0502|Gonal-f|sts|450|ae|1|hgl|1|pakki|á 0,75ml + leysir|G03GA05|01.04.2003||R|A|1|0|1|E|0|SEE|0|0|0|100|SEK|27782|36774|lyfalmen|||00|1|0|6|Gróco ehf|Serono Europe|Follitrópín alfa||27782||27782|36774 010182|J05AB1401|Valcyte|filmhtfl|450|mg|60|stk|1|plglas||J05AB14|01.11.2002||R|A|3|0|0|0|1|RRL|0|0|0|100|DKK|246168|308347|lyfsjukr|||00|60|0|30|Icepharma hf|Roche Registration Limited|Valgancíklóvír||246168||246168|308347 010187|H01AX0101|Somavert|sts|10|mg|30|hgl|1|pakki|+ leysir|H01AX01|01.02.2004||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|425520|531640|lyfsjukr|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Pegvisómant||425520||425520|531640 010203|B03XA0201|Aranesp|stl|500|mcg/spr|1|ml|1|spr|áfyllt sprauta|B03XA02|01.04.2005||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|178206|223734|lyfsjukr|||00|1|0|111|Vistor hf|Amgen|Darbepóetín alfa||178206||178206|223734 010234|J01DH0301|Invanz|irs|1|g/hgl|1|hgl|1|pakki||J01DH03|01.08.2002||R|A|2|0|1|0|1|MSD|0|0|0|100|XEU|8312|11901|lyfsjukr|||00|1|0|0|Icepharma hf|M.S.D.|Ertapenem||8312||8312|11901 010240|N06AX1102|Remeron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|13021|18396|lyfalmen|V1153|12754|00|96|0|96|Vistor hf|N.V. Organon|Mirtazapín||13021||13021|18396 010254|N06AX1102|Remeron Smelt|munndr.t|45|mg|96|stk|1|þpakki||N06AX11|01.05.2003||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|19727|26745|lyfalmen|||00|96|0|144|Vistor hf|N.V. Organon|Mirtazapín||19727||19727|26745 010312|N06DX0101|Ebixa|töflur|10|mg|30|stk|1|þpakki||N06DX01|01.10.2002||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|8708|12658|lyfalmen|||00|30|0|15|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||8708||8708|12658 010323|N06DX0101|Ebixa|töflur|10|mg|50|stk|1|þpakki||N06DX01|01.10.2002||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|14223|19893|lyfalmen|||00|50|0|25|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||14223||14223|19893 010334|N06DX0101|Ebixa|töflur|10|mg|100|stk|1|þpakki||N06DX01|01.10.2002||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|25607|34066|lyfalmen|||00|100|0|50|Lundbeck Export A/S|H. Lundbeck A/S|Memantín||25607||25607|34066 010339|C09DA0701|MicardisPlus|töflur|92,5|mg|28|stk|1|þpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|B|0|BII|0|0|0|100|DKK|3940|6187|lyfalmen|||00|28|0|56|Vistor hf|Boehringer Ingelheim International |||3940||3940|6187 010348|J07BB0203|Vaxigrip|bóluefni|0| |0,5|ml|10|spr|einnotaspr|J07BB02|01.10.1995||R|K|1|0|0|0|0|SPM|0|0|0|100|XEU|9071|13150|lyfalmen|||51|5|0|0|Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsaðir mótefnavakar||9071||9071|13150 010361|C09DA0701|MicardisPlus|töflur|92,5|mg|98|stk|1|þpakki|80 + 12,5 mg|C09DA07|01.02.2008||R|A|3|0|0|B|0|BII|0|0|0|100|DKK|12728|18031|lyfalmen|||00|98|0|196|Vistor hf|Boehringer Ingelheim International |||12728||12728|18031 010437|QI09AB1301|Stellamune One|stl|0| |100|ml|10|glös|fleyti|QI09AB13|01.09.2008||R|K|3|0|0|0|0|PZR|0|0|0|100|DKK|75103|143231|vetalmen|||00|1000|0|0|Icepharma hf|Pfizer A/S (Í)|||75103||75103|143231 010464|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|50|ml|50|pokar|lausn|B05BB01|01.11.2002||R|A|1,5|0|0|0|1|BAM|0|0|0|100|SEK|12134|16974|lyfsjukr|||00|2500|0|0|Icepharma hf|Baxter Medical AB|Elektrólýtar||12134||12134|16974 010534|B05BA0108|Vaminolac|irl|0| |100|ml|10|fl||B05BA01|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|8476|12136|lyfsjukr|||00|1000|0|1|Icepharma hf|Fresenius Kabi|Amínósýrur||8476||8476|12136 010573|S01AX1901|Oftaquix|augndr|5|mg/ml|5|ml|1|glas||S01AX19|01.08.2002||R|A|3|0|0|0|0|SAO|0|0|1|100|XEU|1350|2672|lyfalmen|||00|5|0|0|Icepharma hf|Santen Oy|Levófloxacín||1350||1350|2672 010591|M05BA0702|Optinate Septimum|filmhtfl|35|mg|4|stk|1|þpakki||M05BA07|01.12.2002||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|4947|7554|lyfalmen|||00|4|0|28|Vistor hf|Sanofi-aventis Norge AS|||4947||4947|7554 010669|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|250|ml|30|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|6428|9203|lyfsjukr|||00|7500|0|8|Icepharma hf|Baxter Medical AB|Kolvetni||6428||6428|9203 010672|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|100|ml|50|pokar|lausn|B05BA03|01.11.2002||R|A|2,5|0|0|0|1|BAM|0|0|0|100|SEK|11788|16544|lyfsjukr|||00|5000|0|5|Icepharma hf|Baxter Medical AB|Kolvetni||11788||11788|16544 010683|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|500|ml|20|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|4487|6424|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|Kolvetni||4487||4487|6424 010691|B05BA0312|Glucos Baxter Viaflo 50 mg/ml|irl|50|mg/ml|1000|ml|10|pokar|lausn|B05BA03|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|2571|3681|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|Kolvetni||2571||2571|3681 010706|S01EE0301|Lumigan|augndr|0,3|mg/ml|3|ml|3|glös||S01EE03|01.04.2005||R|A|2|0|0|*|0|ALL|0|0|0|100|SEK|7331|10789|lyfalmen|||00|9|0|90|Vistor hf|Allergan|Bimatóprost||7331||7331|10789 010707|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|100|ml|50|pokar|lausn|B05BB01|01.11.2002||R|A|2,5|0|0|0|1|BAM|0|0|0|100|SEK|11788|16544|lyfsjukr|||00|5000|0|5|Icepharma hf|Baxter Medical AB|Elektrólýtar||11788||11788|16544 010729|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|250|ml|30|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|6471|9265|lyfsjukr|||00|7500|0|8|Icepharma hf|Baxter Medical AB|Elektrólýtar||6471||6471|9265 010740|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|500|ml|20|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|4314|6177|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|Elektrólýtar||4314||4314|6177 010746|M05BA0702|Optinate Septimum|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.12.2002||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|12829|18157|lyfalmen|V1080|18157|00|12|0|84|Vistor hf|Sanofi-aventis Norge AS|||12829||12829|18157 010760|B05BB0117|Natriumklorid Baxter Viaflo 9 mg/ml|irl|9|mg/ml|1000|ml|10|pokar|lausn|B05BB01|01.11.2002||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|2394|3428|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|Elektrólýtar||2394||2394|3428 010804|C02KX0101|Tracleer|filmhtfl|62,5|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|A|4|0|1|0|1|ACR|0|0|0|100|SEK|426998|533480|lyfsjukr|||00|56|0|14|Swedish Orphan International AB|Actelion Registration Ltd. (S)|Bósentan||426998||426998|533480 010826|C02KX0101|Tracleer|filmhtfl|125|mg|56|stk|1|þpakki||C02KX01|01.11.2003||R|A|4|0|1|0|1|ACR|0|0|0|100|SEK|426998|533480|lyfsjukr|||00|56|0|28|Swedish Orphan International AB|Actelion Registration Ltd. (S)|Bósentan||426998||426998|533480 010837|H01AX0101|Somavert|sts|15|mg|30|hgl|1|pakki|+ leysir|H01AX01|01.02.2004||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|635963|793641|lyfsjukr|||00|30|0|45|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Pegvisómant||635963||635963|793641 010848|H01AX0101|Somavert|sts|20|mg|30|hgl|1|pakki|+ leysir|H01AX01|01.02.2004||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|846398|1055633|lyfsjukr|||00|30|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Pegvisómant||846398||846398|1055633 010890|A02BC0107|Lomex-T|sh-tfl|20|mg|28|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|1785|2672|lyfalmen|||10|28|0|28|Actavis Group hf|Actavis hf|Ómeprazól||1350||1350|2672 010900|A01AB0301|Corsodyl|munnh.l|2|mg/ml|300|ml|1|fl||A01AB03|01.07.1986||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|300|0|20|Icepharma hf|GlaxoSmithKline CH A/S|Klórhexidín||||| 010912|A02BC0107|Lomex-T|sh-tfl|20|mg|100|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|E|0|ACA|0|0|0|100|IKR|6037|7550|lyfalmen|||10|100|0|100|Actavis Group hf|Actavis hf|Ómeprazól||4944||4944|7550 010923|A02BC0107|Lomex-T|sh-tfl|20|mg|56|stk|1|glas||A02BC01|01.06.2002||R|A|2|0|0|E|0|ACA|0|0|0|100|IKR|3384|4259|lyfalmen|||10|56|0|56|Actavis Group hf|Actavis hf|Ómeprazól||2519||2519|4259 010924|L01DC0103|Bleomycin Baxter|sts|15000|ae|10|hgl|1|pakki||L01DC01|01.04.1998||R|K|3,5|0|1|0|1|BAM|0|0|0|100|SEK|46783|60112|lyfsjukr|||03|10|0|0|Icepharma hf|Baxter Medical AB|Bleómýcín||46783||46783|60112 010935|J01CF0201|Ekvacillin|sts/irs|1|g|10|hgl|1|pakki||J01CF02|01.10.2003||R|A|3|0|0|0|1|REP|0|0|0|100|SEK|2691|3853|lyfsjukr|||03|10|0|5|Vistor hf|Recip AB|Kloxacillín||2691||2691|3853 010938|A02BC0304|Lanzo Melt|munndr.t|15|mg|28|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|WAB|0|0|0|100|SEK|2833|4685|lyfalmen|||00|28|0|14|Icepharma hf|Wyeth AB|Lansóprazól||2833||2833|4685 010951|N05AX1201|Abilify|töflur|10|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|22556|30267|lyfalmen|||00|28|0|19|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||22556||22556|30267 010953|N05AX1201|Abilify|töflur|15|mg|28|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|22556|30267|lyfalmen|||00|28|0|28|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||22556||22556|30267 010959|A01AB0301|Corsodyl|munnh.hl|10|mg/g|50|g|1|túpa||A01AB03|01.09.1982||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|50|0|17|Icepharma hf|GlaxoSmithKline CH A/S|Klórhexidín||||| 011008|N05AX1201|Abilify|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|37748|49181|lyfalmen|V1702|49181|00|56|0|37|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||37748||37748|49181 011019|N05AX1201|Abilify|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.01.2005||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|37748|49181|lyfalmen|V1703|49181|00|56|0|56|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||37748||37748|49181 011078|B05AA0702|Hemohes 6%|irl|60|mg/ml|500|ml|1|plpoki|án PVC (Ecobag)|B05AA07|01.05.2002|28.02.2009|R|A|2|0|0|0|1|BRA|0|0|0|100|XEU|||lyfsjukr|||00|500|0|0|Actavis Group hf|Braun|Hýdróxyetýl sterkja||||| 011163|A07EA0601|Entocort|forðahlk|3|mg|100|stk|1|glas||A07EA06|01.10.1996||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|17238|23646|lyfalmen|||00|100|0|33|Vistor hf|AstraZeneca A/S DK|Búdesóníð||17238||17238|23646 011207|M01AH0501|Arcoxia|filmhtfl|60|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|A|3|0|0|E|0|MSD|0|0|1|100|XEU|5989|8968|lyfalmen|||00|28|0|28|Icepharma hf|M.S.D.|Etoríkoxíb||5989||5989|8968 011271|M01AH0501|Arcoxia|filmhtfl|90|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|A|3|0|0|E|0|MSD|0|0|1|100|XEU|5989|8968|lyfalmen|||00|28|0|42|Icepharma hf|M.S.D.|Etoríkoxíb||5989||5989|8968 011314|N06AB1001|Cipralex|töflur|20|mg|100|stk|1|plglas||N06AB10|01.08.2002||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|24417|32584|lyfalmen|V2170|32021|00|100|0|200|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||24417||24417|32584 011335|C09CA0102|Lopress|töflur|12,5|mg|28|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|992|2187|lyfalmen|V0195|2187|00|28|0|7|Actavis Group hf|Actavis hf|Lósartan||992||992|2187 011353|N05AF0502|Cisordinol Depot|stl|500|mg/ml|1|ml|5|lykjur||N05AF05|01.10.1988||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|12504|17752|lyfalmen|||02|5|0|167|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||12504||12504|17752 011369|C09CA0102|Lopress|töflur|50|mg|28|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|1427|2777|lyfalmen|||00|28|0|28|Actavis Group hf|Actavis hf|Lósartan||1427||1427|2777 011380|C09CA0102|Lopress|töflur|50|mg|98|stk|1|glas||C09CA01|01.11.2002||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|4069|5469|lyfalmen|V0197|5469|00|98|0|98|Actavis Group hf|Actavis hf|Lósartan||3411||3411|5469 011409|R03AK0703|Symbicort forte Turbuhaler|innúðadu|329|mcg/sk|60|sk|1|pakki|320+9 mcg/sk|R03AK07|01.05.2003||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|7732|11333|lyfalmen|||00|60|0|30|Vistor hf|AstraZeneca A/S DK|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||7732||7732|11333 011453|G04BE0901|Levitra|filmhtfl|5|mg|12|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|11830|16894|lyfalmen|||00|12|0|6|Vistor hf|Bayer AG-|Vardenafíl||11830||11830|16894 011489|N06BA0402|Concerta|forðatfl|18|mg|30|stk|1|glas||N06BA04|01.01.2003||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|6392|9515|lyfalmen|||00|30|0|18|Vistor hf|Janssen-Cilag AB|Metýlfenídat||6392||6392|9515 011532|B05BC0101|Mannitol Baxter Viaflo|irl|150|mg/ml|500|ml|20|plpok|lausn|B05BC01|01.11.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|7509|10751|lyfsjukr|||02|10000|0|0|Icepharma hf|Baxter Medical AB|Mannitól||7509||7509|10751 011540|N01AX1401|S-Ketamin "Pfizer"|stl|5|mg/ml|5|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|A|3|1|0|0|1|PFI|0|0|0|100|DKK|2455|3515|lyfsjukr|||00|50|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Esketamín||2455||2455|3515 011547|M01AH0501|Arcoxia|filmhtfl|120|mg|28|stk|1|þpakki||M01AH05|01.10.2002||R|A|3|0|0|E|0|MSD|0|0|1|100|XEU|5989|8968|lyfalmen|||00|28|0|56|Icepharma hf|M.S.D.|Etoríkoxíb||5989||5989|8968 011555|N06BA0402|Concerta|forðatfl|36|mg|30|stk|1|glas||N06BA04|01.01.2003||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|8350|12172|lyfalmen|||00|30|0|36|Vistor hf|Janssen-Cilag AB|Metýlfenídat||8350||8350|12172 011561|QN05CM9203|Chanazine, vet.|stl|2|%|25|ml|1|hgl||QN05CM92|01.09.2002||R|A|5|0|0|0|0|CHP|1|0|0|100|USD|1620|3197|vetalmen|||00|25|0|0|Icepharma hf|Chanelle Pharmaceuticals |||1620||1620|3197 011609|N01AX1401|S-Ketamin "Pfizer"|stl|25|mg/ml|2|ml|10|lykjur|lausn|N01AX14|01.08.2005||R|A|3|1|0|0|1|PFI|0|0|0|100|DKK|4910|7030|lyfsjukr|||00|20|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Esketamín||4910||4910|7030 011620|G03CA0311|Estrogel|hlaup|0,6|mg/g|64|sk|1|fl|með skammtadælu|G03CA03|01.03.2000||R|A|2|0|0|E|0|OLF|0|0|0|100|SEK|1321|2633|lyfalmen|||00|64|0|29|Gróco ehf|Oy Leiras Finland Ab|Estradíól||1321||1321|2633 011690|J05AB0402|Copegus|töflur|200|mg|168|stk|1|plglas||J05AB04|01.03.2003||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|107980|136303|lyfsjukr|||00|168|0|34|Icepharma hf|Roche Registration Limited|Ribavirin||107980||107980|136303 011810|D11AX1501|Elidel|krem|1|%|60|g|1|túpa||D11AX15|01.11.2002||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|10477|15058|lyfalmen|||00|60|0|60|Vistor hf|Novartis Healthcare A/S-|Pímekrólímus||10477||10477|15058 011863|N06AB0602|Sertral|töflur|100|mg|28|stk|1|glas||N06AB06|01.10.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2003|3559|lyfalmen|V0935|3559|00|28|0|56|Actavis Group hf|Actavis hf|Sertralín||2003||2003|3559 011880|N06AB0602|Sertral|töflur|100|mg|98|stk|1|glas||N06AB06|01.10.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|7008|10351|lyfalmen|V0937|10351|00|98|0|196|Actavis Group hf|Actavis hf|Sertralín||7008||7008|10351 011953|N01BB0103|Marcain spinal|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|3946|5650|lyfsjukr|||02|20|0|0|Vistor hf|AstraZeneca A/S DK|Búpívakaín||3946||3946|5650 011969|N01BB0105|Marcain spinal tung|stl|5|mg/ml|4|ml|5|gl-lyk||N01BB01|01.01.2003||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|3584|5131|lyfsjukr|||02|20|0|0|Vistor hf|AstraZeneca A/S DK|Búpívakaín||3584||3584|5131 011986|C10AA0403|Lescol depot|forðatfl|80|mg|28|stk|1|þpakki||C10AA04|01.06.2004||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|4543|7005|lyfalmen|||00|28|0|56|Vistor hf|Novartis Healthcare A/S-|Flúvastatín||4543||4543|7005 011997|C10AA0403|Lescol depot|forðatfl|80|mg|98|stk|1|þpakki||C10AA04|01.06.2004||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|15639|21656|lyfalmen|||00|98|0|196|Vistor hf|Novartis Healthcare A/S-|Flúvastatín||15639||15639|21656 012030|J05AG0301|Stocrin|töflur|600|mg|30|stk|1|glas||J05AG03|01.01.2003||R|A|2|0|1|0|1|MSD|0|0|0|100|XEU|45879|58987|lyfsjukr|||00|30|0|30|Icepharma hf|M.S.D.|Efavirenz||45879||45879|58987 012209|G04CB0201|Avodart|hylki|0,5|mg|90|stk|1|pakki|mjúk hylki|G04CB02|01.05.2003||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|10659|15305|lyfalmen|||00|90|0|90|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Dútasteríð||10659||10659|15305 012260|R01AC0301|Lastin|nefúði|1|mg/ml|20|ml|1|glas||R01AC03|01.06.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|1248|2534|lyfalmen|||00|20|0|36|Vistor hf|Meda AB|Azelastínum||1248||1248|2534 012273|G04BE0801|Cialis|filmhtfl|10|mg|4|stk|1|þpakki||G04BE08|01.02.2003||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|6113|9136|lyfalmen|||00|4|0|4|Icepharma hf|Lilly ICOS Limited|Tadalafíl||6113||6113|9136 012278|N07BA0106|Nicotinell|forðapl|7|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|7|0|4|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 012309|QP52AA5104|Zantel|töflur|550|mg|20|stk|1|þpakki|50+500 mg|QP52AA51|01.12.2003||R|A|3|0|0|0|0|ICE|0|0|0|100|USD|5687|9842|vetorma|||00|20|0|0|Icepharma hf|Icepharma hf|||5687||5687|9842 012310|A10BB1201|Amaryl|töflur|1|mg|30|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|825|1960|lyfalmen|||00|30|0|15|Vistor hf|Aventis Pharma |Glímepíríð||825||825|1960 012326|N06BA0402|Concerta|forðatfl|54|mg|30|stk|1|glas||N06BA04|01.08.2005||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|9896|14270|lyfalmen|||00|30|0|54|Vistor hf|Janssen-Cilag AB|Metýlfenídat||9896||9896|14270 012461|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 012504|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|2|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 012508|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 012577|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.12.2003||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|2|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 012640|QP52AA5104|Zantel|töflur|550|mg|100|stk|1|þpakki|50+500 mg|QP52AA51|01.12.2003||R|A|3|0|0|0|0|ICE|0|0|0|100|USD|26729|46256|vetorma|||00|100|0|0|Icepharma hf|Icepharma hf|||26729||26729|46256 012716|N07BA0106|Nicotinell|forðapl|14|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|7|0|7|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 012738|M05BC0101|InductOs|ígr.sett|12|mg|1|stk|1|pakki||M05BC01|01.09.2003||R|A|3|0|1|0|1|WTE|0|0|0|100|USD|502092|626972|lyfsjukr|||00|1|0|0|Icepharma hf|Wyeth Europe|Díbótermín alfa||502092||502092|626972 012770|G04BE0901|Levitra|filmhtfl|5|mg|4|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|4218|6564|lyfalmen|||00|4|0|2|Vistor hf|Bayer AG-|Vardenafíl||4218||4218|6564 012792|G04BE0901|Levitra|filmhtfl|10|mg|4|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|4667|7174|lyfalmen|||00|4|0|4|Vistor hf|Bayer AG-|Vardenafíl||4667||4667|7174 012799|N07BA0106|Nicotinell|forðapl|21|mg/sólh|7|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|7|0|10|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 012816|G04BE0901|Levitra|filmhtfl|10|mg|12|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|13748|19301|lyfalmen|||00|12|0|12|Vistor hf|Bayer AG-|Vardenafíl||13748||13748|19301 012838|G04BE0901|Levitra|filmhtfl|20|mg|4|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|5786|8692|lyfalmen|||00|4|0|8|Vistor hf|Bayer AG-|Vardenafíl||5786||5786|8692 012860|G04BE0901|Levitra|filmhtfl|20|mg|12|stk|1|þpakki||G04BE09|01.05.2003||R|A|3|0|0|0|0|BAG|0|0|0|100|XEU|16729|23013|lyfalmen|||00|12|0|24|Vistor hf|Bayer AG-|Vardenafíl||16729||16729|23013 012880|J01CR0202|Augmentin|mixtduft|62,5|mg/ml|80|ml|1|glas|50+12.5 mg|J01CR02|01.10.1989||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|718|1815|lyfalmen|||08|80|0|4|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||718||718|1815 012921|G03AA1301|Evra|forðapl|0| |9|stk|1|pakki|6 mg+600 mcg|G03AA13|01.11.2003||R|A|2|0|0|0|0|JCI|0|0|0|100|SEK|3962|6217|lyfalmen|||00|9|0|0|Vistor hf|Janssen-Cilag International N.V.|Norelgestromín og östrógen||3962||3962|6217 012953|G03BA0306|Testogel|hlaup|50|mg|30|sk-pokar|1|pakki||G03BA03|01.12.2003||R|A|3|0|0|E|0|LBI|0|0|0|100|SEK|6125|9152|lyfalmen|||00|30|0|30|Icepharma hf|Laboratoires Besins International|Testósterón||6125||6125|9152 013068|N06BA0403|Ritalin Uno|hylki|20|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|6276|9357|lyfalmen|||00|30|0|20|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||6276||6276|9357 013070|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|6882|13280|vetalmen|||00|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||6882||6882|13280 013079|N06BA0403|Ritalin Uno|hylki|40|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|10242|14739|lyfalmen|||00|30|0|40|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||10242||10242|14739 013082|QM01AE9101|Rimadyl vet.|tuggutfl|50|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|1785|3522|vetalmen|||00|20|0|0|Icepharma hf|Pfizer Oy Animal Health|||1785||1785|3522 013097|A02BC0301|Lanzo|munndr.t|15|mg|14|stk|1|þpakki||A02BC03|01.02.2007||R|A|3|0|0|0|0|WAB|0|0|0|100|USD|1270|2564|lyfalmen|||00|14|0|7|Icepharma hf|Wyeth AB|Lansóprazól||1270||1270|2564 013100|R07AX0101|INOmax|innö.gas|400|ppm|2|l|1|gashyl||R07AX01|01.01.2004||R|A|2|0|1|0|1|AGA|0|0|0|100|XEU|22573|29971|lyfsjukr|||00|2|0|0|Ísaga ehf|AGA AB|Nituroxíð||22573||22573|29971 013172|J06BB0101|Rhophylac|stl|1500|ae|2|ml|1|spr||J06BB01|01.02.2004||R|K|3|0|0|0|1|ZLB|0|0|0|100|SEK|8775|12564|lyfsjukr|||17|2|0|0|Icepharma hf|ZLB GmbH|And-D(rh) immúnóglóbúlín||8775||8775|12564 013259|B02BD0402|BeneFIX|sts|0| |250|ae|1|hgl|+leysir|B02BD04|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|USD|33191|43190|lyfsjukr|||00|250|0|1|Icepharma hf|Wyeth Europe|Storkuþáttur IX||33191||33191|43190 013270|B02BD0402|BeneFIX|sts|0| |500|ae|1|hgl|+leysir|B02BD04|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|USD|66386|84518|lyfsjukr|||00|500|0|1|Icepharma hf|Wyeth Europe|Storkuþáttur IX||66386||66386|84518 013308|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|4520|8781|vetalmen|||00|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||4520||4520|8781 013317|QM01AE9101|Rimadyl vet.|tuggutfl|100|mg|100|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|10863|20864|vetalmen|||00|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||10863||10863|20864 013328|QM01AE9101|Rimadyl vet.|tuggutfl|20|mg|20|stk|1|pakki||QM01AE91|01.08.2005||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|1140|2250|vetalmen|||00|20|0|0|Icepharma hf|Pfizer Oy Animal Health|||1140||1140|2250 013341|B02BD0206|Advate|sts|1500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BAL|0|0|0|100|SEK|180008|225977|lyfsjukr|||00|1|0|3|Lyfjaver ehf|Baxter Medical AB (L)|Storkuþáttur VIII||180008||180008|225977 013362|B02BD0206|Advate|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|30001|39219|lyfsjukr|||00|1|0|0|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||30001||30001|39219 013365|B02BD0206|Advate|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|120005|151274|lyfsjukr|||00|1|0|2|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||120005||120005|151274 013373|B02BD0206|Advate|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.06.2005||R|K|2|0|0|0|1|BER|0|0|0|100|SEK|58440|74625|lyfsjukr|||00|1|0|2|Lyfjaver ehf|Baxter AG (L)|Storkuþáttur VIII||58440||58440|74625 013485|C10AX0901|Ezetrol|töflur|10|mg|98|stk|1|þpakki||C10AX09|01.05.2003||R|A|2|0|0|0|0|MSD|0|0|0|100|XEU|20757|28027|lyfalmen|||00|98|0|98|Icepharma hf|M.S.D.|Ezetimíb||20757||20757|28027 013544|L04AB0401|Humira|stl|40|mg/spr|0,8|ml|2|spr||L04AB04|01.12.2003||R|K|1,5|0|1|0|1|ABB|0|0|0|100|DKK|188813|236940|lyfsjukr|||00|2|0|28|Vistor hf|Abbott|Adalimumab||188813||188813|236940 013593|A01AA3001|Xerodent|munnstfl|0| |90|stk|1|plglas|28,6 mg /0,25 mg|A01AA30|01.01.2008||L|A|2|0|0|0|0|AGT|0|0|1|100|IKR|||lyfalmen|||00|90|0|0|Actavis Group hf|Actavis Group hf|Blöndur|||||1367 013660|A10AD0116|Mixtard 30 InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar sprautur|A10AD01|01.03.2002|30.04.2009|R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|6327|9426|lyfalmen|||00|15|0|38|Vistor hf|Novo-Nordisk|Insúlín (manna)||6327||6327|9426 013672|N03AG0101|Depakine|mixtúra|200|mg/ml|40|ml|1|glas||N03AG01|01.12.1978||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1272|2567|lyfalmen|||00|40|0|5|Vistor hf|Sanofi-aventis Norge AS|Valpróínsýra||1272||1272|2567 013707|N01BB0203|Xylocain|hlaup|20|mg/ml|30|g|1|túpa||N01BB02|01.10.2003||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|457|1461|lyfalmen|||00|30|0|0|Vistor hf|AstraZeneca A/S DK|Lídókaín||457||457|1461 013718|M05BA0801|Zometa|irþ|4|mg/hgl|5|ml|1|hgl|lausn|M05BA08|01.05.2004||R|A|3|0|1|0|1|NOE|0|0|0|100|DKK|46561|59836|lyfsjukr|||00|5|0|1|Vistor hf|Novartis Europharm Ltd|||46561||46561|59836 013756|C09DA0307|Diovan Comp 160/25 mg|filmhtfl|185|mg|28|stk|1|þpakki||C09DA03|01.04.2005||R|A|2|0|0|B|0|NOH|0|0|0|100|DKK|4778|7324|lyfalmen|||00|28|0|56|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||4778||4778|7324 013767|C09DA0307|Diovan Comp 160/25 mg|filmhtfl|185|mg|98|stk|1|þpakki||C09DA03|01.04.2005||R|A|2|0|0|B|0|NOH|0|0|0|100|DKK|16430|22640|lyfalmen|||00|98|0|196|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||16430||16430|22640 013861|J01CR0202|Augmentin|töflur|625|mg|20|stk|1|þpakki|500+125 mg|J01CR02|01.01.2003||R|A|3|0|0|0|0|GSK|0|0|1|100|IKR|1215|2489|lyfalmen|V0465|2489|00|20|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1215||1215|2489 013901|A10AC0108|Insulatard InnoLet|stl|100|ae/ml|3|ml|5|spr|áfylltar spr.|A10AC01|01.02.2002||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|7075|10442|lyfalmen|||00|15|0|38|Vistor hf|Novo-Nordisk|Insúlín (manna)||7075||7075|10442 013909|A10AB0107|Actrapid NovoLet|stl|100|ae/ml|3|ml|5|rörlyk|einnotapen|A10AB01|01.08.2003||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|5496|8299|lyfalmen|||51|15|0|38|Vistor hf|Novo-Nordisk|Insúlín (manna)||5496||5496|8299 013950|A10AB0101|Actrapid|stl|100|ae/ml|10|ml|1|hgl||A10AB01|01.03.2004||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|2693|4495|lyfalmen|||51|10|0|25|Vistor hf|Novo-Nordisk|Insúlín (manna)||2693||2693|4495 013957|A10AC0109|Insulatard FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AC01|01.02.2004||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|5064|7712|lyfalmen|||00|15|0|38|Vistor hf|Novo-Nordisk|Insúlín (manna)||5064||5064|7712 013971|L01XE0101|Glivec|filmhtfl|100|mg|60|stk|1|þpakki||L01XE01|01.05.2004||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|224055|280816|lyfsjukr|||00|60|0|0|Vistor hf|Novartis Europharm Ltd|Imatiníb||224055||224055|280816 013982|L01XE0101|Glivec|filmhtfl|400|mg|30|stk|1|þpakki||L01XE01|01.05.2004||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|396157|495083|lyfsjukr|||00|30|0|0|Vistor hf|Novartis Europharm Ltd|Imatiníb||396157||396157|495083 014010|A10AC0103|Insulatard|stl|100|ae/ml|10|ml|1|hgl||A10AC01|01.04.1986||R|K|2.5|0|0|*|0|NON|0|0|0|100|DKK|2669|4462|lyfalmen|||71|10|0|25|Vistor hf|Novo-Nordisk|Insúlín (manna)||2669||2669|4462 014031|A02BC0501|Nexium|sts|40|mg|5|ml|10|hgl|lausn|A02BC05|01.04.2004||R|A|2|0|0|0|1|AZD|0|0|0|100|SEK|14348|19731|lyfsjukr|||00|50|0|13|Vistor hf|AstraZeneca A/S DK|Esómeprazól||14348||14348|19731 014081|N03AX1401|Keppra|mixtúra|100|mg|300|ml|1|glas||N03AX14|01.12.2006||R|A|3|0|1|E|0|UCB|0|0|0|100|DKK|23865|31897|lyfalmen|||00|300|0|20|Vistor hf|U.C.B|Levetíracetam||23865||23865|31897 014094|H05AA0202|Forsteo|stl|250|mcg/ml|3|ml|1|penni|20 mcg/80 mcl|H05AA02|01.11.2003||R|K|2|0|0|0|0|ELD|0|0|0|100|XEU|61237|78425|lyfalmen|||AC|3|0|38|Icepharma hf|Eli Lilly Nederland -|Teriparatíð||61237||61237|78425 014138|B05BA1020|StructoKabiven elektrolyfri|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|36569|47396|lyfsjukr|||00|5908|0|0|Icepharma hf|Fresenius Kabi|Blöndur||36569||36569|47396 014261|D10AX0302|Finacea|hlaup|15|%|30|g|1|túpa||D10AX03|01.04.2005||R|A|3|0|0|0|0|IGB|0|0|0|100|SEK|1266|2558|lyfalmen|||00|30|0|30|Icepharma hf|Intendis GmbH Berlin|Azelainsýra||1266||1266|2558 014285|B05BA1020|StructoKabiven elektrolyfri|irl|2100|kcal|1970|ml|2|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|22527|29914|lyfsjukr|||00|3940|0|0|Icepharma hf|Fresenius Kabi|Blöndur||22527||22527|29914 014290|S01GX0201|Livostin|augndr|0,5|mg/ml|4|ml|1|glas||S01GX02|01.10.1991||L|A|2|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||29|4|0|0|Vistor hf|Janssen-Cilag AB|Levókabastín||||| 014352|B05BA1015|StructoKabiven|irl|1100|kcal|986|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|24805|32750|lyfsjukr|||00|3944|0|0|Icepharma hf|Fresenius Kabi|Blöndur||24805||24805|32750 014361|B05BA1015|StructoKabiven|irl|1600|kcal|1477|ml|4|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|32462|42283|lyfsjukr|||00|5908|0|0|Icepharma hf|Fresenius Kabi|Blöndur||32462||32462|42283 014372|B05BA1015|StructoKabiven|irl|2100|kcal|1970|ml|2|pokar|fleyti|B05BA10|01.03.2004||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|22527|29914|lyfsjukr|||00|3940|0|0|Icepharma hf|Fresenius Kabi|Blöndur||22527||22527|29914 014453|G02BA0302|Mirena|leginnle|20|mcg/sólh|1|stk|1|pakki||G02BA03|01.04.1994||R|A|3|0|0|0|0|SCH|0|0|0|100|SEK|15237|21155|lyfalmen|||23|1|0|1825|Icepharma hf|Schering Oy|Plast lyfjalykkja (IUD) með prógestógen||15237||15237|21155 014510|J05AF0801|Hepsera|töflur|10|mg|30|stk|1|glas||J05AF08|01.03.2009||R|A|2|0|1|0|1|GIS|0|0|0|100|DKK|84184|106677|lyfsjukr|||0|30|0|30|Gilead Sience Sweden AB|Gilead Science International ltd.|||||84184|106677 014541|QA02BX1201|Orbeseal|spenalyf|2,6|g/dælu|24|dælur|1|pakki||QA02BX12|01.04.2005||R|A|5|0|0|0|0|PFI|0|0|0|100|XEU|5798|11216|vetalmen|||16|24|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5798||5798|11216 014583|J05AX0701|Fuzeon|sts|90|mg/ml|60|hgl|1|pakki|+ leysir|J05AX07|01.12.2003||R|A|2|0|1|0|1|RRL|0|0|0|100|DKK|297763|372582|lyfsjukr|||00|60|0|0|Icepharma hf|Roche Registration Limited|Enfúvirtíð||297763||297763|372582 014679|N02AA0501|Oxycontin|forðatfl|5|mg|28|stk|1|þpakki||N02AA05|01.12.2005||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|2453|4169|lyfalmen|||10|28|0|2|Icepharma hf|Norpharma |Oxýcódon||2453||2453|4169 014702|C09CA0601|Atacand|töflur|32|mg|28|stk|1|þpakki||C09CA06|01.06.2005||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|4276|6643|lyfalmen|||00|28|0|112|Vistor hf|AstraZeneca A/S DK|Candesartan||4276||4276|6643 014713|C09CA0601|Atacand|töflur|32|mg|98|stk|1|þpakki||C09CA06|01.06.2005||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|14471|20201|lyfalmen|||00|98|0|392|Vistor hf|AstraZeneca A/S DK|Candesartan||14471||14471|20201 014728|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|K|2|0|1|0|1|AEU|0|0|0|100|DKK|76754|97426|lyfsjukr|||00|2|0|4|Vistor hf|Amgen Europe B.V.|Fílgrastím||76754||76754|97426 014739|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|5|spr|áfyllt sprauta, lausn|L03AA02|01.12.2003||R|K|2|0|1|0|1|AEU|0|0|0|100|DKK|118817|149795|lyfsjukr|||00|2|0|7|Vistor hf|Amgen Europe B.V.|Fílgrastím||118817||118817|149795 014847|L04AA1801|Certican|töflur|0,25|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|A|3|0|1|*|0|NOV|0|0|0|100|DKK|19645|26643|lyfalmen|||00|60|0|10|Icepharma hf|Novartis Healthcare A/S|Everolímus||19645||19645|26643 014853|L04AA1801|Certican|töflur|0,75|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|A|3|0|1|*|0|NOV|0|0|0|100|DKK|59281|75990|lyfalmen|||00|60|0|30|Icepharma hf|Novartis Healthcare A/S|Everolímus||59281||59281|75990 014859|L04AA1801|Certican|töflur|0,5|mg|60|stk|1|þpakki||L04AA18|01.04.2007||R|A|3|0|1|*|0|NOV|0|0|0|100|DKK|39460|51313|lyfalmen|||00|60|0|20|Icepharma hf|Novartis Healthcare A/S|Everolímus||39460||39460|51313 015037|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|90|stk|1|glas||M01AX05|01.10.2006||L|A|2|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||00|90|0|24|Icepharma hf|Pharma Nord ApS|Glúkósamín||||| 015230|R01AC0301|Lastin|nefúði|1|mg/ml|10|ml|1|glas||R01AC03|01.06.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|636|1703|lyfalmen|||00|10|0|18|Vistor hf|Meda AB|Azelastínum||636||636|1703 015301|M01AX0502|Glucosamin Pharma Nord|hylki|400|mg|270|stk|1|glas||M01AX05|01.10.2006||L|A|2|0|0|0|0|PNA|0|0|1|100|IKR|||lyflausa|||00|270|0|72|Icepharma hf|Pharma Nord ApS|Glúkósamín||||| 015316|N06AX1103|Miron|filmhtfl|30|mg|100|stk|1|plglas||N06AX11|01.07.2003||R|A|2|0|0|B|0|ACA|0|1|0|100|IKR|4886|7471|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|Mirtazapín||4886||4886|7471 015343|A10AE0501|Levemir FlexPen|stl|100|ae/ml|3|ml|5|pennar||A10AE05|01.12.2005||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|9601|13869|lyfalmen|||00|15|0|38|Vistor hf|Novo-Nordisk|Insúlín detemír||9601||9601|13869 015344|N06AX1103|Miron|filmhtfl|30|mg|30|stk|1|plglas||N06AX11|01.07.2003||R|A|2|0|0|B|0|ACA|0|1|0|100|IKR|2563|4318|lyfalmen|||00|30|0|30|Actavis Group hf|Actavis hf|Mirtazapín||2563||2563|4318 015381|H02AB0104|Betapred|lausnart|0,5|mg|100|stk|1|glas||H02AB01|01.01.1998||R|A||0|0|E|0|LVE|0|0|1|100|IKR|2760|4586|lyfalmen|||00|100|1|33|Lyfjaver ehf|Lyfjaver - óskráð lyf|Betametasón||2760||2760|4586 015419|G03CA0316|Vivelle Dot|forðapl|25|mcg/sólh|8|stk|1|pakki||G03CA03|01.02.2006||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|1109|2345|lyfalmen|||23|8|0|14|Vistor hf|Novartis Healthcare A/S-|Estradíól||1109||1109|2345 015442|N02CC0103|Imigran Radis|filmhtfl|100|mg|6|stk|1|þpakki||N02CC01|01.10.2005||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|2084|3442|lyfalmen|V0832|3442|00|6|0|12|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||1917||1917|3442 015443|N02CC0103|Imigran Radis|filmhtfl|50|mg|12|stk|1|þpakki||N02CC01|01.10.2005||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|3042|4556|lyfalmen|V0831|4556|00|12|0|12|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||2738||2738|4556 015448|A10AE0502|Levemir Penfill|stl|100|ae/ml|3|ml|5|rörlyk||A10AE05|01.03.2007||R|K|2|0|0|*|0|NON|0|0|0|100|DKK|10778|15467|lyfalmen|||00|15|0|38|Vistor hf|Novo-Nordisk|Insúlín detemír||10778||10778|15467 015532|L01CX0101|Yondelis|irþ|1|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|K|3|0|1|0|1|PAM|0|0|0|100|DKK|351784|439839|lyfsjukr|||00|1|0|0|Lyfjaver ehf|Pharma Mar S.A.|Trabecetedín||351784||351784|439839 015598|L01CX0101|Yondelis|irþ|0,25|mg/hgl|1|hgl|1|pakki||L01CX01|01.03.2008||R|K|3|0|1|0|1|PAM|0|0|0|100|DKK|93502|118277|lyfsjukr|||00|1|0|0|Lyfjaver ehf|Pharma Mar S.A.|Trabecetedín||93502||93502|118277 015605|N04BA0301|Stalevo|filmhtfl|262,5|mg|30|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|6238|9306|lyfalmen|||00|30|0|3|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||6238||6238|9306 015652|N04BA0301|Stalevo|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|13748|19301|lyfalmen|V1732|19300|00|100|0|11|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||13748||13748|19301 015655|N04BA0301|Stalevo|filmhtfl|387,5|mg|30|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|6238|9306|lyfalmen|||00|30|0|10|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||6238||6238|9306 015663|N04BA0301|Stalevo|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|20704|27961|lyfalmen|V1731|27960|00|100|0|33|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||20704||20704|27961 015677|N05CF0201|Stilnoct|töflur|10|mg|1000|stk|1|þpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|33913|44407|lyfalmen|||00|1000|0|1000|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||33913||33913|44407 015679|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|þpakki||J05AE08|01.04.2005||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|81381|103187|lyfsjukr|||43|60|0|0|Vistor hf|Bristol-Myers Squibb|Atazanavír||81381||81381|103187 015695|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|þpakki||J05AE08|01.04.2005||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|81381|103187|lyfsjukr|||43|60|0|0|Vistor hf|Bristol-Myers Squibb|Atazanavír||81381||81381|103187 015699|J05AE0801|Reyataz|hylki|150|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|81381|103187|lyfsjukr|||43|60|0|0|Vistor hf|Bristol-Myers Squibb|Atazanavír||81381||81381|103187 015707|N04BA0301|Stalevo|filmhtfl|325|mg|30|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|6238|9306|lyfalmen|||00|30|0|7|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||6238||6238|9306 015718|N04BA0301|Stalevo|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.03.2004||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|13603|19121|lyfalmen|V1730|19121|00|100|0|22|Vistor hf|Orion Corporation|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||13603||13603|19121 015723|J05AE0801|Reyataz|hylki|200|mg|60|stk|1|plglas||J05AE08|01.06.2008||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|81381|103187|lyfsjukr|||43|60|0|0|Vistor hf|Bristol-Myers Squibb|Atazanavír||81381||81381|103187 015733|L04AA0602|Myfortic|sh-tfl|180|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|A|2,5|0|1|*|0|NOH|0|0|0|100|DKK|28258|37366|lyfalmen|||00|120|0|10|Vistor hf|Novartis Healthcare A/S-|Mýcófenólsýra||28258||28258|37366 015755|L04AA0602|Myfortic|sh-tfl|360|mg|120|stk|1|þpakki||L04AA06|01.11.2004||R|A|2,5|0|1|*|0|NOH|0|0|0|100|DKK|49146|63372|lyfalmen|||00|120|0|22|Vistor hf|Novartis Healthcare A/S-|Mýcófenólsýra||49146||49146|63372 015800|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA04|01.01.1977||R|A|2|0|0|E|0|ALC|0|0|0|100|USD|972|2159|lyfalmen|||06|15|0|0|K.Pétursson hf|Alcon|Cýklópentólat||972||972|2159 015823|QP54AB5205|Advocate stórir kettir|bl.lausn|110|mg|0,8|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|3244|5614|vetorma|||16|2|0|0|Vistor hf|Bayer HealthCare AG|||3244||3244|5614 015833|J01DC0204 |Cefuroxim Villerton|sts|750|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|A|3|0|0|0|1|VIL|0|0|0|100|NOK|3814|5461|lyfsjukr|||00|750|0|0|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||||3814|5461 015844|J01DC0204 |Cefuroxim Villerton|sts|1500|mg/hgl|10|hgl|1|pakki||J01DC02|01.05.2009||R|A|3|0|0|0|1|VIL|0|0|0|100|NOK|7296|10446|lyfsjukr|||00|1500|0|0|Lyfjaver ehf|Villerton Invest AS|Cefúroxím||||7296|10446 015855|QP54AB5206|Advocate yfirstærðar hundar|bl.lausn|125|mg|4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|4559|7890|vetorma|||16|12|0|0|Vistor hf|Bayer HealthCare AG|||4559||4559|7890 015873|QP54AB5202|Advocate litlir kettir|bl.lausn|110|mg|0,4|ml|3|túpa|100+10 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|2894|5008|vetorma|||16|1|0|0|Vistor hf|Bayer HealthCare AG|||2894||2894|5008 015882|QP54AB5203|Advocate millistórir hundar|bl.lausn|125|mg|1|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|3628|6278|vetorma|||16|3|0|0|Vistor hf|Bayer HealthCare AG|||3628||3628|6278 015883|M01CC0101|Atamir|hylki|250|mg|50|stk|1|þpakki||M01CC01|01.05.1978||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|4623|7114|lyfalmen|||10|50|0|25|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||4623||4623|7114 015904|QP54AB5204|Advocate stórir hundar|bl.lausn|125|mg|2,5|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|4065|7035|vetorma|||16|8|0|0|Vistor hf|Bayer HealthCare AG|||4065||4065|7035 015912|D11AX1401|Protopic|smyrsli|0,03|%|10|g|1|túpa||D11AX14|01.03.2009||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|2044|3614|lyfalmen|||0|10|0|0|Vistor hf|Astellas Pharma A/S|Takrólímus||||2044|3614 015923|D11AX1401|Protopic|smyrsli|0,1|%|10|g|1|túpa||D11AX14|01.10.2007||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|2296|3956|lyfalmen|||00|10|0|0|Vistor hf|Astellas Pharma A/S|Takrólímus||2296||2296|3956 015929|N02AA0110|Morphine Sulphate BP|stl|10|mg/ml|1|ml|10|lykjur||N02AA01|01.07.2003||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1453|2812|lyfalmen|||02|10|0|3|Icepharma hf|Martindale Pharmaceuticals|Morfín||1453||1453|2812 015944|QP54AB5201|Advocate litlir hundar|bl.lausn|125|mg|0,4|ml|3|túpa|100+25 mg|QP54AB52|01.02.2006||R|A|2|0|0|0|0|BHC|0|0|0|100|DKK|3244|5614|vetorma|||16|1|0|0|Vistor hf|Bayer HealthCare AG|||3244||3244|5614 015964|N06AB0501|Seroxat|töflur|10|mg|28|stk|1|þpakki||N06AB05|01.12.2006||R|A|3|0|0|B|0|GSK|0|1|0|100|GBP|1398|2738|lyfalmen|||00|28|0|14|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1398||1398|2738 015985|C09AA0401|Coversyl|töflur|8|mg|90|stk|1|þpakki||C09AA04|01.06.2005||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|15769|21817|lyfalmen|||00|90|0|180|Icepharma hf|Servier|Perindópríl||15769||15769|21817 016000|N02CC0501|Almogran|töflur|12,5|mg|6|stk|1|þpakki|filmuhúðaðar töflur|N02CC05|01.05.2001||R|A|5|0|0|E|0|LAA|0|0|0|100|SEK|4875|7456|lyfalmen|||00|6|0|6|Vistor hf|Laboratorios Almirall S.A.|Almótriptan||4875||4875|7456 016003|C09AA0401|Coversyl|töflur|8|mg|30|stk|1|þpakki||C09AA04|01.06.2005||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|5304|8038|lyfalmen|||00|30|0|60|Icepharma hf|Servier|Perindópríl||5304||5304|8038 016011|N02CC0501|Almogran|töflur|12,5|mg|9|stk|1|þpakki|filmuhúðaðar töflur|N02CC05|01.05.2001||R|A|5|0|0|E|0|LAA|0|0|0|100|SEK|6903|10208|lyfalmen|||00|9|0|9|Vistor hf|Laboratorios Almirall S.A.|Almótriptan||6903||6903|10208 016017|C10AA0701|Crestor|filmhtfl|10|mg|100|stk|1|þpakki||C10AA07|01.03.2004||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|12228|17409|lyfalmen|||00|100|0|100|Vistor hf|AstraZeneca A/S DK|||12228||12228|17409 016021|N02AB0203|Pethidine BP|stl|50|mg/ml|1|ml|10|lykjur||N02AB02|01.07.2003||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1080|2306|lyfalmen|||02|10|0|1|Icepharma hf|Martindale Pharmaceuticals|Petidín||1080||1080|2306 016028|C10AA0701|Crestor|filmhtfl|20|mg|100|stk|1|þpakki||C10AA07|01.03.2004||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|18319|24992|lyfalmen|||00|100|0|200|Vistor hf|AstraZeneca A/S DK|||18319||18319|24992 016032|N02AB0203|Pethidine BP|stl|50|mg/ml|2|ml|10|lykjur||N02AB02|01.01.2004||R|A|3|1|0|0|0|MAP|0|0|0|100|GBP|1144|2393|lyfalmen|||02|20|0|2|Icepharma hf|Martindale Pharmaceuticals|Petidín||1144||1144|2393 016038|N02CC0501|Almogran|töflur|12,5|mg|3|stk|1|þpakki|filmuhúðaðar töflur|N02CC05|01.05.2001||R|A|5|0|0|E|0|LAA|0|0|0|100|SEK|2517|4256|lyfalmen|||00|3|0|3|Vistor hf|Laboratorios Almirall S.A.|Almótriptan||2517||2517|4256 016066|R02AA0303|Strepsils Sukkerfri med Citron og Örter|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.10.2005||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||| 016125|M02AA1001|Orudis|hlaup|25|mg/g|60|g|1|túpa||M02AA10|01.03.2000||L|A|2|0|0|0|0|SNO|0|0|1|100|IKR|||lyflausa|||00|60|0|0|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||||| 016178|A10BD0301|Avandamet|filmhtfl|502|mg|112|stk|1|þpakki|500+2mg|A10BD03|01.03.2004||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|7526|11054|lyfalmen|||00|112|0|56|GlaxoSmithKline ehf|SmithKline Beecham PLC|Metformín og rosiglítazón||7526||7526|11054 016209|N05AX0801|Risperdal|töflur|2|mg|28|stk|1|þpakki|frostþ. töflur|N05AX08|01.09.2004||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|7313|10764|lyfalmen|||00|28|0|11|Vistor hf|Janssen-Cilag AB|Risperídón||7313||7313|10764 016239|A10BD0301|Avandamet|filmhtfl|501|mg|112|stk|1|þpakki|500+1mg|A10BD03|01.03.2004||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|4210|6554|lyfalmen|||00|112|0|56|GlaxoSmithKline ehf|SmithKline Beecham PLC|Metformín og rosiglítazón||4210||4210|6554 016285|N03AX1601|Lyrica|hylki|150|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|3346|5381|lyfalmen|||00|14|0|7|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3346||3346|5381 016294|N03AX1601|Lyrica|hylki|75|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|7108|10486|lyfalmen|||00|56|0|14|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||7108||7108|10486 016296|G03GA0801|Ovitrelle|stl|250|mcg/spr|0,5|ml|1|spr|lausn|G03GA08|01.03.2004||R|K|2|0|1|E|0|SEE|0|0|0|100|SEK|4548|7012|lyfalmen|||00|0|0|1|Gróco ehf|Serono Europe|Chóríógónadótrópín alfa||4548||4548|7012 016315|N03AX1601|Lyrica|hylki|150|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|10820|15524|lyfalmen|||00|56|0|28|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||10820||10820|15524 016318|N03AX1601|Lyrica|hylki|75|mg|14|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|2248|3891|lyfalmen|||00|14|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2248||2248|3891 016323|N03AX1601|Lyrica|hylki|300|mg|56|stk|1|þpakki||N03AX16|01.12.2004||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|15869|21942|lyfalmen|||00|56|0|56|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||15869||15869|21942 016337|C08CA0302|Lomir Retard|forðahlk|5|mg|100|stk|1|þpakki||C08CA03|01.04.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|11363|16261|lyfalmen|||10|100|0|100|Vistor hf|Novartis Healthcare A/S-|Ísradipín||11363||11363|16261 016353|N05AX0801|Risperdal|töflur|1|mg|28|stk|1|þpakki|frostþ. töflur|N05AX08|01.08.2004||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|4119|6430|lyfalmen|||00|28|0|6|Vistor hf|Janssen-Cilag AB|Risperídón||4119||4119|6430 016363|L01BC0108|Cytarabine Pfizer|stl/irl|20|mg/ml|5|ml|5|hgl||L01BC01|01.11.2000||R|A|1.5|0|1|0|1|PFI|0|0|0|100|DKK|4721|6759|lyfsjukr|||00|25|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Cýtarabín||4721||4721|6759 016364|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|2|ml|5|hgl||L01BA01|01.10.1995||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|5977|8558|lyfsjukr|||00|10|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metótrexat||5977||5977|8558 016374|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|20|ml|1|hgl||L01BC01|01.10.1995||R|A|1.5|0|1|0|1|PFI|0|0|0|100|DKK|17358|23478|lyfsjukr|||00|20|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Cýtarabín||17358||17358|23478 016382|J02AC0301|Vfend|mixtúra|40|mg/ml|70|ml|1|fl||J02AC03|01.03.2005||R|A|1,5|0|0|0|1|PFI|0|0|0|100|DKK|143118|180049|lyfsjukr|||00|70|0|7|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Voricónazól||143118||143118|180049 016385|L01BC0108|Cytarabine Pfizer|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.10.1995||R|A|1.5|0|1|0|1|PFI|0|0|0|100|DKK|8680|12428|lyfsjukr|||00|10|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Cýtarabín||8680||8680|12428 016395|N03AX1601|Lyrica|hylki|25|mg|56|stk|1|þpakki||N03AX16|01.01.2007||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|3343|5377|lyfalmen|||00|56|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3343||3343|5377 016396|L01BA0108|Methotrexate Pfizer|stl/irl|25|mg/ml|20|ml|1|hgl||L01BA01|01.10.1995||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|8026|11491|lyfsjukr|||00|20|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metótrexat||8026||8026|11491 016474|L01XA0209|Carboplatin Pfizer|irþ|10|mg/ml|5|ml|5|hgl||L01XA02|01.08.1998||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|27208|35741|lyfsjukr|||00|25|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Karbóplatín||27208||27208|35741 016502|N07BA0111|Nicorette Classic|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.03.2004||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016506|N07BA0111|Nicorette Classic|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.03.2004||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|4|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016516|L01XA0209|Carboplatin Pfizer|irþ|10|mg/ml|45|ml|5|hgl||L01XA02|01.08.1998||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|228489|286336|lyfsjukr|||00|225|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Karbóplatín||228489||228489|286336 016524|N07BA0111|Nicorette Classic|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|210|0|14|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016528|N07BA0111|Nicorette Classic|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2004||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|210|0|28|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016534|L01XA0209|Carboplatin Pfizer|irþ|10|mg/ml|15|ml|5|hgl||L01XA02|01.08.1998||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|80134|101634|lyfsjukr|||00|75|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Karbóplatín||80134||80134|101634 016561|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|7|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016572|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016589|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|4|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016590|N07BA0113|Nicorette Freshmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016596|N05AX1201|Abilify|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.02.2006||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|18969|25801|lyfalmen|V1701|25330|00|28|0|6|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||18969||18969|25801 016605|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|14|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016611|N07BA0113|Nicorette Freshmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.09.2005||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28|Vistor hf|McNeil Denmark ApS|Nikótín||||| 016622|A06AG1101|Microlax|innhl|0| |5|ml|50|túpa||A06AG11|01.09.2005||L|A|5|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||56|250|0|50|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||7080 016635|N05AX1201|Abilify|töflur|5|mg|56|stk|1|þpakki||N05AX12|01.02.2006||R|A|2|0|0|*|0|OTS|0|1|0|100|DKK|37937|49417|lyfalmen|||00|56|0|12|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||37937||37937|49417 016637|J01CR0201|Amoksiklav|töflur|1000|mg|12|stk|1|pakki|875+125 mg|J01CR02|01.08.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1026|2233|lyfalmen|V0466|2233|00|12|0|12|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1026||1026|2233 016640|B03XA0103|NeoRecormon|stl|30000|ae/spr|0,6|ml|4|spr||B03XA01|01.05.2007||R|K|2|0|1|0|1|ROC|0|0|0|100|DKK|244598|306392|lyfsjukr|||00|2|0|180|Icepharma hf|Roche|Epóetín||244598||244598|306392 016686|H01AC0110|NutropinAq|stl|5|mg/ml|2|ml|3|rörlyk||H01AC01|01.03.2005||R|A|1,5|0|1|0|1|IPL|0|0|0|100|DKK|213835|268092|lyfsjukr|||00|6|0|0|Icepharma hf|Ipsen Ltd.|Sómatrópín||213835||213835|268092 016699|A10BA0202|Glucophage (Lyfjaver)|töflur|500|mg|400|stk|1|plglas||A10BA02|01.09.2003||R|A|5|0|0|*|0|LVR|0|0|0|100|NOK|2780|4613|lyfalmen|||00|400|0|100|Lyfjaver ehf|Lyfjaver ehf|Metformín||2780||2780|4613 016727|N06BA0403|Ritalin Uno|hylki|30|mg|30|stk|1|glas||N06BA04|01.02.2004||R|A|3|1|0|0|0|NOH|0|0|0|100|DKK|8363|12189|lyfalmen|||00|30|0|30|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||8363||8363|12189 016728|H01AC0110|NutropinAq|stl|5|mg/ml|2|ml|1|rörlyk||H01AC01|01.03.2005||R|A|1,5|0|1|0|1|IPL|0|0|0|100|DKK|71279|90610|lyfsjukr|||00|2|0|0|Icepharma hf|Ipsen Ltd.|Sómatrópín||71279||71279|90610 016736|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|200|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|3796|5992|lyfalmen|V0789|5992|10|200|0|40|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||3796||3796|5992 016772|N03AF0107|Tegretol Retard (Lyfjaver)|forðatfl|400|mg|200|stk|1|plglas||N03AF01|01.09.2003||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|6922|10234|lyfalmen|V0713|10234|10|200|0|80|Lyfjaver ehf|Lyfjaver ehf|Karbamazepín||6922||6922|10234 016791|H05BX0101|Mimpara|filmhtfl|60|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|65688|83967|lyfalmen|||00|28|0|28|Vistor hf|Amgen Europe B.V.|Cinacalcet||65688||65688|83967 016802|H05BX0101|Mimpara|filmhtfl|90|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|97096|123069|lyfalmen|||00|28|0|42|Vistor hf|Amgen Europe B.V.|Cinacalcet||97096||97096|123069 016868|H05BX0101|Mimpara|filmhtfl|30|mg|28|stk|1|pakki||H05BX01|01.05.2005||R|A|4|0|0|0|0|AEU|0|0|0|100|DKK|31597|41523|lyfalmen|||00|28|0|0|Vistor hf|Amgen Europe B.V.|Cinacalcet||31597||31597|41523 016892|G03GA0502|Gonal-f|stl|900|ae/penna|1,5|ml|1|penni|áfylltur penni (66 mcg) |G03GA05|01.07.2004||R|K|1|0|1|E|0|SEE|0|0|0|100|SEK|51954|66868|lyfalmen|||00|2|0|12|Gróco ehf|Serono Europe|Follitrópín alfa||51954||51954|66868 016927|G03GA0502|Gonal-f|stl|300|ae/penna|0,5|ml|1|penni|(22 mcg) áfylltur penni|G03GA05|01.07.2004||R|K|1|0|1|E|0|SEE|0|0|0|100|SEK|19873|26927|lyfalmen|||00|0|0|4|Gróco ehf|Serono Europe|Follitrópín alfa||19873||19873|26927 016938|G03GA0502|Gonal-f|stl|450|ae/penna|0,75|ml|1|penni|áfylltur penni (33 mcg) |G03GA05|01.07.2004||R|K|1|0|1|E|0|SEE|0|0|0|100|SEK|29807|39295|lyfalmen|||00|1|0|6|Gróco ehf|Serono Europe|Follitrópín alfa||29807||29807|39295 016943|A02BC0301|Lanzo|munndr.t|30|mg|14|stk|1|þpakki||A02BC03|01.02.2007||R|A|3|0|0|0|0|WAB|0|0|0|100|USD|2355|4036|lyfalmen|||00|14|0|14|Icepharma hf|Wyeth AB|Lansóprazól||2355||2355|4036 016954|A02BC0301|Lanzo|munndr.t|30|mg|28|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|WAB|0|0|0|100|USD|4569|7041|lyfalmen|||00|28|0|28|Icepharma hf|Wyeth AB|Lansóprazól||4569||4569|7041 016957|A02BC0301|Lanzo|munndr.t|15|mg|98|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|WAB|0|0|0|100|USD|8897|12914|lyfalmen|||00|98|0|49|Icepharma hf|Wyeth AB|Lansóprazól||8897||8897|12914 016965|A02BC0301|Lanzo|munndr.t|30|mg|56|stk|1|þpakki||A02BC03|01.01.2004||R|A|3|0|0|0|0|WAB|0|0|0|100|USD|8964|13005|lyfalmen|||00|56|0|56|Icepharma hf|Wyeth AB|Lansóprazól||8964||8964|13005 016973|J05AF0901|Emtriva|hylki|200|mg|30|stk|1|glas||J05AF09|01.04.2004||R|A|3|0|1|0|1|GIS|0|0|0|100|XEU|41072|53002|lyfsjukr|||00|30|0|30|Gilead Sience Sweden AB|Gilead Science International ltd.|Emtrícítabín||41072||41072|53002 016976|A02BC0301|Lanzo|munndr.t|30|mg|98|stk|1|þpakki||A02BC03|01.02.2007||R|A|3|0|0|0|0|WAB|0|0|0|100|USD|15704|21736|lyfalmen|||00|98|0|98|Icepharma hf|Wyeth AB|Lansóprazól||15704||15704|21736 016979|N02AE0103|Norspan|forðapl|5|mg|4|stk|1|þpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|3543|5648|lyfalmen|||00|4|0|17|Icepharma hf|Norpharma |Búprenorfín||3543||3543|5648 016981|QA02BX1202|Orbesealer vet.|spenalyf|2,6|g/dælu|60|dælur|1|pakki||QA02BX12|01.12.2006||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|19191|36727|vetalmen|||16|60|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||19191||19191|36727 017006|B05BA1019|StructoKabiven Perifer|irl|830|kcal|1206|ml|4|pokar|fleyti|B05BA10|01.06.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|33204|43206|lyfsjukr|||00|4824|0|0|Icepharma hf|Fresenius Kabi|Blöndur||33204||33204|43206 017020|G03DA0201|Depo-Provera|stl|50|mg/ml|3|ml|1|hgl||G03DA02|01.12.1972||R|A|5|0|0|E|0|PFI|0|0|0|100|DKK|1563|2961|lyfalmen|||03|3|0|21|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Medroxýprógesterón||1563||1563|2961 017111|A09AA0201|Combizym|töflur|0| |100|stk|1|þpakki||A09AA02|01.07.1988||R|A|2|0|0|E|0|DSG|0|0|0|100|XEU|1581|2986|lyfalmen|||10|100|0|25|Icepharma hf|Daiichi Sankyo Europe GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||1581||1581|2986 017130|L01BC0109|DepoCyte|stl|50|mg/hgl|5|ml|1|hgl||L01BC01|01.07.2005||R|K|2|0|1|0|1|SKY|0|0|0|100|DKK|294115|368041|lyfsjukr|||00|5|0|0|Icepharma hf|SkyPharma PLC|Cýtarabín||294115||294115|368041 017145|C08DB0102|Cardizem Retard|forðatfl|180|mg|60|stk|1|glas||C08DB01|01.04.1990||R|A|2|0|0|B|0|FRO|0|0|0|100|DKK|7080|10448|lyfalmen|||10|60|0|45|Vistor hf|Ferrosan A/S|Diltíazem||7080||7080|10448 017195|L01XX3201|Velcade|sts|3,5|mg/hgl|1|hgl|1|pakki|lausn|L01XX32|01.09.2004||R|A|3|0|1|0|1|JCI|0|0|0|100|SEK|159899|200942|lyfsjukr|||00|1|0|0|Vistor hf|Janssen-Cilag International N.V.|Bortezomíb||159899||159899|200942 017203|M05BA0601|Bondronat|irþ|1|mg/ml|6|ml|1|hgl||M05BA06|01.09.2004||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|46369|59597|lyfsjukr|||00|6|0|1|Icepharma hf|Roche|||46369||46369|59597 017204|B05BA1019|StructoKabiven Perifer|irl|1300|kcal|1904|ml|3|pokar|fleyti|B05BA10|01.06.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|34319|44595|lyfsjukr|||00|5712|0|0|Icepharma hf|Fresenius Kabi|Blöndur||34319||34319|44595 017210|C03DA0102|Spirix|töflur|25|mg|100|stk|1|glas||C03DA01|01.02.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|1472|2838|lyfalmen|V0221|2838|00|100|0|33|Gróco ehf|Nycomed Danmark A/S|Spírónólaktón||1472||1472|2838 017234|L03AB0701|Avonex|stl|30|mcg/spr|0,5|ml|4|spr|lausn, áfylltar sprautur|L03AB07|01.12.2003||R|K|2|0|1|0|1|BIN|0|0|0|100|XEU|137976|173648|lyfsjukr|||00|2|0|28|Icepharma hf|Biogen Idec Ltd|Interferón beta-1a||137976||137976|173648 017238|M05BA0601|Bondronat|filmhtfl|50|mg|28|stk|1|þpakki||M05BA06|01.08.2004||R|A|1|0|0|0|0|ROC|0|0|0|100|DKK|51748|66611|lyfalmen|||00|28|0|0|Icepharma hf|Roche|||51748||51748|66611 017247|M05BA0601|Bondronat|filmhtfl|50|mg|84|stk|1|þpakki||M05BA06|01.08.2004||R|A|1|0|0|0|0|ROC|0|0|0|100|DKK|154458|194485|lyfalmen|||00|84|0|0|Icepharma hf|Roche|||154458||154458|194485 017266|N02AE0103|Norspan|forðapl|10|mg|4|stk|1|þpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|6271|9350|lyfalmen|||00|4|0|33|Icepharma hf|Norpharma |Búprenorfín||6271||6271|9350 017294|N03AX1202|Gabapentin NM Pharma|hylki|300|mg|100|stk|1|glas||N03AX12|01.10.2007||R|A|2|0|0|E|0|MNA|0|0|0|100|SEK|5084|7740|lyfalmen|V0714|7740|00|100|0|17|Actavis Group PTC ehf|Merck NM AB|Gabapentín||5084||5084|7740 017326|N02AE0103|Norspan|forðapl|20|mg|4|stk|1|þpakki||N02AE01|01.01.2006||R|A|2|1|0|E|0|NOP|0|0|0|100|DKK|11712|16734|lyfalmen|||00|4|0|67|Icepharma hf|Norpharma |Búprenorfín||11712||11712|16734 017327|C03DA0102|Spirix|töflur|50|mg|100|stk|1|glas||C03DA01|01.02.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|2756|4580|lyfalmen|||00|100|0|67|Gróco ehf|Nycomed Danmark A/S|Spírónólaktón||2756||2756|4580 017331|A04AD1201|Emend|hylki|0| |3|stk|1|þpakki|samsett pakkning|A04AD12|01.04.2004||R|A|2,5|0|0|0|1|MSD|0|0|0|100|XEU|11661|16385|lyfsjukr|||00|3|0|0|Icepharma hf|M.S.D.|Aprepitant||11661||11661|16385 017365|J01CR0201|Amoksiklav|töflur|375|mg|20|stk|1|glas|250+125 mg|J01CR02|01.12.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|792|1915|lyfalmen|||00|20|0|5|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||792||792|1915 017384|H02AB0701|Deltison|töflur|50|mg|30|stk|1|glas||H02AB07|01.08.2005||R|A|2|0|0|E|0|REP|0|0|1|100|SEK|2833|4685|lyfalmen|||00|30|0|150|Vistor hf|Recip AB|Prednisón||2833||2833|4685 017541|N07CA0101|Betaserc|töflur|16|mg|100|stk|1|þpakki||N07CA01|01.06.1999||R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|7390|10869|lyfalmen|||00|100|0|67|Medico ehf|Solvay Duphar |Betahistín||7390||7390|10869 017556|J01CR0201|Amoksiklav|töflur|625|mg|20|stk|1|glas|500+125 mg|J01CR02|01.12.2003||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1215|2489|lyfalmen|V0465|2489|00|20|0|12|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1215||1215|2489 017564|QM01AC0601|Metacam|mixtúra|15|mg/ml|100|ml|1|fl||QM01AC06|01.09.2004||R|A|2|0|0|0|0|BOI|0|0|0|100|DKK|6849|13218|vetalmen|||00|100|0|0|Vistor hf|Boehringer Ingelheim|||6849||6849|13218 017763|N06DA0401|Reminyl|forðahlk|16|mg|84|stk|1|þpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|35085|45866|lyfalmen|V1371|45866|00|84|0|84|Vistor hf|Janssen-Cilag AB|Galantamín||35085||35085|45866 017773|N06DA0401|Reminyl|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|11402|16313|lyfalmen|V1370|16005|00|28|0|14|Vistor hf|Janssen-Cilag AB|Galantamín||11402||11402|16313 017792|C03DA0401|Inspra|filmhtfl|50|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|11461|16394|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Eplerenón||11461||11461|16394 017809|N06DA0401|Reminyl|forðahlk|24|mg|84|stk|1|þpakki||N06DA04|01.08.2005||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|43836|56761|lyfalmen|||00|84|0|126|Vistor hf|Janssen-Cilag AB|Galantamín||43836||43836|56761 017963|C03DA0401|Inspra|filmhtfl|25|mg|30|stk|1|þpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|11461|16394|lyfalmen|||00|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Eplerenón||11461||11461|16394 018044|D06BX0103|Rozex|hlaup|7,5|mg/g|30|g|1|túpa||D06BX01|01.01.1998||R|A||0|0|0|0|LDR|0|0|1|100|IKR|1373|2704|lyfalmen|||00|30|1|30|Parlogis hf|Parlogis - óskráð lyf|Metrónídazól||1373||1373|2704 018268|G03FA1701|Angemin|töflur|0| |84|stk|1|þpakki|2+1 mg|G03FA17|01.06.2005||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|5918|8871|lyfalmen|||00|84|0|84|Icepharma hf|Bayer Schering Pharma AG|Dróspírenón og östrogen||5918||5918|8871 018311|C09CA0801|Olmetec|filmhtfl|10|mg|28|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|2763|4590|lyfalmen|||00|28|0|14|Gróco ehf|Daiichi Sankyo Europe GmbH-|||2763||2763|4590 018446|C09CA0801|Olmetec|filmhtfl|40|mg|28|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|4080|6377|lyfalmen|||00|28|0|56|Gróco ehf|Daiichi Sankyo Europe GmbH-|||4080||4080|6377 018453|L02BA0301|Faslodex|stl|250|mg/spr|5|ml|1|spr||L02BA03|01.06.2004||R|K|3|0|1|0|1|ASZ|0|0|0|100|SEK|60001|76569|lyfsjukr|||00|5|0|0|Vistor hf|AstraZeneca UK Ltd|Fulvestrant||60001||60001|76569 018502|C09CA0801|Olmetec|filmhtfl|40|mg|98|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|12779|18095|lyfalmen|||00|98|0|196|Gróco ehf|Daiichi Sankyo Europe GmbH-|||12779||12779|18095 018512|C09CA0801|Olmetec|filmhtfl|10|mg|98|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|8975|13020|lyfalmen|||00|98|0|49|Gróco ehf|Daiichi Sankyo Europe GmbH-|||8975||8975|13020 018514|J07BA0101|FSME-Immun Junior|stl|1,2|mcg/sk|0,25|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|K|2,5|0|0|0|0|BAA|0|0|0|100|SEK|3201|5184|lyfalmen|||02|0|0|0|Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin með blóðmaur||3201||3201|5184 018527|J07BA0102|FSME-Immun Vuxen|stl|2,4|mcg/sk|0,5|ml|1|spr|bóluefni|J07BA01|01.06.2004||R|K|2,5|0|0|0|0|BAA|0|0|0|100|SEK|3496|5585|lyfalmen|||02|0|0|0|Icepharma hf|Baxter AG|Heilabólguveira óvirk, borin með blóðmaur||3496||3496|5585 018534|C09CA0801|Olmetec|filmhtfl|20|mg|98|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|10541|15145|lyfalmen|||00|98|0|98|Gróco ehf|Daiichi Sankyo Europe GmbH-|||10541||10541|15145 018535|N03AX0901|Lamictal|dreifit.|25|mg|42|stk|1|þpakki||N03AX09|01.11.2004||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|1499|2875|lyfalmen|||00|42|0|4|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||1499||1499|2875 018558|L01CD0102|Paclitaxel Mayne|irþ|6|mg/ml|5|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|16095|21906|lyfsjukr|||00|5|0|0|Icepharma hf|Mayne Pharma Plc|Paklítaxel||16095||16095|21906 018569|L01CD0102|Paclitaxel Mayne|irþ|6|mg/ml|25|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|79583|100948|lyfsjukr|||00|25|0|0|Icepharma hf|Mayne Pharma Plc|Paklítaxel||79583||79583|100948 018586|C09CA0801|Olmetec|filmhtfl|20|mg|28|stk|1|þpakki||C09CA08|01.05.2005||R|A|3|0|0|B|0|DSH|0|0|0|100|DKK|3431|5496|lyfalmen|||00|28|0|28|Gróco ehf|Daiichi Sankyo Europe GmbH-|||3431||3431|5496 018591|L01CD0102|Paclitaxel Mayne|irþ|6|mg/ml|16,7|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|32417|42227|lyfsjukr|||00|17|0|0|Icepharma hf|Mayne Pharma Plc|Paklítaxel||32417||32417|42227 018594|G04BD0801|Vesicare|filmhtfl|10|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|8456|12316|lyfalmen|||00|30|0|60|Vistor hf|Astellas Pharma A/S|Sólífenacín||8456||8456|12316 018617|L01CD0102|Paclitaxel Mayne|irþ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.10.2005|31.03.2009|R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|87947|111362|lyfsjukr|||00|50|0|0|Icepharma hf|Mayne Pharma Plc|Paklítaxel||87947||87947|111362 018663|J01DD0401|Rocephalin|stþ|1|g|1|stk|5|hgl|+ leysir, lausn|J01DD04|01.10.1985||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|13987|19281|lyfsjukr|||03|5|0|2|Icepharma hf|Roche|Ceftríaxón||13987||13987|19281 018670|C09CA0301|Diovan|filmhtfl|40|mg|14|stk|1|þpakki||C09CA03|01.07.2005||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|1492|2865|lyfalmen|||00|14|0|7|Vistor hf|Novartis Healthcare A/S-|Valsartan||1492||1492|2865 018677|G04BD0801|Vesicare|filmhtfl|10|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|22987|30804|lyfalmen|||00|90|0|180|Vistor hf|Astellas Pharma A/S|Sólífenacín||22987||22987|30804 018681|C09CA0301|Diovan|filmhtfl|40|mg|28|stk|1|þpakki||C09CA03|01.07.2005||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|2986|4893|lyfalmen|||00|28|0|14|Vistor hf|Novartis Healthcare A/S-|Valsartan||2986||2986|4893 018682|H02AB0604|Decortin H|töflur|5|mg|100|stk|1|þpakki||H02AB06|11.06.2004||R|A|3|0|0|B|0|MAC|0|0|1|100|XEU|1135|2381|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck KgaA (A) |Prednisólón||1135||1135|2381 018685|G04BD0801|Vesicare|filmhtfl|5|mg|30|stk|1|þpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|6767|10024|lyfalmen|||00|30|0|30|Vistor hf|Astellas Pharma A/S|Sólífenacín||6767||6767|10024 018694|G04BD0801|Vesicare|filmhtfl|5|mg|90|stk|1|þpakki||G04BD08|01.11.2004||R|A|3|0|0|E|0|ASP|0|0|0|100|XEU|18512|25232|lyfalmen|||00|90|0|90|Vistor hf|Astellas Pharma A/S|Sólífenacín||18512||18512|25232 018714|C03DA0401|Inspra|filmhtfl|50|mg|100|stk|1|þpakki||C03DA04|01.08.2005||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|38210|49756|lyfalmen|||00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Eplerenón||38210||38210|49756 018779|L03AX1301|Copaxone|stl|20|mg/spr|28|spr|1|pakki|+ leysir|L03AX13|01.08.2004||R|K|2|0|1|0|1|TEP|0|0|0|100|NOK|136585|171916|lyfsjukr|||00|28|0|0|Vistor hf|Teva Pharmaceuticals Limited|Glatíramer acetat||||136585|171916 018894|N06DA0202|Aricept (Lyfjaver)|töflur|5|mg|98|stk|1|þpakki||N06DA02|01.01.2005||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|49021|62707|lyfalmen|V0375|39189|00|98|0|65|Lyfjaver ehf|Lyfjaver ehf|Dónepezíl||48612||48612|62707 018908|N06DA0202|Aricept (Lyfjaver)|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.01.2005||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|53213|67668|lyfalmen|V0376|43720|00|98|0|131|Lyfjaver ehf|Lyfjaver ehf|Dónepezíl||52597||52597|67668 018927|M05BA0402|Fosamax (Lyfjaver)|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.03.2004||R|A|2|0|0|E|0|LVR|0|0|0|100|XEU|14927|20769|lyfalmen|V0718|12241|00|12|0|84|Lyfjaver ehf|Lyfjaver ehf|Alendrónsýra||14927||14927|20769 018956|R06AX2201|Kestine|töflur|20|mg|30|stk|1|þpakki||R06AX22|01.10.2005||R|A|3|0|0|E|0|ALF|0|0|1|100|DKK|3183|5160|lyfalmen|||00|30|0|60|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||3183||3183|5160 018967|R06AX2201|Kestine|töflur|20|mg|100|stk|1|þpakki||R06AX22|01.10.2005||R|A|3|0|0|E|0|ALF|0|0|1|100|DKK|9847|14203|lyfalmen|||00|100|0|200|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||9847||9847|14203 018975|J05AE0701|Telzir|filmhtfl|700|mg|60|stk|1|glas||J05AE07|01.12.2004||R|A|3|0|1|0|1|GGL|0|0|0|100|GBP|55642|71142|lyfsjukr|||43|60|0|30|GlaxoSmithKline ehf|Glaxo Group Limited|Fosamprenavír||55642||55642|71142 018978|C03CA0101|Furix|töflur|20|mg|100|stk|1|glas||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|609|1667|lyfalmen|||00|100|0|50|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||609||609|1667 018980|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|1|hgl|20mg/ml+36mcg/ml|QN01BB52|01.02.2004||R|S|2|0|0|0|0|KEL|1|0|0|100|NOK|1159|2287|vetalmen|||27|100|0|0|Icepharma hf|Kela Laboratoria NV|||1159||1159|2287 018995|N02AB0301|Durogesic|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|12976|18340|lyfalmen|V1052|13959|00|5|0|62|Vistor hf|Janssen-Cilag AB|Fentanýl||12976||12976|18340 019065|N06DA0302|Exelon (Lyfjaver)|hylki|6|mg|56|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|15029|20896|lyfalmen|||00|56|0|37|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||15029||15029|20896 019079|N06DA0302|Exelon (Lyfjaver)|hylki|4,5|mg|56|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|15029|20896|lyfalmen|||00|56|0|28|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||15029||15029|20896 019082|N06DA0302|Exelon (Lyfjaver)|hylki|3|mg|56|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|14733|19827|lyfalmen|V1372|19825|00|56|0|19|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||14170||14170|19827 019094|N02AB0301|Durogesic|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|8418|12264|lyfalmen|V1051|10216|00|5|0|42|Vistor hf|Janssen-Cilag AB|Fentanýl||8418||8418|12264 019099|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|20662|27592|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||20662||20662|27592 019102|N06DA0302|Exelon (Lyfjaver)|hylki|1,5|mg|28|stk|1|þpakki||N06DA03|01.04.2004||R|A|5|0|0|E|0|LVR|0|0|0|100|DKK|7514|11037|lyfalmen|||00|28|0|5|Lyfjaver ehf|Lyfjaver ehf|Rívastigmín||7514||7514|11037 019108|N02AB0301|Durogesic|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|4549|7014|lyfalmen|V1050|5709|00|5|0|21|Vistor hf|Janssen-Cilag AB|Fentanýl||4549||4549|7014 019112|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|23122|30654|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||23122||23122|30654 019121|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|13480|18650|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||13480||13480|18650 019132|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|15297|20912|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||15297||15297|20912 019167|N02AB0301|Durogesic|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|14546|20295|lyfalmen|V1053|16612|00|5|0|83|Vistor hf|Janssen-Cilag AB|Fentanýl||14546||14546|20295 019293|B02BC0001|TachoSil|svampur|5,5|mg|1|stk|1|pakki|+ 2,0 IU - 9,5x4,8 cm|B02BC00|01.05.2005||R|A|3|0|1|0|1|NYG|0|0|0|100|DKK|58179|74300|lyfsjukr|||00|1|0|0|Gróco ehf|Nycomed Danmark A/S|||58179||58179|74300 019295|B01AE0601|Angiox|sts/irs|250|mg|10|hgl|1|pakki|þykkni, lausn|B01AE06|01.05.2005||R|A|3|0|1|0|1|NYG|0|0|0|100|XEU|758880|946673|lyfsjukr|||00|10|0|0|Gróco ehf|Nycomed Danmark A/S|Bívalirúdín||758880||758880|946673 019339|N07BA0110|Nicotinell Lakrids|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019421|N06AX2102|Yentreve|hylki|20|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|XEU|6980|10313|lyfalmen|||00|56|0|0|Icepharma hf|Eli Lilly Nederland -|||6980||6980|10313 019445|L01XC0701|Avastin|irþ|25|mg/ml|4|ml|1|hgl|lausn|L01XC07|01.05.2005||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|60709|77450|lyfsjukr|||AC|4|0|0|Icepharma hf|Roche Registration Limited|Bevacizúmab||60709||60709|77450 019469|N06AX2102|Yentreve|hylki|40|mg|56|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|XEU|6980|10313|lyfalmen|||00|56|0|0|Icepharma hf|Eli Lilly Nederland -|||6980||6980|10313 019491|N06AX2102|Yentreve|hylki|40|mg|140|stk|1|þpakki|sýruþ.hylki, hörð|N06AX21|01.10.2004||R|A|2|0|0|0|0|ELD|0|0|0|100|XEU|17176|23569|lyfalmen|||00|140|0|0|Icepharma hf|Eli Lilly Nederland -|||17176||17176|23569 019513|C03CA0101|Furix|töflur|40|mg|100|stk|1|glas||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|612|1671|lyfalmen|||00|100|0|100|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||612||612|1671 019589|C09CA0401|Aprovel|filmhtfl|150|mg|28|stk|1|þpakki||C09CA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|3716|5883|lyfalmen|||00|28|0|28|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan||3716||3716|5883 019600|C09CA0401|Aprovel|filmhtfl|150|mg|98|stk|1|þpakki||C09CA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|9284|13439|lyfalmen|||00|98|0|98|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan||9284||9284|13439 019611|C09CA0401|Aprovel|filmhtfl|300|mg|28|stk|1|þpakki||C09CA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|5296|8027|lyfalmen|||00|28|0|56|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan||5296||5296|8027 019622|C09CA0401|Aprovel|filmhtfl|300|mg|98|stk|1|þpakki||C09CA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|17681|24198|lyfalmen|||00|98|0|196|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan||17681||17681|24198 019659|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|13|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019670|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|0|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019672|N07BA0110|Nicotinell Lakrids|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|13|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019681|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|24|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|2|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019699|C09DA0401|CoAprovel|filmhtfl|162,5|mg|28|stk|1|þpakki|150+12,5 mg|C09DA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|3716|5883|lyfalmen|||00|28|0|28|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan og þvagræsilyf||3716||3716|5883 019710|C09DA0401|CoAprovel|filmhtfl|162,5|mg|98|stk|1|þpakki|150+12,5 mg|C09DA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|12975|18339|lyfalmen|||00|98|0|98|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan og þvagræsilyf||12975||12975|18339 019711|L01BC0501|Gemzar|irs|200|mg|1|hgl|1|pakki||L01BC05|01.03.1999||R|A|3|0|1|0|1|ELI|0|0|0|100|XEU|6181|8850|lyfsjukr|||00|1|0|0|Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||6181||6181|8850 019713|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|14|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019721|C09DA0401|CoAprovel|filmhtfl|312,5|mg|28|stk|1|þpakki|300+12,5 mg|C09DA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|5296|8027|lyfalmen|||00|28|0|56|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan og þvagræsilyf||5296||5296|8027 019724|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|24|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|24|0|3|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019732|C09DA0401|CoAprovel|filmhtfl|312,5|mg|98|stk|1|þpakki|300+12,5 mg|C09DA04|01.09.2005||R|A|3|0|0|B|0|SBM|0|0|0|100|NOK|17681|24198|lyfalmen|||00|98|0|196|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan og þvagræsilyf||17681||17681|24198 019739|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019745|C03CA0101|Furix|töflur|40|mg|250|stk|1|glas|til vélskömmtunar|C03CA01|01.04.2005||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|639|1708|lyfalmen|||00|250|0|250|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||639||639|1708 019760|L01BC0501|Gemzar|irs|1|g|1|hgl|1|pakki||L01BC05|01.03.1999||R|A|3|0|1|0|1|ELI|0|0|0|100|XEU|30789|40200|lyfsjukr|||00|1|0|0|Icepharma hf|Eli Lilly Danmark A/S|Gemcitabín||30789||30789|40200 019781|L01XC0701|Avastin|irþ|25|mg/ml|16|ml|1|hgl|lausn|L01XC07|01.05.2005||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|222136|278427|lyfsjukr|||AC|16|0|0|Icepharma hf|Roche Registration Limited|Bevacizúmab||222136||222136|278427 019782|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019786|J01CA0410|Amoxicillin Merck NM|hylki|500|mg|20|stk|1|glas||J01CA04|01.04.1993||R|A|4|0|0|0|0|MNA|0|0|1|100|SEK|922|2092|lyfalmen|||10|20|0|10|Actavis Group PTC ehf|Merck NM AB|Amoxicillín||922||922|2092 019793|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.12.2006||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 019797|L01BA0401|Alimta|irþ|500|mg/hgl|1|hgl|1|pakki||L01BA04|01.03.2005||R|A|2|0|1|0|1|ELD|0|0|0|100|XEU|223871|280587|lyfsjukr|||00|1|0|0|Icepharma hf|Eli Lilly Nederland -|Pemetrexed||223871||223871|280587 019811|N06BA0901|Strattera|hylki|10|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|12780|18096|lyfalmen|||00|28|0|4|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12780||12780|18096 019833|N06BA0901|Strattera|hylki|18|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|12780|18096|lyfalmen|||00|28|0|6|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12780||12780|18096 019837|G03GA0601|Puregon|stl|900|ae/rörly|1,08|ml|1|lykja||G03GA06|01.10.2005||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|61014|78147|lyfalmen|||00|1|0|12|Vistor hf|N.V. Organon|Follitrópín beta||61014||61014|78147 019857|N06BA0901|Strattera|hylki|25|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|12780|18096|lyfalmen|||00|28|0|9|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12780||12780|18096 019882|N06BA0901|Strattera|hylki|40|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|12780|18096|lyfalmen|||00|28|0|14|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12780||12780|18096 019904|N06BA0901|Strattera|hylki|60|mg|28|stk|1|glas|hart|N06BA09|01.08.2006||R|A|3|0|1|0|0|ELI|0|0|0|100|XEU|12780|18096|lyfalmen|||00|28|0|21|Icepharma hf|Eli Lilly Danmark A/S|Atomoxetín||12780||12780|18096 019916|V03AF0801|Kepivance|sts|6,25|mg/hgl|6|hgl|1|pakki|lausn|V03AF08|01.07.2006||R|K|4|0|1|0|1|BIA|0|0|0|100|DKK|802155|1000550|lyfsjukr|||02|6|0|9|Vistor hf|Biovitrum AB (publ)|Palifermín||802155||802155|1000550 019931|N04BC0403|Adartrel|filmhtfl|0,25|mg|12|stk|1|þpakki||N04BC04|01.12.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|367|1338|lyfalmen|||00|12|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||367||367|1338 019938|J05AR0201|Kivexa|filmhtfl|900|mg|30|stk|1|þpakki|600+300 mg|J05AR02|01.05.2004||R|A|3|0|1|0|1|GGL|0|0|0|100|GBP|63052|80367|lyfsjukr|||00|30|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|Lamívúdín og abacavír||63052||63052|80367 019968|J01CA0410|Amoxicillin Merck NM|hylki|500|mg|30|stk|1|glas||J01CA04|01.04.1995||R|A|4|0|0|0|0|MNA|0|0|1|100|SEK|1380|2713|lyfalmen|||10|30|0|15|Actavis Group PTC ehf|Merck NM AB|Amoxicillín||1380||1380|2713 020016|B03AA0704|Duroferon|forðatfl|100|mg|100|stk|1|glas||B03AA07|01.03.1979||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||43|100|0|50|Vistor hf|AstraZeneca A/S DK|Ferrósúlfat||||| 020048|M02AA1502|Voltaren|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.03.2009||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||0|100|0|0|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak||||| 020134|N07BA0114|Nicotinell Classic|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|13|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 020180|C03CC0101|Edecrin|sts|0| |50|mg|1|hgl||C03CC01|01.05.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|19615|26288|lyfsjukr|||00|50|1|1|Parlogis hf|Parlogis - óskráð lyf|||19615||19615|26288 020193|N07BA0114|Nicotinell Classic|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.01.2005||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|96|0|6|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 020238|G04CA0203|Omnic Ocas|forðatfl|0,4|mg|30|stk|1|þpakki||G04CA02|01.04.2006||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|4551|7016|lyfalmen|||00|30|0|30|Vistor hf|Astellas Pharma A/S|Tamsúlósín||4551||4551|7016 020244|J07CA0204|Boostrix Polio|stl|0| |0,5|ml|10|áf.spr|dreifa|J07CA02|01.09.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|24584|32792|lyfalmen|||00|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, kíghósti, mænusótt, stífkrampi||24584||24584|32792 020276|A06AB0203|Dulcolax (Lyfjaver)|eþ-stil|10|mg|50|stk|1|þpakki||A06AB02|01.07.2005||R|A|5|0|0|0|0|LVR|0|0|0|100|NOK|2466|4187|lyfalmen|||04|50|0|50|Lyfjaver ehf|Lyfjaver ehf|Bisakódýl||2466||2466|4187 020277|N06AX1602|Efexor Depot|forðahlk|37,5|mg|7|stk|1|þpakki||N06AX16|01.02.2007||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|813|1944|lyfalmen|||00|7|0|3|Icepharma hf|Wyeth AB|Venlafaxín||813||813|1944 020338|G04CA0203|Omnic Ocas|forðatfl|0,4|mg|90|stk|1|þpakki||G04CA02|01.04.2006||R|A|2|0|0|E|0|ASP|0|0|0|100|XEU|10005|14418|lyfalmen|||00|90|0|90|Vistor hf|Astellas Pharma A/S|Tamsúlósín||10005||10005|14418 020355|L02AE0203|Eligard|sts|22,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|71056|90650|lyfalmen|||02|2|0|0|Vistor hf|Astellas Pharma A/S|Leuprórelín||71056||71056|90650 020364|N04BC0403|Adartrel|filmhtfl|0,5|mg|84|stk|1|þpakki||N04BC04|01.06.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|3867|6088|lyfalmen|||00|84|0|7|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||3867||3867|6088 020398|N06AB1001|Cipralex|dropar|10|mg/ml|28|ml|1|glas||N06AB10|01.11.2005||R|A|2|0|0|B|0|LBK|0|1|0|100|DKK|3703|5866|lyfalmen|||00|28|0|28|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||3703||3703|5866 020417|N04BC0403|Adartrel|filmhtfl|2|mg|84|stk|1|þpakki||N04BC04|01.12.2006||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|11181|16014|lyfalmen|||00|84|0|28|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||11181||11181|16014 020427|L02AE0203|Eligard|sts|7,5|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.07.2006||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|25148|33494|lyfalmen|||02|2|0|0|Vistor hf|Astellas Pharma A/S|Leuprórelín||25148||25148|33494 020444|D07AB0201|Locoid|krem|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|740|1845|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||740||740|1845 020456|M05BX0301|Protelos|mixt.kyr|2|g|28|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|7062|10424|lyfalmen|||00|28|0|28|Icepharma hf|Servier|Strontíum ranelat||7062||7062|10424 020457|D07AB0201|Locoid|krem|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|2159|3770|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||2159||2159|3770 020494|N03AX1102|Topimax (Lyfjaver)|töflur|25|mg|60|stk|1|plglas||N03AX11|01.08.2004||R|A|3|0|0|E|0|LVR|0|0|0|100|SEK|4266|5887|lyfalmen|V0709|5887|00|60|0|5|Lyfjaver ehf|Lyfjaver ehf|Tópíramat||3719||3719|5887 020510|N03AX1102|Topimax (Lyfjaver)|töflur|50|mg|60|stk|1|plglas||N03AX11|01.07.2005||R|A|3|0|0|E|0|LVR|0|0|0|100|SEK|6217|9151|lyfalmen|V0710|9150|00|60|0|10|Lyfjaver ehf|Lyfjaver ehf|Tópíramat||6124||6124|9151 020516|N03AX1102|Topimax (Lyfjaver)|töflur|100|mg|60|stk|1|plglas||N03AX11|01.09.2004||R|A|3|0|0|E|0|LVR|0|0|0|100|SEK|12393|15845|lyfalmen|V0711|15545|00|60|0|20|Lyfjaver ehf|Lyfjaver ehf|Tópíramat||11057||11057|15845 020523|N06AB1002|Cipralex (D.A.C.)|töflur|10|mg|28|stk|1|þpakki||N06AB10|01.07.2004||R|A|3|0|0|B|0|DAC|0|1|0|100|DKK|3220|5210|lyfalmen|V0939|5210|00|28|0|28|D.A.C. ehf|D.A.C. ehf|Escítalópram||3220||3220|5210 020533|M05BX0301|Protelos|mixt.kyr|2|g|84|sk-pokar|1|pakki|dreifa|M05BX03|01.08.2005||R|A|3|0|0|0|0|SEV|0|0|0|100|DKK|20719|27980|lyfalmen|||00|84|0|84|Icepharma hf|Servier|Strontíum ranelat||20719||20719|27980 020616|G03CA0319|Vagifem (D.A.C.)|sk-tfl|25|mcg|15|stk|1|þpakki|0|G03CA03|01.07.2004||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|2051|3624|lyfalmen|V0418|3624|5|15|0|15|D.A.C. ehf|D.A.C. ehf|Estradíól||2051||2051|3624 020648|R06AX2201|Kestine|töflur|20|mg|10|stk|1|þpakki||R06AX22|01.10.2005||L|A|3|0|0|0|0|ALF|0|0|1|100|IKR|||lyflausa|||00|10|0|20|Gróco ehf|Almirall-Prodesfarma S.A.|Ebastín||||| 020649|N03AX1203|Neurontin (D.A.C.)|hylki|300|mg|50|stk|1|þpakki||N03AX12|01.07.2004||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK||5108|lyfalmen|||10|50|0|8|D.A.C. ehf|D.A.C. ehf|Gabapentín||3145||3145|5108 020700|L04AA2101|Raptiva|sts|100|mg/ml|125|mg|4|hgl|+ leysir|L04AA21|01.05.2005|31.03.2009|R|K|4|0|1|0|1|SEE|0|0|0|100|SEK|149341|187797|lyfsjukr|||00|500|0|50|Gróco ehf|Serono Europe|||149341||149341|187797 020711|G03AC0302|Postinor|töflur|1500|mcg|1|stk|1|þpakki||G03AC03|01.01.2007||L|A|4|0|0|0|0|MEI|0|0|0|100|IKR|||lyflausa|||23|1|0|0|Icepharma hf|Medimpex UK Limited|Levonorgestrel||||| 020763|R03AK0704|Symbicort Turbuhaler (D.A.C.)|innúðadu|164,5|mcg/sk|120|sk|1|pakki|160+4,5 mcg/sk|R03AK07|01.08.2004||R|A|2|0|0|B|0|DAC|0|0|0|100|SEK|7715|11310|lyfalmen|V0990|11310|0|120|0|30|D.A.C. ehf|D.A.C. ehf|Formóteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||7715||7715|11310 020770|QP54AA5101|Eqvalan Duo|pasta|0| |7,74|g|1|sk-dæl||QP54AA51|01.10.2006||R|A|3|0|0|0|0|MES|0|0|0|100|XEU|2268|3925|vetorma|||16|8|0|0|Vistor hf|Merial SAS|||2268||2268|3925 020774|L04AB0101|Enbrel|sts|0| |50|mg|4|hgl|+ leysir|L04AB01|01.10.2005||R|K|3|0|1|0|1|WTE|0|0|0|100|USD|204816|256863|lyfsjukr|||00|200|0|29|Icepharma hf|Wyeth Europe|Etanercept||204816||204816|256863 020826|N06AX1601|Efexor|töflur|37,5|mg|28|stk|1|þpakki||N06AX16|01.10.1996||R|A|3|0|0|B|0|WLN|0|1|0|100|USD|2424|4130|lyfalmen|||00|28|0|10|Icepharma hf|Wyeth Lederle Nordiska|Venlafaxín||||2424|4130 020924|J01FA1003|Zithromax (D.A.C.)|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.09.2007||R|A|2|0|0|0|0|DAC|0|0|1|100|DKK|2811|4655|lyfalmen|V0429|4655|00|3|0|5|D.A.C. ehf|D.A.C. ehf|Azitrómýcín||2811||2811|4655 021031|R05CB0102|Mucomyst|lausn|200|mg/ml|10|ml|10|hgl|innöndunarvökvi|R05CB01|01.11.2006||R|K|3|0|0|E|0|BIP|0|0|0|100|SEK|5510|8318|lyfalmen|||00|100|0|0|Vistor hf|BioPhausia AB|Acetýlcýstein||5510||5510|8318 021048|R03DC0301|Singulair|filmhtfl|10|mg|28|stk|1|þpakki||R03DC03|01.09.1998||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|6158|9197|lyfalmen|||63|28|0|28|Icepharma hf|M.S.D.|Montelúkast||6158||6158|9197 021053|D10AD0301|Differin|hlaup|0,1|%|60|g|1|túpa||D10AD03|01.12.2007||R|A|3|0|0|0|0|GAN|0|0|0|100|SEK|2121|3719|lyfalmen|||00|60|0|60|Icepharma hf|Galderma Nordic AB|Adapalen||2121||2121|3719 021057|J01CR0203|Augmentine (D.A.C.)|töflur|625|mg|12|stk|1|þpakki|500+125 mg|J01CR02|01.05.2005||R|A|2|0|0|0|0|DAC|0|0|1|100|IKR|714|1809|lyfalmen|||00|12|0|8|D.A.C. ehf|D.A.C. ehf|Amoxicillín og ensímblokkar||714||714|1809 021091|S01ED5107|Xalacom (D.A.C.)|augndr|5,05|mg/ml|2,5|ml|1|glas|5mg/ml+50mcg/ml |S01ED51|01.11.2004||R|K|2|0|0|*|0|DAC|0|0|0|100|DKK|3519|5616|lyfalmen|V0988|5616|06|2|0|0|D.A.C. ehf|D.A.C. ehf|Tímólól í blöndum||3519||3519|5616 021107|N05AH0403|Seroquel (D.A.C.)|töflur|100|mg|60|stk|1|þpakki||N05AH04|01.05.2005||R|A|3|0|0|*|0|DAC|0|1|0|100|SEK|9051|11558|lyfalmen|||00|60|0|15|D.A.C. ehf|D.A.C. ehf|Quetíapín||7898||7898|11558 021120|N03AX1103|Topamax (D.A.C.)|töflur|100|mg|60|stk|1|þpakki||N03AX11|01.11.2004||R|A|3|0|0|E|0|DAC|0|0|0|100|SEK|11974|15545|lyfalmen|V0711|15545|00|60|0|20|D.A.C. ehf|D.A.C. ehf|Tópíramat||10836||10836|15545 021149|J01CR0203|Augmentine (D.A.C.)|töflur|1000|mg|12|stk|1|þpakki|875+125 mg|J01CR02|01.05.2005||R|A|1,5|0|0|0|0|DAC|0|0|1|100|IKR|1093|2233|lyfalmen|V0466|2233|00|12|0|12|D.A.C. ehf|D.A.C. ehf|Amoxicillín og ensímblokkar||1026||1026|2233 021161|M01AB0513|Vostar-S|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.03.2005||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|453|1436|lyfalmen|V0609|1424|00|30|0|15|Actavis Group hf|Actavis hf|Díklófenak||439||439|1436 021169|S01XA1201|Corneregel|augnhl|50|mg/g|10|g|1|túpa||S01XA12|01.08.2005||R|A|2|0|0|E|0|GEM|0|0|0|100|XEU|1038|2249|lyfalmen|||00|10|0|0|Actavis Group hf|Gerhard Mann|Dexpantenól||1038||1038|2249 021221|R03AC0303|Terbasmin Turbuhaler (D.A.C.)|innönddu|0,5|mg/sk|200|sk|1|stauk||R03AC03|01.11.2004||R|A|2|0|0|B|0|DAC|0|0|1|100|SEK|1705|3154|lyfalmen|V0987|3154|23|200|0|50|D.A.C. ehf|D.A.C. ehf|Terbútalín||1705||1705|3154 021226|N06AB0603|Zoloft (D.A.C.)|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.09.2007||R|A|5|0|0|B|0|DAC|0|1|0|100|DKK|3959|3455|lyfalmen|V0931|2428|00|28|0|28|D.A.C. ehf|D.A.C. ehf|Sertralín||1927||1927|3455 021227|M01AB0513|Vostar-S|filmhtfl|50|mg|100|stk|1|þpakki||M01AB05|01.03.2005||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|1187|2451|lyfalmen|V0610|2451|00|100|0|50|Actavis Group hf|Actavis hf|Díklófenak||1187||1187|2451 021232|N06AB0603|Zoloft (D.A.C.)|filmhtfl|100|mg|28|stk|1|þpakki||N06AB06|01.11.2004||R|A|5|0|0|B|0|DAC|0|1|0|100|DKK|6178|5228|lyfalmen|V0935|3559|00|28|0|56|D.A.C. ehf|D.A.C. ehf|Sertralín||3233||3233|5228 021257|G03BA0307|Nebido|stl|250|mg/ml|4|ml|1|lykja||G03BA03|01.07.2005||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|15261|21185|lyfalmen|||02|4|0|56|Icepharma hf|Bayer Schering Pharma AG|Testósterón||15261||15261|21185 021278|S01EE0102|Xalatan (D.A.C.)|augndr|50|mcg/ml|2,5|ml|1|glas||S01EE01|01.03.2009||R|K|3|0|0|*|0|DAC|0|0|0|100|DKK|2781|4614|lyfalmen|V1989|4614|0|2|0|25|D.A.C. ehf|D.A.C. ehf|Latanóprost||||2781|4614 021325|R03BB0402|Spiriva (D.A.C.)|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki + Handihaler|R03BB04|01.11.2004||R|A|2|0|0|B|0|DAC|0|0|0|100|DKK|7202|10614|lyfalmen|V0985|10614|0|30|0|30|D.A.C. ehf|D.A.C. ehf|Tíótrópíumbrómíð||7202||7202|10614 021341|R03AK0603|Seretide Diskus (Lyfjaver)|innúðadu|550|mcg/sk|60|sk|1|pakki|50+500 mcg, discus|R03AK06|01.05.2009||R|A|1,5|0|0|B|0|LVR|0|0|0|100|GBP|8328|12142|lyfalmen|V0993|12142|23|60|0|30|Lyfjaver ehf|Lyfjaver ehf|||||8328|12142 021345|R03DC0301|Singulair|filmhtfl|10|mg|98|stk|1|þpakki||R03DC03|01.09.1998||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|18862|25668|lyfalmen|||63|98|0|98|Icepharma hf|M.S.D.|Montelúkast||18862||18862|25668 021365|R03AK0603|Seretide Diskus (Lyfjaver)|innúðadu|300|mcg/sk|60|sk|1|pakki|50+250 mcg, discus|R03AK06|01.05.2009||R|A|1,5|0|0|B|0|LVR|0|0|0|100|GBP|6362|9474|lyfalmen|V0992|9474|23|60|0|30|Lyfjaver ehf|Lyfjaver ehf|||||6362|9474 021373|A02BC0504|Nexium Mups (D.A.C.)|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.04.2006||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|4929|7529|lyfalmen|V0085|7529|00|28|0|37|D.A.C. ehf|D.A.C. ehf|Esómeprazól||4929||4929|7529 021375|M01AB0512|Voltaren Dolo|töflur|12,5|mg|20|stk|1|þpakki||M01AB05|01.10.2004||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|20|0|2|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak||||| 021398|L02BB0303|Casodex (D.A.C.)|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.11.2004||R|A|5|0|0|*|0|DAC|0|0|0|100|XEU|18481|21158|lyfalmen|V0560|21158|00|30|0|30|D.A.C. ehf|D.A.C. ehf|Bíkalútamíð||15239||15239|21158 021417|R01AD0504|Rhinocort (D.A.C.)|nefúði|64|mcg/sk|120|sk|1|fl||R01AD05|01.11.2004||R|A|2|0|0|E|0|DAC|0|0|1|100|SEK|1377|2709|lyfalmen|V0965|2709|24|120|0|38|D.A.C. ehf|D.A.C. ehf|Búdesóníð||1377||1377|2709 021426|N04BX0203|Comtan (D.A.C.)|filmhtfl|200|mg|100|stk|1|glas||N04BX02|01.11.2004||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|12396|17618|lyfalmen|V0729|17618|0|100|0|20|D.A.C. ehf|D.A.C. ehf|Entakapón||12396||12396|17618 021428|A06AB0201|Dulcolax|eþ-stil|10|mg|6|stk|1|pakki||A06AB02|01.01.1995||L|A|5|0|0|0|0|BOI|0|0|0|100|IKR|||lyflausa|||04|6|0|6|Vistor hf|Boehringer Ingelheim|Bisakódýl||||| 021447|N04BC0402|Requip (D.A.C.)|töflur|2|mg|84|stk|1|plglas||N04BC04|01.11.2004||R|A|2|0|0|E|0|DAC|0|0|0|100|GBP|11049|15834|lyfalmen|V0728|15834|00|84|0|28|D.A.C. ehf|D.A.C. ehf|Rópíníról||11049||11049|15834 021469|R03DC0301|Singulair|tuggutfl|5|mg|98|stk|1|þpakki||R03DC03|01.09.1998||R|A|2|0|0|B|0|MSD|0|0|0|100|XEU|23050|30882|lyfalmen|||63|98|0|49|Icepharma hf|M.S.D.|Montelúkast||23050||23050|30882 021494|N01AX1003|Propolipid|stl|10|mg/ml|20|ml|5|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2839|4065|lyfsjukr|||02|100|0|0|Icepharma hf|Fresenius Kabi|Própófól||2839||2839|4065 021548|R03BA0204|Pulmicort Turbuhaler (D.A.C.)|innúðadu|200|mcg/sk|100|sk|1|stauk||R03BA02|01.05.2005||R|A|2|0|0|B|0|DAC|0|0|0|100|SEK|2857|4717|lyfalmen|||23|100|0|25|D.A.C. ehf|D.A.C. ehf|Búdesóníð||2857||2857|4717 021559|R03BA0204|Pulmicort Turbuhaler (D.A.C.)|innúðadu|400|mcg/sk|100|sk|1|stauk||R03BA02|01.05.2005||R|A|2|0|0|B|0|DAC|0|0|0|100|SEK|4676|7186|lyfalmen|||23|100|0|50|D.A.C. ehf|D.A.C. ehf|Búdesóníð||4676||4676|7186 021593|H01BA0201|Minirin|frþ.tfl|60|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|4740|7273|lyfalmen|||00|30|0|4|Vistor hf|Ferring Lægemidler A/S|Desmópressín||4740||4740|7273 021604|H01BA0201|Minirin|frþ.tfl|60|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|14979|20834|lyfalmen|||00|100|0|15|Vistor hf|Ferring Lægemidler A/S|Desmópressín||14979||14979|20834 021613|C10AA0701|Crestor|filmhtfl|5|mg|98|stk|1|þpakki||C10AA07|01.01.2006||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|11975|17091|lyfalmen|||00|98|0|49|Vistor hf|AstraZeneca A/S DK|||11975||11975|17091 021614|H01BA0201|Minirin|frþ.tfl|120|mcg|30|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FAB|0|0|0|100|DKK|8833|12827|lyfalmen|||00|30|0|9|Vistor hf|Ferring AB, Svíþjóð|Desmópressín||8833||8833|12827 021636|N01AX1003|Propolipid|stl|10|mg/ml|100|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|28458|37298|lyfsjukr|||02|1000|0|0|Icepharma hf|Fresenius Kabi|Própófól||28458||28458|37298 021641|H01BA0201|Minirin|frþ.tfl|120|mcg|100|stk|1|þpakki||H01BA02|01.10.2005||R|A|2|0|0|E|0|FEL|0|0|0|100|DKK|25499|33931|lyfalmen|||00|100|0|30|Vistor hf|Ferring Lægemidler A/S|Desmópressín||25499||25499|33931 021647|N01AX1003|Propolipid|stl|20|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|37190|48169|lyfsjukr|||02|500|0|0|Icepharma hf|Fresenius Kabi|Própófól||37190||37190|48169 021659|V01AA0304|Alutard SQ, derm. pter.|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|24816|33081|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|rykmaurar||24816||24816|33081 021674|C10AA0701|Crestor|filmhtfl|5|mg|28|stk|1|þpakki||C10AA07|01.01.2006||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|3764|5948|lyfalmen|||00|28|0|14|Vistor hf|AstraZeneca A/S DK|||3764||3764|5948 021676|N01AX1003|Propolipid|stl|10|mg/ml|50|ml|10|hgl|innr.lyf, fleyti|N01AX10|01.07.2005||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|17502|23657|lyfsjukr|||02|500|0|0|Icepharma hf|Fresenius Kabi|Própófól||17502||17502|23657 021677|B02AA0202|Tranexamsyre "Pfizer"|stl|100|mg/ml|5|ml|10|lykjur||B02AA02|01.11.2005||R|A|3|0|0|0|1|PFI|0|0|0|100|DKK|4678|6698|lyfsjukr|||02|50|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Tranexamsýra||4678||4678|6698 021709|V01AA0304|Alutard SQ, derm. pter.|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|19867|26919|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|rykmaurar||19867||19867|26919 021721|N06AX2101|Cymbalta|sh-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|A|3|0|0|B|0|ELD|0|1|0|100|XEU|4229|6579|lyfalmen|V1951|6464|00|28|0|14|Icepharma hf|Eli Lilly Nederland -|||4229||4229|6579 021829|H01BA0203|Minirin (D.A.C.)|töflur|0,2|mg|30|stk|1|plglas||H01BA02|01.08.2006|28.02.2009|R|A|2|0|0|E|0|DAC|0|0|0|100|DKK|8457|12317|lyfalmen|||00|30|0|15|D.A.C. ehf|D.A.C. ehf|Desmópressín||8457||8457|12317 021862|A02BC0505|Nexium (D.A.C.)|sh-tfl|40|mg|28|stk|1|veski||A02BC05|01.02.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|4929|7529|lyfalmen|V0085|7529|00|28|0|37|D.A.C. ehf|D.A.C. ehf|Esómeprazól||4929||4929|7529 021950|B05AA0705|HyperHAES|irl|0| |250|ml|10|pokar||B05AA07|01.07.2005||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|26077|34333|lyfsjukr|||00|2500|0|2|Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||26077||26077|34333 021967|N06AX2101|Cymbalta|sh-hylki|60|mg|28|stk|1|þpakki||N06AX21|01.04.2005||R|A|3|0|0|B|0|ELD|0|1|0|100|XEU|5677|8544|lyfalmen|||00|28|0|28|Icepharma hf|Eli Lilly Nederland -|||5677||5677|8544 021975|N06AX2101|Cymbalta|sh-hylki|60|mg|98|stk|1|þpakki||N06AX21|01.04.2005||R|A|3|0|0|B|0|ELD|0|1|0|100|XEU|19859|26909|lyfalmen|||00|98|0|98|Icepharma hf|Eli Lilly Nederland -|||19859||19859|26909 022020|V01AA0304|Alutard SQ, derm. pter.|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|19867|26919|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|rykmaurar||19867||19867|26919 022045|L01XE0301|Tarceva|filmhtfl|25|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|92591|117143|lyfsjukr|||00|30|0|0|Icepharma hf|Roche Registration Limited|Erlótiníb||92591||92591|117143 022087|QG03DA0201|Perlutex, vet.|töflur|5|mg|20|stk|1|þpakki||QG03DA02|01.10.1995||R|A|5|0|0|0|0|LAH|0|0|0|100|DKK|725|1431|vetalmen|||16|20|0|0|Vistor hf|LEO Animal Health A/S|||725||725|1431 022128|A01AA0117|Fludent Banan|munnstfl|0,25|mg|200|stk|1|plglas||A01AA01|01.01.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||00|200|0|45|Actavis Group hf|Actavis Group hf|Natríumflúoríð||||| 022132|C10BA0201|Inegy|töflur|30|mg|98|stk|1|þpakki|10 mg + 20 mg|C10BA02|01.09.2005||R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|29762|39239|lyfalmen|||00|98|0|131|Icepharma hf|M.S.D.|Ezetimíb og simvastatín||29762||29762|39239 022159|C10BA0201|Inegy|töflur|50|mg|98|stk|1|þpakki|10 mg + 40 mg|C10BA02|01.09.2005||R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|34795|45505|lyfalmen|||00|98|0|261|Icepharma hf|M.S.D.|Ezetimíb og simvastatín||34795||34795|45505 022181|C10BA0201|Inegy|töflur|90|mg|98|stk|1|þpakki|10 mg + 80 mg|C10BA02|01.09.2005||R|A|1,5|0|0|0|0|MSD|0|0|0|100|XEU|36778|47974|lyfalmen|||00|98|0|523|Icepharma hf|M.S.D.|Ezetimíb og simvastatín||36778||36778|47974 022191|L01XE0301|Tarceva|filmhtfl|100|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|320258|400589|lyfsjukr|||00|30|0|0|Icepharma hf|Roche Registration Limited|Erlótiníb||320258||320258|400589 022205|L01XE0301|Tarceva|filmhtfl|150|mg|30|stk|1|þpakki||L01XE03|01.01.2006||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|381259|476535|lyfsjukr|||00|30|0|0|Icepharma hf|Roche Registration Limited|Erlótiníb||381259||381259|476535 022215|N06AB0504|Paxetin|töflur|20|mg|20|stk|1|glas||N06AB05|01.01.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|584|1489|lyfalmen|V0917|1424|00|20|0|20|Actavis Group hf|Actavis hf|Paroxetín||478||478|1489 022218|QP52AA5102|Drontal Comp.vet.|töflur|0| |24|stk|1|þpakki||QP52AA51|01.01.2006||R|A|5|0|0|0|0|BAN|0|0|0|100|DKK|10469|18117|vetorma|||00|24|0|0|Vistor hf|Bayer Animal Health GmbH|||10469||10469|18117 022250|M03AX0103|Vistabel|sts|50|ein/hgl|1|hgl|1|pakki|4 Allerg.ein/0,1ml|M03AX01|01.02.2008||R|K|2|0|1|0|0|ALL|0|0|0|100|SEK|23823|31845|lyfalmen|||02|1|0|0|Vistor hf|Allergan|Clostridium botulinum toxín-A||23823||23823|31845 022261|QP52AA5107|Profender fyrir kisur 5-8 kg|bl.lausn|1,12|ml/sk|1,12|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BHC|0|0|0|100|DKK|2315|4006|vetorma|||00|2|0|0|Vistor hf|Bayer HealthCare AG|||2315||2315|4006 022269|C08CA0101|Norvasc|töflur|5|mg|30|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|2974|4876|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Amlódipín||2974||2974|4876 022281|QP52AA5102|Drontal Comp.vet.|töflur|0| |2|stk|1|þpakki||QP52AA51|01.10.1991||L|A|5|0|0|0|0|BAN|0|0|0|100|DKK|||vetorma|||00|2|0|0|Vistor hf|Bayer Animal Health GmbH||||||1930 022293|C08CA0101|Norvasc|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|6941|4580|lyfalmen|V0308|3043|00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Amlódipín||2756||2756|4580 022368|C08CA0101|Norvasc|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.01.1992||R|A|4|0|0|B|0|PFI|0|0|0|100|DKK|10767|6786|lyfalmen|V0310|4428|00|100|0|200|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Amlódipín||4381||4381|6786 022407|QP52AA5106|Profender fyrir kisur 2,5-5 kg|bl.lausn|0,7|ml/sk|0,7|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BHC|0|0|0|100|DKK|2192|3793|vetorma|||00|1|0|0|Vistor hf|Bayer HealthCare AG|||2192||2192|3793 022440|D07AB0203|Locoid Lipid|krem|1|mg/g|30|g|1|túpa|feitt|D07AB02|01.07.1986||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|758|1869|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||758||758|1869 022451|D07AB0203|Locoid Lipid|krem|1|mg/g|100|g|1|túpa|feitt|D07AB02|01.04.1987||R|A|3|0|0|B|0|ASP|0|0|1|100|XEU|2205|3833|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||2205||2205|3833 022465|QP52AA5105|Profender fyrir kisur 0,5-2,5 kg|bl.lausn|0,35|ml/sk|0,35|ml|2|skammt||QP52AA51|01.09.2006||R|A|3|0|0|0|0|BHC|0|0|0|100|DKK|1419|2456|vetorma|||00|1|0|0|Vistor hf|Bayer HealthCare AG|||1419||1419|2456 022532|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|28|stk|1|þpakki||C09DA03|01.11.2003||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|4776|7322|lyfalmen|||00|28|0|56|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||4776||4776|7322 022537|N06AB0504|Paxetin|töflur|20|mg|100|stk|1|glas||N06AB05|01.01.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|2400|3506|lyfalmen|V0919|3240|00|100|0|100|Actavis Group hf|Actavis hf|Paroxetín||1964||1964|3506 022577|N06AB0504|Paxetin|töflur|20|mg|60|stk|1|glas||N06AB05|01.01.2005||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|1554|2556|lyfalmen|V0918|2385|00|60|0|60|Actavis Group hf|Actavis hf|Paroxetín||1264||1264|2556 022585|L04AX0304|Metotrexato Lederle (D.A.C.)|töflur|2,5|mg|50|stk|1|glas||L04AX03|01.08.2005||R|A|3|0|0|*|0|DAC|0|0|0|100|SEK|1433|2785|lyfalmen|||00|50|0|50|D.A.C. ehf|D.A.C. ehf|Metótrexat||1433||1433|2785 022609|A07EC0205|Pentasa (D.A.C)|forðatfl|500|mg|60|stk|1|þpakki||A07EC02|01.08.2006||R|A|3|0|0|B|0|DAC|0|0|0|100|DKK|4006|6277|lyfalmen|||10|60|0|20|D.A.C. ehf|D.A.C. ehf|Mesalazín (5-amínósalicýlsýra)||4006||4006|6277 022708|C09DA0303|Diovan Comp 160/12,5 mg|filmhtfl|172,5|mg|98|stk|1|þpakki||C09DA03|01.11.2003||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|15727|21765|lyfalmen|V0192|17884|00|98|0|196|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||15727||15727|21765 022802|L01XC0401|MabCampath|irþ|30|mg/ml|1|ml|3|hgl||L01XC04|01.07.2007||R|K|2|0|1|0|1|GEU|0|0|0|100|SEK|225471|282579|lyfsjukr|||00|3|0|0|Icepharma hf|Genzyme Europe B.V. (I)|Alemtuzumab||225471||225471|282579 022845|S01XA2019|Oftagel|augnhl|2,5|mg/g|0,5|g|30|sk-hyl||S01XA20|01.05.2007||L|A|3|0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen|||00|15|0|0|Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar sam­setningar|||||2761 022904|D10BA0102|Decutan|hylki|10|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|A|3|0|1|C|0|ACA|0|0|0|30|IKR|1407|2750|lyfalmen|||67|30|0|10|Actavis Group hf|Actavis hf|Ísótretínóín||1407||1407|2750 022915|D10BA0102|Decutan|hylki|20|mg|30|stk|1|þpakki||D10BA01|01.02.2006||R|A|3|0|1|C|0|ACA|0|0|0|30|IKR|2450|4165|lyfalmen|||67|30|0|20|Actavis Group hf|Actavis hf|Ísótretínóín||2450||2450|4165 022962|V01AA1104|Alutard SQ, hrossaværur|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|24816|33081|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|dýr||24816||24816|33081 022970|V01AA1104|Alutard SQ, hrossaværur|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|19867|26919|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|dýr||19867||19867|26919 023036|R03BB0101|Atrovent|innúðadu|40|mcg|100|stk|1|pakki|þp+M-úðari|R03BB01|01.07.1992||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|4017|6292|lyfalmen|||19|100|0|33|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||4017||4017|6292 023047|G04BD1001|Emselex|forðatfl|7,5|mg|28|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|5775|8677|lyfalmen|||00|28|0|28|Vistor hf|Novartis Europharm Ltd|Darífenacín||5775||5775|8677 023063|J05AR0301|Truvada|filmhtfl|445|mg|30|stk|1|glas|200+245 mg|J05AR03|01.03.2006||R|A|3|0|1|0|1|GIS|0|0|0|100|DKK|122751|154692|lyfsjukr|||00|30|0|0|Gilead Sience Sweden AB|Gilead Science International ltd.|Tenófóvír dísóproxíl og emtrícítabín||122751||122751|154692 023066|V03AE0301|Fosrenol|tuggutfl|500|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|A|2|0|1|0|0|SHI|0|0|0|100|DKK|30693|40398|lyfalmen|||00|90|0|20|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||30693||30693|40398 023080|V03AE0301|Fosrenol|tuggutfl|750|mg|90|stk|1|pakki||V03AE03|01.03.2006||R|A|2|0|1|0|0|SHI|0|0|0|100|DKK|41003|53234|lyfalmen|||00|90|0|30|Lyfjaver ehf|Shire Pharmaceuticals Contracts Ltd.|Lanthanum karbónat||41003||41003|53234 023124|G04BD1001|Emselex|forðatfl|7,5|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|20764|28036|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|Darífenacín||20764||20764|28036 023146|G04BD1001|Emselex|forðatfl|15|mg|28|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|5833|8756|lyfalmen|||00|28|0|56|Vistor hf|Novartis Europharm Ltd|Darífenacín||5833||5833|8756 023193|G04BD1001|Emselex|forðatfl|15|mg|98|stk|1|þpakki||G04BD10|01.07.2005||R|A|3|0|0|E|0|NOE|0|0|0|100|DKK|20975|28299|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|Darífenacín||20975||20975|28299 023325|V03AB2501|Lanexat|stl|0,1|mg/ml|5|ml|5|lykjur||V03AB25|01.07.1989||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|21291|28375|lyfsjukr|||02|25|0|0|Icepharma hf|Roche|Flúmazeníl||21291||21291|28375 023376|N03AX1204|Gabapentin Merck NM|hylki|400|mg|100|stk|1|glas||N03AX12|01.05.2004||R|A|2|0|0|E|0|MNA|0|0|0|100|SEK|6941|10260|lyfalmen|V0715|10260|00|100|0|22|Actavis Group PTC ehf|Merck NM AB|Gabapentín||6941||6941|10260 023409|N01BB2004|Oraqix|thhlaup|5|%|1,7|g|20|rörlyk||N01BB20|01.09.2006||R|A|3|0|0|0|0|DED|0|0|0|100|XEU|16853|23167|lyfalmen|||00|34|0|0|Vistor hf|Dentsply DeTrey GmbH|Blöndur||16853||16853|23167 023414|B03XA0201|Aranesp|stl|20|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|8775|12564|lyfsjukr|||00|0|0|4|Vistor hf|Amgen|Darbepóetín alfa||8775||8775|12564 023419|B03XA0201|Aranesp|stl|80|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|34543|44874|lyfsjukr|||00|0|0|18|Vistor hf|Amgen|Darbepóetín alfa||34543||34543|44874 023425|B03XA0201|Aranesp|stl|60|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|26144|34417|lyfsjukr|||00|0|0|13|Vistor hf|Amgen|Darbepóetín alfa||26144||26144|34417 023441|B03XA0201|Aranesp|stl|150|mcg/pen|0,3|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|62238|79354|lyfsjukr|||00|0|0|33|Vistor hf|Amgen|Darbepóetín alfa||62238||62238|79354 023447|B03XA0201|Aranesp|stl|100|mcg/pen|0,5|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|41552|53600|lyfsjukr|||00|0|0|22|Vistor hf|Amgen|Darbepóetín alfa||41552||41552|53600 023448|J06BA0207|Kiovig|irl|100|mg/ml|10|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|8230|11783|lyfsjukr|||00|10|0|0|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||8230||8230|11783 023452|B03XA0201|Aranesp|stl|300|mcg/pen|0,6|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|124395|156739|lyfsjukr|||00|1|0|67|Vistor hf|Amgen|Darbepóetín alfa||124395||124395|156739 023459|J06BA0207|Kiovig|irl|100|mg/ml|25|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|20577|27486|lyfsjukr|||00|25|0|0|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||20577||20577|27486 023463|B03XA0201|Aranesp|stl|40|mcg/pen|0,4|ml|1|penni|áfylltur penni|B03XA02|01.01.2006||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|17088|23142|lyfsjukr|||00|0|0|9|Vistor hf|Amgen|Darbepóetín alfa||17088||17088|23142 023468|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|20|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|2|0|0|E|0|GGL|0|0|0|100|GBP|12094|17242|lyfalmen|||00|10|0|20|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||12094||12094|17242 023470|J06BA0207|Kiovig|irl|100|mg/ml|50|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|41154|53104|lyfsjukr|||00|50|0|0|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||41154||41154|53104 023476|J06BA0207|Kiovig|irl|100|mg/ml|100|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|82306|104338|lyfsjukr|||00|100|0|0|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||82306||82306|104338 023479|B01AX0501|Arixtra|stl|5|mg/spr|0,4|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|8466|12329|lyfalmen|||00|3|0|14|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||8466||8466|12329 023480|B03XA0201|Aranesp|stl|500|mcg/pen|1|ml|1|penni|áfyllur penni|B03XA02|01.07.2007||R|K|2|0|1|0|1|AMG|0|0|0|100|DKK|198954|249565|lyfsjukr|||00|1|0|111|Vistor hf|Amgen|Darbepóetín alfa||198954||198954|249565 023487|J06BA0207|Kiovig|irl|100|mg/ml|200|ml|1|glerfl||J06BA02|01.09.2007||R|K|2|0|0|0|1|BAA|0|0|0|100|SEK|164613|206811|lyfsjukr|||00|200|0|0|Icepharma hf|Baxter AG|Immúnóglóbúlín, normal, manna, gefin í æð||164613||164613|206811 023491|B01AX0501|Arixtra|stl|10|mg/spr|0,8|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|16931|23264|lyfalmen|||00|6|0|28|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||16931||16931|23264 023501|B01AX0501|Arixtra|stl|7,5|mg/spr|0,6|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|3|0|0|E|0|GGL|0|0|0|100|GBP|12699|17995|lyfalmen|||00|4|0|21|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||12699||12699|17995 023506|J05AE0901|Aptivus|hylki|250|mg|120|stk|1|glas||J05AE09|01.03.2007||R|A|3|0|1|0|1|BII|0|0|0|100|DKK|142351|179094|lyfsjukr|||00|120|0|30|Vistor hf|Boehringer Ingelheim International |Tipranavír||142351||142351|179094 023509|B01AC0401|Plavix|töflur|75|mg|100|stk|1|þpakki||B01AC04|01.07.2007||R|A|3|0|0|E|0|SBM|0|0|0|100|NOK|24184|32294|lyfalmen|||00|100|0|100|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||24184||24184|32294 023544|B01AX0501|Arixtra|stl|2,5|mg/spr|0,5|ml|7|spr|áfyllt sprauta|B01AX05|01.08.2006||R|A|2|0|0|E|0|GGL|0|0|0|100|GBP|4121|6433|lyfalmen|||00|4|0|7|GlaxoSmithKline ehf|Glaxo Group Limited|Fondaparinux||4121||4121|6433 023590|S01ED0106|Timosan Depot|augnhl|1|mg/g|0,4|g|30|sk-hyl||S01ED01|01.07.2007||R|A|2,5|0|0|*|0|SAO|0|0|0|100|XEU|3683|5838|lyfalmen|||00|12|0|60|Icepharma hf|Santen Oy|Tímólól||3683||3683|5838 023708|J05AE0101|Invirase|filmhtfl|500|mg|120|stk|1|glas||J05AE01|01.01.2006||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|65723|83693|lyfsjukr|||00|120|0|100|Icepharma hf|Roche|Saquínavír||65723||65723|83693 023809|A10AE0404|Lantus [OptiClik]|stl|100|ein/ml|3|ml|5|rörlyk|fyrir OptiClik|A10AE04|01.04.2007||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|9693|13994|lyfalmen|||00|15|0|38|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||9693||9693|13994 023968|G04BE0302|Revatio|filmhtfl|20|mg|90|stk|1|þpakki||G04BE03|01.08.2006||R|A|5|0|1|0|1|PFL|0|0|0|100|DKK|112435|141849|lyfsjukr|||00|90|0|36|Vistor hf|Pfizer Limited|Síldenafíl||112435||112435|141849 024018|N04BA0204|Sinemet 25/100|töflur|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.10.1985||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|3896|6127|lyfalmen|||00|100|0|17|Icepharma hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||3896||3896|6127 024024|J01AA1201|Tygacil|irs|50|mg|10|hgl|1|pakki||J01AA12|01.02.2007||R|A|1,5|0|0|0|1|WTE|0|0|0|100|USD|87303|110560|lyfsjukr|||00|10|0|5|Icepharma hf|Wyeth Europe|Tigecýklín||87303||87303|110560 024037|J01DB0401|Kefzol|sts|1|g|10|stk|1|hgl||J01DB04|01.09.2005||R|A|2|0|0|0|1|NOM|0|0|0|100|IKR|5443|7793|lyfsjukr|||03|10|0|3|Icepharma hf|NordMedica ApS|Cefazólín||5443||5443|7793 024056|N02AB0301|Durogesic|forðapl|12|mcg/klst|5|stk|1|þpakki||N02AB03|01.02.2006||R|A|2|1|0|E|0|JAS|0|0|0|100|SEK|3927|6170|lyfalmen|||00|5|0|10|Vistor hf|Janssen-Cilag AB|Fentanýl||3927||3927|6170 024090|N04BD0201|Azilect|töflur|1|mg|30|stk|1|glas||N04BD02|01.10.2005||R|A|3|0|0|E|0|TPG|0|0|0|100|DKK|20177|27305|lyfalmen|||00|30|0|30|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||20177||20177|27305 024135|B05BB0119|Ringer-Acetat Baxter Viaflo|irl|0| |1000|ml|10|pokar|lausn|B05BB01|01.10.2005||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|2054|2941|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|Elektrólýtar||2054||2054|2941 024147|A10BD0301|Avandamet|filmhtfl|1002|mg|112|stk|1|þpakki|1000+2mg|A10BD03|01.10.2005||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|8478|12345|lyfalmen|||00|112|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Metformín og rosiglítazón||8478||8478|12345 024169|A10BD0301|Avandamet|filmhtfl|1004|mg|112|stk|1|þpakki|1000+4mg|A10BD03|01.10.2005||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|14824|20641|lyfalmen|||00|112|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Metformín og rosiglítazón||14824||14824|20641 024200|N04BD0201|Azilect|töflur|1|mg|100|stk|1|þpakki||N04BD02|01.10.2005||R|A|3|0|0|E|0|TPG|0|0|0|100|DKK|67258|85921|lyfalmen|||00|100|0|100|Lundbeck Export A/S|Teva Pharma GmbH|Rasagilín||67258||67258|85921 024307|V01AA1105|Alutard SQ, hundahar|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|24816|33081|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|dýr||24816||24816|33081 024478|V04CL0024|Soluprick SQ ALK553 - hundahár|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|7812|11442|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7812||7812|11442 024481|R03CC0301|Bricanyl|mixtúra|0,3|mg/ml|100|ml|1|fl||R03CC03|01.03.2006||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|367|1338|lyfalmen|||00|100|0|2|Vistor hf|AstraZeneca A/S DK|Terbútalín||367||367|1338 024482|V04CL0025|Soluprick SQ ALK555 - kattahár|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|7812|11442|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7812||7812|11442 024504|V04CL0011|Soluprick SQ ALK106 - Rauðölur|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13163|18573|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||13163||13163|18573 024510|V04CL0012|Soluprick SQ ALK107 - Gráölur|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13163|18573|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||13163||13163|18573 024526|V04CL0014|Soluprick SQ ALK113 - Hesliviður|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13185|18600|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||13185||13185|18600 024532|V04CL0015|Soluprick SQ ALK203 - Háliðagras|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13163|18573|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||13163||13163|18573 024559|V04CL0016|Soluprick SQ ALK214 -Axhnoðapunktur|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13163|18573|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||13163||13163|18573 024565|V04CL0017|Soluprick SQ ALK218 - Hávingull|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13320|18768|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||13320||13320|18768 024576|V04CL0018|Soluprick SQ ALK223 - Vallarrýgresi|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13163|18573|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||13163||13163|18573 024583|V04CL0019|Soluprick SQ ALK225 - Vallarfoxgras|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|7812|11442|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7812||7812|11442 024589|V04CL0020|Soluprick SQ ALK228 - Vallarsveifgras|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13163|18573|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||13163||13163|18573 024590|M05BA0802|Aclasta|irl|5|mg|100|ml|1|fl|lausn|M05BA08|01.07.2005||R|A|3|0|1|E|0|NOE|0|0|0|100|DKK|74359|94762|lyfalmen|||00|100|0|125|Vistor hf|Novartis Europharm Ltd|||74359||74359|94762 024600|V04CL0021|Soluprick SQ ALK231 - Rúgur|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|13320|18768|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||13320||13320|18768 024603|V04CL0009|Soluprick Negativ Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|3|0|0|0|0|ALK|0|0|0|100|DKK|1604|3017|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||1604||1604|3017 024622|V04CL0013|Soluprick SQ ALK108 - Birkifrjó|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|7812|11442|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7812||7812|11442 024644|V04CL0023|Soluprick SQ ALK552 - Hrossaværur|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|7812|11442|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7812||7812|11442 024670|V04CL0022|Soluprick SQ ALK504 - Rykmaur|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|2|0|0|0|0|ALK|0|0|0|100|DKK|7812|11442|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7812||7812|11442 024681|V04CL0010|Soluprick Positiv Kontrol|lausn|10|HEP|2|ml|1|hgl||V04CL00|01.04.2006||R|K|3|0|0|0|0|ALK|0|0|0|100|DKK|1604|3017|lyfalmen|||02|2|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||1604||1604|3017 025093|C01BD0102|Trangorex (D.A.C.)|töflur|200|mg|30|stk|1|þpakki||C01BD01|01.08.2006||R|A|3|0|0|B|0|DAC|0|0|0|100|NOK|1042|2254|lyfalmen|V0143|2191|70|30|0|30|D.A.C. ehf|D.A.C. ehf|Amíódarón||1042||1042|2254 025126|M05BB0301|Fosavance|töflur|0| |4|stk|1|þpakki|70mg+70mcg|M05BB03|01.10.2006||R|A|1,5|0|0|E|0|MSD|0|0|0|100|XEU|5878|8817|lyfalmen|||00|4|0|0|Icepharma hf|M.S.D.|Alendrónsýra og kólekalsíferól||5878||5878|8817 025142|D07AB0202|Locoid Crelo|lausn|1|mg/g|30|g|1|glas|á húð|D07AB02|01.04.1994||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|937|2112|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||937||937|2112 025155|V01AA1105|Alutard SQ, hundahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|19867|26919|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|dýr||19867||19867|26919 025174|D07AB0202|Locoid Crelo|lausn|1|mg/g|100|g|1|glas|á húð|D07AB02|01.04.1994||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|2681|4479|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||2681||2681|4479 025180|R03BA0201|Pulmicort|innúðal|100|mcg/sk|120|sk|1|stauk||R03BA02|01.01.2009||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|1801|3284|lyfalmen|||0|120|0|15|Vistor hf|AstraZeneca A/S DK|Búdesóníð||1801||1801|3284 025191|R03BA0201|Pulmicort|innúðal|200|mcg/sk|120|sk|1|stauk||R03BA02|01.01.2009||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|3426|5490|lyfalmen|||0|120|0|30|Vistor hf|AstraZeneca A/S DK|Búdesóníð||3426||3426|5490 025262|V01AA1105|Alutard SQ, hundahar|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|19867|26919|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|dýr||19867||19867|26919 025300|J01DB0101|Keflex|mixtúrud|50|mg/ml|100|ml|1|glas||J01DB01|01.03.1983||R|A|3|0|0|0|0|NMA|0|0|1|100|IKR|959|2142|lyfalmen|||08|100|0|2|Icepharma hf|NordMedica A/S|Cefalexín||959||959|2142 025306|M05BB0301|Fosavance|töflur|0| |12|stk|1|þpakki|70mg+70mcg|M05BB03|01.10.2006||R|A|1,5|0|0|E|0|MSD|0|0|0|100|XEU|17373|23814|lyfalmen|||00|12|0|0|Icepharma hf|M.S.D.|Alendrónsýra og kólekalsíferól||17373||17373|23814 025311|J01DB0101|Keflex|töflur|500|mg|14|stk|1|þpakki||J01DB01|01.07.1988||R|A|3|0|0|0|0|NMA|0|0|1|100|IKR|794|1918|lyfalmen|||00|14|0|4|Icepharma hf|NordMedica A/S|Cefalexín||794||794|1918 025317|J05AF1001|Baraclude|filmhtfl|1|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|102192|129097|lyfsjukr|||00|30|0|60|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||102192||102192|129097 025323|J05AF1001|Baraclude|filmhtfl|0,5|mg|30|stk|1|þpakki||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|101029|127649|lyfsjukr|||00|30|0|30|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||101029||101029|127649 025388|QM01AC0601|Metacam|stl|5|mg/ml|20|ml|1|hgl||QM01AC06|01.10.2006||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|9845|18924|vetalmen|||00|20|0|0|Vistor hf|Boehringer Ingelheim|||9845||9845|18924 025425|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|30|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|A|3|0|1|0|0|ALK|0|0|0|100|DKK|18237|24890|lyfalmen|||00|30|0|0|Vistor hf|ALK-Abello A/S|grasfrjó||18237||18237|24890 025444|C09CA0301|Diovan|filmhtfl|320|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.04.2007||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|22181|29800|lyfalmen|||00|98|0|392|Vistor hf|Novartis Healthcare A/S-|Valsartan||22181||22181|29800 025455|C09CA0301|Diovan|töflur|320|mg|28|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.04.2007||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|6470|9620|lyfalmen|||00|28|0|112|Vistor hf|Novartis Healthcare A/S-|Valsartan||6470||6470|9620 025471|N06AB1002|Cipralex (D.A.C.)|töflur|20|mg|28|stk|1|þpakki||N06AB10|01.12.2006||R|A|3|0|0|B|0|DAC|0|1|0|100|DKK|6881|10178|lyfalmen|V1039|10178|00|28|0|56|D.A.C. ehf|D.A.C. ehf|Escítalópram||6881||6881|10178 025555|N05AX0803|Risperdal Consta|sts|50|mg|1|hgl|1|pakki||N05AX08|01.04.2003||R|K|3|0|0|*|0|JAS|0|1|0|100|SEK|28896|38160|lyfalmen|||00|1|0|28|Vistor hf|Janssen-Cilag AB|Risperídón||28896||28896|38160 025578|S01EC0302|Trusopt (D.A.C.)|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.01.2007||R|A|2|0|0|*|0|DAC|0|0|0|100|XEU|1922|3449|lyfalmen|V1090|3449|06|5|0|17|D.A.C. ehf|D.A.C. ehf|Dorzólamíð||1922||1922|3449 025588|M05BA0602|Bonviva|filmhtfl|150|mg|1|stk|1|þpakki||M05BA06|01.01.2006||R|A|2|0|0|E|0|RRL|0|0|0|100|DKK|5391|8156|lyfalmen|||00|1|0|30|Icepharma hf|Roche Registration Limited|||5391||5391|8156 025599|M05BA0602|Bonviva|filmhtfl|150|mg|3|stk|1|þpakki||M05BA06|01.01.2006||R|A|2|0|0|E|0|RRL|0|0|0|100|DKK|15396|21353|lyfalmen|||00|3|0|90|Icepharma hf|Roche Registration Limited|||15396||15396|21353 025676|L01CB0201|Vumon|stl|10|mg/ml|5|ml|10|lykjur||L01CB02|01.05.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|34429|44732|lyfsjukr|||00|50|1|0|Distica|Distica - óskráð lyf|||34429||34429|44732 025677|S01ED5109|Cosopt (D.A.C.)|augndr|5|mg/ml|5|ml|1|glas||S01ED51|01.04.2006||R|A|2|0|0|*|0|DAC|0|0|0|100|XEU|2754|4380|lyfalmen|V0989|4380|06|5|0|0|D.A.C. ehf|D.A.C. ehf|Tímólól í blöndum||2608||2608|4380 025698|N05AX0803|Risperdal Consta|sts|25|mg|1|hgl|1|pakki||N05AX08|01.04.2003||R|K|3|0|0|*|0|JAS|0|1|0|100|SEK|15426|21390|lyfalmen|||00|1|0|14|Vistor hf|Janssen-Cilag AB|Risperídón||15426||15426|21390 025709|N05AX0803|Risperdal Consta|sts|37,5|mg|1|hgl|1|pakki||N05AX08|01.04.2003||R|K|3|0|0|*|0|JAS|0|1|0|100|SEK|22312|29963|lyfalmen|||00|1|0|21|Vistor hf|Janssen-Cilag AB|Risperídón||22312||22312|29963 025725|R01AD0505|Rhinocort Turbuhaler (D.A.C.)|nefúðad|100|mcg/sk|200|sk|1|stauk||R01AD05|01.01.2007||R|A|2|0|0|E|0|DAC|0|0|1|100|SEK|3623|5757|lyfalmen|V0966|5757|23|200|0|100|D.A.C. ehf|D.A.C. ehf|Búdesóníð||3623||3623|5757 025736|V01AA0217|Grazax 75.000 SQ-T|lausnart|75000|ein|100|stk|1|þpakki|frostþurrkaðar|V01AA02|01.02.2008||R|A|3|0|1|0|0|ALK|0|0|0|100|DKK|56936|73070|lyfalmen|||00|100|0|0|Vistor hf|ALK-Abello A/S|grasfrjó||56936||56936|73070 025747|C01BB0101|Xylocard 100 mg/ 5 ml|stl|20|mg/ml|5|ml|5|gl-lyk||C01BB01|01.12.2006||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|6142|8794|lyfsjukr|||02|25|0|0|Vistor hf|AstraZeneca A/S DK|Lídókaín||6142||6142|8794 025841|V01AA1106|Alutard SQ, kattahar|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|24816|33081|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|dýr||24816||24816|33081 025958|M01AE0215|Naproxen Merck NM|töflur|250|mg|100|stk|1|glas||M01AE02|01.01.1991||R|A|4|0|0|E|0|MNA|0|0|1|100|SEK|836|1975|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck NM AB|Naproxen||836||836|1975 025965|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|1|l|1|fl||QP54AA01|01.04.1992||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|3588|6209|vetorma|||16|1|0|0|Vistor hf|Merial (MSD)|||3588||3588|6209 025985|M01AE0215|Naproxen Merck NM|töflur|500|mg|50|stk|1|þpakki||M01AE02|01.01.1991||R|A|4|0|0|E|0|MNA|0|0|1|100|SEK|862|2010|lyfalmen|||00|50|0|50|Actavis Group PTC ehf|Merck NM AB|Naproxen||862||862|2010 025994|M01AE0215|Naproxen Merck NM|töflur|500|mg|100|stk|1|glas||M01AE02|01.01.1991||R|A|4|0|0|E|0|MNA|0|0|1|100|SEK|1538|2928|lyfalmen|||00|100|0|100|Actavis Group PTC ehf|Merck NM AB|Naproxen||1538||1538|2928 026021|QP54AA0102|Oramec Drench, vet.|mixtúra|0,8|mg/ml|2,5|l|1|fl||QP54AA01|01.04.1992||R|A|3|0|0|0|0|MEF|0|0|0|100|XEU|8120|14052|vetorma|||16|2|0|0|Vistor hf|Merial (MSD)|||8120||8120|14052 026096|V01AA1106|Alutard SQ, kattahar|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|19867|26919|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|dýr||19867||19867|26919 026682|J01XE0101|Furadantin|töflur|50|mg|100|stk|1|glas||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1726|3183|lyfalmen|||00|100|0|25|Vistor hf|Recip AB|Nítrófúrantóín||1726||1726|3183 027094|J01XE0101|Furadantin|töflur|5|mg|50|stk|1|glas||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|359|1328|lyfalmen|||00|50|0|1|Vistor hf|Recip AB|Nítrófúrantóín||359||359|1328 027144|M01CC0101|Atamir|hylki|150|mg|50|stk|1|þpakki||M01CC01|01.06.1982||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|2774|4605|lyfalmen|||10|50|0|15|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||2774||2774|4605 027235|G03HA0103|Cyproteron Merck NM|töflur|50|mg|50|stk|1|glas||G03HA01|01.04.1997||R|A|5|0|0|*|0|MNA|0|0|0|100|SEK|6906|10212|lyfalmen|||00|50|0|25|Actavis Group PTC ehf|Merck NM AB|Cýpróterón||6906||6906|10212 027281|N06DA0204 |Donepezil Actavis|filmhtfl|5|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|30365|39989|lyfalmen|V0375|39989|00|100|0|67|Actavis Group hf|Actavis hf|Dónepezíl||||30365|39989 027305|N06DA0204 |Donepezil Actavis|filmhtfl|10|mg|100|stk|1|þpakki||N06DA02|01.05.2009||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|34078|44612|lyfalmen|V0376|44612|00|100|0|133|Actavis Group hf|Actavis hf|Dónepezíl||||34078|44612 027362|L01AX0302 |Temodal (Lyfjaver)|hylki|20|mg|20|stk|1|glas||L01AX03|01.05.2009||R|A|3|0|1|0|1|LVR|0|0|0|100|NOK|68603|87278|lyfsjukr|||00|20|0|0|Lyfjaver ehf|Lyfjaver ehf|Temozolomid||||68603|87278 027373|L01AX0302 |Temodal (Lyfjaver)|hylki|100|mg|5|stk|1|glas||L01AX03|01.05.2009||R|A|3|0|1|0|1|LVR|0|0|0|100|NOK|83871|106287|lyfsjukr|||00|5|0|0|Lyfjaver ehf|Lyfjaver ehf|Temozolomid||||83871|106287 027385|L01AX0302 |Temodal (Lyfjaver)|hylki|250|mg|5|stk|1|glas||L01AX03|01.05.2009||R|A|3|0|1|0|1|LVR|0|0|0|100|NOK|181026|227245|lyfsjukr|||00|5|0|0|Lyfjaver ehf|Lyfjaver ehf|Temozolomid||||181026|227245 027397|G02CX0102 |Tractocile (Lyfjaver)|stl|7,5|mg/ml|0,9|ml|1|hgl|lausn|G02CX01|01.05.2009||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|5489|7859|lyfsjukr|||00|1|0|0|Lyfjaver ehf|Lyfjaver ehf|Atosíban||||5489|7859 027408|G02CX0102 |Tractocile (Lyfjaver)|irþ|7,5|mg/ml|5|ml|1|hgl|lausn|G02CX01|01.05.2009||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|16352|22226|lyfsjukr|||00|5|0|0|Lyfjaver ehf|Lyfjaver ehf|Atosíban||||16352|22226 027559|N03AX1501|Zonegran|hylki|25|mg|14|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|1755|3222|lyfalmen|||00|14|0|2|Vistor hf|Eisai Ltd|||1755||1755|3222 027586|N03AX1501|Zonegran|hylki|25|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|7021|10368|lyfalmen|||00|56|0|7|Vistor hf|Eisai Ltd|||7021||7021|10368 027595|N03AX1501|Zonegran|hylki|50|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|9397|13593|lyfalmen|||00|56|0|14|Vistor hf|Eisai Ltd|||9397||9397|13593 027604|N03AX1501|Zonegran|hylki|100|mg|56|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|12412|17638|lyfalmen|||00|56|0|28|Vistor hf|Eisai Ltd|||12412||12412|17638 027649|H03AA0105|Levaxin|töflur|0,05|mg|100|stk|1|glas||H03AA01|01.04.2004||R|A|2|0|0|B|0|NYG|0|0|0|100|DKK|905|2069|lyfalmen|V0431|1912|00|100|0|33|Gróco ehf|Nycomed Danmark A/S|Levótýroxínnatríum||905||905|2069 027656|H03AA0105|Levaxin|töflur|0,1|mg|100|stk|1|glas||H03AA01|01.03.2003||R|A|2|0|0|B|0|NYG|0|0|0|100|DKK|863|2012|lyfalmen|V0430|1746|00|100|0|67|Gróco ehf|Nycomed Danmark A/S|Levótýroxínnatríum||863||863|2012 027795|J02AC0401|Noxafil|mixtúra|40|mg/ml|105|ml|1|fl||J02AC04|01.08.2006||R|A|2|0|1|0|1|SCP|0|0|0|100|DKK|126513|159376|lyfsjukr|||00|105|0|1|Icepharma hf|SP Europe|Posacónazól||126513||126513|159376 027968|N05AX1201|Abilify|munndr.t|10|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|A|1,5|0|0|*|0|OTS|0|1|0|100|DKK|24350|32501|lyfalmen|||00|28|0|19|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||24350||24350|32501 027977|N05AX1201|Abilify|munndr.t|15|mg|28|stk|1|þpakki||N05AX12|01.01.2007||R|A|1,5|0|0|*|0|OTS|0|1|0|100|DKK|24350|32501|lyfalmen|||00|28|0|28|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||24350||24350|32501 028314|J07AP0301|Typhim Vi|stl|25|mcg/spr|0,5|ml|1|áf.spr|m/ aðsk. nál|J07AP03|01.05.2008||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|2598|4366|lyfalmen|||02|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsaðir mótefna­vakar||2598||2598|4366 028351|J07BL0101|Stamaril|sts|0| |0,5|ml|10|hgl|+ 10 áf.spr. með leysi|J07BL01|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|21813|29342|lyfalmen|||02|5|0|0|Icepharma hf|Sanofi Pasteur MSD|Gulusótt, veikluð veira||21813||21813|29342 028360|J07BG0101|Rabies - Imovax|bóluefni|0| |1|ml|1|hgl||J07BG01|01.01.1996||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|8347|12168|lyfalmen|||02|1|0|0|Icepharma hf|Aventis Pasteur MSD A/S|Hundaæði, dauð veira||8347||8347|12168 028387|M03BX0104|Baklofen Merck NM|töflur|25|mg|50|stk|1|glas|0|M03BX01|01.10.2008||R|A|3|0|0|E|0|MNA|0|0|1|100|SEK|1239|2522|lyfalmen|V0712|2522|00|50|0|25|Actavis Group PTC ehf|Merck NM AB|Baklófen||1239||1239|2522 028405|M01AE0216|Naproxen-E Merck NM|sh-tfl|500|mg|50|stk|1|plglas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|1765|3236|lyfalmen|||10|50|0|50|Actavis Group PTC ehf|Merck NM AB|Naproxen||1765||1765|3236 028498|C08DB0102|Cardizem Retard|forðatfl|120|mg|60|stk|1|glas||C08DB01|01.04.1987||R|A|3|0|0|B|0|FRO|0|0|0|100|DKK|3375|5420|lyfalmen|V0351|3898|10|60|0|30|Vistor hf|Ferrosan A/S|Diltíazem||3375||3375|5420 028575|N03AX0901 |Lamictal|dreifit.|5|mg|56|stk|1|þpakki||N03AX09|01.05.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|ISK|||lyfalmen|||00|56|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||| 028586|N03AX0901 |Lamictal|dreifit.|100|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|ISK|||lyfalmen|||00|98|0|33|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||| 028597|D07BB0401|Locoidol|krem|0| |30|g|1|túpa||D07BB04|01.01.1990||R|A|4|0|0|B|0|ASP|0|0|1|100|XEU|928|2100|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat og sýkla­eyðandi lyf||928||928|2100 028598|N03AX0901 |Lamictal|dreifit.|200|mg|98|stk|1|þpakki||N03AX09|01.05.2009||R|A|3|0|0|E|0|GSK|0|0|0|100|ISK|||lyfalmen|||00|98|0|65|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||||| 028606|QN05CM1801|Dexdomitor|stl|0,5|mg/ml|10|ml|1|hgl||QN05CM18|01.11.2007||R|A|3|0|0|0|0|OCO|0|0|0|100|DKK|8170|15734|vetalmen|||27|10|0|0|Icepharma hf|Orion Corporation (I)|||8170||8170|15734 028761|A03FA0101|Primperan|stl|5|mg/ml|2|ml|12|lykjur||A03FA01|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|918|2086|lyfalmen|||02|24|0|4|Vistor hf|Sanofi-aventis Norge AS|Metóklópramíð||918||918|2086 028787|A04AA0201|Kytril|töflur|1|mg|10|stk|1|þpakki||A04AA02|01.10.1994||R|A|3|0|0|E|0|ROA|0|0|0|100|DKK|12200|17374|lyfalmen|||00|10|0|5|Icepharma hf|Roche as|Granisetrón||12200||12200|17374 029025|D07AC0301|Ibaril|smyrsli|2,5|mg/g|50|g|1|túpa||D07AC03|01.12.1978||R|A|1,5|0|0|B|0|SNO|0|0|1|100|NOK|2105|3697|lyfalmen|||20|50|0|50|Vistor hf|Sanofi-aventis Norge AS|Desoxímetasón||2105||2105|3697 029066|R01AD0801|Flixonase|nefúði|50|mcg/sk|16|ml|1|stauk|120 sk|R01AD08|01.04.1992||R|A|2|0|0|E|0|GSK|0|0|1|100|GBP|1023|2229|lyfalmen|||24|16|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||||1023|2229 029116|A03FA0101|Primperan|töflur|10|mg|40|stk|1|þpakki||A03FA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|972|2159|lyfalmen|||00|40|0|13|Vistor hf|Sanofi-aventis Norge AS|Metóklópramíð||972||972|2159 029287|C03DB0105 |Amiloride|töflur|5|mg|28|stk|1|þpakki||C03DB01|01.04.2009||R|A|3|0|0|E|0|AUK|0|0|0|100|GBP|239|1165|lyfalmen|||00|28|0|14|Actavis Group hf|Actavis UK Ltd.|||||239|1165 029298|D07AB0101|Emovat|krem|0,5|mg/g|25|g|1|túpa||D07AB01|01.01.1985|30.04.2009|R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|411|1398|lyfalmen|||20|25|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasón||411||411|1398 029307|A07EA0603|Entocort enema (D.A.C.)|endaþ.dr|0,02|mg/ml|7|stk|1|þpakki||A07EA06|01.01.2007||R|A|2|0|0|B|0|DAC|0|0|0|100|SEK|7003|10344|lyfalmen|||0|7|0|0|D.A.C. ehf|D.A.C. ehf|||||7003|10344 029352|C10AA0103|Zocor (Lyfjaver)|töflur|10|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|XEU|8594|5898|lyfalmen|||00|98|0|65|Lyfjaver ehf|Lyfjaver ehf|Simvastatín||3727||3727|5898 029361|C10AA0103|Zocor (Lyfjaver)|töflur|20|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|XEU|7778|9273|lyfalmen|||00|98|0|131|Lyfjaver ehf|Lyfjaver ehf|Simvastatín||6214||6214|9273 029370|C10AA0103|Zocor (Lyfjaver)|töflur|40|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|3|0|0|0|0|LVR|0|0|0|100|XEU|12224|12512|lyfalmen|V0367|3052|00|98|0|261|Lyfjaver ehf|Lyfjaver ehf|Simvastatín||8601||8601|12512 029379|C10AA0103|Zocor (Lyfjaver)|töflur|80|mg|98|stk|1|þpakki||C10AA01|01.09.2005||R|A|1,5|0|0|0|0|LVR|0|0|0|100|XEU|17189|23585|lyfalmen|||00|98|0|523|Lyfjaver ehf|Lyfjaver ehf|Simvastatín||17189||17189|23585 029517|L01BB0503 |Fludarabin Actavis|sts/irs|25|mg/ml|50|mg|1|hgl||L01BB05|01.04.2009||R|A|2|0|1|0|1|AGP|0|0|0|100|XEU|32238|42004|lyfsjukr|||00|50|0|0|Actavis Group hf|Actavis Group PTC ehf|Flúdarabín||||32238|42004 029528|L01CA0402 |Vinorelbin Actavis|irþ|10|mg/ml|5|ml|1|hgl||L01CA04|01.04.2009||R|K|3|0|1|0|1|AGP|0|0|0|100|XEU|20747|27698|lyfsjukr|||00|5|0|0|Actavis Group hf|Actavis Group PTC ehf|Vínorelbín||||20747|27698 029574|L01XX1904 |Irinotecan Actavis|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.04.2009||R|A|3|0|1|0|1|AGT|0|0|0|100|XEU|20782|27741|lyfsjukr|||00|5|0|0|Actavis Group hf|Actavis Group hf|Írinótekan||||20782|27741 029860|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2|Vistor hf|McNeil Denmark ApS|Nikótín||||| 029869|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|7|Vistor hf|McNeil Denmark ApS|Nikótín||||| 029878|N07BA0121|Nicorette Fruitmint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14|Vistor hf|McNeil Denmark ApS|Nikótín||||| 029887|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|4|Vistor hf|McNeil Denmark ApS|Nikótín||||| 029896|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|14|Vistor hf|McNeil Denmark ApS|Nikótín||||| 029905|N07BA0121|Nicorette Fruitmint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2006||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28|Vistor hf|McNeil Denmark ApS|Nikótín||||| 030054|J05AE0302|Norvir (D.A.C.)|hylki|100|mg|84|stk|1|glas|mjúk hylki|J05AE03|01.12.2008||R|K|2|0|1|0|1|DAC|0|0|0|100|DKK|19289|25882|lyfsjukr|||00|84|0|7|D.A.C. ehf|D.A.C. ehf|Ritonavír||||19289|25882 030315|N03AX1501|Zonegran|hylki|100|mg|98|stk|1|þpakki||N03AX15|01.03.2007||R|A|3|0|0|E|0|EIS|0|0|0|100|SEK|21711|29215|lyfalmen|||00|98|0|49|Vistor hf|Eisai Ltd|||21711||21711|29215 030361|D07AB0101|Emovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AB01|01.01.1985||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|455|1458|lyfalmen|||20|25|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasón||455||455|1458 030387|D07AB0101|Emovat|smyrsli|0,5|mg/g|100|g|1|túpa||D07AB01|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|1792|3272|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasón||1792||1792|3272 030588|M01AX0501|Glucomed|töflur|625|mg|60|stk|1|þpakki||M01AX05|01.07.2006||L|A|3|0|0|0|0|NAV|0|0|1|100|IKR|||lyflausa|||00|60|0|25|Icepharma hf|Navamedic ASA|Glúkósamín||||| 030627|N05AH0201|Leponex|töflur|100|mg|100|stk|1|glas||N05AH02|01.04.1993||R|A|5|0|0|*|0|NOH|0|1|0|100|DKK|10711|15376|lyfalmen|V1400|15163|00|100|0|33|Vistor hf|Novartis Healthcare A/S-|Klózapín||10711||10711|15376 030635|N05AH0201|Leponex|töflur|25|mg|100|stk|1|glas||N05AH02|01.04.1993||R|A|5|0|0|*|0|NOH|0|1|0|100|DKK|3637|5776|lyfalmen|V1401|5773|00|100|0|8|Vistor hf|Novartis Healthcare A/S-|Klózapín||||3637|5776 030754|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|770|l|1|hylki|kælt|V03AN01|01.03.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|770|0|0|Strandmöllen A/S|Strandmöllen A/S|Súrefni||||| 030765|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|11000|l|1|hylki|kælt|V03AN01|01.03.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|11000|0|0|Strandmöllen A/S|Strandmöllen A/S|Súrefni||||| 030940|C07AB0207|Metoprolol Merck NM|töflur|50|mg|100|stk|1|glas||C07AB02|01.10.1995||R|A|3|0|0|B|0|MNA|0|0|0|100|SEK|827|1963|lyfalmen|||00|100|0|33|Actavis Group PTC ehf|Merck NM AB|Metóprólól||827||827|1963 031039|C07AB0207|Metoprolol Merck NM|töflur|100|mg|100|stk|1|glas||C07AB02|01.10.1995||R|A|3|0|0|B|0|MNA|0|0|0|100|SEK|1206|2477|lyfalmen|||00|100|0|67|Actavis Group PTC ehf|Merck NM AB|Metóprólól||1206||1206|2477 031070|A04AD0101|Scopoderm|forðapl|1|mg/72kls|2|stk|1|pakki||A04AD01|01.07.1985||R|A|2|0|0|E|0|NHE|0|0|1|100|DKK|857|2003|lyfalmen|||23|2|0|2|Artasan ehf|Novartis Healthcare A/S-A|Skópólamín||857||857|2003 031088|A10AB0401|Humalog|stl|100|ae/ml|10|ml|1|hgl||A10AB04|01.01.1997||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|3244|5243|lyfalmen|||17|10|0|25|Icepharma hf|Eli Lilly Nederland -|Insúlín lispró||3244||3244|5243 031261|A10AB0604|Apidra [opticlik]|stl|100|ein/ml|3|ml|5|rörlyk||A10AB06|01.04.2007||R|K|2|0|0|*|0|SAA|0|0|0|100|NOK|4678|7189|lyfalmen|||02|15|0|38|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||4678||4678|7189 031555|J06BA0105|Gammanorm (D.A.C.)|stl|165|mg/ml|10|ml|1|lykja||J06BA01|01.03.2009|31.03.2009|R|K|3|0|0|0|1|DAC|0|0|0|100|DKK|12741|17730|lyfsjukr|||0|10|0|0|D.A.C. ehf|D.A.C. ehf|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í æð||||12741|17730 031773|C01DA0801|Sorbangil|töflur|20|mg|100|stk|1|glas||C01DA08|01.01.1985||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|1936|3468|lyfalmen|||00|100|0|33|Vistor hf|Recip AB|Ísósorbíð dínítrat||1936||1936|3468 031849|A10AB0503|NovoRapid Penfill|stl|100|ein/ml|3|ml|5|rörlyk||A10AB05|01.07.2002||R|K|2,5|0|0|*|0|NON|0|0|0|100|DKK|6456|9601|lyfalmen|||02|15|0|38|Vistor hf|Novo-Nordisk|Insúlín aspart||6456||6456|9601 031942|H01BA0401|Glypressin|sts|1|mg/hgl|1|mg|5|hgl|og leysir|H01BA04|01.01.1998||R|A|3|0|0|0|1|FEL|0|0|0|100|DKK|38016|49197|lyfsjukr|||00|5|0|0|Vistor hf|Ferring Lægemidler A/S|Terlípressín||38016||38016|49197 031971|C07AA0704|Sotalol Merck NM|töflur|160|mg|100|stk|1|plglas||C07AA07|01.01.1994||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|1689|3132|lyfalmen|||00|100|0|100|Actavis Group PTC ehf|Merck NM AB|Sótalól||1689||1689|3132 032122|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.02.2009||R|A|3|0|0|0|1|STM|0|0|0|100|DKK|9912|14192|lyfsjukr|||0|4|0|0|Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíð||||9912|14192 032145|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.02.2009||R|A|3|0|0|0|1|STM|0|0|0|100|DKK|14488|19905|lyfsjukr|||0|10|0|0|Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíð||||14488|19905 032179|N01AX1302|Lyfjatviköfnunarefnisoxid Strandmöllen|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.02.2009||R|A|3|0|0|0|1|STM|0|0|0|100|DKK|50131|64281|lyfsjukr|||0|50|0|0|Strandmöllen A/S|Strandmöllen A/S|di-Nitrogen oxíð||||50131|64281 032190|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|1|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|1|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|1|0|0|Strandmøllen A/S|Strandmøllen A/S|Súrefni||||| 032202|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|2|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|2|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|2|0|0|Strandmøllen A/S|Strandmøllen A/S|Súrefni||||| 032236|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|4|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|4|0|0|Strandmøllen A/S|Strandmøllen A/S|Súrefni||||| 032247|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|5|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|5|0|0|Strandmøllen A/S|Strandmøllen A/S|Súrefni||||| 032258|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|10|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|10|0|0|Strandmöllen A/S|Strandmöllen A/S|Súrefni||||| 032270|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|20|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|20|0|0|Strandmøllen A/S|Strandmøllen A/S|Súrefni||||| 032281|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|50|l|1|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|50|0|0|Strandmøllen A/S|Strandmøllen A/S|Súrefni||||| 032304|V03AN0102|Lyfjasurefni Strandmøllen|lyfjagas|100|%|50|l|12|hylki|undir þrýstingi|V03AN01|01.01.2009||L|A|3|0|0|0|0|STM|0|0|0|100|IKR|||lyflausa|||0|600|0|0|Strandmøllen A/S|Strandmøllen A/S|Súrefni||||| 032523|N05AX1201|Abilify|mixtúra|1|mg/ml|150|ml|1|fl||N05AX12|01.02.2007||R|K|2|0|0|*|0|OTS|0|1|0|100|DKK|25286|33666|lyfalmen|||00|150|0|10|Vistor hf|Otsuka Pharmaceutical Europe Ltd.|Aripiprazól||25286||25286|33666 032649|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|50|ml|1|hgl|plast|QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|3913|6772|vetorma|||27|50|0|0|Vistor hf|Merial (MSD)|||3913||3913|6772 032660|L03AB0702|Rebif|stl|0||0,5|ml|12|áf.spr|8,88+22 mcg|L03AB07|01.02.2009||R|K|2|0|1|0|1|SEN|0|0|0|100|SEK|128914|162365|lyfsjukr|||0|6|0|0|Gróco ehf|Serono Nordic|Interferón beta-1a||||128914|162365 032664|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|200|ml|1|fl||QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|13914|24079|vetorma|||27|200|0|0|Vistor hf|Merial (MSD)|||13914||13914|24079 033159|S01FA0103|Isopto Atropin 1 %|augndr|1|%|5|ml|1|glas||S01FA01|01.05.1983||R|A|3|0|0|E|0|ALC|0|0|0|100|USD|471|1480|lyfalmen|||06|5|0|0|K.Pétursson hf|Alcon|Atrópín||471||471|1480 033251|S01CA0102|Tobradex|augndr|0| |5|ml|1|glas|3+1 mg/ml|S01CA01|01.06.2007||R|A|3|0|0|E|0|ALC|0|0|1|100|USD|1260|2550|lyfalmen|||00|5|0|0|K.Pétursson hf|Alcon|Dexametasón||1260||1260|2550 034033|QJ01M0001|Baytril vet.|töflur|50|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|2554|5036|vetalmen|||0|10|0|0|Vistor hf|Bayer Animal Health GmbH|||||2554|5036 034157|J07AM5104|Diftavax|bóluefni|0| |0,5|ml|1|spr|einnota sprauta|J07AM51|01.01.2000||R|K|3|0|0|0|0|SPM|0|0|1|100|XEU|769|1884|lyfalmen|||AC|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Stífkrampatoxóíð í blöndum með barnaveikistoxóíðum||769||769|1884 034616|N05CM0201|Heminevrin|mixtúra|50|mg/ml|300|ml|1|glas||N05CM02|01.07.2006||R|K|2|0|0|0|0|ARA|0|0|1|100|SEK|1975|3521|lyfalmen|||00|300|0|10|Vistor hf|Astra|Clómetíazól||1975||1975|3521 034934|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|20|sk-hyl||S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|1888|3402|lyfalmen|||00|6|0|0|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1888||1888|3402 034983|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|40|sk-hyl||S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|3237|5233|lyfalmen|||00|12|0|0|Vistor hf|Novartis Healthcare A/S-|Díklófenak||3237||3237|5233 035024|V03AB1402|Protaminsulfat Leo Pharma|stl|10|mg/ml|5|ml|5|hgl||V03AB14|01.06.2007||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|9128|13069|lyfsjukr|||02|25|0|0|Vistor hf|LEO Pharma A/S|Prótamín||9128||9128|13069 035099|C02CA0404 |Carduran CR (D.A.C.)|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.05.2009||R|A|2|0|0|E|0|DAC|0|0|0|100|DKK|9436|13645|lyfalmen|V2120|13645|00|100|0|100|D.A.C. ehf|D.A.C. ehf|Doxazósín||||9436|13645 035155|N03AX1403 |Keppra (D.A.C.)|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.05.2009||R|A|3|0|1|E|0|DAC|0|0|0|100|DKK|19460|26413|lyfalmen|V1710|26413|00|100|0|25|D.A.C. ehf|D.A.C. ehf|Levetíracetam||||19460|26413 035177|N03AX1203 |Neurontin (D.A.C.)|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|6166|9208|lyfalmen|V0714|7740|10|100|0|17|D.A.C. ehf|D.A.C. ehf|Gabapentín||||6166|9208 035200|N03AX1203 |Neurontin (D.A.C.)|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|17207|23608|lyfalmen|V2160|23608|00|100|0|33|D.A.C. ehf|D.A.C. ehf|Gabapentín||||17207|23608 035212|A07EC0202|Pentasa|forðatfl|500|mg|300|stk|1|þpakki||A07EC02|01.04.1992||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|17884|24451|lyfalmen|||10|300|0|100|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||17884||17884|24451 035222|N06DA0403 |Reminyl (D.A.C.)|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.05.2009||R|A|2|0|0|E|0|DAC|0|0|0|100|SEK|11175|16005|lyfalmen|V1370|16005|00|28|0|14|D.A.C. ehf|D.A.C. ehf|Galantamín||||11175|16005 035234|M01AB5502 |Arthrotec (D.A.C.)|töflur|50,2|mg|100|stk|1|þpakki|0,2+50 mg|M01AB55|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|1|100|DKK|5277|8002|lyfalmen|V2130|8002|0|100|0|50|D.A.C. ehf|D.A.C. ehf|||||5277|8002 035506|N03AX0903|Lamotrin|dreifit.|25|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1435|2788|lyfalmen|||00|56|0|5|Actavis Group hf|Actavis hf|Lamótrigín||1435||1435|2788 035515|N03AX0903|Lamotrin|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1844|3343|lyfalmen|V0703|3343|00|56|0|9|Actavis Group hf|Actavis hf|Lamótrigín||1844||1844|3343 035524|N03AX0903|Lamotrin|dreifit.|100|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|3321|5347|lyfalmen|V0705|5347|00|56|0|19|Actavis Group hf|Actavis hf|Lamótrigín||3321||3321|5347 035533|N03AX0903|Lamotrin|dreifit.|200|mg|56|stk|1|þpakki||N03AX09|01.11.2005||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|5919|8873|lyfalmen|V0706|8873|00|56|0|37|Actavis Group hf|Actavis hf|Lamótrigín||5919||5919|8873 035542|S01LA0301|Macugen|stl|0,3|mg/spr|1|spr|1|pakki|lausn|S01LA03|01.06.2006||R|A|1,5|0|1|0|1|PFI|0|0|0|100|DKK|124045|156304|lyfsjukr|||00|1|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Pegaptaníb||124045||124045|156304 035824|C01AA0503|Lanoxin|stl|0,25|mg/ml|2|ml|5|lykjur||C01AA05|01.07.2000||R|A||0|0|0|1|PCO|0|0|0|100|IKR|926|1326|lyfsjukr|||00|10|1|0|Distica|Distica - óskráð lyf|Digoxín||926||926|1326 035832|B05BA0202|Intralipid 200 mg/ml|irl|200|mg/ml|500|ml|12|fl||B05BA02|01.08.1980||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|46465|59716|lyfsjukr|||00|6000|0|6|Icepharma hf|Fresenius Kabi|Fitusambönd||46465||46465|59716 035840|C01AA0503|Lanoxin|mixtúra|50|mcg/ml|60|ml|1|glas||C01AA05|01.03.1978||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|900|2062|lyfalmen|||00|60|0|12|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Digoxín||900||900|2062 035865|C01AA0503|Lanoxin|töflur|0,25|mg|100|stk|1|glas||C01AA05|01.08.1978||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|480|1492|lyfalmen|||00|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Digoxín||480||480|1492 036145|M01AC0202|Tilcotil|töflur|20|mg|60|stk|1|glas||M01AC02|01.04.1988||R|A|3|0|0|E|0|MAS|0|0|1|100|SEK|5326|8068|lyfalmen|||00|60|0|60|Vistor hf|Meda AS|Tenoxíkam||5326||5326|8068 036332|L01XE0401|Sutent|hylki|12,5|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|PFL|0|0|0|100|DKK|225410|282503|lyfsjukr|||00|30|0|0|Vistor hf|Pfizer Limited|Sunitíníb||225410||225410|282503 036341|L01XE0401|Sutent|hylki|25|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|PFL|0|0|0|100|DKK|432669|540540|lyfsjukr|||00|30|0|0|Vistor hf|Pfizer Limited|Sunitíníb||432669||432669|540540 036351|L01XE0401|Sutent|hylki|50|mg|30|stk|1|glas||L01XE04|01.10.2006||R|A|2|0|1|0|1|PFL|0|0|0|100|DKK|864772|1078509|lyfsjukr|||00|30|0|0|Vistor hf|Pfizer Limited|Sunitíníb||864772||864772|1078509 036442|J01CE0204|Kaavepenin|töflur|800|mg|20|stk|1|þpakki||J01CE02|01.01.1988||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|754|1864|lyfalmen|||00|20|0|8|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||754||754|1864 036517|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|60|ml|1|glas||J01CE02|01.07.1992||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|1205|2476|lyfalmen|||08|60|0|3|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1205||1205|2476 036541|A03AX1301|Minifom|dropar|0| |30|ml|1|glas|+drteljari|A03AX13|01.12.1975||L|S|3|0|0|0|0|AZD|0|0|0|100|IKR|||lyflausa|||00|30|0|6|Vistor hf|AstraZeneca A/S DK|Silíkonsambönd||||| 036616|J01CE0204|Kaavepenin|mixt.kyr|100|mg/ml|125|ml|1|glas||J01CE02|01.07.1992||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|2378|4067|lyfalmen|||08|125|0|6|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||2378||2378|4067 036665|J01CE0204|Kaavepenin|töflur|800|mg|30|stk|1|þpakki||J01CE02|01.01.1988||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|721|1819|lyfalmen|||00|30|0|12|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||721||721|1819 037278|N04BC0404|Requip Depot|forðatfl|2|mg|42|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|6424|9558|lyfalmen|||00|42|0|14|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||6424||6424|9558 037287|N04BC0404|Requip Depot|forðatfl|2|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|12849|18182|lyfalmen|||00|84|0|28|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||12849||12849|18182 037305|N04BC0404|Requip Depot|forðatfl|4|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|25200|33559|lyfalmen|||00|84|0|56|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||25200||25200|33559 037323|N04BC0404|Requip Depot|forðatfl|8|mg|84|stk|1|plglas||N04BC04|01.09.2008||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|49504|63817|lyfalmen|||00|84|0|112|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||49504||49504|63817 037358|N04BA0201|Madopar|töflur|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.07.1990||R|A|4|0|0|E|0|ROC|0|0|0|100|DKK|2912|4792|lyfalmen|||00|100|0|17|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2912||2912|4792 037531|D07AC1301|Elocon|húðlausn|0,1|%|30|ml|1|glas||D07AC13|01.01.2009||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1152|2404|lyfalmen|||0|30|0|30|Vistor hf|Schering-Plough|Mómetasón||1152||1152|2404 037754|J01EA0102|Monotrim|töflur|100|mg|30|stk|1|glas||J01EA01|01.03.1980||R|A|5|0|0|0|0|HEX|0|0|1|100|DKK|693|1781|lyfalmen|||00|30|0|8|Vistor hf|Hexal A/S|Trímetóprím||693||693|1781 037846|A12BA0101|Kaleorid|forðatfl|750|mg|100|stk|1|glas||A12BA01|01.12.1972||L|A|5|0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen|||10|100|0|25|Vistor hf|LEO Pharma A/S|Kalíumklóríð|||||2143 037853|A12BA0101|Kaleorid|forðatfl|750|mg|250|stk|1|glas||A12BA01|01.12.1972||L|A|5|0|0|E|0|LEP|0|0|0|100|DKK|||lyfalmen|||10|250|0|62|Vistor hf|LEO Pharma A/S|Kalíumklóríð|||||3572 037861|C03AA0301|Aquazið|töflur|25|mg|100|stk|1|glas||C03AA03|01.05.1983|31.03.2009|R|A|4|0|0|E|0|ACA|0|0|0|100|IKR|812|1942|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf||812|812|812|812|1942 037929|J01EA0102|Monotrim|töflur|100|mg|100|stk|1|glas||J01EA01|01.03.1980||R|A|5|0|0|0|0|HEX|0|0|1|100|DKK|1864|3370|lyfalmen|||00|100|0|25|Vistor hf|Hexal A/S|Trímetóprím||1864||1864|3370 038174|N06AB0501|Seroxat|töflur|20|mg|20|stk|1|þpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|100|IKR|664|1489|lyfalmen|V0917|1424|00|20|0|20|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||478||478|1489 038257|N06AB0501|Seroxat|töflur|20|mg|60|stk|1|þpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|100|IKR|1766|2556|lyfalmen|V0918|2385|00|60|0|60|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1264||1264|2556 038448|N06AB0501|Seroxat|töflur|20|mg|100|stk|1|þpakki||N06AB05|01.04.1993||R|A|3|0|0|B|0|GSK|0|1|0|100|IKR|2667|3506|lyfalmen|V0919|3240|00|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Paroxetín||1964||1964|3506 038513|D06BA0101|Flamazine|krem|10|mg/g|50|g|1|túpa||D06BA01|01.10.1988||R|A|3|0|0|0|0|SON|0|0|1|100|DKK|1073|2296|lyfalmen|||00|50|0|50|Icepharma hf|Smith & Nephew|Silfursúlfadíazín||1073||1073|2296 038607|L03AA1301|Neulasta|stl|6|mg/penna|0,6|ml|1|penni|áfylltur penni, lausn|L03AA13|01.07.2006||R|K|2,5|0|1|0|1|AEU|0|0|0|100|DKK|219689|275380|lyfsjukr|||00|1|0|0|Vistor hf|Amgen Europe B.V.|Pegfilgrastím||219689||219689|275380 038828|C09AA0401|Coversyl|töflur|4|mg|90|stk|1|þpakki||C09AA04|01.01.1992||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|10262|14766|lyfalmen|||00|90|0|90|Icepharma hf|Servier|Perindópríl||10262||10262|14766 038877|N07CA0101|Betaserc|töflur|8|mg|100|stk|1|þpakki||N07CA01|01.12.1982||R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|4520|6974|lyfalmen|||00|100|0|33|Medico ehf|Solvay Duphar |Betahistín||4520||4520|6974 038915|J01FA1004|Zitromax UNO|forðakyr|0| |2|g|1|fl||J01FA10|01.10.2007||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|3055|4986|lyfalmen|||00|2|0|7|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Azitrómýcín||3055||3055|4986 039005|L01XA0301|Eloxatin|irþ|5|mg/ml|10|ml|1|hgl||L01XA03|01.03.2007||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|38600|49925|lyfsjukr|||00|10|0|0|Vistor hf|Sanofi-aventis Norge AS|Oxalíplatín||38600||38600|49925 039014|L01XA0301|Eloxatin|irþ|5|mg/ml|20|ml|1|hgl||L01XA03|01.03.2007||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|67166|85489|lyfsjukr|||00|20|0|0|Vistor hf|Sanofi-aventis Norge AS|Oxalíplatín||67166||67166|85489 039575|D01AE1503 |Lamisil (D.A.C.)|krem|10|mg/g|15|g|1|túpa||D01AE15|01.05.2009||L|A|5|0|0|0|0|DAC|0|0|1|100|ISK|||lyflausa|||00|15|0|15|D.A.C. ehf|D.A.C. ehf|Terbínafín||||| 039669|C01BA0302|Durbis Retard|forðatfl|250|mg|100|stk|1|glas||C01BA03|01.05.1983||R|A|1|0|0|B|0|SNO|0|0|0|100|NOK|5992|8972|lyfalmen|||10|100|0|62|Vistor hf|Sanofi-aventis Norge AS|Dísópýramíð||5992||5992|8972 039776|J01FA1001|Zitromax|mixtúrud|40|mg/ml|15|ml|1|glas||J01FA10|01.07.1994||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|1514|2895|lyfalmen|||00|15|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Azitrómýcín||1514||1514|2895 039784|J01FA1001|Zitromax|mixtúrud|40|mg/ml|22,5|ml|1|glas||J01FA10|01.01.1995||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|2323|3993|lyfalmen|||00|22|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Azitrómýcín||2323||2323|3993 039909|L01AA0101|Sendoxan|sts|200|mg|1|stk|1|hgl||L01AA01|01.07.1992||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|353|505|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter Medical AB|Cýklófosfamíð||353||353|505 039958|L01AA0101|Sendoxan|sts|500|mg|1|stk|1|hgl||L01AA01|01.01.1988||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|811|1161|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter Medical AB|Cýklófosfamíð||811||811|1161 040089|L01AA0101|Sendoxan|sts|1|g|1|stk|1|hgl||L01AA01|01.07.1994||R|A|3|0|1|0|1|BAM|0|0|0|100|SEK|1439|2060|lyfsjukr|||02|1|0|0|Icepharma hf|Baxter Medical AB|Cýklófosfamíð||1439||1439|2060 040287|N03AF0104|Tegretol|töflur|200|mg|200|stk|1|þpakki||N03AF01|01.04.1993||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|3852|6068|lyfalmen|||00|200|0|40|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||3852||3852|6068 040543|S01XA2012|Dacriosol|augndr|3|mg/ml|15|ml|1|glas||S01XA20|01.03.2000||L|A|4|0|0|E|0|ALC|0|0|0|100|IKR|||lyfalmen|||06|15|0|0|K.Pétursson hf|Alcon|Gervitár og aðrar óvirkar sam­setningar|||||1579 041059|J07BH0101|Rotarix|mixtduft|0| |1|hgl|1|pakki|+áf.munnspr.m/leysi|J07BH01|01.07.2007||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|8326|12139|lyfalmen|||00|1|0|0|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Rota-veira, veikluð veira||8326||8326|12139 041423|G03AA1203|Yasminelle|töflur|0||63|stk|1|þpakki|3+0,02 mg|G03AA12|01.12.2006||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|2782|4616|lyfalmen|||00|63|0|0|Icepharma hf|Bayer Schering Pharma AG|Dróspírenón og östrógen||2782||2782|4616 041488|N06AB1002 |Cipralex (D.A.C.)|filmhtfl|20|mg|98|stk|1|þpakki||N06AB10|01.05.2009||R|A|3|0|0|B|0|DAC|0|1|0|100|DKK|23451|31381|lyfalmen|V2170|31381|00|98|0|196|D.A.C. ehf|D.A.C. ehf|Escítalópram||||23451|31381 041749|QI04AB0101|Lambivac, vet.|stl|126|Lf/ml|100|ml|1|fl|dreifa|QI04AB01|01.04.2007||R|K|3|0|0|0|0|INI|0|0|0|100|DKK|4513|7810|vetorma|||AA|100|0|0|Icepharma hf|Intervet International B.V.|||4513||4513|7810 041795|M02AA1503 |Voltaren Emulgel (D.A.C.)|hlaup|11,6|mg/g|100|g|1|túpa||M02AA15|01.05.2009||L|A|3|0|0|0|0|DAC|0|0|1|100|ISK|||lyflausa|||0|100|0|0|D.A.C. ehf|D.A.C. ehf|Díklófenak||||| 041815|V08CA1101|Vasovist|stl|0,25|mmol/ml|10|ml|10|hgl|lausn|V08CA11|01.12.2006||R|A|3|0|0|0|0|SAG|0|0|0|100|SEK|170820|214856|lyfalmen|||02|100|0|0|Icepharma hf|Schering AG|Gadófosveset||170820||170820|214856 041996|A06AG1101|Microlax|innhl|0| |5|ml|4|túpa||A06AG11|01.12.1972||L|A|5|0|0|0|0|MCN|0|0|0|100|IKR|||lyflausa|||56|20|0|4|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum||||| 042036|C07AB0205|Seloken|stl|1|mg/ml|5|ml|5|lykjur||C07AB02|01.01.1985||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|1280|2577|lyfalmen|||02|25|0|0|Vistor hf|AstraZeneca A/S DK|Metóprólól||1280||1280|2577 042101|N01BB0902|Naropin|irl|2|mg/ml|100|ml|5|plpok||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|9595|13738|lyfsjukr|||00|500|0|0|Vistor hf|AstraZeneca A/S DK|Rópívakaín||9595||9595|13738 042305|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3741|5356|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||3741||3741|5356 042314|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4718|6755|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||4718||4718|6755 042323|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4459|6384|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||4459||4459|6384 042332|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|6761|9680|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||6761||6761|9680 042346|N07BA0137 |Nicorette (D.A.C.)|innsogsl|10|mg|42|rör|1|pakki|þp+munnstk|N07BA01|01.05.2009||L|A|3|0|0|0|0|DAC|0|0|1|100|ISK|||lyflausa|||00|42|0|7|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 042357|N07BA0141 |Nicotinell Fruktsmak (D.A.C.)|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|ISK|||lyflausa|||00|204|0|14|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 042360|B05BA0311|Glucos Fresenius Kabi|irl|500|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|7761|11112|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||7761||7761|11112 042368|A06AB0602 |Senokot|töflur|7,5|mg|500|stk|1|glas||A06AB06|01.04.2009||R|A|3|0|0|0|0|REB|0|0|0|100|GBP|2135|3738|lyfalmen|||00|500|0|0|Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Senna||||2135|3738 042369|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|40|plpok|Excel umbúðir|B05BA03|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|8489|12154|lyfsjukr|||00|4000|0|4|Icepharma hf|Fresenius Kabi|Kolvetni||8489||8489|12154 042387|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|4508|6454|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||4508||4508|6454 042396|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3307|4735|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||3307||3307|4735 042405|B05BB0213|Kalium-Natrium-Glucose "Fresenius Kabi"|irl|0| |1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2851|4082|lyfsjukr|||02|10000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||2851||2851|4082 042442|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|50|ml|40|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|9963|14265|lyfsjukr|||00|2000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar||9963||9963|14265 042460|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|15|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|4034|5776|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar||4034||4034|5776 042469|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|2249|3220|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar||2249||2249|3220 042478|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|100|ml|40|plpok|Excel umbúðir|B05BB01|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|7436|10646|lyfsjukr|||00|4000|0|4|Icepharma hf|Fresenius Kabi|Elektrólýtar||7436||7436|10646 042524|B05BB0115|Ringer-acetat Fresenius Kabi|irl|0| |1000|ml|10|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2522|3611|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar||2522||2522|3611 042549|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|1|dæla|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|794|1918|lyfalmen|||02|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||794||794|1918 042551|B05BB0209 |Glucos 100 mg/ml med Na40 + K20 Fres|irl|0||1000|ml|10|plpok||B05BB02|01.04.2009||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3230|4625|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||||3230|4625 042556|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|20|dælur|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|15174|21077|lyfalmen|||02|10|0|0|Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||15174||15174|21077 042615|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|0| |1000|ml|10|plpok|Freeflex umbúðir|B05BB02|01.05.2007||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3504|5017|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||3504||3504|5017 042669|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|0| |100|ml|40|plastl|fyrir stungulyf|V07AB|01.04.2008||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|4000|0|0|Icepharma hf|Fresenius Kabi|||||| 043232|N05CD0305|Flunitrazepam Merck NM|töflur|1|mg|30|stk|1|þpakki||N05CD03|01.10.1992||R|A|5|1|0|0|0|MNA|0|0|0|100|SEK|316|1269|lyfalmen|||00|30|0|30|Actavis Group PTC ehf|Merck NM AB|Flúnítrazepam||316||316|1269 043257|N01BB0902|Naropin|stl/irl|2|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|2995|4288|lyfsjukr|||00|100|0|0|Vistor hf|AstraZeneca A/S DK|Rópívakaín||2995||2995|4288 043379|R03AC1201|Serevent|innúðal|25|mcg/sk|120|sk|1|stauk|HFA 134a|R03AC12|01.04.2007||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|3571|5686|lyfalmen|||24|120|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||3571||3571|5686 043547|N01BB0902|Naropin|stl|7,5|mg/ml|20|ml|5|plastl||N01BB09|01.05.1998||R|A|3|0|0|0|1|AZD|0|0|0|100|SEK|5505|7882|lyfsjukr|||00|100|0|0|Vistor hf|AstraZeneca A/S DK|Rópívakaín||5505||5505|7882 043729|N05CD0503|Halcion|töflur|0,125|mg|30|stk|1|þpakki||N05CD05|01.12.1983||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|579|1626|lyfalmen|||00|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Tríazólam||579||579|1626 043745|G03CA0401|Ovestin|töflur|2|mg|30|stk|1|þpakki||G03CA04|01.07.1989||R|A|5|0|0|E|0|ORG|0|0|0|100|DKK|1237|2519|lyfalmen|||10|30|0|30|Vistor hf|N.V. Organon|Estríól||1237||1237|2519 043919|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|10|ml|20|lykjur|fyrir stl|V07AB|01.07.1995||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|200|0|0|Icepharma hf|Fresenius Kabi|||||| 043935|V07AB13|Sterilt vatten/vann/vand Fresenius Kabi|leysir|0| |10|ml|20|plastl|fyrir stungulyf|V07AB|01.10.1994||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|200|0|0|Icepharma hf|Fresenius Kabi|||||| 044360|B03AC0203|Venofer (Lyfjaver)|stl|20|mg/ml|5|ml|5|lykjur||B03AC02|01.05.2006||R|A|3|0|0|E|0|LVR|0|0|1|100|NOK|13209|18630|lyfalmen|V0011|18630|00|25|0|5|Lyfjaver ehf|Lyfjaver ehf|Járnoxíð (sykurflétta)||13209||13209|18630 044624|G04BE0303|Viagra (D.A.C.)|filmhtfl|100|mg|4|stk|1|þpakki||G04BE03|01.11.2006||R|A|5|0|0|0|0|DAC|0|0|0|100|DKK|5692|8565|lyfalmen|V1300|8565|00|4|0|8|D.A.C. ehf|D.A.C. ehf|Síldenafíl||5692||5692|8565 045013|L01XX1902|Campto|irþ|20|mg/ml|5|ml|1|hgl||L01XX19|01.01.1999||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|38881|50274|lyfsjukr|||00|5|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Írinótekan||38881||38881|50274 045104|L04AX0102|Imurel|töflur|25|mg|50|stk|1|þpakki||L04AX01|01.10.1995||R|A|5|0|0|*|0|GSK|0|0|0|100|GBP|1263|2554|lyfalmen|||10|50|0|8|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Azatíóprín||1263||1263|2554 045379|N07BA0128|Nicorette Classic (Lyfjaver)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2006||L|A|2.5|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|210|0|14|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045385|J07BF0301|Imovax Polio|bóluefni|0| |0,5|ml|10|dælur|einnota|J07BF03|01.01.1996||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|7586|11135|lyfalmen|||02|5|0|0|Icepharma hf|Sanofi Pasteur MSD|Mænusótt, dauð veira||7586||7586|11135 045388|N07BA0128|Nicorette Classic (Lyfjaver)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2006||L|A|2.5|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|210|0|28|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045397|N07BA0127|Nicorette Mint (Lyfjaver)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.03.2006||L|A|2.5|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|210|0|14|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045406|N07BA0127|Nicorette Mint (Lyfjaver)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.03.2006||L|A|2.5|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|210|0|28|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045578|N07BA0122|Nicorette (Lyfjaver)|nefúði|500|mcg/sk|200|skammtar|1|glas||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|200|0|3|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045587|N07BA0122|Nicorette (Lyfjaver)|tungur.t|2|mg|105|stk|1|þpakki||N07BA01|01.03.2006||L|A|3|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|105|0|7|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045596|N07BA0122|Nicorette (Lyfjaver)|innsogsl|10|mg|18|rör|1|þpakki|+ munnstk|N07BA01|01.03.2006||L|A|3|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|18|0|3|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045605|N07BA0122|Nicorette (Lyfjaver)|innsogsl|10|mg|42|rör|1|þpakki|+ munnstk|N07BA01|01.03.2006||L|A|3|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|42|0|7|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045614|N07BA0123|Nicotinell (Lyfjaver)|forðapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|21|0|32|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045896|N07BA0124|Nicotinell Mint (Lyfjaver)|tyggigúm|2|mg|84|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|84|0|6|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045905|N07BA0124|Nicotinell Mint (Lyfjaver)|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|204|0|14|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045915|N07BA0124|Nicotinell Mint (Lyfjaver)|tyggigúm|4|mg|84|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|84|0|11|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045924|N07BA0124|Nicotinell Mint (Lyfjaver)|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|204|0|27|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045933|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|2|mg|84|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|84|0|6|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045942|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|204|0|14|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045951|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|4|mg|84|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|84|0|11|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 045960|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.03.2006||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|204|0|27|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 046077|QJ01DD9101|Convenia|sts|80|mg/ml|10|ml|1|hgl|+leysir, lausn|QJ01DD91|01.01.2008||R|K|2|0|0|0|0|PFV|0|0|0|100|DKK|21708|41522|vetalmen|||27|10|0|0|Icepharma hf|Pfizer vet.|||21708||21708|41522 046269|C09AA0502|Ramil|töflur|2,5|mg|100|stk|1|þpakki||C09AA05|01.03.2006||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1943|3477|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|Ramipríl||1943||1943|3477 046396|A04AA0102|Ondansetron Vian|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.02.2008||R|A|3|0|0|E|0|VIS|0|0|0|100|IKR|5076|7729|lyfalmen|V1088|7729|02|10|0|1|Icepharma hf|Vian SA|Ondansetrón||5076||5076|7729 046405|A10BB1202|Glimeryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|IKR|769|1884|lyfalmen|V0001|1884|00|90|0|45|Actavis Group hf|Actavis hf|Glímepíríð||769||769|1884 046414|A10BB1202|Glimeryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|IKR|1215|2489|lyfalmen|V0002|2489|00|90|0|90|Actavis Group hf|Actavis hf|Glímepíríð||1215||1215|2489 046423|A10BB1202|Glimeryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.05.2006||R|A|3|0|0|*|0|ACA|0|0|0|100|IKR|1622|3042|lyfalmen|V0003|3042|00|90|0|135|Actavis Group hf|Actavis hf|Glímepíríð||1622||1622|3042 046687|A04AA0102|Ondansetron Vian|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.02.2008||R|A|3|0|0|E|0|VIS|0|0|0|100|IKR|8305|12111|lyfalmen|V1089|12111|02|20|0|2|Icepharma hf|Vian SA|Ondansetrón||8305||8305|12111 047042|L04AB0101|Enbrel|stl|0| |25|mg|4|áf.spr|lausn|L04AB01|01.05.2008||R|K|2|0|1|0|1|WTE|0|0|0|100|USD|106391|134324|lyfsjukr|||00|100|0|14|Icepharma hf|Wyeth Europe|Etanercept||106391||106391|134324 047159|C07AA0704|Sotalol Merck NM|töflur|40|mg|100|stk|1|glas||C07AA07|01.01.1994||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|853|1998|lyfalmen|||00|100|0|25|Actavis Group PTC ehf|Merck NM AB|Sótalól||853||853|1998 047340|J01CA0406|Flemoxin Solutab|lausnart|500|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|1134|2379|lyfalmen|||23|14|0|7|Vistor hf|Astellas Pharma A/S|Amoxicillín||1134||1134|2379 047442|N01AX1301|Niontix|lyfjagas|100|%|10|l|1|hylki||N01AX13|01.06.2008||R|A|5|0|0|0|1|AGA|0|0|0|100|IKR|13388|18536|lyfsjukr|||00|10|0|0|Ísaga ehf|AGA AB|di-Nitrogen oxíð||13388||13388|18536 047460|N01AX1301|Niontix|lyfjagas|100|%|50|l|1|hylki||N01AX13|01.06.2008||R|A|5|0|0|0|1|AGA|0|0|0|100|IKR|47555|61073|lyfsjukr|||00|50|0|0|Ísaga ehf|AGA AB|di-Nitrogen oxíð||47555||47555|61073 047560|L04AB0101|Enbrel|stl|0| |50|mg|4|áf.spr|lausn|L04AB01|01.05.2008||R|K|2|0|1|0|1|WTE|0|0|0|100|USD|211766|265516|lyfsjukr|||00|200|0|29|Icepharma hf|Wyeth Europe|Etanercept||211766||211766|265516 047563|R03DC0101|Accolate|töflur|20|mg|98|stk|1|þpakki||R03DC01|01.04.1998||R|A|3|0|0|B|0|ASZ|0|0|0|100|SEK|8686|12628|lyfalmen|||00|98|0|49|Vistor hf|AstraZeneca UK Ltd|Zafírlúkast||8686||8686|12628 048015|B05AA0111|Albumin Baxter|irl|50|g/líter|250|ml|1|hgl||B05AA01|01.06.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|4432|6346|lyfsjukr|||02|250|0|0|Icepharma hf|Baxter Medical AB|Albúmín||4432||4432|6346 048043|B05AA0111|Albumin Baxter|irl|200|g/líter|100|ml|1|hgl||B05AA01|01.06.2007||R|A|3|0|0|0|1|BAM|0|0|0|100|SEK|6996|10017|lyfsjukr|||02|100|0|0|Icepharma hf|Baxter Medical AB|Albúmín||6996||6996|10017 048199|A03CA0201|Librax|töflur|0| |100|stk|1|glas||A03CA02|01.12.1972||R|A|5|0|0|E|0|VAL|0|0|0|100|DKK|2266|3915|lyfalmen|||00|100|0|0|Icepharma hf|Valeant Pharmaceuticals B.V.|Klídín og geðlyf||2266||2266|3915 048297|C09DA0101|Cozaar Comp|filmhtfl|112,5|mg|98|stk|1|þpakki|100+12,5 mg|C09DA01|01.06.2007||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|17738|24269|lyfalmen|||00|98|0|196|Icepharma hf|M.S.D.|Lósartan og þvagræsilyf||17738||17738|24269 048355|C01DA0801|Sorbangil|töflur|40|mg|100|stk|1|glas||C01DA08|01.10.1988||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|3940|6187|lyfalmen|||00|100|0|67|Vistor hf|Recip AB|Ísósorbíð dínítrat||3940||3940|6187 048447|G03AA0901|Marvelon|töflur|0| |63|stk|1|þpakki||G03AA09|01.07.1986||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|1842|3340|lyfalmen|||23|63|0|84|Vistor hf|N.V. Organon|Desógestrel og östrógen||1842||1842|3340 048452|M01AE5101|Ibukod|töflur|0| |30|stk|1|glas|10+200 mg|M01AE51|01.11.2006||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|650|1722|lyfalmen|||00|30|0|5|Actavis Group hf|Actavis hf|Íbúprófen í blöndum||650||650|1722 048488|L04AA0601|Cellcept|töflur|500|mg|150|stk|1|þpakki||L04AA06|01.03.1999||R|A|3|0|1|*|0|ROC|0|0|0|100|DKK|66651|85165|lyfalmen|||00|150|0|38|Icepharma hf|Roche|Mýcófenólsýra||66651||66651|85165 048520|N04BD0104|Selegilin Merck NM|töflur|5|mg|100|stk|1|glas||N04BD01|01.10.1995|31.03.2009|R|A|1.5|0|0|E|0|MNA|0|0|0|100|SEK|2358|4040|lyfalmen|||00|100|0|100|Actavis Group PTC ehf|Merck NM AB|Selegilín||2358||2358|4040 048611|N04BD0104|Selegilin Merck NM|töflur|10|mg|100|stk|1|glas||N04BD01|01.07.1994||R|A|1.5|0|0|E|0|MNA|0|0|0|100|SEK|8222|11998|lyfalmen|||00|100|0|200|Actavis Group PTC ehf|Merck NM AB|Selegilín||8222||8222|11998 048744|N02BE0101|Panodil|töflur|500|mg|100|stk|1|glas||N02BE01|01.03.1984||R|A|4|0|0|0|0|GCH|0|0|1|100|DKK|495|1512|lyfalmen|V0772|1355|00|100|0|17|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||495||495|1512 049015|A02BA0201|Asyran|töflur|300|mg|100|stk|1|þpakki||A02BA02|01.10.1987||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|3269|5277|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|Ranitidín||3269||3269|5277 049169|M05BA0602|Bonviva|stl|1|mg/ml|3|ml|1|spr||M05BA06|01.10.2006||R|A|2|0|0|E|0|RRL|0|0|0|100|DKK|19608|26597|lyfalmen|||00|3|0|0|Icepharma hf|Roche Registration Limited|||19608||19608|26597 049395|B01AC0701|Persantin|töflur|100|mg|100|stk|1|glas||B01AC07|01.10.1985||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|2807|4650|lyfalmen|||00|100|0|25|Vistor hf|Boehringer Ingelheim|Dípýrídamól||2807||2807|4650 049502|D01AC0801|Fungoral|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1993||L|A|3|0|0|0|0|JAS|0|0|1|100|IKR|||lyflausa|||23|60|0|60|Vistor hf|Janssen-Cilag AB|Ketókónazól||||| 049524|S01ED5110|Duotrav|augndr|0| |2,5|ml|1|glas|40 mcg/ml+5 mg/ml|S01ED51|01.06.2007||R|A|3|0|0|*|0|ALC|0|0|0|100|USD|3549|5657|lyfalmen|||00|2|0|0|K.Pétursson hf|Alcon|Tímólól í blöndum||3549||3549|5657 049533|S01ED5110|Duotrav|augndr|0| |2,5|ml|3|glas|40 mcg/ml+5 mg/ml|S01ED51|01.06.2007||R|A|3|0|0|*|0|ALC|0|0|0|100|USD|10446|15016|lyfalmen|||00|8|0|0|K.Pétursson hf|Alcon|Tímólól í blöndum||10446||10446|15016 049551|D01AE1601|Loceryl|lakk|50|mg/ml|5|ml|1|glas||D01AE16|01.10.1992||R|A|3|0|0|0|0|GAN|0|0|1|100|CHF|8045|11758|lyfalmen|||23|5|0|5|Icepharma hf|Galderma Nordic AB|Amorolfín||8045||8045|11758 049561|C10AA0104|Simvastatin (Portfarma)|filmhtfl|10|mg|98|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|E|0|POF|0|0|0|100|IKR|1059|2277|lyfalmen|||00|98|0|65|PortFarma ehf|PortFarma|Simvastatín||1059||1059|2277 049579|C10AA0104|Simvastatin (Portfarma)|filmhtfl|20|mg|98|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|E|0|POF|0|0|0|100|IKR|1154|2265|lyfalmen|||00|98|0|131|PortFarma ehf|PortFarma|Simvastatín||1050||1050|2265 049597|C10AA0104|Simvastatin (Portfarma)|filmhtfl|40|mg|100|stk|1|þpakki||C10AA01|01.07.2006||R|A|2|0|0|0|0|POF|0|0|0|100|IKR|1827|3097|lyfalmen|||00|100|0|267|PortFarma ehf|PortFarma|Simvastatín||1663||1663|3097 049650|D01BA0201|Lamisil|töflur|250|mg|28|stk|1|þpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|8006|4829|lyfalmen|V0343|4435|00|28|0|28|Vistor hf|Novartis Healthcare A/S-|Terbínafín||2939||2939|4829 049678|C09AA0502|Ramil|töflur|5|mg|100|stk|1|þpakki||C09AA05|01.04.2006||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2519|4259|lyfalmen|||00|100|0|200|Actavis Group hf|Actavis hf|Ramipríl||2519||2519|4259 049684|D01AE1501|Lamisil|krem|10|mg/g|30|g|1|túpa||D01AE15|01.04.1993||R|A|5|0|0|0|0|NHE|0|0|1|100|DKK|2075|3656|lyfalmen|||00|30|0|30|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín||2075||2075|3656 049687|C09AA0502|Ramil|töflur|10|mg|100|stk|1|þpakki||C09AA05|01.08.2005||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|4132|6448|lyfalmen|||00|100|0|400|Actavis Group hf|Actavis hf|Ramipríl||4132||4132|6448 049750|L04AD0103|Sandimmun Neoral (D.A.C.)|hylki|25|mg|30|stk|1|þpakki||L04AD01|01.04.2006||R|A|3|0|0|*|0|DAC|0|0|0|100|DKK|5152|7832|lyfalmen|||10|30|0|3|D.A.C. ehf|D.A.C. ehf|Ciklospórín||5152||5152|7832 049760|L04AD0103|Sandimmun Neoral (D.A.C.)|hylki|100|mg|30|stk|1|þpakki||L04AD01|01.04.2006||R|A|3|0|0|*|0|DAC|0|0|0|100|DKK|18907|25724|lyfalmen|||10|30|0|12|D.A.C. ehf|D.A.C. ehf|Ciklospórín||18907||18907|25724 049778|M05BA0405|Fosamax (D.A.C.)|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.04.2006||R|A|3|0|0|E|0|DAC|0|0|0|100|XEU|15441|20769|lyfalmen|V0718|12241|00|12|0|84|D.A.C. ehf|D.A.C. ehf|Alendrónsýra||14927||14927|20769 049908|L04AA0601|Cellcept|hylki|250|mg|300|stk|1|þpakki||L04AA06|01.03.1999||R|A|3|0|1|*|0|ROC|0|0|0|100|DKK|80844|102836|lyfalmen|||00|300|0|38|Icepharma hf|Roche|Mýcófenólsýra||80844||80844|102836 050179|N01AF0301|Pentothal Natrium|sts|2,5|g|1|stk|12|hgl||N01AF03|01.07.1990||R|A|4|0|0|0|1|HOS|0|0|0|100|DKK|8190|11726|lyfsjukr|||02|12|0|0|Vistor hf|Hospira Enterprises B.V.|Tíópentalnatríum||8190||8190|11726 050342|L01XE0501|Nexavar|filmhtfl|200|mg|112|stk|1|þpakki||L01XE05|01.12.2006||R|A|2,5|0|1|0|1|BHC|0|0|0|100|SEK|551965|668447|lyfsjukr|||00|112|0|0|Vistor hf|Bayer HealthCare AG|Sorafeníb||535405||535405|668447 050605|N03AX1601|Lyrica|hylki|225|mg|14|stk|1|þpakki||N03AX16|01.04.2007||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|3853|6069|lyfalmen|||00|14|0|56|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||3853||3853|6069 050614|N03AX1601|Lyrica|hylki|225|mg|56|stk|1|þpakki||N03AX16|01.04.2007||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|13742|19294|lyfalmen|||00|56|0|42|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||13742||13742|19294 050651|C02CA0402|Carduran Retard|forðatfl|4|mg|30|stk|1|þpakki||C02CA04|01.01.2007||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|3192|5172|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxazósín||3192||3192|5172 050660|C02CA0402|Carduran Retard|forðatfl|4|mg|100|stk|1|þpakki||C02CA04|01.01.2007||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|9628|13906|lyfalmen|V2120|13645|00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxazósín||9628||9628|13906 050914|N02BE0101|Panodil|eþ-stil|1|g|10|stk|1|pakki||N02BE01|01.10.1989||R|A|5|0|0|0|0|GCH|0|0|1|100|DKK|491|1507|lyfalmen|||04|10|0|3|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||491||491|1507 051011|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa|+sk.dæla|D06BB03|01.07.1994||L|A|2|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|2|0|2|Icepharma hf|GlaxoSmithKline CH A/S|Acíklóvír||||| 051029|N03AG0102|Orfiril|sh-tfl|150|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|1749|3214|lyfalmen|||10|100|0|10|Vistor hf|Desitin Artzneimittel|Valpróínsýra||1749||1749|3214 051058|M02AA1002|Orudis (D.A.C.)|hlaup|25|mg/g|60|g|1|túpa||M02AA10|01.01.2007||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|60|0|0|D.A.C. ehf|D.A.C. ehf|Ketóprófen||||| 051076|D05AX5202|Daivobet (D.A.C.)|smyrsli|0| |60|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.01.2007||R|A|2|0|0|B|0|DAC|0|0|0|100|DKK|9310|13475|lyfalmen|V0391|13475|00|60|0|0|D.A.C. ehf|D.A.C. ehf|Kalcípótríól í blöndum||9310||9310|13475 051110|N03AG0102|Orfiril|sh-tfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|2323|3993|lyfalmen|||10|100|0|20|Vistor hf|Desitin Artzneimittel|Valpróínsýra||2323||2323|3993 051193|R05CB0102|Mucomyst|freyðit|200|mg|25|stk|1|glas||R05CB01|01.01.1986||R|A|2|0|0|E|0|BIP|0|0|1|100|SEK|466|1473|lyfalmen|||72|25|0|10|Vistor hf|BioPhausia AB|Acetýlcýstein||466||466|1473 051331|R06AX2602|Nefoxef|töflur|120|mg|30|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MYL|0|0|1|100|SEK|998|2195|lyfalmen|V1910|2195|00|30|0|30|Actavis Group PTC ehf|Mylan AB|Fexófenadín||998||998|2195 051340|R06AX2602|Nefoxef|filmhtfl|120|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MYL|0|0|1|100|SEK|3009|4924|lyfalmen|V1911|4924|00|100|0|100|Actavis Group PTC ehf|Mylan AB|Fexófenadín||3009||3009|4924 051349|R06AX2602|Nefoxef|filmhtfl|180|mg|30|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MYL|0|0|1|100|SEK|1538|2928|lyfalmen|V1912|2928|00|30|0|45|Actavis Group PTC ehf|Mylan AB|Fexófenadín||1538||1538|2928 051358|R06AX2602|Nefoxef|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.07.2008||R|A|2|0|0|E|0|MYL|0|0|1|100|SEK|4447|6875|lyfalmen|V1913|6875|00|100|0|150|Actavis Group PTC ehf|Mylan AB|Fexófenadín||4447||4447|6875 051425|R05CB0102|Mucomyst|freyðit|200|mg|100|stk|1|glas||R05CB01|01.01.1986||R|A|2|0|0|E|0|BIP|0|0|1|100|SEK|1764|3234|lyfalmen|||72|100|0|40|Vistor hf|BioPhausia AB|Acetýlcýstein||1764||1764|3234 051550|N03AX1401|Keppra|irþ|100|mg/ml|5|ml|10|hgl||N03AX14|01.02.2007||R|A|2|0|1|0|1|UCB|0|0|0|100|DKK|35964|46643|lyfsjukr|||00|50|0|3|Vistor hf|U.C.B|Levetíracetam||35964||35964|46643 051713|A02BC0504|Nexium Mups (D.A.C.)|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.04.2006||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|3736|5910|lyfalmen|V0084|5910|00|28|0|19|D.A.C. ehf|D.A.C. ehf|Esómeprazól||3736||3736|5910 051732|C08CA0104|Amlódipín PortFarma|töflur|5|mg|100|stk|1|þpakki||C08CA01|01.12.2006||R|A|2,5|0|0|B|0|POF|0|0|0|100|IKR|1909|3043|lyfalmen|V0308|3043|00|100|0|0|PortFarma ehf|PortFarma |Amlódipín||1623||1623|3043 051750|C08CA0104|Amlódipín PortFarma|töflur|10|mg|100|stk|1|þpakki||C08CA01|01.12.2006||R|A|2,5|0|0|B|0|POF|0|0|0|100|IKR|3111|4428|lyfalmen|V0310|4428|00|100|0|0|PortFarma ehf|PortFarma |Amlódipín||2644||2644|4428 052305|L01XE0601|Sprycel|filmhtfl|20|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|396046|494945|lyfsjukr|||00|60|0|0|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||396046||396046|494945 052333|L01XE0601|Sprycel|filmhtfl|50|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|797967|995336|lyfsjukr|||00|60|0|0|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||797967||797967|995336 052360|L01XE0601|Sprycel|filmhtfl|70|mg|60|stk|1|glas||L01XE06|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|807094|1006700|lyfsjukr|||00|60|0|0|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |Dasatíníb||807094||807094|1006700 052478|D06BB0305|Zovirax (D.A.C.)|krem|50|mg/g|2|g|1|túpa|+sk.dæla|D06BB03|01.03.2007||L|A|3|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|2|0|2|D.A.C. ehf|D.A.C. ehf|Acíklóvír||||| 052498|V03AF0302|Rescuvolin|sts|15|mg|1|stk|25|hgl||V03AF03|01.01.1995||R|A|3|0|0|0|1|PHC|0|0|0|100|XEU|34050|44260|lyfsjukr|||63|25|0|6|Actavis Group hf|Pharmachemie|Kalsíumfólínat||34050||34050|44260 052505|B05BA1014|Kabiven|irl|1900|kcal|2053|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|41976|54128|lyfsjukr|||00|8212|0|8|Icepharma hf|Fresenius Kabi|Blöndur||41976||41976|54128 052515|B05BA1014|Kabiven|irl|2300|kcal|2566|ml|3|pokar||B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|33725|43855|lyfsjukr|||00|7698|0|8|Icepharma hf|Fresenius Kabi|Blöndur||33725||33725|43855 052522|V03AF0302|Rescuvolin|sts|50|mg|1|stk|10|hgl||V03AF03|01.01.1995||R|A|3|0|0|0|1|PHC|0|0|0|100|XEU|45461|58466|lyfsjukr|||63|10|0|8|Actavis Group hf|Pharmachemie|Kalsíumfólínat||45461||45461|58466 052524|B05BA1010|Kabiven Peripheral|irl|1400|kcal|1920|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|39023|50451|lyfsjukr|||00|7680|0|8|Icepharma hf|Fresenius Kabi|Blöndur||39023||39023|50451 052533|B05BA1010|Kabiven Peripheral|irl|1700|kcal|2400|ml|3|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|32420|42230|lyfsjukr|||00|7200|0|7|Icepharma hf|Fresenius Kabi|Blöndur||32420||32420|42230 052542|B05BA1015|StructoKabiven|irl|2100|kcal|1970|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|43954|56590|lyfsjukr|||00|7880|0|8|Icepharma hf|Fresenius Kabi|Blöndur||43954||43954|56590 052560|B05BA1019|StructoKabiven Perifer|irl|1300|kcal|1904|ml|4|pokar|fleyti|B05BA10|01.03.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|40893|52779|lyfsjukr|||00|7616|0|8|Icepharma hf|Fresenius Kabi|Blöndur||40893||40893|52779 053006|N05CF0203|Zolpidem Merck NM|filmhtfl|10|mg|100|stk|1|þpakki||N05CF02|01.11.2006||R|A|2|0|0|0|0|MYL|0|0|0|100|SEK|2494|4225|lyfalmen|V0903|4225|00|100|0|100|Actavis Group PTC ehf|Mylan AB|Zolpidem||2494||2494|4225 053025|G03HB0102|Diane mite|töflur|0| |63|stk|1|þpakki||G03HB01|01.07.1989||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|2476|4200|lyfalmen|||23|63|0|63|Icepharma hf|Bayer Schering Pharma AG|Cýpróterón og östrógen||2476||2476|4200 053043|J05AE0601|Kaletra|filmhtfl|250|mg|120|stk|1|glös|200+50 mg|J05AE06|01.11.2006||R|A|2|0|1|0|1|ABT|0|0|0|100|DKK|78576|99695|lyfsjukr|||00|120|0|30|Vistor hf|Abbott Laboratories Ltd|Lopinavír||78576||78576|99695 053231|J07BB0201|Fluarix|bóluefni|0| |0,5|ml|10|spr|einnotaspr|J07BB02|01.10.1994||R|K|1|0|0|0|0|GSK|0|0|0|100|GBP|5753|8647|lyfalmen|||02|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsaðir mótefnavakar||5753||5753|8647 053371|L04AA1301|Arava|töflur|10|mg|100|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|34942|45688|lyfalmen|||00|100|0|50|Vistor hf|Sanofi - aventis Deutschland GmbH|LeflúnómíðFvöðva||34942||34942|45688 053397|L04AA1301|Arava|töflur|20|mg|30|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|10826|15532|lyfalmen|||00|30|0|30|Vistor hf|Sanofi - aventis Deutschland GmbH|LeflúnómíðFvöðva||10826||10826|15532 053413|L04AA1301|Arava|töflur|20|mg|100|stk|1|glas||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|33427|43802|lyfalmen|||00|100|0|100|Vistor hf|Sanofi - aventis Deutschland GmbH|LeflúnómíðFvöðva||33427||33427|43802 053546|L04AA1301|Arava|töflur|100|mg|3|stk|1|þpakki||L04AA13|01.11.2000||R|A|3|0|1|*|0|SDE|0|0|0|100|NOK|5194|7889|lyfalmen|||00|3|0|20|Vistor hf|Sanofi - aventis Deutschland GmbH|LeflúnómíðFvöðva||5194||5194|7889 053680|J05AE1001|Prezista|filmhtfl|300|mg|120|stk|1|plglas||J05AE10|01.04.2007||R|A|2|0|1|0|1|JCI|0|0|0|100|SEK|112709|142190|lyfsjukr|||43|120|0|0|Vistor hf|Janssen-Cilag International N.V.|||112709||112709|142190 053689|N05CF0203|Zolpidem Merck NM|filmhtfl|10|mg|20|stk|1|þpakki||N05CF02|01.11.2006||R|A|2|0|0|0|0|MYL|0|0|1|100|SEK|531|1561|lyfalmen|V0902|1561|00|20|0|20|Actavis Group PTC ehf|Mylan AB|Zolpidem||531||531|1561 053905|N02AA0305|Hydromorphone Hydrochloride Inj. USP|stl|20|mg/ml|1|ml|10|lykjur||N02AA03|01.05.2006||R|A|2|1|0|0|0|MAP|0|0|0|100|GBP|14699|20485|lyfalmen|||00|10|0|50|Icepharma hf|Martindale Pharmaceuticals|Hýdrómorphón||14699||14699|20485 053991|D10AF0101|Dalacin|lausn|10|mg/ml|30|ml|1|glas|Áburður, lausn|D10AF01|01.07.1985||R|A|2,5|0|0|0|0|PFI|0|0|0|100|DKK|1189|2454|lyfalmen|||20|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||1189||1189|2454 054130|J01CA0405|Flemoxin|mixtúrud|50|mg/ml|100|ml|1|glas||J01CA04|01.11.1979|30.04.2009|R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|1263||lyfalmen|||8|100|0|5|Vistor hf|Astellas Pharma A/S|Amoxicillín||1263||1263|2554 054148|J01CA0405|Flemoxin|dropar|100|mg/ml|20|ml|1|glas||J01CA04|01.11.1979||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|822|1956|lyfalmen|||28|20|0|2|Vistor hf|Astellas Pharma A/S|Amoxicillín||822||822|1956 054213|J07AG0101|Act-Hib|bóluefni|34|mcg/hgl|0,5|ml|1|hgl|+ leysir (10+24 mcg)|J07AG01|01.07.1994||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|2689|4489|lyfalmen|||02|0|0|0|Icepharma hf|Aventis Pasteur MSD A/S|Haemophilus influenzae B||2689||2689|4489 054247|R01AA0503|Nezeril|nefdr|0,25|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||23|2|0|1|Vistor hf|AstraZeneca A/S DK|Oxýmetazólín||||| 054278|D01AE1502|Lamisil Once|húðlausn|1|%|4|g|1|túpa||D01AE15|01.12.2006||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|4|0|0|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín||||| 054369|J05AB0402|Copegus|filmhtfl|400|mg|56|stk|1|plglas||J05AB04|01.05.2007||R|A|3|0|1|0|1|RRL|0|0|0|100|DKK|74291|94360|lyfsjukr|||00|56|0|22|Icepharma hf|Roche Registration Limited|Ribavirin||74291||74291|94360 054403|R01AA0503|Nezeril|nefdr|0,5|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||23|2|0|2|Vistor hf|AstraZeneca A/S DK|Oxýmetazólín||||| 054533|N05BB0101|Atarax|mixtúra|2|mg/ml|200|ml|1|glas||N05BB01|01.10.1994||R|A|3|0|0|0|0|UCN|0|0|1|100|SEK|1237|2519|lyfalmen|||00|200|0|5|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1237||1237|2519 054552|N06AB0308|Fluoxetin Actavis|lausnart|20|mg|30|stk|1|þpakki||N06AB03|01.10.2006||R|A|3|0|0|B|0|ACA|0|1|0|100|IKR|949|2128|lyfalmen|V0914|2128|10|30|0|30|Actavis Group hf|Actavis hf|Flúoxetín||949||949|2128 054601|QB03AC9001|Idofer, vet.|stl|200|mg/ml|100|ml|5|fl|plastfl.|QB03AC90|01.05.1999||R|A|2|0|0|0|0|BID|1|0|0|100|DKK|13248|25407|vetalmen|||27|500|0|0|Vistor hf|Boehringer Ingelheim Danmark|||13248||13248|25407 054650|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|20|stk||QG03DA02|01.12.1978||R|A|5|0|0|0|0|PAL|1|0|0|100|DKK|8011|13863|vetorma|||16|20|0|0|Icepharma hf|Pfizer Oy Animal Health|||8011||8011|13863 055186|J01FA0103|Ery-Max|sh-hylki|250|mg|20|stk|1|þpakki||J01FA01|01.01.1986||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|695|1784|lyfalmen|||10|20|0|5|Vistor hf|Recip AB|Erýtrómýcín||695||695|1784 055277|N02AA0101|Contalgin|forðatfl|60|mg|100|stk|1|þpakki||N02AA01|01.10.1995||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|12120|17274|lyfalmen|||10|100|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||12120||12120|17274 055392|J04AK0102|Pyrazinamid|töflur|500|mg|100|stk|1|glas||J04AK01|01.04.2005||R|A||0|0|E|0|LDR|0|0|0|100|IKR|3734|5908|lyfalmen|||00|100|1|33|Parlogis hf|Parlogis - óskráð lyf|||3734||3734|5908 055749|N07BA0107|Nicotinell Mint|munnstfl|1|mg|36|stk|1|pakki||N07BA01|01.06.2000||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|36|0|1|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 055939|N07BA0107|Nicotinell Mint|munnstfl|1|mg|96|stk|1|pakki||N07BA01|01.06.2000||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|96|0|3|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 056015|C10AA0503|Atacor|filmhtfl|10|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|4359|6756|lyfalmen|V0337|6756|00|100|0|100|Actavis Group hf|Actavis hf|Atorvastatín||4359||4359|6756 056024|C10AA0503|Atacor|filmhtfl|20|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|6185|9234|lyfalmen|V0338|9234|00|100|0|200|Actavis Group hf|Actavis hf|Atorvastatín||6185||6185|9234 056033|C10AA0503|Atacor|filmhtfl|40|mg|100|stk|1|glas||C10AA05|01.06.2006||R|A|2|0|0|0|0|ACA|0|0|0|100|IKR|7867|11516|lyfalmen|V0339|11516|00|100|0|400|Actavis Group hf|Actavis hf|Atorvastatín||7867||7867|11516 056523|J01FA0103|Ery-Max|sh-hylki|250|mg|40|stk|1|þpakki||J01FA01|01.01.1986||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1134|2379|lyfalmen|||10|40|0|10|Vistor hf|Recip AB|Erýtrómýcín||1134||1134|2379 056879|V07AY02|Palacos cum Gentamicin (Paranova)|sement|500|mg|40,5|g|2|pakkar|+ leysir|V07AY|01.06.1997||R|A|4|0|0|0|1|PAN|0|0|0|100|DKK|27187|35715|lyfsjukr|||00|81|0|0|xxxxx|Paranova A/S|||27187||27187|35715 056915|L04AA2301|Tysabri|irþ|300|mg/hgl|15|ml|1|hgl|lausn|L04AA23|01.09.2007||R|K|4|0|1|0|1|EPI|0|0|0|100|XEU|251210|314624|lyfsjukr|||00|15|0|30|Icepharma hf|Elan Pharma International|Natalizumab||251210||251210|314624 056961|J05AF0702|Viread (Paranova)|filmhtfl|245|mg|30|stk|1|plglas||J05AF07|01.05.2008||R|A|3|0|1|0|1|POF|0|0|0|100|DKK|69175|87990|lyfsjukr|||00|30|0|30|PortFarma ehf|PortFarma |Tenófóvír dísóproxíl||69175||69175|87990 057307|H01CB0201|Sandostatin|stl|200|mcg/ml|5|ml|1|hgl||H01CB02|01.01.1991||R|K|4|0|1|0|1|NOH|0|0|0|100|DKK|19361|25972|lyfsjukr|||02|5|0|1|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||19361||19361|25972 057349|H01CB0201|Sandostatin|stl|100|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|10288|14676|lyfsjukr|||02|5|0|1|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||10288||10288|14676 057422|B05XA3102|Tracel|irþ|0| |10|ml|20|plastl||B05XA31|01.01.1987||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|6699|9591|lyfsjukr|||00|200|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með öðrum efnum||6699||6699|9591 057455|H01CB0201|Sandostatin|stl|50|mcg/ml|1|ml|5|lykjur||H01CB02|01.01.1991||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|5538|7929|lyfsjukr|||02|5|0|0|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||5538||5538|7929 057703|J01DD0401|Rocephalin|irþ|2|g|5|hgl|1|pakki|lausn|J01DD04|01.10.1985||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|25789|33975|lyfsjukr|||00|5|0|5|Icepharma hf|Roche|Ceftríaxón||25789||25789|33975 057924|C09DA0401|CoAprovel|filmhtfl|325|mg|28|stk|1|þpakki|300+25 mg|C09DA04|01.03.2007||R|A|2|0|0|B|0|SBM|0|0|0|100|NOK|5069|7719|lyfalmen|||00|28|0|56|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan og þvagræsilyf||5069||5069|7719 057933|C09DA0401|CoAprovel|filmhtfl|325|mg|98|stk|1|þpakki|300+25 mg|C09DA04|01.03.2007||R|A|2|0|0|B|0|SBM|0|0|0|100|NOK|18035|24639|lyfalmen|||00|98|0|196|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Irbesartan og þvagræsilyf||18035||18035|24639 057978|N07BA0301|Champix|filmhtfl|0| |25|stk|1|þpakki|0,5 mg og 1 mg|N07BA03|01.01.2007|31.03.2009|R|A|2|0|0|0|0|PFL|0|0|1|100|DKK|4843|7413|lyfalmen|||00|25|0|10|Vistor hf|Pfizer Limited|||4843||4843|7413 057987|N07BA0301|Champix|filmhtfl|1|mg|28|stk|1|þpakki||N07BA03|01.01.2007|31.03.2009|R|A|2|0|0|0|0|PFL|0|0|1|100|DKK|5411|8183|lyfalmen|||00|28|0|14|Vistor hf|Pfizer Limited|||5411||5411|8183 057996|N07BA0301|Champix|filmhtfl|1|mg|56|stk|1|þpakki||N07BA03|01.01.2007|31.03.2009|R|A|2|0|0|0|0|PFL|0|0|1|100|DKK|10876|15600|lyfalmen|||00|56|0|28|Vistor hf|Pfizer Limited|||10876||10876|15600 058014|N07BA0301|Champix|filmhtfl|1|mg|112|stk|1|þpakki||N07BA03|01.03.2009||R|A|2|0|0|0|0|PFL|0|0|1|100|DKK|20993|28321|lyfalmen|||0|112|0|56|Vistor hf|Pfizer Limited|||||20993|28321 058164|A03BB0101|Buscopan|stl|20|mg/ml|1|ml|5|lykjur||A03BB01|01.10.1995||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|444|1443|lyfalmen|||02|5|0|2|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||444||444|1443 058397|J07BM0101|Gardasil|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM01|01.01.2007||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|20939|28254|lyfalmen|||02|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerð 6, 11, 16, 18)||20939||20939|28254 058503|J01EA0105|Trimetoprim AstraZeneca|mixtúra|10|mg/ml|100|ml|1|fl|dreifa|J01EA01|01.01.2004||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|861|2009|lyfalmen|||00|100|0|2|Vistor hf|Recip AB|Trímetóprím||861||861|2009 058506|J05AF1001|Baraclude|mixtúra|0,05|mg/ml|210|ml|1|fl||J05AF10|01.09.2007||R|A|2|0|1|0|1|BSP|0|0|0|100|DKK|117866|148611|lyfsjukr|||00|210|0|21|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |Entecavír||117866||117866|148611 058735|C03CA0105|Lasix Retard|forðahlk|30|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|1474|2841|lyfalmen|||43|100|0|75|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||1474||1474|2841 058768|C03CA0105|Lasix Retard|forðahlk|60|mg|100|stk|1|þpakki||C03CA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|2324|3994|lyfalmen|||43|100|0|150|Vistor hf|Sanofi-aventis Norge AS|Fúrósemíð||2324||2324|3994 058958|J07CA0601|Infanrix-Polio + Hib|bóluefni|0| |0,5|ml|1|dæla|einnota dæla|J07CA06|01.03.1999||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|4070|6364|lyfalmen|||51|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||4070||4070|6364 059204|C01DA0801|Sorbangil|töflur|5|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|1437|2790|lyfalmen|||00|250|0|21|Vistor hf|Recip AB|Ísósorbíð dínítrat||1437||1437|2790 059569|L02AE0203|Eligard|sts|45|mg/sk|2|spr|1|sett|+ leysir|L02AE02|01.05.2008||R|K|2|0|1|*|0|ASP|0|0|0|100|XEU|107931|136559|lyfalmen|||02|2|0|0|Vistor hf|Astellas Pharma A/S|Leuprórelín||107931||107931|136559 059659|J07CA0601|Infanrix-Polio + Hib|bóluefni|0| |0,5|ml|10|spr||J07CA06|01.01.2007||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|31071|40868|lyfalmen|||51|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||31071||31071|40868 059687|J05AR0302|Truvada (Paranova)|filmhtfl|445|mg|30|stk|1|plglas|200+245 mg|J05AR03|01.05.2008||R|A|3|0|1|0|1|POF|0|0|0|100|DKK|119069|150108|lyfsjukr|||00|30|0|0|PortFarma ehf|PortFarma |Tenófóvír dísóproxíl og emtrícítabín||119069||119069|150108 059823|N07BC5101|Suboxone|tungur.t|2,5|mg|28|stk|1|þpakki|2+0,5 mg|N07BC51|01.05.2007||R|A|3|1|1|0|1|SCP|0|0|0|100|DKK|7525|10774|lyfsjukr|||00|28|0|7|Vistor hf|Schering-Plough|Búprenorfín í blöndum||7525||7525|10774 059824|C07AB0310|Atenolol Merck NM|töflur|25|mg|98|stk|1|þpakki||C07AB03|01.04.1992||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|768|1883|lyfalmen|||00|98|0|33|Actavis Group PTC ehf|Merck NM AB|Atenólól||768||768|1883 059842|N07BC5101|Suboxone|tungur.t|10|mg|28|stk|1|þpakki|8+2 mg|N07BC51|01.07.2007||R|A|3|1|1|0|1|SCP|0|0|0|100|DKK|17063|23111|lyfsjukr|||00|28|0|28|Vistor hf|Schering-Plough|Búprenorfín í blöndum||17063||17063|23111 060560|V03AC0301|Exjade|dreifit.|500|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|406988|508885|lyfalmen|||00|84|0|0|Vistor hf|Novartis Europharm Ltd|Deferasírox||406988||406988|508885 060569|V03AC0301|Exjade|dreifit.|250|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|206111|258793|lyfalmen|||00|84|0|0|Vistor hf|Novartis Europharm Ltd|Deferasírox||206111||206111|258793 060578|V03AC0301|Exjade|dreifit.|125|mg|84|stk|1|þpakki||V03AC03|01.03.2007||R|A|3|0|1|0|0|NOE|0|0|0|100|DKK|103056|130490|lyfalmen|||00|84|0|0|Vistor hf|Novartis Europharm Ltd|Deferasírox||103056||103056|130490 060848|N06AA0402|Anafranil Retard|forðatfl|75|mg|100|stk|1|þpakki||N06AA04|01.10.1989||R|A|5|0|0|B|0|NOH|0|1|0|100|DKK|7922|11591|lyfalmen|||10|100|0|75|Vistor hf|Novartis Healthcare A/S-|Klómípramín||7922||7922|11591 060905|C01DA0204|Nitromex|tungur.t|0,5|mg|120|stk|1|glas||C01DA02|01.01.1993||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|120|0|24|Actavis Group hf|Actavis Group hf|Glýcerýltrínítrat|||||1912 060913|C01DA0204|Nitromex|tungur.t|0,25|mg|120|stk|1|glas||C01DA02|01.01.1993||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|120|0|12|Actavis Group hf|Actavis Group hf|Glýcerýltrínítrat|||||1912 061414|QA04AD901|Cerenia|töflur|60|mg|4|stk|1|þpakki||QA04AD90|01.02.2009||R|A|2|0|0|0|0|PFA|0|0|0|100|DKK|2859|5617|vetalmen|||0|4|0|0|Icepharma hf|Pfizer Animal Health|||||2859|5617 061442|QA04AD901|Cerenia|töflur|24|mg|4|stk|1|þpakki||QA04AD90|01.02.2009||R|A|2|0|0|0|0|PFA|0|0|0|100|DKK|1498|2956|vetalmen|||0|4|0|0|Icepharma hf|Pfizer Animal Health|||||1498|2956 061451|QA04AD901|Cerenia|stl|10|mg/ml|20|ml|1|hgl|lausn|QA04AD90|01.02.2009||R|A|2|0|0|0|0|PFA|1|0|0|100|DKK|8849|17027|vetalmen|||00|20|0|0|Icepharma hf|Pfizer Animal Health|||||8849|17027 061460|G03CX0102|Livial (D.A.C.)|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.05.2009||R|A|2|0|0|E|0|DAC|0|0|0|100|DKK|7782|11401|lyfalmen|V1030|11401|00|84|0|84|D.A.C. ehf|D.A.C. ehf|Tíbólón||||7782|11401 061465|M02AA0701|Felden gel|hlaup|5|mg/g|50|g|1|glas||M02AA07|01.04.1996||L|A|3|0|0|0|0|PFI|0|0|1|100|IKR|||lyflausa|||23|50|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Píroxíkam||||| 061481|G03CX0101|Livial|töflur|2,5|mg|84|stk|1|þpakki||G03CX01|01.07.1998||R|A|2|0|0|E|0|ORG|0|0|0|100|DKK|7940|11615|lyfalmen|V1030|11401|00|84|0|84|Vistor hf|N.V. Organon|Tíbólón||||7940|11615 061580|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdæla|26|g|1|spr||QP52AF02|01.04.1992||L|A|1|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|26|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||1905 061715|L01XE0901|Torisel|irþ|25|mg/ml|1|hgl|1|pakki||L01XE09|01.05.2008||R|A|2|0|1|0|1|WTE|0|0|0|100|USD|179173|224938|lyfsjukr|||00|1|0|0|Icepharma hf|Wyeth Europe|Temsirolímus||179173||179173|224938 061762|N02BA0106|Magnyl|töflur|500|mg|50|stk|1|þpakki||N02BA01|01.12.1983||L|A|1|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|50|0|8|Actavis Group hf|Actavis hf|Acetýlsalicýlsýra||||| 061937|L04AD0101|Sandimmun|irþ|50|mg/ml|1|ml|10|lykjur||L04AD01|01.10.1985||R|A|4|0|0|0|1|NOH|0|0|0|100|DKK|6858|9819|lyfsjukr|||00|10|0|2|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||6858||6858|9819 061961|J01XX0901|Cubicin|irs|350|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|K|3|0|1|0|1|NOE|0|0|0|100|DKK|18019|24301|lyfsjukr|||00|1|0|1|Vistor hf|Novartis Europharm Ltd|Daptomýcín||18019||18019|24301 061970|J01XX0901|Cubicin|irs|500|mg|1|hgl|1|pakki|lausn|J01XX09|01.04.2007||R|K|3|0|1|0|1|NOE|0|0|0|100|DKK|25505|33621|lyfsjukr|||00|1|0|2|Vistor hf|Novartis Europharm Ltd|Daptomýcín||25505||25505|33621 062117|N05BA1204|Tafil Retard|forðatfl|0,5|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|526|1554|lyfalmen|||10|30|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||526||526|1554 062343|A10BD0401|Avaglim|filmhtfl|0| |28|stk|1|þpakki|4+4 mg|A10BD04|01.03.2008||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|4723|7250|lyfalmen|||00|28|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Glímepíríð og rosiglítazón||4723||4723|7250 062379|A10BD0401|Avaglim|filmhtfl|0| |28|stk|1|þpakki|8+4 mg|A10BD04|01.03.2008||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|7067|10431|lyfalmen|||00|28|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Glímepíríð og rosiglítazón||7067||7067|10431 062638|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|20|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|7641|10940|lyfsjukr|||02|20|0|0|Icepharma hf|Wyeth AB|Metótrexat||7641||7641|10940 062661|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|1|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|865|1238|lyfsjukr|||02|1|0|0|Icepharma hf|Wyeth AB|Metótrexat||865||865|1238 062711|J01EE0103|Primazol|töflur|480|mg|30|stk|1|glas|80+400 mg|J01EE01|01.10.1995|31.03.2009|R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|694|1782|lyfalmen|||00|30|0|8|Actavis Group hf|Actavis hf|Súlfametoxazól og trímetóprím||694||694|1782 062729|N05BA1204|Tafil Retard|forðatfl|0,5|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|0|100|DKK|1108|2344|lyfalmen|||10|60|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||1108||1108|2344 062737|B03BA0102|Betolvex|töflur|1|mg|100|stk|1|glas||B03BA01|01.03.2008||R|A|5|0|0|E|0|AGT|0|0|1|100|XEU|2126|3725|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis Group hf|||2126||2126|3725 062745|QP53AF0102|Sebacil vet.|húðlausn|500|mg/ml|1000|ml|1|fl||QP53AF01|01.05.2005||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|18729|32411|vetorma|||16|1000|0|0|Vistor hf|Bayer Animal Health GmbH|||18729||18729|32411 062935|G03AA1005|Harmonet|töflur|0| |63|stk|1|pakki|þp 20+75 mcg|G03AA10|01.11.1998||R|A|3|0|0|0|0|WEM|0|0|0|100|USD|1987|3537|lyfalmen|||23|63|0|63|Icepharma hf|Wyeth Medica|Gestóden og östrógen||1987||1987|3537 062987|J07BM0201|Cervarix|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM02|01.11.2007||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|15635|21651|lyfalmen|||02|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|Papillomavírus (manna gerð 16, 18)||15635||15635|21651 063057|J05AB0901|Famvir|töflur|125|mg|10|stk|1|þpakki||J05AB09|01.10.1995||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|5341|8088|lyfalmen|||00|10|0|2|Vistor hf|Novartis Healthcare A/S-|Famcíclóvír||5341||5341|8088 063453|J01CA0406|Flemoxin Solutab|lausnart|750|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|2155|3765|lyfalmen|||23|14|0|10|Vistor hf|Astellas Pharma A/S|Amoxicillín||2155||2155|3765 063661|A06AD1107|Medilax|mixtúra|667|mg/ml|500|ml|1|plastf||A06AD11|01.06.2007||L|A|2|0|0|0|0|MET|0|0|0|100|DKK|||lyfalmen|||00|500|0|50|Vistor hf|Medic Team|Laktúlósa|||||2872 063697|D01BA0203|Terbinafin Actavis|töflur|250|mg|28|stk|1|glas||D01BA02|01.11.2006||R|A|3|0|0|0|0|ACA|0|0|0|100|IKR|2649|4435|lyfalmen|V0343|4435|00|28|0|28|Actavis Group hf|Actavis hf|Terbínafín||2649||2649|4435 063706|R06AX2702|Aerius (D.A.C.)|töflur|5|mg|30|stk|1|þpakki||R06AX27|01.11.2006||R|A|2|0|0|E|0|DAC|0|0|1|100|DKK|2154|3763|lyfalmen|V1901|3763|00|30|0|30|D.A.C. ehf|D.A.C. ehf|Deslóratadín||2154||2154|3763 063715|R06AX2702|Aerius (D.A.C.)|töflur|5|mg|100|stk|1|þpakki||R06AX27|01.05.2009||R|A|2|0|0|E|0|DAC|0|0|1|100|DKK|5052|7696|lyfalmen|V1902|7696|00|100|0|100|D.A.C. ehf|D.A.C. ehf|Deslóratadín||||5052|7696 063818|J06BB0102|Rhesonativ|stl|625|ae/ml|2|ml|1|lykja||J06BB01|01.05.2008||R|K|2,5|0|0|0|1|OCT|0|0|0|100|DKK|11423|16089|lyfsjukr|||17|2|0|0|Vistor hf|Octapharma AB|And-D(rh) immúnóglóbúlín||11423||11423|16089 063923|QP54AB5207|Equest Pramox vet|hlaup|0| |11,8|g|1|sk-dæl|19,5mg/g+121,7mg/g|QP54AB52|01.12.2006||R|A|2|0|0|0|0|FDV|0|0|0|100|XEU|2637|4563|vetorma|||16|12|0|0|Vistor hf|Fort Dodge Veterinär GmbH|||2637||2637|4563 063941|N05BA1204|Tafil Retard|forðatfl|1|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|1108|2344|lyfalmen|||10|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||1108||1108|2344 063958|N05BA1204|Tafil Retard|forðatfl|1|mg|60|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|0|100|DKK|2254|3899|lyfalmen|||10|60|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||2254||2254|3899 064069|B01AC2101|Remodulin|irl|2,5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2.5|0|1|0|1|UTE|0|0|0|100|XEU|1128499|1406849|lyfsjukr|||00|1|0|12|Icepharma hf|United Therapeutics Europe Ltd.|||||1128499|1406849 064106|B01AC2101|Remodulin|irl|1|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2.5|0|1|0|1|UTE|0|0|0|100|XEU|451399|563859|lyfsjukr|||00|1|0|5|Icepharma hf|United Therapeutics Europe Ltd.|||||451399|563859 064170|N05BA1204|Tafil Retard|forðatfl|2|mg|30|stk|1|þpakki||N05BA12|01.04.1996||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|2438|4149|lyfalmen|||10|30|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||2438||2438|4149 064224|B01AC2101|Remodulin|irl|10|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2.5|0|1|0|1|UTE|0|0|0|100|XEU|4513996|5621793|lyfsjukr|||00|1|0|47|Icepharma hf|United Therapeutics Europe Ltd.|||||4513996|5621793 064233|B01AC2101|Remodulin|irl|5|mg/ml|20|ml|1|hgl|lausn|B01AC21|01.11.2008||R|A|2.5|0|1|0|1|UTE|0|0|0|100|XEU|2256999|2811831|lyfsjukr|||00|1|0|23|Icepharma hf|United Therapeutics Europe Ltd.|||||2256999|2811831 064733|J07BB0203|Vaxigrip|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07BB02|01.10.1985||R|K|1|0|0|0|0|SPM|0|0|0|100|XEU|908|2073|lyfalmen|||51|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Inflúensa, hreinsaðir mótefnavakar||908||908|2073 065032|D10AF5101|Duac|hlaup|0| |25|g|1|túpa|50 mg/g + 10 mg/g|D10AF51|01.01.2007||R|A|1,5|0|0|0|0|SLL|0|0|0|100|DKK|2527|4270|lyfalmen|||38|25|0|0|Vistor hf|Stiefel Laboratories (UK) Ltd.|Klindamýcín í blöndum||2527||2527|4270 065060|J07BD5202|MMR II|bóluefni|0| |0,5|ml|10|hgl|+ leysir|J07BD52|01.11.1998||R|K|2|0|0|0|0|MEX|0|0|0|100|XEU|13593|19108|lyfalmen|||51|5|0|0|Icepharma hf|Aventis Pasteur MSD A/S|mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||13593||13593|19108 065094|V08AB0901|Visipaque|stl|150|mg J/ml|50|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|5486|7855|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||5486||5486|7855 065314|G01AF0201|Canesten|sk-stil|100|mg|6|stk|1|pakki|+stjaka|G01AF02|01.12.1982||L|A|4|0|0|0|0|BAS|0|0|0|100|IKR|||lyflausa|||25|6|0|6|Vistor hf|Bayer A/S|Klótrímazól||||| 065332|G01AF0201|Canesten|sk-stil|500|mg|1|stk|1|pakki|+stjaka|G01AF02|01.04.1985||L|A|5|0|0|0|0|BAS|0|0|0|100|IKR|||lyflausa|||25|1|0|5|Vistor hf|Bayer A/S|Klótrímazól||||| 065540|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|15297|20912|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||15297||15297|20912 065706|S01EE0101|Xalatan|augndr|50|mcg/sk|2,5|ml|1|glas||S01EE01|01.10.1999||R|K|3|0|0|*|0|PFI|0|0|0|100|DKK|2837|4690|lyfalmen|V1989|4614|06|2|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Latanóprost||2837||2837|4690 065722|S01EE0101 |Xalatan|augndr|50|mcg/ml|2,5|ml|3|glas||S01EE01|01.05.2009||R|K|3|0|0|*|0|PFI|0|0|0|100|DKK|7804|11431|lyfalmen|||06|8|0|75|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Latanóprost||||7804|11431 065979|C09CA0101|Cozaar|töflur|12,5|mg|28|stk|1|þpakki||C09CA01|01.03.1999||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|2218|3850|lyfalmen|V0195|2187|00|28|0|7|Icepharma hf|M.S.D.|Lósartan||2218||2218|3850 066241|C03EA0103|Hydramil|töflur|55|mg|100|stk|1|glas|5+50 mg|C03EA01|01.08.1984||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|238|1163|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|Hýdróklórtíazíð og kalíumsparandi lyf||238||238|1163 066278|R03BB0403|Spiriva Respimat|innöndl|2,5|mcg/sk|60|skammtar|1|pakki|lausn|R03BB04|01.04.2008||R|A|2|0|0|B|0|BII|0|0|0|100|DKK|7492|11007|lyfalmen|||00|60|0|8|Vistor hf|Boehringer Ingelheim International |Tíótrópíumbrómíð||7492||7492|11007 066287|B05AA0704|Voluven|irl|60|mg/ml|500|ml|20|pokar|Freeflex umbúðir|B05AA07|01.05.2008||R|A|5|0|0|0|1|FRP|0|0|0|100|DKK|34465|44776|lyfsjukr|||00|10000|0|10|Icepharma hf|Fresenius Kabi|Hýdróxyetýl sterkja||34465||34465|44776 066399|N07BA0106|Nicotinell|forðapl|7|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|21|0|10|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 066407|N07BA0106|Nicotinell|forðapl|14|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|21|0|21|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 066423|N07BA0106|Nicotinell|forðapl|21|mg/sólh|21|stk|1|pakki||N07BA01|01.04.1992||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||23|21|0|32|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 066548|QG03FA0401|Prid, vet.|lykkja|10|mg|10|stk|1|pakki|m. hylki|QG03FA04|01.08.1984||R|A|2|0|0|0|0|CES|1|0|0|100|XEU|21764|41628|vetalmen|||16|10|0|0|Icepharma hf|Ceva Sante Animale|||21764||21764|41628 066563|N06AA0405|Klomipramin Merck NM|töflur|10|mg|100|stk|1|glas||N06AA04|01.10.1992||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|860|2007|lyfalmen|||00|100|0|10|Actavis Group PTC ehf|Merck NM AB|Klómípramín||860||860|2007 066621|N06AA0405|Klomipramin Merck NM|töflur|25|mg|100|stk|1|glas||N06AA04|01.10.1992||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|794|1918|lyfalmen|V0908|1918|00|100|0|25|Actavis Group PTC ehf|Merck NM AB|Klómípramín||794||794|1918 066688|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|6|glerfl||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|4575|6550|lyfsjukr|||02|120|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||4575||4575|6550 066751|C01BD0103|Cordarone (D.A.C.)|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.11.2006||R|K|5|0|0|B|0|DAC|0|0|0|100|NOK|2340|4016|lyfalmen|V0144|4016|70|30|0|15|D.A.C. ehf|D.A.C. ehf|Amíódarón||2340||2340|4016 067025|J01CA0406|Flemoxin Solutab|lausnart|125|mg|20|stk|1|þpakki||J01CA04|01.01.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|669|1748|lyfalmen|||23|20|0|2|Vistor hf|Astellas Pharma A/S|Amoxicillín||669||669|1748 067124|N07CA0101|Betaserc|töflur|16|mg|84|stk|1|þpakki||N07CA01|01.04.1993||R|A|5|0|0|E|0|SOL|0|0|0|100|DKK|7390|10869|lyfalmen|||00|84|0|56|Medico ehf|Solvay Duphar |Betahistín||7390||7390|10869 067587|N05BB0101|Atarax|töflur|25|mg|100|stk|1|þpakki||N05BB01|01.07.1994||R|A|5|0|0|0|0|UCN|0|0|0|100|SEK|1237|2519|lyfalmen|||00|100|0|33|Vistor hf|UCB Nordic A/S|Hýdroxýzín||1237||1237|2519 067641|N05CD0204|Mogadon (D.A.C.)|töflur|5|mg|50|stk|1|þpakki||N05CD02|01.11.2006||R|A|5|0|0|0|0|DAC|0|0|1|100|DKK|787|1908|lyfalmen|V0901|1908|00|50|0|50|D.A.C. ehf|D.A.C. ehf|Nítrazepam||787||787|1908 067751|J02AC0102|Candizol|hylki|50|mg|7|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1740|3202|lyfalmen|V0551|3202|10|7|0|2|Actavis Group hf|Actavis hf|Flúkónazól||1740||1740|3202 067769|J02AC0102|Candizol|hylki|50|mg|30|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|7143|10534|lyfalmen|V0552|10534|10|30|0|8|Actavis Group hf|Actavis hf|Flúkónazól||7143||7143|10534 067785|J02AC0102|Candizol|hylki|150|mg|1|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|754|1864|lyfalmen|V0554|1864|10|1|0|1|Actavis Group hf|Actavis hf|Flúkónazól||754||754|1864 067793|J02AC0102|Candizol|hylki|150|mg|2|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1441|2796|lyfalmen|V0555|2796|10|2|0|2|Actavis Group hf|Actavis hf|Flúkónazól||1441||1441|2796 067801|J02AC0102|Candizol|hylki|150|mg|4|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|2500|4233|lyfalmen|V0556|4233|10|4|0|3|Actavis Group hf|Actavis hf|Flúkónazól||2500||2500|4233 067827|J02AC0102|Candizol|hylki|200|mg|30|stk|1|glas||J02AC01|01.12.1998||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|26738|35474|lyfalmen|V0557|35474|10|30|0|30|Actavis Group hf|Actavis hf|Flúkónazól||26738||26738|35474 068312|QN01AX0302|Narketan, vet.|stl|100|mg/ml|50|ml|1|hgl||QN01AX03|01.01.1991||R|A|2,5|1|0|0|0|VEQ|1|0|0|100|XEU|6346|12259|vetalmen|||27|50|0|0|Icepharma hf|Vétoquinol AG|||6346||6346|12259 068437|C01BC0401|Tambocor|töflur|100|mg|20|stk|1|þpakki||C01BC04|01.04.1987||R|A|5|0|1|B|0|MEB|0|0|0|100|SEK|2080|3663|lyfalmen|||00|20|0|10|Vistor hf|Meda AB (V)|Flekaíníð||2080||2080|3663 068445|C01BC0401|Tambocor|töflur|100|mg|100|stk|1|þpakki||C01BC04|01.04.1987||R|A|5|0|1|B|0|MEB|0|0|0|100|SEK|6133|9163|lyfalmen|||00|100|0|50|Vistor hf|Meda AB (V)|Flekaíníð||6133||6133|9163 068923|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|10|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|200|0|0|Actavis Group hf|Braun|||||| 068933|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|20|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|400|0|0|Actavis Group hf|Braun|||||| 068951|V07AB09|Sterilt Vann B. Braun|leysir|0||10|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|200|0|0|Actavis Group hf|Braun|||||| 068960|V07AB09|Sterilt Vann B. Braun|leysir|0||20|ml|20|lykja|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|400|0|0|Actavis Group hf|Braun|||||| 069799|D01AE1501|Lamisil|krem|10|mg/g|15|g|1|túpa||D01AE15|01.04.1993||L|A|5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|15|0|15|Artasan ehf|Novartis Healthcare A/S-A|Terbínafín||||| 069807|D01BA0201|Lamisil|töflur|250|mg|14|stk|1|þpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|4952|3211|lyfalmen|||00|14|0|14|Vistor hf|Novartis Healthcare A/S-|Terbínafín||1747||1747|3211 069815|D01BA0201|Lamisil|töflur|250|mg|98|stk|1|þpakki||D01BA02|01.04.1993||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|31896|16993|lyfalmen|||00|98|0|98|Vistor hf|Novartis Healthcare A/S-|Terbínafín||11903||11903|16993 069833|J01DB0101|Keflex|töflur|500|mg|40|stk|1|þpakki||J01DB01|01.07.2007||R|A|3|0|0|0|0|NMA|0|0|1|100|IKR|3033|4956|lyfalmen|||00|40|0|10|Icepharma hf|NordMedica A/S|Cefalexín||3033||3033|4956 069842|J01DB0101|Keflex|töflur|500|mg|20|stk|1|þpakki||J01DB01|01.07.2007||R|A|3|0|0|0|0|NMA|0|0|1|100|IKR|1516|2898|lyfalmen|||00|20|0|5|Icepharma hf|NordMedica A/S|Cefalexín||1516||1516|2898 070342|V08AB0201|Omnipaque|stl|350|mg J/ml|100|ml|10|glerfl||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|44276|56991|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||44276||44276|56991 070359|L01DB0701|Novantrone|irþ|2|mg/ml|10|ml|1|hgl||L01DB07|01.07.1987||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|32079|41806|lyfsjukr|||00|10|0|0|Icepharma hf|Wyeth AB|Mítoxantrón||32079||32079|41806 070514|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|30|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|7360|10538|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar||7360||7360|10538 070523|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|20|plpok|Freeflex umbúðir|B05BB01|01.05.2007||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|5235|7495|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar||5235||5235|7495 070533|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|30|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|9194|13164|lyfsjukr|||00|7500|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||9194||9194|13164 070542|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|20|plpok|Freeflex umbúðir|B05BA03|01.05.2007||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|5851|8377|lyfsjukr|||00|10000|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||5851||5851|8377 070557|QH01BB0203|Partoxin vet.|stl|17|mcg|10|ml|10|hgl||QH01BB02|01.12.2006||R|A|2|0|0|0|0|PSW|1|0|0|100|SEK|4976|9650|vetalmen|||27|100|0|0|Vistor hf|Pharmaxim Sweden AB|||4976||4976|9650 070623|C03AA0301|Aquazið|töflur|12,5|mg|100|stk|1|glas||C03AA03|01.03.1984|31.03.2009|R|A|4|0|0|E|0|ACA|0|0|0|100|IKR|748|1855|lyfalmen|||00|100|0|50|Actavis Group hf|Actavis hf|||748||748|1855 070797|N05AX0801|Risperdal|mixtúra|1|mg/ml|100|ml|1|fl|með skammtasprautu|N05AX08|01.01.1997||R|A|2|0|0|*|0|JAS|0|1|0|100|SEK|15683|21710|lyfalmen|||00|100|0|20|Vistor hf|Janssen-Cilag AB|Risperídón||15683||15683|21710 071076|QA12CE9902|Selevitan, vet.|kyrni|0| |1250|g|1|plbrús||QA12CE99|01.12.2006||R|A|3|0|0|0|0|PSW|0|0|0|100|SEK|5268|10206|vetalmen|||16|1250|0|0|Vistor hf|Pharmaxim Sweden AB|||5268||5268|10206 071134|N05AN0104|Litiumsitrat Actavis|töflur|500|mg|100|stk|1|glas||N05AN01|01.10.1995||R|A|5|0|0|*|0|ACA|0|1|0|100|IKR|728|1828|lyfalmen|||00|100|0|22|Actavis Group hf|Actavis hf|Litíum||728||728|1828 071217|C03EA0104|Hydramil mite|töflur|27,5|mg|100|stk|1|glas|2.5+25 mg|C03EA01|01.08.1984||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|158|1055|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|Hýdróklórtíazíð og kalíumsparandi lyf||158||158|1055 071223|N02BG0801|Prialt|irl|100|mcg/ml|1|ml|1|hgl||N02BG08|01.06.2007||R|K|3|0|1|0|1|EIS|0|0|0|100|SEK|55633|71131|lyfsjukr|||00|1|0|8|Vistor hf|Eisai Ltd|Ziconotíð||55633||55633|71131 071232|N02BG0801|Prialt|irl|100|mcg/ml|5|ml|1|hgl||N02BG08|01.06.2007||R|K|3|0|1|0|1|EIS|0|0|0|100|SEK|278164|348182|lyfsjukr|||00|5|0|42|Vistor hf|Eisai Ltd|Ziconotíð||278164||278164|348182 072132|QN05CM9001|Domosedan, vet.|stl|10|mg/ml|5|ml|1|hgl||QN05CM90|01.01.1991||R|A|3|0|0|0|0|ORF|1|0|0|100|DKK|8095|15591|vetalmen|||27|5|0|0|Vistor hf|Orion-Farmos|||8095||8095|15591 072371|A04AA0201|Kytril|stl|1|mg/ml|3|ml|5|lykjur||A04AA02|01.04.1993||R|A|3|0|0|E|0|ROA|0|0|0|100|DKK|14166|19822|lyfalmen|||00|15|0|5|Icepharma hf|Roche as|Granisetrón||14166||14166|19822 072520|V01AA1104|Alutard SQ, hrossaværur|stl|0,01|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA11|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|19867|26919|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|dýr||19867||19867|26919 072751|N01AH0301|Sufenta|stl|5|mcg/ml|2|ml|5|lykjur||N01AH03|01.06.2000||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|559|800|lyfsjukr|||02|10|0|0|Vistor hf|Janssen-Cilag AB|Súfentaníl||559||559|800 072770|L04AB0401|Humira|stl|40|mg/penna|0,8|ml|2|pennar||L04AB04|01.06.2007||R|K|1,5|0|1|0|1|ABB|0|0|0|100|DKK|188813|236940|lyfsjukr|||00|2|0|28|Vistor hf|Abbott|Adalimumab||188813||188813|236940 072892|N01AH0301|Sufenta|stl|50|mcg/ml|1|ml|5|lykjur||N01AH03|01.10.1992||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|1712|2451|lyfsjukr|||02|5|0|0|Vistor hf|Janssen-Cilag AB|Súfentaníl||1712||1712|2451 072978|A10BX0401|Byetta|stl|5|mcg/sk|1,2|ml|1|penni|lausn|A10BX04|01.05.2007||R|K|2|0|0|*|0|ELN|0|0|0|100|XEU|15477|21454|lyfalmen|||00|1|0|20|Icepharma hf|Eli Lilly Nederland|Exenatíð||15477||15477|21454 072996|A10BX0401|Byetta|stl|10|mcg/sk|2,4|ml|1|penni|lausn|A10BX04|01.05.2007||R|K|2|0|0|*|0|ELN|0|0|0|100|XEU|15477|21454|lyfalmen|||00|2|0|40|Icepharma hf|Eli Lilly Nederland|Exenatíð||15477||15477|21454 073205|N05AF0103|Fluanxol Mite|filmhtfl|0,5|mg|100|stk|1|glas||N05AF01|01.12.1972||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|1357|2682|lyfalmen|||00|100|0|8|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1357||1357|2682 073224|A09AA0205|Creon|sh-hylki|150|mg|100|stk|1|plglas||A09AA02|01.01.2008||R|A|2|0|0|E|0|SOY|0|0|0|100|XEU|4002|5389|lyfalmen|||10|100|0|100|Medico ehf|Solvay Pharmaceuticals GmbH|Hvatablöndur (lípasi, próteasi o.s.frv.)||3352||3352|5389 073684|N05AF0103|Fluanxol Mite|filmhtfl|1|mg|100|stk|1|glas||N05AF01|01.12.1972||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|1700|3147|lyfalmen|||00|100|0|17|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||1700||1700|3147 073825|N05BA1203|Tafil|töflur|0,25|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|317|1271|lyfalmen|||00|20|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||317||317|1271 073833|N05BA1203|Tafil|töflur|0,25|mg|50|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|854|1999|lyfalmen|||00|50|0|12|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||854||854|1999 073841|N05BA1203|Tafil|töflur|0,25|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|1237|2519|lyfalmen|||00|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||1237||1237|2519 073858|N05BA1203|Tafil|töflur|0,5|mg|20|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|536|1568|lyfalmen|||00|20|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||536||536|1568 073866|N05BA1203|Tafil|töflur|0,5|mg|50|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|930|2102|lyfalmen|||00|50|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||930||930|2102 073874|N05BA1203|Tafil|töflur|0,5|mg|100|stk|1|þpakki||N05BA12|01.04.1987||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|1847|3347|lyfalmen|||00|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||1847||1847|3347 074042|C09DB0101|Exforge|filmhtfl|85|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|3730|5902|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||3730||3730|5902 074051|C09DB0101|Exforge|filmhtfl|85|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|10863|15582|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||10863||10863|15582 074060|C09DB0101|Exforge|filmhtfl|165|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|4760|7300|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||4760||4760|7300 074069|C09DB0101|Exforge|filmhtfl|165|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|15725|21763|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||15725||15725|21763 074078|C09DB0101|Exforge|filmhtfl|170|mg|28|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|4760|7300|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||4760||4760|7300 074087|C09DB0101|Exforge|filmhtfl|170|mg|98|stk|1|pakki||C09DB01|01.04.2007||R|A|1,5|0|0|B|0|NOE|0|0|0|100|DKK|15725|21763|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|Valsartín og amlódipín||15725||15725|21763 074229|A08AA1001|Reductil|hylki|10|mg|28|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|6626|9832|lyfalmen|||00|28|0|28|Vistor hf|Abbott Laboratories A/S|Sibutramin||6626||6626|9832 074443|V08CA0301|Omniscan|stl|0,5|mmol/ml|5|ml|10|hgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|22740|30179|lyfsjukr|||00|50|0|0|Icepharma hf|GE Healthcare AS|Gadódíamíð||22740||22740|30179 074468|N05BA0105|Stesolid|töflur|5|mg|25|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|238|1163|lyfalmen|||00|25|0|12|Actavis Group hf|Actavis Group hf|Díazepam||238||238|1163 074484|N05BA0105|Stesolid|töflur|5|mg|50|stk|1|glas||N05BA01|01.12.1980||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|484|1497|lyfalmen|||00|50|0|25|Actavis Group hf|Actavis Group hf|Díazepam||484||484|1497 074617|QI06AA0402|Fel-O-Vax PCT vet.|bóluefni|0| |1|ml|25|spr|áfyllt sprauta|QI06AA04|01.06.2000||R|K|2|0|0|0|0|SCA|1|0|0|100|DKK|21511|37226|vetorma|||58|25|0|0|Vistor hf|Scan Vet Animal Health AS|||21511||21511|37226 074674|D06BB0401|Condyline|áburður|5|mg/ml|3,5|ml|1|glas|til penslu|D06BB04|01.07.1988||R|A|2|0|0|0|0|GAN|0|0|1|100|XEU|2263|3911|lyfalmen|||23|4|0|4|Icepharma hf|Galderma Nordic AB|Pódófýllótoxín||2263||2263|3911 074732|A08AA1001|Reductil|hylki|15|mg|28|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|6626|9832|lyfalmen|||00|28|0|42|Vistor hf|Abbott Laboratories A/S|Sibutramin||6626||6626|9832 074922|R06AX2601|Telfast|töflur|120|mg|30|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|1400|2401|lyfalmen|V1910|2195|00|30|0|30|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1150||1150|2401 075044|J02AB0201|Fungoral|töflur|200|mg|10|stk|1|þpakki||J02AB02|01.01.1985||R|A|5|0|0|0|0|JAS|0|0|1|100|SEK|1419|2766|lyfalmen|||69|10|0|10|Vistor hf|Janssen-Cilag AB|Ketókónazól||1419||1419|2766 075068|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|20|stk|1|þpakki||N07BA01|01.10.2008||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|20|0|1|Vistor hf|McNeil Denmark ApS|Nikótín||||| 075069|R06AX2601|Telfast|töflur|180|mg|30|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|1980|3240|lyfalmen|V1912|2928|00|30|0|45|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||1768||1768|3240 075078|N07BA0131|Nicorette Microtab Classic|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|90|0|6|Vistor hf|McNeil Denmark ApS|Nikótín||||| 075087|N02BE5102|Parkodin|töflur|510|mg|300|stk|1|plglas|10+500 mg|N02BE51|01.07.2007||R|A|5|1|0|0|0|ACA|0|0|1|100|IKR|1500|2876|lyfalmen|||00|300|0|50|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||1500||1500|2876 075096|N02AA5902|Parkodin forte|töflur|530|mg|300|stk|1|plglas|30+500 mg|N02AA59|01.07.2007||R|A|5|1|0|0|0|ACA|0|0|1|100|NOK|2497|4229|lyfalmen|||00|300|0|300|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||2497||2497|4229 075305|N02BE0108|Paratabs Retard|forðatfl|500|mg|300|stk|1|plglas||N02BE01|01.10.2007||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|1536|2925|lyfalmen|||10|300|0|50|Actavis Group hf|Actavis hf|Paracetamól||1536||1536|2925 075382|V01AA0503|Soluprick SQ, rauðölur|lausn|10|HEP|3|ml|1|hgl||V01AA05|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7713|11307|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|trjáfrjó||7713||7713|11307 075408|V01AA0504|Soluprick SQ, graölur|lausn|10|HEP|3|ml|1|hgl||V01AA05|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7713|11307|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|trjáfrjó||7713||7713|11307 075424|V01AA0501|Soluprick SQ, birkifrjo|lausn|10|HEP|3|ml|1|hgl||V01AA05|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7713|11307|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|trjáfrjó||7713||7713|11307 075440|V01AA0502|Soluprick SQ, hesliviður|lausn|10|HEP|3|ml|1|hgl||V01AA05|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7713|11307|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|trjáfrjó||7713||7713|11307 075465|V04CL0006|Soluprick SQ, haliðagras|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7713|11307|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7713||7713|11307 075481|V04CL0004|Soluprick SQ, hafrar|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7713|11307|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7713||7713|11307 075507|V04CL0005|Soluprick SQ, axhnoðapunktur|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7713|11307|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7713||7713|11307 075523|V04CL0002|Soluprick SQ, havingull|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7713|11307|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7713||7713|11307 075549|V04CL0008|Soluprick SQ, vallarrygresi|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7713|11307|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7713||7713|11307 075564|V04CL0003|Soluprick SQ, vallarfoxgras|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7713|11307|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7713||7713|11307 075580|V04CL0007|Soluprick SQ, vallarsveifgras|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7713|11307|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7713||7713|11307 075606|V04CL0001|Soluprick SQ, rugur|lausn|10|HEP|3|ml|1|hgl||V04CL00|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7713|11307|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|Ofnæmisvakar (allergenar) til greiningar á ofnæmissjúkdómum||7713||7713|11307 075663|V01AA0302|Soluprick SQ, derm.pter.|lausn|10|HEP|3|ml|1|hgl||V01AA03|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7713|11307|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|rykmaurar||7713||7713|11307 075689|V01AA1103|Soluprick SQ, hrossaværur|lausn|10|HEP|3|ml|1|hgl||V01AA11|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7713|11307|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|dýr||7713||7713|11307 075705|V01AA1102|Soluprick SQ, hundahar|lausn|10|HEP|3|ml|1|hgl||V01AA11|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7713|11307|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|dýr||7713||7713|11307 075721|V01AA1101|Soluprick SQ, kattahar|lausn|10|HEP|3|ml|1|hgl||V01AA11|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7713|11307|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|dýr||7713||7713|11307 075724|B02BD0402|BeneFIX|sts|0| |1000|ae|1|hgl|+leysir|B02BD04|01.02.2004||R|K|3|0|0|0|1|WTE|0|0|0|100|USD|132770|167166|lyfsjukr|||00|1000|0|3|Icepharma hf|Wyeth Europe|Storkuþáttur IX||132770||132770|167166 075787|QS02CA0102|Canaural|eyrnadr|0| |25|ml|1|glas||QS02CA01|01.12.1982||R|A|3|0|0|0|0|VEX|0|0|0|100|DKK|2161|4264|vetalmen|||13|25|0|0|Vistor hf|VetXX A/S|||2161||2161|4264 076033|A10BH0101|Januvia|filmhtfl|100|mg|98|stk|1|þpakki||A10BH01|01.11.2007||R|A|3|0|0|*|0|MSD|0|0|0|100|XEU|27977|37016|lyfalmen|||00|98|0|0|Icepharma hf|M.S.D.|Sítagliptín||27977||27977|37016 076281|R01AX0301|Atrovent|nefúði|21|mcg/sk|30|ml|1|stauk|380 sk.|R01AX03|01.01.2000||R|A|2|0|0|E|0|BOI|0|0|1|100|DKK|2662|4453|lyfalmen|||24|30|0|33|Vistor hf|Boehringer Ingelheim|Ípratrópínbrómíð||2662||2662|4453 076369|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|20|stk|1|þpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|738|1792|lyfalmen|V1070|1792|00|20|0|2|PortFarma ehf|PortFarma |Risperídón||701||701|1792 076378|N05AX0805|Risperidon Portfarma|filmhtfl|0,5|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|2033|3185|lyfalmen|V1075|3185|00|60|0|6|PortFarma ehf|PortFarma |Risperídón||1728||1728|3185 076387|N05AX0805|Risperidon Portfarma|filmhtfl|1|mg|60|stk|1|þpakki||N05AX08|01.07.2007||R|A|3|0|0|*|0|POF|0|1|0|100|IKR|2876|4040|lyfalmen|V0791|4040|00|60|0|12|PortFarma ehf|PortFarma |Risperídón||2358||2358|4040 076533|N05AB0301 |Trilafon|filmhtfl|2|mg|100|stk|1|þpakki||N05AB03|01.04.2009||R|A|2|0|0|*|0|SCP|0|1|0|100|DKK|924|2094|lyfalmen|V2070|2094|00|100|0|7|Vistor hf|Schering-Plough|Perfenazín||||924|2094 076542|N05AB0301 |Trilafon|filmhtfl|4|mg|100|stk|1|þpakki||N05AB03|01.04.2009||R|A|2|0|0|*|0|SCP|0|1|0|100|DKK|1281|2579|lyfalmen|V2071|2579|00|100|0|13|Vistor hf|Schering-Plough|Perfenazín||||1281|2579 076551|N05AB0301 |Trilafon|filmhtfl|8|mg|100|stk|1|þpakki||N05AB03|01.04.2009||R|A|2|0|0|*|0|SCP|0|1|0|100|DKK|1825|3317|lyfalmen|V2072|3317|00|100|0|27|Vistor hf|Schering-Plough|Perfenazín||||1825|3317 076752|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|100|ml|1|hgl|plast|QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|7407|12818|vetorma|||27|100|0|0|Vistor hf|Merial (MSD)|||7407||7407|12818 077215|A03000001|Relistor|stl|20|mg/ml|0,6|ml|1|hgl|lausn|A03|01.01.2009||R|A|2|0|0|0|0|WTE|0|0|0|100|USD|6433|9570|lyfalmen|||0|12|0|0|Icepharma hf|Wyeth Europe|||6433||6433|9570 077420|N02BE5102|Parkodin|töflur|510|mg|30|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1985||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|200|1112|lyfalmen|||00|30|0|5|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||200||200|1112 077446|N02BE5102|Parkodin|töflur|510|mg|100|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1985||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|505|1526|lyfalmen|||00|100|0|17|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||505||505|1526 077875|A02BA0205|Zantac|stl|25|mg/ml|2|ml|5|lykjur||A02BA02|01.10.1987||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|669|1748|lyfalmen|||02|10|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín||669||669|1748 077951|M01AB0514|Voltfast (D.A.C.)|filmhtfl|50|mg|30|stk|1|þpakki||M01AB05|01.04.2007||R|A|5|0|0|0|0|DAC|0|0|1|100|IKR|955|1424|lyfalmen|V0609|1424|10|30|0|15|D.A.C. ehf|D.A.C. ehf|Díklófenak||430||430|1424 078568|J01CE0204|Kaavepenin|töflur|250|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|444|1443|lyfalmen|||00|20|0|2|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||444||444|1443 078576|J01CE0204|Kaavepenin|töflur|250|mg|40|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|676|1758|lyfalmen|||00|40|0|5|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||676||676|1758 078709|N06AB0303|Serol|töflur|10|mg|30|stk|1|glas||N06AB03|01.04.1994||R|A|5|0|0|B|0|ACA|0|1|0|100|IKR|1226|2504|lyfalmen|||00|30|0|15|Actavis Group hf|Actavis hf|Flúoxetín||1226||1226|2504 078717|N06AB0303|Serol|töflur|10|mg|100|stk|1|glas||N06AB03|01.04.1994||R|A|5|0|0|B|0|ACA|0|1|0|100|IKR|4110|6418|lyfalmen|||00|100|0|50|Actavis Group hf|Actavis hf|Flúoxetín||4110||4110|6418 078741|N06AX0306|Mianserin Merck NM|töflur|30|mg|100|stk|1|glas||N06AX03|01.01.1994||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|2782|4616|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck NM AB|Míanserín||2782||2782|4616 078782|L01XA0208|Carboplatin Mayne|irþ|10|mg/ml|5|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|5247|7512|lyfsjukr|||00|5|0|0|Icepharma hf|Mayne Pharma Plc|Karbóplatín||5247||5247|7512 078790|L01XA0208|Carboplatin Mayne|irþ|10|mg/ml|15|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|15457|21111|lyfsjukr|||00|15|0|0|Icepharma hf|Mayne Pharma Plc|Karbóplatín||15457||15457|21111 078824|L01XA0208|Carboplatin Mayne|irþ|10|mg/ml|45|ml|1|hgl||L01XA02|01.04.1992||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|17165|23238|lyfsjukr|||00|45|0|0|Icepharma hf|Mayne Pharma Plc|Karbóplatín||17165||17165|23238 078933|L03AB0801|Betaferon|sts|8|mi.ae/ml|15|spr|1|pakki|+leysir|L03AB08|01.01.2002||R|A|2|0|1|0|1|SAG|0|0|0|100|SEK|134765|169650|lyfsjukr|||00|15|0|30|Icepharma hf|Schering AG|Interferón beta-1b||134765||134765|169650 079061|C09CA0101|Cozaar|töflur|50|mg|98|stk|1|þpakki||C09CA01|01.01.1995||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|9221|6085|lyfalmen|V0197|5469|00|98|0|98|Icepharma hf|M.S.D.|Lósartan||3865||3865|6085 079103|L01AA0601|Holoxan|sts/irs|500|mg|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|2009|2876|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter Medical AB|Ífosfamíð||2009||2009|2876 079111|L01AA0601|Holoxan|sts/irs|1|g|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|3469|4967|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter Medical AB|Ífosfamíð||3469||3469|4967 079129|L01AA0601|Holoxan|sts/irs|2|g|1|stk|1|hgl||L01AA06|01.07.1998||R|A|5|0|1|0|1|BAM|0|0|0|100|SEK|6233|8924|lyfsjukr|||00|1|0|0|Icepharma hf|Baxter Medical AB|Ífosfamíð||6233||6233|8924 079202|J05AH0201|Tamiflu|hylki|75|mg|10|stk|1|þpakki||J05AH02|01.11.2002||R|A|5|0|0|0|0|RRL|0|0|0|100|DKK|3471|5551|lyfalmen|||00|10|0|5|Icepharma hf|Roche Registration Limited|Oseltamivír||3471||3471|5551 079236|L01CA0206|Vincristine Mayne|stl|1|mg/ml|1|ml|5|hgl||L01CA02|01.01.1991||R|K|2|0|1|0|1|MAY|0|0|0|100|SEK|7012|10039|lyfsjukr|||02|5|0|0|Icepharma hf|Mayne Pharma Plc|Vínkristín||7012||7012|10039 079269|N05AB0302|Trilafon decanoat|stl|108,2|mg/ml|1|ml|10|lykjur||N05AB03|01.01.1988||R|A|3|0|0|*|0|SCP|0|1|0|100|DKK|20727|27990|lyfalmen|||02|10|0|155|Vistor hf|Schering-Plough|Perfenazín||20727||20727|27990 079616|L01CA0206|Vincristine Mayne|stl|1|mg/ml|2|ml|5|hgl||L01CA02|01.07.2004||R|K|2|0|1|0|1|MAY|0|0|0|100|SEK|10975|15531|lyfsjukr|||02|10|0|0|Icepharma hf|Mayne Pharma Plc|Vínkristín||10975||10975|15531 079749|J01CF0101|Diclocil|sts/irs|1|g|1|stk|5|hgl||J01CF01|01.04.1987||R|A|3|0|0|0|1|BRS|0|0|0|100|DKK|2146|3073|lyfsjukr|||03|5|0|2|Vistor hf|Bristol-Myers Squibb|Díkloxacillín||2146||2146|3073 080106|J01MA0203|Siprox|töflur|250|mg|10|stk|1|þpakki||J01MA02|01.10.1992||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|393|1374|lyfalmen|V0514|1374|00|10|0|2|Actavis Group hf|Actavis hf|Cíprófloxacín||393||393|1374 080115|J01MA0203|Siprox|töflur|250|mg|20|stk|1|þpakki||J01MA02|01.10.1992||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|638|1706|lyfalmen|V0518|1706|00|20|0|5|Actavis Group hf|Actavis hf|Cíprófloxacín||638||638|1706 080124|J01MA0203|Siprox|töflur|500|mg|10|stk|1|þpakki||J01MA02|01.05.2008||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|647|1718|lyfalmen|V0522|1718|00|10|0|5|Actavis Group hf|Actavis hf|Cíprófloxacín||647||647|1718 080133|J01MA0203|Siprox|töflur|500|mg|20|stk|1|þpakki||J01MA02|01.01.1994||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|1168|2425|lyfalmen|V0526|2425|00|20|0|10|Actavis Group hf|Actavis hf|Cíprófloxacín||1168||1168|2425 080424|G01AF0502|Pevaryl Depot|sk-stil|150|mg|1|stk|1|still||G01AF05|01.04.1989||L|A|3|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||05|1|0|2|Vistor hf|Janssen-Cilag AB|Ekónazól||||| 080507|N06AA1001|Noritren|töflur|50|mg|100|stk|1|glas||N06AA10|01.04.1986||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|2327|3998|lyfalmen|||00|100|0|67|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||2327||2327|3998 080524|N06AX1202|Wellbutrin Retard|töflur|300|mg|30|stk|1|þpakki|m/br. losunarhraða|N06AX12|01.07.2007||R|A|1,5|0|0|B|0|GSK|0|1|1|100|GBP|5836|8760|lyfalmen|||00|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Buprofienum||5836||5836|8760 080542|N06AX1202|Wellbutrin Retard|töflur|150|mg|30|stk|1|þpakki|m/br. losunarhraða|N06AX12|01.07.2007||R|A|1,5|0|0|B|0|GSK|0|1|1|100|GBP|3147|5111|lyfalmen|||00|30|0|15|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Buprofienum||3147||3147|5111 080549|QP54AA0103|Ivomec, vet.|stl|10|mg/ml|500|ml|1|fl||QP54AA01|01.01.1985||R|A|5|0|0|0|0|MEF|1|0|0|100|XEU|31529|54563|vetorma|||27|500|0|0|Vistor hf|Merial (MSD)|||31529||31529|54563 080564|L01DB0601|Zavedos|sts|5|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|24891|32857|lyfsjukr|||00|1|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ídarúbicín||24891||24891|32857 080820|L01DB0601|Zavedos|sts|10|mg|1|stk|1|hgl||L01DB06|01.01.1992||R|A|3|0|1|0|1|PFI|0|0|0|100|DKK|49448|63430|lyfsjukr|||00|1|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ídarúbicín||49448||49448|63430 081315|M09AX0101|Artzal|stl|10|mg/ml|2,5|ml|5|dælur|einnota dælur plast|M09AX01|01.11.1998||R|A|3,5|0|0|E|0|AZD|0|0|0|100|SEK|35873|46847|lyfalmen|||02|12|0|35|Vistor hf|AstraZeneca A/S DK|Natríumhýalúrónat||35873||35873|46847 081507|G04BE0802|Cialis (D.A.C.)|filmhtfl|20|mg|4|stk|1|þpakki||G04BE08|01.05.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|XEU|6011|8998|lyfalmen|V1350|8998|00|4|0|8|D.A.C. ehf|D.A.C. ehf|Tadalafíl||||6011|8998 081525|V03AN0101|Conoxia|innö.gas|100|%|10|l|1|hylki|MO10|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|10|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081534|V03AN0101|Conoxia|innö.gas|100|%|20|l|1|hylki|MO20|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|20|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081539|M01AE0102|Ibufen|töflur|400|mg|100|stk|1|glas||M01AE01|01.01.1988||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|357|1325|lyfalmen|||00|100|0|33|Actavis Group hf|Actavis hf|Íbúprófen||357||357|1325 081543|V03AN0101|Conoxia|innö.gas|100|%|50|l|1|hylki|Mo50|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|50|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081552|V03AN0101|Conoxia|innö.gas|100|%|5|l|1|hylki|MO5|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|5|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081561|V03AN0101|Conoxia|innö.gas|100|%|50|l|12|hylki|MS5I|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|600|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081571|V03AN0101|Conoxia|innö.gas|100|%|2|l|1|hylki|MO2c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|2|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081588|C10AA0302|Pravachol|töflur|40|mg|28|stk|1|þpakki||C10AA03|01.06.1998|30.04.2009|R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|6606|9805|lyfalmen|||00|28|0|56|Vistor hf|Bristol-Myers Squibb|Pravastatín||6606||6606|9805 081589|V03AN0101|Conoxia|innö.gas|100|%|1|l|1|hylki|MO1|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|1|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081598|V03AN0101|Conoxia|innö.gas|100|%|2,5|l|1|hylki|MO2,5c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|2|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081625|V03AN0101|Conoxia|innö.gas|100|%|2|l|1|hylki|MO2|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|2|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081634|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4b|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|4|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081671|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|4|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081680|V03AN0101|Conoxia|innö.gas|100|%|4|l|1|hylki|MO4c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|4|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081689|V03AN0101|Conoxia|innö.gas|100|%|1|l|1|hylki|MO1c|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|1|0|0|Ísaga ehf|AGA AB|Súrefni||||| 081745|N05CD0801|Dormicum|stl|5|mg/ml|1|ml|10|lykjur||N05CD08|01.07.1985||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|2140|3064|lyfsjukr|||02|10|0|3|Icepharma hf|Roche|Mídazólam||2140||2140|3064 081897|N05AH0305|Zyprexa Velotab (D.A.C.)|munndr.t|10|mg|28|stk|1|þpakki||N05AH03|01.05.2007||R|A|3|0|0|*|0|DAC|0|1|0|100|XEU|19860|26911|lyfalmen|V0813|26911|00|28|0|28|D.A.C. ehf|D.A.C. ehf|Olanzapín||19860||19860|26911 081987|A10AB0602|Apidra [solostar]|stl|100|ein/ml|3|ml|5|lyfjap|áflylltir|A10AB06|01.01.2008||R|K|2|0|0|*|0|SAA|0|0|0|100|NOK|5232|7940|lyfalmen|||02|15|0|38|Vistor hf|Sanofi - Aventis|Insúlín glúlisín||5232||5232|7940 081996|A10AE0403|Lantus [SoloStar]|stl|100|ein/ml|3|ml|5|lyfjap||A10AE04|01.01.2008||R|K|2|0|0|*|0|SDE|0|0|0|100|NOK|9132|13233|lyfalmen|||00|15|0|38|Vistor hf|Sanofi - aventis Deutschland GmbH|Insulín glargín||9132||9132|13233 082233|V03AN0101|Conoxia|innö.gas|100|%|36|l|1|hylki|Hemlox|V03AN01|01.04.2007||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|36|0|0|Ísaga ehf|AGA AB|Súrefni||||| 082685|R03BA0502|Flixotide Diskus|innúðadu|250|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|2992|4901|lyfalmen|||23|60|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2992||2992|4901 082701|J01CA0410|Amoxicillin Merck NM|mixt.kyr|50|mg/ml|60|ml|1|glas||J01CA04|01.07.1998||R|A|2|0|0|0|0|MNA|0|0|1|100|SEK|586|1636|lyfalmen|||00|60|0|3|Actavis Group PTC ehf|Merck NM AB|Amoxicillín||586||586|1636 082719|R03BA0502|Flixotide Diskus|innúðadu|500|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|3|0|0|B|0|GSK|0|0|0|100|GBP|4888|7474|lyfalmen|||23|60|0|50|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||4888||4888|7474 082792|J01CA0410|Amoxicillin Merck NM|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CA04|01.07.1998||R|A|2|0|0|0|0|MNA|0|0|1|100|SEK|917|2085|lyfalmen|||00|125|0|6|Actavis Group PTC ehf|Merck NM AB|Amoxicillín||917||917|2085 082842|J01CA0410|Amoxicillin Merck NM|mixt.kyr|50|mg/ml|200|ml|1|glas||J01CA04|01.07.1998||R|A|2|0|0|0|0|MNA|0|0|1|100|SEK|1465|2828|lyfalmen|||00|200|0|10|Actavis Group PTC ehf|Merck NM AB|Amoxicillín||1465||1465|2828 082883|R03BA0201|Pulmicort|innúðal|0,125|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|4606|7091|lyfalmen|||00|100|0|6|Vistor hf|AstraZeneca A/S DK|Búdesóníð||4606||4606|7091 082933|R03BA0201|Pulmicort|innúðal|0,25|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|5061|7708|lyfalmen|||00|40|0|12|Vistor hf|AstraZeneca A/S DK|Búdesóníð||5061||5061|7708 082958|N06DA0301|Exelon|hylki|1,5|mg|56|stk|1|þpakki||N06DA03|01.10.2008||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|13566|19075|lyfalmen|||00|56|0|9|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||13566||13566|19075 082990|N06DA0301|Exelon|hylki|1,5|mg|112|stk|1|þpakki||N06DA03|01.01.1999|30.04.2009|R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|27497|36419|lyfalmen|||00|112|0|19|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||27497||27497|36419 083113|L02BG0301|Arimidex|töflur|1|mg|28|stk|1|þpakki||L02BG03|01.03.1998||R|A|5|0|0|*|0|ASZ|0|0|0|100|SEK|16042|22157|lyfalmen|||00|28|0|28|Vistor hf|AstraZeneca UK Ltd|Anastrózól||16042||16042|22157 083121|N06DA0301|Exelon|hylki|3|mg|56|stk|1|þpakki||N06DA03|01.10.2008||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|14169|19825|lyfalmen|V1372|19825|00|56|0|19|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||14169||14169|19825 083154|R03BA0201|Pulmicort|innúðal|0,5|mg/ml|2|ml|20|plhylk|í vél|R03BA02|01.01.1997||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|6435|9573|lyfalmen|||00|40|0|25|Vistor hf|AstraZeneca A/S DK|Búdesóníð||6435||6435|9573 083204|N06DA0301|Exelon|hylki|3|mg|112|stk|1|þpakki||N06DA03|01.01.1999|30.04.2009|R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|26353|34994|lyfalmen|||00|112|0|37|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||26353||26353|34994 083360|G03GA0501|Gonal-F|sts|75|ae/lykju|10|lykjur|1|pakki|+ leysir 1 ml|G03GA05|01.04.1997||R|A|2|0|1|E|0|SEN|0|0|0|100|SEK|44113|57106|lyfalmen|||03|10|0|10|Gróco ehf|Serono Nordic|Follitrópín alfa||44113||44113|57106 083451|G03GA0501|Gonal-F|sts|150|ae/lykju|10|lykjur|1|pakki|+ leysir 1 ml|G03GA05|01.04.1997||R|A|2|0|1|E|0|SEN|0|0|0|100|SEK|89626|113769|lyfalmen|||03|10|0|20|Gróco ehf|Serono Nordic|Follitrópín alfa||89626||89626|113769 083592|J05AE0301|Norvir|mixtúra|80|mg/ml|90|ml|5|glös||J05AE03|01.08.2003||R|K|0,5|0|1|0|1|ABL|0|0|0|100|DKK|79178|100444|lyfsjukr|||00|450|0|30|Vistor hf|Abbott Laboratories A/S|Ritonavír||79178||79178|100444 083634|N06DA0301|Exelon|hylki|6|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|30745|40463|lyfalmen|||00|112|0|75|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||30745||30745|40463 083964|L02AE0101|Suprefact|nefúði|0,1|mg/sk|10|g|4|stk|+ sk-dæla|L02AE01|01.10.1987|31.03.2009|R|A|2.5|0|1|0|1|SNO|0|0|0|100|NOK|36627|47468|lyfsjukr|||23|40|0|33|Vistor hf|Sanofi-aventis Norge AS|Búserelín||36627||36627|47468 083980|L02AE0101|Suprefact|stl|1|mg/ml|5,5|ml|2|hgl||L02AE01|01.10.1987||R|A|3|0|1|0|1|SNO|0|0|0|100|NOK|8020|11483|lyfsjukr|||02|11|0|7|Vistor hf|Sanofi-aventis Norge AS|Búserelín||8020||8020|11483 084160|C03CA0101|Furix|stl|10|mg/ml|2|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|277|1216|lyfalmen|||02|10|0|2|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||277||277|1216 084376|C03CA0101|Furix|stl|10|mg/ml|4|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|535|1566|lyfalmen|||02|20|0|5|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||535||535|1566 084669|B03XA0301|Mircera|stl|150|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|65473|83381|lyfsjukr|||00|0|0|0|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||65473||65473|83381 084673|P01BC0103|Kinin Actavis|töflur|100|mg|100|stk|1|glas||P01BC01|01.10.1995||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1161|2416|lyfalmen|||00|100|0|7|Actavis Group hf|Actavis hf|Kínín||1161||1161|2416 084678|B03XA0301|Mircera|stl|200|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|85376|108161|lyfsjukr|||00|0|0|0|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||85376||85376|108161 084687|B03XA0301|Mircera|stl|250|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|101791|128597|lyfsjukr|||00|0|0|0|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||101791||101791|128597 084696|B03XA0301|Mircera|stl|50|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|21959|29206|lyfsjukr|||00|0|0|0|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||21959||21959|29206 084699|P01BC0103|Kinin Actavis|töflur|250|mg|100|stk|1|glas||P01BC01|01.10.1995||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|2458|4176|lyfalmen|||00|100|0|17|Actavis Group hf|Actavis hf|Kínín||2458||2458|4176 084705|B03XA0301|Mircera|stl|75|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|32859|42777|lyfsjukr|||00|0|0|0|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||32859||32859|42777 084714|B03XA0301|Mircera|stl|100|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.03.2008||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|43710|56286|lyfsjukr|||00|0|0|0|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||43710||43710|56286 084751|B03XA0301 |Mircera|stl|30|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|13031|18091|lyfsjukr|||00|0|0|8|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||13031|18091 084778|B03XA0301 |Mircera|stl|120|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|49673|63710|lyfsjukr|||00|0|0|30|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||49673|63710 084787|B03XA0301 |Mircera|stl|360|mcg/spr|0,3|ml|1|áf.spr||B03XA03|01.05.2009||R|K|2|0|1|0|1|RRL|0|0|0|100|DKK|152988|192338|lyfsjukr|||00|0|0|90|Icepharma hf|Roche Registration Limited|Metoxý pólyetýlen glýkól-epoetin beta||||152988|192338 084878|N03AF0301|Inovelon|filmhtfl|100|mg|10|stk|1|þpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|943|2120|lyfalmen|||00|10|0|0|Vistor hf|Eisai Ltd|Rúfínamíð||943||943|2120 084887|N03AF0301|Inovelon|filmhtfl|200|mg|60|stk|1|þpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|10902|15635|lyfalmen|||00|60|0|0|Vistor hf|Eisai Ltd|Rúfínamíð||10902||10902|15635 084896|N03AF0301|Inovelon|filmhtfl|400|mg|100|stk|1|þpakki||N03AF03|01.09.2007||R|A|3|0|1|E|0|EIS|0|0|0|100|SEK|36345|47435|lyfalmen|||00|100|0|0|Vistor hf|Eisai Ltd|Rúfínamíð||36345||36345|47435 085068|N02AA0101|Contalgin|forðatfl|100|mg|100|stk|1|þpakki||N02AA01|01.10.1985||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|20100|27209|lyfalmen|||10|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||20100||20100|27209 085105|A02BC0108|Omeprazol Actavis|sh-hylki|10|mg|98|stk|1|þpakki||A02BC01|01.02.2009||R|A|3|0|0|E|0|AGT|0|0|0|100|IKR|6411|7407|lyfalmen|||0|98|0|49|Actavis Group hf|Actavis Group hf|Ómeprazól||4839||4839|7407 085132|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|56|stk|1|glas||A02BC01|01.02.2009||R|A|3|0|0|E|0|AGT|0|0|0|100|IKR|2540|4287|lyfalmen|||0|56|0|56|Actavis Group hf|Actavis Group hf|Ómeprazól||||2540|4287 085141|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|98|stk|1|glas||A02BC01|01.02.2009||R|A|3|0|0|E|0|AGT|0|0|0|100|IKR|4530|6988|lyfalmen|||0|98|0|98|Actavis Group hf|Actavis Group hf|Ómeprazól||||4530|6988 085160|A02BC0108|Omeprazol Actavis|sh-hylki|40|mg|28|stk|1|þpakki||A02BC01|01.02.2009||R|A|3|0|0|0|0|AGT|0|0|0|100|IKR|3291|5306|lyfalmen|||0|28|0|56|Actavis Group hf|Actavis Group hf|Ómeprazól||||3291|5306 085205|S01AX1901|Oftaquix|augndr|5|mg/ml|0,5|ml|30|sk-hyl||S01AX19|01.03.2008||R|A|2|0|0|0|0|SAO|0|0|1|100|XEU|3132|5091|lyfalmen|||00|15|0|0|Icepharma hf|Santen Oy|Levófloxacín||3132||3132|5091 085316|N06DA0301|Exelon|hylki|4,5|mg|112|stk|1|þpakki||N06DA03|01.01.1999||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|30745|40463|lyfalmen|||00|112|0|56|Vistor hf|Novartis Healthcare A/S-|Rívastigmín||30745||30745|40463 085407|R03AC0206|Ventoline|lausn|1|mg/ml|2,5|ml|20|lykjur|f. vél|R03AC02|01.04.1992||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|736|1839|lyfalmen|||00|50|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||736||736|1839 085423|B01AB0401|Fragmin|stl|25000|ae/ml|4|ml|1|hgl|með rotvörn|B01AB04|01.04.1993||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|13495|18669|lyfsjukr|||00|4|0|40|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||13495||13495|18669 085542|G03GA0202|Menopur|sts|0| |75|ae|5|hgl|+ leysir|G03GA02|01.03.2001||R|A|2|0|1|E|0|FEL|0|0|0|100|DKK|20923|28234|lyfalmen|||00|375|0|12|Vistor hf|Ferring Lægemidler A/S|Menótrópín||20923||20923|28234 085551|G03GA0202|Menopur|sts|0| |75|ae|10|hgl|+ leysir|G03GA02|01.03.2001||R|A|2|0|1|E|0|FEL|0|0|0|100|DKK|37223|48528|lyfalmen|||00|750|0|25|Vistor hf|Ferring Lægemidler A/S|Menótrópín||37223||37223|48528 085829|S01EB0104|Pilokarpin|augndr|2|%|0,15|ml|20|skammt|án rotvarnar|S01EB01|01.01.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|1929|3458|lyfalmen|||00|3|1|8|Parlogis hf|Parlogis - óskráð lyf|Pílókarpín||1929||1929|3458 085969|R06AX2601|Telfast|töflur|120|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|4861|5541|lyfalmen|V1911|4924|00|100|0|100|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||3464||3464|5541 086108|R06AX2601|Telfast|töflur|180|mg|100|stk|1|þpakki||R06AX26|01.11.1999||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|5846|7790|lyfalmen|V1913|6875|00|100|0|150|Vistor hf|Sanofi-aventis Norge AS|Fexófenadín||5121||5121|7790 086207|J01DD0202|Fortum|sts|1|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|8153|11673|lyfsjukr|||03|5|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||8153||8153|11673 086231|J01DD0202|Fortum|sts|2|g/hgl|5|hgl|1|pakki||J01DD02|01.08.2002||R|A|3|0|0|0|1|GSK|0|0|0|100|GBP|13463|18629|lyfsjukr|||03|5|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ceftazidím||13463||13463|18629 086434|L04AA2401|Orencia|stl/irþ|250|mg/hgl|1|hgl|1|hgl|+ sprauta|L04AA24|01.02.2008||R|K|2|0|1|0|1|BSP|0|0|0|100|DKK|65433|83332|lyfsjukr|||00|1|0|9|Icepharma hf|Bristol-Myers Squibb Pharma (UK) Ltd |||65433||65433|83332 087014|J05AF1101|Sebivo|filmhtfl|600|mg|28|stk|1|þpakki||J05AF11|01.07.2008||R|A|2|0|1|0|1|NOH|0|0|0|100|DKK|76357|96932|lyfsjukr|||00|28|0|0|Vistor hf|Novartis Healthcare A/S-|||76357||76357|96932 087114|G03CX0101|Livial|töflur|2,5|mg|28|stk|1|þpakki||G03CX01|01.07.1998||R|A|2|0|0|E|0|ORG|0|0|0|100|DKK|3332|5362|lyfalmen|||00|28|0|28|Vistor hf|N.V. Organon|Tíbólón||3332||3332|5362 087215|A03AX1335|Imogaze|hylki|240|mg|30|stk|1|þpakki|mjúk hylki|A03AX13|01.12.2008||L|A|3|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||00|30|0|14|Vistor hf|Janssen-Cilag AB|Silíkonsambönd||||| 087260|J05AX0901|Celsentri|filmhtfl|150|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|A|3|0|1|0|1|PFL|0|0|0|100|DKK|165653|208105|lyfsjukr|||00|60|0|0|Vistor hf|Pfizer Limited|Maravíroc||165653||165653|208105 087296|C07AB0309|Atenolol Actavis|töflur|100|mg|100|stk|1|glas||C07AB03|01.10.1985|28.02.2009|R|A|4|0|0|B|0|ACA|0|0|0|100|IKR|||lyfalmen|||00|100|0|133|Actavis Group hf|Actavis hf|Atenólól||||| 087304|N05CF0101|Imovane|töflur|7,5|mg|10|stk|1|þpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|1|100|NOK|261|1195|lyfalmen|||00|10|0|10|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||261||261|1195 087312|N05CF0101|Imovane|töflur|7,5|mg|30|stk|1|þpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|230|1152|lyfalmen|||00|30|0|30|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||230||230|1152 087320|N05CF0101|Imovane|töflur|7,5|mg|100|stk|1|þpakki||N05CF01|01.10.1995||R|A|3|0|0|0|0|SNO|0|0|0|100|NOK|2719|4530|lyfalmen|||00|100|0|100|Vistor hf|Sanofi-aventis Norge AS|Zópíklón||2719||2719|4530 087445|A02BX1301|Gaviscon|mixtúra|0| |500|ml|1|glas||A02BX13|01.08.1984||L|A|2|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||01|500|0|0|Vistor hf|Nordic Drugs AB|Algínsýra||||| 087759|G03GB0202|Pergotime|töflur|50|mg|5|stk|1|þpakki||G03GB02|01.07.1986||R|A|5|0|0|E|0|EME|0|0|0|100|SEK|733|1835|lyfalmen|||00|5|0|28|MedFarm ehf|E. Merck AB|Klómífen||733||733|1835 087760|N07BA0129|Nicorette Freshmint (Lyfjaver)|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|105|0|7|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 087769|N07BA0129|Nicorette Freshmint (Lyfjaver)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.06.2004||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|210|0|14|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 087778|N07BA0129|Nicorette Freshmint (Lyfjaver)|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|105|0|14|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 087787|N07BA0129|Nicorette Freshmint (Lyfjaver)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|210|0|28|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 087796|N07BA0130|Nicorette Fruitmint (Lyfjaver)|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|105|0|7|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 087805|N07BA0130|Nicorette Fruitmint (Lyfjaver)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|210|0|14|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 087814|N07BA0130|Nicorette Fruitmint (Lyfjaver)|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||23|105|0|14|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 087823|N07BA0130|Nicorette Fruitmint (Lyfjaver)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|210|0|28|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 087832|L02BB0304|Bicalutamid Actavis|filmhtfl|50|mg|30|stk|1|þpakki||L02BB03|01.09.2007||R|A|3|0|0|*|0|AGP|0|0|0|100|XEU|15239|21158|lyfalmen|V0560|21158|00|30|0|30|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíð||15239||15239|21158 087932|A02BX1301|Gaviscon|tuggutfl|0| |20|stk|1|þpakki||A02BX13|01.10.1993||L|A|1,5|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||00|20|0|0|Vistor hf|Nordic Drugs AB|Algínsýra||||| 088006|N07BA0126|Nicotinell Mint (Lyfjaver)|tyggigúm|2|mg|96|stk|1|þpakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|96|0|6|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 088015|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|2|mg|96|stk|1|pakki||N07BA01|01.06.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|96|0|6|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 088051|L03AB0503|IntronA (Lyfjaver)|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.06.2007||R|K|1,25|0|1|0|1|LVR|0|0|0|100|NOK|25365|33447|lyfsjukr|||00|1|0|9|Lyfjaver ehf|Lyfjaver ehf|Interferón alfa-2b||25365||25365|33447 088224|L03AB0503|IntronA (Lyfjaver)|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.06.2007||R|K|1,25|0|1|0|1|LVR|0|0|0|100|NOK|41315|53305|lyfsjukr|||00|1|0|15|Lyfjaver ehf|Lyfjaver ehf|Interferón alfa-2b||41315||41315|53305 088233|L03AB0503|IntronA (Lyfjaver)|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.06.2007||R|K|1,25|0|1|0|1|LVR|0|0|0|100|NOK|84567|107153|lyfsjukr|||00|1|0|30|Lyfjaver ehf|Lyfjaver ehf|Interferón alfa-2b||84567||84567|107153 088261|R01AD1201|Avamys|nefúði|27,5|mcg/sk|120|sk|1|glas||R01AD12|01.04.2008||R|A|3|0|0|E|0|GGL|0|0|1|100|GBP|1282|2580|lyfalmen|||00|120|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|Flútíkasón fúróat||1282||1282|2580 088310|M01AX0101|Relifex|lausnart|1|g|20|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|1541|2932|lyfalmen|||14|20|0|20|Vistor hf|Meda AB|Nabúmeton||1541||1541|2932 088328|M01AX0101|Relifex|lausnart|1|g|100|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|7640|11208|lyfalmen|||14|100|0|100|Vistor hf|Meda AB|Nabúmeton||7640||7640|11208 088393|A03FA0101|Primperan|eþ-stil|20|mg|6|stk|1|pakki||A03FA01|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|477|1488|lyfalmen|||04|6|0|4|Vistor hf|Sanofi-aventis Norge AS|Metóklópramíð||477||477|1488 088632|C09CA0302|Diovan (D.A.C.)|töflur|160|mg|98|stk|1|þpakki|filmuhúðaðar töflur|C09CA03|01.05.2007||R|A|3|0|0|B|0|DAC|0|0|0|100|DKK|15411|17267|lyfalmen|V1111|14055|00|98|0|196|D.A.C. ehf|D.A.C. ehf|Valsartan||12114||12114|17267 088723|L01XE0701|Tyverb|filmhtfl|250|mg|70|stk|1|þpakki||L01XE07|01.11.2008||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|158317|198972|lyfsjukr|||00|70|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|||||158317|198972 088814|L02BB0304|Bicalutamid Actavis|filmhtfl|150|mg|30|stk|1|þpakki||L02BB03|01.12.2008||R|A|3|0|0|*|0|AGP|0|0|0|100|XEU|50716|54161|lyfalmen|V0561|54161|00|30|0|30|Actavis Group hf|Actavis Group PTC ehf|Bíkalútamíð||41748||41748|54161 089003|G03CA0308|Progynon|töflur|2|mg|84|stk|1|þpakki||G03CA03|01.12.1972||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|1224|2501|lyfalmen|V0408|2082|00|84|0|84|Icepharma hf|Bayer Schering Pharma AG|Estradíól||1224||1224|2501 089094|A02BX1301|Gaviscon|tuggutfl|0| |120|stk|1|þpakki||A02BX13|01.01.1989||L|A|1,5|0|0|0|0|NDR|0|0|0|100|IKR|||lyflausa|||00|120|0|0|Vistor hf|Nordic Drugs AB|Algínsýra||||| 089114|J05AX0901|Celsentri|filmhtfl|300|mg|60|stk|1|þpakki||J05AX09|01.04.2008||R|A|3|0|1|0|1|PFL|0|0|0|100|DKK|165653|208105|lyfsjukr|||00|60|0|0|Vistor hf|Pfizer Limited|Maravíroc||165653||165653|208105 090159|C08DB0101|Cardizem|töflur|60|mg|100|stk|1|glas||C08DB01|01.10.1995||R|A|3|0|0|B|0|FRO|0|0|0|100|DKK|2139|3743|lyfalmen|V0352|1798|00|100|0|25|Vistor hf|Ferrosan A/S|Diltíazem||2139||2139|3743 090232|L01XC0601|Erbitux|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.04.2007||R|K|3|0|1|0|1|MRK|0|0|0|100|XEU|41892|54023|lyfsjukr|||00|20|0|0|Vistor hf|Merck KgaA (V)|Cetúxímab||41892||41892|54023 090242|L01XC0601|Erbitux|irl|5|mg/ml|100|ml|1|hgl|lausn|L01XC06|01.04.2007||R|K|3|0|1|0|1|MRK|0|0|0|100|XEU|209458|262643|lyfsjukr|||00|100|0|0|Vistor hf|Merck KgaA (V)|Cetúxímab||209458||209458|262643 090460|L04AB0102|Enbrel (Lyjaver)|stl|0| |25|mg|4|áf.spr|lausn|L04AB01|01.06.2007||R|K|3|0|1|0|1|LVR|0|0|0|100|NOK|82601|104706|lyfsjukr|||00|100|0|14|Lyfjaver ehf|Lyfjaver ehf|Etanercept||82601||82601|104706 090469|L04AB0102|Enbrel (Lyjaver)|stl|0| |50|mg|4|áf.spr|lausn|L04AB01|01.06.2007||R|K|3|0|1|0|1|LVR|0|0|0|100|NOK|172238|216304|lyfsjukr|||00|200|0|29|Lyfjaver ehf|Lyfjaver ehf|Etanercept||172238||172238|216304 090662|R01AD1101|Nasacort|nefúði|55|mcg/sk|16,5|ml|1|stauk|120 sk|R01AD11|01.11.1998||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|1805|3290|lyfalmen|||24|16|0|30|Vistor hf|Sanofi-aventis Norge AS|Tríamcínólón||1805||1805|3290 090688|A06AB0602|Senokot|töflur|7,5|mg|60|stk|1|þpakki||A06AB06|01.10.1990||R|A|3|0|0|0|0|REB|0|0|0|100|GBP|384|1361|lyfalmen|||00|60|0|0|Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Senna||384||384|1361 091360|C08DB0108|Korzem-R|forðatfl|120|mg|60|stk|1|þpakki||C08DB01|01.04.2008||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2253|3898|lyfalmen|V0351|3898|10|60|0|30|Actavis Group hf|Actavis hf|Diltíazem||2253||2253|3898 091642|L03AX1302|Copaxone (Lyfjaver)|stl|20|mg/spr|28|spr|1|pakki|lausn|L03AX13|01.06.2007||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|135700|170814|lyfsjukr|||00|28|0|0|Lyfjaver ehf|Lyfjaver ehf|Glatíramer acetat||135700||135700|170814 091751|A10BB1201|Amaryl|töflur|1|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|1770|2263|lyfalmen|V0001|1884|00|90|0|45|Vistor hf|Aventis Pharma |Glímepíríð||1048||1048|2263 091769|A10BB1201|Amaryl|töflur|2|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|3185|3097|lyfalmen|V0002|2489|00|90|0|90|Vistor hf|Aventis Pharma |Glímepíríð||1663||1663|3097 092005|N06AB1001 |Cipralex|dropar|20|mg/ml|15|ml|1|glerfl||N06AB10|01.04.2009||R|A|2|0|0|0|0|LBK|0|0|0|100|DKK|3968|6225|lyfalmen|||00|15|0|30|Lundbeck Export A/S|H. Lundbeck A/S|Escítalópram||||3968|6225 092014|L03AB0703|Rebif (Lyfjaver)|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.06.2007||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|135718|170836|lyfsjukr|||00|6|0|61|Lyfjaver ehf|Lyfjaver ehf|Interferón beta-1a||135718||135718|170836 092024|L03AB0703|Rebif (Lyfjaver)|stl|44|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.06.2007||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|174767|219452|lyfsjukr|||00|6|0|123|Lyfjaver ehf|Lyfjaver ehf|Interferón beta-1a||174767||174767|219452 092130|QJ01CA0401|Clamoxyl, vet.|töflur|200|mg|100|stk|1|þpakki||QJ01CA04|01.10.1987||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|7494|14446|vetalmen|||16|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||7494||7494|14446 092361|B01AC0401|Plavix|töflur|75|mg|28|stk|1|þpakki||B01AC04|01.12.1999||R|A|3|0|0|E|0|SBM|0|0|0|100|NOK|7392|10872|lyfalmen|||00|28|0|28|Vistor hf|Sanofi Pharma Bristol Meyer Squibb|Klópídógrel||7392||7392|10872 092750|N05AH0203|Leponex (D.A.C.)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2007||R|A|5|0|0|*|0|DAC|0|1|0|100|DKK|10554|15163|lyfalmen|V1400|15163|00|100|0|33|D.A.C. ehf|D.A.C. ehf|Klózapín||||10554|15163 092769|C09DA0305|Diovan Comp 320/12,5 mg|filmhtfl|332,5|mg|98|stk|1|þpakki|320/12,5 mg|C09DA03|01.11.2008||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|27143|35978|lyfalmen|||00|98|0|392|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||||27143|35978 092787|C09DA0306|Diovan Comp 320/25 mg|filmhtfl|345|mg|98|stk|1|þpakki|320/25 mg|C09DA03|01.11.2008||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|27143|35978|lyfalmen|||00|98|0|392|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||||27143|35978 093260|N02CC0101|Imigran|stl|12|mg/ml|0,5|ml|2|spr|+ penni|N02CC01|01.10.1992||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|5079|7733|lyfalmen|||00|1|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||5079||5079|7733 093496|A07EC0204|Asacol|sh-tfl|800|mg|60|stk|1|þpakki||A07EC02|01.01.2003||R|A|2|0|0|B|0|TIL|0|0|0|100|SEK|6303|9394|lyfalmen|||00|60|0|32|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||6303||6303|9394 093617|QG03DA0202|Veramix, vet.|sk-svamp|60|mg|1|stk|100|stk||QG03DA02|01.10.1991||R|A|5|0|0|0|0|PAL|1|0|0|100|DKK|27103|46903|vetorma|||00|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||27103||27103|46903 093625|B03AA0702|Ferlen-R|forðatfl|100|mg|100|stk|1|glas||B03AA07|01.04.1993||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||10|100|0|50|Actavis Group hf|Actavis hf|Ferrósúlfat||||| 093708|L01DB0701|Novantrone|irþ|2|mg/ml|5|ml|1|hgl||L01DB07|01.07.1987||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|16175|22005|lyfsjukr|||00|5|0|0|Icepharma hf|Wyeth AB|Mítoxantrón||16175||16175|22005 093757|N02AA0501|Oxycontin|forðatfl|80|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|18154|24787|lyfalmen|||10|28|0|30|Icepharma hf|Norpharma |Oxýcódon||18154||18154|24787 093799|N02AA0501|Oxycontin|forðatfl|80|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|59854|76703|lyfalmen|||10|98|0|261|Icepharma hf|Norpharma |Oxýcódon||59854||59854|76703 093823|S01EC0102|Diamox Depot|forðahlk|250|mg|100|stk|1|hylki||S01EC01|01.04.1998||R|A|2|0|0|*|0|GPL|0|0|0|100|USD|2109|3702|lyfalmen|||10|100|0|33|Icepharma hf|Goldshield Pharmaceuticals Ltd|Acetazólamíð||2109||2109|3702 093824|N06AB0403|Cipramil (D.A.C.)|filmhtfl|20|mg|28|stk|1|þpakki||N06AB04|01.03.2009||R|A|3|0|0|B|0|DAC|0|1|0|100|DKK|3258|3598|lyfalmen|V0923|2562|0|28|0|28|D.A.C. ehf|D.A.C. ehf|Cítalópram||2032||2032|3598 093849|S01EC0102|Diamox Depot|forðahlk|500|mg|100|stk|1|hylki||S01EC01|01.12.1972||R|A|2|0|0|*|0|GPL|0|0|0|100|USD|4218|6564|lyfalmen|||10|100|0|67|Icepharma hf|Goldshield Pharmaceuticals Ltd|Acetazólamíð||4218||4218|6564 093969|G03FB0507|Trisekvens (D.A.C.)|töflur|0| |84|stk|1|skífup||G03FB05|01.05.2007||R|A|4|0|0|E|0|DAC|0|0|0|100|DKK|2686|4485|lyfalmen|V0385|4485|23|84|0|84|D.A.C. ehf|D.A.C. ehf|Noretísterón og östrógen||2686||2686|4485 094132|QM01A0001|Metacam fyrir ketti|mixtúra|0,5|mg/ml|15|ml|1|fl||QM01AC06|01.01.2009||R|A|3|0|0|0|0|BOI|0|0|0|100|DKK|1826|3603|vetalmen|||00|8|0|0|Vistor hf|Boehringer Ingelheim|||1826||1826|3603 094287|L04AD0201|Advagraf|forðahlk|0,5|mg|50|stk|1|þpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|13329|18780|lyfalmen|||00|50|0|5|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||13329||13329|18780 094296|L04AD0201|Advagraf|forðahlk|1|mg|50|stk|1|þpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|19092|25955|lyfalmen|||00|50|0|10|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||19092||19092|25955 094305|L04AD0201|Advagraf|forðahlk|5|mg|50|stk|1|þpakki||L04AD02|01.10.2007||R|A|3|0|1|*|0|APE|0|0|0|100|XEU|85909|109142|lyfalmen|||00|50|0|10|Vistor hf|Astellas Phama Europe B.V.|Tacrolimus||85909||85909|109142 094933|A03000001|Relistor|stl|20|mg/ml|0,6|ml|7|hgl|lausn|A03|01.01.2009||R|A|2|0|0|0|0|WTE|0|0|0|100|USD|44984|58190|lyfalmen|||0|84|0|0|Icepharma hf|Wyeth Europe|||44984||44984|58190 095208|G04BX0101|Emgesan|töflur|250|mg|100|stk|1|glas||G04BX01|01.03.2001||R|A||0|0|0|0|PCO|0|0|0|100|IKR|1577|2980|lyfalmen|||00|100|1|50|Distica|Distica - óskráð lyf|||1577||1577|2980 095588|N07BB0101|Antabus|freyðit|400|mg|50|stk|1|glas||N07BB01|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|0|100|DKK|3389|5439|lyfalmen|||00|50|0|100|Actavis Group hf|Actavis Group hf|Dísúlfíram||3389||3389|5439 095652|N05AX1301|Invega|forðatfl|3|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|14905|20742|lyfalmen|||00|28|0|0|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||14905||14905|20742 095662|N05AX1301|Invega|forðatfl|3|mg|56|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|35895|46874|lyfalmen|||00|56|0|0|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||35895||35895|46874 095680|N05AX1301|Invega|forðatfl|6|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|14905|20742|lyfalmen|||00|28|0|0|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||14905||14905|20742 095689|N05AX1301|Invega|forðatfl|6|mg|56|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|32527|42681|lyfalmen|||00|56|0|0|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||32527||32527|42681 095707|N05AX1301|Invega|forðatfl|9|mg|28|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|14905|20742|lyfalmen|||00|28|0|0|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||14905||14905|20742 095716|N05AX1301|Invega|forðatfl|9|mg|56|stk|1|þpakki||N05AX13|01.02.2008||R|A|2|0|0|*|0|JCI|0|1|0|100|SEK|57270|73486|lyfalmen|||00|56|0|0|Vistor hf|Janssen-Cilag International N.V.|Paliperídón||57270||57270|73486 095924|QM01AE9102|Canidryl|töflur|20|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|3730|7276|vetalmen|||00|100|0|0|Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||3730||3730|7276 095933|QM01AE9102|Canidryl|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|4921|9545|vetalmen|||00|100|0|0|Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||4921||4921|9545 095942|QM01AE9102|Canidryl|töflur|100|mg|100|stk|1|pakki||QM01AE91|01.05.2007||R|A|3|0|0|0|0|CHD|0|0|0|100|XEU|8962|17242|vetalmen|||00|100|0|0|Dýraheilsa/Icevet ehf|Chanelle Pharmaceuticals (D)|||8962||8962|17242 096115|V03AF0101|Uromitexan|stl|100|mg/ml|4|ml|15|lykjur||V03AF01|01.10.1990||R|A|5|0|0|0|1|BAM|0|0|0|100|SEK|2313|3312|lyfsjukr|||02|60|0|0|Icepharma hf|Baxter Medical AB|Mesna||2313||2313|3312 096169|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|1|hgl|0|J06BA01|01.10.2008||R|K|3|0|0|0|1|OCT|0|0|0|100|DKK|14006|19305|lyfsjukr|||17|10|0|0|Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í æð||14006||14006|19305 096178|J06BA0103|Gammanorm|stl|165|mg/ml|10|ml|10|hgl|0|J06BA01|01.10.2008||R|K|3|0|0|0|1|OCT|0|0|0|100|DKK|140058|176240|lyfsjukr|||17|100|0|0|Vistor hf|Octapharma AB|Immúnóglóbúlín, normal, manna, sem ekki eru gefin í æð||140058||140058|176240 096251|D06AX1301|Altargo|smyrsli|1|%|5|g|1|túpa||D06AX13|01.11.2007||R|A|2|0|0|0|0|GGL|0|0|1|100|GBP|1360|2686|lyfalmen|||00|5|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|Retapamúlín||1360||1360|2686 096260|N06DA0301|Exelon|forðapl|4,6|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|16470|22690|lyfalmen|||00|30|0|0|Vistor hf|Novartis Europharm Ltd|Rívastigmín||16470||16470|22690 096351|S01AA1302|Fucithalmic (D.A.C.)|augndr|10|mg/g|5|g|1|túpa||S01AA13|01.06.2007||R|A|3|0|0|E|0|DAC|0|0|1|100|DKK|809|1816|lyfalmen|V1500|1816|07|5|0|0|D.A.C. ehf|D.A.C. ehf|Fúsidínsýra||719||719|1816 096488|L04AX0401|Revlimid|hylki|5|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|A|2|0|1|0|1|CEE|0|0|0|100|XEU|993265|1238482|lyfsjukr|||0|21|0|0|Celgene Europe ltd|Celgene Europe ltd|||||993265|1238482 096497|L04AX0401|Revlimid|hylki|10|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|A|2|0|1|0|1|CEE|0|0|0|100|XEU|911977|1137279|lyfsjukr|||0|21|0|0|Celgene Europe ltd|Celgene Europe ltd|||||911977|1137279 096506|L04AX0401|Revlimid|hylki|15|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|A|2|0|1|0|1|CEE|0|0|0|100|XEU|959679|1196668|lyfsjukr|||0|21|0|0|Celgene Europe ltd|Celgene Europe ltd|||||959679|1196668 096515|L04AX0401|Revlimid|hylki|25|mg|21|stk|1|þpakki|hart|L04AX04|01.03.2009||R|A|2|0|1|0|1|CEE|0|0|0|100|XEU|1053805|1313855|lyfsjukr|||0|21|0|0|Celgene Europe ltd|Celgene Europe ltd|||||1053805|1313855 096679|N06DA0301|Exelon|forðapl|9,5|mg/sólh|30|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|16470|22690|lyfalmen|||00|30|0|0|Vistor hf|Novartis Europharm Ltd|Rívastigmín||16470||16470|22690 096685|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|30|stk|1|þpakki||C03BA11|01.03.1999||R|A|2|0|0|E|0|SEV|0|0|0|100|DKK|1575|2978|lyfalmen|||00|30|0|18|Icepharma hf|Servier|Indapamíð||1575||1575|2978 096688|N06DA0301|Exelon|forðapl|9,5|mg/sólh|60|pokar|1|pakki||N06DA03|01.01.2008||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|32942|43198|lyfalmen|||00|60|0|0|Vistor hf|Novartis Europharm Ltd|Rívastigmín||32942||32942|43198 096896|J02AX0601|Ecalta|irs|100|mg/hgl|1|hgl|1|pakki|+ leysir, lausn|J02AX06|01.03.2008||R|A|3|0|1|0|1|PFL|0|0|0|100|DKK|90833|114955|lyfsjukr|||00|1|0|0|Vistor hf|Pfizer Limited|Anidulafungin||90833||90833|114955 097269|J01FF0103|Dalacin (D.A.C.)|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.06.2007||R|A|5|0|0|0|0|DAC|0|0|1|100|DKK|3516|3811|lyfalmen|V0426|3811|00|20|0|5|D.A.C. ehf|D.A.C. ehf|Klindamýcín||2189||2189|3811 097288|R06AX2701|Aerius|mixtúra|0,5|mg/ml|120|ml|1|fl||R06AX27|01.10.2008||R|A|2|0|0|E|0|SCP|0|0|1|100|DKK|1138|2385|lyfalmen|||00|120|0|12|Vistor hf|Schering-Plough|Deslóratadín||1138||1138|2385 097297|L02BG0402|Femar (D.A.C.)|töflur|2,5|mg|100|stk|1|þpakki||L02BG04|01.06.2007||R|A|5|0|0|*|0|DAC|0|0|0|100|DKK|63230|80764|lyfalmen|V0563|80764|00|100|0|100|D.A.C. ehf|D.A.C. ehf|Letrózól||63116||63116|80764 097442|L01CB0101|Vepesid|hylki|50|mg|20|stk|1|glas||L01CB01|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|13690|18912|lyfsjukr|||00|20|1|0|Distica|Distica - óskráð lyf|||13690||13690|18912 097642|J07AJ5201|Infanrix|bóluefni|0| |0,5|ml|1|spr|einnota glerspr.|J07AJ52|01.04.1998||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|1690|3134|lyfalmen|||02|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Kíghósti, í blöndum með öðrum toxóíðum||1690||1690|3134 097790|N03AX1201|Neurontin|hylki|300|mg|100|stk|1|þpakki||N03AX12|01.04.1995||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|8932|9379|lyfalmen|V0714|7740|10|100|0|17|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gabapentín||6292||6292|9379 097816|N03AX1201|Neurontin|hylki|400|mg|100|stk|1|þpakki||N03AX12|01.04.1995||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|11701|12307|lyfalmen|V0715|10260|10|100|0|22|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gabapentín||8450||8450|12307 097881|A10BB1201|Amaryl|töflur|3|mg|90|stk|1|þpakki||A10BB12|01.09.1997||R|A|3|0|0|*|0|AVP|0|0|0|100|NOK|4135|3823|lyfalmen|V0003|3042|00|90|0|135|Vistor hf|Aventis Pharma |Glímepíríð||2198||2198|3823 097887|N02CC0104|Sumacta|húðuðtfl|50|mg|12|stk|1|þpakki||N02CC01|01.11.2007||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|2738|4556|lyfalmen|V0831|4556|00|12|0|12|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||2738||2738|4556 097896|N02CC0104|Sumacta|húðuðtfl|100|mg|6|stk|1|þpakki||N02CC01|01.11.2007||R|A|3|0|0|E|0|AGP|0|0|0|100|IKR|1917|3442|lyfalmen|V0832|3442|00|6|0|12|Actavis Group hf|Actavis Group PTC ehf|Súmatriptan||1917||1917|3442 097905|N06AX1104|Miron Smelt|munndr.t|15|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|A|2|0|0|B|0|AGP|0|1|0|100|XEU|1519|2902|lyfalmen|V1151|2902|00|30|0|15|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||1519||1519|2902 098059|C09CA0303|Valpress|filmhtfl|80|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|A|2|0|0|B|0|ACA|0|0|0|100|XEU|6728|9971|lyfalmen|V1110|9971|00|98|0|98|Actavis Group hf|Actavis hf|Valsartan||6728||6728|9971 098068|C09CA0303|Valpress|filmhtfl|160|mg|98|stk|1|þpakki||C09CA03|01.12.2007||R|A|2|0|0|B|0|ACA|0|0|0|100|XEU|9738|14055|lyfalmen|V1111|14055|00|98|0|196|Actavis Group hf|Actavis hf|Valsartan||9738||9738|14055 098228|J07AJ5201|Infanrix|bóluefni|0| |0,5|ml|10|spr|einnota glerspr.|J07AJ52|01.04.1998||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|16439|22652|lyfalmen|||02|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Kíghósti, í blöndum með öðrum toxóíðum||16439||16439|22652 098459|N06AB0309 |Fontex (D.A.C.)|dreifit.|20|mg|30|stk|1|þpakki||N06AB03|01.05.2009||R|A|2|0|0|B|0|DAC|0|1|0|100|XEU|3247|5247|lyfalmen|||00|30|0|30|D.A.C. ehf|D.A.C. ehf|Flúoxetín||||3247|5247 098468|N06AB0309 |Fontex (D.A.C.)|dreifit.|20|mg|100|stk|1|þpakki||N06AB03|01.05.2009||R|A|2|0|0|B|0|DAC|0|1|0|100|XEU|10804|15502|lyfalmen|||00|100|0|100|D.A.C. ehf|D.A.C. ehf|Flúoxetín||||10804|15502 098486|G03GA002|Pergoveris|sts|225|ae|1|hgl|1|pakki|+ leysir|G03GA00|01.03.2009||R|A|3|0|1|E|0|SEE|0|0|0|100|SEK|11579|16554|lyfalmen|||0|1|0|0|Gróco ehf|Serono Europe|||||11579|16554 098504|G03GA002|Pergoveris|sts|225|ae|10|hgl|1|pakki|+ leysir|G03GA00|01.03.2009||R|A|3|0|1|E|0|SEE|0|0|0|100|SEK|107412|135913|lyfalmen|||0|1|0|0|Gróco ehf|Serono Europe|||||107412|135913 098582|S01ED0201|Betoptic|augndr|5|mg/ml|5|ml|1|glas||S01ED02|01.04.2006||R|A|3|0|0|*|0|PCO|0|0|0|100|IKR|1186|2450|lyfalmen|||06|5|1|25|Distica|Distica - óskráð lyf|||1186||1186|2450 098722|J07BM0101|Gardasil|stl|0| |0,5|ml|1|áf.spr|dreifa|J07BM01|01.08.2008||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|20720|27981|lyfalmen|||02|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Papillomavírus (manna gerð 6, 11, 16, 18)||20720||20720|27981 099242|S01AA1301|Fucithalmic|augndr|10|mg/g|5|g|1|túpa||S01AA13|01.04.1988||R|A|3|0|0|E|0|LEP|0|0|1|100|DKK|732|1834|lyfalmen|V1500|1816|07|5|0|0|Vistor hf|LEO Pharma A/S|Fúsidínsýra||732||732|1834 099476|N05AH0404|Quetiapin Merck NM|filmhtfl|25|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MEK|0|1|0|100|SEK|5151|7831|lyfalmen|V0725|7831|00|100|0|6|Actavis Group PTC ehf|Merck NM AB (A)|Quetíapín||5151||5151|7831 099485|N05AH0404|Quetiapin Merck NM|filmhtfl|100|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MEK|0|1|0|100|SEK|11763|16803|lyfalmen|V0726|16803|00|100|0|25|Actavis Group PTC ehf|Merck NM AB (A)|Quetíapín||11763||11763|16803 099494|N05AH0404|Quetiapin Merck NM|filmhtfl|200|mg|100|stk|1|þpakki||N05AH04|01.03.2008||R|A|2|0|0|*|0|MEK|0|1|0|100|SEK|19035|25884|lyfalmen|V0727|25884|00|100|0|50|Actavis Group PTC ehf|Merck NM AB (A)|Quetíapín||19035||19035|25884 099620|N02AX0210|Nobligan (D.A.C.)|hylki|50|mg|20|stk|1|pakki||N02AX02|01.09.2007||R|A|5|0|0|E|0|DAC|0|0|1|100|DKK|584|1633|lyfalmen|V0730|1238|10|20|0|3|D.A.C. ehf|D.A.C. ehf|Tramadól||584||584|1633 099705|D08AG0201|Betadine|áburður|100|mg/ml|500|ml|1|brusar|vatnsl|D08AG02|01.04.1985||L|A|3|0|0|0|0|MUN|0|0|0|100|IKR|||lyflausa|||00|500|0|500|Icepharma hf|Mundipharma|Joð/pólývídón||||| 099721|D08AG0201|Betadine|lyf.sápa|75|mg/ml|500|ml|1|brusar||D08AG02|01.04.1985||L|A|3|0|0|0|0|MUN|0|0|0|100|IKR|||lyflausa|||00|500|0|500|Icepharma hf|Mundipharma|Joð/pólývídón||||| 099746|N07BA0125|Nicotinell Fruit (Lyfjaver)|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.09.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|96|0|13|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 099755|N07BA0124|Nicotinell Mint (Lyfjaver)|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.09.2007||L|A|2|0|0|0|0|LVR|0|0|1|100|IKR|||lyflausa|||00|96|0|13|Lyfjaver ehf|Lyfjaver ehf|Nikótín||||| 100008|V08AB0501|Ultravist|stl/irl|300|mg J/ml|50|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|43145|55583|lyfsjukr|||02|500|0|0|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||43145||43145|55583 100016|V08AB0501|Ultravist|stl/irl|300|mg J/ml|100|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|63868|81383|lyfsjukr|||02|1000|0|0|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||63868||63868|81383 100024|V08AB0501|Ultravist|stl/irl|370|mg J/ml|50|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|46717|60030|lyfsjukr|||02|500|0|0|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||46717||46717|60030 100032|V08AB0501|Ultravist|stl/irl|370|mg J/ml|100|ml|10|hgl||V08AB05|01.04.1987||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|103729|131010|lyfsjukr|||02|1000|0|0|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||103729||103729|131010 100291|G04BE0801|Cialis|filmhtfl|2,5|mg|28|stk|1|þpakki||G04BE08|01.11.2008||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|13438|18915|lyfalmen|||00|28|0|7|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||13438|18915 100300|G04BE0801|Cialis|filmhtfl|5|mg|28|stk|1|þpakki||G04BE08|01.11.2008||R|A|2|0|0|0|0|LIL|0|0|0|100|XEU|13438|18915|lyfalmen|||00|28|0|14|Icepharma hf|Lilly ICOS Limited|Tadalafíl||||13438|18915 100305|G03GA0701|Luveris|sts|75|ae/hgl|1|hgl|1|pakki|+ leysir í hgl|G03GA07|01.08.2001||R|A|3|0|1|E|0|ARS|0|0|0|100|SEK|12475|17716|lyfalmen|||00|1|0|1|Gróco ehf|Ares-Serono|Lutropin alfa||12475||12475|17716 100412|M01AC0101|Felden|töflur|20|mg|30|stk|1|þpakki||M01AC01|01.01.1997||R|A|4|0|0|E|0|PFI|0|0|1|100|DKK|2089|3675|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Píroxíkam||2089||2089|3675 101106|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|17559|24046|lyfalmen|V2160|23608|0|100|0|33|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gabapentín||17559||17559|24046 101115|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.03.2009||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|29599|39036|lyfalmen|||0|100|0|44|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gabapentín||29599||29599|39036 101386|R06AX1301|Clarityn|mixtúra|1|mg/ml|100|ml|1|glas||R06AX13|01.10.1995||L|A|3|0|0|0|0|SCP|0|0|1|100|IKR|||lyflausa|||00|100|0|10|Vistor hf|Schering-Plough|Lóratadín||||| 101543|G03GA0701|Luveris|sts|75|ae/hgl|3|hgl|1|pakki|+ leysir í hgl|G03GA07|01.08.2001||R|A|3|0|1|E|0|ARS|0|0|0|100|SEK|37424|48778|lyfalmen|||00|3|0|3|Gróco ehf|Ares-Serono|Lutropin alfa||37424||37424|48778 101550|G03GA0701|Luveris|sts|75|ae/hgl|10|hgl|1|pakki|+ leysir í hgl|G03GA07|01.08.2001||R|A|3|0|1|E|0|ARS|0|0|0|100|SEK|124750|157499|lyfalmen|||00|10|0|10|Gróco ehf|Ares-Serono|Lutropin alfa||124750||124750|157499 101691|C08CA0502|Adalat Oros|forðatfl|20|mg|28|stk|1|þpakki||C08CA05|01.10.1999||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|1862|3367|lyfalmen|||00|28|0|19|Vistor hf|Bayer HealthCare AG|Nífedipín||1862||1862|3367 101709|C08CA0502|Adalat Oros|forðatfl|20|mg|98|stk|1|þpakki||C08CA05|01.10.1999||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|5843|8770|lyfalmen|||00|98|0|65|Vistor hf|Bayer HealthCare AG|Nífedipín||5843||5843|8770 101742|N06AX1104|Miron Smelt|munndr.t|30|mg|30|stk|1|þpakki||N06AX11|01.11.2007||R|A|2|0|0|B|0|AGP|0|1|0|100|XEU|2467|4188|lyfalmen|V1152|4188|00|30|0|30|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||2467||2467|4188 101751|N06AX1104|Miron Smelt|munndr.t|30|mg|96|stk|1|þpakki||N06AX11|01.11.2007||R|A|2|0|0|B|0|AGP|0|1|0|100|XEU|8779|12754|lyfalmen|V1153|12754|00|96|0|96|Actavis Group hf|Actavis Group PTC ehf|Mirtazapín||8779||8779|12754 101769|N02AX0211|Nobligan Retard (D.A.C.)|forðatfl|150|mg|100|stk|1|þpakki||N02AX02|01.09.2007||R|A|5|0|0|E|0|DAC|0|0|1|100|DKK|9008|13065|lyfalmen|V0736|10573|00|100|0|50|D.A.C. ehf|D.A.C. ehf|Tramadól||9008||9008|13065 101823|QM01AC0602|Metacam fyrir hesta|mixtúra|15|mg/ml|250|ml|1|fl||QM01AC06|01.02.2009||R|A|2|0|0|0|0|BOI|0|0|0|100|DKK|11265|21629|vetalmen|||0|250|0|0|Vistor hf|Boehringer Ingelheim|||||11265|21629 102863|C01DA1401|Imdur|forðatfl|60|mg|28|stk|1|þpakki||C01DA14|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|1357|2682|lyfalmen|||43|28|0|42|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||1357||1357|2682 102871|C01DA1401|Imdur|forðatfl|60|mg|98|stk|1|þpakki||C01DA14|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3106|5055|lyfalmen|V0139|2746|43|98|0|147|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||3106||3106|5055 102905|N01AX1001|Diprivan|stl|10|mg/ml|50|ml|1|dæla|einnota dæla|N01AX10|01.01.1994||R|A|2|0|0|0|1|ASZ|0|0|0|100|SEK|2167|3103|lyfsjukr|||02|50|0|0|Vistor hf|AstraZeneca UK Ltd|Própófól||2167||2167|3103 102939|N01AX1001|Diprivan|stl|20|mg/ml|50|ml|1|dæla|einnota dæla|N01AX10|01.01.1988||R|A|2|0|0|0|1|ASZ|0|0|0|100|SEK|4496|6437|lyfsjukr|||00|50|0|0|Vistor hf|AstraZeneca UK Ltd|Própófól||4496||4496|6437 103633|C09DA0105|Presmin Combo|filmhtfl|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.02.2008||R|A|1,25|0|0|B|0|POF|0|0|0|100|XEU|7253|9525|lyfalmen|V0198|9525|00|98|0|98|PortFarma ehf|PortFarma |Lósartan og þvagræsilyf||6400||6400|9525 103642|C09DA0105|Presmin Combo|filmhtfl|125|mg|98|stk|1|þpakki|100+25 mg|C09DA01|01.02.2008||R|A|1,25|0|0|B|0|POF|0|0|0|100|XEU|12008|15220|lyfalmen|V0193|15220|00|98|0|196|PortFarma ehf|PortFarma |Lósartan og þvagræsilyf||10596||10596|15220 103651|C09CA0104|Presmin|filmhtfl|50|mg|98|stk|1|þpakki||C09CA01|01.02.2008||R|A|2|0|0|B|0|POF|0|0|0|100|IKR|4295|5469|lyfalmen|V0197|5469|00|98|0|98|PortFarma ehf|PortFarma |Lósartan||3411||3411|5469 103660|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.02.2008||R|A|3|0|0|E|0|POF|0|0|1|100|GBP|2374|3597|lyfalmen|V0507|3597|00|10|0|2|PortFarma ehf|PortFarma |Valacíklóvír||2031||2031|3597 103669|J05AB1103|Valaciklovir Portfarma|töflur|500|mg|40|stk|1|þpakki||J05AB11|01.02.2008||R|A|3|0|0|E|0|POF|0|0|1|100|GBP|9870|12283|lyfalmen|V0508|12244|00|40|0|7|PortFarma ehf|PortFarma |Valacíklóvír||8432||8432|12283 103678|N06AX1604|Venlafaxin Portfarma|forðahlk|75|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|A|3|0|0|B|0|POF|0|1|0|100|USD|14761|18547|lyfalmen|V0955|18547|00|100|0|75|PortFarma ehf|PortFarma |Venlafaxín||13142||13142|18547 103687|N06AX1604|Venlafaxin Portfarma|forðahlk|150|mg|100|stk|1|þpakki||N06AX16|01.12.2007||R|A|3|0|0|B|0|POF|0|1|0|100|USD|28093|33324|lyfalmen|V0956|33324|00|100|0|150|PortFarma ehf|PortFarma |Venlafaxín||25011||25011|33324 103937|A06AG0201|Toilax|innhl|2|mg/ml|5|ml|5|túpa||A06AG02|01.12.1975||L|A|2|0|0|0|0|ERC|0|0|0|100|DKK|||lyfalmen|||56|25|0|5|Vistor hf|Orion Pharma|Bisakódýl|||||1784 103952|A06AG0201|Toilax|innhl/tf|0| |1|stk|1|pakki|túpa+4 tfl|A06AG02|01.12.1972||L|A|2|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||00|1|0|1|Vistor hf|Orion Pharma|Bisakódýl||||| 104034|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|13480|18650|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||13480||13480|18650 104179|N06AB0603|Zoloft (D.A.C.)|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.05.2009||R|A|5|0|0|B|0|DAC|0|1|0|30|DKK|11916|17011|lyfalmen|V0933|6361|00|98|0|98|D.A.C. ehf|D.A.C. ehf|Sertralín||||11916|17011 104471|H01BA0201|Minirin|nefdr|0,1|mg/ml|2,5|ml|1|glas|+2 slöngur|H01BA02|01.01.1988||R|K|3|0|0|E|0|FEL|0|0|0|100|DKK|3799|5996|lyfalmen|||23|2|0|10|Vistor hf|Ferring Lægemidler A/S|Desmópressín||3799||3799|5996 104498|N05CH0101|Circadin|forðatfl|2|mg|21|stk|1|þpakki||N05CH01|01.11.2007||R|A|5|0|0|0|0|NEU|0|0|1|100|DKK|2622|4399|lyfalmen|||00|21|0|0|Gróco ehf|Neurim Pharmaceuticals EEC Ltd|Melatonin||2622||2622|4399 104760|A07EC0202|Pentasa|eþ-stil|1|g|28|stk|1|pakki||A07EC02|01.07.1991||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|9585|13848|lyfalmen|||04|28|0|19|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||9585||9585|13848 104836|A07EC0202|Pentasa|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.01.1990||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|5562|8388|lyfalmen|||56|700|0|5|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||5562||5562|8388 104851|A07EC0202|Pentasa|forðatfl|500|mg|100|stk|1|þpakki||A07EC02|01.04.1992||R|A|3|0|0|B|0|FER|0|0|0|100|DKK|6814|10087|lyfalmen|||10|100|0|33|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||6814||6814|10087 105023|V08AB0901|Visipaque|stl|270|mg J/ml|20|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|5432|7777|lyfsjukr|||02|200|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||5432||5432|7777 105278|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|28|stk|1|veski||A02BC05|01.09.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|3736|5910|lyfalmen|V0084|5910|00|28|0|19|D.A.C. ehf|D.A.C. ehf|Esómeprazól||3736||3736|5910 105287|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|56|stk|1|veski||A02BC05|01.09.2007|31.03.2009|R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|6964|10291|lyfalmen|||0|56|0|37|D.A.C. ehf|D.A.C. ehf|Esómeprazól||6964||6964|10291 105297|A02BC0505|Nexium (D.A.C.)|sh-tfl|20|mg|100|stk|1|glas||A02BC05|01.09.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|13015|18389|lyfalmen|V0087|18389|00|100|0|67|D.A.C. ehf|D.A.C. ehf|Esómeprazól||13015||13015|18389 105306|A02BC0505|Nexium (D.A.C.)|sh-tfl|40|mg|100|stk|1|glas||A02BC05|01.09.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|SEK|17570|24060|lyfalmen|V0089|24060|00|100|0|133|D.A.C. ehf|D.A.C. ehf|Esómeprazól||17570||17570|24060 105315|G03AA0705 |Microgynon (D.A.C.)|töflur|0||63|stk|1|þpakki||G03AA07|01.05.2009||R|A|5|0|0|0|0|DAC|0|0|0|100|SEK|1000|2197|lyfalmen|||23|63|0|84|D.A.C. ehf|D.A.C. ehf|Levónorgestrel og östrógen||||1000|2197 105379|N03AG0601|Gabitril|töflur|10|mg|100|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|19857|26907|lyfalmen|||00|100|0|33|Icepharma hf|Cephalon France|Tíagabín||19857||19857|26907 105387|N03AG0601|Gabitril|töflur|15|mg|50|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|16382|22581|lyfalmen|||00|50|0|25|Icepharma hf|Cephalon France|Tíagabín||16382||16382|22581 105395|N03AG0601|Gabitril|töflur|15|mg|100|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|29787|39270|lyfalmen|||00|100|0|50|Icepharma hf|Cephalon France|Tíagabín||29787||29787|39270 105403|N03AG0601|Gabitril|töflur|5|mg|50|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|8191|11956|lyfalmen|||00|50|0|8|Icepharma hf|Cephalon France|Tíagabín||8191||8191|11956 105437|N03AG0601|Gabitril|töflur|5|mg|100|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|14893|20727|lyfalmen|||00|100|0|17|Icepharma hf|Cephalon France|Tíagabín||14893||14893|20727 105445|N03AG0601|Gabitril|töflur|10|mg|50|stk|1|glas||N03AG06|01.01.1997||R|A|3|0|0|E|0|CPF|0|0|0|100|NOK|10921|15661|lyfalmen|||00|50|0|17|Icepharma hf|Cephalon France|Tíagabín||10921||10921|15661 105586|C09XA02|Rasilez|filmhtfl|150|mg|28|stk|1|þpakki||C09XA|01.01.2008||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|4760|7300|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|||4760||4760|7300 105597|C09XA02|Rasilez|filmhtfl|150|mg|98|stk|1|þpakki|2 x 49 töflur|C09XA|01.01.2008||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|14764|20566|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|||14764||14764|20566 105608|C09XA02|Rasilez|filmhtfl|300|mg|28|stk|1|þpakki||C09XA|01.01.2008||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|4760|7300|lyfalmen|||00|28|0|0|Vistor hf|Novartis Europharm Ltd|||4760||4760|7300 105620|C09XA02|Rasilez|filmhtfl|300|mg|98|stk|1|þpakki|2 x 49 töflur|C09XA|01.01.2008||R|A|2|0|0|B|0|NOE|0|0|0|100|DKK|15725|21763|lyfalmen|||00|98|0|0|Vistor hf|Novartis Europharm Ltd|||15725||15725|21763 105785|N01BB0301|Carbocain|stl|10|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2192|3815|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|Mepívakaín||2192||2192|3815 105796|N01BB0301|Carbocain|stl|20|mg/ml|20|ml|5|hgl||N01BB03|01.02.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2387|4080|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|Mepívakaín||2387||2387|4080 106021|J01FA0901|Klacid|töflur|250|mg|14|stk|1|þpakki||J01FA09|01.04.1992||R|A|5|0|0|0|0|ABS|0|0|1|100|DKK|3412|5471|lyfalmen|||63|14|0|7|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||3412||3412|5471 106486|C09AA0207|Enalapril Portfarma|töflur|5|mg|100|stk|1|þpakki||C09AA02|01.01.2009||R|A|2|0|0|B|0|POF|0|0|0|100|IKR|802|1929|lyfalmen|V0167|1929|0|100|0|50|PortFarma ehf|PortFarma|Enalapríl||802||802|1929 106497|C09AA0207|Enalapril Portfarma|töflur|10|mg|100|stk|1|þpakki||C09AA02|01.01.2009||R|A|2|0|0|B|0|POF|0|0|0|100|IKR|1153|2405|lyfalmen|V0168|2405|0|100|0|100|PortFarma ehf|PortFarma|Enalapríl||1153||1153|2405 106508|C09AA0207|Enalapril Portfarma|töflur|20|mg|100|stk|1|þpakki||C09AA02|01.01.2009||R|A|2|0|0|B|0|POF|0|0|0|100|IKR|2725|4538|lyfalmen|V0169|4538|0|100|0|200|PortFarma ehf|PortFarma|Enalapríl||2725||2725|4538 106567|J05AB0102|Zovir|irs|500|mg/hgl|5|hgl|1|pakki||J05AB01|01.01.1995||R|A|5|0|0|0|1|GSK|0|0|0|100|GBP|17449|23592|lyfsjukr|||00|5|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||17449||17449|23592 106898|J05AB0102|Zovir|irs|250|mg/hgl|5|hgl|1|pakki||J05AB01|01.07.1989||R|A|5|0|0|0|1|GSK|0|0|0|100|GBP|9650|13816|lyfsjukr|||00|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||9650||9650|13816 106963|M05BA0201|Bonefos|töflur|800|mg|30|stk|1|þpakki||M05BA02|01.03.2004||R|A|3|0|0|E|0|LEI|0|0|0|100|SEK|16668|22937|lyfalmen|||10|30|0|15|Icepharma hf|Leiras Oy|Klódrónsýra||16668||16668|22937 107050|A10BD0401|Avaglim|filmhtfl|0| |84|stk|1|þpakki|4+4 mg|A10BD04|01.03.2008||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|13994|19608|lyfalmen|||00|84|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Glímepíríð og rosiglítazón||13994||13994|19608 107061|A10BD0401|Avaglim|filmhtfl|0| |84|stk|1|þpakki|8+4 mg|A10BD04|01.03.2008||R|A|2|0|0|*|0|GSK|0|0|0|100|GBP|21068|28415|lyfalmen|||00|84|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Glímepíríð og rosiglítazón||21068||21068|28415 107219|A07EC0102|Salazopyrin EN|sh-tfl|500|mg|100|stk|1|glas||A07EC01|01.04.1987||R|A|5|0|0|B|0|PFI|0|0|0|100|DKK|1989|3540|lyfalmen|||10|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Súlfasalazín||1989||1989|3540 107268|M05BA0201|Bonefos|töflur|800|mg|30|stk|1|glas||M05BA02|01.01.1997||R|A|3|0|0|E|0|LEI|0|0|0|100|SEK|16668|22937|lyfalmen|||10|30|0|15|Icepharma hf|Leiras Oy|Klódrónsýra||16668||16668|22937 107532|N02BE0106|Parasupp|eþ-stil|60|mg|10|stk|1|pakki||N02BE01|01.06.1984||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||04|10|0|0|Actavis Group hf|Actavis hf|Paracetamól||||| 107583|N03AF0202 |Trileptal (D.A.C.)|filmhtfl|300|mg|100|stk|1|þpakki||N03AF02|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|5505|8311|lyfalmen|V2150|8311|00|100|0|30|D.A.C. ehf|D.A.C. ehf|Oxkarbazepín||||5505|8311 107594|QP54AA0104|Bimectin Horse Oral Paste|pasta|18,7|mg/g|6,42|g|1|áf.spr||QP54AA01|01.04.2008||L|A|2|0|0|0|0|ICV|0|0|0|100|XEU|||vetorma|||16|6|0|0|Icepharma hf|Icevet ehf||||||2729 107607|A02BA0201|Asyran|töflur|150|mg|60|stk|1|þpakki||A02BA02|01.07.1986||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1117|2356|lyfalmen|||00|60|0|30|Actavis Group hf|Actavis hf|Ranitidín||1117||1117|2356 108209|N02BE0106|Parasupp|eþ-stil|500|mg|10|stk|1|pakki||N02BE01|01.06.1984||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||04|10|0|2|Actavis Group hf|Actavis hf|Paracetamól||||| 108308|C08CA0501|Adalat|töflur|10|mg|100|stk|1|þpakki||C08CA05|01.01.1991||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|2860|4722|lyfalmen|||63|100|0|33|Vistor hf|Bayer HealthCare AG|Nífedipín||2860||2860|4722 108540|A10BH0201|Galvus|töflur|50|mg|30|stk|1|þpakki||A10BH02|01.09.2008||R|A|2|0|0|*|0|NOE|0|0|0|100|DKK|4472|6909|lyfalmen|||00|30|0|0|Vistor hf|Novartis Europharm Ltd|Vildagliptín||4472||4472|6909 108562|A10BH0201|Galvus|töflur|50|mg|90|stk|1|þpakki||A10BH02|01.09.2008||R|A|2|0|0|*|0|NOE|0|0|0|100|DKK|12198|17371|lyfalmen|||00|90|0|0|Vistor hf|Novartis Europharm Ltd|Vildagliptín||12198||12198|17371 108803|QN01BB5202|Lidokel Adrenalin vet. Kela|stl|20|mg/ml|100|ml|12|hgl|20mg/ml+36mcg/ml|QN01BB52|01.12.2003||R|S|2|0|0|0|0|KEL|1|0|0|100|NOK|1151|2271|vetalmen|||27|1200|0|0|Icepharma hf|Kela Laboratoria NV|||1151||1151|2271 108845|R01AD0501|Rhinocort Aqua|nefúði|32|mcg/sk|120|sk|1|fl||R01AD05|01.10.1988||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|976|2165|lyfalmen|||24|120|0|19|Vistor hf|AstraZeneca A/S DK|Búdesóníð||976||976|2165 108852|R01AD0501|Rhinocort Aqua|nefúði|64|mcg/sk|120|sk|1|fl||R01AD05|01.10.1988||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|1485|2856|lyfalmen|V0965|2709|24|120|0|38|Vistor hf|AstraZeneca A/S DK|Búdesóníð||1485||1485|2856 108860|N02AX0203|Tramol|hylki|50|mg|20|stk|1|glas||N02AX02|01.03.1998||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|293|1238|lyfalmen|V0730|1238|00|20|0|3|Actavis Group hf|Actavis hf|Tramadól||293||293|1238 108878|N02AX0203|Tramol|hylki|50|mg|100|stk|1|glas||N02AX02|01.03.1998||R|A|5|0|0|E|0|ACA|0|0|1|100|IKR|504|1524|lyfalmen|V0731|1524|00|100|0|17|Actavis Group hf|Actavis hf|Tramadól||504||504|1524 109207|N02AA5901|Panocod|töflur|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.01.1992||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|220|1139|lyfalmen|V0775|1129|00|20|0|7|Vistor hf|Sanofi-aventis Norge AS|Kódein í blöndum nema með geðlyfjum||220||220|1139 109223|N02AA5901|Panocod|töflur|530|mg|100|stk|1|pakki|þp 30+500 mg|N02AA59|01.01.1992||R|A|5|1|0|0|0|SNO|0|0|1|100|NOK|841|1982|lyfalmen|V0780|1963|00|100|0|33|Vistor hf|Sanofi-aventis Norge AS|Kódein í blöndum nema með geðlyfjum||841||841|1982 109421|V01AA0303|Alutard SQ, derm.farinae|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA03|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|24816|33081|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|rykmaurar||24816||24816|33081 109439|V01AA0303|Alutard SQ, derm.farinae|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA03|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|19867|26919|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|rykmaurar||19867||19867|26919 109462|V01AA0301|Soluprick SQ, derm.farinae|lausn|10|HEP|3|ml|1|hgl||V01AA03|01.07.1999||R|K|2|0|0|E|0|ALK|0|0|0|100|DKK|7713|11307|lyfalmen|||02|3|0|0|Vistor hf|ALK-Abello A/S|rykmaurar||7713||7713|11307 109678|N02BE0107|Paratabs|töflur|500|mg|20|stk|1|þpakki||N02BE01|01.12.1983||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|20|0|3|Actavis Group hf|Actavis hf|Paracetamól||||| 109728|N02BE0107|Paratabs|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.07.1992||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|5|Actavis Group hf|Actavis hf|Paracetamól||||| 109751|N02BE0107|Paratabs|töflur|500|mg|100|stk|1|þpakki||N02BE01|01.11.1981||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|379|1355|lyfalmen|V0772|1355|00|100|0|17|Actavis Group hf|Actavis hf|Paracetamól||379||379|1355 110072|S01ED0105|Optimol|augndr|2,5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|654|1728|lyfalmen|||06|5|0|25|Icepharma hf|Santen Oy|Tímólól||654||654|1728 110080|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|1|glas||S01ED01|01.01.1987||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|729|1830|lyfalmen|||06|5|0|25|Icepharma hf|Santen Oy|Tímólól||729||729|1830 110242|V03AN0101|Conoxia|innö.gas|100|%|3|l|1|hylki|MO3c|V03AN01|01.04.2008||L|A|0|0|0|0|0|AGA|0|0|0|100|IKR|||lyflausa|||00|3|0|0|Ísaga ehf|AGA AB|Súrefni||||| 110395|G03AA0902|Mercilon|töflur|0| |63|stk|1|þpakki||G03AA09|01.07.1990||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|1574|2976|lyfalmen|||23|63|0|84|Vistor hf|N.V. Organon|Desógestrel og östrógen||1574||1574|2976 110635|C08DA0104|Veraloc Retard|forðatfl|200|mg|100|stk|1|glas||C08DA01|01.10.1988||R|A|4|0|0|B|0|ORC|0|0|0|100|DKK|4611|7098|lyfalmen|||10|100|0|83|Vistor hf|Orion Corporation|Verapamíl||4611||4611|7098 111505|G04BE0802|Cialis (D.A.C.)|filmhtfl|20|mg|8|stk|1|þpakki||G04BE08|01.10.2007||R|A|3|0|0|0|0|DAC|0|0|0|100|XEU|11841|16909|lyfalmen|V1351|16909|00|8|0|16|D.A.C. ehf|D.A.C. ehf|Tadalafíl||||11841|16909 111955|N02BE0101|Panodil|töflur|1|g|100|stk|1|glas||N02BE01|01.05.2003||R|A|5|0|0|0|0|GCH|0|0|1|100|DKK|766|1880|lyfalmen|||00|100|0|33|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||766||766|1880 112359|S01AA1101|Garamycin|augndr|3|mg/ml|5|ml|1|glas||S01AA11|01.03.1977||R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|824|1959|lyfalmen|||06|5|0|0|Vistor hf|Schering-Plough|Gentamícín||824||824|1959 112441|A10BB0701|Mindiab|töflur|2,5|mg|100|stk|1|þpakki||A10BB07|01.07.1990||R|A|5|0|0|*|0|PFI|0|0|0|100|DKK|1309|2617|lyfalmen|||68|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Glípízíð||1309||1309|2617 112615|C01DA0201|Discotrine|forðapl|15|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|SEK|3562|5674|lyfalmen|||23|30|0|90|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||3562||3562|5674 112641|M05BA0407 |Alendronat Ranbaxy|töflur|70|mg|12|stk|1|þpakki||M05BA04|01.04.2009||R|A|2|0|0|E|0|RAN|0|0|0|100|XEU|8401|12241|lyfalmen|V0718|12241|00|12|0|84|Gróco ehf|Ranbaxy (UK) Ltd|Alendrónsýra||||8401|12241 113394|A10BD0801|Eucreas|filmhtfl|0||60|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|A|1.5|0|0|*|0|NOE|0|0|0|100|DKK|9861|14222|lyfalmen|||00|60|0|0|Vistor hf|Novartis Europharm Ltd|||||9861|14222 113403|A10BD0801|Eucreas|filmhtfl|0||180|stk|1|þpakki|50mg/850mg|A10BD08|01.11.2008||R|A|1.5|0|0|*|0|NOE|0|0|0|100|DKK|27143|35978|lyfalmen|||00|180|0|0|Vistor hf|Novartis Europharm Ltd|||||27143|35978 113412|A10BD0801|Eucreas|filmhtfl|0||60|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|A|1.5|0|0|*|0|NOE|0|0|0|100|DKK|9861|14222|lyfalmen|||00|60|0|0|Vistor hf|Novartis Europharm Ltd|||||9861|14222 113415|B01AB0501|Klexane|stl|100|mg/ml|0,2|ml|10|stk|einnota dæla|B01AB05|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|3376|5422|lyfalmen|||00|2|0|10|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3376||3376|5422 113421|A10BD0801|Eucreas|filmhtfl|0||180|stk|1|þpakki|50mg/1000mg|A10BD08|01.11.2008||R|A|1.5|0|0|*|0|NOE|0|0|0|100|DKK|27143|35978|lyfalmen|||00|180|0|0|Vistor hf|Novartis Europharm Ltd|||||27143|35978 113704|B01AB0501|Klexane|stl|100|mg/ml|0,4|ml|10|stk|einnota dæla|B01AB05|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|5476|8272|lyfalmen|||00|4|0|20|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||5476||5476|8272 113796|L01XC0602|Erbitux (Lyfjaver)|irl|5|mg/ml|20|ml|1|hgl|lausn|L01XC06|01.04.2008||R|K|2|0|1|0|1|LVR|0|0|0|100|NOK|36106|46819|lyfsjukr|||00|20|0|0|Lyfjaver ehf|Lyfjaver ehf|Cetúxímab||36106||36106|46819 113818|L01XE0801|Tasigna|hylki|200|mg|112|stk|1|þpakki||L01XE08|01.06.2008||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|752701|938980|lyfsjukr|||00|112|0|0|Vistor hf|Novartis Europharm Ltd|Nilotiníb||752701||752701|938980 113894|J01CE0204|Kaavepenin|töflur|1|g|20|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|597|1651|lyfalmen|||00|20|0|10|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||597||597|1651 113902|J01CE0204|Kaavepenin|töflur|1|g|30|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|872|2024|lyfalmen|||00|30|0|15|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||872||872|2024 113910|J01CE0204|Kaavepenin|töflur|1|g|40|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|1157|2410|lyfalmen|||00|40|0|20|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||1157||1157|2410 114033|R03AC0210|Ventolin Diskus|innúðadu|200|mcg/sk|60|skammtar|1|stk|Diskus tæki|R03AC02|01.03.1999||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|740|1845|lyfalmen|||23|60|0|15|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||740||740|1845 114395|N06AB0505|Paroxetin Ranbaxy|filmhtfl|20|mg|100|stk|1|þpakki||N06AB05|01.11.2008||R|A|3|0|0|B|0|RAN|0|1|0|100|IKR|2160|3240|lyfalmen|V0919|3240|00|100|0|100|Gróco ehf|Ranbaxy (UK) Ltd|Paroxetín||1768||1768|3240 114406|N06AB0505|Paroxetin Ranbaxy|filmhtfl|20|mg|60|stk|1|þpakki||N06AB05|01.11.2008||R|A|3|0|0|B|0|RAN|0|1|0|100|IKR|1390|2385|lyfalmen|V0918|2385|00|60|0|60|Gróco ehf|Ranbaxy (UK) Ltd|Paroxetín||1138||1138|2385 114417|N06AB0505|Paroxetin Ranbaxy|filmhtfl|20|mg|20|stk|1|þpakki||N06AB05|01.11.2008||R|A|3|0|0|B|0|RAN|0|1|0|100|IKR|526|1424|lyfalmen|V0917|1424|00|20|0|20|Gróco ehf|Ranbaxy (UK) Ltd|Paroxetín||430||430|1424 114447|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|1|glas|+ dorzólamíð 20 mg|S01ED51|01.03.1999||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|2662|4453|lyfalmen|V0989|4380|06|5|0|0|Icepharma hf|M.S.D.|Tímólól í blöndum||2662||2662|4453 115163|B01AE0701|Pradaxa|hylki|75|mg|10|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|2|0|0|E|0|BII|0|0|0|100|DKK|4242|6597|lyfalmen|||0|750|0|0|Vistor hf|Boehringer Ingelheim International|||4242||4242|6597 115285|J01CA0410|Amoxicillin Merck NM|töflur|750|mg|20|stk|1|þpakki||J01CA04|01.10.1998||R|A|4|0|0|0|0|MNA|0|0|1|100|SEK|1684|3126|lyfalmen|||00|20|0|15|Actavis Group PTC ehf|Merck NM AB|Amoxicillín||1684||1684|3126 115318|B01AE0701|Pradaxa|hylki|75|mg|30|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|2|0|0|E|0|BII|0|0|0|100|DKK|12716|18016|lyfalmen|||0|2250|0|0|Vistor hf|Boehringer Ingelheim International|||12716||12716|18016 115330|B01AE0701|Pradaxa|hylki|75|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|2|0|0|E|0|BII|0|0|0|100|DKK|25432|33848|lyfalmen|||0|4500|0|0|Vistor hf|Boehringer Ingelheim International|||25432||25432|33848 115341|B01AE0701|Pradaxa|hylki|110|mg|10|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|2|0|0|E|0|BII|0|0|0|100|DKK|4242|6597|lyfalmen|||0|1100|0|0|Vistor hf|Boehringer Ingelheim International|||4242||4242|6597 115353|B01AE0701|Pradaxa|hylki|110|mg|30|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|2|0|0|E|0|BII|0|0|0|100|DKK|12716|18016|lyfalmen|||0|3300|0|0|Vistor hf|Boehringer Ingelheim International|||12716||12716|18016 115364|B01AE0701|Pradaxa|hylki|110|mg|60|stk|1|þpakki|hart|B01AE07|01.01.2009||R|A|2|0|0|E|0|BII|0|0|0|100|DKK|25432|33848|lyfalmen|||0|6600|0|0|Vistor hf|Boehringer Ingelheim International|||25432||25432|33848 115642|S01EC0301|Trusopt|augndr|20|mg/ml|5|ml|1|glas||S01EC03|01.04.1996||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|1963|3504|lyfalmen|V1090|3449|06|5|0|17|Icepharma hf|M.S.D.|Dorzólamíð||1963||1963|3504 115808|R06AX0201|Periactin|töflur|4|mg|100|stk|1|þpakki||R06AX02|01.10.2005||R|A|3|0|0|E|0|MSD|0|0|1|100|XEU|1241|2524|lyfalmen|||00|100|0|33|Icepharma hf|M.S.D.|Cýpróheptadín||1241||1241|2524 115931|R03AC1202|Serevent Diskus|innúðadu|50|mcg/sk|60|sk|1|pakki||R03AC12|01.01.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|3415|5475|lyfalmen|||23|60|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról||3415||3415|5475 115980|P03AX0301|Prioderm|húðlausn|5|mg/ml|55|ml|1|glas||P03AX03|01.12.1983||L|A|3|0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa|||23|55|0|0|Icepharma hf|Norpharma |Malatíón||||| 116004|J01DC0202|Zinacef|sts|1,5|g|5|hgl|1|pakki||J01DC02|01.06.2005||R|A|2|0|0|0|1|GSK|0|0|0|100|GBP|3664|5246|lyfsjukr|||03|5|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||3664||3664|5246 116046|J01DC0202|Zinacef|sts|750|mg|1|stk|5|hgl||J01DC02|01.09.1983||R|A|2|0|0|0|1|GSK|0|0|0|100|GBP|1915|2742|lyfsjukr|||03|5|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||1915||1915|2742 116137|D07AC1301|Elocon|krem|1|mg/g|20|g|1|túpa|feitt|D07AC13|01.04.1994|30.04.2009|R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|815|1946|lyfalmen|||20|20|0|20|Vistor hf|Schering-Plough|Mómetasón||815||815|1946 116160|D07AC1301|Elocon|krem|1|mg/g|50|g|1|túpa|feitt|D07AC13|01.04.1994|30.04.2009|R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|1802|3286|lyfalmen|||20|50|0|50|Vistor hf|Schering-Plough|Mómetasón||1802||1802|3286 116244|D11AF01|Verucid|áburður|0| |10|ml|1|glas||D11AF|01.11.1981||L|K|2|0|0|0|0|GAN|0|0|0|100|IKR|||lyflausa|||23|10|0|10|Icepharma hf|Galderma Nordic AB|||||| 116327|D07AC1301 |Elocon|krem|0,1|%|100|g|1|túpa||D07AC13|01.04.2009||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|3061|4994|lyfalmen|||0|100|0|100|Vistor hf|Schering-Plough|Mómetasón||||3061|4994 116368|D07AC1301|Elocon|smyrsli|1|mg/g|20|g|1|túpa||D07AC13|01.04.1994|30.04.2009|R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|815|1946|lyfalmen|||20|20|0|20|Vistor hf|Schering-Plough|Mómetasón||815||815|1946 116400|D07AC1301|Elocon|smyrsli|1|mg/g|50|g|1|túpa||D07AC13|01.04.1994|30.04.2009|R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1792|3272|lyfalmen|||20|50|0|50|Vistor hf|Schering-Plough|Mómetasón||1792||1792|3272 116418|D07AC1301 |Elocon|smyrsli|0,1|%|100|g|1|túpa||D07AC13|01.04.2009||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|3061|4994|lyfalmen|||0|100|0|100|Vistor hf|Schering-Plough|Mómetasón||||3061|4994 116551|M01AE0102|Ibufen|töflur|200|mg|20|stk|1|þpakki||M01AE01|01.12.2008||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|20|0|3|Actavis Group hf|Actavis hf|Íbúprófen||||| 116573|M01AE0102|Ibufen|töflur|400|mg|30|stk|1|þpakki||M01AE01|01.05.2008||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|10|Actavis Group hf|Actavis hf|Íbúprófen||||| 116584|M01AE0102|Ibufen|töflur|400|mg|100|stk|1|þpakki||M01AE01|01.08.2008||R|A|5|0|0|E|0|ACA|0|0|1|100|XEU|809|1938|lyfalmen|||00|100|0|33|Actavis Group hf|Actavis hf|Íbúprófen||809||809|1938 116595|M01AE0102|Ibufen|töflur|600|mg|30|stk|1|þpakki||M01AE01|01.07.2008||R|A|2|0|0|E|0|ACA|0|0|1|100|XEU|453|1455|lyfalmen|||00|30|0|15|Actavis Group hf|Actavis hf|Íbúprófen||453||453|1455 116606|M01AE0102|Ibufen|töflur|600|mg|100|stk|1|þpakki||M01AE01|01.05.2008||R|A|2|0|0|E|0|ACA|0|0|1|100|XEU|1094|2325|lyfalmen|||00|100|0|50|Actavis Group hf|Actavis hf|Íbúprófen||1094||1094|2325 116694|G04BD1101|Toviaz|forðatfl|4|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|PFL|0|0|0|100|DKK|18622|25369|lyfalmen|||00|84|0|0|Vistor hf|Pfizer Limited|||||18622|25369 116705|G04BD1101|Toviaz|forðatfl|4|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|PFL|0|0|0|100|DKK|6590|9783|lyfalmen|||00|28|0|0|Vistor hf|Pfizer Limited|||||6590|9783 116716|G04BD1101|Toviaz|forðatfl|8|mg|28|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|PFL|0|0|0|100|DKK|7000|10340|lyfalmen|||00|28|0|0|Vistor hf|Pfizer Limited|||||7000|10340 116727|G04BD1101|Toviaz|forðatfl|8|mg|84|stk|1|þpakki||G04BD11|01.11.2008||R|A|2|0|0|E|0|PFL|0|0|0|100|DKK|21092|28445|lyfalmen|||00|84|0|0|Vistor hf|Pfizer Limited|||||21092|28445 116985|N06AX1607 |Efexor Depot (D.A.C.)|forðahlk|75|mg|98|stk|1|þpakki||N06AX16|01.05.2009||R|A|3|0|0|B|0|DAC|0|1|0|100|USD|17165|23555|lyfalmen|V0955|18176|00|98|0|74|D.A.C. ehf|D.A.C. ehf|Venlafaxín||||17165|23555 116997|N05AX1203|Abilify (Lyfjaver)|töflur|10|mg|56|stk|1|þpakki||N05AX12|01.05.2008||R|A|3|0|0|*|0|LVR|0|1|0|100|DKK|37748|49181|lyfalmen|V1702|49181|00|56|0|37|Lyfjaver ehf|Lyfjaver ehf|Aripiprazól||37748||37748|49181 117008|N05AX1203|Abilify (Lyfjaver)|töflur|15|mg|56|stk|1|þpakki||N05AX12|01.05.2008||R|A|3|0|0|*|0|LVR|0|1|0|100|DKK|37748|49181|lyfalmen|V1703|49181|00|56|0|56|Lyfjaver ehf|Lyfjaver ehf|Aripiprazól||37748||37748|49181 117408|QA12AX0001|Calcimag vet. Kela|irl|0| |500|ml|12|plastf||QA12AX00|01.04.2004||R|A|2|0|0|0|0|KEL|1|0|0|100|NOK|9390|18058|vetalmen|||00|6000|0|0|Icepharma hf|Kela Laboratoria NV|||9390||9390|18058 117515|M01AE0303|Orudis|forðahlk|200|mg|100|stk|1|hylki||M01AE03|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|8019|11723|lyfalmen|||10|100|0|133|Vistor hf|Sanofi-aventis Norge AS|Ketóprófen||8019||8019|11723 117531|N04BA0201|Madopar|hylki|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.07.1974||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|5966|8937|lyfalmen|||00|100|0|33|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||5966||5966|8937 117550|N05AH0405|Seroquel Prolong|forðatfl|50|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|12305|17505|lyfalmen|||00|100|0|12|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||12305|17505 117561|N05AH0405|Seroquel Prolong|forðatfl|200|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|21747|29260|lyfalmen|||00|100|0|50|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||21747|29260 117564|N04BA0201|Madopar|hylki|62,5|mg|100|stk|1|glas|50+12.5 mg|N04BA02|01.06.1981||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|2460|4179|lyfalmen|||10|100|0|8|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2460||2460|4179 117573|N05AH0405|Seroquel Prolong|forðatfl|300|mg|10|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|3760|5943|lyfalmen|||00|10|0|8|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||3760|5943 117584|N05AH0405|Seroquel Prolong|forðatfl|300|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|37603|49001|lyfalmen|||00|100|0|75|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||37603|49001 117595|N05AH0405|Seroquel Prolong|forðatfl|400|mg|100|stk|1|þpakki||N05AH04|01.12.2008||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|43494|56335|lyfalmen|||00|100|0|100|Vistor hf|AstraZeneca UK Ltd|Quetíapín||||43494|56335 117721|D11AF01|Verucid|hlaup|0| |5|g|1|túpa||D11AF|01.08.1984||L|A|3|0|0|0|0|GAN|0|0|0|100|IKR|||lyflausa|||23|5|0|5|Icepharma hf|Galderma Nordic AB|||||| 117770|QP51AJ0101|Baycox Vet.|mixtúra|50|mg/ml|250|ml|1|fl||QP51AJ01|01.12.2005||R|A|5|0|0|0|0|BAN|0|0|0|100|DKK|9937|17196|vetorma|||00|250|0|0|Vistor hf|Bayer Animal Health GmbH|||9937||9937|17196 117788|C08CA0502|Adalat Oros|forðatfl|30|mg|28|stk|1|þpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|2621|4397|lyfalmen|||61|28|0|28|Vistor hf|Bayer HealthCare AG|Nífedipín||2621||2621|4397 117796|C08CA0502|Adalat Oros|forðatfl|30|mg|98|stk|1|þpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|4610|7096|lyfalmen|||61|98|0|98|Vistor hf|Bayer HealthCare AG|Nífedipín||4610||4610|7096 117820|C08CA0502|Adalat Oros|forðatfl|60|mg|98|stk|1|þpakki||C08CA05|01.07.1994||R|A|4|0|0|B|0|BHC|0|0|0|100|SEK|11052|15838|lyfalmen|||61|98|0|196|Vistor hf|Bayer HealthCare AG|Nífedipín||11052||11052|15838 117929|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|100|ml|12|fl||QA12AA00|01.04.2004||R|A|2|0|0|0|0|KEL|0|0|0|100|NOK|6559|12665|vetalmen|||00|1200|0|0|Icepharma hf|Kela Laboratoria NV|||6559||6559|12665 117937|QA12AA0001|Calci-kel vet. Kela|irl|20,8|mg/ml|500|ml|12|plastf||QA12AA00|01.04.2004||R|A|2|0|0|0|0|KEL|0|0|0|100|NOK|11504|22085|vetalmen|||00|6000|0|0|Icepharma hf|Kela Laboratoria NV|||11504||11504|22085 118020|N05AH0306|Olanzapin Actavis|filmhtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.05.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|4086|4584|lyfalmen|V0809|4584|00|28|0|7|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||2759||2759|4584 118043|N05AH0306|Olanzapin Actavis|filmhtfl|5|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|5807|6161|lyfalmen|V0810|6161|00|28|0|14|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||3921||3921|6161 118076|N05AH0306|Olanzapin Actavis|filmhtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|22522|21113|lyfalmen|V0812|21113|00|56|0|56|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||15203||15203|21113 118087|N05AH0306|Olanzapin Actavis|filmhtfl|15|mg|28|stk|1|þpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|17205|16601|lyfalmen|V0815|16601|00|28|0|42|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||11614||11614|16601 118158|J01DC0203|Zinnat|mixt.kyr|25|mg/ml|100|ml|1|glas||J01DC02|01.10.1990||R|A|2|0|0|0|0|GSK|0|0|1|100|GBP|1649|3078|lyfalmen|||65|100|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||1649||1649|3078 118231|N01AX1301|Niontix|lyfjagas|100|%|4|l|1|hylki||N01AX13|01.06.2008||R|A|3|0|0|0|1|AGA|0|0|0|100|IKR|9512|13619|lyfsjukr|||00|4|0|0|Ísaga ehf|AGA AB|di-Nitrogen oxíð||9512||9512|13619 118307|A02BA0201|Asyran|töflur|150|mg|30|stk|1|þpakki||A02BA02|01.04.1994||L|A|3|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||00|30|0|15|Actavis Group hf|Actavis hf|Ranitidín||||| 118315|M01AB0505|Voltaren|eþ-stil|100|mg|5|stk|1|pakki||M01AB05|01.01.1986||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|728|1828|lyfalmen|||04|5|0|5|Vistor hf|Novartis Healthcare A/S-|Díklófenak||728||728|1828 118323|M01AB0505|Voltaren|eþ-stil|100|mg|50|stk|1|pakki||M01AB05|01.01.1986||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|7290|10733|lyfalmen|||04|50|0|50|Vistor hf|Novartis Healthcare A/S-|Díklófenak||7290||7290|10733 118349|D07AC1301|Elocon|áburður|1|mg/g|20|ml|1|glas||D07AC13|01.04.1994|30.04.2009|R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|815|1946|lyfalmen|||20|20|0|20|Vistor hf|Schering-Plough|Mómetasón||815||815|1946 118406|A02BA0201|Asyran|töflur|300|mg|30|stk|1|þpakki||A02BA02|01.04.1994||R|A|3|0|0|E|0|ACA|0|0|0|100|IKR|1062|2282|lyfalmen|||00|30|0|30|Actavis Group hf|Actavis hf|Ranitidín||1062||1062|2282 118484|N05AH0306|Olanzapin Actavis|filmhtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.04.2008||R|A|2|0|0|*|0|AGP|0|1|0|100|XEU|17706|17058|lyfalmen|V0811|17058|00|56|0|42|Actavis Group hf|Actavis Group PTC ehf|Olanzapín||11951||11951|17058 118570|A07EC0203|Pentasa Sachets|forðakyr|1|g|50|stk|1|pakki||A07EC02|01.04.1998||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|9397|13593|lyfalmen|||00|50|0|33|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||9397||9397|13593 118612|A07EC0203|Pentasa Sachets|forðakyr|1|g|150|stk|1|pakki|3 x 50 stk|A07EC02|01.04.1998||R|A|2|0|0|B|0|FER|0|0|0|100|DKK|27641|36598|lyfalmen|||00|150|0|100|Vistor hf|Ferring|Mesalazín (5-amínósalicýlsýra)||27641||27641|36598 118674|N05AH0204|Leponex (Lyfjaver)|töflur|25|mg|100|stk|1|glas||N05AH02|01.05.2008||R|A|5|0|0|*|0|LVR|0|1|0|100|DKK|3635|5773|lyfalmen|V1401|5773|00|100|0|8|Lyfjaver ehf|Lyfjaver ehf|Klózapín||||3635|5773 118685|N05AH0204|Leponex (Lyfjaver)|töflur|100|mg|100|stk|1|glas||N05AH02|01.05.2008||R|A|5|0|0|*|0|LVR|0|1|0|100|DKK|10710|15374|lyfalmen|V1400|15163|00|100|0|33|Lyfjaver ehf|Lyfjaver ehf|Klózapín||||10710|15374 119031|L01XC0801|Vectibix|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XC08|01.06.2008||R|K|3|0|1|0|1|AEU|0|0|0|100|DKK|85912|108828|lyfsjukr|||00|5|0|0|Vistor hf|Amgen Europe B.V.|Panitúmúmab||85912||85912|108828 119719|C09BA0801|Inhibace Comp.|töflur|17,5|mg|98|stk|1|pakki|þp ( 5+ 12,5 mg)|C09BA08|01.12.1997||R|A|3|0|0|B|0|ROC|0|0|0|100|DKK|12980|18345|lyfalmen|||00|98|0|98|Icepharma hf|Roche|Cílazapríl og þvagræsilyf||12980||12980|18345 119962|M01AE0109|Ibuprofen Portfarma|filmhtfl|400|mg|30|stk|1|þpakki||M01AE01|01.03.2008||L|A|3|0|0|0|0|POF|0|0|1|100|IKR|||lyflausa|||00|30|0|10|PortFarma ehf|PortFarma|Íbúprófen||||| 119984|C02KX0201|Volibris|filmhtfl|5|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|A|2|0|1|0|0|GGL|0|0|0|100|GBP|453872|567256|lyfalmen|||00|30|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|||||453872|567256 120007|C02KX0201|Volibris|filmhtfl|10|mg|30|stk|1|þpakki||C02KX02|01.12.2008||R|A|2|0|1|0|0|GGL|0|0|0|100|GBP|453872|567256|lyfalmen|||00|30|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|||||453872|567256 120022|S01FA0401|Cyclogyl 1 %|augndr|10|mg/ml|10|ml|1|glas||S01FA04|01.10.2003||R|A|2|0|0|E|0|ALC|0|0|0|100|USD|974|2162|lyfalmen|||06|10|0|0|K.Pétursson hf|Alcon|Cýklópentólat||974||974|2162 120062|L01BA0401|Alimta|irþ|100|mg/hgl|1|hgl|1|pakki||L01BA04|01.11.2008||R|A|2|0|1|0|1|LIL|0|0|0|100|XEU|48100|61752|lyfsjukr|||00|1|0|0|Icepharma hf|Lilly ICOS Limited|Pemetrexed||||48100|61752 120341|N06DA0402|Reminyl (Lyfjaver)|forðahlk|8|mg|28|stk|1|þpakki||N06DA04|01.05.2008||R|A|2|0|0|E|0|LVR|0|0|0|100|SEK|12190|16301|lyfalmen|V1370|16005|00|28|0|14|Lyfjaver ehf|Lyfjaver ehf|Galantamín||11393||11393|16301 120353|N06DA0402|Reminyl (Lyfjaver)|forðahlk|16|mg|84|stk|1|þpakki||N06DA04|01.05.2008||R|A|2|0|0|E|0|LVR|0|0|0|100|SEK|37511|45866|lyfalmen|V1371|45866|00|84|0|84|Lyfjaver ehf|Lyfjaver ehf|Galantamín||35085||35085|45866 120950|N06AB1003|Cipralex (Lyfjaver)|filmhtfl|10|mg|28|stk|1|þpakki||N06AB10|01.05.2008||R|A|3|0|0|B|0|LVR|0|1|0|100|DKK|3284|5297|lyfalmen|V0939|5210|00|28|0|28|Lyfjaver ehf|Lyfjaver ehf|Escítalópram||3284||3284|5297 120961|N06AB1003|Cipralex (Lyfjaver)|filmhtfl|10|mg|200|stk|1|plglas||N06AB10|01.05.2008||R|A|3|0|0|B|0|LVR|0|1|0|100|NOK|21043|28384|lyfalmen|||00|200|0|200|Lyfjaver ehf|Lyfjaver ehf|Escítalópram||21043||21043|28384 120973|N03AX1402|Keppra (Lyfjaver)|filmhtfl|500|mg|100|stk|1|þpakki||N03AX14|01.05.2008||R|A|3|0|1|E|0|LVR|0|0|0|100|DKK|19857|26907|lyfalmen|V1710|26413|00|100|0|25|Lyfjaver ehf|Lyfjaver ehf|Levetíracetam||||19857|26907 121164|A02BC0501 |Nexium|mixt.kyr|10|mg|28|sk-pokar|1|pakki|dreifa|A02BC05|01.04.2009||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|5031|7668|lyfalmen|||00|28|0|9|Vistor hf|AstraZeneca A/S DK|Esómeprazól||||5031|7668 121269|N05CD0505|Triazolam NM Pharma|töflur|0,25|mg|100|stk|1|glas||N05CD05|01.07.1991||R|A|4|0|0|0|0|MNA|0|0|0|100|SEK|717|1813|lyfalmen|||00|100|0|100|Actavis Group PTC ehf|Merck NM AB|Tríazólam||717||717|1813 121286|M03AC0901 |Esmeron|stl|10|mg/ml|5|ml|10|hgl||M03AC09|01.04.2009||R|K|3|0|0|0|1|ORG|0|0|0|100|DKK|10088|14427|lyfsjukr|||00|50|0|0|Vistor hf|N.V. Organon|Rókúrón, brómíð||||10088|14427 121327|R03AC0204|Ventolin|innúðal|0,1|mg/sk|200|sk|1|stauk||R03AC02|01.12.1972||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|336|1296|lyfalmen|||24|200|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||336||336|1296 121562|B03BB0104|Folic Acid|töflur|5|mg|28|stk|1|þpakki||B03BB01|01.01.2008||R|A|2|0|0|E|0|AUK|0|0|1|100|GBP|381|1357|lyfalmen|||00|28|0|28|Actavis Group hf|Actavis UK Ltd.|Fólínsýra||381||381|1357 121582|N06AA0401|Anafranil|töflur|25|mg|100|stk|1|þpakki||N06AA04|01.03.1977||R|A|5|0|0|B|0|NOH|0|1|0|100|DKK|2048|3620|lyfalmen|V0908|1918|00|100|0|25|Vistor hf|Novartis Healthcare A/S-|Klómípramín||2048||2048|3620 121863|A07EC0204|Asacol|eþ-stil|500|mg|30|stk|1|pakki||A07EC02|01.01.2000||R|A|3|0|0|B|0|TIL|0|0|0|100|SEK|3110|5061|lyfalmen|||98|30|0|10|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||3110||3110|5061 123166|M01AE5101|Ibukod|töflur|0| |100|stk|1|glas|10+200 mg|M01AE51|01.10.1998||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|1507|2885|lyfalmen|||00|100|0|17|Actavis Group hf|Actavis hf|Íbúprófen í blöndum||1507||1507|2885 123216|N05BA0105|Stesolid|eþ-stil|5|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|564|1606|lyfalmen|||04|10|0|5|Actavis Group hf|Actavis Group hf|Díazepam||564||564|1606 123224|N05BA0105|Stesolid|eþ-stil|10|mg|10|stk|1|pakki||N05BA01|01.07.2005||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|879|2033|lyfalmen|||04|10|0|10|Actavis Group hf|Actavis Group hf|Díazepam||879||879|2033 123264|A07AA0904|Vancomycin Alpharma|hylki|125|mg|28|stk|1|þpakki|hart hylki|A07AA09|01.04.1996||R|A|2|0|0|E|0|ALP|0|0|1|100|DKK|12372|17588|lyfalmen|||0|28|0|2|Actavis Group hf|Alpharma ApS|Vankómýcín||||12372|17588 123273|N05BA0603|Temesta|töflur|1|mg|100|stk|1|þpakki||N05BA06|01.11.2005||R|A|3|0|0|0|0|LDR|0|0|1|100|IKR|1755|3222|lyfalmen|||00|100|1|40|Parlogis hf|Parlogis - óskráð lyf|||1755||1755|3222 123275|A07AA0904|Vancomycin Alpharma|hylki|250|mg|28|stk|1|þpakki|hart hylki|A07AA09|01.04.1996||R|A|2|0|0|E|0|ALP|0|0|1|100|DKK|24777|33032|lyfalmen|||00|28|0|4|Actavis Group hf|Alpharma ApS|Vankómýcín||||24777|33032 123308|R03BB0404 |Spiriva (Lyfjaver)|innönddu|18|mcg/hylk|30|hylki|1|pakki|hart hylki|R03BB04|01.05.2009||R|A|2|0|0|B|0|LVR|0|0|0|100|DKK|6943|10262|lyfalmen|V2110|10262|00|30|0|30|Lyfjaver ehf|Lyfjaver ehf|Tíótrópíumbrómíð||||6943|10262 123319|M05BA0704|Optinate Septimum (Lyfjaver)|filmhtfl|35|mg|12|stk|1|þpakki||M05BA07|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|NOK|13278|18716|lyfalmen|V1080|18157|00|12|0|84|Lyfjaver ehf|Lyfjaver ehf|||13278||13278|18716 123414|C01AA0504|Lanoxin mite|töflur|62,5|mcg|100|stk|1|glas||C01AA05|01.03.1978||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|303|1252|lyfalmen|||00|100|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Digoxín||303||303|1252 123596|N02AA5904|Ibukod sterkar|töflur|0| |100|stk|1|glas|30+200 mg|N02AA59|01.10.1998|31.03.2009|R|A|2|1|0|0|0|ACA|0|0|1|100|IKR|2116|3712|lyfalmen|||00|100|0|33|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||2116||2116|3712 123992|N07XX0201|Rilutek|töflur|50|mg|56|stk|1|þpakki||N07XX02|01.05.1998||R|A|3|0|0|E|0|AVS|0|0|0|100|NOK|40718|52879|lyfalmen|||00|56|0|28|Vistor hf|Aventis Pharma SA|Rílúzól||40718||40718|52879 124248|R06AD0301|Torecan|töflur|6,5|mg|20|stk|1|þpakki||R06AD03|01.10.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|974|2162|lyfalmen|||00|20|1|10|Parlogis hf|Parlogis - óskráð lyf|||974||974|2162 124354|G02AB0101|Methergin|töflur|0,125|mg|30|stk|1|þpakki||G02AB01|01.03.1980||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|1022|2227|lyfalmen|||00|30|0|19|Vistor hf|Novartis Healthcare A/S-|Metýlergómetrín||1022||1022|2227 124727|C09AA0201|Daren|töflur|10|mg|30|stk|1|glas||C09AA02|01.01.1994||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|612|1671|lyfalmen|||00|30|0|30|Actavis Group hf|Actavis hf|Enalapríl||612||612|1671 125054|C09AA0201|Daren|töflur|10|mg|100|stk|1|glas||C09AA02|01.01.1994||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1153|2405|lyfalmen|V0168|2405|00|100|0|100|Actavis Group hf|Actavis hf|Enalapríl||1153||1153|2405 125163|C01BD0104|Cordarone (Lyfjaver)|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.01.2009||R|A|5|0|0|B|0|LVR|0|0|0|100|NOK|2386|4078|lyfalmen|V0144|4016|0|30|0|15|Lyfjaver ehf|Lyfjaver ehf|Amíódarón||2386||2386|4078 126163|N05AX1202|Abilify (D.A.C)|töflur|5|mg|28|stk|1|þpakki||N05AX12|01.05.2008||R|A|3|0|0|*|0|DAC|0|1|0|100|DKK|22104|25330|lyfalmen|V1701|25330|00|28|0|6|D.A.C. ehf|D.A.C. ehf|Aripiprazól||18590||18590|25330 126231|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|262,5|mg|100|stk|1|glas|50+12,5+200mg|N04BA03|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|18391|19300|lyfalmen|V1732|19300|00|100|0|11|Lyfjaver ehf|Lyfjaver ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||13747||13747|19300 126242|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|325|mg|100|stk|1|glas|100+25+200mg|N04BA03|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|16318|19121|lyfalmen|V1730|19121|00|100|0|22|Lyfjaver ehf|Lyfjaver ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||13603||13603|19121 126253|N04BA0302|Stalevo (Lyfjaver)|filmhtfl|387,5|mg|100|stk|1|glas|150+37,5+200mg|N04BA03|01.05.2008||R|A|3|0|0|E|0|LVR|0|0|0|100|DKK|20703|27960|lyfalmen|V1731|27960|00|100|0|33|Lyfjaver ehf|Lyfjaver ehf|Levódópa, dópadekarboxýlasa­hemill og COMT-hemill||20703||20703|27960 126326|A07DA0301|Imodium|töflur|2|mg|16|stk|1|þpakki||A07DA03|01.10.1991||L|A|5|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||10|16|0|3|Vistor hf|Janssen-Cilag AB|Lóperamíð||||| 126374|L01XX1702|Hycamtin|hylki|1|mg|10|stk|1|þpakki|hart|L01XX17|01.11.2008||R|K|3|0|1|0|1|GSK|0|0|0|100|GBP|105844|133643|lyfsjukr|||00|10|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Tópótecan||||105844|133643 126385|L01XX1702|Hycamtin|hylki|0,25|mg|10|stk|1|þpakki|hart|L01XX17|01.11.2008||R|K|3|0|1|0|1|GSK|0|0|0|100|GBP|27163|35685|lyfsjukr|||00|10|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Tópótecan||||27163|35685 126540|J01GB0303|Gentacoll|vsvamp|1,3|mg/fercm|1|stk|1|pakki|10X10 cm|J01GB03|01.10.1995||R|A|3|0|0|0|1|INN|0|0|0|100|XEU|25929|34149|lyfsjukr|||00|1|0|1|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|Gentamícín||25929||25929|34149 126561|A02BC0305|Lansoprazol Ranbaxy|sþ-hylki|15|mg|28|stk|1|þpakki||A02BC03|01.09.2008||R|A|1,5|0|0|0|0|RAN|0|0|0|100|IKR|1607|2219|lyfalmen|||00|28|0|14|Gróco ehf|Ranbaxy (UK) Ltd|Lansóprazól||1016||1016|2219 126572|A02BC0305|Lansoprazol Ranbaxy|sþ-hylki|15|mg|56|stk|1|þpakki||A02BC03|01.09.2008||R|A|1,5|0|0|E|0|RAN|0|0|0|100|IKR|3045|3598|lyfalmen|||00|56|0|28|Gróco ehf|Ranbaxy (UK) Ltd|Lansóprazól||2032||2032|3598 126583|A02BC0305|Lansoprazol Ranbaxy|sþ-hylki|30|mg|28|stk|1|þpakki||A02BC03|01.09.2008||R|A|1,5|0|0|0|0|RAN|0|0|0|100|IKR|1607|2219|lyfalmen|||00|28|0|28|Gróco ehf|Ranbaxy (UK) Ltd|Lansóprazól||1016||1016|2219 126594|A02BC0305|Lansoprazol Ranbaxy|sþ-hylki|30|mg|56|stk|1|þpakki||A02BC03|01.09.2008||R|A|1,5|0|0|E|0|RAN|0|0|0|100|IKR|3045|3598|lyfalmen|||00|56|0|56|Gróco ehf|Ranbaxy (UK) Ltd|Lansóprazól||2032||2032|3598 126649|J01GB0303|Gentacoll|vsvamp|1,3|mg/fercm|1|stk|1|pakki|5X5 cm|J01GB03|01.10.1995||R|A|3|0|0|0|1|INN|0|0|0|100|XEU|8643|12375|lyfsjukr|||00|1|0|0|Innocoll Pharmaceuticals Ltd.|Innocoll Pharmaceuticals Ltd.|Gentamícín||8643||8643|12375 126953|A07DA0301|Imodium|töflur|2|mg|100|stk|1|þpakki||A07DA03|01.10.1991||R|A|5|0|0|E|0|JAS|0|0|0|100|SEK|1640|3066|lyfalmen|||10|100|0|20|Vistor hf|Janssen-Cilag AB|Lóperamíð||1640||1640|3066 126974|N06AX2104|Cymbalta (D.A.C.)|sh-hylki|30|mg|28|stk|1|þpakki||N06AX21|01.07.2008||R|A|3|0|0|B|0|DAC|0|1|0|100|XEU|4144|6464|lyfalmen|V1951|6464|00|28|0|14|D.A.C. ehf|D.A.C. ehf|||||4144|6464 127383|R02AA0302|Strepsils med honning og citron|sogtfl|0||36|stk|1|þpakki||R02AA03|01.01.2009||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|36|0|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||| 128058|N05AH0301|Zyprexa|húðuðtfl|5|mg|28|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|9856|6161|lyfalmen|V0810|6161|00|28|0|14|Icepharma hf|Eli Lilly Nederland -|Olanzapín||3921||3921|6161 128131|QG51BE0002|Sulfa-Streptocillin vet.|legstil|0||30|stk|1|þpakki||QG51BE00|01.03.2009||R|A|2|0|0|0|0|BID|1|0|0|100|DKK|6199|11979|vetalmen|||0|30|0|0|Vistor hf|Boehringer Ingelheim Danmark|||||6199|11979 128173|C08DA0107|Verapamil Merck NM|töflur|40|mg|100|stk|1|glas||C08DA01|01.01.1990||R|A|5|0|0|B|0|MNA|0|0|0|100|SEK|460|1465|lyfalmen|||00|100|0|17|Actavis Group PTC ehf|Merck NM AB|Verapamíl||460||460|1465 128348|C03AB0102|Centyl mite med kaliumklorid|töflur|0| |100|stk|1|glas||C03AB01|01.05.1999||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|1260|2550|lyfalmen|||10|100|0|50|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||1260||1260|2550 128864|N07BA0136|Nicorette Spicemint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|30|0|2|Vistor hf|McNeil Denmark ApS|Nikótín||||| 128875|N07BA0136|Nicorette Spicemint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|30|0|4|Vistor hf|McNeil Denmark ApS|Nikótín||||| 128886|N07BA0136|Nicorette Spicemint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14|Vistor hf|McNeil Denmark ApS|Nikótín||||| 128897|N07BA0136|Nicorette Spicemint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28|Vistor hf|McNeil Denmark ApS|Nikótín||||| 128934|V03AF0101|Uromitexan|stl|100|mg/ml|10|ml|10|lykjur||V03AF01|01.10.1990||R|A|5|0|0|0|1|BAM|0|0|0|100|SEK|3984|5704|lyfsjukr|||02|100|0|0|Icepharma hf|Baxter Medical AB|Mesna||3984||3984|5704 129098|N05AH0301|Zyprexa|húðuðtfl|7,5|mg|56|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|30102|17058|lyfalmen|V0811|17058|00|56|0|42|Icepharma hf|Eli Lilly Nederland -|Olanzapín||11951||11951|17058 129106|N05AH0301|Zyprexa|húðuðtfl|10|mg|56|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|38272|21113|lyfalmen|V0812|21113|00|56|0|56|Icepharma hf|Eli Lilly Nederland -|Olanzapín||15203||15203|21113 129668|A02AH0002|Natriumbikarbonat|töflur|1|g|100|stk|1|glas||A02AH00|01.08.2005||L|A|5|0|0|0|0|REP|0|0|0|100|SEK|||lyfalmen|||00|100|0|0|Vistor hf|Recip AB||||||2679 129817|R03BB0101|Atrovent|innúðal|0,25|mg/ml|2|ml|60|plastl|í vél|R03BB01|01.04.1989||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|5078|7731|lyfalmen|||00|120|0|100|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||5078||5078|7731 130013|N05AH0401|Seroquel|töflur|100|mg|100|stk|1|þpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|15393|18909|lyfalmen|V0726|16803|00|100|0|25|Vistor hf|AstraZeneca UK Ltd|Quetíapín||13433||13433|18909 130021|N05AH0401|Seroquel|töflur|200|mg|100|stk|1|þpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|24366|28659|lyfalmen|V0727|25884|00|100|0|50|Vistor hf|AstraZeneca UK Ltd|Quetíapín||21264||21264|28659 130575|C03CA0101|Furix|stl|10|mg/ml|25|ml|5|lykjur||C03CA01|01.03.2003||R|A|5|0|0|E|0|NYG|0|0|0|100|DKK|4086|6385|lyfalmen|||02|125|0|31|Gróco ehf|Nycomed Danmark A/S|Fúrósemíð||4086||4086|6385 130596|N07BA0301|Champix|filmhtfl|0||53|stk|1|þpakki|0,5 mg og 1 mg|N07BA03|01.02.2009||R|A|2|0|0|0|0|PFL|0|0|1|100|DKK|11627|16619|lyfalmen|||0|53|0|21|Vistor hf|Pfizer Limited|||||11627|16619 130772|QI10A0001 |Alpha Ject 3000|stl|||500|ml|1|plpoki||QI10A|01.05.2009||R|K|1,25|0|0|0|0|PHA|0|0|0|100|NOK|57487|109675|vetalmen|||0|500|0|0|Vistor hf|PHARMAQ AS|||||57487|109675 131334|N03AB0205|Fenantoin Recip|töflur|100|mg|100|stk|1|glas||N03AB02|01.06.2004||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|391|1371|lyfalmen|||00|100|0|33|Vistor hf|Recip AB|Fenýtóín||391||391|1371 131383|N03AA0204|Fenemal Recip|töflur|15|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|750|1858|lyfalmen|||00|100|0|15|Vistor hf|Recip AB|||750||750|1858 131417|N03AA0204|Fenemal Recip|töflur|50|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|821|1955|lyfalmen|||00|100|0|50|Vistor hf|Recip AB|||821||821|1955 131441|N03AA0204|Fenemal Recip|töflur|100|mg|100|stk|1|glas||N03AA02|01.06.2004||R|A|5|0|0|E|0|REP|0|0|0|100|SEK|909|2074|lyfalmen|||00|100|0|100|Vistor hf|Recip AB|||909||909|2074 131565|G03CA0306|Evorel|forðapl|100|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|5479|8276|lyfalmen|||23|26|0|182|Vistor hf|Janssen-Cilag AB|Estradíól||5479||5479|8276 131729|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|20|stk|1|þpakki||N07BA01|01.10.2008||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|20|0|1|Vistor hf|McNeil Denmark ApS|Nikótín||||| 131740|N07BA0132|Nicorette Microtab Lemon|tungur.t|2|mg|90|stk|1|þpakki||N07BA01|01.10.2008||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|90|0|6|Vistor hf|McNeil Denmark ApS|Nikótín||||| 131817|B01AX0601 |Xarelto|filmhtfl|10|mg|10|stk|1|þpakki||B01AX06|01.05.2009||R|A|3|0|0|E|0|BHC|0|0|0|100|SEK|7458|10961|lyfalmen|||0|10|0|0|Vistor hf|Bayer HealthCare AG|||||7458|10961 131828|B01AX0601 |Xarelto|filmhtfl|10|mg|30|stk|1|þpakki||B01AX06|01.05.2009||R|A|3|0|0|E|0|BHC|0|0|0|100|SEK|22374|30041|lyfalmen|||0|30|0|0|Vistor hf|Bayer HealthCare AG|||||22374|30041 131840|B01AX0601 |Xarelto|filmhtfl|10|mg|100|stk|1|þpakki||B01AX06|01.05.2009||R|A|3|0|0|E|0|BHC|0|0|0|100|SEK|74579|95036|lyfalmen|||0|100|0|0|Vistor hf|Bayer HealthCare AG|||||74579|95036 131995|J01AA0203|Doxytab|töflur|100|mg|30|stk|1|glas||J01AA02|01.04.1987|28.02.2009|R|A|4|0|0|0|0|ACA|0|0|1|100|IKR|||lyfalmen|||00|30|0|30|Actavis Group hf|Actavis hf|Doxýcýklín||||| 132229|N06AA0905|Amitriptyline|töflur|10|mg|28|stk|1|þpakki||N06AA09|01.04.2008||R|A|3|0|0|B|0|AUK|0|1|0|100|GBP|237|1087|lyfalmen|||00|28|0|4|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||182||182|1087 132240|N06AA0905|Amitriptyline|töflur|25|mg|28|stk|1|þpakki||N06AA09|01.04.2008||R|A|3|0|0|B|0|AUK|0|1|0|100|GBP|312|1189|lyfalmen|||00|28|0|9|Actavis Group hf|Actavis UK Ltd.|Amitriptýlín||257||257|1189 132361|C09DA0309|Valpress Comp|filmhtfl|172,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|A|2,5|0|0|B|0|AGP|0|0|0|100|XEU|12610|17884|lyfalmen|V0192|17884|00|98|0|196|Actavis Group hf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||12610||12610|17884 132372|C09DA0309|Valpress Comp|filmhtfl|92,5|mg|98|stk|1|þpakki||C09DA03|01.10.2008||R|A|2,5|0|0|B|0|AGP|0|0|0|100|XEU|8727|12683|lyfalmen|V0191|12683|00|98|0|98|Actavis Group hf|Actavis Group PTC ehf|Valsartan og þvagræsilyf||8727||8727|12683 132662|R05DA0403|Kodein Recip|töflur|25|mg|100|stk|1|glas||R05DA04|01.08.2005||R|A|5|1|0|E|0|REP|0|0|1|100|SEK|1443|2799|lyfalmen|||00|100|0|25|Vistor hf|Recip AB|Kódein||1443||1443|2799 132663|N06BA0402|Concerta|forðatfl|27|mg|30|stk|1|glas||N06BA04|01.02.2009||R|A|3|1|0|0|0|JAS|0|0|0|100|SEK|7401|10884|lyfalmen|||0|30|0|27|Vistor hf|Janssen-Cilag AB|Metýlfenídat||||7401|10884 132761|D08AG0201|Betadine|áburður|100|mg/ml|8|ml|1|glas||D08AG02|01.01.1986||L|A|3|0|0|0|0|NAP|0|0|0|100|IKR|||lyflausa|||23|8|0|8|Icepharma hf|Napp|Joð/pólývídón||||| 132845|S01HA0401|Alcaine|augndr|5|mg/ml|15|ml|1|glas||S01HA04|01.09.2003||R|K|2|0|0|0|0|ALC|0|0|0|100|USD|1111|2348|lyfalmen|||06|15|0|0|K.Pétursson hf|Alcon|Proxýmetakaín||1111||1111|2348 132852|A07BA0104|Kolsuspension|mixtúra|150|mg/ml|100|ml|1|fl|dreifa|A07BA01|01.08.2005||L|A|3|0|0|0|0|ABI|0|0|0|100|IKR|||lyflausa|||00|100|0|3|Vistor hf|Abigo Medical AB|Lyfjakol||||| 132902|G03AB0402|Trinovum 28|töflur|0| |84|stk|1|þpakki||G03AB04|01.01.1993||R|A|2,5|0|0|0|0|JAS|0|0|0|100|SEK|820|1953|lyfalmen|||23|84|0|84|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||820||820|1953 133074|L03AA1001|Granocyte|sts|33,6|millj ae|1|stk|5|hgl|+ leysir|L03AA10|01.07.1994||R|A|2|0|1|0|1|CSA|0|0|0|100|NOK|82713|104845|lyfsjukr|||02|5|0|4|Vistor hf|Chugai sanofi-aventis|Lenógrastím||82713||82713|104845 133097|M03AX0104|NeuroBloc|stl|5000|ein/ml|0,5|ml|1|hgl||M03AX01|01.02.2009||R|K|0|0|1|0|1|EIS|0|0|0|100|SEK|32759|42652|lyfsjukr|||0|1|0|0|Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||32759|42652 133109|M03AX0104|NeuroBloc|stl|5000|ein/ml|1|ml|1|hgl||M03AX01|01.02.2009||R|K|0|0|1|0|1|EIS|0|0|0|100|SEK|36599|47433|lyfsjukr|||0|1|0|0|Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||36599|47433 133120|M03AX0104|NeuroBloc|stl|5000|ein/ml|2|ml|1|hgl||M03AX01|01.02.2009||R|K|0|0|1|0|1|EIS|0|0|0|100|SEK|40666|52497|lyfsjukr|||0|1|0|0|Vistor hf|Eisai Ltd|Clostridium botulinum toxín-A||||40666|52497 133736|J04AB0201|Rimactan|hylki|150|mg|100|stk|1|glas||J04AB02|01.04.1993||R|A|4|0|0|E|0|SAD|0|0|0|100|SEK|8782|12758|lyfalmen|||10|100|0|25|Icepharma hf|Sandoz GmbH|Rífampicín||8782||8782|12758 134274|J02AC0302|Vfend (D.A.C.)|filmhtfl|200|mg|14|stk|1|þpakki||J02AC03|01.05.2008||R|A|3|0|0|0|1|DAC|0|0|0|100|DKK|112908|142438|lyfsjukr|||00|14|0|7|D.A.C. ehf|D.A.C. ehf|Voricónazól||112908||112908|142438 134338|J01FA0901|Klacid|mixt.kyr|50|mg/ml|50|ml|1|glas|pl.fl. m/sk.sprautu|J01FA09|01.07.1998||R|A|2|0|0|0|0|ABS|0|0|1|100|DKK|2423|4129|lyfalmen|||00|50|0|5|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||2423||2423|4129 134498|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|5|ml|1|hgl||L01DB03|01.04.2009||R|K|1|0|1|0|1|AGT|0|0|0|100|XEU|2602|3725|lyfsjukr|||0|5|0|0|Actavis Group hf|Actavis Group hf|Epírúbicín||||2602|3725 134509|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|10|ml|1|hgl||L01DB03|01.04.2009||R|K|1|0|1|0|1|AGT|0|0|0|100|XEU|3889|5568|lyfsjukr|||0|10|0|0|Actavis Group hf|Actavis Group hf|Epírúbicín||||3889|5568 134520|L01DB0302 |Epirubicin Actavis|stl|2|mg/ml|25|ml|1|hgl||L01DB03|01.04.2009||R|K|1|0|1|0|1|AGT|0|0|0|100|XEU|10883|15417|lyfsjukr|||0|25|0|0|Actavis Group hf|Actavis Group hf|Epírúbicín||||10883|15417 134862|J05AR0601|Atripla|filmhtfl|0| |30|stk|1|glas|600+200+245 mg|J05AR06|01.07.2008||R|A|2|0|1|0|1|GSI|0|0|0|100|DKK|168764|211883|lyfsjukr|||00|30|0|0|Lyfjaver ehf|Gilead Science International (L)|Emtrícítabín, tenófóvír dísóproxíl og efavírenz||168687||168687|211883 135095|M01AC0101|Felden|töflur|20|mg|60|stk|1|þpakki||M01AC01|01.01.1997||R|A|4|0|0|E|0|PFI|0|0|1|100|DKK|4364|6763|lyfalmen|||00|60|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Píroxíkam||4364||4364|6763 135111|H01AC0101|Genotropin|sts|0| |12|mg|1|rörlyk|tvíhólfa|H01AC01|01.04.1992||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|73605|93506|lyfsjukr|||00|12|0|18|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sómatrópín||73605||73605|93506 135319|C08DA0107|Verapamil Merck NM|töflur|80|mg|100|stk|1|glas||C08DA01|01.01.1990||R|A|5|0|0|B|0|MNA|0|0|0|100|SEK|912|2078|lyfalmen|||00|100|0|33|Actavis Group PTC ehf|Merck NM AB|Verapamíl||912||912|2078 135434|R03BA0502|Flixotide Diskus|innúðadu|100|mcg/sk|60|sk|1|pakki|í diskus-t|R03BA05|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|2095|3683|lyfalmen|||23|60|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2095||2095|3683 136168|G03AB0401|Trinovum|töflur|0| |63|stk|1|þpakki||G03AB04|01.10.1988||R|A|2,5|0|0|0|0|JAS|0|0|0|100|SEK|820|1953|lyfalmen|||23|63|0|84|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||820||820|1953 136200|J04AC0102|Tibinide|töflur|300|mg|100|stk|1|glas||J04AC01|01.07.2005||R|A|5|0|0|0|0|REP|0|0|0|100|SEK|6095|9112|lyfalmen|||00|100|0|100|Vistor hf|Recip AB|Ísóníazíð||6095||6095|9112 136564|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|10|hgl|röntgenskuggaefni|V08CA01|01.01.1993||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|100107|126501|lyfsjukr|||02|150|0|0|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||100107||100107|126501 136572|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|10|hgl|röntgenskuggaefni|V08CA01|01.06.1997||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|74129|94158|lyfsjukr|||02|100|0|0|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||74129||74129|94158 136998|L01CD0103|Paclitaxel Hospira|irþ|6|mg/ml|50|ml|1|hgl|lausn|L01CD01|01.10.2005||R|A|2|0|1|0|1|MAY|0|0|0|100|SEK|93011|117666|lyfsjukr|||00|50|0|0|Icepharma hf|Mayne Pharma Plc|Paklítaxel||||93011|117666 137141|N02BA5102|Treo|freyðit|0| |20|stk|1|glas||N02BA51|01.07.1988||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||14|20|0|3|Vistor hf|McNeil Denmark ApS|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole||||| 137158|N02BA5102|Treo|freyðit|0| |60|stk|1|glas||N02BA51|01.07.1988||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||14|60|0|10|Vistor hf|McNeil Denmark ApS|Acetýlsalicýlsýra í blöndum, þó ekki með geðlyfjum (psychole||||| 137364|N05AB0301|Trilafon|töflur|4|mg|100|stk|1|þpakki||N05AB03|01.01.1986||R|A|5|0|0|*|0|SCP|0|1|0|100|DKK|1516|2898|lyfalmen|V2071|2579|00|100|0|13|Vistor hf|Schering-Plough|Perfenazín||1516||1516|2898 137455|N05AB0301|Trilafon|töflur|2|mg|100|stk|1|þpakki||N05AB03|01.01.1986||R|A|5|0|0|*|0|SCP|0|1|0|100|DKK|1005|2204|lyfalmen|V2070|2094|00|100|0|7|Vistor hf|Schering-Plough|Perfenazín||1005||1005|2204 137513|S01XA2011|Oculac|augndr|0| |10|ml|1|glas|með rotvörn|S01XA20|01.10.1999||L|A|2|0|0|E|0|NOH|0|0|0|100|DKK|||lyfalmen|||00|10|0|0|Vistor hf|Novartis Healthcare A/S-|Gervitár og aðrar óvirkar sam­setningar|||||1546 137521|S01XA2011|Oculac|augndr|0| |0,4|ml|20|sk-hyl|án rotvarnar|S01XA20|01.10.1999||L|A|2|0|0|E|0|NOH|0|0|0|100|DKK|||lyfalmen|||00|8|0|0|Vistor hf|Novartis Healthcare A/S-|Gervitár og aðrar óvirkar sam­setningar|||||1929 137641|S01LA0401|Lucentis|stl|10|mg/ml|0,23|ml|1|hgl|lausn|S01LA04|01.03.2007||R|A|2|0|1|0|1|NOE|0|0|0|100|DKK|159921|200969|lyfsjukr|||00|0|0|0|Vistor hf|Novartis Europharm Ltd|Ranibizumab||159921||159921|200969 137679|A09AA0205|Creon|sh-hylki|0| |100|stk|1|glas|plastglas|A09AA02|01.04.1990||R|A|2|0|0|E|0|KAC|0|0|0|100|XEU|4449|6878|lyfalmen|||10|100|0|100|Medico ehf|Kali-Chemie|Hvatablöndur (lípasi, próteasi o.s.frv.)||4449||4449|6878 137809|M05BA0302|Pamidronatdinatrium Hospira|irþ|3|mg/ml|5|ml|5|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|28191|36965|lyfsjukr|||00|25|0|1|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||28191||28191|36965 137820|M05BA0302|Pamidronatdinatrium Hospira|irþ|3|mg/ml|10|ml|1|hgl|lausn |M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|11626|16342|lyfsjukr|||00|10|0|0|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||11626||11626|16342 137831|M05BA0303|Pamidronatdinatrium Hospira|irþ|6|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|15240|20841|lyfsjukr|||00|10|0|1|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||15240||15240|20841 137842|M05BA0304|Pamidronatdinatrium Hospira|irþ|9|mg/ml|10|ml|1|hgl|lausn|M05BA03|01.05.2005||R|A|3|0|0|0|1|MAY|0|0|0|100|SEK|20025|26799|lyfsjukr|||00|10|0|2|Icepharma hf|Mayne Pharma Plc|Pamídrónsýra||20025||20025|26799 137992|J01XA0106|Vancomycin Hospira|irs|500|mg/hgl|500|mg|1|hgl||J01XA01|01.04.1997||R|A|2|0|0|0|1|HOS|0|0|0|100|DKK|2190|3136|lyfsjukr|||00|500|0|0|Vistor hf|Hospira Enterprises B.V.|Vankómýcín||2190||2190|3136 138073|J01XA0106|Vancomycin Hospira|irs|1|g/hgl|1|g|1|hgl||J01XA01|01.04.1997||R|A|2|0|0|0|1|HOS|0|0|0|100|DKK|2977|4262|lyfsjukr|||00|1|0|0|Vistor hf|Hospira Enterprises B.V.|Vankómýcín||2977||2977|4262 138560|S01ED0105|Optimol|augndr|2,5|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|2052|3625|lyfalmen|||00|15|0|60|Icepharma hf|Santen Oy|Tímólól||2052||2052|3625 138594|S01ED0105|Optimol|augndr|5|mg/ml|0,5|ml|60|sk-hyl|án rotvarnar|S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|2179|3797|lyfalmen|||00|30|0|60|Icepharma hf|Santen Oy|Tímólól||2179||2179|3797 139410|QP52AC1302|Panacur, vet.|mixtúra|100|mg/ml|250|ml|1|fl||QP52AC13|01.07.1987||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|2771|4795|vetorma|||13|250|0|0|Icepharma hf|Intervet International B.V.|||2771||2771|4795 139840|R06AA0401|Tavegyl|töflur|1|mg|100|stk|1|þpakki||R06AA04|01.08.1981||R|A|5|0|0|E|0|NHE|0|0|1|100|DKK|3047|4975|lyfalmen|||00|100|0|50|Artasan ehf|Novartis Healthcare A/S-A|Klemastín||3047||3047|4975 140118|A10BA0202|Glucophage (Lyfjaver)|töflur|1000|mg|180|stk|1|glas||A10BA02|01.07.2008||R|A|3|0|0|*|0|LVR|0|0|0|100|NOK|2824|4673|lyfalmen|||00|180|0|90|Lyfjaver ehf|Lyfjaver ehf|Metformín||2824||2824|4673 140130|V03AB3501 |Bridion|stl|100|mg/ml|2|ml|10|hgl||V03AB35|01.04.2009||R|A|3|0|1|0|1|ORG|0|0|0|100|DKK|173845|218305|lyfsjukr|||00|20|0|0|Vistor hf|N.V. Organon|||||173845|218305 140141|V03AB3501 |Bridion|stl|100|mg/ml|5|ml|10|hgl||V03AB35|01.04.2009||R|A|3|0|1|0|1|ORG|0|0|0|100|DKK|434615|542963|lyfsjukr|||00|50|0|0|Vistor hf|N.V. Organon|||||434615|542963 140186|R03BB0101|Atrovent|innúðadu|40|mcg|100|stk|1|þpakki||R03BB01|01.10.1988||R|A|2|0|0|B|0|BOI|0|0|0|100|DKK|2563|4318|lyfalmen|||19|100|0|33|Vistor hf|Boehringer Ingelheim|Ípratrópíumbrómíð||2563||2563|4318 140327|N04BC0502|Sifrol|töflur|0,088|mg|30|stk|1|þpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|1734|3193|lyfalmen|||00|30|0|1|Vistor hf|Boehringer Ingelheim International |Pramipexól||1734||1734|3193 140442|N05AF0503|Cisordinol-Acutard|stl|50|mg/ml|1|ml|10|lykjur||N05AF05|01.01.1991||R|A|2|0|0|0|1|LBK|0|1|0|100|DKK|14370|19758|lyfsjukr|||02|10|0|33|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||14370||14370|19758 140566|H01BB0201|Syntocinon|stl|10|ae/ml|1|ml|5|lykjur||H01BB02|01.12.1972||R|K|5|0|0|0|1|NOH|0|0|0|100|DKK|648|928|lyfsjukr|||02|5|0|3|Vistor hf|Novartis Healthcare A/S-|Oxýtócín||648||648|928 140954|N07BA0103|Nicorette|nefúði|10|mg/ml|10|ml|1|glas||N07BA01|01.04.1994||L|A|2|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|10|0|3|Vistor hf|McNeil Denmark ApS|Nikótín||||| 141044|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|spr|einnotaspr|H02AB04|01.04.1994||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|1371|2701|lyfalmen|||03|2|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metýlprednisólón||1371||1371|2701 141164|N01BB2005|Emla (D.A.C.)|krem|5|%|5|g|5|túpa|0|N01BB20|01.11.2008||R|A|3|0|0|0|0|DAC|0|0|1|100|SEK|3023|4943|lyfalmen|V2002|4943|00|25|0|5|D.A.C. ehf|D.A.C. ehf|Blöndur||||3023|4943 141175|J01CA0409|Flemoxin (D.A.C.)|mixtúrud|50|mg/ml|100|ml|1|glas||J01CA04|01.10.2008||R|A|4|0|0|0|0|DAC|0|0|1|100|XEU|1383|2717|lyfalmen|||08|80|0|0|D.A.C. ehf|D.A.C. ehf|Amoxicillín||||1383|2717 141197|N02BE0112|Perfalgan (D.A.C.)|irl|10|mg/ml|100|ml|12|hgl||N02BE01|01.05.2008||R|A|2|0|0|0|1|DAC|0|0|0|100|DKK|9044|12949|lyfsjukr|||00|1200|0|4|D.A.C. ehf|D.A.C. ehf|Paracetamól||9044||9044|12949 141208|B03AC0204|Venofer (D.A.C.)|stl|20|mg/ml|5|ml|5|lykjur||B03AC02|01.10.2008||R|A|3|0|0|E|0|DAC|0|0|1|100|CHF|14186|19847|lyfalmen|V0011|18630|00|25|0|5|D.A.C. ehf|D.A.C. ehf|Járnoxíð (sykurflétta)||14186||14186|19847 141219|J02AC0302|Vfend (D.A.C.)|irs|200|mg|1|hgl|1|pakki||J02AC03|01.05.2008||R|A|3|0|0|0|1|DAC|0|0|0|100|DKK|27412|35995|lyfsjukr|||00|1|0|0|D.A.C. ehf|D.A.C. ehf|Voricónazól||27412||27412|35995 141432|N04BC0502|Sifrol|töflur|0,18|mg|30|stk|1|þpakki||N04BC05|01.05.2005||R|A||0|0|E|0|BII|0|0|0|100|DKK|3351|5388|lyfalmen|||00|30|0|2|Vistor hf|Boehringer Ingelheim International |Pramipexól||3351||3351|5388 141684|G03AA1205|Yaz|filmhtfl|0||84|stk|1|þpakki|0,02mg/3mg|G03AA12|01.02.2009||R|A|5|0|0|0|0|BAB|0|0|0|100|SEK|4034|5080|lyfalmen|||0|84|0|0|Icepharma hf|Bayer AB|Dróspírenón og östrógen||3124||3124|5080 141751|J01EE0106|Co-trimoxazole|töflur|480|mg|28|stk|1|glas|80+400 mg|J01EE01|01.02.2008||R|A|5|0|0|0|0|AUK|0|0|1|100|GBP|630|1695|lyfalmen|||00|28|0|7|Actavis Group hf|Actavis UK Ltd.|Súlfametoxazól og trímetóprím||||630|1695 141945|N04BC0502|Sifrol|töflur|0,18|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|9263|13411|lyfalmen|||00|100|0|7|Vistor hf|Boehringer Ingelheim International|Pramipexól||9263||9263|13411 142059|C07AA0509|Propranolol Merck NM|töflur|10|mg|100|stk|1|glas||C07AA05|01.10.1992||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|436|1432|lyfalmen|||00|100|0|6|Actavis Group PTC ehf|Merck NM AB|Própranólól||436||436|1432 142190|C07AA0509|Propranolol Merck NM|töflur|40|mg|100|stk|1|glas||C07AA05|01.10.1992||R|A|5|0|0|B|0|MNA|0|0|0|100|SEK|560|1600|lyfalmen|||00|100|0|25|Actavis Group PTC ehf|Merck NM AB|Própranólól||560||560|1600 142299|C01BD0101|Cordarone|stl|50|mg/ml|3|ml|10|lykjur||C01BD01|01.04.1987||R|A|2|0|0|0|1|SNO|0|0|0|100|NOK|7954|11388|lyfsjukr|||02|30|0|8|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||7954||7954|11388 142307|C01BD0101|Cordarone|töflur|200|mg|30|stk|1|þpakki||C01BD01|01.04.1987||R|A|5|0|0|B|0|SNO|0|0|0|100|NOK|995|2191|lyfalmen|V0143|2191|70|30|0|30|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||995||995|2191 142323|J01XX0501|Haiprex|töflur|1|g|100|stk|1|glas||J01XX05|01.10.1995||R|A|5|0|0|0|0|MEB|0|0|1|100|SEK|2383|4074|lyfalmen|||00|100|0|50|Vistor hf|Meda AB (V)|Metenamín||2383||2383|4074 142596|C07AA0509|Propranolol Merck NM|töflur|80|mg|100|stk|1|glas||C07AA05|01.10.1992||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|776|1893|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck NM AB|Própranólól||776||776|1893 143339|H02AB0403|Solu-Medrol|sts|125|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.07.1974||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|2089|3675|lyfalmen|||03|1|0|6|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metýlprednisólón||2089||2089|3675 143347|H02AB0403|Solu-Medrol|sts|500|mg|1|stk|1|hgl|+ leysir|H02AB04|01.07.1974||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|4689|6713|lyfsjukr|||03|1|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metýlprednisólón||4689||4689|6713 143412|S01BA0401|Ultracortenol|augnsm|5|mg/g|5|g|1|túpa||S01BA04|01.12.1972||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|743|1849|lyfalmen|||07|5|0|0|Vistor hf|Novartis Healthcare A/S-|Prednisólón||743||743|1849 143413|S01JX|Methocel 2%|lausn|20|mg/ml|30|ml|1|glas||S01|01.05.1998||R|A||0|0|0|0|PCO|0|0|1|100|IKR|1370|2700|lyfalmen|||00|30|1|0|Distica|Distica - óskráð lyf|||1370||1370|2700 143511|J07BC2002|Twinrix Peadriatric|bóluefni|0| |0,5|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|3234|5229|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|blöndur||3234||3234|5229 143586|S01FA0601|Mydriacyl 1 %|augndr|10|mg/ml|15|ml|1|glas||S01FA06|01.09.2003||R|A|3|0|0|0|0|ALC|0|0|0|100|USD|917|2085|lyfalmen|||06|15|0|0|K.Pétursson hf|Alcon|Trópíkamíð||917||917|2085 143602|J01FA1001|Zitromax|töflur|500|mg|2|stk|1|þpakki||J01FA10|01.11.1998||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|1776|3250|lyfalmen|||00|2|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Azitrómýcín||1776||1776|3250 143610|N02CX0201|Catapresan|töflur|25|mcg|100|stk|1|þpakki||N02CX02|01.04.1974||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|2268|3918|lyfalmen|||00|100|0|25|Vistor hf|Boehringer Ingelheim|Klónidín||2268||2268|3918 143631|A10BD0701|Janumet|filmhtfl|0||56|stk|1|þpakki|50/1000mg|A10BD07|01.03.2009||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|8829|12822|lyfalmen|||0|56|0|0|Icepharma hf|M.S.D.|||||8829|12822 143653|N06AB0403|Cipramil (D.A.C.)|töflur|20|mg|98|stk|1|glas||N06AB04|01.11.2008||R|A|3|0|0|B|0|DAC|0|1|0|100|DKK|10988|6182|lyfalmen|V0926|4223|00|98|0|98|D.A.C. ehf|D.A.C. ehf|Cítalópram||3936||3936|6182 143727|D07AB0201|Locoid|smyrsli|1|mg/g|30|g|1|túpa||D07AB02|01.07.1985||R|A|5|0|0|B|0|ASP|0|0|1|100|XEU|937|2112|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||937||937|2112 143800|N05AN0101|Litarex|forðatfl|564|mg|100|stk|1|glas||N05AN01|01.04.1974||R|A|5|0|0|*|0|AGT|0|1|0|100|DKK|1224|2501|lyfalmen|||10|100|0|25|Actavis Group hf|Actavis Group hf|Litíum||1224||1224|2501 143891|J01FA1001|Zitromax|töflur|500|mg|3|stk|1|þpakki||J01FA10|01.11.1998||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|2838|4692|lyfalmen|V0429|4655|00|3|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Azitrómýcín||2838||2838|4692 143917|L01DB0301|Farmorubicin|stl|2|mg/ml|5|ml|1|hgl|plasthgl|L01DB03|01.09.1998||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|4294|6148|lyfsjukr|||02|5|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Epírúbicín||4294||4294|6148 143933|L01DB0301|Farmorubicin|stl|2|mg/ml|10|ml|1|hgl|plasthgl|L01DB03|01.09.1998||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|8253|11816|lyfsjukr|||02|10|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Epírúbicín||8253||8253|11816 144030|N04BA0207|Sinemet depot mite|forðatfl|125|mg|100|stk|1|glas|25+100 mg|N04BA02|01.04.1992||R|A|2|0|0|E|0|MSD|0|0|0|100|XEU|3840|6051|lyfalmen|||10|100|0|17|Icepharma hf|M.S.D.|Levódópa og dópadekarboxýl­asa­hemill||3840||3840|6051 144089|J07BC0203|Vaqta|bóluefni|50|ein|1|ml|1|spr|áfyllt spr. með nál|J07BC02|01.03.2001||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|4837|7404|lyfalmen|||51|1|0|0|Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||4837||4837|7404 144105|L01DB0301|Farmorubicin|stl|2|mg/ml|25|ml|1|hgl|plasthgl|L01DB03|01.09.1998||R|K|3|0|1|0|1|PFI|0|0|0|100|DKK|15092|20657|lyfsjukr|||02|25|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Epírúbicín||15092||15092|20657 144139|H01AC0106|Norditropin Simplexx|stl|10|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|97634|123422|lyfsjukr|||AC|2|0|22|Vistor hf|Novo-Nordisk|Sómatrópín||97634||97634|123422 144330|A02BC0108|Omeprazol Actavis|sh-hylki|20|mg|28|stk|1|þpakki||A02BC01|01.02.2009||L|A|3|0|0|0|0|AGT|0|0|0|100|IKR|||lyflausa|||0|28|0|28|Actavis Group hf|Actavis Group hf|Ómeprazól||||| 144436|H01AC0106|Norditropin Simplexx|stl|6,7|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|61302|78188|lyfsjukr|||AC|2|0|15|Vistor hf|Novo-Nordisk|Sómatrópín||61302||61302|78188 144725|H01AC0106|Norditropin Simplexx|stl|3,3|mg/ml|1,5|ml|1|rörlyk||H01AC01|01.02.2000||R|K|2|0|1|0|1|NON|0|0|0|100|DKK|39858|51491|lyfsjukr|||AC|2|0|7|Vistor hf|Novo-Nordisk|Sómatrópín||39858||39858|51491 144808|D07AB0201|Locoid|lausn|1|mg/ml|30|ml|1|glas||D07AB02|01.10.1986||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|915|2082|lyfalmen|||20|30|0|30|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||915||915|2082 144964|N05BA0205|Risolid|filmhtfl|10|mg|24|stk|1|plglas||N05BA02|01.04.2008||R|A|5|0|0|0|0|AGT|0|0|1|100|XEU|425|1417|lyfalmen|||00|24|0|8|Actavis Group hf|Actavis Group hf|Klórdíazepoxíð||425||425|1417 144980|N05BA0205|Risolid|filmhtfl|25|mg|24|stk|1|plglas||N05BA02|01.04.2008||R|A|5|0|0|0|0|AGT|0|0|1|100|XEU|735|1838|lyfalmen|||00|24|0|20|Actavis Group hf|Actavis Group hf|Klórdíazepoxíð||735||735|1838 145292|J07BC0203|Vaqta|bóluefni|25|ein|0,5|ml|1|spr|áfyllt spr. með nál|J07BC02|01.03.2001||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|3238|5235|lyfalmen|||51|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3238||3238|5235 145508|D07AC0104|Diproderm|krem|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|A|5|0|0|B|0|SCP|0|0|1|100|DKK|5022|7655|lyfalmen|||20|100|0|100|Vistor hf|Schering-Plough|Betametasón||5022||5022|7655 145540|P02CX0101|Vanquin|mixtúra|10|mg/ml|30|ml|1|glas||P02CX01|01.12.1972||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||24|30|0|0|Vistor hf|Recip AB|Pýrvín||||| 145607|P02CX0101|Vanquin|töflur|50|mg|8|stk|1|þpakki||P02CX01|01.12.1972||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||23|8|0|0|Vistor hf|Recip AB|Pýrvín||||| 145631|P02CX0101|Vanquin|töflur|50|mg|32|stk|1|þpakki||P02CX01|01.01.1995||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||23|32|0|0|Vistor hf|Recip AB|Pýrvín||||| 145698|N05AH0301|Zyprexa|húðuðtfl|10|mg|28|stk|1|þpakki||N05AH03|01.03.1998||R|A|3|0|0|*|0|ELD|0|1|0|100|XEU|21304|28708|lyfalmen|||00|28|0|28|Icepharma hf|Eli Lilly Nederland -|Olanzapín||21304||21304|28708 146207|L01XX1903|Irinotecan Mayne|irþ|20|mg/ml|2|ml|1|hgl|lausn|L01XX19|01.03.2009||R|A|3|0|1|0|1|MAY|0|0|0|100|XEU|10580|15040|lyfsjukr|||0|2|0|0|Icepharma hf|Mayne Pharma Plc|Írinótekan||||10580|15040 146218|L01XX1903|Irinotecan Mayne|irþ|20|mg/ml|5|ml|1|hgl|lausn|L01XX19|01.03.2009||R|A|3|0|1|0|1|MAY|0|0|0|100|XEU|25061|33068|lyfsjukr|||0|5|0|0|Icepharma hf|Mayne Pharma Plc|Írinótekan||||25061|33068 146530|P01AB0102|Flagyl|töflur|400|mg|10|stk|1|þpakki||P01AB01|01.10.1995||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|778|1896|lyfalmen|||41|10|0|2|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||778||778|1896 147241|L01BC0102|Arabine|stl/irl|100|mg/ml|1|ml|5|hgl||L01BC01|01.03.2009||R|A|3|0|1|0|1|MAY|0|0|0|100|XEU|4913|7034|lyfsjukr|||0|5|0|0|Icepharma hf|Mayne Pharma Plc|Cýtarabín||||4913|7034 147252|L01BC0102|Arabine|stl/irl|100|mg/ml|10|ml|1|hgl||L01BC01|01.03.2009||R|A|3|0|1|0|1|MAY|0|0|0|100|XEU|4145|5935|lyfsjukr|||0|10|0|0|Icepharma hf|Mayne Pharma Plc|Cýtarabín||||4145|5935 147512|G03DA0202|Perlutex|töflur|5|mg|50|stk|1|þpakki||G03DA02|01.03.1981||R|A|5|0|0|E|0|LEP|0|0|0|100|DKK|1294|2596|lyfalmen|||00|50|0|50|Vistor hf|LEO Pharma A/S|Medroxýprógesterón||1294||1294|2596 147702|B05AA0501|Macrodex 60 mg/ml med glukos|irl|0| |500|ml|12|pokar||B05AA05|01.07.1991||R|A|2|0|0|0|1|MAB|0|0|0|100|SEK|12141|16983|lyfsjukr|||00|6000|0|6|Vistor hf|Meda AB|Dextran||12141||12141|16983 147728|B05AA0508|Rheomacrodex med glukos|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|A|2|0|0|0|1|MAB|0|0|0|100|SEK|19408|26030|lyfsjukr|||00|6000|0|6|Vistor hf|Meda AB|Dextran||19408||19408|26030 147926|J01GB0301|Garamycin|stl|40|mg/ml|2|ml|100|hgl||J01GB03|01.12.1975||R|A|5|0|0|0|1|SCP|0|0|0|100|DKK|41302|53288|lyfsjukr|||02|200|0|33|Vistor hf|Schering-Plough|Gentamícín||41302||41302|53288 148213|R05CB1301|Pulmozyme|innúðal|1|mg/ml|2,5|ml|30|lykjur||R05CB13|01.01.1997||R|K|2|0|0|0|0|ROA|0|0|1|100|DKK|124911|157699|lyfalmen|||00|750|0|30|Icepharma hf|Roche as|Dornase alfa||124911||124911|157699 148452|N04AA0201|Akineton|töflur|2|mg|100|stk|1|þpakki||N04AA02|01.11.2005||R|A|5|0|0|*|0|LFS|0|1|0|100|DKK|1079|2305|lyfalmen|||00|100|0|20|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||1079||1079|2305 148917|L01BA0301|Tomudex|irs|2|mg/hgl|1|hgl|1|pakki||L01BA03|01.03.1998||R|A|3|0|1|0|1|HON|0|0|0|100|SEK|21164|28217|lyfsjukr|||00|1|0|0|Vistor hf|Hospira Nordic AB (V)|Raltítrexed||21164||21164|28217 148939|D05AX5202|Daivobet (D.A.C.)|smyrsli|0||120|g|1|túpa|50 mcg/g+0,5 mg/g|D05AX52|01.11.2008||R|A|2|0|0|B|0|DAC|0|0|0|100|DKK|15939|19381|lyfalmen|V2001|19381|00|120|0|120|D.A.C. ehf|D.A.C. ehf|Kalcípótríól í blöndum||13812||13812|19381 148950|N06DA0203 |Aricept (D.A.C.)|töflur|5|mg|98|stk|1|þpakki||N06DA02|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|47639|61496|lyfalmen|V0375|39189|00|98|0|65|D.A.C. ehf|D.A.C. ehf|Dónepezíl||||47639|61496 148961|N06DA0203 |Aricept (D.A.C.)|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|0|100|DKK|51545|66359|lyfalmen|V0376|43720|00|98|0|131|D.A.C. ehf|D.A.C. ehf|Dónepezíl||||51545|66359 148972|C09DA0304|Diovan Comp 160/12,5 mg (D.A.C.)|filmhtfl|172,5|mg|98|stk|1|þpakki|160/12,5 mg|C09DA03|01.11.2008||R|A|3|0|0|B|0|DAC|0|0|0|100|DKK|15449|21419|lyfalmen|V0192|17884|00|98|0|196|D.A.C. ehf|D.A.C. ehf|Valsartan og þvagræsilyf||||15449|21419 148999|QN05CM9201|Rompun, vet.|stl|20|mg/ml|25|ml|1|hgl||QN05CM92|01.12.1972||R|A|3,25|0|0|0|0|BAN|1|0|0|100|DKK|3703|7225|vetalmen|||27|25|0|0|Vistor hf|Bayer Animal Health GmbH|||3703||3703|7225 149146|N05AG0201|Orap|töflur|1|mg|75|stk|1|þpakki||N05AG02|01.03.2004||R|A|5|0|0|0|0|PCO|0|1|0|100|IKR|1719|3173|lyfalmen|||00|75|1|19|Distica|Distica - óskráð lyf|||1719||1719|3173 150243|J04AB0201|Rimactan|hylki|300|mg|100|stk|1|glas||J04AB02|01.04.1993||R|A|4|0|0|E|0|SAD|0|0|0|100|SEK|13590|19105|lyfalmen|||10|100|0|50|Icepharma hf|Sandoz GmbH|Rífampicín||13590||13590|19105 150996|J07AH0401|Mencevax ACWY|stl|50|mcg|0,5|ml|1|hgl||J07AH04|01.11.2008||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|3397|5450|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|||||3397|5450 151191|N05AF0102|Fluanxol Depot|stl|20|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1977||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|7309|10759|lyfalmen|||02|10|0|50|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||7309||7309|10759 151217|G01AF0102|Flagyl|sk-stil|500|mg|10|stk|1|pakki|+ hanskar|G01AF01|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1049|2264|lyfalmen|||05|10|0|10|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1049||1049|2264 151518|N06DX0101|Ebixa|filmhtfl|20|mg|28|stk|1|þpakki||N06DX01|01.11.2008||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|16255|22422|lyfalmen|||00|28|0|28|Lundbeck Export A/S - útibú Íslandi|H. Lundbeck A/S|Memantín||||16255|22422 151529|N06DX0101|Ebixa|filmhtfl|20|mg|98|stk|1|þpakki||N06DX01|01.11.2008||R|A|4|0|0|E|0|LBK|0|0|0|100|DKK|50190|64672|lyfalmen|||00|28|0|98|Lundbeck Export A/S - útibú Íslandi|H. Lundbeck A/S|Memantín||||50190|64672 151640|G04CA0204|Tamsulogen|hylki|0,4|mg|90|stk|1|þpakki|með br. losunarhraða|G04CA02|01.05.2006||R|A|3|0|0|E|0|MYL|0|0|0|100|SEK|6038|6986|lyfalmen|V0437|6694|00|90|0|90|Actavis Group PTC ehf|Mylan AB|Tamsúlósín||4529||4529|6986 151928|N06AA1201|Sinquan|hylki|25|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|1638|3063|lyfalmen|||10|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxepín||1638||1638|3063 151944|N06AA1201|Sinquan|hylki|10|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|1130|2374|lyfalmen|||10|100|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxepín||1130||1130|2374 152223|M03BX0103|Lioresal|stl|50|mcg/ml|1|ml|5|lykjur|stl.intrathecal.|M03BX01|01.10.1995||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|712|1019|lyfsjukr|||02|5|0|0|Vistor hf|Novartis Healthcare A/S-|Baklófen||712||712|1019 152348|M02AA0701|Felden gel|hlaup|5|mg/g|25|g|1|glas||M02AA07|01.04.1996||L|A|3|0|0|0|0|PFI|0|0|1|100|IKR|||lyflausa|||23|25|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Píroxíkam||||| 152397|R03BA0202|Pulmicort Turbuhaler|innúðadu|100|mcg/sk|200|sk|1|stauk||R03BA02|01.04.1991||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|3767|5952|lyfalmen|||23|200|0|25|Vistor hf|AstraZeneca A/S DK|Búdesóníð||3767||3767|5952 152413|R03BA0202|Pulmicort Turbuhaler|innúðadu|200|mcg/sk|200|sk|1|stauk||R03BA02|01.10.1989||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|5830|8752|lyfalmen|||23|200|0|50|Vistor hf|AstraZeneca A/S DK|Búdesóníð||5830||5830|8752 152421|R03BA0202|Pulmicort Turbuhaler|innúðadu|400|mcg/sk|200|sk|1|stauk||R03BA02|01.10.1989||R|A|2|0|0|B|0|ASZ|0|0|0|100|SEK|9762|14088|lyfalmen|||23|200|0|100|Vistor hf|AstraZeneca UK Ltd|Búdesóníð||9762||9762|14088 152991|J02AC0201|Sporanox|hylki|100|mg|4|stk|1|þpakki||J02AC02|01.01.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|1585|2991|lyfalmen|||10|4|0|2|Vistor hf|Janssen-Cilag AB|Ítracónazól||1585||1585|2991 153080|R06AE0704|Histasin|töflur|10|mg|10|stk|1|þpakki||R06AE07|01.01.1998||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|10|0|10|Actavis Group hf|Actavis hf|Cetirizín||||| 153122|N01BB5203|Xylocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|(10mg+5míkróg)/ml|N01BB52|01.10.1995||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|1698|3145|lyfalmen|||17|100|0|0|Vistor hf|AstraZeneca A/S DK|||1698||1698|3145 153197|R06AE0704|Histasin|töflur|10|mg|30|stk|1|þpakki||R06AE07|01.01.1998||L|A|3|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|30|0|30|Actavis Group hf|Actavis hf|Cetirizín||||| 153254|N01BB0203|Xylocain|stl|20|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|1920|3446|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|Lídókaín||1920||1920|3446 153270|N01BB0203|Xylocain|stl|10|mg/ml|20|ml|5|hgl|með rotvörn|N01BB02|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|1534|2922|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|Lídókaín||1534||1534|2922 153288|R06AE0704|Histasin|töflur|10|mg|100|stk|1|þpakki||R06AE07|01.01.1998||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|2214|3845|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|Cetirizín||2214||2214|3845 153379|J02AA0104|AmBisome|irs|50|mg/hgl|10|hgl|1|pakki||J02AA01|01.07.2001||R|A|3|0|0|0|1|GIS|0|0|0|100|DKK|377855|472297|lyfsjukr|||00|10|0|14|Gilead Sience Sweden AB|Gilead Science International ltd.|Amfóterícín||377855||377855|472297 153536|J02AC0201|Sporanox|hylki|100|mg|15|stk|1|þpakki||J02AC02|01.04.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|5311|8048|lyfalmen|||10|15|0|8|Vistor hf|Janssen-Cilag AB|Ítracónazól||5311||5311|8048 153575|M01AH0102 |Celebra (D.A.C.)|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.05.2009||R|A|3|0|0|E|0|DAC|0|0|1|100|DKK|14139|19788|lyfalmen|V2140|19788|00|100|0|100|D.A.C. ehf|D.A.C. ehf|Celekoxíb||||14139|19788 153593|B03BA0302|Vibeden|stl|1|mg/ml|1|ml|5|lykjur||B03BA03|01.12.1972||R|A|2|0|0|E|0|HEX|0|0|1|100|DKK|6978|10310|lyfalmen|||02|5|0|250|Vistor hf|Hexal A/S|Hýdroxókóbalamín||6978||6978|10310 153734|L01CA0101|Velbe|sts|10|mg/hgl|1|sk|1|hgl||L01CA01|01.01.1998||R|K||0|1|0|1|LDR|0|0|0|100|IKR|2880|4123|lyfsjukr|||00|1|1|0|Parlogis hf|Parlogis - óskráð lyf|||2880||2880|4123 154464|D05AX5203 |Xamiol|hlaup|0||30|g|1|plastf|50 mcg/g+0,5 mg/g|D05AX52|01.05.2009||R|A||0|0|B|0|LEP|0|0|0|100|DKK|4800|7354|lyfalmen|||00|30|0|0|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||||4800|7354 154475|D05AX5203 |Xamiol|hlaup|0||60|g|1|plastf|50 mcg/g+0,5 mg/g|D05AX52|01.05.2009||R|A||0|0|B|0|LEP|0|0|0|100|DKK|9192|13314|lyfalmen|||00|60|0|0|Vistor hf|LEO Pharma A/S|Kalcípótríól í blöndum||||9192|13314 154484|G04CA0102|Xatral Uno|forðatfl|10|mg|30|stk|1|þpakki||G04CA01|01.01.2003||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|5696|8570|lyfalmen|||00|30|0|40|Vistor hf|Sanofi-aventis Norge AS|Alfúzósín||5696||5696|8570 154591|M01AB5501|Arthrotec|töflur|50,2|mg|20|stk|1|pakki|þp (0,2+50 mg)|M01AB55|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|1375|2706|lyfalmen|||10|20|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||1375||1375|2706 154708|M01AB5501|Arthrotec|töflur|50,2|mg|100|stk|1|pakki|þp (0,2+50 mg)|M01AB55|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|5384|8147|lyfalmen|V2130|8002|10|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5384||5384|8147 154732|G04CA0102|Xatral Uno|forðatfl|10|mg|90|stk|1|þpakki||G04CA01|01.01.2003||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|12067|17208|lyfalmen|||00|90|0|120|Vistor hf|Sanofi-aventis Norge AS|Alfúzósín||12067||12067|17208 155085|L01AA0201|Leukeran|töflur|2|mg|25|stk|1|glas||L01AA02|01.06.2001||R|K|3|0|0|*|0|GSK|0|0|0|100|GBP|1196|2463|lyfalmen|||00|25|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Chlorambucíl||1196||1196|2463 155390|N05AF0301|Truxal|töflur|50|mg|100|stk|1|glas||N05AF03|01.12.1972||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|1717|3170|lyfalmen|||00|100|0|17|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||1717||1717|3170 155432|N05AF0301|Truxal|töflur|15|mg|100|stk|1|glas||N05AF03|01.12.1972||R|A|5|0|0|*|0|LBK|0|1|0|100|DKK|532|1562|lyfalmen|||00|100|0|5|Lundbeck Export A/S|H. Lundbeck A/S|Klórprótixen||532||532|1562 155648|J02AC0201|Sporanox|hylki|100|mg|28|stk|1|þpakki||J02AC02|01.04.1995||R|A|3|0|0|0|0|JAS|0|0|1|100|SEK|10049|14477|lyfalmen|||00|28|0|14|Vistor hf|Janssen-Cilag AB|Ítracónazól||10049||10049|14477 156505|A08AB0101|Xenical|hylki|120|mg|42|stk|1|þpakki||A08AB01|01.07.1999||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|6457|9603|lyfalmen|||00|42|0|14|Icepharma hf|Roche|Orlístat||6457||6457|9603 156596|A08AB0101|Xenical|hylki|120|mg|84|stk|1|þpakki||A08AB01|01.07.1999||R|A|3|0|0|0|0|ROC|0|0|0|100|DKK|9446|13659|lyfalmen|||00|84|0|28|Icepharma hf|Roche|Orlístat||||9446|13659 156661|P02CA0101|Vermox|töflur|100|mg|6|stk|1|þpakki||P02CA01|01.12.1982||R|A|5|0|0|0|0|JAS|0|0|0|100|SEK|323|1279|lyfalmen|||00|6|0|3|Vistor hf|Janssen-Cilag AB|Mebendazól||323||323|1279 156964|N07BA0137 |Nicorette (D.A.C.)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2.5|0|0|0|0|DAC|0|0|1|100|ISK|||lyflausa|||23|210|0|14|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 156986|N07BA0138 |Nicorette Freshmint (D.A.C.)|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|ISK|||lyflausa|||23|105|0|14|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 156997|N07BA0138 |Nicorette Freshmint (D.A.C.)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|ISK|||lyflausa|||00|210|0|28|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157020|N07BA0138 |Nicorette Freshmint (D.A.C.)|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|ISK|||lyflausa|||23|105|0|7|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157031|N07BA0138 |Nicorette Freshmint (D.A.C.)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|ISK|||lyflausa|||00|210|0|14|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157053|N07BA0139 |Nicorette Fruitmint (D.A.C.)|tyggigúm|4|mg|105|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|ISK|||lyflausa|||23|105|0|14|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157064|N07BA0139 |Nicorette Fruitmint (D.A.C.)|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|ISK|||lyflausa|||00|210|0|28|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157086|N07BA0139 |Nicorette Fruitmint (D.A.C.)|tyggigúm|2|mg|105|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|ISK|||lyflausa|||23|105|0|7|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157097|N07BA0139 |Nicorette Fruitmint (D.A.C.)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2|0|0|0|0|DAC|0|0|1|100|ISK|||lyflausa|||00|210|0|14|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157206|QP52AF0201|Banminth, vet.|pasta|11,4|g/skdæla|26|g|10|spr|.|QP52AF02|01.04.1992||R|A|1|0|0|0|0|PAL|0|0|0|100|DKK|7446|12886|vetorma|||16|260|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health|||7446||7446|12886 157419|N07BA0134 |Nicotinell Mint (D.A.C.)|munnstfl|1|mg|204|stk|1|pakki||N07BA01|01.05.2009||L|A|3|0|0|0|0|DAC|0|0|1|100|ISK|||lyflausa|||23|204|0|7|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157430|N07BA0140 |Nicorette Peppermynte (D.A.C.)|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.05.2009||L|A|2.5|0|0|0|0|DAC|0|0|1|100|ISK|||lyflausa|||23|210|0|14|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157463|N07BA0134 |Nicotinell Mint (D.A.C.)|munnstfl|2|mg|96|stk|1|pakki||N07BA01|01.05.2009||L|A|3|0|0|0|0|DAC|0|0|1|100|ISK|||lyflausa|||23|96|0|6|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157598|N07BA0134|Nicotinell Mint (D.A.C.)|tyggigúm|4|mg|96|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|96|0|13|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157609|N07BA0134|Nicotinell Mint (D.A.C.)|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|204|0|27|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157642|N07BA0134|Nicotinell Mint (D.A.C.)|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.12.2008||L|A|2|0|0|0|0|DAC|0|0|1|100|IKR|||lyflausa|||00|204|0|14|D.A.C. ehf|D.A.C. ehf|Nikótín||||| 157768|S01AA3001|Terramycin Polymyxin B|augnsm|0| |3,5|g|1|túpa||S01AA30|01.01.2000||R|S|5|0|0|E|0|PCO|0|0|1|100|IKR|554|1592|lyfalmen|||07|4|1|0|Distica|Distica - óskráð lyf|||554||554|1592 157909|D07XC0101|Diprosalic|áburður|0| |100|ml|1|glas||D07XC01|01.01.1987||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|3440|5509|lyfalmen|||20|100|0|100|Vistor hf|Schering-Plough|Betametasón||3440||3440|5509 158287|N03AF0104|Tegretol|töflur|200|mg|50|stk|1|þpakki||N03AF01|01.12.1972||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|1028|2235|lyfalmen|||00|50|0|10|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1028||1028|2235 158431|B02BD0801 |NovoSeven|sts|1|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|A|2|0|1|0|1|NON|0|0|0|100|DKK|105630|133377|lyfsjukr|||00|1|0|0|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||||105630|133377 158442|B02BD0801 |NovoSeven|sts|2|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|A|2|0|1|0|1|NON|0|0|0|100|DKK|211260|264886|lyfsjukr|||00|1|0|0|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||||211260|264886 158453|B02BD0801 |NovoSeven|sts|5|mg|1|hgl|1|pakki|+leysir, lausn|B02BD08|01.04.2009||R|A|2|0|1|0|1|NON|0|0|0|100|DKK|599024|747652|lyfsjukr|||00|1|0|0|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||||599024|747652 158608|J02AX0501|Mycamine|irs|50|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|A|3|0|1|0|1|APG|0|0|0|100|XEU|54004|69102|lyfsjukr|||0|1|0|0|Vistor hf|Astellas Pharma GmbH|||||54004|69102 158619|J02AX0501|Mycamine|irs|100|mg|1|hgl|1|pakki||J02AX05|01.03.2009||R|A|3|0|1|0|1|APG|0|0|0|100|XEU|85055|107761|lyfsjukr|||0|1|0|0|Vistor hf|Astellas Pharma GmbH|||||85055|107761 158683|H01BB0201|Syntocinon|nefúði|6,7|mcg/sk|5|ml|1|stauk||H01BB02|01.07.1988||R|K|4|0|0|E|0|NOH|0|0|0|100|DKK|1144|2393|lyfalmen|||23|5|0|13|Vistor hf|Novartis Healthcare A/S-|Oxýtócín||1144||1144|2393 158725|M01AB0515|Diklofenak Merck NM|sþ-tfl|50|mg|100|stk|1|þpakki||M01AB05|01.12.2008||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|855|2001|lyfalmen|V0608|2001|10|100|0|50|Actavis Group PTC ehf|Mylan AB|Díklófenak||||855|2001 158729|C07AB0208|Selo-ZOC (D.A.C.)|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.11.2008||R|A|3|0|0|B|0|DAC|0|0|0|100|SEK|2016|3576|lyfalmen|V2003|3576|00|98|0|31|D.A.C. ehf|D.A.C. ehf|Metóprólól||||2016|3576 159107|N02AB0303|Fentanyl Actavis|forðapl|25|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|3588|5709|lyfalmen|V1050|5709|00|5|0|21|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||||3588|5709 159118|N02AB0303|Fentanyl Actavis|forðapl|50|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|6909|10216|lyfalmen|V1051|10216|00|5|0|42|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||||6909|10216 159130|N02AB0303|Fentanyl Actavis|forðapl|75|mcg/klst|5|stk|1|þpakki||N02AB03|01.12.2008||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|9667|13959|lyfalmen|V1052|13959|00|5|0|62|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||||9667|13959 159141|N02AB0303|Fentanyl Actavis|forðapl|100|mcg/klst|5|stk|1|þpakki||N02AB03|01.01.1996||R|A|2|1|0|E|0|AGP|0|0|0|100|XEU|11622|16612|lyfalmen|V1053|16612|00|5|0|83|Actavis Group hf|Actavis Group PTC ehf|Fentanýl||||11622|16612 159517|N06AB0401|Cipramil|töflur|20|mg|56|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|6635|4576|lyfalmen|V0925|3253|00|56|0|56|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2753||2753|4576 159533|L02BG0601|Aromasin|töflur|25|mg|30|stk|1|þpakki||L02BG06|01.06.2001||R|A|3|0|0|*|0|PFI|0|0|0|100|DKK|26269|34890|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Exemestan||26269||26269|34890 159541|N06AB0401|Cipramil|töflur|40|mg|56|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|13581|12367|lyfalmen|V0929|7881|00|56|0|112|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||8494||8494|12367 159558|N06AB0401|Cipramil|töflur|10|mg|28|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|1920|2526|lyfalmen|V0921|1893|00|28|0|14|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||1242||1242|2526 159632|N06AB0401|Cipramil|töflur|20|mg|28|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|3325|3598|lyfalmen|V0923|2562|00|28|0|28|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2032||2032|3598 159640|N06AB0401|Cipramil|töflur|40|mg|28|stk|1|þpakki||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|6851|4827|lyfalmen|V0927|3332|00|28|0|56|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||2938||2938|4827 159772|B01AD0701|Rapilysin|sts|10|ae/hgl|2|hgl|1|pakki|+ leysir|B01AD07|01.02.2002||R|A|3|0|0|0|1|ACA|0|0|0|100|DKK|173550|217937|lyfsjukr|||00|2|0|1|Actavis Group PTC ehf|Actavis Group PTC ehf|Reteplasi||173550||173550|217937 159806|QG51BE0001|Streptoc. m/sulfadim., vet.|legstil|0| |50|stk|50|stilar||QG51BE00|01.11.1979|31.03.2009|R|A|2|0|0|0|0|BID|1|0|0|100|DKK|9605|18467|vetalmen|||00|2500|0|0|Vistor hf|Boehringer Ingelheim Danmark|||9605||9605|18467 160325|N05BA0105|Stesolid|stl|5|mg/ml|2|ml|25|lykjur||N05BA01|01.04.1974||R|A|3|0|0|0|1|AGT|0|0|0|100|DKK|2322|3325|lyfsjukr|||02|50|0|25|Actavis Group hf|Actavis Group hf|Díazepam||2322||2322|3325 160408|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|45479|58489|lyfsjukr|||00|100|0|0|Icepharma hf|GE Healthcare AS|Gadódíamíð||45479||45479|58489 160457|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|68218|86799|lyfsjukr|||00|150|0|0|Icepharma hf|GE Healthcare AS|Gadódíamíð||68218||68218|86799 160523|N05AB0401|Stemetil|töflur|5|mg|100|stk|1|þpakki||N05AB04|01.06.1981||R|A|5|0|0|*|0|SNO|0|1|0|100|NOK|888|2045|lyfalmen|||00|100|0|5|Vistor hf|Sanofi-aventis Norge AS|Próklórperazín||888||888|2045 160531|C10AC0101|Questran|skammtar|4|g|50|skammtar|1|pakki||C10AC01|01.04.1988||R|A|5|0|0|0|0|BRS|0|0|0|100|DKK|2418|4122|lyfalmen|||42|50|0|14|Vistor hf|Bristol-Myers Squibb|Kólestýramín||2418||2418|4122 160622|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|90958|115110|lyfsjukr|||00|200|0|0|Icepharma hf|GE Healthcare AS|Gadódíamíð||90958||90958|115110 160739|M01AB0515|Diklofenak Merck NM|sþ-tfl|50|mg|30|stk|1|þpakki||M01AB05|01.12.2008||R|A|5|0|0|E|0|MYL|0|0|1|100|SEK|323|1279|lyfalmen|||10|30|0|15|Actavis Group PTC ehf|Mylan AB|Díklófenak||||323|1279 160945|N02AA5901|Panocod|freyðit|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.01.1992||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|346|1310|lyfalmen|||14|20|0|7|Vistor hf|Sanofi-aventis Norge AS|Kódein í blöndum nema með geðlyfjum||346||346|1310 161065|J05AG0401|Intelence|töflur|100|mg|120|stk|1|glas||J05AG04|01.02.2009||R|A|2|0|1|0|1|JCI|0|0|0|100|SEK|75442|95793|lyfsjukr|||0|120|0|30|Vistor hf|Janssen-Cilag International N.V.|||||75442|95793 161075|H02AB0403|Solu-Medrol|sts|40|mg|1|stk|1|hgl|Act-O-Vial|H02AB04|01.08.1980||R|A|2|0|0|B|0|PFI|0|0|1|100|DKK|783|1903|lyfalmen|||03|1|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metýlprednisólón||783||783|1903 161091|H02AB0901|Solu-Cortef|sts|250|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|1831|2622|lyfsjukr|||03|1|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Hýdrókortisón||1831||1831|2622 161117|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|5|hgl|Act-O-Vial |H02AB09|01.08.1998||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|3141|4497|lyfsjukr|||03|5|0|17|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Hýdrókortisón||3141||3141|4497 161125|H02AB0901|Solu-Cortef|sts|100|mg|1|stk|1|hgl|Act-O-Vial|H02AB09|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|718|1815|lyfalmen|||03|1|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Hýdrókortisón||718||718|1815 161133|G03CA0306|Evorel|forðapl|75|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|4877|7459|lyfalmen|||23|26|0|136|Vistor hf|Janssen-Cilag AB|Estradíól||4877||4877|7459 161547|L02BG0601|Aromasin|töflur|25|mg|100|stk|1|þpakki||L02BG06|01.06.2001||R|A|3|0|0|*|0|PFI|0|0|0|100|DKK|68695|87710|lyfalmen|||00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Exemestan||68695||68695|87710 161802|V03AF0401|Isovorin|stl|10|mg/ml|2,5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|WAB|0|0|0|100|USD|2770|3966|lyfsjukr|||00|2|0|1|Icepharma hf|Wyeth AB|Kalsíumlevófólínat||2770||2770|3966 161901|D11AC0301|Selsun|hársápa|25|mg/ml|120|ml|1|glas||D11AC03|01.12.1972||L|A|3|0|0|0|0|CHT|0|0|0|100|IKR|||lyflausa|||01|120|0|120|Vitaflo Scandinavia AB|Chattem Clobal Consumer Products|Selensambönd||||| 162016|V03AF0401|Isovorin|stl|10|mg/ml|5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|WAB|0|0|0|100|USD|5660|8104|lyfsjukr|||00|5|0|2|Icepharma hf|Wyeth AB|Kalsíumlevófólínat||5660||5660|8104 162305|V03AF0401|Isovorin|stl|10|mg/ml|17,5|ml|1|hgl||V03AF04|01.02.1998||R|K|2|0|0|0|1|WAB|0|0|0|100|USD|15133|20708|lyfsjukr|||00|18|0|6|Icepharma hf|Wyeth AB|Kalsíumlevófólínat||15133||15133|20708 162354|A07EC0101|Salazopyrin|töflur|500|mg|100|stk|1|glas||A07EC01|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|0|100|DKK|2420|4124|lyfalmen|||00|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Súlfasalazín||2420||2420|4124 162929|G04CA0205 |Ranomax|forðahlk|0,4|mg|100|stk|1|þpakki||G04CA02|01.04.2009||R|A|4|0|0|E|0|RAN|0|0|0|100|XEU|4862|7438|lyfalmen|V0437|7438|00|100|0|100|Gróco ehf|Ranbaxy (UK) Ltd|Tamsúlósín||||4862|7438 162933|R03BA0501|Flixotide|innúðal|50|mcg/sk|120|sk|1|stauk||R03BA05|01.07.1994||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|2095|3683|lyfalmen|||24|120|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2095||2095|3683 163089|N06BA0401|Ritalin|töflur|10|mg|30|stk|1|þpakki||N06BA04|01.12.1972||R|A|2|1|0|0|0|NOH|0|0|0|100|DKK|1218|2493|lyfalmen|||00|30|0|10|Vistor hf|Novartis Healthcare A/S-|Metýlfenídat||||1218|2493 163246|P01AB0102|Flagyl|töflur|400|mg|30|stk|1|þpakki||P01AB01|01.10.1995||R|A|4|0|0|0|0|SNO|0|0|1|100|NOK|1713|3165|lyfalmen|||41|30|0|6|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||1713||1713|3165 163274|C03AA0304|Dehydratin Neo|töflur|25|mg|20|stk|1|pakki||C03AA03|01.02.2009||R|A|3|0|0|E|0|AEA|0|0|0|100|XEU|207|1121|lyfalmen|||0|20|0|20|Actavis hf|Actavis EAD|||||207|1121 163493|R03BA0501|Flixotide|innúðal|125|mcg/sk|120|sk|1|stauk||R03BA05|01.07.1994||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|2791|4628|lyfalmen|||24|120|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||2791||2791|4628 163709|V03AE0101|Resonium|duft|0| |454|g|1|stauk||V03AE01|01.01.2000||R|A||0|0|0|0|PCO|0|0|0|100|IKR|6575|9763|lyfalmen|||00|454|1|0|Distica|Distica - óskráð lyf|||6575||6575|9763 164251|L01BB0201|Puri-nethol|töflur|50|mg|25|stk|1|glas||L01BB02|01.06.2001||R|A|5|0|0|*|0|GSK|0|0|0|100|GBP|2635|4416|lyfalmen|||00|25|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Merkaptópúrín||2635||2635|4416 164807|N04BD0105|Selegilin Mylan|töflur|5|mg|100|stk|1|glas||N04BD01|01.10.1995||R|A|1.5|0|0|E|0|MNA|0|0|0|100|SEK|2494|4225|lyfalmen|||00|100|0|100|Actavis Group PTC ehf|Merck NM AB|Selegilín||||2494|4225 164871|A07EC0204|Asacol|eþ-stil|500|mg|60|stk|1|pakki||A07EC02|01.01.2000||R|A|3|0|0|B|0|TIL|0|0|0|100|SEK|6092|9108|lyfalmen|V0299|9108|98|60|0|20|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||6092||6092|9108 165001|C05AA0102|Proctosedyl|eþ-stil|0| |12|stk|1|pakki||C05AA01|01.12.1972||L|K|1,5|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||04|12|0|0|Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón||||| 165019|C05AA0102|Proctosedyl|eþ-smyr|0| |30|g|1|túpa||C05AA01|01.03.1981||L|A|3|0|0|0|0|SNO|0|0|0|100|IKR|||lyflausa|||00|30|0|0|Vistor hf|Sanofi-aventis Norge AS|Hýdrókortisón||||| 165306|QN05CM9501|Dorbene vet.|stl|1|mg/ml|10|mg|1|hgl||QN05CM95|01.05.2009||R|A|3|0|0|0|0|LAS|1|0|0|100|XEU|7079|13656|vetalmen|||0|10|0|0|Dýraheilsa ehf|Laboratorios SYVA S.A.|||||7079|13656 165431|C08CA0202|Plendil|forðatfl|2,5|mg|98|stk|1|þpakki||C08CA02|01.01.1992||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|4834|7400|lyfalmen|||43|98|0|49|Vistor hf|AstraZeneca A/S DK|Felódipín||4834||4834|7400 165449|C08CA0202|Plendil|forðatfl|10|mg|98|stk|1|þpakki||C08CA02|01.10.1995||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|4220|6567|lyfalmen|V0324|3906|43|98|0|196|Vistor hf|AstraZeneca A/S DK|Felódipín||4220||4220|6567 165548|C08CA0202|Plendil|forðatfl|5|mg|98|stk|1|þpakki||C08CA02|01.10.1995||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2724|4537|lyfalmen|V0316|2769|43|98|0|98|Vistor hf|AstraZeneca A/S DK|Felódipín||2724||2724|4537 165589|QH02AB0602|Prednisolonacetat, vet."Intervet"|stl|10|mg/ml|50|ml|5|hgl||QH02AB06|01.12.1972|31.03.2009|R|A|5|0|0|0|0|INI|1|0|0|100|DKK|6535|12619|vetalmen|||58|250|0|0|Icepharma hf|Intervet International B.V.|||6535||6535|12619 165639|H01CA0201|Synarela|nefúði|200|mcg/sk|4|ml|1|stauk|30 sk|H01CA02|01.04.1992||R|A|2|0|1|E|0|PFI|0|0|0|100|DKK|14762|20564|lyfalmen|||23|4|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Nafarelín||14762||14762|20564 165761|R06AE0501|Postafen|töflur|25|mg|100|stk|1|þpakki||R06AE05|01.12.1972||R|A|5|0|0|E|0|UCN|0|0|1|100|SEK|859|2006|lyfalmen|||00|100|0|50|Vistor hf|UCB Nordic A/S|Meklózín||859||859|2006 165779|R06AE0501|Postafen|töflur|25|mg|25|stk|1|þpakki||R06AE05|01.12.1972||R|A|5|0|0|E|0|UCN|0|0|1|100|SEK|304|1253|lyfalmen|||00|25|0|12|Vistor hf|UCB Nordic A/S|Meklózín||304||304|1253 165787|R06AE0501|Postafen|töflur|25|mg|10|stk|1|þpakki||R06AE05|01.12.1972||L|A|5|0|0|0|0|UCN|0|0|1|100|IKR|||lyflausa|||00|10|0|5|Vistor hf|UCB Nordic A/S|Meklózín||||| 165894|V08CA0301|Omniscan|stl|0,5|mmol/ml|50|ml|10|plhgl|röntgenskuggaefni fyrir MRT|V08CA03|01.06.1997||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|227395|284974|lyfsjukr|||00|500|0|0|Icepharma hf|GE Healthcare AS|Gadódíamíð||227395||227395|284974 165928|V08AB0901|Visipaque|stl|270|mg J/ml|50|ml|10|fl|plastfl.|V08AB09|01.05.1999||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|13480|18650|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||13480||13480|18650 166033|R06AB0201|Polaramin|forðatfl|6|mg|100|stk|1|þpakki||R06AB02|01.06.1980||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|2534|4279|lyfalmen|||10|100|0|100|Vistor hf|Schering-Plough|Dexklórfeníramín||2534||2534|4279 166090|N05AA0401|Plegicil|töflur|10|mg|10|stk|1|glas||N05AA04|01.03.2007||R|A|5|0|0|0|0|PSW|0|0|0|100|SEK|891|2050|lyfalmen|||00|10|0|1|Vistor hf|Pharmaxim Sweden AB|Aceprómazín||891||891|2050 166157|P01BA0201|Plaquenil|töflur|200|mg|100|stk|1|þpakki||P01BA02|01.12.1972||R|A|3|0|0|B|0|SNO|0|0|0|100|NOK|2356|4038|lyfalmen|||00|100|0|39|Vistor hf|Sanofi-aventis Norge AS|Hydroxýklórókín||2356||2356|4038 166165|H01CA0201|Synarela|nefúði|200|mcg/sk|8|ml|1|stauk|60 sk|H01CA02|01.04.1992||R|A|2|0|1|E|0|PFI|0|0|0|100|DKK|16711|22990|lyfalmen|||23|8|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Nafarelín||16711||16711|22990 166272|V08AB0901|Visipaque|stl|320|mg J/ml|50|ml|10|fl|plastfl.|V08AB09|01.05.1999||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|15297|20912|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||15297||15297|20912 166918|J02AA0102|Amphocil|irs|50|mg/hgl|1|hgl|1|pakki||J02AA01|01.04.1996||R|A|2|0|0|0|1|TRP|0|0|0|100|SEK|25167|33200|lyfsjukr|||00|1|0|1|Vitaflo Scandinavia AB|Three Rivers Pharmaceuticals Limited|Amfóterícín||25167||25167|33200 167007|J02AA0102|Amphocil|irs|100|mg/hgl|1|hgl|1|pakki||J02AA01|01.04.1996||R|A|2|0|0|0|1|TRP|0|0|0|100|SEK|50333|64532|lyfsjukr|||00|1|0|3|Vitaflo Scandinavia AB|Three Rivers Pharmaceuticals Limited|Amfóterícín||50333||50333|64532 168716|N03AF0105|Tegretol Retard|forðatfl|200|mg|50|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|1173|2432|lyfalmen|||10|50|0|10|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1173||1173|2432 168740|N03AF0105|Tegretol Retard|forðatfl|200|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3817|6020|lyfalmen|V0789|5992|10|200|0|40|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||3817||3817|6020 168815|N03AF0105|Tegretol Retard|forðatfl|400|mg|30|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|1228|2507|lyfalmen|||10|30|0|12|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1228||1228|2507 168971|N03AF0105|Tegretol Retard|forðatfl|400|mg|200|stk|1|þpakki||N03AF01|01.07.1988||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|7133|10520|lyfalmen|V0713|10234|10|200|0|80|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||7133||7133|10520 168997|L01CA0401|Navelbine|irþ|10|mg/ml|1|ml|10|hgl||L01CA04|01.03.1998||R|K|3|0|1|0|1|PFP|0|0|0|100|SEK|45340|58316|lyfsjukr|||00|10|0|0|Vistor hf|Pierre Fabre Pharma|Vínorelbín||45340||45340|58316 169433|L01CA0401|Navelbine|irþ|10|mg/ml|5|ml|10|hgl||L01CA04|01.03.1998||R|K|3|0|1|0|1|PFP|0|0|0|100|SEK|205926|258245|lyfsjukr|||00|50|0|0|Vistor hf|Pierre Fabre Pharma|Vínorelbín||205926||205926|258245 169540|P01BB0101|Paludrin|töflur|100|mg|100|stk|1|glas||P01BB01|01.01.1998||R|A||0|0|0|0|PCO|0|0|0|100|IKR|1500|2876|lyfalmen|||00|100|1|50|Distica|Distica - óskráð lyf|||1500||1500|2876 169557|J05AB0601|Cymevene|irs|500|mg|5|hgl|1|pakki|+innr.sía|J05AB06|01.10.1995||R|A|3|0|0|0|1|ROA|0|0|0|100|DKK|24845|32800|lyfsjukr|||00|5|0|5|Icepharma hf|Roche as|Gancíklóvír||24845||24845|32800 169664|J07BK0101|Varilrix|bóluefni|0| |0,5|ml|1|hgl|þurrefni + 0.5 ml leysir|J07BK01|01.10.1995||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|5216|7919|lyfalmen|||02|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Hlaupabóla, veikluð veira||5216||5216|7919 169912|N01BB0102|Marcain|stl|2,5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3025|4945|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|Búpívakaín||3025||3025|4945 169920|N01BB0102|Marcain|stl|5|mg/ml|20|ml|5|gl-hgl|án rotv|N01BB01|01.03.2003||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3249|5249|lyfalmen|||02|100|0|0|Vistor hf|AstraZeneca A/S DK|Búpívakaín||3249||3249|5249 170092|J07BC2001|Twinrix Adult|bóluefni|0| |1|ml|1|dæla|einnota dæla|J07BC20|01.01.1999||R|K|3|0|0|0|0|GLB|0|0|0|100|GBP|4777|7323|lyfalmen|||00|1|0|0|GlaxoSmithKline ehf|GlaxoSmithKline Biologicals SA|blöndur||4777||4777|7323 170225|R01AA0702|Otrivin|nefdr|1|mg/ml|10|ml|1|glas||R01AA07|01.12.1972||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|12|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín||||| 170233|R01AA0702|Otrivin|nefdr|0,5|mg/ml|10|ml|1|glas||R01AA07|01.12.1972||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|6|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín||||| 170514|C01BC0301|Rytmonorm|töflur|150|mg|100|stk|1|þpakki||C01BC03|01.04.1996||R|A|5|0|1|B|0|ABS|0|0|0|100|XEU|5004|7631|lyfalmen|||59|100|0|50|Vistor hf|Abbott Scandinavia AB|Própafenón||5004||5004|7631 170548|C01BC0301|Rytmonorm|töflur|300|mg|100|stk|1|þpakki||C01BC03|01.04.1996||R|A|5|0|1|B|0|ABS|0|0|0|100|XEU|9190|13312|lyfalmen|||59|100|0|100|Vistor hf|Abbott Scandinavia AB|Própafenón||9190||9190|13312 170555|N01BB5301|Carbocain adrenalin|stl|10|mg/ml|20|ml|5|hgl|10 mg+5 míkróg/ml|N01BB53|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|2081|3664|lyfalmen|||17|100|0|0|Vistor hf|AstraZeneca A/S DK|||2081||2081|3664 170712|A07AA0901|Vancocin|hylki|125|mg|30|stk|1|þpakki|hart hylki|A07AA09|01.10.1988||R|A|2|0|0|E|0|NMA|0|0|1|100|IKR|10000|14411|lyfalmen|||10|30|0|2|Icepharma hf|NordMedica A/S|Vankómýcín||10000||10000|14411 171603|N01BB5101|Marcain adrenalin|stl|2,5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|3047|4975|lyfalmen|||17|100|0|0|Vistor hf|AstraZeneca A/S DK|||3047||3047|4975 171611|N01BB5101|Marcain adrenalin|stl|5|mg/ml|20|ml|5|hgl||N01BB51|01.12.1982||R|S|2|0|0|0|0|AZD|0|0|1|100|SEK|3283|5296|lyfalmen|||17|100|0|0|Vistor hf|AstraZeneca A/S DK|||3283||3283|5296 171777|H03BB0101|Neo-Mercazole|töflur|5|mg|100|stk|1|glas||H03BB01|01.08.2005||R|A||0|0|B|0|LDR|0|0|0|100|IKR|732|1834|lyfalmen|||00|100|1|33|Parlogis hf|Parlogis - óskráð lyf|||732||732|1834 171793|N03AX1101|Topimax|töflur|25|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|3720|5889|lyfalmen|V0709|5887|00|60|0|5|Vistor hf|Janssen-Cilag AB|Tópíramat||3720||3720|5889 171876|N03AX1101|Topimax|töflur|50|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|6123|9150|lyfalmen|V0710|9150|00|60|0|10|Vistor hf|Janssen-Cilag AB|Tópíramat||6123||6123|9150 171991|V08CA0101|Magnevist|stl|469|mg/ml|15|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|45502|58517|lyfsjukr|||02|75|0|0|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||45502||45502|58517 172049|V08CA0101|Magnevist|stl|469|mg/ml|10|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|39088|50532|lyfsjukr|||02|50|0|0|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||39088||39088|50532 172353|N03AX1101|Topimax|töflur|100|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|11057|15845|lyfalmen|V0711|15545|00|60|0|20|Vistor hf|Janssen-Cilag AB|Tópíramat||11057||11057|15845 172395|N03AX1101|Topimax|töflur|200|mg|60|stk|1|þpakki||N03AX11|01.01.2003||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|22678|30419|lyfalmen|||00|60|0|40|Vistor hf|Janssen-Cilag AB|Tópíramat||22678||22678|30419 172411|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|5|spr|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|67935|86447|lyfsjukr|||02|100|0|0|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||67935||67935|86447 172619|L01AB0101|Myleran|töflur|2|mg|100|stk|1|glas||L01AB01|01.06.2001||R|A|3|0|0|*|0|GSK|0|0|0|100|GBP|2661|4451|lyfalmen|||00|100|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Búsúlfan||2661||2661|4451 172627|C07FB0202|Logimax forte|forðatfl|105|mg|98|stk|1|pakki|þp 10 + 95 mg|C07FB02|01.07.1999||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|12383|17602|lyfalmen|||00|98|0|0|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóðþrýst­ings­­lækkandi lyf||12383||12383|17602 172684|N02AA0303|Palladon|forðahlk|4|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|6805|10075|lyfalmen|||10|56|0|11|Icepharma hf|Norpharma |Hýdrómorphón||6805||6805|10075 172692|N02AA0303|Palladon|forðahlk|8|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|12987|18354|lyfalmen|||10|56|0|22|Icepharma hf|Norpharma |Hýdrómorphón||12987||12987|18354 172759|N02AA0303|Palladon|forðahlk|16|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|21599|29076|lyfalmen|||10|56|0|45|Icepharma hf|Norpharma |Hýdrómorphón||21599||21599|29076 172767|J07AJ5204|DiTeKik|bóluefni|0| |0,5|ml|1|hgl||J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2348|4027|lyfalmen|||51|0|0|0|Icepharma hf|Statens Serum Institut|Kíghósti, í blöndum með öðrum toxóíðum||2348||2348|4027 172775|J07AJ5204|DiTeKik|bóluefni|0| |0,5|ml|1|spr|einnota sprauta|J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2348|4027|lyfalmen|||51|0|0|0|Icepharma hf|Statens Serum Institut|Kíghósti, í blöndum með öðrum toxóíðum||2348||2348|4027 172825|J07CA0203|DiTeKiPol|bóluefni|0| |0,5|ml|1|spr|einnota sprauta|J07CA02|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|3344|5378|lyfalmen|||51|0|0|0|Icepharma hf|Statens Serum Institut|barnaveiki, kíghósti, mænusótt, stífkrampi||3344||3344|5378 172874|D01AC0801|Fungoral|krem|20|mg/g|30|g|1|túpa||D01AC08|01.10.1989||R|A|5|0|0|0|0|JAS|0|0|1|100|SEK|844|1986|lyfalmen|||00|30|0|30|Vistor hf|Janssen-Cilag AB|Ketókónazól||844||844|1986 172916|N02AA0303|Palladon|forðahlk|24|mg|56|stk|1|þpakki||N02AA03|01.09.2000||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|24796|33056|lyfalmen|||10|56|0|67|Icepharma hf|Norpharma |Hýdrómorphón||24796||24796|33056 173088|N05CD0202|Mogadon|töflur|5|mg|50|stk|1|þpakki||N05CD02|01.12.1972||R|A|5|0|0|0|0|VAL|0|0|1|100|DKK|802|1929|lyfalmen|V0901|1908|00|50|0|50|Icepharma hf|Valeant Pharmaceuticals B.V.|Nítrazepam||802||802|1929 173310|N05BE0107|Buspiron Merck NM|töflur|5|mg|100|stk|1|þpakki||N05BE01|01.04.1995||R|A|5|0|0|E|0|MEK|0|0|1|100|SEK|2399|4096|lyfalmen|||00|100|0|17|Actavis Group PTC ehf|Merck NM AB (A)|||2399||2399|4096 173344|A06AG1101|Microlax|innhl|0| |5|ml|12|túpa||A06AG11|01.12.1972||L|A|5|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||56|60|0|12|Vistor hf|McNeil Denmark ApS|Lárýlsúlfat, þ.m.t. í blöndum|||||3477 173518|N05BE0107|Buspiron Merck NM|töflur|10|mg|100|stk|1|þpakki||N05BE01|01.04.1995||R|A|5|0|0|E|0|MEK|0|0|1|100|SEK|5122|7791|lyfalmen|||00|100|0|33|Actavis Group PTC ehf|Merck NM AB (A)|||5122||5122|7791 173641|M01AC0202|Tilcotil|töflur|20|mg|10|stk|1|þpakki||M01AC02|01.04.1988||R|A|5|0|0|E|0|MAS|0|0|1|100|SEK|920|2089|lyfalmen|||00|10|0|10|Vistor hf|Meda AS|Tenoxíkam||920||920|2089 173856|N05CF0104|Zopiklon Merck NM|töflur|5|mg|30|stk|1|þpakki||N05CF01|01.10.2001||R|A|2|0|0|0|0|MNA|0|0|1|100|SEK|294|1239|lyfalmen|||00|30|0|20|Actavis Group PTC ehf|Merck NM AB|Zópíklón||294||294|1239 173898|N07AA0201|Mestinon|töflur|10|mg|250|stk|1|glas||N07AA02|01.05.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|2087|3673|lyfalmen|||00|250|1|14|Parlogis hf|Parlogis - óskráð lyf|||2087||2087|3673 173948|N07AA0201|Mestinon|töflur|60|mg|150|stk|1|glas||N07AA02|01.05.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|9140|13244|lyfalmen|||00|150|1|50|Parlogis hf|Parlogis - óskráð lyf|||9140||9140|13244 173955|N05BA0106|Stesolid Novum|stl|5|mg/ml|2|ml|10|lykjur||N05BA01|01.07.1985||R|A|2|0|0|0|1|AGT|0|0|0|100|DKK|1410|2019|lyfsjukr|||02|20|0|10|Actavis Group hf|Actavis Group hf|Díazepam||1410||1410|2019 174300|J01CE0204|Kaavepenin|töflur|800|mg|14|stk|1|þpakki||J01CE02|01.01.1989||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|562|1603|lyfalmen|||00|14|0|6|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||562||562|1603 174359|J01CE0204|Kaavepenin|töflur|1|g|14|stk|1|þpakki||J01CE02|01.01.1989||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|574|1619|lyfalmen|||00|14|0|7|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||574||574|1619 174433|S01EA0501 |Alphagan|augndr|2|mg/ml|5|ml|1|glas||S01EA05|01.04.2009||R|A|4|0|0|*|0|ALL|0|0|0|100|SEK|1716|3169|lyfalmen|||00|5|0|25|Vistor hf|Allergan|||||1716|3169 174615|N05CF0104|Zopiklon Merck NM|töflur|7,5|mg|30|stk|1|þpakki||N05CF01|01.09.1999|30.04.2009|R|A|2|0|0|0|0|MNA|0|0|0|100|SEK|188||lyfalmen|||00|30|0|30|Actavis Group PTC ehf|Merck NM AB|Zópíklón||188||188|1096 174664|S01EA0501 |Alphagan|augndr|2|mg/ml|5|ml|3|glös||S01EA05|01.04.2009||R|A|4|0|0|*|0|ALL|0|0|0|100|SEK|5035|7673|lyfalmen|||00|15|0|150|Vistor hf|Allergan|||||5035|7673 175612|J05AB1101|Valtrex|töflur|500|mg|10|stk|1|þpakki||J05AB11|01.10.1996||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|2374|3597|lyfalmen|V0507|3597|00|10|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||2031||2031|3597 176214|N05AH0301|Zyprexa|húðuðtfl|2,5|mg|28|stk|1|þpakki||N05AH03|01.01.1999||R|A|2|0|0|*|0|ELD|0|1|0|100|XEU|7112|4584|lyfalmen|V0809|4584|00|28|0|7|Icepharma hf|Eli Lilly Nederland -|Olanzapín||2759||2759|4584 177022|J01MA0101|Tarivid|töflur|200|mg|20|stk|1|þpakki||J01MA01|01.10.1988||R|A|3|0|0|0|0|SNO|0|0|1|100|NOK|4177|6509|lyfalmen|||00|20|0|10|Vistor hf|Sanofi-aventis Norge AS|Ófloxacín||4177||4177|6509 177253|N03AG0101|Depakine|sh-tfl|200|mg|40|stk|1|glas||N03AG01|01.04.1986||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|730|1831|lyfalmen|||43|40|0|5|Vistor hf|Sanofi-aventis Norge AS|Valpróínsýra||730||730|1831 177295|M02AA1501|Voltaren Emulgel|hlaup|11,6|mg/g|50|g|1|túpa||M02AA15|01.10.2004||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|50|0|0|Artasan ehf|Novartis Healthcare A/S-A|Díklófenak||||| 177311|QJ51RC2202|Nafpenzal vet.|spenalyf|0| |3|g|4|spr||QJ51RC22|01.04.1985||R|A|2|0|0|0|0|INI|0|0|0|100|XEU|648|1279|vetalmen|||16|12|0|0|Icepharma hf|Intervet International B.V.|||648||648|1279 177360|H02AB0103|Diprospan|stl|7|mg/ml|1|ml|1|hgl|5 + 2 mg/ml|H02AB01|01.09.2004||R|A|2|0|0|B|0|SPL|0|0|1|100|DKK|750|1858|lyfalmen|||03|1|0|5|Vistor hf|Schering-Plough Europe|Betametasón||750||750|1858 178004|H02AB0801|Kenalog|stl|40|mg/ml|1|ml|1|hgl||H02AB08|01.02.2002||R|A|3|0|0|E|0|PCO|0|0|1|100|IKR|557|1596|lyfalmen|||03|1|1|5|Distica|Distica - óskráð lyf|Tríamcínólón||557||557|1596 179267|M03AC0901|Esmeron|stl|10|mg/ml|5|ml|12|hgl||M03AC09|01.01.1997||R|K|3|0|0|0|1|ORG|0|0|0|100|DKK|10790|15301|lyfsjukr|||00|60|0|0|Vistor hf|N.V. Organon|Rókúrón, brómíð||10790||10790|15301 179333|R02AA0304|Strepsils Menthol|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.12.2005||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||| 180166|A07EC0301|Dipentum|hylki|250|mg|100|stk|1|glas||A07EC03|01.01.1990||R|A|5|0|0|B|0|UCB|0|0|0|100|DKK|5895|8840|lyfalmen|||10|100|0|25|Vistor hf|U.C.B|Olsalazín||5895||5895|8840 180539|R01AA0705|Otrivin Menthol ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.05.2001||L|A|2,5|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|12|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín||||| 180646|C10AA0302|Pravachol|töflur|20|mg|98|stk|1|þpakki||C10AA03|01.08.2008||R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|15714|21749|lyfalmen|||00|98|0|98|Vistor hf|Bristol-Myers Squibb|Pravastatín||15714||15714|21749 180729|S03CA0401|Hydrocortison m.Terram.|aug.eydr|0| |5|ml|1|túpa|+ Polymyxin B|S03CA04|01.11.1981||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|892|2051|lyfalmen|||30|5|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Hýdrókortisón og sýkingalyf||892||892|2051 181131|J01EE0103|Primazol|mixtúra|48|mg/ml|100|ml|1|glas|8+40 mg/ml|J01EE01|01.04.1989||R|A|2|0|0|0|0|ACA|0|0|1|100|XEU|756|1866|lyfalmen|||01|100|0|2|Actavis Group hf|Actavis hf|Súlfametoxazól og trímetóprím||756||756|1866 181255|G01AF0201|Canesten|sk-krem|10|mg/g|50|g|1|sett|+stjaka|G01AF02|01.12.1982||L|A|3|0|0|0|0|BAS|0|0|0|100|IKR|||lyflausa|||23|50|0|5|Vistor hf|Bayer A/S|Klótrímazól||||| 181552|QJ51DA3201|Pathozone, vet.|spenalyf|250|mg/dælu|10|ml|10|dælur|dæla + rýja|QJ51DA32|01.10.1995||R|A|1,5|0|0|0|0|PFV|0|0|0|100|DKK|7633|14711|vetalmen|||16|100|0|0|Icepharma hf|Pfizer vet.|||7633||7633|14711 181750|L01BA0105|Methotrexate Wyeth Lederle|irþ|100|mg/ml|10|ml|1|hgl||L01BA01|01.04.1991||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|30631|40003|lyfsjukr|||00|10|0|0|Icepharma hf|Wyeth AB|Metótrexat||30631||30631|40003 181990|L01BA0105|Methotrexate Wyeth Lederle|irþ|100|mg/ml|50|ml|1|hgl||L01BA01|01.04.1991||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|41749|53845|lyfsjukr|||00|50|0|0|Icepharma hf|Wyeth AB|Metótrexat||41749||41749|53845 182170|QM01AG9001|Finadyne, vet.|kyrni|25|mg/g|10|g|10|skammt||QM01AG90|01.01.1991||R|A|2|0|0|0|0|SPA|0|0|0|100|DKK|4999|9694|vetalmen|||16|100|0|0|Vistor hf|Schering-Plough A/S|||4999||4999|9694 183327|QM01AG9001|Finadyne, vet.|stl|50|mg/ml|50|ml|1|hgl||QM01AG90|01.07.1992||R|A|2|0|0|0|0|SPA|1|0|0|100|DKK|5526|10697|vetalmen|||27|50|0|0|Vistor hf|Schering-Plough A/S|||5526||5526|10697 183871|H02AA0201|Florinef|töflur|0,1|mg|100|stk|1|glas||H02AA02|01.12.1972||R|K|2|0|0|B|0|BRS|0|0|0|100|DKK|1218|2493|lyfalmen|||00|100|0|100|Vistor hf|Bristol-Myers Squibb|Flúdrókortisón||1218||1218|2493 183947|P01AB0102|Flagyl|töflur|200|mg|21|stk|1|þpakki||P01AB01|01.10.1995||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|855|2001|lyfalmen|||41|21|0|2|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||855||855|2001 184143|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|2|stk|1|þpakki||N02CC03|01.05.2001||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|1539|2929|lyfalmen|||00|2|0|2|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||1539||1539|2929 184176|J01CR0201|Amoksiklav|mixtúrud|31,25|mg/ml|100|ml|1|glas|25+6.25 mg/ml|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|437|1433|lyfalmen|||08|100|0|2|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||437||437|1433 184192|J01CR0201|Amoksiklav|mixtúrud|62,5|mg/ml|100|ml|1|glas|50+12.5 mg/ml|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|795|1919|lyfalmen|||08|100|0|5|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||795||795|1919 184200|J01CR0201|Amoksiklav|töflur|375|mg|15|stk|1|glas|250+125 mg|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|555|1594|lyfalmen|||00|15|0|4|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||555||555|1594 184234|A07EC0204|Asacol|innhl|10|mg/ml|100|ml|7|stk||A07EC02|01.02.2000||R|A|3|0|0|B|0|TIL|0|0|0|100|SEK|4226|6575|lyfalmen|||98|700|0|5|Icepharma hf|Tillotts Pharma AB|Mesalazín (5-amínósalicýlsýra)||4226||4226|6575 184259|L02BG0401|Femar|töflur|2,5|mg|30|stk|1|þpakki||L02BG04|01.03.1998||R|A|5|0|0|*|0|NOH|0|0|0|100|DKK|23894|31933|lyfalmen|||00|30|0|30|Vistor hf|Novartis Healthcare A/S-|Letrózól||23894||23894|31933 184275|L02BG0401|Femar|töflur|2,5|mg|100|stk|1|þpakki||L02BG04|01.03.1998||R|A|5|0|0|*|0|NOH|0|0|0|100|DKK|63116|80764|lyfalmen|V0563|80764|00|100|0|100|Vistor hf|Novartis Healthcare A/S-|Letrózól||||63116|80764 184341|J01CR0201|Amoksiklav|töflur|625|mg|16|stk|1|glas|500+125 mg|J01CR02|01.01.1996||R|A|2|0|0|0|0|LPM|0|0|1|100|IKR|1104|2339|lyfalmen|||00|16|0|8|Actavis Group hf|LEK Pharmaceuticals d.d.|Amoxicillín og ensímblokkar||1104||1104|2339 184432|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|6|stk|1|þpakki||N02CC03|01.05.2001||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|4635|7130|lyfalmen|||00|6|0|6|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||4635||4635|7130 184671|N06AX0306|Mianserin Merck NM|filmhtfl|10|mg|90|stk|1|þpakki||N06AX03|01.06.2008||R|A|3|0|0|B|0|MNA|0|1|0|100|SEK|995|2191|lyfalmen|V1140|2191|00|90|0|15|Actavis Group PTC ehf|Merck NM AB|Míanserín||995||995|2191 187203|B01AA0101|Dicumarol|töflur|20|mg|100|stk|1|glas||B01AA01|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|3601|5727|lyfalmen|||00|100|1|20|Distica|Distica - óskráð lyf|||3601||3601|5727 188631|N03AG0102|Orfiril|mixtúra|60|mg/ml|250|ml|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|3003|4916|lyfalmen|||00|250|0|10|Vistor hf|Desitin Artzneimittel|Valpróínsýra||3003||3003|4916 188987|S01EC0101|Diamox|töflur|250|mg|100|stk|1|glas||S01EC01|01.12.1972||R|A|4|0|0|*|0|GPL|0|0|0|100|XEU|2085|3670|lyfalmen|||00|100|0|33|Icepharma hf|Goldshield Pharmaceuticals Ltd|Acetazólamíð||2085||2085|3670 189126|L02BB0301|Casodex|töflur|150|mg|30|stk|1|þpakki||L02BB03|01.05.2000||R|A|4|0|0|*|0|ASZ|0|0|0|100|SEK|48474|57708|lyfalmen|V0561|54161|00|30|0|90|Vistor hf|AstraZeneca UK Ltd|Bíkalútamíð||44597||44597|57708 189175|V03AC0101|Desferal|irs|500|mg|10|hgl|1|pakki|lausn|V03AC01|01.04.2007||R|A|4|0|0|0|1|NOV|0|0|0|100|DKK|10669|15150|lyfsjukr|||00|10|0|0|Icepharma hf|Novartis Healthcare A/S|Deferoxamín||10669||10669|15150 189506|H02AB0401|Depo-Medrol|stl|40|mg/ml|5|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|3113|5065|lyfalmen|||03|5|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metýlprednisólón||3113||3113|5065 189514|H02AB0401|Depo-Medrol|stl|40|mg/ml|2|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|1331|2647|lyfalmen|||03|2|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metýlprednisólón||1331||1331|2647 189522|H02AB0401|Depo-Medrol|stl|40|mg/ml|1|ml|1|hgl||H02AB04|01.12.1972||R|A|5|0|0|B|0|PFI|0|0|1|100|DKK|697|1786|lyfalmen|||03|1|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Metýlprednisólón||697||697|1786 190702|M01AB0101|Confortid|eþ-stil|100|mg|10|stk|1|pakki||M01AB01|01.12.1972||R|A|3|0|0|E|0|AGT|0|0|1|100|DKK|827|1963|lyfalmen|||04|10|0|10|Actavis Group hf|Actavis Group hf|Indómetacín||827||827|1963 190728|M01AB0101|Confortid|eþ-stil|50|mg|10|stk|1|pakki||M01AB01|01.12.1972||R|A|3|0|0|E|0|AGT|0|0|1|100|DKK|448|1448|lyfalmen|||04|10|0|5|Actavis Group hf|Actavis Group hf|Indómetacín||448||448|1448 190751|M01AB0101|Confortid|hylki|25|mg|100|stk|1|glas||M01AB01|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|1817|3306|lyfalmen|||10|100|0|25|Actavis Group hf|Actavis Group hf|Indómetacín||1817||1817|3306 191064|B05XC03|Vitalipid Infant|irþ|0| |10|ml|10|lykjur||B05XC|01.10.1985||R|K|2|0|0|0|1|FRP|0|0|0|100|DKK|4582|6560|lyfsjukr|||00|100|0|0|Icepharma hf|Fresenius Kabi|||4582||4582|6560 191247|B05XC02|Vitalipid Adult|irþ|0| |10|ml|10|lykjur||B05XC|01.10.1985||R|K|2|0|0|0|1|FRP|0|0|0|100|DKK|4673|6691|lyfsjukr|||00|100|0|0|Icepharma hf|Fresenius Kabi|||4673||4673|6691 191254|B05XC01|Soluvit|irs|0| |10|ml|10|hgl||B05XC|01.10.1985||R|K||0|0|0|1|FRP|0|0|0|100|DKK|6034|8639|lyfsjukr|||00|100|0|0|Icepharma hf|Fresenius Kabi|||6034||6034|8639 191403|R01AA0503|Nezeril|nefúði|0,25|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||23|8|0|5|Vistor hf|AstraZeneca A/S DK|Oxýmetazólín||||| 191916|S01AA0101|Chloromycetin|augnsm|10|mg/g|4|g|1|túpa||S01AA01|01.12.1972||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|508|1530|lyfalmen|||07|4|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klóramfeníkól||508||508|1530 192617|C03AB0101|Centyl med kaliumklorid|sh-tfl|0| |100|stk|1|glas||C03AB01|01.12.1972||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|1647|3075|lyfalmen|||10|100|0|100|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||1647||1647|3075 192625|C03AB0101|Centyl med kaliumklorid|sh-tfl|0| |25|stk|1|glas||C03AB01|01.12.1972||R|A|3|0|0|E|0|LEP|0|0|0|100|DKK|459|1463|lyfalmen|||10|25|0|25|Vistor hf|LEO Pharma A/S|Bendróflúmetíazíð og kalíum||459||459|1463 193573|R06AB0201|Polaramin|forðatfl|6|mg|25|stk|1|þpakki||R06AB02|01.10.1991||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|690|1777|lyfalmen|||10|25|0|25|Vistor hf|Schering-Plough|Dexklórfeníramín||690||690|1777 193821|A12AA0601|Calcium-Sandoz|freyðit|500|mg|20|stk|1|glas||A12AA06|01.12.1972||L|A|3|0|0|0|0|SAN|0|0|0|100|IKR|||lyfalmen|||14|20|0|22|Vistor hf|Sandoz A/S|Kalsíumlaktóglúkónat|||||2085 193862|A12AA0201|Calcium Sandoz|stl|100|mg/ml|10|ml|5|lykjur||A12AA02|01.12.1972||R|A|5|0|0|0|0|SAN|0|0|0|100|DKK|1153|2405|lyfalmen|||02|50|0|3|Vistor hf|Sandoz A/S|Kalsíumglúbíónat||1153||1153|2405 194076|N02CA5201|Cafergot|töflur|0| |20|stk|1|þpakki||N02CA52|01.03.1999||R|A|3|0|0|E|0|LDR|0|0|0|100|IKR|2645|4430|lyfalmen|||00|20|1|5|Parlogis hf|Parlogis - óskráð lyf|||2645||2645|4430 194209|L01BA0105|Methotrexate Wyeth Lederle|stl/irl|25|mg/ml|2|ml|1|hgl||L01BA01|01.10.1985||R|A|3|0|1|0|1|WAB|0|0|0|100|USD|1204|1724|lyfsjukr|||02|2|0|0|Icepharma hf|Wyeth AB|Metótrexat||1204||1204|1724 194258|A03BB0101|Buscopan|töflur|10|mg|100|stk|1|glas||A03BB01|01.12.1972||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|2107|3700|lyfalmen|||00|100|0|17|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||2107||2107|3700 194266|A03BB0101|Buscopan|töflur|10|mg|20|stk|1|glas||A03BB01|01.12.1972||R|A|5|0|0|E|0|BOI|0|0|0|100|DKK|507|1528|lyfalmen|||00|20|0|3|Vistor hf|Boehringer Ingelheim|Bútýlskópólamín||507||507|1528 194720|N03AX0901|Lamictal|dreifit.|5|mg|28|stk|1|þpakki||N03AX09|01.01.1996||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|639|1708|lyfalmen|||00|28|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||639||639|1708 194795|M05BA0301|Aredia|irs|90|mg/hgl|1|hgl|1|pakki|+ 10 ml leysir|M05BA03|01.03.1998|30.04.2009|R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|39687|51278|lyfsjukr|||00|1|0|2|Vistor hf|Novartis Healthcare A/S-|Pamídrónsýra||39687||39687|51278 194977|J01MA0202|Ciproxin|töflur|250|mg|10|stk|1|þpakki||J01MA02|01.10.1988||R|A|5|0|0|0|0|BHC|0|0|1|100|SEK|1772|3245|lyfalmen|V0514|1374|00|10|0|2|Vistor hf|Bayer HealthCare AG|Cíprófloxacín||1772||1772|3245 194985|J01MA0202|Ciproxin|töflur|250|mg|20|stk|1|þpakki||J01MA02|01.10.1988||R|A|5|0|0|0|0|BHC|0|0|1|100|SEK|3844|6057|lyfalmen|V0518|1706|00|20|0|5|Vistor hf|Bayer HealthCare AG|Cíprófloxacín||3844||3844|6057 195032|J01MA0202|Ciproxin|töflur|500|mg|10|stk|1|þpakki||J01MA02|01.01.1991||R|A|5|0|0|0|0|BHC|0|0|1|100|SEK|3765|5950|lyfalmen|V0522|1718|00|10|0|5|Vistor hf|Bayer HealthCare AG|Cíprófloxacín||3765||3765|5950 195065|J01MA0202|Ciproxin|töflur|500|mg|20|stk|1|þpakki||J01MA02|01.01.1991||R|A|5|0|0|0|0|BHC|0|0|1|100|SEK|7303|10751|lyfalmen|V0526|2425|00|20|0|10|Vistor hf|Bayer HealthCare AG|Cíprófloxacín||7303||7303|10751 195149|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|5|lykjur||B03BA02|01.11.1981||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|1973|3518|lyfalmen|||03|5|0|250|Actavis Group hf|Actavis Group hf|Cýanókóbalamíntannín-komplex||1973||1973|3518 195156|B03BA0201|Betolvex|stl|1|mg/ml|1|ml|1|lykja||B03BA02|01.12.1972||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|806|1934|lyfalmen|||03|1|0|50|Actavis Group hf|Actavis Group hf|Cýanókóbalamíntannín-komplex||806||806|1934 195354|A07DA0301|Imodium|töflur|2|mg|40|stk|1|þpakki||A07DA03|01.10.1991||R|A|5|0|0|E|0|JAS|0|0|0|100|SEK|866|2016|lyfalmen|||10|40|0|8|Vistor hf|Janssen-Cilag AB|Lóperamíð||866||866|2016 195610|G03AC0801|Implanon|vefjalyf|68|mg|1|stk|1|pakki||G03AC08|01.02.2001||R|A|5|0|0|0|0|ORG|0|0|0|100|DKK|22235|29868|lyfalmen|||00|1|0|1015|Vistor hf|N.V. Organon|Etónógestrel||22235||22235|29868 195669|D01AC2002|Pevisone|krem|0| |15|g|1|túpa||D01AC20|01.10.1988||R|A|4|0|0|0|0|JAS|0|0|1|100|SEK|669|1748|lyfalmen|||20|15|0|15|Vistor hf|Janssen-Cilag AB|Blöndur||669||669|1748 195768|R01BA0101|Rinexin|forðatfl|50|mg|30|stk|1|þpakki||R01BA01|01.03.1981||R|A|5|0|0|E|0|REP|0|0|1|100|SEK|322|1277|lyfalmen|||10|30|0|15|Vistor hf|Recip AB|Fenýlprópanólamín||322||322|1277 195776|R01BA0101|Rinexin|forðatfl|50|mg|100|stk|1|glas||R01BA01|01.03.1981||R|A|5|0|0|E|0|REP|0|0|1|100|SEK|763|1876|lyfalmen|||10|100|0|50|Vistor hf|Recip AB|Fenýlprópanólamín||763||763|1876 196121|G03AB0302|Triquilar|töflur|80|mcg|63|stk|1|pakki|þp, 50+30 míkróg etc.|G03AB03|01.01.1985||R|A|5|0|0|0|0|BAP|0|0|0|100|SEK|1216|2491|lyfalmen|||23|63|0|84|Icepharma hf|Bayer Schering Pharma AG|Levónorgestrel og östrógen||1216||1216|2491 197103|QH01CA9001|Receptal, vet.|stl|4|mcg/ml|10|ml|1|hgl||QH01CA90|01.07.1998||R|A|5|0|0|0|0|INI|1|0|0|100|DKK|2620|5162|vetalmen|||27|10|0|0|Icepharma hf|Intervet International B.V.|||2620||2620|5162 197111|QH01CA9001|Receptal, vet.|stl|4|mcg/ml|10|ml|5|hgl||QH01CA90|01.07.1986||R|A|5|0|0|0|0|INI|1|0|0|100|DKK|12474|23932|vetalmen|||27|50|0|0|Icepharma hf|Intervet International B.V.|||12474||12474|23932 197343|D11AX0101|Regaine|húðlausn|20|mg/ml|60|ml|1|glas||D11AX01|01.10.1988||L|A|4|0|0|0|0|MCN|0|0|0|100|DKK|||lyfalmen|||00|60|0|60|Vistor hf|McNeil Denmark ApS|Mínoxidíl|||||6018 197400|S01GA5101|Antistina-Privin|augndr|5,25|mg/ml|10|ml|1|glas|5+0,25 mg|S01GA51|01.03.1981||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|780|1899|lyfalmen|||06|10|0|0|Vistor hf|Novartis Healthcare A/S-|Nafazólín í blöndum með öðrum efnum||780||780|1899 197533|N03AX0901|Lamictal|dreifit.|100|mg|56|stk|1|þpakki||N03AX09|01.01.1996||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|3690|5347|lyfalmen|V0705|5347|00|56|0|19|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||3321||3321|5347 197657|N05BA1203|Tafil|töflur|1|mg|20|stk|1|þpakki||N05BA12|01.10.1990||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|872|2024|lyfalmen|||00|20|0|20|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||872||872|2024 197673|N05BA1203|Tafil|töflur|1|mg|100|stk|1|þpakki||N05BA12|01.10.1990||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|4133|6449|lyfalmen|||00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Alprazólam||4133||4133|6449 197848|N01BB0203|Xylocain|hlaup|20|mg/ml|10|g|10|plspr||N01BB02|01.10.2003||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|2375|4063|lyfalmen|||00|100|0|0|Vistor hf|AstraZeneca A/S DK|Lídókaín||2375||2375|4063 198432|N02BE5102|Parkodin|eþ-stil|510|mg|10|stk|1|pakki|10+500 mg|N02BE51|01.04.1992||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|498|1516|lyfalmen|||04|10|0|2|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||498||498|1516 198580|L01AA0301|Alkeran|töflur|2|mg|25|stk|1|glas||L01AA03|01.06.2001||R|K|2|0|1|*|0|GSK|0|0|0|100|GBP|1608|3023|lyfalmen|||00|25|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Melphalan||1608||1608|3023 198648|L01BC0203|Flurablastin|stl|50|mg/ml|20|ml|10|hgl||L01BC02|01.04.1991||R|A|2|0|1|0|1|PFI|0|0|0|100|DKK|10404|14820|lyfsjukr|||02|200|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúóróúracíl||10404||10404|14820 198861|N04AA0201|Akineton|stl|5|mg/ml|1|ml|5|lykjur||N04AA02|01.12.1975||R|A|5|0|0|0|1|LFS|0|1|0|100|DKK|426|610|lyfsjukr|||02|5|0|2|Vistor hf|Laboratorio Farmaceutico (S.I.T.)|Bíperíden||426||426|610 199091|L01XX1101|Estracyt|hylki|140|mg|100|stk|1|glas||L01XX11|01.12.1978||R|A|5|0|0|*|0|PFI|0|0|0|100|DKK|37976|49465|lyfalmen|||00|100|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Estramústín||37976||37976|49465 199307|L01CB0101|Vepesid|stl|20|mg/ml|5|ml|10|hgl||L01CB01|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|17114|23174|lyfsjukr|||00|50|1|0|Distica|Distica - óskráð lyf|||17114||17114|23174 199539|N05CD0503|Halcion|töflur|0,25|mg|30|stk|1|þpakki||N05CD05|01.11.1981||R|A|4|0|0|0|0|PFI|0|0|1|100|DKK|903|2066|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Tríazólam||903||903|2066 199737|G02CB0301|Dostinex|töflur|0,5|mg|8|stk|1|glas||G02CB03|01.07.1993||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|7852|11496|lyfalmen|||44|8|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Kabególín||7852||7852|11496 199836|B01AC1301|ReoPro|stl|2|mg/ml|5|ml|1|hgl||B01AC13|01.09.1997||R|K|3|0|0|0|1|CET|0|0|0|100|XEU|57698|73702|lyfsjukr|||00|5|0|0|Icepharma hf|Centocor -|Abciximab||57698||57698|73702 300373|A05AA0201|Destolit|töflur|150|mg|60|stk|1|glas||A05AA02|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|4982|7601|lyfalmen|||00|60|1|12|Distica|Distica - óskráð lyf|||4982||4982|7601 327817|A03AA0701|Dicykloverinklorid|mixtúra|1|mg/ml|100|ml|1|glas|sykursaft|A03AA07|01.01.2000||R|A||0|1|E|0|LDR|0|0|0|100|IKR|3959|6213|lyfalmen|||00|100|1|1|Parlogis hf|Parlogis - óskráð lyf|||3959||3959|6213 335968|A04AD0102|Skopolamin|stl|0,3|mg/ml|1|ml|10|lykjur||A04AD01|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|6034|9029|lyfalmen|||00|10|1|0|Parlogis hf|Parlogis - óskráð lyf|Skópólamín||6034||6034|9029 336792|A03AA0701|Dicykloverinklorid|mixtúra|1|mg/ml|100|ml|1|glas|sykurlaus|A03AA07|01.01.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|2125|3724|lyfalmen|||00|100|1|1|Parlogis hf|Parlogis - óskráð lyf|||2125||2125|3724 338236|C01CA0301|Noradrenalin|stl|1|mg/ml|2|ml|10|lykjur||C01CA03|01.01.2000||R|A||0|0|0|1|LDR|0|0|0|100|IKR|3940|5641|lyfsjukr|||00|20|1|3|Parlogis hf|Parlogis - óskráð lyf|||3940||3940|5641 370007|B02BA0102|Konakion Novum|stl|10|mg/ml|0,2|ml|5|lykjur||B02BA01|01.10.1995||R|A|3|0|0|0|1|ROC|0|0|0|100|DKK|584|836|lyfsjukr|||02|1|0|0|Icepharma hf|Roche|Fýtómenadíón||584||584|836 370353|V08AB0501|Ultravist|stl/irl|300|mg J/ml|20|ml|10|hgl||V08AB05|01.04.1989||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|17583|23758|lyfsjukr|||02|200|0|0|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||17583||17583|23758 370940|J01DB0401|Kefzol|sts|1|g|1|stk|1|hgl||J01DB04|01.07.1995||R|A|2|0|0|0|1|NOM|0|0|0|100|IKR|544|779|lyfsjukr|||03|1|0|0|Icepharma hf|NordMedica ApS|Cefazólín||544||544|779 371583|A06AG1001|Klyx|innhl|0| |240|ml|1|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||23|240|0|1|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum||||| 371609|A06AG1001|Klyx|innhl|0| |120|ml|1|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|IKR|||lyflausa|||23|120|0|1|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum||||| 371617|A06AG1001|Klyx|innhl|0| |120|ml|10|fl||A06AG10|01.12.1978||L|A|1,5|0|0|0|0|FEL|0|0|0|100|SEK|||lyfalmen|||23|1200|0|10|Vistor hf|Ferring Lægemidler A/S|Dókúsatnatríum, þ.m.t. í blöndum|||||8238 371658|A02BA0201|Asyran|töflur|150|mg|10|stk|1|þpakki||A02BA02|01.10.1995||L|A|3|0|0|0|0|ACA|0|0|0|100|IKR|||lyflausa|||00|10|0|5|Actavis Group hf|Actavis hf|Ranitidín||||| 372037|N05AL0501|Solian|töflur|50|mg|30|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|2861|4723|lyfalmen|||00|30|0|4|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||2861||2861|4723 372045|N05AL0501|Solian|töflur|50|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|8021|11725|lyfalmen|||00|90|0|11|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||8021||8021|11725 372151|N04BA0209|Madopar Quick "125"|lausnart|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.11.2000||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|4214|6559|lyfalmen|||00|100|0|17|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||4214||4214|6559 372177|N07BA0103|Nicorette|innsogsl|10|mg|42|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|42|0|7|Vistor hf|McNeil Denmark ApS|Nikótín||||| 372185|N07BA0103|Nicorette|innsogsl|10|mg|18|rör|1|pakki|þp+munnstk|N07BA01|01.09.1977||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|18|0|3|Vistor hf|McNeil Denmark ApS|Nikótín||||| 372615|M05BA0401|Fosamax|töflur|10|mg|98|stk|1|þpakki||M05BA04|01.01.1996|30.04.2009|R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|17118|23497|lyfalmen|||00|98|0|98|Icepharma hf|M.S.D.|Alendrónsýra||17118||17118|23497 372714|N05AL0501|Solian|töflur|200|mg|30|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|9564|13819|lyfalmen|||00|30|0|15|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||9564||9564|13819 372722|B02BD0801|NovoSeven|sts|1,2|mg|1|hgl|1|pakki|+leysir|B02BD08|01.10.2006||R|K|2|0|0|0|1|NON|0|0|0|100|DKK|122539|154429|lyfsjukr|||00|1|0|0|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||122539||122539|154429 372730|B02BD0801|NovoSeven|sts|2,4|mg|1|hgl|1|pakki|+leysir|B02BD08|01.10.2006||R|K|2|0|0|0|1|NON|0|0|0|100|DKK|244683|306498|lyfsjukr|||00|1|0|0|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||244683||244683|306498 372748|B02BD0801|NovoSeven|sts|4,8|mg|1|hgl|1|pakki|+leysir|B02BD08|01.10.2006||R|K|2|0|0|0|1|NON|0|0|0|100|DKK|562872|702643|lyfsjukr|||00|1|0|0|Vistor hf|Novo-Nordisk|Eptacog alfa (virkjað)||562872||562872|702643 373001|G03AB0501|Gracial|töflur|0| |66|stk|1|pakki|þp 3 x (15+7 stk)|G03AB05|01.07.1998||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|2555|4308|lyfalmen|||23|66|0|88|Vistor hf|N.V. Organon|Desógestrel og östrógen||2555||2555|4308 373241|N05AL0501|Solian|töflur|200|mg|90|stk|1|þpakki||N05AL05|01.01.2005||R|A|3|0|0|*|0|SNO|0|1|0|100|NOK|25360|33758|lyfalmen|||00|90|0|45|Vistor hf|Sanofi-aventis Norge AS|Amísúlpríð||25360||25360|33758 373324|R03AK0602|Seretide Diskus|innúðadu|150|mcg/sk|60|sk|1|pakki|50+100 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|B|0|GSK|0|0|0|100|GBP|4074|6369|lyfalmen|||23|60|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||4074||4074|6369 373340|R03AK0602|Seretide Diskus|innúðadu|300|mcg/sk|60|sk|1|pakki|50+250 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|B|0|GSK|0|0|0|100|GBP|6364|9477|lyfalmen|V0992|9474|23|60|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||||6364|9477 373365|R03AK0602|Seretide Diskus|innúðadu|550|mcg/sk|60|sk|1|pakki|50+500 mcg, discus|R03AK06|01.05.2000||R|A|1,5|0|0|B|0|GSK|0|0|0|100|GBP|8329|12143|lyfalmen|V0993|12142|23|60|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salmeteról og önnur lyf gegn teppusjúkdómum í öndunarvegi||||8329|12143 373951|G02CB0301|Dostinex|töflur|0,5|mg|2|stk|1|glas||G02CB03|01.04.1998||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|2981|4886|lyfalmen|||44|2|0|1|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Kabególín||2981||2981|4886 374231|A10BA0201|Glucophage|töflur|500|mg|100|stk|1|þpakki||A10BA02|01.01.1987||R|A|5|0|0|*|0|MCK|0|0|0|100|XEU|800|1926|lyfalmen|||00|100|0|25|Icepharma hf|Merck Santé s.a.s.|Metformín||800||800|1926 374348|G04CA0201|Omnic|forðahlk|0,4|mg|30|stk|1|þpakki||G04CA02|01.08.1998||R|A|4|0|0|E|0|YAM|0|0|0|100|XEU|5058|7704|lyfalmen|||00|30|0|30|Vistor hf|Yamanouchi Europe|Tamsúlósín||5058||5058|7704 374397|J05AB1101|Valtrex|töflur|250|mg|60|stk|1|þpakki||J05AB11|01.01.2003||R|A|2|0|0|E|0|GSK|0|0|1|100|GBP|10701|15362|lyfalmen|||00|60|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||10701||10701|15362 374504|G01AF0502|Pevaryl Depot|krem/sti|0| |15|g|1|sett|kr.+1sk-stíll m.forðaverkun|G01AF05|01.01.1997||L|A|3|0|0|0|0|JAS|0|0|0|100|IKR|||lyflausa|||00|15|0|2|Vistor hf|Janssen-Cilag AB|Ekónazól||||| 374520|L02BB0301|Casodex|töflur|50|mg|30|stk|1|þpakki||L02BB03|01.04.1997||R|A|5|0|0|*|0|ASZ|0|0|0|100|SEK|18735|25510|lyfalmen|V0560|21158|00|30|0|30|Vistor hf|AstraZeneca UK Ltd|Bíkalútamíð||18735||18735|25510 374579|R01AC0101|Lomudal Nasal|nefúði|5,2|mg/sk|15|ml|1|glas||R01AC01|01.10.1992||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|2581|4343|lyfalmen|||23|15|0|15|Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||2581||2581|4343 374587|B01AB0501|Klexane|stl|100|mg/ml|0,6|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|7415|10903|lyfalmen|||00|6|0|30|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||7415||7415|10903 374595|B01AB0501|Klexane|stl|100|mg/ml|0,8|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|8246|12031|lyfalmen|||00|8|0|40|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||8246||8246|12031 374603|B01AB0501|Klexane|stl|100|mg/ml|1|ml|10|lykjur|einnota dæla|B01AB05|01.01.1993||R|A|3|0|0|E|0|SNO|0|0|1|100|NOK|11241|16095|lyfalmen|||00|10|0|50|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||11241||11241|16095 377242|J01FA0901|Klacid|töflur|500|mg|14|stk|1|þpakki||J01FA09|01.04.1992||R|A|5|0|0|0|0|ABS|0|0|1|100|DKK|4577|7052|lyfalmen|||63|14|0|14|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||4577||4577|7052 377259|J01FA0901|Klacid|töflur|500|mg|100|stk|1|glas||J01FA09|01.04.1992||R|A|2|0|0|0|0|ABS|0|0|1|100|DKK|37440|48798|lyfalmen|||63|100|0|100|Vistor hf|Abbott Scandinavia AB|Klaritrómýcín||37440||37440|48798 377333|J05AB1101|Valtrex|töflur|500|mg|42|stk|1|þpakki||J05AB11|01.10.1996||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|10364|12856|lyfalmen|V0508|12856|00|42|0|7|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Valacíklóvír||8854||8854|12856 379669|H01CB0202|Sandostatin Lar|sts|10|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|160695|201933|lyfsjukr|||00|2|0|14|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||160695||160695|201933 379677|H01CB0202|Sandostatin Lar|sts|20|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|179364|225176|lyfsjukr|||00|2|0|29|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||179364||179364|225176 379685|H01CB0202|Sandostatin Lar|sts|30|mg|2|ml|1|hgl|+ leysir|H01CB02|01.01.1999||R|K|3|0|1|0|1|NOH|0|0|0|100|DKK|225134|282159|lyfsjukr|||00|2|0|43|Vistor hf|Novartis Healthcare A/S-|Oktreótíð||225134||225134|282159 379875|N05BA0105|Stesolid|innhl|5|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|1538|2928|lyfalmen|||00|12|0|2|Actavis Group hf|Actavis Group hf|Díazepam||1538||1538|2928 379883|N05BA0105|Stesolid|innhl|10|mg/2.5ml|2,5|ml|5|túpa||N05BA01|01.10.1995||R|A|3|0|0|0|0|AGT|0|0|1|100|DKK|1901|3420|lyfalmen|||00|12|0|5|Actavis Group hf|Actavis Group hf|Díazepam||1901||1901|3420 379925|L01CD0201|Taxotere|irs|40|mg/ml|0,5|ml|1|hgl|+ leysir|L01CD02|01.10.1996||R|K|1,5|0|1|0|1|AVS|0|0|0|100|NOK|27016|35502|lyfsjukr|||00|0|0|0|Vistor hf|Aventis Pharma SA|Docetaxel||27016||27016|35502 379933|L01CD0201|Taxotere|irs|40|mg/ml|2|ml|1|hgl|+ leysir|L01CD02|01.10.1996||R|K|2|0|1|0|1|AVS|0|0|0|100|NOK|108479|136924|lyfsjukr|||00|2|0|0|Vistor hf|Aventis Pharma SA|Docetaxel||108479||108479|136924 380642|A10AD0402|Humalog Mix50 100 E/ml Pen|stl|100|ae/ml|3|ml|5|pennar||A10AD04|01.12.2001||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|6116|9140|lyfalmen|||17|15|0|38|Icepharma hf|Eli Lilly Nederland -|Insulín lispro||6116||6116|9140 381194|A10AD0401|Humalog Mix25 100 E/ml Pen|stl|100|ae/ml|3|ml|5|pennar||A10AD04|01.09.1999||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|6010|8996|lyfalmen|||00|15|0|38|Icepharma hf|Eli Lilly Nederland -|Insulín lispro||6010||6010|8996 382531|C10AA0101|Zocor|töflur|40|mg|98|stk|1|þpakki||C10AA01|01.07.1995||R|A|2|0|0|0|0|MSD|0|0|0|100|XEU|15480|3222|lyfalmen|V0367|3052|00|98|0|261|Icepharma hf|M.S.D.|Simvastatín||1755||1755|3222 383000|R03CC1201|Bambec|töflur|10|mg|100|stk|1|glas||R03CC12|01.10.1991||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|5821|8740|lyfalmen|||00|100|0|50|Vistor hf|AstraZeneca A/S DK|Bambúteról||5821||5821|8740 383075|N02AA5904|Ibukod sterkar|töflur|0| |20|stk|1|glas|30+200 mg|N02AA59|01.02.1999||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|460|1465|lyfalmen|||00|20|0|7|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||460||460|1465 383117|QP52AA5103|Drontal Vet.|töflur|250|mg|2|stk|1|pakki|230+20 mg|QP52AA51|01.06.2000||L|A|5|0|0|0|0|BAN|0|0|0|100|DKK|||vetorma|||00|2|0|0|Vistor hf|Bayer Animal Health GmbH||||||1746 383133|QP52AA5103|Drontal Vet.|töflur|250|mg|20|stk|1|pakki|230+20 mg|QP52AA51|01.06.2000||R|A|5|0|0|0|0|BAN|0|0|0|100|DKK|7895|13663|vetorma|||00|20|0|0|Vistor hf|Bayer Animal Health GmbH|||7895||7895|13663 383257|D01AC0802|Dermatin|sápa|20|mg/ml|60|ml|1|glas||D01AC08|01.07.1998||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||23|60|0|60|Actavis Group hf|Actavis hf|Ketókónazól||||| 383265|D01AC0802|Dermatin|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.07.1998||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||23|120|0|120|Actavis Group hf|Actavis hf|Ketókónazól||||| 383737|R06AX1301|Clarityn|freyðit|10|mg|10|stk|1|þpakki||R06AX13|01.10.1995||L|A|2|0|0|0|0|SCP|0|0|1|100|IKR|||lyflausa|||00|10|0|10|Vistor hf|Schering-Plough|Lóratadín||||| 386953|L02BG0301|Arimidex|töflur|1|mg|98|stk|1|þpakki||L02BG03|01.03.1998||R|A|5|0|0|*|0|ASZ|0|0|0|100|SEK|52454|67490|lyfalmen|||00|98|0|98|Vistor hf|AstraZeneca UK Ltd|Anastrózól||52454||52454|67490 387662|QA12CC0202|Magnesiumsulfat Icepharma vet.|stl|200|mg/ml|100|ml|1|plhgl||QA12CC02|01.07.1996||R|A|3|0|0|0|0|ICE|0|0|0|100|XEU|746|1472|vetalmen|||00|100|0|0|Icepharma hf|Icepharma hf|||746||746|1472 387746|J02AA0101|Abelcet|irþ|5|mg/ml|20|ml|10|hgl|+ síunálar|J02AA01|01.04.1996||R|K|2|0|0|0|1|ZPL|0|0|0|100|DKK|228778|286696|lyfsjukr|||00|200|0|29|Zeneus Pharma Limited|Zeneus Pharma Limited|Amfóterícín||228778||228778|286696 388256|N01BB2001|Emla|krem|0| |5|g|5|túpa|+12 umbúð.|N01BB20|01.01.1987||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3085|5027|lyfalmen|V2002|4943|00|25|0|5|Vistor hf|AstraZeneca A/S DK|Blöndur||3085||3085|5027 388264|N01BB2001|Emla|krem|0| |30|g|1|túpa||N01BB20|01.01.1987||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|3480|5563|lyfalmen|||00|30|0|30|Vistor hf|AstraZeneca A/S DK|Blöndur||3480||3480|5563 388272|N01BB2001|Emla|plástur|0| |2|stk|1|pakki||N01BB20|01.04.1994||L|A|2|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||23|2|0|0|Vistor hf|AstraZeneca A/S DK|Blöndur||||| 388280|N01BB2001|Emla|plástur|0| |20|stk|1|pakki||N01BB20|01.04.1994||R|A|2|0|0|0|0|AZD|0|0|1|100|SEK|6494|9653|lyfalmen|||23|20|0|0|Vistor hf|AstraZeneca A/S DK|Blöndur||6494||6494|9653 388660|C09BA0201|Darazið|töflur|22,5|mg|100|stk|1|glas|10+12.5 mg|C09BA02|01.04.1998||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|2966|4865|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|Enalapríl og þvagræsilyf||2966||2966|4865 389106|G03FA0103|Femanor|töflur|0| |84|stk|1|pakki|þp 2+1 mg |G03FA01|01.08.1998||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|2425|4131|lyfalmen|V0388|4131|23|84|0|84|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2425||2425|4131 389122|G03FB0503|Femasekvens|töflur|0| |84|stk|1|pakki|þp samsett pk. |G03FB05|01.08.1998||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|2216|3848|lyfalmen|||23|84|0|84|Vistor hf|BioPhausia AB|Noretísterón og östrógen||2216||2216|3848 389155|G03CA0312|Femanest|töflur|2|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|915|2082|lyfalmen|V0408|2082|00|84|0|84|Vistor hf|BioPhausia AB|Estradíól||915||915|2082 389171|G03CA0312|Femanest|töflur|1|mg|84|stk|1|þpakki||G03CA03|01.05.1997||R|A|3|0|0|E|0|BIP|0|0|0|100|DKK|650|1722|lyfalmen|||00|84|0|42|Vistor hf|BioPhausia AB|Estradíól||650||650|1722 389361|V08AB0501|Ultravist|stl/irl|300|mg J/ml|500|ml|8|fl||V08AB05|01.04.1989||R|A|3|0|0|0|1|BAP|0|0|0|100|SEK|308019|385351|lyfsjukr|||02|4000|0|0|Icepharma hf|Bayer Schering Pharma AG|Jóprómíð||308019||308019|385351 389395|S01BC0301|Voltaren Ophtha|augndr|1|mg/ml|0,3|ml|10|sk-hyl|einnota hylki|S01BC03|01.04.1996||R|A|2|0|0|E|0|NOH|0|0|1|100|DKK|991|2185|lyfalmen|||00|3|0|0|Vistor hf|Novartis Healthcare A/S-|Díklófenak||991||991|2185 389577|A04AA0201|Kytril|töflur|2|mg|5|stk|1|þpakki||A04AA02|01.10.1994||R|A|3|0|0|E|0|ROA|0|0|0|100|DKK|12200|17374|lyfalmen|||00|5|0|5|Icepharma hf|Roche as|Granisetrón||12200||12200|17374 389783|J01CF0501|Heracillin|töflur|500|mg|30|stk|1|glas||J01CF05|01.10.1985||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|2368|4054|lyfalmen|||00|30|0|8|Vistor hf|Recip AB|Flúkloxacillín||2368||2368|4054 390757|A07AA0201|Mycostatin|mixtúra|100000|ae/ml|100|ml|1|glas||A07AA02|01.04.1974||R|K|1|0|0|E|0|BRS|0|0|1|100|DKK|3456|5530|lyfalmen|||01|100|0|7|Vistor hf|Bristol-Myers Squibb|Nýstatín||3456||3456|5530 390971|M01AH0101|Celebra|hylki|100|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|7655|11229|lyfalmen|||00|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Celekoxíb||7655||7655|11229 390997|M01AH0101|Celebra|hylki|200|mg|20|stk|1|þpakki||M01AH01|01.07.2002||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|3070|5007|lyfalmen|||00|20|0|20|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Celekoxíb||3070||3070|5007 391268|M01AH0101|Celebra|hylki|200|mg|100|stk|1|þpakki||M01AH01|01.07.2002||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|14428|20148|lyfalmen|V2140|19788|00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Celekoxíb||14428||14428|20148 391730|N01BB0203|Xylocain|úðalyf|100|mg/ml|50|ml|1|glas|+ sk-úðari|N01BB02|01.10.1990||R|A|3|0|0|0|0|AZD|0|0|1|100|SEK|2810|4654|lyfalmen|||00|50|0|0|Vistor hf|AstraZeneca A/S DK|Lídókaín||2810||2810|4654 393918|QJ51CF0204|Orbenin vet.|spenalyf|500|mg/dælu|1|stk|24|spr||QJ51CF02|01.09.1983||R|S|4|0|0|0|0|PAL|0|0|0|100|XEU|5129|9941|vetalmen|||16|24|0|0|Icepharma hf|Pfizer Oy Animal Health|||5129||5129|9941 393934|N07BA0109|Nicotinell Fruit|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|14|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 393942|N07BA0109|Nicotinell Fruit|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 393959|N07BA0107|Nicotinell Mint|tyggigúm|2|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|14|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 394262|N07BA0107|Nicotinell Mint|tyggigúm|4|mg|204|stk|1|þpakki||N07BA01|01.06.1998||L|A|2|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|204|0|27|Artasan ehf|Novartis Healthcare A/S-A|Nikótín||||| 395715|D10AD0301|Differin|hlaup|0,1|%|30|g|1|túpa||D10AD03|01.07.2001||R|A|3|0|0|0|0|GAN|0|0|0|100|SEK|931|2104|lyfalmen|||00|30|0|30|Icepharma hf|Galderma Nordic AB|Adapalen||931||931|2104 395954|V08CA0101|Magnevist|stl|469|mg/ml|30|ml|10|hgl|röntgenskuggaefni|V08CA01|01.04.2007||R|A|5|0|0|0|1|BAP|0|0|0|100|SEK|178469|224061|lyfsjukr|||02|300|0|0|Icepharma hf|Bayer Schering Pharma AG|Gadópentetat||178469||178469|224061 397745|L01BC0601|Xeloda|töflur|150|mg|60|stk|1|þpakki||L01BC06|01.01.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|10983|15541|lyfsjukr|||00|60|0|0|Icepharma hf|Roche|Capecitabín||10983||10983|15541 397752|L01BC0601|Xeloda|töflur|500|mg|120|stk|1|þpakki||L01BC06|01.01.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|63671|81138|lyfsjukr|||00|120|0|0|Icepharma hf|Roche|Capecitabín||63671||63671|81138 399519|N03AX0901|Lamictal|dreifit.|50|mg|56|stk|1|þpakki||N03AX09|01.03.1999||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|2049|3343|lyfalmen|V0703|3343|00|56|0|9|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||1844||1844|3343 399527|N03AX0901|Lamictal|dreifit.|200|mg|56|stk|1|þpakki||N03AX09|01.03.1999||R|A|3|0|0|E|0|GSK|0|0|0|100|IKR|6434|8873|lyfalmen|V0706|8873|00|56|0|37|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lamótrigín||5919||5919|8873 399733|B01AB0401|Fragmin|stl|25000|ae/ml|0,3|ml|10|spr|einnotadæla|B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|11068|15860|lyfalmen|||02|3|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||11068||11068|15860 399782|D06BB0601|Vectavir|krem|10|mg/g|2|g|1|túpa||D06BB06|01.04.1997||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||00|2|0|2|Artasan ehf|Novartis Healthcare A/S-A|Pencíklóvír||||| 400044|S03CA0102|Sofradex|aug.eydr|0| |8|ml|1|glas||S03CA01|01.03.1980||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|1592|3001|lyfalmen|||06|8|0|0|Vistor hf|Sanofi-aventis Norge AS|Dexametasón og sýkingalyf||1592||1592|3001 400101|R05DB2002|Pektolin|mixtúra|0| |150|ml|1|glas||R05DB20|01.06.1981||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|150|0|0|Actavis Group hf|Actavis hf|Blöndur||||| 400143|C10AB0401|Lopid|hylki|300|mg|100|stk|1|þpakki||C10AB04|01.04.1988||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|5697|8571|lyfalmen|||10|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gemfíbrózíl||5697||5697|8571 400267|N05BA0402|Sobril|töflur|25|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|371|1344|lyfalmen|||00|25|0|12|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Oxazepam||371||371|1344 400424|N05BA0402|Sobril|töflur|15|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|604|1660|lyfalmen|||00|100|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Oxazepam||604||604|1660 400432|N05BA0402|Sobril|töflur|15|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|A|3|0|0|0|0|PFI|0|0|1|100|DKK|263|1197|lyfalmen|||00|25|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Oxazepam||263||263|1197 400804|N07BA0103|Nicorette|forðapl|15|mg/16kls|7|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|7|0|8|Vistor hf|McNeil Denmark ApS|Nikótín||||| 401828|N06AA1001|Noritren|töflur|10|mg|100|stk|1|glas||N06AA10|01.01.1985||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|776|1893|lyfalmen|||00|100|0|13|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||776||776|1893 401851|N06AA1001|Noritren|töflur|25|mg|100|stk|1|glas||N06AA10|01.01.1985||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|1242|2526|lyfalmen|||00|100|0|33|Lundbeck Export A/S|H. Lundbeck A/S|Nortriptýlín||1242||1242|2526 401877|C09AA0103|Katopril|töflur|25|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|1246|2531|lyfalmen|||00|100|0|50|Actavis Group hf|Actavis hf|Kaptópríl||1246||1246|2531 401901|C09AA0103|Katopril|töflur|50|mg|100|stk|1|pakki||C09AA01|01.10.1995||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|2000|3554|lyfalmen|||00|100|0|100|Actavis Group hf|Actavis hf|Kaptópríl||2000||2000|3554 402651|J07BB0205|Influvac|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07BB02|01.12.1998||R|K|1|0|0|0|0|SOB|0|0|0|100|XEU|667|1746|lyfalmen|||51|0|0|0|Icepharma hf|Solvay Biologicals B.V.|Inflúensa, hreinsaðir mótefnavakar||667||667|1746 402743|QJ01RA0102|Streptocillin, vet.|stl|0| |100|ml|1|hgl||QJ01RA01|01.11.1979||R|K|2|0|0|0|0|BID|0|0|0|100|DKK|1627|3211|vetalmen|||58|100|0|0|Vistor hf|Boehringer Ingelheim Danmark|||1627||1627|3211 403444|QG02AD9001|Estrumat, vet.|stl|0,25|mg/ml|20|ml|1|hgl||QG02AD90|01.01.1991||R|A|2|0|0|0|0|SPA|1|0|0|100|DKK|5257|10185|vetalmen|||27|20|0|0|Vistor hf|Schering-Plough A/S|||5257||5257|10185 403550|C08CA0302|Lomir Retard|forðahlk|2,5|mg|100|stk|1|þpakki||C08CA03|01.10.1992||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|7162|10560|lyfalmen|||10|100|0|50|Vistor hf|Novartis Healthcare A/S-|Ísradipín||7162||7162|10560 403915|S01GX0101|Lomudal|augndr|20|mg/ml|13,5|ml|1|glas||S01GX01|01.07.1992||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1272|2567|lyfalmen|||06|14|0|0|Vistor hf|Sanofi-aventis Norge AS|Krómóglíkatsýra||1272||1272|2567 404426|S01XA2019|Oftagel|augngel|2,5|mg/g|10|g|1|túpa||S01XA20|01.04.2004||L|A|2,5|0|0|E|0|SAO|0|0|0|100|XEU|||lyfalmen|||00|10|0|0|Icepharma hf|Santen Oy|Gervitár og aðrar óvirkar sam­setningar|||||1731 404533|B01AD0201|Actilyse|sts/irs|50|mg|1|stk|1|hgl|+ leysir|B01AD02|01.07.1989||R|A|3|0|0|0|1|BOI|0|0|0|100|DKK|101302|127988|lyfsjukr|||02|1|0|0|Vistor hf|Boehringer Ingelheim|Alteplasi||101302||101302|127988 404640|A07AA0904|Vancomycin Alpharma|hylki|125|mg|28|stk|1|þpakki|hart hylki|A07AA09|01.04.1996|28.02.2009|R|A|2|0|0|E|0|ALP|0|0|1|100|DKK|||lyfalmen|||00|28|0|2|Actavis Group hf|Alpharma ApS|Vankómýcín||12952||| 404939|B02BA0102|Konakion Novum|stl|10|mg/ml|1|ml|5|lykjur||B02BA01|01.04.1991||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|641|918|lyfsjukr|||02|5|0|2|Icepharma hf|Roche|Fýtómenadíón||641||641|918 405589|J07BD5203|Priorix|bóluefni|0| |0,5|ml|1|hgl|+ einnota dæla|J07BD52|01.03.1999||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|1666|3101|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||1666||1666|3101 405597|J07BD5203|Priorix|bóluefni|0| |0,5|ml|10|hgl||J07BD52|01.11.2001||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|20557|27778|lyfalmen|||00|5|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|mislingar í blöndum með hettusótt og rauðum hundum (veiklaða||20557||20557|27778 405985|N05AE0301|Serdolect|filmhtfl|12|mg|28|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|21095|28448|lyfalmen|||00|28|0|21|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||21095||21095|28448 406025|V08AB0201|Omnipaque|stl|300|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|20662|27592|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||20662||20662|27592 406033|N05AE0301|Serdolect|filmhtfl|16|mg|28|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|21095|28448|lyfalmen|||00|28|0|28|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||21095||21095|28448 406165|N05AE0301|Serdolect|filmhtfl|20|mg|28|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|21095|28448|lyfalmen|||00|28|0|35|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||21095||21095|28448 406322|N05AE0301|Serdolect|filmhtfl|4|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|21306|28711|lyfalmen|||00|100|0|25|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||21306||21306|28711 406355|V08AB0201|Omnipaque|stl|350|mg J/ml|50|ml|10|plastf||V08AB02|01.12.1983||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|23122|30654|lyfsjukr|||02|500|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||23122||23122|30654 406371|N05AE0301|Serdolect|filmhtfl|12|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|64232|82154|lyfalmen|||00|100|0|75|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||64232||64232|82154 406389|N05AE0301|Serdolect|filmhtfl|16|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|69666|88919|lyfalmen|||00|100|0|100|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||69666||69666|88919 406397|N05AE0301|Serdolect|filmhtfl|20|mg|100|stk|1|glas||N05AE03|01.10.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|75101|95686|lyfalmen|||00|100|0|125|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||75101||75101|95686 406462|N05AE0301|Serdolect|filmhtfl|4|mg|30|stk|1|þpakki||N05AE03|01.01.2006||R|A|5|0|1|*|0|LBK|0|1|0|100|DKK|7119|10501|lyfalmen|||00|30|0|8|Lundbeck Export A/S|H. Lundbeck A/S|Sertindólum||7119||7119|10501 406751|M01AB0101|Confortid|hylki|25|mg|30|stk|1|þpakki||M01AB01|01.05.1974||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|586|1636|lyfalmen|||10|30|0|8|Actavis Group hf|Actavis Group hf|Indómetacín||586||586|1636 407395|N02CA7201|Anervan|töflur|160,5|mg|100|stk|1|pakki|þp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|1898|3416|lyfalmen|||00|100|0|50|Vistor hf|Recip AB|Ergotamínlyf í blöndum með geðlyfjum (psycoleptica)||1898||1898|3416 407981|N05BA0402|Sobril|töflur|10|mg|25|stk|1|þpakki||N05BA04|01.01.1985||R|A|1,5|0|0|0|0|PFI|0|0|1|100|DKK|249|1178|lyfalmen|||00|25|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Oxazepam||249||249|1178 407999|N05BA0402|Sobril|töflur|10|mg|100|stk|1|þpakki||N05BA04|01.01.1985||R|A|1,5|0|0|0|0|PFI|0|0|0|100|DKK|703|1794|lyfalmen|||00|100|0|20|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Oxazepam||703||703|1794 408724|D07AC0104|Diproderm|smyrsli|0,5|mg/g|20|g|1|túpa||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1086|2314|lyfalmen|||20|20|0|20|Vistor hf|Schering-Plough|Betametasón||1086||1086|2314 408740|D07AC0104|Diproderm|smyrsli|0,5|mg/g|100|g|1|túpa||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|4983|7603|lyfalmen|||20|100|0|100|Vistor hf|Schering-Plough|Betametasón||4983||4983|7603 408757|D07AC0104|Diproderm|áburður|0,5|mg/ml|20|ml|1|glas||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1086|2314|lyfalmen|||20|20|0|20|Vistor hf|Schering-Plough|Betametasón||1086||1086|2314 408773|D07AC0104|Diproderm|áburður|0,5|mg/ml|100|ml|1|glas||D07AC01|01.03.1977||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|2967|4867|lyfalmen|||20|100|0|100|Vistor hf|Schering-Plough|Betametasón||2967||2967|4867 409078|J02AC0101|Diflucan|mixtúrud|10|mg/ml|35|ml|1|glas||J02AC01|01.07.1992||R|A|2|0|0|0|0|PFI|0|0|1|100|DKK|5334|8079|lyfalmen|||08|35|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||5334||5334|8079 409417|C09CA0701|Micardis|töflur|80|mg|28|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|B|0|BII|0|0|0|100|DKK|3940|6187|lyfalmen|||00|28|0|56|Vistor hf|Boehringer Ingelheim International |||3940||3940|6187 409425|R01AD0502|Rhinocort Turbuhaler|nefúðad|100|mcg/sk|200|sk|1|stauk||R01AD05|01.01.1992||R|A|2|0|0|E|0|AZD|0|0|1|100|SEK|3696|5856|lyfalmen|V0966|5757|23|200|0|100|Vistor hf|AstraZeneca A/S DK|Búdesóníð||3696||3696|5856 409474|C09CA0701|Micardis|töflur|80|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|B|0|BII|0|0|0|100|DKK|12728|18031|lyfalmen|||00|98|0|196|Vistor hf|Boehringer Ingelheim International |||12728||12728|18031 409516|C09CA0701|Micardis|töflur|40|mg|28|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|B|0|BII|0|0|0|100|DKK|3105|5054|lyfalmen|||00|28|0|28|Vistor hf|Boehringer Ingelheim International |||3105||3105|5054 409532|QN05AA0402|Plegicil vet.|stl|10|mg/ml|20|ml|6|hgl||QN05AA04|01.11.2007||R|A|3|0|0|0|0|PSW|1|0|0|100|DKK|10831|20803|vetalmen|||27|120|0|0|Vistor hf|Pharmaxim Sweden AB|||10831||10831|20803 409631|C07AB0309|Atenolol Actavis|töflur|25|mg|100|stk|1|glas||C07AB03|01.04.1987|30.04.2009|R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|575||lyfalmen|||00|100|0|33|Actavis Group hf|Actavis hf|Atenólól||575||575|1621 409763|C09CA0701|Micardis|töflur|40|mg|98|stk|1|þpakki||C09CA07|01.02.2008||R|A|4|0|0|B|0|BII|0|0|0|100|DKK|10313|14836|lyfalmen|||00|98|0|98|Vistor hf|Boehringer Ingelheim International |||10313||10313|14836 410639|P01BA0102|Klorokinfosfat Recip|filmhtfl|250|mg|20|stk|1|þpakki||P01BA01|01.08.2005||R|A|5|0|0|0|0|REP|0|0|0|100|SEK|1103|2337|lyfalmen|||00|20|0|10|Vistor hf|Recip AB|Klórókín||1103||1103|2337 410712|D10AD0102|Aberela|krem|0,05|%|30|g|1|túpa||D10AD01|01.10.2007||R|A|2|0|0|0|0|JAS|0|0|0|100|SEK|646|1717|lyfalmen|||23|30|0|30|Vistor hf|Janssen-Cilag AB|Tretínóín||646||646|1717 411033|M03BX0104|Baklofen Merck NM|töflur|10|mg|50|stk|1|þpakki||M03BX01|01.01.1990||R|A|3|0|0|E|0|MNA|0|0|1|100|SEK|565|1607|lyfalmen|||00|50|0|10|Actavis Group PTC ehf|Merck NM AB|Baklófen||565||565|1607 411389|N05CD0801|Dormicum|stl|5|mg/ml|10|ml|5|lykjur||N05CD08|01.10.1990||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|7483|10714|lyfsjukr|||02|50|0|17|Icepharma hf|Roche|Mídazólam||7483||7483|10714 411827|J05AF0501|Epivir|töflur|150|mg|60|stk|1|glas||J05AF05|01.03.1999||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|23604|31254|lyfsjukr|||00|60|0|30|GlaxoSmithKline ehf|Glaxo Group Limited|Lamívúdín||23604||23604|31254 411868|M01AB0505|Voltaren|sh-tfl|25|mg|100|stk|1|þpakki||M01AB05|01.11.1981||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|1903|3423|lyfalmen|||67|100|0|25|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1903||1903|3423 411918|N02CC0101|Imigran|nefúði|20|mg/sk|6|sk|1|pakki||N02CC01|01.07.2000||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|7384|10861|lyfalmen|||98|6|0|6|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Súmatriptan||7384||7384|10861 412049|L02AE0301|Zoladex|vefjatfl|3,6|mg|1|stk|1|glas|+ dæla|L02AE03|01.01.1990||R|A|3|0|1|*|0|ASZ|0|0|0|100|SEK|21695|29195|lyfalmen|||00|1|0|28|Vistor hf|AstraZeneca UK Ltd|Góserelín||21695||21695|29195 412361|B01AB0501|Klexane|stl|100|mg/ml|3|ml|1|hgl|með rotv.|B01AB05|01.02.1999||R|A|2|0|0|0|1|SNO|0|0|0|100|NOK|3296|4719|lyfsjukr|||00|3|0|15|Vistor hf|Sanofi-aventis Norge AS|Enoxaparín||3296||3296|4719 412395|QM01AE0301|Romefen, vet.|stl|100|mg/ml|100|ml|1|hgl||QM01AE03|01.10.1995||R|A|3|0|0|0|0|MER|1|0|0|100|DKK|10240|19677|vetalmen|||02|100|0|0|Vistor hf|Merial|||10240||10240|19677 412825|L02BA0106|Tamoxifen NM Pharma|töflur|10|mg|100|stk|1|glas||L02BA01|01.01.1990||R|A|5|0|0|*|0|MNA|0|0|0|100|SEK|1873|3382|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck NM AB|Tamoxífen||1873||1873|3382 412833|L02BA0106|Tamoxifen NM Pharma|töflur|20|mg|30|stk|1|glas||L02BA01|01.01.1990||R|A|5|0|0|*|0|MNA|0|0|0|100|SEK|1197|2465|lyfalmen|||00|30|0|30|Actavis Group PTC ehf|Merck NM AB|Tamoxífen||1197||1197|2465 413245|J06BA0205|Sandoglobulin|irs|12|g/fl|12|g|1|sett|leys+áhöld|J06BA02|01.04.1993||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|105218|132864|lyfsjukr|||00|12|0|0|Icepharma hf|CSL Denmark ApS|Immúnóglóbúlín, normal, manna, gefin í æð||105218||105218|132864 413856|M05BA0301|Aredia|irs|15|mg/hgl|4|hgl|1|pakki|+ 4 x 5 ml leysir|M05BA03|01.04.1998|30.04.2009|R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|30132|39382|lyfsjukr|||00|4|0|1|Vistor hf|Novartis Healthcare A/S-|Pamídrónsýra||30132||30132|39382 413864|M05BA0301|Aredia|irs|30|mg/hgl|2|hgl|1|pakki|+ 2 x 10 ml leysir|M05BA03|01.04.1998|30.04.2009|R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|30132|39382|lyfsjukr|||00|2|0|1|Vistor hf|Novartis Healthcare A/S-|Pamídrónsýra||30132||30132|39382 414458|V04CF0102|Tuberkulin|stl|2|TU/0,1ml|1,5|ml|1|hgl||V04CF01|01.01.1998||R|K||0|0|0|0|LDR|0|0|0|100|IKR|2026|3590|lyfalmen|||00|2|1|0|Parlogis hf|Parlogis - óskráð lyf|||2026||2026|3590 414680|C03BA1102|Natrilix Retard|forðatfl|1,5|mg|90|stk|1|þpakki||C03BA11|01.03.1999||R|A|2|0|0|E|0|SEV|0|0|0|100|DKK|4645|7144|lyfalmen|||00|90|0|54|Icepharma hf|Servier|Indapamíð||4645||4645|7144 414789|N03AF0104|Tegretol|mixtúra|20|mg/ml|300|ml|1|glas||N03AF01|01.09.2007||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|1484|2854|lyfalmen|||00|300|0|6|Vistor hf|Novartis Healthcare A/S-|Karbamazepín||1484||1484|2854 415679|G03CA0310|Vagifem|sk-tfl|25|mcg|15|stk|1|pakki|0|G03CA03|01.01.1995||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|2093|3681|lyfalmen|V0418|3624|5|15|0|15|Vistor hf|Novo-Nordisk|Estradíól||2093||2093|3681 415687|V08BA0101|E-Z-HD|mixtduft|0| |12|0z|24|stk|plastdósir|V08BA01|01.01.1988|30.04.2009|R|A|4|0|0|0|1|EZE|0|0|0|100|USD|15945|21719|lyfsjukr|||08|288|0|0|Icepharma hf|E-Z-Em|Baríumsúlfat||15945||15945|21719 415711|V08BA0102|Polibar ACB|innhl|933|mg/g|16|0z|24|stk|plastpokar|V08BA01|01.01.1988|30.04.2009|R|A|2|0|0|0|1|EZE|0|0|0|100|USD|44829|57680|lyfsjukr|||00|384|0|0|Icepharma hf|E-Z-Em|Baríumsúlfat||44829||44829|57680 415737|V08BA0102|Polibar ACB|innhl|933|mg/g|20|0z|24|stk|plastpokar|V08BA01|01.01.1988|30.04.2009|R|A|2|0|0|0|1|EZE|0|0|0|100|USD|56038|71635|lyfsjukr|||00|480|0|0|Icepharma hf|E-Z-Em|Baríumsúlfat||56038||56038|71635 416222|C09DA0101|Cozaar Comp|töflur|62,5|mg|28|stk|1|þpakki|50+12,5 mg|C09DA01|01.09.1997||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|3662|5810|lyfalmen|||00|28|0|28|Icepharma hf|M.S.D.|Lósartan og þvagræsilyf||3662||3662|5810 416446|C09DA0101|Cozaar Comp|töflur|62,5|mg|98|stk|1|þpakki|50+12,5 mg|C09DA01|01.09.1997||R|A|3|0|0|B|0|MSD|0|0|0|100|XEU|9770|9525|lyfalmen|V0198|9525|00|98|0|98|Icepharma hf|M.S.D.|Lósartan og þvagræsilyf||6400||6400|9525 416818|A02BA0205|Zantac|mixtúra|15|mg/ml|300|ml|1|glas||A02BA02|01.07.2000||R|A||0|0|E|0|LDR|0|0|0|100|IKR|3849|6064|lyfalmen|||00|300|1|15|Parlogis hf|Parlogis - óskráð lyf|Ranitidín||3849||3849|6064 416859|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|10|ml|1|túpa||A01AA01|01.10.1995||R|A|5|0|0|E|0|GOG|0|0|1|100|XEU|2957|4853|lyfalmen|||23|10|0|0|Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||2957||2957|4853 416867|A01AA0101|Duraphat|tannlakk|22,6|mg/ml|30|ml|5|túpa||A01AA01|01.10.1988||R|A|5|0|0|E|0|GOG|0|0|1|100|XEU|24870|33148|lyfalmen|||23|150|0|0|Icepharma hf|Colgate Palmolive A/S|Natríumflúoríð||24870||24870|33148 416883|D10AX0301|Skinoren|krem|200|mg/g|30|g|1|túpa||D10AX03|01.07.1991||R|A|5|0|0|0|0|IGB|0|0|0|100|SEK|1024|2230|lyfalmen|||00|30|0|30|Icepharma hf|Intendis GmbH Berlin|Azelainsýra||1024||1024|2230 417238|QM01AE0301|Romefen, vet.|töflur|10|mg|10|stk|1|þpakki||QM01AE03|01.10.1995||R|A|3|0|0|0|0|MER|0|0|0|100|XEU|541|1068|vetalmen|||00|10|0|0|Vistor hf|Merial|||541||541|1068 417832|J05AF0601|Ziagen|filmhtfl|300|mg|60|stk|1|þpakki||J05AF06|01.07.2005||R|A|3|0|1|0|1|GGL|0|0|0|100|GBP|38634|49967|lyfsjukr|||00|60|0|30|GlaxoSmithKline ehf|Glaxo Group Limited|Abacavír||38634||38634|49967 418483|A07EC0201|Mesasal|sh-tfl|250|mg|100|stk|1|þpakki||A07EC02|01.10.1991||R|A|3|0|0|B|0|SNO|0|0|0|100|NOK|4324|6708|lyfalmen|||10|100|0|17|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||4324||4324|6708 418665|D07XC0101|Diprosalic|smyrsli|0| |50|g|1|túpa||D07XC01|01.11.1979||R|A|5|0|0|B|0|SCP|0|0|1|100|DKK|1780|3256|lyfalmen|||20|50|0|50|Vistor hf|Schering-Plough|Betametasón||1780||1780|3256 418731|A07EC0201|Mesasal|eþ-stil|500|mg|60|stk|1|pakki||A07EC02|01.10.1991||R|A|4|0|0|B|0|SNO|0|0|0|100|NOK|8794|12774|lyfalmen|V0299|9108|00|60|0|20|Vistor hf|Sanofi-aventis Norge AS|Mesalazín (5-amínósalicýlsýra)||8794||8794|12774 418988|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|glas||QA07AA01|01.03.1981||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|1993|3933|vetalmen|||13|200|0|0|Vistor hf|Boehringer Ingelheim Danmark|||1993||1993|3933 418996|QA07AA0101|Colinovina, vet.|mixtúra|200|mg/ml|200|ml|1|sett|+ dæla|QA07AA01|01.03.1981||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|2587|5099|vetalmen|||13|200|0|0|Vistor hf|Boehringer Ingelheim Danmark|||2587||2587|5099 419242|A11CC0301|Etalpha|hylki|0,25|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|4177|6509|lyfalmen|||10|100|0|25|Vistor hf|LEO Pharma A/S|Alfakalsídól||4177||4177|6509 419309|A11CC0301|Etalpha|hylki|1|mcg|100|stk|1|þpakki||A11CC03|01.11.1979||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|9864|14226|lyfalmen|||10|100|0|100|Vistor hf|LEO Pharma A/S|Alfakalsídól||9864||9864|14226 419440|L01DB0103|Caelyx|irþ|2|mg/ml|10|ml|1|hgl||L01DB01|01.05.1999||R|K|1,6|0|1|0|1|SCP|0|0|0|100|DKK|68332|86941|lyfsjukr|||00|10|0|0|Vistor hf|Schering-Plough|Doxórúbicín||68332||68332|86941 419820|J05AE0201|Crixivan|hylki|400|mg|180|stk|1|glas||J05AE02|01.04.1997||R|A|3|0|1|0|1|MSD|0|0|0|100|XEU|56681|72435|lyfsjukr|||00|180|0|30|Icepharma hf|M.S.D.|Indínavír||56681||56681|72435 419838|A16AA0401|Cystagon|hylki|150|mg|100|stk|1|glas||A16AA04|01.02.2008||R|A|2|0|1|0|1|ORP|0|0|0|100|DKK|47899|61502|lyfsjukr|||00|100|0|8|Swedish Orphan International AB|Orphan Europe (S)|Mecaptamín||47899||47899|61502 419945|D07AD0101|Dermovat|áburður|0,5|mg/ml|25|ml|1|glas|í hársvörð|D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|780|1899|lyfalmen|||20|25|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||780||780|1899 420117|B01AB0401|Fragmin|stl|10000|ae/ml|1|ml|10|lykjur||B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|12335|17542|lyfalmen|||02|10|0|40|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||12335||12335|17542 420356|B01AB0401|Fragmin|stl|2500|ae/ml|4|ml|10|hgl||B01AB04|01.04.1993||R|A|3|0|0|0|1|PFI|0|0|0|100|DKK|12357|17252|lyfsjukr|||00|40|0|40|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||12357||12357|17252 420471|B01AB0401|Fragmin|stl|12500|ae/ml|0,2|ml|10|spr|einnotadæla|B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|5373|8132|lyfalmen|||02|2|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||5373||5373|8132 420497|B01AB0401|Fragmin|stl|25000|ae/ml|0,2|ml|10|spr|einnotadæla|B01AB04|01.04.1993||R|A|3|0|0|E|0|PFI|0|0|1|100|DKK|7801|11427|lyfalmen|||02|2|0|20|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||7801||7801|11427 421180|C01BD0101|Cordarone|töflur|100|mg|30|stk|1|þpakki||C01BD01|01.07.1989||R|A|5|0|0|B|0|SNO|0|0|0|100|NOK|2388|4081|lyfalmen|V0144|4016|70|30|0|15|Vistor hf|Sanofi-aventis Norge AS|Amíódarón||2388||2388|4081 422121|C07AB0205 |Seloken|töflur|50|mg|100|stk|1|þpakki||C07AB02|01.05.2009||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|1412|2757|lyfalmen|||00|28|0|33|Vistor hf|AstraZeneca A/S DK|Metóprólól||||1412|2757 422246|C07AB0206|Seloken ZOC|forðatfl|95|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|3103|5051|lyfalmen|||43|98|0|62|Vistor hf|AstraZeneca A/S DK|Metóprólól||3103||3103|5051 422337|C07AB0206|Seloken ZOC|forðatfl|190|mg|98|stk|1|þpakki||C07AB02|01.07.1988||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|6111|9133|lyfalmen|||43|98|0|124|Vistor hf|AstraZeneca A/S DK|Metóprólól||6111||6111|9133 422402|G03FB0505|Estracomb|forðapl|0| |8|stk|1|pakki|samsett pk|G03FB05|01.04.1993||R|A|2|0|0|E|0|NOH|0|0|0|100|DKK|2624|4401|lyfalmen|||23|8|0|28|Vistor hf|Novartis Healthcare A/S-|Noretísterón og östrógen||2624||2624|4401 422659|G02CB0102|Parlodel|töflur|2,5|mg|100|stk|1|glas||G02CB01|01.11.1979||R|A|3|0|0|E|0|MAS|0|0|0|100|SEK|7941|11617|lyfalmen|||49|100|0|50|Vistor hf|Meda AS|Brómókriptín||7941||7941|11617 424846|M04AA0103|Hexanurat|töflur|100|mg|100|stk|1|glas||M04AA01|01.02.2006||R|A||0|0|E|0|PCO|0|0|0|100|IKR|391|1371|lyfalmen|||00|100|1|25|Distica|Distica - óskráð lyf|||391||391|1371 424960|QP52AC1302|Panacur, vet.|pasta|187,5|mg/g|24|g|1|sk-dæl||QP52AC13|01.05.1999||L|A|3|0|0|0|0|INI|0|0|0|100|DKK|||vetorma|||16|24|0|0|Icepharma hf|Intervet International B.V.||||||2073 425181|N05CD0305|Flunitrazepam Merck NM|töflur|1|mg|100|stk|1|glas||N05CD03|01.10.1992||R|A|5|1|0|0|0|MNA|0|0|0|100|SEK|887|2044|lyfalmen|||00|100|0|100|Actavis Group PTC ehf|Merck NM AB|Flúnítrazepam||887||887|2044 425538|N04BC0102|Parlodel|hylki|10|mg|100|stk|1|þpakki||N04BC01|01.11.1979||R|A|4|0|0|E|0|MAS|0|0|0|100|SEK|27556|36492|lyfalmen|||52|100|0|25|Vistor hf|Meda AS|Brómókriptín||27556||27556|36492 426122|R01AA0503|Nezeril|nefdr|0,1|mg/ml|0,1|ml|20|sk-hyl||R01AA05|01.01.1987||L|A|2|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||23|2|0|0|Vistor hf|AstraZeneca A/S DK|Oxýmetazólín||||| 426312|J02AC0101|Diflucan|hylki|150|mg|2|stk|1|þpakki||J02AC01|01.04.1993||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|3499|5589|lyfalmen|V0555|2796|10|2|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||3499||3499|5589 426593|J01CE0204|Kaavepenin|töflur|500|mg|20|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|562|1603|lyfalmen|||00|20|0|5|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||562||562|1603 426601|J01CE0204|Kaavepenin|töflur|500|mg|30|stk|1|þpakki||J01CE02|01.10.1985||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|733|1835|lyfalmen|||00|30|0|8|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||733||733|1835 427351|N07BA0103|Nicorette|forðapl|5|mg/16kls|14|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|14|0|5|Vistor hf|McNeil Denmark ApS|Nikótín||||| 427369|N07BA0103|Nicorette|forðapl|10|mg/16kls|14|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|14|0|10|Vistor hf|McNeil Denmark ApS|Nikótín||||| 427377|N07BA0103|Nicorette|forðapl|15|mg/16kls|14|stk|1|pakki||N07BA01|01.07.1992||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|14|0|15|Vistor hf|McNeil Denmark ApS|Nikótín||||| 427765|A06AB0801|Laxoberal|dropar|7,5|mg/ml|30|ml|1|plglas||A06AB08|01.09.2008||L|A|3|0|0|0|0|BII|0|0|0|100|IKR|||lyfalmen|||00|30|0|45|Vistor hf|Boehringer Ingelheim International |Natríum pícós|||||2541 428441|D07AC1301|Elocon|krem|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|1017|2220|lyfalmen|||20|30|0|30|Vistor hf|Schering-Plough|Mómetasón||1017||1017|2220 428524|D07AC1301|Elocon|smyrsli|0,1|%|30|g|1|túpa||D07AC13|01.08.2008||R|A|3|0|0|B|0|SCP|0|0|1|100|DKK|1010|2211|lyfalmen|||20|30|0|30|Vistor hf|Schering-Plough|Mómetasón||1010||1010|2211 428565|J01MA0202|Ciproxin|irl|2|mg/ml|100|ml|10|pokar||J01MA02|01.01.1990||R|A|3|0|0|0|1|BHC|0|0|0|100|SEK|28960|37923|lyfsjukr|||00|1000|0|4|Vistor hf|Bayer HealthCare AG|Cíprófloxacín||28960||28960|37923 428656|J01MA0202|Ciproxin|irl|2|mg/ml|200|ml|10|pokar||J01MA02|01.01.1990||R|A|3|0|0|0|1|BHC|0|0|0|100|SEK|45353|58332|lyfsjukr|||00|2000|0|8|Vistor hf|Bayer HealthCare AG|Cíprófloxacín||45353||45353|58332 428672|J01CA0406|Flemoxin Solutab|lausnart|125|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|513|1537|lyfalmen|||23|14|0|2|Vistor hf|Astellas Pharma A/S|Amoxicillín||513||513|1537 428680|J01CA0406|Flemoxin Solutab|lausnart|250|mg|14|stk|1|þpakki||J01CA04|01.04.1992||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|846|1988|lyfalmen|||23|14|0|4|Vistor hf|Astellas Pharma A/S|Amoxicillín||846||846|1988 428813|C07AB0309|Atenolol Actavis|töflur|25|mg|30|stk|1|glas||C07AB03|01.01.1992||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|180|1085|lyfalmen|||00|30|0|10|Actavis Group hf|Actavis hf|Atenólól||180||180|1085 429167|J07CA0602|Pentavac|bóluefni|0| |0,5|ml|1|hgl|+ dreifa í dælu|J07CA06|01.10.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|5684|8554|lyfalmen|||AC|0|0|0|Icepharma hf|Sanofi Pasteur MSD|barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||5684||5684|8554 429225|J07CA0602|Pentavac|bóluefni|0| |0,5|ml|10|hgl||J07CA06|01.12.1999||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|42514|55115|lyfalmen|||AC|5|0|0|Icepharma hf|Sanofi Pasteur MSD|barnaveiki, haemophilus influenza B, kíghósti, mænusótt, stí||42514||42514|55115 429837|C03DA0101|Aldactone|töflur|100|mg|100|stk|1|þpakki||C03DA01|01.11.1981||R|A|5|0|0|E|0|PFI|0|0|0|100|DKK|5865|8799|lyfalmen|||00|100|0|133|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Spírónólaktón||5865||5865|8799 430009|N01AH0102|Leptanal|stl|50|mcg/ml|10|ml|5|lykjur||N01AH01|01.10.1989||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|1641|2350|lyfsjukr|||02|50|0|0|Vistor hf|Janssen-Cilag AB|Fentanýl||1641||1641|2350 430074|N05CD0801|Dormicum|stl|1|mg/ml|5|ml|10|lykjur||N05CD08|01.07.1990||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|1995|2856|lyfsjukr|||02|50|0|3|Icepharma hf|Roche|Mídazólam||1995||1995|2856 430157|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|100|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.10.1990||R|A|3|0|0|0|0|SPA|0|0|0|100|DKK|3915|7629|vetalmen|||27|100|0|0|Vistor hf|Schering-Plough A/S|||3915||3915|7629 430710|J07AP0301|Typhim Vi|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07AP03|01.07.1994||R|K|3|0|0|0|0|SPM|0|0|0|100|XEU|2598|4366|lyfalmen|||02|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Taugaveiki, hreinsaðir mótefna­vakar||2598||2598|4366 430967|N07BA0105|Nicorette Mint|tyggigúm|2|mg|30|stk|1|þpakki||N07BA01|01.01.1993||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2|Vistor hf|McNeil Denmark ApS|Nikótín||||| 431023|D06AX0101|Fucidin|smyrsli|20|mg/g|15|g|1|túpa||D06AX01|01.04.1989||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|779|1898|lyfalmen|||20|15|0|15|Vistor hf|LEO Pharma A/S|Fúsidínsýra||779||779|1898 431049|C01DA0801|Sorbangil|töflur|10|mg|100|stk|1|þpakki||C01DA08|01.07.1989||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|1135|2381|lyfalmen|||00|100|0|17|Vistor hf|Recip AB|Ísósorbíð dínítrat||1135||1135|2381 431106|N07BA0105|Nicorette Mint|tyggigúm|2|mg|210|stk|1|þpakki||N07BA01|01.10.1995||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|14|Vistor hf|McNeil Denmark ApS|Nikótín||||| 431122|N07BA0105|Nicorette Mint|tyggigúm|4|mg|30|stk|1|þpakki||N07BA01|01.01.1993||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|4|Vistor hf|McNeil Denmark ApS|Nikótín||||| 431171|N07BA0105|Nicorette Mint|tyggigúm|4|mg|210|stk|1|þpakki||N07BA01|01.10.1995||L|A|2.5|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||00|210|0|28|Vistor hf|McNeil Denmark ApS|Nikótín||||| 431205|C08DB0107|Korzem|töflur|30|mg|100|stk|1|þpakki||C08DB01|01.01.1989||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|785|1906|lyfalmen|||00|100|0|12|Actavis Group hf|Actavis hf|Diltíazem||785||785|1906 432880|N02BE0107|Paratabs|töflur|500|mg|300|stk|1|glas|öryggislok|N02BE01|01.11.1981||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|952|2132|lyfalmen|||00|300|0|50|Actavis Group hf|Actavis hf|Paracetamól||952||952|2132 433250|N04BX0201|Comtess|töflur|200|mg|100|stk|1|glas||N04BX02|01.07.1999||R|A|3|0|0|E|0|ORC|0|0|0|100|DKK|12649|17933|lyfalmen|V0729|17618|0|100|0|20|Vistor hf|Orion Corporation|Entakapón||12649||12649|17933 433292|N02AA0106|Contalgin Uno|forðahlk|30|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|2537|4283|lyfalmen|||00|28|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||2537||2537|4283 433300|N02AA0106|Contalgin Uno|forðahlk|60|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|4654|7156|lyfalmen|||00|28|0|17|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||4654||4654|7156 433318|N02AA0106|Contalgin Uno|forðahlk|90|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|6223|9285|lyfalmen|||00|28|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||6223||6223|9285 433326|N02AA0106|Contalgin Uno|forðahlk|120|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|7791|11413|lyfalmen|||00|28|0|34|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||7791||7791|11413 433342|N02AA0106|Contalgin Uno|forðahlk|150|mg|28|stk|1|þpakki||N02AA01|01.05.1998||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|8977|13023|lyfalmen|||00|28|0|42|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||8977||8977|13023 433359|N02AA0106|Contalgin Uno|forðahlk|200|mg|28|stk|1|þpakki||N02AA01|01.05.1998|31.03.2009|R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|11250|16107|lyfalmen|||00|28|0|56|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||11250||11250|16107 433722|J01EE0104|Primazol sterkar|töflur|960|mg|10|stk|1|glas|160+800 mg|J01EE01|01.07.1989||R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|486|1500|lyfalmen|||00|10|0|5|Actavis Group hf|Actavis hf|Súlfametoxazól og trímetóprím||486||486|1500 433730|J01EE0104|Primazol sterkar|töflur|960|mg|20|stk|1|glas|160+800 mg|J01EE01|01.07.1989|31.03.2009|R|A|3|0|0|0|0|ACA|0|0|1|100|IKR|929|2101|lyfalmen|||00|20|0|10|Actavis Group hf|Actavis hf|Súlfametoxazól og trímetóprím||929||929|2101 434639|QP52AC1302|Panacur, vet.|töflur|250|mg|10|stk|1|þpakki||QP52AC13|01.04.1992||L|A|5|0|0|0|0|INI|0|0|0|100|DKK|||vetorma|||99|10|0|0|Icepharma hf|Intervet International B.V.||||||1319 434670|D01AC2001|Daktacort|krem|0| |50|g|1|túpa||D01AC20|01.10.1988||R|K|3|0|0|0|0|JAS|0|0|1|100|SEK|1378|2710|lyfalmen|||20|50|0|50|Vistor hf|Janssen-Cilag AB|Blöndur||1378||1378|2710 434829|C01CA2404|EpiPen|stl|0,3|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|A|1,7|0|0|B|0|ALK|0|0|1|100|DKK|7399|10881|lyfalmen|||00|1|0|1|Vistor hf|ALK-Abello A/S|Epínefrín (adrenalín)||7399||7399|10881 434837|C01CA2405|EpiPen Junior|stl|0,15|mg/sk|1|stk|1|pakki|einnota penni i.m.|C01CA24|01.07.2007||R|A|1,75|0|0|B|0|ALK|0|0|1|100|DKK|7399|10881|lyfalmen|||00|1|0|0|Vistor hf|ALK-Abello A/S|Epínefrín (adrenalín)||7399||7399|10881 434852|N06AB0302|Fontex|lausnart|20|mg|100|stk|1|pakki|þp (10x10 stk)|N06AB03|01.06.1998||R|A|2|0|0|B|0|ELI|0|1|0|100|XEU|11025|15802|lyfalmen|||00|100|0|100|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||11025||11025|15802 435537|N02CC0301|Zomig|töflur|5|mg|6|stk|1|þpakki||N02CC03|01.06.1999||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|5587|8422|lyfalmen|||00|6|0|12|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||5587||5587|8422 435578|N02CC0301|Zomig|töflur|2,5|mg|3|stk|1|þpakki||N02CC03|01.11.1998|30.04.2009|R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|2064|3641|lyfalmen|||00|3|0|3|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||2064||2064|3641 435594|N02CC0301|Zomig|töflur|2,5|mg|6|stk|1|þpakki||N02CC03|01.11.1998||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|4665|7171|lyfalmen|||00|6|0|6|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||4665||4665|7171 435651|N05AH0401|Seroquel|töflur|25|mg|100|stk|1|þpakki||N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|6894|9003|lyfalmen|V0725|7831|00|100|0|6|Vistor hf|AstraZeneca UK Ltd|Quetíapín||6015||6015|9003 435974|C01DA0801|Sorbangil|töflur|10|mg|250|stk|1|plglas||C01DA08|01.04.2004||R|A|3|0|0|B|0|REP|0|0|0|100|SEK|2643|4427|lyfalmen|||00|250|0|42|Vistor hf|Recip AB|Ísósorbíð dínítrat||2643||2643|4427 436022|C09DA0308|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|28|stk|1|pakki||C09DA03|01.10.1999||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|3808|6008|lyfalmen|||00|28|0|28|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||3808||3808|6008 436030|C09DA0308|Diovan Comp 80 mg/12,5 mg|töflur|92,5|mg|98|stk|1|pakki||C09DA03|01.10.1999||R|A|3|0|0|B|0|NOH|0|0|0|100|DKK|10911|15647|lyfalmen|V0191|12683|00|98|0|98|Vistor hf|Novartis Healthcare A/S-|Valsartan og þvagræsilyf||10911||10911|15647 436071|N04BC0401|Requip|töflur|0,25|mg|210|stk|1|þpakki||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|5657|8517|lyfalmen|||00|210|0|9|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||5657||5657|8517 436139|N04BC0401|Requip|töflur|0,5|mg|21|stk|1|þpakki||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|952|2132|lyfalmen|||00|21|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||952||952|2132 436147|M01AE0216|Naproxen-E Merck NM|sh-tfl|250|mg|20|stk|1|þpakki||M01AE02|01.07.1993||L|A|5|0|0|0|0|MNA|0|0|1|100|IKR|||lyflausa|||10|20|0|10|Actavis Group PTC ehf|Merck NM AB|Naproxen||||| 436238|N04BC0401|Requip|töflur|1|mg|84|stk|1|plglas||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|6225|9288|lyfalmen|||00|84|0|14|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||6225||6225|9288 436279|N04BC0401|Requip|töflur|2|mg|84|stk|1|plglas||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|11287|16157|lyfalmen|V0728|15834|00|84|0|28|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||11287||11287|16157 436295|N04BC0401|Requip|töflur|5|mg|84|stk|1|plglas||N04BC04|01.03.1998||R|A|2|0|0|E|0|GSK|0|0|0|100|GBP|23993|32056|lyfalmen|||00|84|0|70|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Rópíníról||23993||23993|32056 436410|D06AX0101|Fucidin|krem|20|mg/g|15|g|1|túpa||D06AX01|01.01.1989||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|758|1869|lyfalmen|||20|15|0|15|Vistor hf|LEO Pharma A/S|Fúsidínsýra||758||758|1869 436527|M01AE0216|Naproxen-E Merck NM|sh-tfl|250|mg|100|stk|1|glas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|1848|3348|lyfalmen|||10|100|0|50|Actavis Group PTC ehf|Merck NM AB|Naproxen||1848||1848|3348 436550|M01AE0211|Naproxen-E NM Pharma|sh-tfl|375|mg|20|stk|1|þpakki||M01AE02|01.01.1995||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|740|1845|lyfalmen|||10|20|0|15|Actavis Group PTC ehf|Merck NM AB|Naproxen||740||740|1845 436626|M01AE0216|Naproxen-E Merck NM|sh-tfl|375|mg|100|stk|1|glas||M01AE02|01.01.1995||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|3059|4992|lyfalmen|||10|100|0|75|Actavis Group PTC ehf|Merck NM AB|Naproxen||3059||3059|4992 436808|M01AE0216|Naproxen-E Merck NM|sh-tfl|500|mg|100|stk|1|glas||M01AE02|01.07.1993||R|A|5|0|0|E|0|MNA|0|0|1|100|SEK|3499|5589|lyfalmen|||10|100|0|100|Actavis Group PTC ehf|Merck NM AB|Naproxen||3499||3499|5589 436915|N05AD0101|Haldol|töflur|1|mg|100|stk|1|þpakki||N05AD01|01.12.1972||R|A|5|0|0|*|0|JAS|0|1|0|100|SEK|861|2009|lyfalmen|||00|100|0|12|Vistor hf|Janssen-Cilag AB|Halóperídól||861||861|2009 436931|N05AD0101|Haldol|töflur|4|mg|100|stk|1|þpakki||N05AD01|01.12.1972||R|A|5|0|0|*|0|JAS|0|1|0|100|SEK|3019|4937|lyfalmen|||00|100|0|50|Vistor hf|Janssen-Cilag AB|Halóperídól||3019||3019|4937 438218|N06AX1602|Efexor Depot|forðahlk|75|mg|100|stk|1|glas||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|18140|24769|lyfalmen|V0955|18547|00|100|0|75|Icepharma hf|Wyeth AB|Venlafaxín||18140||18140|24769 438333|N06AX1602|Efexor Depot|forðahlk|150|mg|28|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|9228|13363|lyfalmen|||00|28|0|42|Icepharma hf|Wyeth AB|Venlafaxín||||9228|13363 438374|N07BC0201|Metadon|töflur|5|mg|20|stk|1|glas||N07BC02|01.01.1998||R|A||1|0|0|0|LDR|0|0|0|100|IKR|498|1516|lyfalmen|||00|20|1|4|Parlogis hf|Parlogis - óskráð lyf|||498||498|1516 438416|S02CA0301|Ciproxin-Hydrocortison|eyrnadr|0| |10|ml|1|túpa|2 mg + 10 mg/ml|S02CA03|01.09.2002||R|A|2|0|0|E|0|ALC|0|0|1|100|USD|1227|2505|lyfalmen|||00|10|0|0|K.Pétursson hf|Alcon|Hýdrókortisón og sýkingalyf||1227||1227|2505 438424|N06AX1602|Efexor Depot|forðahlk|75|mg|28|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|4866|7444|lyfalmen|||00|28|0|21|Icepharma hf|Wyeth AB|Venlafaxín||4866||4866|7444 438432|N06AX1602|Efexor Depot|forðahlk|75|mg|98|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|16760|23051|lyfalmen|V0955|18176|00|98|0|74|Icepharma hf|Wyeth AB|Venlafaxín||16760||16760|23051 438457|N06AX1602|Efexor Depot|forðahlk|150|mg|98|stk|1|þpakki||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|31673|41618|lyfalmen|V0956|32658|00|98|0|147|Icepharma hf|Wyeth AB|Venlafaxín||31673||31673|41618 438465|N06AX1602|Efexor Depot|forðahlk|150|mg|100|stk|1|glas||N06AX16|01.10.1998||R|A|3|0|0|B|0|WAB|0|1|0|100|USD|34247|44822|lyfalmen|V0956|33324|00|100|0|150|Icepharma hf|Wyeth AB|Venlafaxín||34247||34247|44822 438762|R06AX1301|Clarityn|töflur|10|mg|10|stk|1|þpakki||R06AX13|01.07.1989||L|A|4|0|0|0|0|SCP|0|0|1|100|IKR|||lyflausa|||00|10|0|10|Vistor hf|Schering-Plough|Lóratadín||||| 438770|R06AX1301|Clarityn|töflur|10|mg|30|stk|1|þpakki||R06AX13|01.07.1989||R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|2006|3563|lyfalmen|||00|30|0|30|Vistor hf|Schering-Plough|Lóratadín||2006||2006|3563 438788|R06AX1301|Clarityn|töflur|10|mg|100|stk|1|þpakki||R06AX13|01.07.1989||R|A|4|0|0|E|0|SCP|0|0|1|100|DKK|6058|9061|lyfalmen|V0984|3662|00|100|0|100|Vistor hf|Schering-Plough|Lóratadín||6058||6058|9061 439208|J01DC0203|Zinnat|töflur|250|mg|14|stk|1|þpakki||J01DC02|01.10.1990||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|2145|3751|lyfalmen|||66|14|0|7|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Cefúroxím||2145||2145|3751 439489|C07FB0201|Logimax|forðatfl|55|mg|98|stk|1|pakki|þp 5+50 mg|C07FB02|01.04.1997||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|9664|13955|lyfalmen|||00|98|0|98|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóðþrýst­ings­­lækkandi lyf||9664||9664|13955 439794|R01AA0704|Otrivin ukonserveret|nefúði|1|mg/ml|10|ml|1|glas|sk-úðari|R01AA07|01.05.2001||L|A|3|0|0|0|0|NHE|0|0|1|100|IKR|||lyflausa|||06|10|0|12|Artasan ehf|Novartis Healthcare A/S-A|Xýlómetazólín||||| 440099|J01CR0202|Augmentin|mixtduft|91,4|mg/ml|70|ml|1|glas|80+11,4 mg/ml|J01CR02|01.08.1998||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|1066|2287|lyfalmen|||00|70|0|6|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1066||1066|2287 440677|J01CE0105|Penicillin Alpharma|sts|600|mg/hgl|10|hgl|1|pakki|1 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|1514|2168|lyfsjukr|||00|10|0|2|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||1514||1514|2168 440693|J01CE0105|Penicillin Alpharma|sts|1,2|g/hgl|10|hgl|1|pakki|2 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|2391|3423|lyfsjukr|||00|10|0|3|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||2391||2391|3423 440933|M01AB0507|Vostar|eþ-stil|50|mg|10|stk|1|pakki||M01AB05|01.01.1990||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|548|1584|lyfalmen|||04|10|0|5|Actavis Group hf|Actavis hf|Díklófenak||548||548|1584 441006|C03DA0101|Aldactone|töflur|25|mg|100|stk|1|þpakki||C03DA01|01.12.1972||R|A|5|0|0|E|0|PFI|0|0|0|100|DKK|1480|2849|lyfalmen|V0221|2838|00|100|0|33|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Spírónólaktón||1480||1480|2849 441279|D01AC2002|Pevisone|krem|0| |30|g|1|túpa||D01AC20|01.10.1988||R|A|4|0|0|0|0|JAS|0|0|1|100|SEK|1278|2575|lyfalmen|||20|30|0|30|Vistor hf|Janssen-Cilag AB|Blöndur||1278||1278|2575 441634|P03AC0401|Nix|hársápa|10|mg/ml|59|ml|1|pakki||P03AC04|01.01.1996||L|A|2|0|0|0|0|ACH|0|0|0|100|IKR|||lyflausa|||00|59|0|0|Aco Hud Nordic AB|ACO Hud AB|Permetrín||||| 441949|G03DC0202|Primolut N|töflur|5|mg|30|stk|1|glas||G03DC02|01.12.1972||R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|830|1967|lyfalmen|||00|30|0|30|Icepharma hf|Bayer Schering Pharma AG|Noretísterón||830||830|1967 442152|J05AF0101|Retrovir|hylki|250|mg|40|stk|1|þpakki||J05AF01|01.07.1995||R|A|5|0|1|0|1|GSK|0|0|0|100|GBP|28403|37229|lyfsjukr|||61|40|0|17|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Zídóvúdín||28403||28403|37229 443135|H04AA0102|GlucaGen Hypokit|sts|1|mg|1|stk|1|hgl|dæla|H04AA01|01.01.1989||R|K|3|0|0|*|0|NON|0|0|1|100|DKK|3750|5929|lyfalmen|||02|1|0|1|Vistor hf|Novo-Nordisk|Glúkagon||3750||3750|5929 443358|N02AA0101|Contalgin|forðatfl|200|mg|90|stk|1|þpakki||N02AA01|01.04.1993||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|32440|42573|lyfalmen|||10|90|0|180|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||32440||32440|42573 444240|J05AF0401|Zerit|hylki|30|mg|56|stk|1|þpakki||J05AF04|01.11.1998||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|46159|59335|lyfsjukr|||00|56|0|21|Vistor hf|Bristol-Myers Squibb|Stavúdín||46159||46159|59335 444299|J05AF0401|Zerit|hylki|40|mg|56|stk|1|þpakki||J05AF04|01.11.1998||R|A|2|0|1|0|1|BRS|0|0|0|100|DKK|46819|60157|lyfsjukr|||00|56|0|28|Vistor hf|Bristol-Myers Squibb|Stavúdín||46819||46819|60157 444315|N06AB0302|Fontex|lausnart|20|mg|30|stk|1|pakki|þp (2 x 15 stk)|N06AB03|01.06.1998||R|A|2|0|0|B|0|ELI|0|1|0|100|XEU|3312|5335|lyfalmen|V0914|2128|00|30|0|30|Icepharma hf|Eli Lilly Danmark A/S|Flúoxetín||3312||3312|5335 444430|N04BA0208|Madopar Quick "62,5"|lausnart|62,5|mg|100|stk|1|glas|50+12,5 mg|N04BA02|01.11.2000||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|2919|4802|lyfalmen|||00|100|0|8|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||2919||2919|4802 444927|M05BA0601|Bondronat|irþ|1|mg/ml|2|ml|1|hgl||M05BA06|01.04.2006||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|18569|24986|lyfsjukr|||00|2|0|0|Icepharma hf|Roche|||18569||18569|24986 445155|D07CA0102|Fucidin-Hydrocortison|krem|30|mg/g|30|g|1|túpa|20 + 10 mg|D07CA01|01.02.1998||R|A|3|0|0|B|0|LEO|0|0|1|100|DKK|1842|3340|lyfalmen|||00|30|0|30|Vistor hf|LEO A/S|Hýdrókortisón og sýklalyf||1842||1842|3340 445759|G04CB0101|Proscar|töflur|5|mg|98|stk|1|þpakki||G04CB01|01.04.1993||R|A|3|0|0|E|0|MSD|0|0|0|100|XEU|12531|5804|lyfalmen|V0411|5454|10|98|0|98|Icepharma hf|M.S.D.|Fínasteríð||3658||3658|5804 446187|QA12CX9001|Tonophosphan, vet.|stl|200|mg/ml|50|ml|1|hgl||QA12CX90|01.12.1972||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|1479|2919|vetalmen|||27|50|0|0|Icepharma hf|Intervet International B.V.|||1479||1479|2919 446807|J02AC0101|Diflucan|hylki|50|mg|7|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|4134|6450|lyfalmen|V0551|3202|10|7|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||4134||4134|6450 446930|J02AC0101|Diflucan|hylki|150|mg|1|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|1761|3230|lyfalmen|V0554|1864|10|1|0|1|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||1761||1761|3230 447052|B01AB0401|Fragmin|stl|25000|ae/ml|0,72|ml|5|áf.spr|anti Xa|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|11523|16478|lyfalmen|||00|4|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||11523||11523|16478 447110|B01AB0401|Fragmin|stl|25000|ae/ml|0,4|ml|5|áf.spr|anti Xa|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|6573|9760|lyfalmen|||00|2|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||6573||6573|9760 447136|B01AB0401|Fragmin|stl|25000|ae/ml|0,5|ml|5|áf.spr|anti Xa|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|8052|11767|lyfalmen|||00|2|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||8052||8052|11767 447151|B01AB0401|Fragmin|stl|25000|ae/ml|0,6|ml|5|áf.spr|anti Xa|B01AB04|01.04.2008||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|9668|13960|lyfalmen|||00|3|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dalteparín||9668||9668|13960 447912|C08DB0107|Korzem|töflur|60|mg|100|stk|1|þpakki||C08DB01|01.01.1989||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|706|1798|lyfalmen|V0352|1798|00|100|0|25|Actavis Group hf|Actavis hf|Diltíazem||706||706|1798 448217|C05AA0801|Doloproct|eþ-stil|0| |10|stk|1|pakki||C05AA08|01.01.1991||R|A|4|0|0|E|0|IGB|0|0|0|100|SEK|526|1554|lyfalmen|||04|10|0|0|Icepharma hf|Intendis GmbH Berlin|Flúókortólón||526||526|1554 448233|C05AA0801|Doloproct|eþ-krem|0| |30|g|1|túpa||C05AA08|01.01.1991||R|A|3|0|0|E|0|IGB|0|0|0|100|SEK|1027|2234|lyfalmen|||00|30|0|0|Icepharma hf|Intendis GmbH Berlin|Flúókortólón||1027||1027|2234 448498|R03DA0503|Aminophylline|stl|30|mg/ml|10|ml|10|lykjur||R03DA05|01.07.2000||R|A||0|0|E|0|LDR|0|0|0|100|IKR|6496|9656|lyfalmen|||02|100|1|5|Parlogis hf|Parlogis - óskráð lyf|||6496||6496|9656 448688|M03BX0103|Lioresal|töflur|25|mg|50|stk|1|þpakki||M03BX01|01.12.1972||R|A|5|0|0|E|0|NOH|0|0|1|100|DKK|2411|4112|lyfalmen|V0712|2522|00|50|0|25|Vistor hf|Novartis Healthcare A/S-|Baklófen||2411||2411|4112 449595|C07AB0310|Atenolol Merck NM|töflur|50|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|790|1912|lyfalmen|||00|98|0|65|Actavis Group PTC ehf|Merck NM AB|Atenólól||||790|1912 449611|C07AB0310|Atenolol Merck NM|töflur|100|mg|98|stk|1|þpakki||C07AB03|01.01.1991||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|1161|2416|lyfalmen|||00|98|0|131|Actavis Group PTC ehf|Merck NM AB|Atenólól||1161||1161|2416 449819|J01CE0105|Penicillin Alpharma|sts|3|g/hgl|10|hgl|1|pakki|5 millj.ae|J01CE01|01.07.2004||R|A|5|0|0|0|1|AGT|0|0|0|100|DKK|5670|8118|lyfsjukr|||00|10|0|8|Actavis Group hf|Actavis Group hf|Benzýlpenicillín||5670||5670|8118 450155|J01CR0202|Augmentin|töflur|1|g|12|stk|1|pakki|þp 875+125 mg|J01CR02|01.01.1997||R|A|2|0|0|0|0|GSK|0|0|1|100|IKR|1115|2233|lyfalmen|V0466|2233|00|12|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Amoxicillín og ensímblokkar||1026||1026|2233 450734|N05CF0201|Stilnoct|töflur|10|mg|20|stk|1|þpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|1111|1720|lyfalmen|V0902|1561|00|20|0|20|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||648||648|1720 450775|N05CF0201|Stilnoct|töflur|10|mg|100|stk|1|þpakki||N05CF02|01.10.1992||R|A|5|0|0|0|0|SNO|0|0|0|100|NOK|3502|4891|lyfalmen|V0903|4225|00|100|0|100|Vistor hf|Sanofi-aventis Norge AS|Zolpidem||2985||2985|4891 451153|V08CA0301|Omniscan|stl|0,5|mmol/ml|10|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|IKR|45479|58806|lyfalmen|||00|100|0|0|Icepharma hf|GE Healthcare AS|Gadódíamíð||45479||45479|58806 451419|V08CA0301|Omniscan|stl|0,5|mmol/ml|15|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|IKR|68218|87116|lyfalmen|||00|150|0|0|Icepharma hf|GE Healthcare AS|Gadódíamíð||68218||68218|87116 451476|V08CA0301|Omniscan|stl|0,5|mmol/ml|20|ml|10|spr|áfylltar sprautur|V08CA03|01.07.2003||R|A|3|0|0|0|0|GEH|0|0|0|100|IKR|90958|115428|lyfalmen|||00|200|0|0|Icepharma hf|GE Healthcare AS|Gadódíamíð||90958||90958|115428 451989|N06AB0401|Cipramil|töflur|30|mg|28|stk|1|þpakki||N06AB04|01.11.1999||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|5854|7989|lyfalmen|||00|28|0|42|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||5268||5268|7989 451997|N06AB0401|Cipramil|töflur|30|mg|100|stk|1|glas||N06AB04|01.11.1999||R|A|3|0|0|B|0|LBK|0|1|0|100|DKK|19420|25506|lyfalmen|||00|100|0|150|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||18732||18732|25506 452268|J02AC0101|Diflucan|hylki|50|mg|30|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|16968|23310|lyfalmen|V0552|10534|10|30|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||16968||16968|23310 452284|M01AB1501|Toradol|stl|30|mg/ml|1|ml|5|lykjur||M01AB15|01.04.1992||R|A|3|0|0|E|0|ROA|0|0|1|100|DKK|1188|2453|lyfalmen|||00|5|0|5|Icepharma hf|Roche as|Ketórólak||1188||1188|2453 452300|J02AC0101|Diflucan|hylki|50|mg|100|stk|1|þpakki||J02AC01|01.04.1990||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|56826|72933|lyfalmen|||10|100|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||56826||56826|72933 452482|V07AB09|Sterilt Vann B. Braun|leysir|0||100|ml|10|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|1000|0|0|Actavis Group hf|Braun|||||| 452862|D06BB1001|Aldara|krem|50|mg/g|250|mg|12|stk|einnota pokar|D06BB10|01.03.2000||R|A|2|0|0|0|0|LAB|0|0|1|100|SEK|12865|18202|lyfalmen|||00|3000|0|3|Vistor hf|Laboratories 3M Santé|Imikvímóð||12865||12865|18202 452896|A06AD1701|Phosphoral|mixtúra|0| |45|ml|2|fl||A06AD17|01.03.1999||L|A|3|0|0|0|0|LCF|0|0|0|100|IKR|||lyflausa|||00|90|0|0|Vistor hf|Laboratorios Casen-Fleet S.L.U.|Natríumfosföt||||| 452904|N02AA0501|Oxycontin|forðatfl|10|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|2614|4388|lyfalmen|||10|28|0|4|Icepharma hf|Norpharma |Oxýcódon||2614||2614|4388 452920|N02AA0501|Oxycontin|forðatfl|10|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|8603|12515|lyfalmen|||10|98|0|13|Icepharma hf|Norpharma |Oxýcódon||8603||8603|12515 452953|L04AX0102|Imurel|töflur|50|mg|100|stk|1|þpakki||L04AX01|01.10.1995||R|A|5|0|0|*|0|GSK|0|0|0|100|GBP|2457|4175|lyfalmen|||10|100|0|33|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Azatíóprín||2457||2457|4175 452995|N02AA0501|Oxycontin|forðatfl|20|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|4937|7540|lyfalmen|||10|28|0|7|Icepharma hf|Norpharma |Oxýcódon||4937||4937|7540 453126|QP54AA0101|Eqvalan, vet.|pasta|18,7|mg/g|6,4|g|1|sk-dæl||QP54AA01|01.01.1991||L|A|3|0|0|0|0|MEF|0|0|0|100|XEU|||vetorma|||16|6|0|0|Vistor hf|Merial (MSD)||||||2610 453175|N02AA0501|Oxycontin|forðatfl|20|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|15631|21646|lyfalmen|||10|98|0|26|Icepharma hf|Norpharma |Oxýcódon||15631||15631|21646 453498|N02AA0501|Oxycontin|forðatfl|40|mg|28|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|9945|14336|lyfalmen|||10|28|0|15|Icepharma hf|Norpharma |Oxýcódon||9945||9945|14336 453571|N02AA0501|Oxycontin|forðatfl|40|mg|98|stk|1|þpakki||N02AA05|01.04.2003||R|A|3|1|0|E|0|NOP|0|0|0|100|DKK|26836|35596|lyfalmen|||10|98|0|52|Icepharma hf|Norpharma|Oxýcódon||26836||26836|35596 453753|N05AE0401|Zeldox|sts|20|mg/hgl|1|hgl|1|pakki|+leysir|N05AE04|01.03.2002||R|A|3|0|0|0|1|PFI|0|1|0|100|DKK|3693|5287|lyfsjukr|||02|1|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ziprasidon||3693||3693|5287 453795|J07AL0102|Pneumo 23|bóluefni|0| |0,5|ml|1|dæla||J07AL01|01.09.2003||R|K|2|0|0|0|0|SPM|0|0|0|100|XEU|2352|4032|lyfalmen|||00|0|0|0|Icepharma hf|Sanofi Pasteur MSD|Hreinsuð pneumococca poly­sakkaríð mótefnavakar||2352||2352|4032 454199|C10AA0101|Zocor|töflur|20|mg|98|stk|1|þpakki||C10AA01|01.01.1991||R|A|2|0|0|0|0|MSD|0|0|0|100|XEU|10395|8282|lyfalmen|||00|98|0|131|Icepharma hf|M.S.D.|Simvastatín||5484||5484|8282 454439|N06DA0201|Aricept|töflur|5|mg|28|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|15723|21760|lyfalmen|||00|28|0|19|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dónepezíl||15723||15723|21760 454454|N06DA0201|Aricept|töflur|5|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|48612|62707|lyfalmen|V0375|39189|00|98|0|65|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dónepezíl||48612||48612|62707 454678|N06DA0201|Aricept|töflur|10|mg|28|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|17739|24270|lyfalmen|||00|28|0|37|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dónepezíl||17739||17739|24270 454686|N06DA0201|Aricept|töflur|10|mg|98|stk|1|þpakki||N06DA02|01.09.1998||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|52597|67668|lyfalmen|V0376|43720|00|98|0|131|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Dónepezíl||52597||52597|67668 454850|L01XX1701|Hycamtin|irs|4|mg/hgl|1|hgl|1|pakki||L01XX17|01.02.1999||R|A|3|0|1|0|1|GSK|0|0|0|100|GBP|49780|63844|lyfsjukr|||00|1|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Tópótecan||49780||49780|63844 454918|QJ01CE0902|Penovet, vet.|stl|300000|ae/ml|100|ml|1|hgl||QJ01CE09|01.10.1997||R|K|2|0|0|0|0|BID|0|0|0|100|DKK|1119|2208|vetalmen|||16|100|0|0|Vistor hf|Boehringer Ingelheim Danmark|||1119||1119|2208 455329|A10BF0101|Glucobay|töflur|50|mg|30|stk|1|þpakki||A10BF01|01.12.1997||R|A|3|0|0|*|0|BHC|0|0|0|100|SEK|847|1990|lyfalmen|||00|30|0|5|Vistor hf|Bayer HealthCare AG|Acarbósa||847||847|1990 455337|A10BF0101|Glucobay|töflur|50|mg|120|stk|1|þpakki||A10BF01|01.12.1997||R|A|3|0|0|*|0|BHC|0|0|0|100|SEK|3044|4971|lyfalmen|||00|120|0|20|Vistor hf|Bayer HealthCare AG|Acarbósa||3044||3044|4971 455428|B03XA0103|NeoRecormon|sts|10000|ae/rörly|1|ml|3|rörlyk|+leysir|B03XA01|01.02.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|65432|83330|lyfsjukr|||00|3|0|30|Icepharma hf|Roche|Epóetín||65432||65432|83330 455527|B03XA0103|NeoRecormon|sts|20000|ae/rörly|1|ml|3|rörlyk|+leysir|B03XA01|01.02.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|130097|163838|lyfsjukr|||00|3|0|60|Icepharma hf|Roche|Epóetín||130097||130097|163838 455576|B03XA0103|NeoRecormon|sts|100000|ae/hgl|5|ml|1|hgl|+leysir|B03XA01|01.02.2002||R|A|3|0|1|0|1|ROC|0|0|0|100|DKK|212866|266886|lyfsjukr|||00|5|0|10|Icepharma hf|Roche|Epóetín||212866||212866|266886 455584|J05AB0901|Famvir|töflur|500|mg|21|stk|1|þpakki||J05AB09|01.10.1995||R|A|3|0|0|E|0|NOH|0|0|1|100|DKK|22434|30115|lyfalmen|||00|21|0|14|Vistor hf|Novartis Healthcare A/S-|Famcíclóvír||22434||22434|30115 455717|C05AD0102|Sulgan|eþ-smyr|0| |30|g|1|túpa||C05AD01|01.12.1972||L|A|5|0|0|0|0|DOE|0|0|0|100|IKR|||lyflausa|||00|30|0|0|Icepharma hf|Doetsch Grether|Lídókaín||||| 455725|C05AD0102|Sulgan|eþ-stil|0| |10|stk|1|pakki||C05AD01|01.12.1972||L|A|5|0|0|0|0|DOE|0|0|0|100|IKR|||lyflausa|||00|10|0|0|Icepharma hf|Doetsch Grether|Lídókaín||||| 455949|J01AA0207|Doxylin|töflur|100|mg|10|stk|1|þpakki|0|J01AA02|01.10.2008||R|A|4|0|0|0|0|ACA|0|0|1|100|XEU|1021|2226|lyfalmen|||00|10|0|10|Actavis Group hf|Actavis Group hf|Doxýcýklín||1021||1021|2226 455956|J01AA0207|Doxylin|töflur|100|mg|15|stk|1|þpakki||J01AA02|01.01.2009||R|A|4|0|0|0|0|ACA|0|0|1|100|XEU|1113|2351|lyfalmen|||0|15|0|15|Actavis Group hf|Actavis Group hf|Doxýcýklín||1113||1113|2351 455972|J01AA0207|Doxylin|töflur|100|mg|30|stk|1|þpakki|0|J01AA02|01.10.2008||R|A|4|0|0|0|0|ACA|0|0|1|100|XEU|2439|4150|lyfalmen|||00|30|0|30|Actavis Group hf|Actavis Group hf|Doxýcýklín||2439||2439|4150 456079|B05DA0001|Dianeal PD1 Glucose|kvið.sk|13,6|mg/ml|6000|ml|2|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|4071|5829|lyfsjukr|||00|12000|0|12|Icepharma hf|Baxter|||4071||4071|5829 456202|B05DB0001|Dianeal PD1 Glucose|kvið.sk|22,7|mg/ml|6000|ml|2|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|4071|5829|lyfsjukr|||00|12000|0|12|Icepharma hf|Baxter|||4071||4071|5829 456277|B05DA0001|Dianeal PD1 Glucose|kvið.sk|13,6|mg/ml|5000|ml|2|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|4444|6363|lyfsjukr|||00|10000|0|0|Icepharma hf|Baxter|||4444||4444|6363 456392|B05DB0001|Dianeal PD1 Glucose|kvið.sk|22,7|mg/ml|5000|ml|2|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|4444|6363|lyfsjukr|||00|10000|0|0|Icepharma hf|Baxter|||4444||4444|6363 457002|B05DA0001|Dianeal PD1 Glucose|kvið.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|6653|9525|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||6653||6653|9525 457036|B05DB0001|Dianeal PD1 Glucose|kvið.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|6653|9525|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||6653||6653|9525 457069|B05DB0001|Dianeal PD1 Glucose|kvið.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|6653|9525|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||6653||6653|9525 457119|B05DA0002|Dianeal PD1 Glucose Duo|kvið.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|8329|11925|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||8329||8329|11925 457127|N05BA1202|Paxal|töflur|0,25|mg|20|stk|1|glas||N05BA12|01.04.1990|31.03.2009|R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|117|999|lyfalmen|||00|20|0|5|Actavis Group hf|Actavis hf|Alprazólam||117||117|999 457135|N05BA1202|Paxal|töflur|0,25|mg|50|stk|1|glas||N05BA12|01.04.1990|31.03.2009|R|A|5|0|0|0|0|ACA|0|0|0|100|IKR|246|1174|lyfalmen|||00|50|0|12|Actavis Group hf|Actavis hf|Alprazólam||246||246|1174 457143|N05BA1202|Paxal|töflur|0,25|mg|100|stk|1|glas||N05BA12|01.04.1990|31.03.2009|R|A|5|0|0|0|0|ACA|0|0|0|100|IKR|461|1466|lyfalmen|||00|100|0|25|Actavis Group hf|Actavis hf|Alprazólam||461||461|1466 457150|N05BA1202|Paxal|töflur|0,5|mg|20|stk|1|glas||N05BA12|01.04.1990|31.03.2009|R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|199|1110|lyfalmen|||00|20|0|10|Actavis Group hf|Actavis hf|Alprazólam||199||199|1110 457192|N05BA1202|Paxal|töflur|0,5|mg|50|stk|1|glas||N05BA12|01.04.1990|31.03.2009|R|A|5|0|0|0|0|ACA|0|0|0|100|IKR|440|1437|lyfalmen|||00|50|0|25|Actavis Group hf|Actavis hf|Alprazólam||440||440|1437 457242|B05DB0002|Dianeal PD1 Glucose Duo|kvið.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|8119|11624|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||8119||8119|11624 457291|B05DB0002|Dianeal PD1 Glucose Duo|kvið.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|10794|15306|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||10794||10794|15306 458067|N05CM0201|Heminevrin|hylki|300|mg|25|stk|1|glas||N05CM02|01.12.1998||R|A|2|0|0|0|0|ARA|0|0|1|100|SEK|977|2166|lyfalmen|||00|25|0|5|Vistor hf|Astra|Clómetíazól||977||977|2166 458349|J01CA0801|Selexid|töflur|200|mg|20|stk|1|þpakki||J01CA08|01.12.1980||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|1638|3063|lyfalmen|||43|20|0|7|Vistor hf|LEO Pharma A/S|Pívmecillínam||1638||1638|3063 458356|J01CA0801|Selexid|töflur|200|mg|30|stk|1|þpakki||J01CA08|01.12.1980||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|2456|4173|lyfalmen|||43|30|0|10|Vistor hf|LEO Pharma A/S|Pívmecillínam||2456||2456|4173 458422|J01CA0801|Selexid|töflur|200|mg|100|stk|1|þpakki||J01CA08|01.12.2007||R|A|3|0|0|0|0|LEP|0|0|1|100|DKK|8938|12970|lyfalmen|V0456|12970|00|100|0|33|Vistor hf|LEO Pharma A/S|Pívmecillínam||8938||8938|12970 458737|B05DA0003|Dianeal PD4 Glucose Duo|kvið.sk|13,6|mg/ml|2000|ml|5|pokar||B05DA00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|10879|15412|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||10879||10879|15412 458778|B05DB0003|Dianeal PD4 Glucose Duo|kvið.sk|22,7|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|10879|15412|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||10879||10879|15412 458794|B05DB0003|Dianeal PD4 Glucose Duo|kvið.sk|38,6|mg/ml|2000|ml|5|pokar||B05DB00|01.03.1999||R|A|2|0|0|0|1|BAX|0|0|0|100|SEK|10879|15412|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter|||10879||10879|15412 459214|B05DB0004|Nutrineal PD4 1,1% Amino Acids Clear|kvið.sk|0| |2000|ml|5|pokar||B05DB00|01.06.2004||R|S|2|0|0|0|1|BAM|0|0|0|100|SEK|12943|17982|lyfsjukr|||00|10000|0|10|Icepharma hf|Baxter Medical AB|||12943||12943|17982 459354|J01FF0101|Dalacin|stl|150|mg/ml|2|ml|1|lykja||J01FF01|01.11.1979||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|1455|2083|lyfsjukr|||02|2|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||1455||1455|2083 459412|M05BA0601|Bondronat|irþ|1|mg/ml|2|ml|5|lykjur||M05BA06|01.02.2002||R|A|5|0|0|0|1|ROC|0|0|0|100|DKK|87384|110661|lyfsjukr|||00|10|0|2|Icepharma hf|Roche|||87384||87384|110661 459420|J01FF0101|Dalacin|stl|150|mg/ml|4|ml|1|lykja||J01FF01|01.11.1979||R|A|2|0|0|0|1|PFI|0|0|0|100|DKK|1785|2556|lyfsjukr|||02|4|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||1785||1785|2556 459727|S01ED0105|Optimol|augndr|2,5|mg/ml|5|ml|3|glös||S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|2067|3645|lyfalmen|||06|15|0|75|Icepharma hf|Santen Oy|Tímólól||2067||2067|3645 459743|S01ED0105|Optimol|augndr|5|mg/ml|5|ml|3|glös||S01ED01|01.01.1995||R|A|3|0|0|*|0|SAO|0|0|0|100|XEU|2267|3917|lyfalmen|||06|15|0|75|Icepharma hf|Santen Oy|Tímólól||2267||2267|3917 459859|B02AA0201|Cyklokapron|töflur|500|mg|30|stk|1|þpakki||B02AA02|01.04.1989||R|A|3|0|0|E|0|MAS|0|0|1|100|SEK|2221|3854|lyfalmen|||00|30|0|8|Vistor hf|Meda AS|Tranexamsýra||2221||2221|3854 459867|B02AA0201|Cyklokapron|töflur|500|mg|60|stk|1|þpakki||B02AA02|01.04.1989||R|A|3|0|0|E|0|MAS|0|0|1|100|SEK|4517|6970|lyfalmen|||00|60|0|15|Vistor hf|Meda AS|Tranexamsýra||4517||4517|6970 460071|J01CA0406|Flemoxin Solutab|lausnart|250|mg|20|stk|1|þpakki||J01CA04|01.07.1989||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|1029|2237|lyfalmen|||23|20|0|5|Vistor hf|Astellas Pharma A/S|Amoxicillín||1029||1029|2237 460170|J07BC0202|Avaxim|bóluefni|0| |0,5|ml|1|dæla|einnota dæla|J07BC02|01.04.1998||R|K|3|0|0|0|0|MEX|0|0|0|100|XEU|4343|6734|lyfalmen|||51|0|0|0|Icepharma hf|Aventis Pasteur MSD A/S|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||4343||4343|6734 460196|J01CA0406|Flemoxin Solutab|lausnart|500|mg|20|stk|1|þpakki||J01CA04|01.07.1989||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|1540|2930|lyfalmen|||23|20|0|10|Vistor hf|Astellas Pharma A/S|Amoxicillín||1540||1540|2930 460303|J01CA0406|Flemoxin Solutab|lausnart|750|mg|20|stk|1|þpakki||J01CA04|01.07.1989||R|A|5|0|0|0|0|ASP|0|0|1|100|XEU|2801|4641|lyfalmen|||23|20|0|15|Vistor hf|Astellas Pharma A/S|Amoxicillín||2801||2801|4641 460618|L01AX0301|Temodal|hylki|5|mg|20|stk|1|glas| |L01AX03|01.05.2001||R|A|3|0|1|0|1|SCP|0|0|0|100|DKK|18526|24932|lyfsjukr|||00|20|0|0|Vistor hf|Schering-Plough|Temozolomid||18526||18526|24932 460782|D01AC0801|Fungoral|sápa|20|mg/ml|120|ml|1|glas||D01AC08|01.10.1992||L|A|3|0|0|0|0|JAS|0|0|1|100|SEK|||lyflausa|||23|120|0|120|Vistor hf|Janssen-Cilag AB|Ketókónazól||||| 460972|J07BB0205|Influvac|bóluefni|0| |0,5|ml|10|spr|einnotaspr|J07BB02|01.12.1998||R|K|1|0|0|0|0|SOB|0|0|0|100|XEU|6214|9273|lyfalmen|||51|5|0|0|Icepharma hf|Solvay Biologicals B.V.|Inflúensa, hreinsaðir mótefnavakar||6214||6214|9273 461178|L01AX0301|Temodal|hylki|20|mg|20|stk|1|glas| |L01AX03|01.05.2001||R|A|3|0|1|0|1|SCP|0|0|0|100|DKK|74100|94122|lyfsjukr|||00|20|0|0|Vistor hf|Schering-Plough|Temozolomid||74100||74100|94122 461335|L01AX0301|Temodal|hylki|100|mg|5|stk|1|glas| |L01AX03|01.05.2001||R|A|3|0|1|0|1|SCP|0|0|0|100|DKK|90591|114653|lyfsjukr|||00|5|0|0|Vistor hf|Schering-Plough|Temozolomid||90591||90591|114653 461467|L01AX0301|Temodal|hylki|250|mg|5|stk|1|glas| |L01AX03|01.05.2001||R|A|3|0|1|0|1|SCP|0|0|0|100|DKK|195531|245304|lyfsjukr|||00|5|0|0|Vistor hf|Schering-Plough|Temozolomid||195531||195531|245304 461731|N02BE5102|Parkodin|töflur|510|mg|10|stk|1|pakki|þp 10+500 mg|N02BE51|01.01.1989||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|193|1102|lyfalmen|||00|10|0|2|Actavis Group hf|Actavis hf|Paracetamól í blöndum nema með geðlyfjum (psycholeptica)||193||193|1102 462028|D07AD0101|Dermovat|krem|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|624|1687|lyfalmen|||20|25|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||624||624|1687 462036|D07AD0101|Dermovat|krem|0,5|mg/g|100|g|1|túpa||D07AD01|01.07.1995|30.04.2009|R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|2216|3848|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||2216||2216|3848 462044|D07AD0101|Dermovat|smyrsli|0,5|mg/g|25|g|1|túpa||D07AD01|01.09.1982||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|624|1687|lyfalmen|||20|25|0|25|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||624||624|1687 462051|D07AD0101|Dermovat|smyrsli|0,5|mg/g|100|g|1|túpa||D07AD01|01.07.1995|30.04.2009|R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|2216|3848|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Klóbetasól||2216||2216|3848 462143|B05AA0703|Hemohes 10%|irl|100|mg/ml|500|ml|10|fl||B05AA07|01.11.1999|28.02.2009|R|A|3|0|0|0|1|BRA|0|0|0|100|XEU|||lyfsjukr|||00|5000|0|5|Actavis Group hf|Braun|Hýdróxyetýl sterkja||||| 462226|B05AA0702|Hemohes 6%|irl|60|mg/ml|500|ml|10|fl||B05AA07|01.11.1999|28.02.2009|R|A|3|0|0|0|1|BRA|0|0|0|100|XEU|||lyfsjukr|||00|5000|0|5|Actavis Group hf|Braun|Hýdróxyetýl sterkja||||| 462358|A07EA0601|Entocort|innhl|20|mcg/ml|7|stk|1|pakki|samsett pk|A07EA06|01.04.1993||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|7147|10539|lyfalmen|||56|7|0|7|Vistor hf|AstraZeneca A/S DK|Búdesóníð||7147||7147|10539 462986|QM01AE9101|Rimadyl vet.|stl|50|mg/ml|20|ml|1|hgl||QM01AE91|01.06.2000||R|K|3|0|0|0|0|PAL|1|0|0|100|DKK|6860|13238|vetalmen|||02|20|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health|||6860||6860|13238 463612|QM01AE9101|Rimadyl vet.|töflur|50|mg|100|stk|1|pakki||QM01AE91|01.06.2000||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|5472|10595|vetalmen|||00|100|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health|||5472||5472|10595 464164|N02BE0101|Panodil|töflur|500|mg|30|stk|1|þpakki||N02BE01|01.04.1992||L|A|5|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|30|0|5|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||||| 464370|N05AD0301|Buronil|töflur|25|mg|100|stk|1|glas||N05AD03|01.12.1972||R|A|5|0|0|*|0|OVA|0|1|0|100|DKK|1811|3298|lyfalmen|||00|100|0|8|Swedish Orphan International AB|Ovation Healthcare International Ltd.|Melperón||1811||1811|3298 465203|QJ01RA0103|Depomycine, vet.|stl|0| |100|ml|1|hgl||QJ01RA01|01.12.1982||R|S|3|0|0|0|0|INI|0|0|0|100|DKK|1215|2398|vetalmen|||58|100|0|0|Icepharma hf|Intervet International B.V.|||1215||1215|2398 465237|QJ01CR5001|Duplocillin L.A., vet.|stl|0| |100|ml|1|hgl||QJ01CR50|01.05.1983||R|S|3|0|0|0|0|INI|1|0|0|100|DKK|1148|2265|vetalmen|||58|100|0|0|Icepharma hf|Intervet International B.V.|||1148||1148|2265 465260|QJ01AA0603|Engemycin, vet.|stl|100|mg/ml|100|ml|1|hgl||QJ01AA06|01.12.1982||R|A|3|0|0|0|0|INI|0|0|0|100|DKK|1231|2429|vetalmen|||27|100|0|0|Icepharma hf|Intervet International B.V.|||1231||1231|2429 465278|QJ51RC2301|Nafpenzal DC, vet.|spenalyf|0| |3|g|4|spr||QJ51RC23|01.04.1985||R|A|3|0|0|0|0|INI|0|0|0|100|XEU|648|1279|vetalmen|||16|12|0|0|Icepharma hf|Intervet International B.V.|||648||648|1279 466086|N02AA0101|Contalgin|forðatfl|10|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|768|1883|lyfalmen|||10|25|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||768||768|1883 466094|N02AA0101|Contalgin|forðatfl|10|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|2694|4496|lyfalmen|||10|100|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||2694||2694|4496 466169|N02AA0101|Contalgin|forðatfl|30|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|1633|3056|lyfalmen|||10|25|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||1633||1633|3056 466219|N02AA0101|Contalgin|forðatfl|30|mg|100|stk|1|þpakki||N02AA01|01.08.1984||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|6555|9736|lyfalmen|||10|100|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||6555||6555|9736 466466|N02AA0101|Contalgin|forðatfl|60|mg|25|stk|1|þpakki||N02AA01|01.10.1995||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|3141|5103|lyfalmen|||10|25|0|15|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||3141||3141|5103 466482|L04AD0102|Sandimmun Neoral|hylki|25|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|8763|12732|lyfalmen|||10|50|0|5|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||8763||8763|12732 466680|N02AA0101|Contalgin|forðatfl|100|mg|25|stk|1|þpakki||N02AA01|01.07.1992||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|5027|7662|lyfalmen|||10|25|0|25|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||5027||5027|7662 466813|N06AG0201|Aurorix|töflur|150|mg|100|stk|1|þpakki||N06AG02|01.10.1990||R|A|5|0|0|B|0|MAS|0|1|0|100|SEK|4954|7563|lyfalmen|||64|100|0|50|Vistor hf|Meda AS|Móklóbemíð||4954||4954|7563 467191|L03AA0201|Neupogen|stl|0,6|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|K|2|0|1|0|1|AEU|0|0|0|100|DKK|16235|22080|lyfsjukr|||00|0|0|1|Vistor hf|Amgen Europe B.V.|Fílgrastím||16235||16235|22080 467258|L03AA0201|Neupogen|stl|0,96|mg/ml|0,5|ml|1|spr|áfyllt sprauta, lausn|L03AA02|01.02.2004||R|K|2|0|1|0|1|AEU|0|0|0|100|DKK|25444|33545|lyfsjukr|||00|0|0|1|Vistor hf|Amgen Europe B.V.|Fílgrastím||25444||25444|33545 467480|L03AB0502|IntronA|stl|18|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|27550|36167|lyfsjukr|||00|1|0|9|Vistor hf|Schering-Plough|Interferón alfa-2b||27550||27550|36167 467498|L03AB0502|IntronA|stl|30|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|44874|57736|lyfsjukr|||00|1|0|15|Vistor hf|Schering-Plough|Interferón alfa-2b||44874||44874|57736 467514|L04AA1001|Rapamune|mixtúra|1|mg/ml|60|ml|1|fl||L04AA10|01.04.2004||R|A|2|0|1|*|0|WTE|0|0|0|100|USD|38254|49811|lyfalmen|||00|60|0|20|Icepharma hf|Wyeth Europe|Sirolimus||38254||38254|49811 467563|L04AD0102|Sandimmun Neoral|hylki|50|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|16988|23335|lyfalmen|||10|50|0|10|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||16988||16988|23335 467621|L03AB0502|IntronA|stl|60|millj ae|1,2|ml|1|penni|Fjölskammtapenni|L03AB05|01.02.2001||R|K|1,25|0|1|0|1|SCP|0|0|0|100|DKK|91857|116229|lyfsjukr|||00|1|0|30|Vistor hf|Schering-Plough|Interferón alfa-2b||91857||91857|116229 467720|L04AD0102|Sandimmun Neoral|hylki|100|mg|50|stk|1|þpakki||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|32154|42217|lyfalmen|||10|50|0|20|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||32154||32154|42217 467993|N05AD0101|Haldol|stl|5|mg/ml|1|ml|5|lykjur||N05AD01|01.08.2000||R|A|5|0|0|0|1|JAS|0|1|0|100|SEK|695|995|lyfsjukr|||00|5|0|3|Vistor hf|Janssen-Cilag AB|Halóperídól||695||695|995 468082|N06AB0401|Cipramil|töflur|10|mg|100|stk|1|plglas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|6557|6608|lyfalmen|V0922|4508|00|100|0|50|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||4250||4250|6608 468116|N01AH0102|Leptanal|stl|50|mcg/ml|2|ml|5|lykjur||N01AH01|01.11.2001||R|A|3|1|0|0|1|JAS|0|0|0|100|SEK|405|580|lyfsjukr|||02|10|0|0|Vistor hf|Janssen-Cilag AB|Fentanýl||405||405|580 468124|N06AB0401|Cipramil|töflur|20|mg|100|stk|1|glas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|11441|6290|lyfalmen|V0926|4309|00|100|0|100|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||4016||4016|6290 468165|N06AB0401|Cipramil|töflur|40|mg|100|stk|1|glas||N06AB04|01.04.1993||R|A|5|0|0|B|0|LBK|0|1|0|100|DKK|24125|12816|lyfalmen|V0930|8459|00|100|0|200|Lundbeck Export A/S|H. Lundbeck A/S|Cítalópram||8825||8825|12816 469346|C10AB0401|Lopid|töflur|600|mg|98|stk|1|þpakki||C10AB04|01.07.1991||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|10400|14954|lyfalmen|||00|98|0|49|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gemfíbrózíl||10400||10400|14954 469742|N02AX0206|Nobligan Retard|forðatfl|200|mg|20|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|2970|4871|lyfalmen|||00|20|0|13|Icepharma hf|Grunenthal|Tramadól||2970||2970|4871 469817|N02AX0206|Nobligan Retard|forðatfl|200|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|12105|17256|lyfalmen|V0738|13656|00|100|0|67|Icepharma hf|Grunenthal|Tramadól||12105||12105|17256 469866|N02AX0206|Nobligan Retard|forðatfl|150|mg|20|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|2322|3991|lyfalmen|||00|20|0|10|Icepharma hf|Grunenthal|Tramadól||2322||2322|3991 469874|N02AX0206|Nobligan Retard|forðatfl|150|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|9191|13313|lyfalmen|V0736|10573|00|100|0|50|Icepharma hf|Grunenthal|Tramadól||9191||9191|13313 469890|N02AX0206|Nobligan Retard|forðatfl|100|mg|20|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1578|2982|lyfalmen|V0733|2461|00|20|0|7|Icepharma hf|Grunenthal|Tramadól||1578||1578|2982 469932|N02AX0206|Nobligan Retard|forðatfl|100|mg|100|stk|1|pakki||N02AX02|01.05.2000||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|6278|9360|lyfalmen|V0734|7182|00|100|0|33|Icepharma hf|Grunenthal|Tramadól||6278||6278|9360 470385|R03BA0501|Flixotide|innúðal|250|mcg/sk|120|sk|1|stauk||R03BA05|01.04.1995||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|5036|7674|lyfalmen|||24|120|0|50|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||5036||5036|7674 470989|V08AB0201|Omnipaque|stl|180|mg J/ml|15|ml|10|plastf||V08AB02|01.01.2005||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|6223|8910|lyfsjukr|||02|150|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||6223||6223|8910 471144|V08AB0201|Omnipaque|stl|240|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|7625|10917|lyfsjukr|||02|200|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||7625||7625|10917 471151|V08AB0201|Omnipaque|stl|300|mg J/ml|10|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|6396|9157|lyfsjukr|||02|100|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||6396||6396|9157 471169|V08AB0201|Omnipaque|stl|300|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|9018|12912|lyfsjukr|||02|200|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||9018||9018|12912 471177|V08AB0201|Omnipaque|stl|350|mg J/ml|20|ml|10|plastf||V08AB02|01.10.1998||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|9600|13745|lyfsjukr|||02|200|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||9600||9600|13745 471425|A10BB0701|Mindiab|töflur|5|mg|100|stk|1|þpakki||A10BB07|01.07.1990||R|A|5|0|0|*|0|PFI|0|0|0|100|DKK|2037|3605|lyfalmen|||68|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Glípízíð||2037||2037|3605 471821|QP52AC1302|Panacur, vet.|töflur|250|mg|20|stk|1|þpakki||QP52AC13|01.04.1992||L|A|5|0|0|0|0|INI|0|0|0|100|DKK|||vetorma|||99|20|0|0|Icepharma hf|Intervet International B.V.||||||2392 471938|L01AA0101|Sendoxan|töflur|50|mg|100|stk|1|þpakki||L01AA01|01.01.1988||R|A|3|0|0|*|0|BAM|0|0|0|100|SEK|2138|3742|lyfalmen|||00|100|0|0|Icepharma hf|Baxter Medical AB|Cýklófosfamíð||2138||2138|3742 471953|QV03AB9001|Antisedan, vet.|stl|5|mg/ml|10|ml|1|hgl||QV03AB90|01.08.2006||R|A|3|0|0|0|0|ORC|1|0|0|100|DKK|4871|9450|vetalmen|||27|10|0|0|Vistor hf|Orion Corporation|||4871||4871|9450 472092|C07AB0206|Seloken ZOC|forðatfl|47,5|mg|98|stk|1|þpakki||C07AB02|01.07.1989||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2057|3632|lyfalmen|V2003|3576|43|98|0|31|Vistor hf|AstraZeneca A/S DK|Metóprólól||2057||2057|3632 472332|J07BC0201|Havrix|bóluefni|1440|ein/ml|0,5|ml|1|dæla|einnota dæla|J07BC02|01.10.1995||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|2332|4005|lyfalmen|||02|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||2332||2332|4005 473348|A03AA0402|Spasmerin|töflur|135|mg|50|stk|1|glas||A03AA04|01.07.1990||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|957|2139|lyfalmen|||00|50|0|22|Actavis Group hf|Actavis hf|Mebeverín||957||957|2139 473371|A03AA0402|Spasmerin|töflur|135|mg|100|stk|1|glas||A03AA04|01.07.1990||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|1680|3120|lyfalmen|||00|100|0|45|Actavis Group hf|Actavis hf|Mebeverín||1680||1680|3120 474007|B05AA0507|Promiten|stl|150|mg/ml|20|ml|20|lykjur|plastlykjur|B05AA05|01.03.1999||R|A|3|0|0|0|1|MAB|0|0|0|100|SEK|12902|17930|lyfsjukr|||00|400|0|0|Vistor hf|Meda AB|Dextran||12902||12902|17930 474106|M02AA1301|Deep Relief|hlaup|5|%|50|g|1|túpa||M02AA13|01.06.2000||L|A|3|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||00|50|0|0|Icepharma hf|Mentholatum Company Ltd.|Íbúprófen||||| 474114|N02CA7201|Anervan|töflur|160,5|mg|30|stk|1|pakki|þp (0,5+10+50+100 mg)|N02CA72|01.10.1995||R|A|3|0|0|E|0|REP|0|0|0|100|SEK|925|2096|lyfalmen|||00|30|0|15|Vistor hf|Recip AB|Ergotamínlyf í blöndum með geðlyfjum (psycoleptica)||925||925|2096 474197|M02AA1301|Deep Relief|hlaup|5|%|15|g|1|túpa||M02AA13|01.06.2000||L|A|3|0|0|0|0|MEN|0|0|1|100|IKR|||lyflausa|||00|15|0|0|Icepharma hf|Mentholatum Company Ltd.|Íbúprófen||||| 474395|J05AG0101|Viramune|töflur|200|mg|60|stk|1|þpakki||J05AG01|01.03.2007||R|A|3|0|1|0|1|BII|0|0|0|100|DKK|42632|54944|lyfsjukr|||00|60|0|30|Vistor hf|Boehringer Ingelheim International |Nevírapín||42632||42632|54944 474551|R01AD0901|Nasonex|nefúði|50|mcg/sk|140|skammtar|1|úðagl|18 g í pakkn.|R01AD09|01.05.1998||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|1973|3518|lyfalmen|||00|140|0|35|Vistor hf|Schering-Plough|Mómetasón||1973||1973|3518 475327|N02BE0113|Pinex Junior|eþ-stil|250|mg|10|stk|1|pakki||N02BE01|01.07.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||04|10|0|1|Actavis Group hf|Actavis Group hf|Paracetamól||||| 475434|B01AA0301|Kovar|töflur|2|mg|100|stk|1|glas||B01AA03|01.10.1995||R|A|5|0|0|E|0|ACA|0|0|0|100|IKR|720|1817|lyfalmen|||00|100|0|27|Actavis Group hf|Actavis hf|Warfarín||720||720|1817 475467|G03CA0306|Evorel|forðapl|50|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|3765|5950|lyfalmen|||23|26|0|91|Vistor hf|Janssen-Cilag AB|Estradíól||3765||3765|5950 475491|N02AA5902|Parkodin forte|töflur|530|mg|20|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|A|2|0|0|0|0|ACA|0|0|1|100|NOK|213|1129|lyfalmen|V0775|1129|00|20|0|7|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||213||213|1129 475533|N02AA5902|Parkodin forte|töflur|530|mg|30|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|A|2|0|0|0|0|ACA|0|0|1|100|NOK|295|1241|lyfalmen|||00|30|0|10|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||295||295|1241 475715|N02AA5902|Parkodin forte|töflur|530|mg|100|stk|1|pakki|þp 30+500 mg|N02AA59|01.04.1992||R|A|2|1|0|0|0|ACA|0|0|1|100|NOK|827|1963|lyfalmen|V0780|1963|00|100|0|33|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||827||827|1963 475756|C09AA0801|Inhibace|töflur|2,5|mg|98|stk|1|þpakki||C09AA08|01.07.1991||R|A|3|0|0|B|0|ROC|0|0|0|100|DKK|6382|9501|lyfalmen|||00|98|0|98|Icepharma hf|Roche|Cílazapríl||6382||6382|9501 475798|R03AC1302|Oxis Turbuhaler|innúðadu|4,5|mcg/sk|60|sk|1|stauk||R03AC13|01.10.1997||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|3078|5017|lyfalmen|||00|60|0|11|Vistor hf|AstraZeneca A/S DK|Formóteról||3078||3078|5017 475822|R03AC1302|Oxis Turbuhaler|innúðadu|9|mcg/sk|60|sk|1|stauk||R03AC13|01.10.1997||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|4117|6427|lyfalmen|||00|60|0|22|Vistor hf|AstraZeneca A/S DK|Formóteról||4117||4117|6427 475889|C09AA0801|Inhibace|töflur|5|mg|98|stk|1|þpakki||C09AA08|01.07.1991||R|A|3|0|0|B|0|ROC|0|0|0|100|DKK|12238|17421|lyfalmen|||00|98|0|196|Icepharma hf|Roche|Cílazapríl||12238||12238|17421 475921|A10AB0404|Humalog Pen|stl|100|ae/ml|3|ml|5|pennar|einnota pennar|A10AB04|01.11.1999||R|K|2|0|0|*|0|ELD|0|0|0|100|XEU|6012|8999|lyfalmen|||00|15|0|38|Icepharma hf|Eli Lilly Nederland -|Insúlín lispró||6012||6012|8999 476093|A10AC0106|Humulin NPH Pen|stl|100|ae/ml|3|ml|5|pennar|Einnota pennar|A10AC01|01.06.1999||R|K|2|0|0|*|0|ELI|0|0|0|100|XEU|4846|7417|lyfalmen|||51|15|0|38|Icepharma hf|Eli Lilly Danmark A/S|Insúlín (manna)||4846||4846|7417 476580|R03AC0206|Ventoline|lausn|2|mg/ml|2,5|ml|20|lykjur|f. vél|R03AC02|01.04.1992||R|A|3|0|0|B|0|GSK|0|0|1|100|GBP|1076|2301|lyfalmen|||00|50|0|10|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Salbútamól||1076||1076|2301 476648|N05AH0401|Seroquel|töflur|100|mg|30|stk|1|þpakki|stakskammtar|N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|6279|9361|lyfalmen|||00|30|0|8|Vistor hf|AstraZeneca UK Ltd|Quetíapín||6279||6279|9361 476655|N05AH0401|Seroquel|töflur|200|mg|30|stk|1|þpakki|stakskammtar|N05AH04|01.09.1998||R|A|3|0|0|*|0|ASZ|0|1|0|100|SEK|9542|13789|lyfalmen|||00|30|0|15|Vistor hf|AstraZeneca UK Ltd|Quetíapín||9542||9542|13789 477059|P01BB5101|Malarone|filmhtfl|350|mg|12|stk|1|glas|250 + 100 mg|P01BB51|01.02.2006||R|A|5|0|0|0|0|GSK|0|0|0|100|GBP|4224|6573|lyfalmen|||00|12|0|3|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Prógúaníl í blöndum||4224||4224|6573 477547|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|0| |20|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|200|0|0|Icepharma hf|Fresenius Kabi|||||| 477554|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|0| |50|ml|10|hgl|fyrir stungulyf|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|500|0|0|Icepharma hf|Fresenius Kabi|||||| 477752|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|20|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|200|0|0|Icepharma hf|Fresenius Kabi|||||| 477760|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|50|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|500|0|0|Icepharma hf|Fresenius Kabi|||||| 477786|V07AB14|Natriumklorid Fresenius Kabi|leysir|9|mg/ml|100|ml|10|hgl|fyrir stungulyf|V07AB|01.08.2004||L|A|3|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||02|1000|0|0|Icepharma hf|Fresenius Kabi|||||| 479691|C09AA0701|Cibacen|töflur|10|mg|98|stk|1|þpakki||C09AA07|01.07.1991||R|A|3|0|0|B|0|MAS|0|0|0|100|SEK|9213|13343|lyfalmen|||00|98|0|131|Vistor hf|Meda AS|Benazepríl||9213||9213|13343 479717|C09AA0701|Cibacen|töflur|20|mg|98|stk|1|þpakki||C09AA07|01.07.1991||R|A|3|0|0|B|0|MAS|0|0|0|100|SEK|19765|26792|lyfalmen|||00|98|0|261|Vistor hf|Meda AS|Benazepríl||19765||19765|26792 480863|G03XC0101|Evista|töflur|60|mg|28|stk|1|þpakki||G03XC01|01.02.1999||R|A|3|0|0|E|0|DSG|0|0|0|100|SEK|4263|6625|lyfalmen|||00|28|0|28|Icepharma hf|Daiichi Sankyo Europe GmbH|Raloxífen||4263||4263|6625 480897|G03XC0101|Evista|töflur|60|mg|84|stk|1|þpakki||G03XC01|01.02.1999||R|A|3|0|0|E|0|DSG|0|0|0|100|SEK|11037|15818|lyfalmen|||00|84|0|84|Icepharma hf|Daiichi Sankyo Europe GmbH|Raloxífen||11037||11037|15818 481168|N06AX1201|Zyban|forðatfl|150|mg|60|stk|1|þpakki||N06AX12|01.09.2000||R|A|2|0|0|0|0|GSK|0|1|1|100|GBP|7074|10440|lyfalmen|||00|60|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Buprofienum||||7074|10440 481176|N06AX1201|Zyban|forðatfl|150|mg|100|stk|1|þpakki||N06AX12|01.09.2000||R|A|2|0|0|0|0|GSK|0|1|1|100|GBP|10917|15655|lyfalmen|||00|100|0|50|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Buprofienum||10917||10917|15655 481598|M03AX0102|Dysport|sts|500|ein|1|hgl|1|pakki||M03AX01|01.05.2003||R|K|2|0|1|0|1|INP|0|0|0|100|XEU|40542|52342|lyfsjukr|||02|1|0|0|Icepharma hf|Institut Produits Synthése (IPSEN) AB|Clostridium botulinum toxín-A||40542||40542|52342 483552|J02AC0101|Diflucan|hylki|200|mg|28|stk|1|þpakki||J02AC01|01.08.2000||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|63514|81260|lyfalmen|V0557|33109|10|28|0|28|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||63514||63514|81260 483602|J02AC0101|Diflucan|irl|2|mg/ml|50|ml|1|fl||J02AC01|01.04.1990||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|3682|5272|lyfsjukr|||00|50|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||3682||3682|5272 483636|N07BA0103|Nicorette|tungur.t|2|mg|30|stk|1|þpakki||N07BA01|01.02.1999||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|30|0|2|Vistor hf|McNeil Denmark ApS|Nikótín||||| 483644|N07BA0103|Nicorette|tungur.t|2|mg|105|stk|1|þpakki||N07BA01|01.02.1999||L|A|3|0|0|0|0|MCN|0|0|1|100|IKR|||lyflausa|||23|105|0|7|Vistor hf|McNeil Denmark ApS|Nikótín||||| 483685|J02AC0101|Diflucan|irl|2|mg/ml|100|ml|1|hgl||J02AC01|01.03.2001||R|A|5|0|0|0|1|PFI|0|0|0|100|DKK|5580|7989|lyfsjukr|||00|100|0|1|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||5580||5580|7989 484022|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|3|spr|+ leysir|L02AE04|01.01.1995||R|K|3|0|1|0|1|FER|0|0|0|100|DKK|84203|106700|lyfsjukr|||00|3|0|84|Vistor hf|Ferring|Triptórelín||84203||84203|106700 484238|D11AX1001|Propecia|töflur|1|mg|28|stk|1|þpakki||D11AX10|01.08.1999||R|A|3|0|0|0|0|MSD|0|0|0|100|XEU|6844|10128|lyfalmen|||00|28|0|28|Icepharma hf|M.S.D.|Fínasteríð||6844||6844|10128 484618|A01AD0201|Andolex|lausn|1,5|mg/ml|300|ml|1|glas|lausn til munnskolunar|A01AD02|01.01.1996||R|A|3|0|0|E|0|MEB|0|0|1|100|SEK|1215|2489|lyfalmen|||00|300|0|0|Vistor hf|Meda AB (V)|Benzýdamín||1215||1215|2489 484832|B05BB0118|Natrium Bicarbonat|irl|50|mg/ml|100|ml|1|fl||B05BB01|01.05.2004|30.04.2009|R|A||0|0|0|1|LDR|0|0|0|100|IKR|543|777|lyfsjukr|||00|100|1|0|Parlogis hf|Parlogis - óskráð lyf|Elektrólýtar||543||543|777 486779|M01AE0215|Naproxen Merck NM|töflur|250|mg|20|stk|1|þpakki||M01AE02|01.04.1995||L|A|4|0|0|0|0|MNA|0|0|1|100|IKR|||lyflausa|||00|20|0|10|Actavis Group PTC ehf|Merck NM AB|Naproxen||||| 486860|S01BA0101|Maxidex|augndr|1|mg/ml|5|ml|1|glas||S01BA01|01.01.1977||R|A|3|0|0|E|0|ALC|0|0|1|100|USD|680|1763|lyfalmen|||29|5|0|0|K.Pétursson hf|Alcon|Dexametasón||680||680|1763 486886|S01CA0101|Maxitrol|augndr|0| |5|ml|1|glas||S01CA01|01.07.1990||R|A|2|0|0|E|0|ALC|0|0|1|100|USD|669|1748|lyfalmen|||29|5|0|0|K.Pétursson hf|Alcon|Dexametasón||669||669|1748 487264|C09AA0401|Coversyl|töflur|2|mg|30|stk|1|þpakki||C09AA04|01.01.1992||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|2547|4297|lyfalmen|||00|30|0|15|Icepharma hf|Servier|Perindópríl||2547||2547|4297 487280|C09AA0401|Coversyl|töflur|4|mg|30|stk|1|þpakki||C09AA04|01.01.1992||R|A|2|0|0|B|0|SEV|0|0|0|100|DKK|3717|5885|lyfalmen|||00|30|0|30|Icepharma hf|Servier|Perindópríl||3717||3717|5885 487900|J01XE0101|Furadantin|töflur|50|mg|25|stk|1|þpakki||J01XE01|01.03.2004||R|A|3|0|0|0|0|REP|0|0|1|100|SEK|737|1841|lyfalmen|||00|25|0|6|Vistor hf|Recip AB|Nítrófúrantóín||737||737|1841 487959|N02BE0113|Pinex Junior|eþ-stil|125|mg|10|stk|1|pakki||N02BE01|01.07.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||04|10|0|0|Actavis Group hf|Actavis Group hf|Paracetamól||||| 488049|M01AX0101|Relifex|töflur|500|mg|20|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|793|1917|lyfalmen|||00|20|0|10|Vistor hf|Meda AB|Nabúmeton||793||793|1917 488056|M01AX0101|Relifex|töflur|500|mg|60|stk|1|plglas||M01AX01|01.07.1998||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|2360|4043|lyfalmen|||00|60|0|30|Vistor hf|Meda AB|Nabúmeton||2360||2360|4043 488114|N02BE0114|Pinex|eþ-stil|500|mg|10|stk|1|pakki||N02BE01|01.07.2008||L|A|5|0|0|0|0|AGT|0|0|1|100|IKR|||lyflausa|||04|10|0|2|Actavis Group hf|Actavis Group hf|Paracetamól||||| 488767|D05BB0201|Neotigason|hylki|10|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|A|3|0|1|B|0|ACA|0|0|0|100|DKK|9962|14359|lyfalmen|||67|50|0|14|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||9962||9962|14359 488791|D05BB0201|Neotigason|hylki|25|mg|50|stk|1|þpakki||D05BB02|01.04.1992||R|A|3|0|1|B|0|ACA|0|0|0|100|DKK|17982|24573|lyfalmen|||67|50|0|36|Actavis Group PTC ehf|Actavis Group PTC ehf|Acitretín||17982||17982|24573 489591|M01AB0506|Voltaren Rapid|töflur|50|mg|10|stk|1|þpakki||M01AB05|01.01.1996||R|A|3|0|0|0|0|NOH|0|0|1|100|IKR|338|1101|lyfalmen|||67|10|0|5|Vistor hf|Novartis Healthcare A/S-|Díklófenak||192||192|1101 489609|M01AB0506|Voltaren Rapid|töflur|50|mg|30|stk|1|þpakki||M01AB05|01.01.1996||R|A|3|0|0|0|0|NOH|0|0|1|100|IKR|960|1474|lyfalmen|V0609|1424|67|30|0|15|Vistor hf|Novartis Healthcare A/S-|Díklófenak||467||467|1474 490417|G03FB0504|Evorel Sequi|forðapl|0| |8|stk|1|pakki||G03FB05|01.08.1999||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|2218|3850|lyfalmen|||23|8|0|28|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2218||2218|3850 490425|G03FA0104|Evorel Conti|forðapl|0| |8|stk|1|pakki||G03FA01|01.08.1999||R|A|2|0|0|E|0|JAS|0|0|0|100|SEK|2599|4367|lyfalmen|||23|8|0|28|Vistor hf|Janssen-Cilag AB|Noretísterón og östrógen||2599||2599|4367 490557|A04AA0201|Kytril|stl|1|mg/ml|1|ml|5|lykjur||A04AA02|01.10.1999||R|A|3|0|0|E|0|ROA|0|0|0|100|DKK|8777|12751|lyfalmen|||00|5|0|2|Icepharma hf|Roche as|Granisetrón||8777||8777|12751 490797|C10AA0501|Zarator|töflur|10|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|4829|7394|lyfalmen|||00|30|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||4829||4829|7394 490805|C10AA0501|Zarator|töflur|10|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|11077|10588|lyfalmen|V0337|6756|00|100|0|100|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||7183||7183|10588 490813|C10AA0501|Zarator|töflur|20|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|7494|11010|lyfalmen|||00|30|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||7494||7494|11010 490821|C10AA0501|Zarator|töflur|20|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|15719|14407|lyfalmen|V0338|9234|00|100|0|200|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||9997||9997|14407 490839|C10AA0501|Zarator|töflur|40|mg|30|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|11632|16626|lyfalmen|||00|30|0|120|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||11632||11632|16626 490854|C10AA0501|Zarator|töflur|40|mg|100|stk|1|þpakki||C10AA05|01.03.1998||R|A|3|0|0|0|0|PFI|0|0|0|100|DKK|19993|17886|lyfalmen|V0339|11516|00|100|0|400|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Atorvastatín||12611||12611|17886 491639|N06DA0301|Exelon|mixtúra|2|mg/ml|120|ml|1|fl||N06DA03|01.05.2003||R|A|2|0|0|E|0|NOE|0|0|0|100|DKK|22553|30263|lyfalmen|||00|120|0|27|Vistor hf|Novartis Europharm Ltd|Rívastigmín||22553||22553|30263 491860|L03AX0301|Oncotice|duft|500|millj ae|3|hgl|1|pakki|Fyrir ídreypivökva.|L03AX03|01.03.1999||R|K|1|0|1|0|1|ORG|0|0|0|100|DKK|49524|63525|lyfsjukr|||00|3|0|21|Vistor hf|N.V. Organon|BCG bóluefni||49524||49524|63525 492405|N04BA0202|Madopar Depot|forðahlk|125|mg|100|stk|1|hylki|100+25 mg|N04BA02|01.01.1991||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|3473|5553|lyfalmen|||10|100|0|17|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3473||3473|5553 492520|A02BC0105|Losec MUPS|sh-tfl|10|mg|100|stk|1|glas||A02BC01|01.01.1999||R|A|3|0|0|0|0|AZD|0|0|0|100|SEK|10478|15060|lyfalmen|||00|100|0|50|Vistor hf|AstraZeneca A/S DK|Ómeprazól||10478||10478|15060 492546|A02BC0102 |Losec|sh-tfl|20|mg|14|stk|1|þpakki||A02BC01|01.05.2009||L|A|3|0|0|0|0|AZD|0|0|0|100|ISK|||lyflausa|||00|14|0|7|Vistor hf|AstraZeneca A/S DK|Ómeprazól||||| 492587|N06AX0303|Mianserin NM Pharma|töflur|10|mg|100|stk|1|glas||N06AX03|01.01.1994||R|A|5|0|0|B|0|MNA|0|1|0|100|SEK|1304|2610|lyfalmen|V1140|2434|00|100|0|17|Actavis Group PTC ehf|Merck NM AB|Míanserín||1304||1304|2610 493148|C10AA0302|Pravachol|töflur|20|mg|28|stk|1|þpakki||C10AA03|01.07.1989||R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|4382|6787|lyfalmen|||00|28|0|28|Vistor hf|Bristol-Myers Squibb|Pravastatín||4382||4382|6787 494013|N06AA0601|Surmontil|töflur|25|mg|100|stk|1|glas||N06AA06|01.10.1995||R|A|5|0|0|B|0|SNO|0|1|0|100|NOK|1513|2894|lyfalmen|||00|100|0|17|Vistor hf|Sanofi-aventis Norge AS|Trímípramín||1513||1513|2894 494138|N02CX0101|Sandomigrin|töflur|0,5|mg|100|stk|1|þpakki||N02CX01|01.04.1974||R|A|5|0|0|E|0|NOH|0|0|0|100|DKK|4018|6293|lyfalmen|||00|100|0|33|Vistor hf|Novartis Healthcare A/S-|Pízótífen||4018||4018|6293 494237|L01XC0201|MabThera|irþ|100|mg|10|ml|2|hgl|lausn|L01XC02|01.11.2003||R|A|2,5|0|1|0|1|RRL|0|0|0|100|DKK|89392|113161|lyfsjukr|||00|20|0|0|Icepharma hf|Roche Registration Limited|Rítúxímab||89392||89392|113161 494286|L01XC0201|MabThera|irþ|500|mg|50|ml|1|hgl|lausn|L01XC02|01.11.2003||R|A|2,5|0|1|0|1|RRL|0|0|0|100|DKK|223481|280101|lyfsjukr|||00|50|0|0|Icepharma hf|Roche Registration Limited|Rítúxímab||223481||223481|280101 494559|D10AF0101|Dalacin|fleyti|10|mg/ml|60|ml|1|glas|Áburður, fleyti|D10AF01|01.10.1995||R|A|2|0|0|0|0|PFI|0|0|0|100|DKK|2321|3990|lyfalmen|||00|60|0|60|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||2321||2321|3990 494682|G03CA0320|Estrofem 2 mg|töflur|2|mg|84|stk|1|skífup||G03CA03|01.12.1980||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|2647|4432|lyfalmen|V0408|2082|23|84|0|84|Vistor hf|Novo-Nordisk|Estradíól||2647||2647|4432 494724|G03FA0102|Kliogest|töflur|0| |84|stk|1|skífup||G03FA01|01.10.1986||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|3358|5397|lyfalmen|V0388|4131|23|84|0|84|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||3358||3358|5397 494831|B01AC0702|Persantin retard|forðahlk|200|mg|60|stk|1|glas|hart hylki|B01AC07|01.04.2006||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|3234|5229|lyfalmen|||00|60|0|30|Vistor hf|Boehringer Ingelheim International |Dípýrídamól||3234||3234|5229 495259|A02BA0205|Zantac|freyðit|150|mg|15|stk|2|stauk|2 x 15 stk.|A02BA02|01.04.1990||L|A|2|0|0|0|0|GSK|0|0|0|100|IKR|||lyflausa|||14|30|0|15|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ranitidín||||| 495283|A04AA0101|Zofran|töflur|8|mg|15|stk|1|þpakki||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|17336|23768|lyfalmen|||00|15|0|8|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||17336||17336|23768 495382|A04AA0101|Zofran|stl|2|mg/ml|2|ml|5|lykjur||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|6743|9991|lyfalmen|V1088|7729|02|10|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||6743||6743|9991 495390|A04AA0101|Zofran|stl|2|mg/ml|4|ml|5|lykjur||A04AA01|01.01.1991||R|A|3|0|0|E|0|GSK|0|0|0|100|GBP|9633|13913|lyfalmen|V1089|12111|02|20|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Ondansetrón||9633||9633|13913 495572|N03AX1201|Neurontin|filmhtfl|600|mg|100|stk|1|þpakki||N03AX12|01.04.2002||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|17559|24046|lyfalmen|V2160|23608|00|100|0|33|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gabapentín||17559||17559|24046 495580|N03AX1201|Neurontin|filmhtfl|800|mg|100|stk|1|þpakki||N03AX12|01.04.2002||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|29599|39036|lyfalmen|||00|100|0|44|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Gabapentín||29599||29599|39036 495820|J05AH0101|Relenza|innúðadu|5|mg/úðask|20|sk|1|stauk|+diskhaler|J05AH01|01.02.2000||R|A|5|0|0|0|0|GSK|0|0|0|100|GBP|2645|4430|lyfalmen|||00|20|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Zanamivír||2645||2645|4430 496174|QJ01M0001|Baytril vet.|töflur|150|mg|10|stk|1|þpakki||QJ01MA90|01.03.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|4323|8406|vetalmen|||0|10|0|0|Vistor hf|Bayer Animal Health GmbH|||||4323|8406 496547|C07AG0101|Trandate|stl|5|mg/ml|20|ml|5|lykjur||C07AG01|01.01.1985||R|A|2|0|0|B|0|GSK|0|0|0|100|GBP|3821|6026|lyfalmen|||02|100|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Labetalól||3821||3821|6026 496554|C07AG0101|Trandate|töflur|100|mg|50|stk|1|glas||C07AG01|01.02.1982||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|965|2150|lyfalmen|||00|50|0|8|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Labetalól||965||965|2150 496752|C07AG0101|Trandate|töflur|200|mg|100|stk|1|glas||C07AG01|01.01.1986||R|A|5|0|0|B|0|GSK|0|0|0|100|GBP|3027|4948|lyfalmen|||00|100|0|33|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Labetalól||3027||3027|4948 496935|N02AG0201|Ketogan|eþ-stil|0| |10|stk|1|pakki||N02AG02|01.07.1994||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|570|1614|lyfalmen|||04|10|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||570||570|1614 496950|N02AG0201|Ketogan|töflur|0| |20|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|A|5|1|0|E|0|PFI|0|0|0|100|DKK|867|2017|lyfalmen|||00|20|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||867||867|2017 497099|N02AG0201|Ketogan|töflur|0| |100|stk|1|þpakki|5 + 25 mg|N02AG02|01.07.1994||R|A|5|1|0|E|0|PFI|0|0|0|100|DKK|3302|5321|lyfalmen|||00|100|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Cetóbemídón og krampalosandi lyf í blöndum||3302||3302|5321 497263|N06BA0103|Amfetamin Actavis|töflur|5|mg|30|stk|1|glas||N06BA01|01.07.1991||R|A|3|1|0|0|0|ACA|0|0|0|100|IKR|1036|2246|lyfalmen|||00|30|0|10|Actavis Group hf|Actavis hf|Amfetamín||1036||1036|2246 497289|C09AA0201|Daren|töflur|5|mg|30|stk|1|glas||C09AA02|01.07.1990||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|419|1409|lyfalmen|||00|30|0|15|Actavis Group hf|Actavis hf|Enalapríl||419||419|1409 497297|C09AA0201|Daren|töflur|5|mg|100|stk|1|glas||C09AA02|01.07.1990||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|802|1929|lyfalmen|V0167|1929|00|100|0|50|Actavis Group hf|Actavis hf|Enalapríl||802||802|1929 497313|C09AA0201|Daren|töflur|20|mg|100|stk|1|glas||C09AA02|01.07.1990||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2725|4538|lyfalmen|V0169|4538|00|100|0|200|Actavis Group hf|Actavis hf|Enalapríl||2725||2725|4538 497511|D08AC0202|Hibitane|sk-krem|10|mg/ml|250|ml|1|glas||D08AC02|01.12.1983||L|A|3|0|0|0|0|BIG|0|0|0|100|IKR|||lyflausa|||00|250|0|250|Icepharma hf|Bioglan AB|Klórhexidín||||| 497818|D07AC0401|Synalar|smyrsli|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|A|3|0|0|B|0|BIG|0|0|1|100|SEK|733|1835|lyfalmen|||20|30|0|30|Icepharma hf|Bioglan AB|Flúócínólón||733||733|1835 498048|H02AB0103|Diprospan|stl|7|mg/ml|2|ml|1|hgl|5 + 2 mg/ml|H02AB01|01.09.2004||R|A|2|0|0|B|0|SCP|0|0|1|100|DKK|1392|2729|lyfalmen|||03|2|0|35|Vistor hf|Schering-Plough|Betametasón||1392||1392|2729 498964|N05AE0401|Zeldox|hylki|20|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|18733|25508|lyfalmen|||00|56|0|14|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ziprasidon||18733||18733|25508 498980|N05AE0401|Zeldox|hylki|40|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|20195|27328|lyfalmen|||00|56|0|28|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ziprasidon||20195||20195|27328 499004|N05AE0401|Zeldox|hylki|60|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|27326|36206|lyfalmen|||00|56|0|42|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ziprasidon||27326||27326|36206 499020|N05AE0401|Zeldox|hylki|80|mg|56|stk|1|þpakki|hart hylki|N05AE04|01.03.2002||R|A|4|0|0|*|0|PFI|0|1|0|100|DKK|31403|41282|lyfalmen|||00|56|0|56|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Ziprasidon||31403||31403|41282 500314|D07AC0401|Synalar|krem|0,25|mg/g|30|g|1|túpa||D07AC04|01.04.1998||R|A|3,5|0|0|B|0|BIG|0|0|1|100|SEK|733|1835|lyfalmen|||20|30|0|30|Icepharma hf|Bioglan AB|Flúócínólón||733||733|1835 501734|M01AB0508|Vostar-R|forðatfl|75|mg|100|stk|1|glas||M01AB05|01.03.2000||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|3199|5182|lyfalmen|||67|100|0|75|Actavis Group hf|Actavis hf|Díklófenak||3199||3199|5182 502047|N04BA0201|Madopar|hylki|125|mg|100|stk|1|glas|100+25 mg|N04BA02|01.12.1983||R|A|3|0|0|E|0|ROC|0|0|0|100|DKK|3624|5758|lyfalmen|||10|100|0|17|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||3624||3624|5758 502187|D07AB0201|Locoid|lausn|1|mg/ml|100|ml|1|glas||D07AB02|01.03.1977||R|A|2|0|0|B|0|ASP|0|0|1|100|XEU|2155|3765|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||2155||2155|3765 502633|N06AA2101|Ludiomil|töflur|25|mg|100|stk|1|þpakki||N06AA21|01.06.1977||R|A|5|0|0|B|0|AMD|0|1|0|100|DKK|3052|4982|lyfalmen|||00|100|0|25|Vistor hf|Amdipharm Ltd|Maprótilín||3052||3052|4982 502930|N05AB0301|Trilafon|töflur|16|mg|100|stk|1|þpakki||N05AB03|01.01.1986|30.04.2009|R|A|5|0|0|*|0|SCP|0|1|0|100|DKK|3977|6237|lyfalmen|||00|100|0|53|Vistor hf|Schering-Plough|Perfenazín||3977||3977|6237 503151|L02AE0401|Decapeptyl Depot|sts|3,75|mg|1|stk|1|spr|+ leysir|L02AE04|01.01.1995||R|K|3|0|1|0|1|FER|0|0|0|100|DKK|31591|41198|lyfsjukr|||00|1|0|28|Vistor hf|Ferring|Triptórelín||31591||31591|41198 503961|D07AC0301|Ibaril|krem|2,5|mg/g|50|g|1|túpa||D07AC03|01.10.1976||R|A|5|0|0|B|0|SNO|0|0|1|100|NOK|2109|3702|lyfalmen|||20|50|0|50|Vistor hf|Sanofi-aventis Norge AS|Desoxímetasón||2109||2109|3702 504266|G03CA0401|Ovestin|töflur|1|mg|90|stk|1|þpakki||G03CA04|01.01.1988||R|A|5|0|0|E|0|ORG|0|0|0|100|DKK|2272|3924|lyfalmen|||00|90|0|45|Vistor hf|N.V. Organon|Estríól||2272||2272|3924 504746|R06AB0201|Polaramin|forðatfl|6|mg|50|stk|1|þpakki||R06AB02|01.01.1977||R|A|3|0|0|E|0|SCP|0|0|1|100|DKK|1324|2637|lyfalmen|||10|50|0|50|Vistor hf|Schering-Plough|Dexklórfeníramín||1324||1324|2637 504753|R06AB0201|Polaramin|töflur|2|mg|50|stk|1|pakki|þp|R06AB02|01.06.2007||R|A|5|0|0|E|0|SCP|0|0|0|100|DKK|617|1678|lyfalmen|||00|50|0|0|Vistor hf|Schering-Plough|Dexklórfeníramín||617||617|1678 504878|N05BA0801|Lexotan|töflur|3|mg|100|stk|1|glas||N05BA08|01.01.1987||R|A|5|0|0|0|0|ROC|0|0|1|100|DKK|1306|2613|lyfalmen|||00|100|0|30|Icepharma hf|Roche|Brómazepam||1306||1306|2613 505743|N06AA2101|Ludiomil|töflur|75|mg|100|stk|1|þpakki||N06AA21|01.05.1978||R|A|5|0|0|B|0|AMD|0|1|0|100|DKK|8398|12237|lyfalmen|||00|100|0|75|Vistor hf|Amdipharm Ltd|Maprótilín||8398||8398|12237 505834|L01DB0101|Adriamycin|stl|2|mg/ml|5|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PFI|0|0|0|100|DKK|3380|4839|lyfsjukr|||02|5|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxórúbicín||3380||3380|4839 505875|L01DB0101|Adriamycin|stl|2|mg/ml|10|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PFI|0|0|0|100|DKK|6580|9421|lyfsjukr|||02|10|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxórúbicín||6580||6580|9421 505883|L01DB0101|Adriamycin|stl|2|mg/ml|25|ml|1|plhgl||L01DB01|01.05.2008||R|K|2|0|1|0|1|PFI|0|0|0|100|DKK|11676|16404|lyfsjukr|||02|25|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxórúbicín||11676||11676|16404 506774|J01GB0301|Garamycin|stl|10|mg/ml|2|ml|10|lykjur||J01GB03|01.11.1977||R|A|5|0|0|0|1|SCP|0|0|0|100|DKK|3196|4576|lyfsjukr|||02|20|0|1|Vistor hf|Schering-Plough|Gentamícín||3196||3196|4576 506949|N01AB0601|Forene|innönd.l|0| |250|ml|1|stauk||N01AB06|01.10.1993||R|A|5|0|0|0|1|ABS|0|0|0|100|DKK|29629|38756|lyfsjukr|||00|250|0|0|Vistor hf|Abbott Scandinavia AB|Ísóflúran||29629||29629|38756 506972|N06AA1201|Sinquan|hylki|50|mg|100|stk|1|þpakki||N06AA12|01.12.1972||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|2505|4240|lyfalmen|||10|100|0|50|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Doxepín||2505||2505|4240 506998|A06AB0202|Toilax|sh-tfl|5|mg|25|stk|1|þpakki||A06AB02|01.12.1975||L|A|3|0|0|0|0|ERC|0|0|0|100|IKR|||lyflausa|||10|25|0|12|Vistor hf|Orion Pharma|Bisakódýl||||| 507004|A06AB0202|Toilax|sh-tfl|5|mg|100|stk|1|þpakki||A06AB02|01.12.1975||R|A|3|0|0|0|0|ERC|0|0|0|100|DKK|409|1395|lyfalmen|||10|100|0|50|Vistor hf|Orion Pharma|Bisakódýl||409||409|1395 507103|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|1|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|24|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||1166 507111|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|24|g|5|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|120|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||4958 507343|QP52AC1302|Panacur, vet.|mixtúra|100|mg/ml|1000|ml|1|fl||QP52AC13|01.12.1978||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|9298|16091|vetorma|||13|1000|0|0|Icepharma hf|Intervet International B.V.|||9298||9298|16091 507582|QJ01EW1001|Tribrissen, vet.|stl|480|mg/ml|50|ml|1|hgl|80+400 mg/ml|QJ01EW10|01.06.1999||R|A|3|0|0|0|0|SPA|0|0|0|100|DKK|2571|5069|vetalmen|||27|50|0|0|Vistor hf|Schering-Plough A/S|||2571||2571|5069 508622|C08DA0103|Isoptin retard|forðatfl|240|mg|98|stk|1|þpakki||C08DA01|01.10.1993||R|A|3|0|0|B|0|ABS|0|0|0|100|DKK|5462|8253|lyfalmen|||10|98|0|98|Vistor hf|Abbott Scandinavia AB|Verapamíl||5462||5462|8253 508671|QJ01M0001|Baytril vet.|mixtúra|25|mg/ml|100|ml|1|plastf||QJ01MA90|01.03.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|5227|10128|vetalmen|||0|100|0|0|Vistor hf|Bayer Animal Health GmbH|||||5227|10128 508689|QJ01M0001|Baytril vet.|stl|50|mg/ml|50|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|4192|8156|vetalmen|||0|50|0|0|Vistor hf|Bayer Animal Health GmbH|||4192||4192|8156 508705|QJ01M0001|Baytril vet.|stl|100|mg/ml|100|ml|1|hgl|lausn|QJ01MA90|01.01.2009||R|A|3|0|0|0|0|BAN|0|0|0|100|DKK|12968|24873|vetalmen|||0|100|0|0|Vistor hf|Bayer Animal Health GmbH|||12968||12968|24873 508952|G03FB0902|Nuvelle|töflur|0| |84|stk|1|þpakki||G03FB09|01.08.1997|30.04.2009|R|A|5|0|0|E|0|BAP|0|0|0|100|SEK|2623|4400|lyfalmen|||00|84|0|84|Icepharma hf|Bayer Schering Pharma AG|Levónorgestrel og östrógen||2623||2623|4400 509042|N05AF0502|Cisordinol Depot|stl|200|mg/ml|1|ml|10|lykjur||N05AF05|01.03.1984||R|A|3|0|0|*|0|LBK|0|1|0|100|DKK|10208|14693|lyfalmen|||02|10|0|133|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||10208||10208|14693 509273|G03CA0401|Ovestin|sk-krem|1|mg/g|15|g|1|túpa|+stjaka|G03CA04|01.01.1988||L|A|3|0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen|||00|15|0|75|Vistor hf|N.V. Organon|Estríól|||||2709 509448|D10AE0102|Panoxyl|hlaup|50|mg/g|40|g|1|túpa||D10AE01|01.12.1982||R|A|5|0|0|0|0|STI|0|0|0|100|XEU|420|1410|lyfalmen|||23|40|0|40|Smerud Medical Research Norway AS|Stiefel Laboratories (UK) Limited (S)|Benzóýl peroxíð||420||420|1410 509455|D10AE0102|Panoxyl|hlaup|100|mg/g|40|g|1|túpa||D10AE01|01.12.1982||R|A|5|0|0|0|0|STI|0|0|0|100|XEU|473|1482|lyfalmen|||23|40|0|40|Smerud Medical Research Norway AS|Stiefel Laboratories (UK) Limited (S)|Benzóýl peroxíð||473||473|1482 509463|D10AE0102|Panoxyl|áburður|50|mg/ml|30|ml|1|fl||D10AE01|01.12.1982||R|A|3|0|0|0|0|STI|0|0|0|100|XEU|347|1311|lyfalmen|||23|30|0|30|Smerud Medical Research Norway AS|Stiefel Laboratories (UK) Limited (S)|Benzóýl peroxíð||347||347|1311 509471|D10AE0102|Panoxyl|krem|50|mg/g|40|g|1|túpa||D10AE01|01.12.1982||R|A|5|0|0|0|0|STI|0|0|0|100|XEU|420|1410|lyfalmen|||23|40|0|40|Smerud Medical Research Norway AS|Stiefel Laboratories (UK) Limited (S)|Benzóýl peroxíð||420||420|1410 509653|J05AR0101|Combivir|filmhtfl|450|mg|60|stk|1|þpakki|150+300 mg|J05AR01|01.05.2004||R|A|2|0|1|0|1|GGL|0|0|0|100|GBP|44837|57690|lyfsjukr|||00|60|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|Zídóvúdín og lamívúdín||44837||44837|57690 510248|B03XA0103|NeoRecormon|stl|1000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|13441|18602|lyfsjukr|||00|2|0|6|Icepharma hf|Roche|Epóetín||13441||13441|18602 510255|B03XA0103|NeoRecormon|stl|2000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|26884|35338|lyfsjukr|||00|2|0|12|Icepharma hf|Roche|Epóetín||26884||26884|35338 510263|B03XA0103|NeoRecormon|stl|3000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|39246|50729|lyfsjukr|||00|2|0|18|Icepharma hf|Roche|Epóetín||39246||39246|50729 510271|B03XA0103|NeoRecormon|stl|5000|ae/spr|0,3|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|66290|84399|lyfsjukr|||00|2|0|30|Icepharma hf|Roche|Epóetín||66290||66290|84399 510305|B03XA0103|NeoRecormon|stl|10000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|110003|138821|lyfsjukr|||00|4|0|60|Icepharma hf|Roche|Epóetín||110003||110003|138821 510321|B03XA0103|NeoRecormon|stl|20000|ae/spr|0,6|ml|6|spr||B03XA01|01.02.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|251395|314854|lyfsjukr|||00|4|0|120|Icepharma hf|Roche|Epóetín||251395||251395|314854 510974|G04CB0102|Finol|töflur|5|mg|98|stk|1|glas||G04CB01|01.01.1998||R|A|3|0|0|E|0|ACA|0|0|0|100|XEU|4263|5454|lyfalmen|V0411|5454|00|98|0|98|Actavis Group hf|Actavis hf|Fínasteríð||3400||3400|5454 511071|C09CA0701|Micardis|töflur|20|mg|28|stk|1|þpakki||C09CA07|01.03.2008||R|A|3|0|0|B|0|BII|0|0|0|100|DKK|2916|4798|lyfalmen|||00|28|0|14|Vistor hf|Boehringer Ingelheim International |||2916||2916|4798 511303|G03FB0501|Trisekvens|töflur|0| |84|stk|1|skífup||G03FB05|01.12.1980||R|A|4|0|0|E|0|NON|0|0|0|100|DKK|2753|4576|lyfalmen|V0385|4485|23|84|0|84|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||2753||2753|4576 511493|B05AA0509|Rheomacrodex med NaCl|irl|100|mg/ml|500|ml|12|pokar||B05AA05|01.07.1991||R|A|2|0|0|0|1|MAB|0|0|0|100|SEK|19408|26030|lyfsjukr|||00|6000|0|6|Vistor hf|Meda AB|Dextran||19408||19408|26030 511501|B05AA0502|Macrodex 60 mg/ml med NaCl|irl|0| |500|ml|12|pokar||B05AA05|01.07.1991||R|A|3|0|0|0|1|MAB|0|0|0|100|SEK|12141|16983|lyfsjukr|||00|6000|0|6|Vistor hf|Meda AB|Dextran||12141||12141|16983 512608|B05XA3101|Peditrace|irþ|0| |10|ml|10|hgl||B05XA31|01.07.1993||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|9726|13925|lyfsjukr|||00|100|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með öðrum efnum||9726||9726|13925 513309|D04AB0101|Xylocain|smyrsli|5|%|35|g|1|pakki||D04AB01|01.09.2003||L|A|5|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||00|35|0|0|Vistor hf|AstraZeneca A/S DK|Lídókaín||||| 514265|R03AC0302|Bricanyl Turbuhaler|innúðadu|0,25|mg/sk|200|sk|1|stauk||R03AC03|01.07.1993||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|1822|3313|lyfalmen|||23|200|0|25|Vistor hf|AstraZeneca A/S DK|Terbútalín||1822||1822|3313 515031|N06AX1801|Edronax|töflur|4|mg|20|stk|1|þpakki||N06AX18|01.06.2000||R|A|3|0|0|B|0|PFI|0|1|0|100|DKK|2147|3754|lyfalmen|||00|20|0|10|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||2147||2147|3754 515049|N06AX1801|Edronax|töflur|4|mg|60|stk|1|þpakki||N06AX18|01.06.2000||R|A|3|0|0|B|0|PFI|0|1|0|100|DKK|5150|7829|lyfalmen|||00|60|0|30|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|||5150||5150|7829 516476|A02BC0105|Losec MUPS|sh-tfl|10|mg|14|stk|1|glas||A02BC01|01.01.1999||R|A|2|0|0|0|0|AZD|0|0|0|100|SEK|1676|3115|lyfalmen|||00|14|0|7|Vistor hf|AstraZeneca A/S DK|Ómeprazól||1676||1676|3115 517714|A10BX0201|Novonorm|töflur|0,5|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|4032|6312|lyfalmen|||00|90|0|11|Vistor hf|Novo-Nordisk|Repaglíníð||4032||4032|6312 517755|A10BX0201|Novonorm|töflur|1|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|4732|7262|lyfalmen|||00|90|0|22|Vistor hf|Novo-Nordisk|Repaglíníð||4732||4732|7262 517813|A10BX0201|Novonorm|töflur|2|mg|90|stk|1|þpakki||A10BX02|01.10.2000||R|A|5|0|0|*|0|NON|0|0|0|100|DKK|5821|8740|lyfalmen|||00|90|0|45|Vistor hf|Novo-Nordisk|Repaglíníð||5821||5821|8740 518241|M01AB0509|Modifenac|forðahlk|75|mg|20|stk|1|þpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|938|2113|lyfalmen|||00|20|0|15|Actavis Group hf|Actavis Group hf|Díklófenak||938||938|2113 518258|M01AB0509|Modifenac|forðahlk|75|mg|100|stk|1|þpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|4462|6896|lyfalmen|||00|100|0|75|Actavis Group hf|Actavis Group hf|Díklófenak||4462||4462|6896 518332|G03AC0901|Cerazette|töflur|75|mcg|84|stk|1|þpakki|3x28 stk|G03AC09|01.01.2001||R|A|3|0|0|0|0|ORG|0|0|0|100|DKK|2132|3734|lyfalmen|||23|84|0|84|Vistor hf|N.V. Organon|Desógestrel||2132||2132|3734 518944|J01CE0205|Kaavepenin Frukt|mixt.kyr|50|mg/ml|125|ml|1|glas||J01CE02|01.10.1985||R|A|2|0|0|0|0|REP|0|0|1|100|SEK|919|2088|lyfalmen|||08|125|0|3|Vistor hf|Recip AB|Fenoxýmetýlpenicillín||919||919|2088 519819|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|1|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|8462|12324|lyfalmen|||02|2|0|6|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||8462||8462|12324 520239|G04BE0301|Viagra|filmhtfl|25|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|4923|7521|lyfalmen|||00|4|0|2|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Síldenafíl||4923||4923|7521 520288|G04BE0301|Viagra|filmhtfl|50|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|5559|8384|lyfalmen|||00|4|0|4|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Síldenafíl||5559||5559|8384 520338|G04BE0301|Viagra|filmhtfl|50|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|16859|23174|lyfalmen|||00|12|0|12|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Síldenafíl||16859||16859|23174 520346|G04BE0301|Viagra|filmhtfl|100|mg|4|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|5967|8938|lyfalmen|V1300|8565|00|4|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Síldenafíl||5967||5967|8938 520379|G04BE0301|Viagra|filmhtfl|100|mg|12|stk|1|pakki||G04BE03|01.07.1999||R|A|5|0|0|0|0|PFI|0|0|0|100|DKK|17851|24409|lyfalmen|||00|12|0|24|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Síldenafíl||17851||17851|24409 520502|C08CA0102|Amlo|töflur|5|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|1623|3043|lyfalmen|V0308|3043|00|100|0|100|Actavis Group hf|Actavis hf|Amlódipín||1623||1623|3043 520577|C08CA0102|Amlo|töflur|10|mg|100|stk|1|plglas||C08CA01|01.03.1998||R|A|2|0|0|B|0|ACA|0|0|0|100|IKR|2644|4428|lyfalmen|V0310|4428|00|100|0|200|Actavis Group hf|Actavis hf|Amlódipín||2644||2644|4428 520759|M03BC5101|Norgesic|töflur|0| |30|stk|1|þpakki||M03BC51|01.03.1981||R|A|5|0|0|E|0|MEB|0|0|1|100|SEK|371|1344|lyfalmen|||00|30|0|9|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||371||371|1344 521203|N04BC0502|Sifrol|töflur|0,7|mg|100|stk|1|þpakki||N04BC05|01.05.2005||R|A|3|0|0|E|0|BII|0|0|0|100|DKK|34548|45197|lyfalmen|||00|100|0|28|Vistor hf|Boehringer Ingelheim International|Pramipexól||34548||34548|45197 521757|L01XX0501|Hydrea|hylki|500|mg|100|stk|1|glas||L01XX05|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|8676|12422|lyfsjukr|||00|100|1|0|Distica|Distica - óskráð lyf|||8676||8676|12422 522003|QJ51RC2302|Streptocillin, vet.|spenalyf|0| |8|g|40|spr||QJ51RC23|01.12.1982||R|A|3|0|0|0|0|BID|0|0|0|100|DKK|8170|15734|vetalmen|||16|320|0|0|Vistor hf|Boehringer Ingelheim Danmark|||8170||8170|15734 522599|J07CA0202|Tetravac|bóluefni|0| |0,5|ml|1|spr|einnota dæla|J07CA02|01.10.1999||R|K|3,5|0|0|0|0|SPM|0|0|0|100|XEU|3399|5453|lyfalmen|||AC|0|0|0|Icepharma hf|Sanofi Pasteur MSD|barnaveiki, kíghósti, mænusótt, stífkrampi||3399||3399|5453 522706|L04AC0201|Simulect|sts|20|mg|1|hgl|1|pakki|+leysir|L04AC02|01.06.2004||R|K|1,5|0|1|0|1|NOE|0|0|0|100|DKK|271683|340113|lyfsjukr|||00|1|0|0|Vistor hf|Novartis Europharm Ltd|Basiliximab||271683||271683|340113 522730|N02AX0204|Tradolan|töflur|50|mg|20|stk|1|þpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|SEK|405|1390|lyfalmen|||00|20|0|3|Vistor hf|Lannacher Heimittel Gmbh|Tramadól||405||405|1390 522771|N02AX0204|Tradolan|töflur|50|mg|100|stk|1|þpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|SEK|1674|3112|lyfalmen|||00|100|0|17|Vistor hf|Lannacher Heimittel Gmbh|Tramadól||1674||1674|3112 522797|N02AX0204|Tradolan|töflur|50|mg|250|stk|1|þpakki||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|DKK|9958|14354|lyfalmen|||00|250|0|208|Vistor hf|Lannacher Heimittel Gmbh|Tramadól||9958||9958|14354 522813|N02AX0204|Tradolan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.08.1998||R|A|5|0|0|E|0|LAN|0|0|1|100|DKK|881|2036|lyfalmen|V0732|2036|02|10|0|2|Vistor hf|Lannacher Heimittel Gmbh|Tramadól||881||881|2036 522839|D05AX0201|Daivonex|lausn|50|mcg/ml|120|ml|1|glas|í hársvörð|D05AX02|01.12.2001||R|A|2|0|0|B|0|LEP|0|0|0|100|DKK|9090|13176|lyfalmen|||00|120|0|0|Vistor hf|LEO Pharma A/S|Kalcípótríól||9090||9090|13176 523043|N02AA5902|Parkodin forte|töflur|530|mg|40|stk|1|pakki|þp 30+500 mg|N02AA59|01.11.1998||R|A|2|0|0|0|0|ACA|0|0|1|100|NOK|378|1353|lyfalmen|||00|40|0|13|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||378||378|1353 523274|S01XA2008|Artelac|augndr|0| |10|ml|1|glas|plastglas|S01XA20|01.05.1998||L|A|3|0|0|E|0|GEM|0|0|0|100|IKR|||lyfalmen|||00|10|0|0|Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar sam­setningar|||||1253 523779|R06AD0201|Phenergan|töflur|25|mg|100|stk|1|þpakki||R06AD02|01.10.1995||R|A|5|0|0|E|0|SNO|0|0|1|100|NOK|1152|2404|lyfalmen|||00|100|0|100|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||1152||1152|2404 523886|L02BB0101|Eulexin|töflur|250|mg|84|stk|1|þpakki||L02BB01|01.01.1993||R|A|5|0|0|*|0|SCP|0|0|0|100|DKK|24405|32569|lyfalmen|||00|84|0|28|Vistor hf|Schering-Plough|Flútamíð||24405||24405|32569 524215|C01DA1401|Imdur|forðatfl|30|mg|28|stk|1|þpakki||C01DA14|01.07.1993||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|932|2105|lyfalmen|||43|28|0|21|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||932||932|2105 524223|C01DA1401|Imdur|forðatfl|30|mg|98|stk|1|þpakki||C01DA14|01.07.1993||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2370|4057|lyfalmen|||43|98|0|74|Vistor hf|AstraZeneca A/S DK|Ísósorbíð mónónítrat||2370||2370|4057 524694|C01DA0204|Nitromex|tungur.t|0,25|mg|30|stk|1|glas||C01DA02|01.12.1983||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|30|0|3|Actavis Group hf|Actavis Group hf|Glýcerýltrínítrat|||||1132 524710|C01DA0204|Nitromex|tungur.t|0,5|mg|30|stk|1|glas||C01DA02|01.11.1981||L|A|2|0|0|B|0|AGT|0|0|0|100|DKK|||lyfalmen|||22|30|0|6|Actavis Group hf|Actavis Group hf|Glýcerýltrínítrat|||||1112 525014|M03BC5101|Norgesic|töflur|0| |100|stk|1|þpakki||M03BC51|01.06.1981||R|A|5|0|0|E|0|MEB|0|0|1|100|SEK|1017|2220|lyfalmen|||00|100|0|29|Vistor hf|Meda AB (V)|Orfenadrín í blöndum||1017||1017|2220 525030|M01AB0505|Voltaren|stl|25|mg/ml|3|ml|5|lykjur|lausn|M01AB05|01.05.2007||R|A|2|0|0|0|0|NOH|0|0|0|100|DKK|1034|2244|lyfalmen|||00|15|0|0|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1034||1034|2244 525147|M01AB0504|Klofen-L|forðahlk|100|mg|30|stk|1|hylki||M01AB05|01.01.1993||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|1532|2919|lyfalmen|||10|30|0|30|Actavis Group hf|Actavis hf|Díklófenak||1532||1532|2919 525170|M01AB0504|Klofen-L|forðahlk|100|mg|100|stk|1|hylki||M01AB05|01.01.1993||R|A|3|0|0|E|0|ACA|0|0|1|100|IKR|5105|7768|lyfalmen|||10|100|0|100|Actavis Group hf|Actavis hf|Díklófenak||5105||5105|7768 525188|N06BA0701|Modiodal|töflur|100|mg|30|stk|1|þpakki||N06BA07|01.03.2002||R|A|5|0|0|0|0|CPA|0|0|0|100|DKK|11263|16125|lyfalmen|||00|30|0|10|Vistor hf|Cephalon France (V)|Modafinil||11263||11263|16125 525998|V07AB1001|Natriumklorid 9 mg/ml Braun|leysir|0,9|%|50|ml|20|lykjur|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||00|1000|0|0|Actavis Group hf|Braun|||||| 526004|V07AB09|Sterilt Vann B. Braun|leysir|0||50|ml|20|hgl|leysir f.stungulyf|V07AB|01.01.2009||L|A|5|0|0|0|0|BRA|0|0|0|100|IKR|||lyflausa|||0|1000|0|0|Actavis Group hf|Braun|||||| 526368|N04BA0201|Madopar|töflur|250|mg|100|stk|1|glas|200+50 mg|N04BA02|01.11.1981||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|7458|10961|lyfalmen|||00|100|0|33|Icepharma hf|Roche|Levódópa og dópadekarboxýl­asa­hemill||7458||7458|10961 526376|N03AG0103|Orfiril Retard|forðatfl|300|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|4703|7223|lyfalmen|||10|100|0|20|Vistor hf|Desitin Artzneimittel|Valpróínsýra||4703||4703|7223 526384|QJ01EW1001|Tribrissen, vet.|pasta|400|mg/g|37,5|g|5|spr|til inntöku|QJ01EW10|01.03.2007||R|A|5|0|0|0|0|SPA|0|0|0|100|DKK|6814|13151|vetalmen|||16|188|0|0|Vistor hf|Schering-Plough A/S|||6814||6814|13151 526798|N03AG0102|Orfiril|sh-tfl|600|mg|100|stk|1|glas||N03AG01|01.10.1995||R|A|5|0|0|E|0|DEA|0|0|0|100|XEU|4171|6501|lyfalmen|||10|100|0|40|Vistor hf|Desitin Artzneimittel|Valpróínsýra||4171||4171|6501 527143|J01XD0102|Flagyl|irl|5|g/1000ml|100|ml|20|pokar||J01XD01|01.12.1983||R|A|3|0|0|0|1|SNO|0|0|0|100|NOK|13833|19090|lyfsjukr|||00|2000|0|7|Vistor hf|Sanofi-aventis Norge AS|Metrónídazól||13833||13833|19090 527523|S01GX0601|Emadine|augndr|0,5|mg/ml|5|ml|1|glas||S01GX06|01.05.2003||R|A|2,5|0|0|E|0|ALC|0|0|0|100|USD|1239|2522|lyfalmen|||00|5|0|0|K.Pétursson hf|Alcon|Emedastín||1239||1239|2522 529263|N07BC0101|Subutex|tungur.t|2|mg|7|stk|1|þpakki||N07BC01|01.11.1999||R|A|1|1|0|0|1|SCP|0|0|0|100|DKK|1961|2808|lyfsjukr|||00|7|0|2|Vistor hf|Schering-Plough|Búprenorfín||1961||1961|2808 529289|R02AA0301|Strepsils|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.09.1982||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||| 529438|QJ51RC2002|Ampiclox vet.|spenalyf|0| |3|g|24|spr|spenadælur|QJ51RC20|01.06.1998||R|A|1.5|0|0|0|0|PAL|0|0|0|100|DKK|4373|8501|vetalmen|||16|72|0|0|Icepharma hf|Pfizer Oy Animal Health|||4373||4373|8501 529446|QJ01CA0401|Clamoxyl, vet.|töflur|40|mg|100|stk|1|þpakki||QJ01CA04|01.10.1987||R|A|3|0|0|0|0|PAL|0|0|0|100|DKK|3766|7345|vetalmen|||16|100|0|0|Icepharma hf|Pfizer Oy Animal Health|||3766||3766|7345 529586|N07BC0101|Subutex|tungur.t|8|mg|7|stk|1|þpakki||N07BC01|01.11.1999||R|A|1|1|0|0|1|SCP|0|0|0|100|DKK|5015|7180|lyfsjukr|||00|7|0|7|Vistor hf|Schering-Plough|Búprenorfín||5015||5015|7180 529735|N03AB0501|Pro-Epanutin|irþ|50|mg/ml|10|ml|10|hgl||N03AB05|01.12.2001||R|K|2|0|0|0|1|PFI|0|0|0|100|DKK|81724|103614|lyfsjukr|||00|100|0|11|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Fosfenýtóín||81724||81724|103614 530030|J06BA0205|Sandoglobulin|irs|1|g/fl|1|g|1|sett|leys+áhöld|J06BA02|01.06.1984||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|9701|13889|lyfsjukr|||00|1|0|0|Icepharma hf|CSL Denmark ApS|Immúnóglóbúlín, normal, manna, gefin í æð||9701||9701|13889 530048|J06BA0205|Sandoglobulin|irs|3|g/fl|3|g|1|sett|leys+áhöld|J06BA02|01.06.1984||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|26305|34617|lyfsjukr|||00|3|0|0|Icepharma hf|CSL Denmark ApS|Immúnóglóbúlín, normal, manna, gefin í æð||26305||26305|34617 530055|J06BA0205|Sandoglobulin|irs|6|g/fl|6|g|1|sett|leys+áhöld|J06BA02|01.06.1984||R|A|3|0|0|0|1|CSL|0|0|0|100|SEK|52609|67366|lyfsjukr|||00|6|0|0|Icepharma hf|CSL Denmark ApS|Immúnóglóbúlín, normal, manna, gefin í æð||52609||52609|67366 530741|G03FA0105|Activelle|töflur|0| |84|stk|1|pakki|þp 1+0,5 mg|G03FA01|01.03.2000||R|A|3|0|0|E|0|NON|0|0|0|100|DKK|3529|5629|lyfalmen|||23|84|0|84|Vistor hf|Novo-Nordisk|Noretísterón og östrógen||3529||3529|5629 531459|R03CC0303|Bricanyl Retard|forðatfl|7,5|mg|100|stk|1|glas||R03CC03|01.01.1985||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2481|4207|lyfalmen|||43|100|0|50|Vistor hf|AstraZeneca A/S DK|Terbútalín||2481||2481|4207 531913|J05AG0101|Viramune|mixtúra|10|mg/ml|240|ml|1|fl||J05AG01|01.03.2007||R|A|0,5|0|1|0|1|BII|0|0|0|100|DKK|9263|13262|lyfsjukr|||00|240|0|6|Vistor hf|Boehringer Ingelheim International |Nevírapín||9263||9263|13262 532374|P02CA0101|Vermox|mixtúra|20|mg/ml|30|ml|1|glas||P02CA01|01.12.1982||R|A|5|0|0|0|0|JAS|0|0|0|100|SEK|315|1268|lyfalmen|||01|30|0|3|Vistor hf|Janssen-Cilag AB|Mebendazól||315||315|1268 533737|R03CC0303|Bricanyl Retard|forðatfl|5|mg|100|stk|1|glas||R03CC03|01.04.1986||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|1675|3113|lyfalmen|||43|100|0|33|Vistor hf|AstraZeneca A/S DK|Terbútalín||1675||1675|3113 534537|J01EE0103|Primazol|töflur|480|mg|20|stk|1|glas|80+400 mg|J01EE01|01.10.1995||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|476|1486|lyfalmen|||00|20|0|5|Actavis Group hf|Actavis hf|Súlfametoxazól og trímetóprím||476||476|1486 535773|P03AA5401|Tenutex|áburður|245|mg/g|100|g|1|túpa|(20 mg + 225 mg)/g|P03AA54|01.12.1997||L|K|3|0|0|0|0|BPA|0|0|0|100|IKR|||lyflausa|||00|100|0|0|Icepharma hf|Bioglan Pharma AB|Dísúlfíram í blöndum||||| 535898|G04BD0401|Ditropan|töflur|5|mg|84|stk|1|þpakki||G04BD04|01.06.1998||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|5826|8747|lyfalmen|||00|84|0|28|Vistor hf|Sanofi-aventis Norge AS|Oxýbútýnín||5826||5826|8747 536029|S01EB0105|Isopto Carpine|augndr|10|mg/ml|10|ml|1|glas||S01EB01|01.03.2000|31.03.2009|R|A|4|0|0|*|0|ALC|0|0|0|100|USD|347|1311|lyfalmen|||06|10|0|25|K.Pétursson hf|Alcon|Pílókarpín||347||347|1311 536037|S01EB0105|Isopto Carpine|augndr|20|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|A|4|0|0|*|0|ALC|0|0|0|100|USD|437|1433|lyfalmen|||06|10|0|25|K.Pétursson hf|Alcon|Pílókarpín||437||437|1433 536052|S01EB0105|Isopto Carpine|augndr|40|mg/ml|10|ml|1|glas||S01EB01|01.03.2000||R|A|4|0|0|*|0|ALC|0|0|0|100|USD|557|1596|lyfalmen|||06|10|0|25|K.Pétursson hf|Alcon|Pílókarpín||557||557|1596 536938|N04BC0102|Parlodel|hylki|5|mg|100|stk|1|þpakki||N04BC01|01.05.1983||R|A|4|0|0|E|0|MAS|0|0|0|100|SEK|14290|19976|lyfalmen|||52|100|0|12|Vistor hf|Meda AS|Brómókriptín||14290||14290|19976 537373|QP52AF0201|Banminth, vet.|pasta|115,3|mg/g|2|g|1|spr||QP52AF02|01.07.1995||L|A|3|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|2|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||642 537720|L01CB0101|Vepesid|hylki|100|mg|10|stk|1|glas||L01CB01|01.01.1998||R|A||0|1|0|1|PCO|0|0|0|100|IKR|13691|18913|lyfsjukr|||00|10|1|0|Distica|Distica - óskráð lyf|||13691||13691|18913 537811|G03CA0401|Ovestin|sk-stil|0,5|mg|15|stk|1|pakki||G03CA04|01.01.1988||L|A|3|0|0|E|0|ORG|0|0|0|100|DKK|||lyfalmen|||05|15|0|38|Vistor hf|N.V. Organon|Estríól|||||2291 538181|A02AD0106|Rennie|sog/tugg|0| |24|stk|1|þpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||00|24|0|2|Icepharma hf|Bayer AB|Blöndur saltsambanda||||| 538199|A02AD0106|Rennie|sog/tugg|0| |48|stk|1|þpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||00|48|0|5|Icepharma hf|Bayer AB|Blöndur saltsambanda||||| 538207|A02AD0106|Rennie|sog/tugg|0| |96|stk|1|þpakki||A02AD01|01.10.1995||L|A|5|0|0|0|0|BAB|0|0|0|100|IKR|||lyflausa|||00|96|0|10|Icepharma hf|Bayer AB|Blöndur saltsambanda||||| 538496|L03AB0702|Rebif|stl|22|mcg/spr|0,5|ml|12|spr|Áfylltar sprautur|L03AB07|01.05.1999||R|K|2|0|1|0|1|SEN|0|0|0|100|SEK|125036|157537|lyfsjukr|||00|6|0|61|Gróco ehf|Serono Nordic|Interferón beta-1a||125036||125036|157537 539031|N03AG0401|Sabrilex|töflur|500|mg|100|stk|1|þpakki||N03AG04|01.10.1992||R|A|5|0|1|E|0|SNO|0|0|0|100|NOK|10501|15091|lyfalmen|||00|100|0|25|Vistor hf|Sanofi-aventis Norge AS|Vígabatrín||10501||10501|15091 539551|N05BA0105|Stesolid|töflur|2|mg|25|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|1|100|DKK|179|1083|lyfalmen|||00|25|0|5|Actavis Group hf|Actavis Group hf|Díazepam||179||179|1083 539577|N05BA0105|Stesolid|töflur|2|mg|100|stk|1|glas||N05BA01|01.12.1972||R|A|5|0|0|0|0|AGT|0|0|0|100|DKK|390|1370|lyfalmen|||00|100|0|20|Actavis Group hf|Actavis Group hf|Díazepam||390||390|1370 539783|D01AC2001|Daktacort|krem|0| |15|g|1|túpa||D01AC20|01.04.1986||L|K|3|0|0|0|0|JAS|0|0|1|100|IKR|||lyflausa|||20|15|0|15|Vistor hf|Janssen-Cilag AB|Blöndur||||| 539973|G01AA1001|Dalacin|sk-krem|20|mg/g|40|g|1|sett|+7 stjökur|G01AA10|01.10.1994||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|2600|4369|lyfalmen|||23|40|0|8|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||2600||2600|4369 540070|D06BA0101|Flamazine|krem|10|mg/g|250|g|1|dos||D06BA01|01.10.1988||R|A|3|0|0|0|0|SON|0|0|1|100|DKK|2850|4708|lyfalmen|||00|250|0|250|Icepharma hf|Smith & Nephew|Silfursúlfadíazín||2850||2850|4708 540989|S01ED5101|Cosopt|augndr|5|mg/ml|5|ml|3|glös|+ dorzólamíð 20 mg|S01ED51|01.07.2000||R|A|2|0|0|*|0|MSD|0|0|0|100|XEU|7985|11676|lyfalmen|||06|15|0|0|Icepharma hf|M.S.D.|Tímólól í blöndum||7985||7985|11676 541060|R03AC0302|Bricanyl Turbuhaler|innúðadu|0,5|mg/sk|200|sk|1|stauk||R03AC03|01.01.1989||R|A|2|0|0|B|0|AZD|0|0|1|100|SEK|1774|3248|lyfalmen|V0987|3154|23|200|0|50|Vistor hf|AstraZeneca A/S DK|Terbútalín||1774||1774|3248 541128|M01CC0101|Atamir|hylki|150|mg|200|stk|1|glas||M01CC01|01.09.1983||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|9721|14032|lyfalmen|||10|200|0|60|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||9721||9721|14032 541136|M01CC0101|Atamir|hylki|250|mg|200|stk|1|plglas||M01CC01|12.10.2004||R|A|5|0|0|B|0|SGM|0|0|0|100|DKK|15745|21788|lyfalmen|||10|200|0|100|Swedish Orphan International AB|Sandoz GmbH (S)|Penicillamín||15745||15745|21788 541169|R02AA0302|Strepsils med honning og citron|sogtfl|0| |24|stk|1|þpakki||R02AA03|01.09.1982||L|A|3|0|0|0|0|RBH|0|0|1|100|IKR|||lyflausa|||09|24|0|0|Artasan ehf|Reckitt Benckiser Healthcare Ltd.-A|Díklórbenzýlalkóhól||||| 542803|C08DA0103|Isoptin retard|forðatfl|240|mg|28|stk|1|þpakki||C08DA01|01.10.1993||R|A|3|0|0|B|0|ABS|0|0|0|100|DKK|1530|2917|lyfalmen|||10|28|0|28|Vistor hf|Abbott Scandinavia AB|Verapamíl||1530||1530|2917 542977|J04BA0201|Dapson|töflur|50|mg|100|stk|1|glas||J04BA02|01.05.1998||R|A||0|1|E|0|LDR|0|0|0|100|IKR|1638|3063|lyfalmen|||00|100|1|100|Parlogis hf|Parlogis - óskráð lyf|||1638||1638|3063 543330|C07AA0302|Visken|töflur|10|mg|98|stk|1|þpakki||C07AA03|01.12.1983||R|A|5|0|0|B|0|NOH|0|0|0|100|DKK|4499|6946|lyfalmen|||00|98|0|65|Vistor hf|Novartis Healthcare A/S-|Pindólól||4499||4499|6946 543413|R06AA5201|Koffinatin|töflur|0| |10|stk|1|þpakki||R06AA52|01.12.1982||L|A|4|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||00|10|0|2|Actavis Group hf|Actavis hf|Dífenhýdramín í blöndum||||| 543686|B02BD0203|ReFacto|sts|250|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2003|30.04.2009|R|K|2|0|0|0|1|WTE|0|0|0|100|USD|23337|30922|lyfsjukr|||00|1|0|0|Icepharma hf|Wyeth Europe|Storkuþáttur VIII||23337||23337|30922 543710|A06AC0101|Vi-Siblin|kyrni|610|mg/g|250|g|1|stauk||A06AC01|01.06.1999||L|A|3|0|0|0|0|REP|0|0|0|100|IKR|||lyflausa|||42|250|0|22|Vistor hf|Recip AB|Semen psyllii (ispaghula)||||| 543744|R01AA0503|Nezeril|nefúði|0,5|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||23|8|0|9|Vistor hf|AstraZeneca A/S DK|Oxýmetazólín||||| 543827|B02BD0203|ReFacto|sts|500|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2003|30.04.2009|R|K|2|0|0|0|1|WTE|0|0|0|100|USD|46246|59444|lyfsjukr|||00|1|0|1|Icepharma hf|Wyeth Europe|Storkuþáttur VIII||46246||46246|59444 543835|B02BD0203|ReFacto|sts|1000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.02.2003|30.04.2009|R|K|2|0|0|0|1|WTE|0|0|0|100|USD|91867|116242|lyfsjukr|||00|1|0|2|Icepharma hf|Wyeth Europe|Storkuþáttur VIII||91867||91867|116242 543850|B02BD0203|ReFacto|sts|2000|ae|1|hgl|1|pakki|+leysir|B02BD02|01.04.2004|30.04.2009|R|K|2|0|0|0|1|WTE|0|0|0|100|USD|167031|209821|lyfsjukr|||00|1|0|4|Icepharma hf|Wyeth Europe|Storkuþáttur VIII||167031||167031|209821 543926|D11AC0302|Selsun Blue|hársápa|10|mg/ml|120|ml|1|glas||D11AC03|01.08.1984||L|A|3|0|0|0|0|CHT|0|0|0|100|IKR|||lyflausa|||01|120|0|120|Vitaflo Scandinavia AB|Chattem Clobal Consumer Products|Selensambönd||||| 544502|G03GA0501|Gonal-F|sts|37,5|ae/lykju|10|lyk|1|pakki|+ leysir 1 ml|G03GA05|01.02.2002||R|A|2|0|1|E|0|SEN|0|0|0|100|SEK|23138|30992|lyfalmen|||00|10|0|5|Gróco ehf|Serono Nordic|Follitrópín alfa||23138||23138|30992 545681|D06AX0901|Bactroban|smyrsli|20|mg/g|15|g|1|túpa||D06AX09|01.07.1994||R|A|2|0|0|0|0|GSK|0|0|1|100|GBP|686|1771|lyfalmen|||00|15|0|15|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Múpírócín||686||686|1771 545814|N05AF0501|Cisordinol|töflur|2|mg|100|stk|1|glas||N05AF05|01.06.1984||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|1217|2492|lyfalmen|||00|100|0|7|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||1217||1217|2492 545848|N05AF0501|Cisordinol|töflur|10|mg|100|stk|1|glas||N05AF05|01.06.1984||R|A|2|0|0|*|0|LBK|0|1|0|100|DKK|3234|5229|lyfalmen|||00|100|0|33|Lundbeck Export A/S|H. Lundbeck A/S|Zúklópentixól||3234||3234|5229 545996|V01AA0507|Alutard SQ, birkifrjo|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA05|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|30897|40652|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|trjáfrjó||30897||30897|40652 546002|V01AA0507|Alutard SQ, birkifrjo|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA05|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|24911|33199|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|trjáfrjó||24911||24911|33199 546044|V01AA0210|Alutard SQ, vallarfoxgras|stl|0| |5|ml|4|hgl|byrjunarsett|V01AA02|01.07.1999||R|K|2|0|1|E|0|ALK|0|0|0|100|DKK|31079|40878|lyfalmen|||02|20|0|0|Vistor hf|ALK-Abello A/S|grasfrjó||31079||31079|40878 546051|V01AA0210|Alutard SQ, vallarfoxgras|stl|0,1|mi.SQ/ml|5|ml|1|hgl|framhaldssett|V01AA02|01.07.1999||R|K|3|0|1|E|0|ALK|0|0|0|100|DKK|26403|35057|lyfalmen|||02|5|0|0|Vistor hf|ALK-Abello A/S|grasfrjó||26403||26403|35057 546143|N02BE0108|Paratabs Retard|forðatfl|500|mg|30|stk|1|þpakki||N02BE01|01.10.1993||L|A|5|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||10|30|0|5|Actavis Group hf|Actavis hf|Paracetamól||||| 546168|N02BE0108|Paratabs Retard|forðatfl|500|mg|100|stk|1|þpakki||N02BE01|01.10.1993||R|A|5|0|0|0|0|ACA|0|0|1|100|IKR|521|1547|lyfalmen|||10|100|0|17|Actavis Group hf|Actavis hf|Paracetamól||521||521|1547 546531|N06AF0101|Marplan|töflur|10|mg|56|stk|1|glas||N06AF01|01.10.2001||R|A||0|0|E|0|LDR|0|0|0|100|IKR|6004|8988|lyfalmen|||00|56|1|37|Parlogis hf|Parlogis - óskráð lyf|||6004||6004|8988 547612|A02BX0202|Antepsin|töflur|1|g|60|stk|1|þpakki||A02BX02|01.01.1986||L|A|5|0|0|0|0|ORC|0|0|0|100|IKR|||lyflausa|||23|60|0|15|Vistor hf|Orion Corporation|Súkralfat||||| 547687|B01AC1601|Integrilin|irl|0,75|mg/ml|100|ml|1|fl||B01AC16|01.07.2000||R|K|3|0|1|0|1|GGL|0|0|0|100|GBP|9575|13709|lyfsjukr|||00|100|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíð||9575||9575|13709 547695|B01AC1601|Integrilin|stl|2|mg/ml|10|ml|1|hgl||B01AC16|01.07.2000||R|K|3|0|1|0|1|GGL|0|0|0|100|GBP|3155|4517|lyfsjukr|||00|10|0|0|GlaxoSmithKline ehf|Glaxo Group Limited|Eptifibatíð||3155||3155|4517 547729|G03GA0601|Puregon|stl|100|ae/hgl|0,5|ml|1|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|8763|12732|lyfalmen|||63|0|0|1|Vistor hf|N.V. Organon|Follitrópín beta||8763||8763|12732 547869|G03GA0601|Puregon|stl|150|ae/hgl|0,5|ml|5|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|54481|70014|lyfalmen|||63|2|0|5|Vistor hf|N.V. Organon|Follitrópín beta||54481||54481|70014 547893|G03GA0601|Puregon|stl|50|ae/hgl|0,5|ml|1|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|4501|6948|lyfalmen|||63|0|0|0|Vistor hf|N.V. Organon|Follitrópín beta||4501||4501|6948 547901|G03GA0601|Puregon|stl|50|ae/hgl|0,5|ml|5|hgl||G03GA06|01.01.2000||R|K|3|0|1|E|0|ORG|0|0|0|100|DKK|21907|29459|lyfalmen|||63|2|0|2|Vistor hf|N.V. Organon|Follitrópín beta||21907||21907|29459 548297|A08AA1001|Reductil|hylki|10|mg|98|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|17574|24065|lyfalmen|||00|98|0|98|Vistor hf|Abbott Laboratories A/S|Sibutramin||17574||17574|24065 548347|A08AA1001|Reductil|hylki|15|mg|98|stk|1|þpakki||A08AA10|01.08.2001||R|A|3|0|0|0|0|ABL|0|0|0|100|DKK|17574|24065|lyfalmen|||00|98|0|147|Vistor hf|Abbott Laboratories A/S|Sibutramin||17574||17574|24065 548511|J01CF0101|Diclocil|sts/irs|500|mg|1|stk|10|hgl||J01CF01|01.04.1987||R|A|3|0|0|0|1|BRS|0|0|0|100|DKK|2146|3073|lyfsjukr|||03|10|0|2|Vistor hf|Bristol-Myers Squibb|Díkloxacillín||2146||2146|3073 548776|M05BA0701|Optinate|filmhtfl|5|mg|28|stk|1|þpakki||M05BA07|01.03.2001||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|5452|8239|lyfalmen|||00|28|0|28|Vistor hf|Sanofi-aventis Norge AS|||5452||5452|8239 548784|M05BA0701|Optinate|filmhtfl|5|mg|84|stk|1|þpakki||M05BA07|01.03.2001||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|14881|20712|lyfalmen|||00|84|0|84|Vistor hf|Sanofi-aventis Norge AS|||14881||14881|20712 548792|M05BA0701|Optinate|filmhtfl|30|mg|28|stk|1|þpakki||M05BA07|01.03.2001||R|A|5|0|0|E|0|SNO|0|0|0|100|NOK|38146|49677|lyfalmen|||00|28|0|168|Vistor hf|Sanofi-aventis Norge AS|||38146||38146|49677 549113|J06BB1601|Synagis|sts|50|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|K|2|0|0|0|1|ABT|0|0|0|100|DKK|106047|133896|lyfsjukr|||17|1|0|0|Vistor hf|Abbott Laboratories Ltd|Palivisumab||106047||106047|133896 549139|N05AD0102|Haldol Depot|stl|100|mg/ml|1|ml|5|lykjur||N05AD01|01.01.1987||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|7894|11553|lyfalmen|||02|5|0|152|Vistor hf|Janssen-Cilag AB|Halóperídól||7894||7894|11553 549170|J06BB1601|Synagis|sts|100|mg/hgl|1|hgl|1|pakki||J06BB16|01.01.2004||R|K|2|0|0|0|1|ABT|0|0|0|100|DKK|152049|191169|lyfsjukr|||17|1|0|0|Vistor hf|Abbott Laboratories Ltd|Palivisumab||152049||152049|191169 550020|J07AP0302|Typherix|bóluefni|50|mcg/ml|0,5|ml|1|spr|einnota sprauta|J07AP03|01.10.2001||R|K|2|0|0|0|0|GSK|0|0|0|100|GBP|1999|3553|lyfalmen|||00|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Taugaveiki, hreinsaðir mótefna­vakar||1999||1999|3553 550061|N02BE0102|Panodil Brus|freyðit|500|mg|24|stk|1|þpakki||N02BE01|01.04.1992||L|A|4|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|24|0|4|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||||| 550624|N02BE0103|Panodil Junior|mixtúra|24|mg/ml|60|ml|1|glas||N02BE01|01.11.1981||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|60|0|0|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||||| 550731|N02BE0103|Panodil Junior|eþ-stil|125|mg|10|stk|1|pakki||N02BE01|01.11.1981||L|A|5|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||00|10|0|0|Icepharma hf|GlaxoSmithKline CH A/S|Paracetamól||||| 551408|N02CC0302|Zomig Rapimelt|munnltfl|2,5|mg|12|stk|1|þpakki||N02CC03|01.05.2001||R|A|3|0|0|E|0|ASZ|0|0|0|100|SEK|9130|13230|lyfalmen|||00|12|0|12|Vistor hf|AstraZeneca UK Ltd|Zolmítriptan||9130||9130|13230 551572|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|1|hgl|dreifa|H02AB08|01.11.2003||R|A|3|0|0|B|0|MAB|0|0|1|100|SEK|1521|2904|lyfalmen|||03|1|0|3|Vistor hf|Meda AB|Tríamcínólón||1521||1521|2904 551606|M01AX0101|Relifex|töflur|500|mg|100|stk|1|þpakki||M01AX01|01.04.1995||R|A|3|0|0|E|0|MAB|0|0|1|100|SEK|3469|5548|lyfalmen|||00|100|0|50|Vistor hf|Meda AB|Nabúmeton||3469||3469|5548 551739|N02AA0102|Morfin|töflur|10|mg|20|stk|1|pakki||N02AA01|01.04.1999||R|S||1|0|E|0|LDR|0|0|0|100|IKR|905|2069|lyfalmen|||00|20|1|2|Parlogis hf|Parlogis - óskráð lyf|Morfín||905||905|2069 551846|A02BC0401|Pariet|sh-tfl|10|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|2417|1904|lyfalmen|||00|28|0|14|Vistor hf|Eisai Ltd|Rabeprazól||784||784|1904 551853|A02BC0401|Pariet|sh-tfl|10|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|E|0|EIS|0|0|0|100|IKR|3931|3808|lyfalmen|||00|56|0|28|Vistor hf|Eisai Ltd|Rabeprazól||2187||2187|3808 551879|A02BC0401|Pariet|sh-tfl|20|mg|14|stk|1|þpakki||A02BC04|01.11.2001||R|A|2|0|0|0|0|EIS|0|0|0|100|SEK|2263|3911|lyfalmen|||00|14|0|14|Vistor hf|Eisai Ltd|Rabeprazól||2263||2263|3911 551929|A02BC0401|Pariet|sh-tfl|20|mg|28|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|0|0|EIS|0|0|0|100|SEK|3956|6209|lyfalmen|||00|28|0|28|Vistor hf|Eisai Ltd|Rabeprazól||3956||3956|6209 551937|A02BC0401|Pariet|sh-tfl|20|mg|56|stk|1|þpakki||A02BC04|01.05.2001||R|A|2|0|0|0|0|EIS|0|0|0|100|SEK|7916|11583|lyfalmen|||00|56|0|56|Vistor hf|Eisai Ltd|Rabeprazól||7916||7916|11583 552224|C08CA0501|Adalat|töflur|20|mg|100|stk|1|þpakki||C08CA05|01.04.1985||R|A|5|0|0|B|0|BHC|0|0|0|100|SEK|3577|5695|lyfalmen|||63|100|0|67|Vistor hf|Bayer HealthCare AG|Nífedipín||3577||3577|5695 552703|M01AB0509|Modifenac|forðahlk|75|mg|10|stk|1|þpakki||M01AB05|01.11.2000||R|A|5|0|0|E|0|AGT|0|0|1|100|DKK|613|1672|lyfalmen|||00|10|0|8|Actavis Group hf|Actavis Group hf|Díklófenak||613||613|1672 552877|N05CF0104|Zopiklon Merck NM|filmhtfl|7,5|mg|500|stk|1|plglas||N05CF01|01.07.2007||R|A|2|0|0|0|0|MNA|0|0|0|100|SEK|4186|6521|lyfalmen|||00|500|0|500|Actavis Group PTC ehf|Merck NM AB|Zópíklón||4186||4186|6521 552901|N03AF0201|Trileptal|filmhtfl|150|mg|100|stk|1|þpakki||N03AF02|01.10.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3572|5688|lyfalmen|||00|100|0|15|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||3572||3572|5688 552919|N03AF0201|Trileptal|filmhtfl|300|mg|50|stk|1|glas||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|3546|5652|lyfalmen|||00|50|0|15|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||3546||3546|5652 553313|N02CC0601|Relpax|töflur|40|mg|3|stk|1|þpakki||N02CC06|01.10.2001||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|2435|4145|lyfalmen|||00|3|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Eletriptan||2435||2435|4145 553339|N02CC0601|Relpax|töflur|40|mg|6|stk|1|þpakki||N02CC06|01.10.2001||R|A|3|0|0|E|0|PFI|0|0|0|100|DKK|4706|7227|lyfalmen|||00|6|0|6|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Eletriptan||4706||4706|7227 554154|QA12CE9902|Selevitan, vet.|stl|0| |100|ml|5|hgl||QA12CE99|01.05.1983||R|A|2|0|0|0|0|BID|0|0|0|100|DKK|7407|14280|vetalmen|||27|500|0|0|Vistor hf|Boehringer Ingelheim Danmark|||7407||7407|14280 555607|N06AB0601|Zoloft|mixtúra|20|mg/ml|60|ml|1|fl||N06AB06|01.03.2001||R|A|3|0|0|B|0|PFI|0|1|0|100|DKK|4991|7613|lyfalmen|||00|60|0|24|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sertralín||4991||4991|7613 556589|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3227|4620|lyfsjukr|||00|6000|0|6|Icepharma hf|Fresenius Kabi|Elektrólýtar||3227||3227|4620 556654|B05BA0313|Glucos 500 mg/ml Fresenius Kabi|irl|500|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.05.2004||R|A|1|0|0|0|1|FRP|0|0|0|100|DKK|6209|8890|lyfsjukr|||00|6000|0|6|Icepharma hf|Fresenius Kabi|Kolvetni||6209||6209|8890 556662|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|5265|7538|lyfsjukr|||00|6000|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||5265||5265|7538 556738|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3879|5554|lyfsjukr|||00|6000|0|6|Icepharma hf|Fresenius Kabi|Kolvetni||3879||3879|5554 556753|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|500|ml|12|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3606|5163|lyfsjukr|||00|6000|0|6|Icepharma hf|Fresenius Kabi|Kolvetni||3606||3606|5163 556936|N03AF0201|Trileptal|filmhtfl|300|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|5618|8464|lyfalmen|V2150|8311|00|100|0|30|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||5618||5618|8464 556944|N03AF0201|Trileptal|filmhtfl|600|mg|50|stk|1|glas||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|6876|10171|lyfalmen|||00|50|0|30|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||6876||6876|10171 556951|N03AF0201|Trileptal|filmhtfl|600|mg|100|stk|1|þpakki||N03AF02|01.02.2000||R|A|3|0|0|E|0|NOH|0|0|0|100|DKK|12240|17424|lyfalmen|||00|100|0|60|Vistor hf|Novartis Healthcare A/S-|Oxkarbazepín||12240||12240|17424 557546|D10AF0202|Zineryt|áburður|0| |30|ml|1|glas|+ leysir|D10AF02|01.07.1985||R|A|2|0|0|0|0|ASP|0|0|0|100|XEU|1632|3055|lyfalmen|||38|30|0|30|Vistor hf|Astellas Pharma A/S|Erýtrómýcín||1632||1632|3055 558585|V08CA0101|Magnevist|stl|469|mg/ml|20|ml|10|hgl|röntgenskuggaefni|V08CA01|01.07.1992||R|A|5|0|0|0|1|SAG|0|0|0|100|SEK|151731|190773|lyfsjukr|||02|200|0|0|Icepharma hf|Schering AG|Gadópentetat||151731||151731|190773 559013|C08DA0103|Isoptin retard|forðatfl|120|mg|28|stk|1|þpakki||C08DA01|01.01.1995||R|A|4|0|0|B|0|ABS|0|0|0|100|DKK|1000|2197|lyfalmen|||10|28|0|14|Vistor hf|Abbott Scandinavia AB|Verapamíl||1000||1000|2197 559021|C08DA0103|Isoptin retard|forðatfl|120|mg|98|stk|1|þpakki||C08DA01|01.01.1995||R|A|4|0|0|B|0|ABS|0|0|0|100|DKK|2243|3884|lyfalmen|||10|98|0|49|Vistor hf|Abbott Scandinavia AB|Verapamíl||2243||2243|3884 559062|N02AX0201|Nobligan|hylki|50|mg|100|stk|1|pakki||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1069|2291|lyfalmen|V0731|1524|10|100|0|17|Icepharma hf|Grunenthal|Tramadól||1069||1069|2291 559070|N02AX0201|Nobligan|hylki|50|mg|20|stk|1|pakki||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|599|1653|lyfalmen|V0730|1238|10|20|0|3|Icepharma hf|Grunenthal|Tramadól||599||599|1653 559104|N02AX0201|Nobligan|eþ-stil|100|mg|20|stk|1|pakki||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|1673|3111|lyfalmen|||04|20|0|7|Icepharma hf|Grunenthal|Tramadól||1673||1673|3111 559120|N02AX0201|Nobligan|stl|50|mg/ml|2|ml|5|lykjur||N02AX02|01.04.1994||R|A|5|0|0|E|0|GRU|0|0|1|100|DKK|962|2146|lyfalmen|V0732|2036|02|10|0|2|Icepharma hf|Grunenthal|Tramadól||962||962|2146 559286|C05BA0101|Hirudoid|krem|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|A|5|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||00|100|0|100|Icepharma hf|STADA Arzneimittel AG|Heparínóíð||||| 559401|S01ED5104|Fotil|augndr|25|mg/ml|5|ml|1|glas|5+20 mg/ml|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|2479|4205|lyfalmen|||06|5|0|0|Icepharma hf|Santen Oy|Tímólól í blöndum||2479||2479|4205 559476|C05BA0101|Hirudoid|hlaup|3|mg/g|100|g|1|túpa||C05BA01|01.08.1984||L|A|5|0|0|0|0|STD|0|0|0|100|IKR|||lyflausa|||00|100|0|0|Icepharma hf|STADA Arzneimittel AG|Heparínóíð||||| 559948|G03CA0303|Estring|sk-hring|7,5|mcg/sólh|1|stk|1|pakki||G03CA03|01.07.1994||R|A|2|0|0|E|0|PFI|0|0|0|100|DKK|7250|10679|lyfalmen|||23|1|0|90|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Estradíól||7250||7250|10679 559963|C01DA0201|Discotrine|forðapl|5|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|SEK|2631|4411|lyfalmen|||23|30|0|30|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||2631||2631|4411 559971|C01DA0201|Discotrine|forðapl|10|mg/sólh|30|stk|1|þpakki||C01DA02|01.01.1994||R|A|3|0|0|B|0|MEB|0|0|0|100|SEK|2907|4785|lyfalmen|||23|30|0|60|Vistor hf|Meda AB (V)|Glýcerýltrínítrat||2907||2907|4785 559989|N01AB0701|Suprane|innönd.l|0| |240|ml|1|fl||N01AB07|01.01.1995||R|A|3|0|0|0|1|BAX|0|0|0|100|DKK|10144|14497|lyfsjukr|||00|240|0|0|Icepharma hf|Baxter|Desflúran||10144||10144|14497 560060|S01XA2004|Vidisic|augngel|2|mg/g|10|g|1|túpa||S01XA20|01.04.1993||L|A|3|0|0|E|0|GEM|0|0|0|100|XEU|||lyfalmen|||07|10|0|0|Actavis Group hf|Gerhard Mann|Gervitár og aðrar óvirkar sam­setningar|||||1290 560326|J05AB0102|Zovir|töflur|200|mg|25|stk|1|þpakki||J05AB01|01.07.1989||R|A|5|0|0|E|0|GSK|0|0|1|100|GBP|2852|4711|lyfalmen|||00|25|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||2852||2852|4711 560334|J05AB0102|Zovir|töflur|200|mg|100|stk|1|þpakki||J05AB01|01.07.1994||R|A|5|0|0|E|0|GSK|0|0|1|100|GBP|11231|16081|lyfalmen|||00|100|0|5|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||11231||11231|16081 560367|D06BB0303|Zovir|krem|50|mg/g|2|g|1|túpa||D06BB03|01.07.1994||L|A|3|0|0|0|0|GCH|0|0|1|100|IKR|||lyflausa|||20|2|0|2|Icepharma hf|GlaxoSmithKline CH A/S|Acíklóvír||||| 560375|S01AD0301|Zovir|augnsm|30|mg/g|4,5|g|1|túpa||S01AD03|01.01.1988||R|A|5|0|0|E|0|GSK|0|0|1|100|GBP|1627|3048|lyfalmen|||07|4|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||1627||1627|3048 560383|J05AB0102|Zovir|mixtúra|40|mg/ml|125|ml|1|glas||J05AB01|01.01.1995||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|5437|8219|lyfalmen|||00|125|0|1|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||5437||5437|8219 560391|J05AB0102|Zovir|mixtúra|80|mg/ml|100|ml|1|glas||J05AB01|01.01.1995||R|A|3|0|0|E|0|GSK|0|0|1|100|GBP|5895|8840|lyfalmen|||00|100|0|2|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Acíklóvír||5895||5895|8840 560490|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|1|lykja||C01CX08|01.09.2001||R|K|3|0|1|0|1|ABS|0|0|0|100|DKK|110659|139638|lyfsjukr|||00|5|0|1|Vistor hf|Abbott Scandinavia AB|Levosimendan||110659||110659|139638 560557|C01CX0801|Simdax|irþ|2,5|mg/ml|5|ml|4|lykjur||C01CX08|01.09.2001||R|K|3|0|1|0|1|ABS|0|0|0|100|DKK|583250|547826|lyfsjukr|||00|20|0|5|Vistor hf|Abbott Scandinavia AB|Levosimendan||438521||438521|547826 561159|S01ED5105|Fotil forte|augndr|45|mg/ml|5|ml|1|glas|5+40 mg/ml|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|2484|4211|lyfalmen|||06|5|0|0|Icepharma hf|Santen Oy|Tímólól í blöndum||2484||2484|4211 561571|N06AX1101|Remeron|töflur|30|mg|250|stk|1|glas|til notkunar vélskömmtun lyfja|N06AX11|01.11.2002||R|A|3|0|0|B|0|ORG|0|1|0|100|DKK|34046|44572|lyfalmen|||00|250|0|250|Vistor hf|N.V. Organon|Mirtazapín||34046||34046|44572 563346|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|3|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|25443|33862|lyfalmen|||02|6|0|17|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||25443||25443|33862 563361|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|5|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|39166|50947|lyfalmen|||02|10|0|29|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||39166||39166|50947 563379|D07AC1701|Cutivat|krem|0,5|mg/g|30|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|634|1701|lyfalmen|||20|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||634||634|1701 563387|D07AC1701|Cutivat|krem|0,5|mg/g|100|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|1969|3512|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||1969||1969|3512 563395|D07AC1701|Cutivat|smyrsli|50|mcg/g|30|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|634|1701|lyfalmen|||20|30|0|30|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||634||634|1701 563403|D07AC1701|Cutivat|smyrsli|50|mcg/g|100|g|1|túpa||D07AC17|01.07.1995||R|A|2|0|0|B|0|GSK|0|0|1|100|GBP|1969|3512|lyfalmen|||20|100|0|100|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Flútíkasón||1969||1969|3512 563502|N02AA0101|Contalgin|forðatfl|5|mg|100|stk|1|þpakki||N02AA01|01.10.1993||R|A|3|1|0|E|0|PFI|0|0|0|100|DKK|1656|3088|lyfalmen|||10|100|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Morfín||1656||1656|3088 563528|M09AX0102|Hyalgan|stl|10,3|mg/ml|2|ml|30|spr|einnota sprauta|M09AX01|01.01.2001||R|A|3|0|0|E|0|NYG|0|0|0|100|DKK|210402|264135|lyfalmen|||02|60|0|172|Gróco ehf|Nycomed Danmark A/S|Natríumhýalúrónat||210402||210402|264135 563577|S01ED5104|Fotil|augndr|25|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|4851|7423|lyfalmen|||00|15|0|0|Icepharma hf|Santen Oy|Tímólól í blöndum||4851||4851|7423 563593|S01ED5105|Fotil forte|augndr|45|mg/ml|0,25|ml|60|sk-hyl|án rotvarnar|S01ED51|01.10.1995||R|K|3|0|0|*|0|SAO|0|0|0|100|XEU|5110|7775|lyfalmen|||00|15|0|0|Icepharma hf|Santen Oy|Tímólól í blöndum||5110||5110|7775 563684|C10AA0401|Lescol|hylki|20|mg|98|stk|1|þpakki||C10AA04|01.10.1997||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|9026|13089|lyfalmen|||00|98|0|49|Vistor hf|Novartis Healthcare A/S-|Flúvastatín||9026||9026|13089 563700|C10AA0401|Lescol|hylki|40|mg|98|stk|1|þpakki||C10AA04|01.10.1997||R|A|3|0|0|0|0|NOH|0|0|0|100|DKK|11428|16349|lyfalmen|||00|98|0|98|Vistor hf|Novartis Healthcare A/S-|Flúvastatín||11428||11428|16349 564088|J05AB0401|Rebetol|hylki|200|mg|168|stk|1|þpakki|hart|J05AB04|01.02.2002||R|A|2|0|1|0|1|SCP|0|0|0|100|DKK|155161|195043|lyfsjukr|||00|168|0|34|Vistor hf|Schering-Plough|Ribavirin||155161||155161|195043 565275|C07AG0202|Dimitone|töflur|12,5|mg|100|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|IKR|6003|8987|lyfalmen|||00|100|1|33|Parlogis hf|Parlogis - óskráð lyf|||6003||6003|8987 565325|C07AG0202|Dimitone|töflur|25|mg|100|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|IKR|9009|13066|lyfalmen|||00|100|1|67|Parlogis hf|Parlogis - óskráð lyf|||9009||9009|13066 565374|C07AG0202|Dimitone|töflur|6,25|mg|28|stk|1|pakki||C07AG02|01.07.2001||R|A||0|0|B|0|LDR|0|0|0|100|IKR|1593|3002|lyfalmen|||00|28|1|5|Parlogis hf|Parlogis - óskráð lyf|||1593||1593|3002 565457|A07EC0301|Dipentum|töflur|500|mg|100|stk|1|glas||A07EC03|01.10.1994||R|A|4|0|0|B|0|UCB|0|0|0|100|DKK|11806|16862|lyfalmen|||00|100|0|50|Vistor hf|U.C.B|Olsalazín||11806||11806|16862 566018|D01BA0201|Lamisil|töflur|125|mg|14|stk|1|þpakki||D01BA02|01.07.1995||R|A|5|0|0|0|0|NOH|0|0|0|100|IKR|3141|2835|lyfalmen|||00|14|0|7|Vistor hf|Novartis Healthcare A/S-|Terbínafín||1470||1470|2835 566182|S01EC0401|Azopt|augndr|10|mg/ml|5|ml|1|glas||S01EC04|01.01.2001||R|A|2|0|0|*|0|ALC|0|0|0|100|USD|1383|2717|lyfalmen|||06|5|0|25|K.Pétursson hf|Alcon|Brinzólamíð||1383||1383|2717 566661|L04AB0101|Enbrel|sts|0| |25|mg|4|hgl|+ leysir|L04AB01|01.11.2000||R|K|3|0|1|0|1|WTE|0|0|0|100|USD|105000|132593|lyfsjukr|||00|100|0|14|Icepharma hf|Wyeth Europe|Etanercept||105000||105000|132593 566992|J02AC0101|Diflucan|hylki|150|mg|4|stk|1|þpakki||J02AC01|01.10.1993||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|5909|8859|lyfalmen|V0556|4233|10|4|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Flúkónazól||5909||5909|8859 567016|R06AD0201|Phenergan|mixtúra|1|mg/ml|100|ml|1|glas||R06AD02|01.10.1995||R|A|2|0|0|E|0|SNO|0|0|1|100|NOK|1503|2880|lyfalmen|||00|100|0|4|Vistor hf|Sanofi-aventis Norge AS|Prómetazín||1503||1503|2880 567073|A10BG0201|Avandia|töflur|4|mg|56|stk|1|þpakki|filmuhúðaðar töflur|A10BG02|01.12.2000||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|7450|10950|lyfalmen|||00|56|0|37|GlaxoSmithKline ehf|SmithKline Beecham PLC|Rósíglítazón||||7450|10950 567149|A10BG0201|Avandia|töflur|8|mg|28|stk|1|þpakki|filmuhúðaðar töflur|A10BG02|01.12.2000||R|A|2|0|0|*|0|SBP|0|0|0|100|GBP|5899|8846|lyfalmen|||00|28|0|37|GlaxoSmithKline ehf|SmithKline Beecham PLC|Rósíglítazón||5899||5899|8846 567503|N05AX0801|Risperdal|töflur|1|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|5664|8527|lyfalmen|V0791|4040|00|60|0|12|Vistor hf|Janssen-Cilag AB|Risperídón||5664||5664|8527 567511|N05AX0801|Risperdal|töflur|2|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|12470|17710|lyfalmen|V0793|8270|00|60|0|24|Vistor hf|Janssen-Cilag AB|Risperídón||12470||12470|17710 567529|N05AX0801|Risperdal|töflur|3|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|20727|27990|lyfalmen|V0794|11709|00|60|0|36|Vistor hf|Janssen-Cilag AB|Risperídón||20727||20727|27990 567537|N05AX0801|Risperdal|töflur|4|mg|60|stk|1|þpakki||N05AX08|01.01.1995||R|A|3|0|0|*|0|JAS|0|1|0|100|SEK|27463|36376|lyfalmen|V0795|18331|00|60|0|48|Vistor hf|Janssen-Cilag AB|Risperídón||27463||27463|36376 567545|R01AC0201|Livostin|nefúði|0,5|mg/úðask|15|ml|1|glas||R01AC02|01.06.1998||L|A|3|0|0|0|0|JAS|0|0|1|100|IKR|||lyflausa|||24|15|0|12|Vistor hf|Janssen-Cilag AB|Levókabastín||||| 567719|C10AA0302|Pravachol|töflur|40|mg|98|stk|1|þpakki||C10AA03|01.06.1998|30.04.2009|R|A|2|0|0|0|0|BRS|0|0|0|100|DKK|18936|25760|lyfalmen|||00|98|0|196|Vistor hf|Bristol-Myers Squibb|Pravastatín||18936||18936|25760 567990|V08AB0901|Visipaque|stl|150|mg J/ml|200|ml|6|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|14023|19326|lyfsjukr|||02|1200|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||14023||14023|19326 568022|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|27452|36045|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||27452||27452|36045 568030|V08AB0901|Visipaque|stl|320|mg J/ml|20|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|5568|7972|lyfsjukr|||02|200|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||5568||5568|7972 568055|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|28937|37894|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||28937||28937|37894 568238|A02BC0401|Pariet|sh-tfl|20|mg|120|stk|1|þpakki||A02BC04|01.05.2002||R|A|2|0|0|0|0|EIS|0|0|0|100|SEK|16169|22315|lyfalmen|||00|120|0|120|Vistor hf|Eisai Ltd|Rabeprazól||16169||16169|22315 568519|N05AB0301|Trilafon|töflur|8|mg|100|stk|1|þpakki||N05AB03|01.01.1986||R|A|5|0|0|*|0|SCP|0|1|0|100|DKK|2059|3635|lyfalmen|V2072|3317|00|100|0|27|Vistor hf|Schering-Plough|Perfenazín||2059||2059|3635 568709|R01AX0601|Bactroban Nasal|nefsm|20|mg/g|3|g|1|túpa||R01AX06|01.07.1994||R|A|3|0|0|0|0|GSK|0|0|1|100|GBP|1020|2225|lyfalmen|||00|3|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Mupirocin||1020||1020|2225 568790|N02AA5902|Parkodin forte|eþ-stil|530|mg|10|stk|1|pakki|30+500 mg|N02AA59|01.07.1993||R|A|2|0|0|0|0|ACA|0|0|1|100|IKR|489|1504|lyfalmen|||04|10|0|3|Actavis Group hf|Actavis hf|Kódein í blöndum nema með geðlyfjum||489||489|1504 568840|C08CA0201|Feldil|forðatfl|5|mg|100|stk|1|glas||C08CA02|01.04.2003||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|1463|2826|lyfalmen|V0316|2826|10|100|0|100|Actavis Group hf|Actavis hf|Felódipín||1463||1463|2826 568865|C08CA0201|Feldil|forðatfl|10|mg|100|stk|1|glas||C08CA02|01.04.2003||R|A|5|0|0|B|0|ACA|0|0|0|100|IKR|2318|3986|lyfalmen|V0324|3986|10|100|0|200|Actavis Group hf|Actavis hf|Felódipín||2318||2318|3986 569467|M03BX0103|Lioresal|stl|2|mg/ml|5|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|A|3|0|0|0|1|NOH|0|0|0|100|DKK|18178|24499|lyfsjukr|||02|5|0|18|Vistor hf|Novartis Healthcare A/S-|Baklófen||18178||18178|24499 569483|M03BX0103|Lioresal|stl|0,5|mg/ml|20|ml|1|lykja|stl.intrathecal.|M03BX01|01.10.1995||R|A|5|0|0|0|1|NOH|0|0|0|100|DKK|18178|24499|lyfsjukr|||02|20|0|18|Vistor hf|Novartis Healthcare A/S-|Baklófen||18178||18178|24499 569897|J07AJ5204|DiTeKik|bóluefni|0| |0,5|ml|1|spr|án nálar|J07AJ52|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|2348|4027|lyfalmen|||51|0|0|0|Icepharma hf|Statens Serum Institut|Kíghósti, í blöndum með öðrum toxóíðum||2348||2348|4027 569913|J07CA0203|DiTeKiPol|bóluefni|0| |0,5|ml|1|spr|án nálar|J07CA02|01.11.1998||R|K|2|0|0|0|0|SSI|0|0|0|100|DKK|3344|5378|lyfalmen|||51|0|0|0|Icepharma hf|Statens Serum Institut|barnaveiki, kíghósti, mænusótt, stífkrampi||3344||3344|5378 572768|B02BC1001|Tisseel Duo Quick|vefjalím|0| |0,5|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|123895|156117|lyfsjukr|||00|5|0|0|Icepharma hf|Baxter|Fíbrínógen manna||123895||123895|156117 572776|B02BC1001|Tisseel Duo Quick|vefjalím|0| |1|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|162172|203772|lyfsjukr|||00|10|0|0|Icepharma hf|Baxter|Fíbrínógen manna||162172||162172|203772 572784|B02BC1001|Tisseel Duo Quick|vefjalím|0| |2|ml|10|stk|samsett pk|B02BC10|01.03.2001||R|I|2|0|0|0|1|BAX|0|0|0|100|SEK|305086|381700|lyfsjukr|||00|20|0|0|Icepharma hf|Baxter|Fíbrínógen manna||305086||305086|381700 573287|G03CA0306|Evorel|forðapl|25|mcg/sólh|26|stk|1|pakki||G03CA03|01.07.1993||R|A|3|0|0|E|0|JAS|0|0|0|100|SEK|3369|5412|lyfalmen|||23|26|0|46|Vistor hf|Janssen-Cilag AB|Estradíól||3369||3369|5412 573477|L01XC0301|Herceptin|sts|150|mg/hgl|1|hgl|1|pakki||L01XC03|01.01.2002||R|A|2|0|1|0|1|ROC|0|0|0|100|DKK|104405|131852|lyfsjukr|||00|1|0|0|Icepharma hf|Roche|Trastuzumab||104405||104405|131852 573634|J01DH0201|Meronem|sts/irs|500|mg/hgl|500|mg|10|hgl||J01DH02|01.10.1995||R|A|4|0|0|0|1|ASZ|0|0|0|100|SEK|26261|34562|lyfsjukr|||00|5000|0|2|Vistor hf|AstraZeneca UK Ltd|Meropenem||26261||26261|34562 573642|J01DH0201|Meronem|sts/irs|1|g/hgl|1|g|10|hgl||J01DH02|01.10.1995||R|A|4|0|0|0|1|ASZ|0|0|0|100|SEK|51397|65857|lyfsjukr|||00|10|0|5|Vistor hf|AstraZeneca UK Ltd|Meropenem||51397||51397|65857 573790|M01AB0506|Voltaren Rapid|töflur|50|mg|100|stk|1|þpakki||M01AB05|01.01.1996||R|A|3|0|0|0|0|NOH|0|0|1|100|IKR|2756|2507|lyfalmen|V0610|2451|67|100|0|50|Vistor hf|Novartis Healthcare A/S-|Díklófenak||1228||1228|2507 575324|N06AB0601|Zoloft|töflur|50|mg|28|stk|1|þpakki||N06AB06|01.10.1995||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|3676|3455|lyfalmen|V0931|2428|00|28|0|28|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sertralín||1927||1927|3455 575340|N06AB0601|Zoloft|töflur|50|mg|98|stk|1|þpakki||N06AB06|01.10.1995||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|12159|9382|lyfalmen|V0933|6361|00|98|0|98|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sertralín||6294||6294|9382 575357|N06AB0601|Zoloft|töflur|100|mg|28|stk|1|þpakki||N06AB06|01.03.2001||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|6304|5228|lyfalmen|V0935|3559|00|28|0|56|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sertralín||3233||3233|5228 575365|N06AB0601|Zoloft|töflur|100|mg|98|stk|1|þpakki||N06AB06|01.03.2001||R|A|5|0|0|B|0|PFI|0|1|0|100|DKK|19833|15278|lyfalmen|V0937|10351|00|98|0|196|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Sertralín||10639||10639|15278 575472|P03AX0301|Prioderm|hársápa|10|mg/ml|40|g|1|túpa||P03AX03|01.04.1994||L|K|2|0|0|0|0|NOP|0|0|0|100|IKR|||lyflausa|||23|40|0|0|Icepharma hf|Norpharma |Malatíón||||| 575506|C01EB1001|Adenocor|stl|3|mg/ml|2|ml|6|hgl||C01EB10|01.11.2007||R|A|3|0|0|0|1|SAA|0|0|0|100|NOK|5815|8326|lyfsjukr|||00|12|0|0|Vistor hf|Sanofi - Aventis|Adenósín||5815||5815|8326 575787|L04AB0201|Remicade|irs|100|mg|1|hgl|1|pakki||L04AB02|01.12.2000||R|K|3|0|1|0|1|CEO|0|0|0|100|DKK|96879|122482|lyfsjukr|||00|1|0|27|Vistor hf|Centocor B.V.|Infliximab||96879||96879|122482 577494|M05BA0101|Didronate|töflur|200|mg|28|stk|1|þpakki||M05BA01|01.04.1996||R|A|4|0|0|E|0|PGA|0|0|0|100|DKK|6521|9690|lyfalmen|||00|28|0|14|Sofus Consulting AB|Procter & Gamble-|Etídrónsýra||6521||6521|9690 577668|C07FB0201|Logimax|forðatfl|55|mg|28|stk|1|pakki|þp 5+50 mg|C07FB02|01.04.1997||R|A|3|0|0|B|0|AZD|0|0|0|100|SEK|2800|4640|lyfalmen|||00|28|0|28|Vistor hf|AstraZeneca A/S DK|Metóprólól og önnur blóðþrýst­ings­­lækkandi lyf||2800||2800|4640 579110|R03CC0301|Bricanyl|stl|0,5|mg/ml|1|ml|10|lykjur||R03CC03|01.12.1972||R|A|2|0|0|B|0|AZD|0|0|0|100|SEK|1090|2320|lyfalmen|||02|10|0|0|Vistor hf|AstraZeneca A/S DK|Terbútalín||1090||1090|2320 579854|L04AX0301|Methotrexate Wyeth Lederle|töflur|2,5|mg|30|stk|1|glas||L04AX03|01.01.1994||R|A|3|0|0|*|0|WAB|0|0|0|100|USD|844|1986|lyfalmen|||00|30|0|30|Icepharma hf|Wyeth AB|Metótrexat||844||844|1986 582080|H01AC0107|Humatrope 6 mg|sts|6|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|31377|40932|lyfsjukr|||02|1|0|9|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||31377||31377|40932 582114|H01AC0108|Humatrope 12 mg|sts|12|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|62471|79644|lyfsjukr|||02|1|0|18|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||62471||62471|79644 582130|H01AC0109|Humatrope 24 mg|sts|24|mg/rörly|1|rörlykj|1|pakki||H01AC01|01.04.1989||R|K|3|0|1|0|1|ELI|0|0|0|100|XEU|125220|157766|lyfsjukr|||02|1|0|36|Icepharma hf|Eli Lilly Danmark A/S|Sómatrópín||125220||125220|157766 582213|R01AA0503|Nezeril|nefúði|0,1|mg/ml|7,5|ml|1|glas|sk-úðari|R01AA05|01.10.1994||L|A|3|0|0|0|0|AZD|0|0|1|100|IKR|||lyflausa|||23|8|0|2|Vistor hf|AstraZeneca A/S DK|Oxýmetazólín||||| 582247|QP54AA0301|Dectomax vet.|stl|10|mg/ml|50|ml|1|hgl||QP54AA03|01.02.1999||R|A|2|0|0|0|0|PAL|1|0|0|100|DKK|5077|8786|vetorma|||16|50|0|0|Icepharma hf|Pfizer Oy Animal Health|||5077||5077|8786 582262|QP54AA0301|Dectomax vet.|stl|10|mg/ml|200|ml|1|hgl||QP54AA03|01.02.1999||R|A|2|0|0|0|0|PAL|1|0|0|100|DKK|19130|33105|vetorma|||16|200|0|0|Icepharma hf|Pfizer Oy Animal Health|||19130||19130|33105 582452|V08AB0201|Omnipaque|stl|300|mg J/ml|100|ml|10|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|39554|51112|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||39554||39554|51112 582635|V08AB0201|Omnipaque|stl|300|mg J/ml|500|ml|6|plastf||V08AB02|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|70812|90028|lyfsjukr|||02|3000|0|0|Icepharma hf|GE Healthcare AS|Jóhexól||70812||70812|90028 582775|C07AB0205|Seloken|töflur|50|mg|28|stk|1|þpakki||C07AB02|01.12.2001|30.04.2009|R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|425|1417|lyfalmen|||00|28|0|9|Vistor hf|AstraZeneca A/S DK|Metóprólól||425||425|1417 582783|C07AB0205|Seloken|töflur|100|mg|28|stk|1|þpakki||C07AB02|01.12.2001||R|A|5|0|0|B|0|AZD|0|0|0|100|SEK|679|1762|lyfalmen|||00|28|0|19|Vistor hf|AstraZeneca A/S DK|Metóprólól||679||679|1762 582882|V08AB0901|Visipaque|stl|270|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|27452|36045|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||27452||27452|36045 583401|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|53298|68224|lyfsjukr|||02|2000|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||53298||53298|68224 583443|C07AA0704|Sotalol Merck NM|töflur|80|mg|100|stk|1|þpakki||C07AA07|01.01.1994||R|A|4|0|0|B|0|MNA|0|0|0|100|SEK|988|2181|lyfalmen|||00|100|0|50|Actavis Group PTC ehf|Merck NM AB|Sótalól||988||988|2181 583450|V08AB0901|Visipaque|stl|270|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|82356|104401|lyfsjukr|||02|3000|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||82356||82356|104401 583518|V08AB0901|Visipaque|stl|320|mg J/ml|100|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|28937|37894|lyfsjukr|||02|1000|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||28937||28937|37894 583609|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|10|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|61388|78296|lyfsjukr|||02|2000|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||61388||61388|78296 583708|V08AB0901|Visipaque|stl|320|mg J/ml|500|ml|6|plastf|lausn|V08AB09|01.06.2004||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|92841|117455|lyfsjukr|||02|3000|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||92841||92841|117455 583849|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|250|ml|20|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|3886|5564|lyfsjukr|||00|5000|0|5|Icepharma hf|Fresenius Kabi|Elektrólýtar||3886||3886|5564 583856|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2024|2898|lyfsjukr|||00|9000|0|9|Icepharma hf|Fresenius Kabi|Elektrólýtar||2024||2024|2898 583914|B05BB0114|Natriumklorid Fresenius Kabi|irl|9|mg/ml|50|ml|30|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|1,5|0|0|0|1|FRP|0|0|0|100|DKK|7473|10699|lyfsjukr|||00|1500|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar||7473||7473|10699 583922|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|250|ml|20|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|6131|8778|lyfsjukr|||00|5000|0|5|Icepharma hf|Fresenius Kabi|Kolvetni||6131||6131|8778 583930|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2978|4264|lyfsjukr|||00|9000|0|9|Icepharma hf|Fresenius Kabi|Kolvetni||2978||2978|4264 584011|B05BA0311|Glucos Fresenius Kabi|irl|50|mg/ml|100|ml|30|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|8512|12187|lyfsjukr|||00|3000|0|3|Icepharma hf|Fresenius Kabi|Kolvetni||8512||8512|12187 584029|B05BA0311|Glucos Fresenius Kabi|irl|100|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3368|4822|lyfsjukr|||00|9000|0|9|Icepharma hf|Fresenius Kabi|Kolvetni||3368||3368|4822 584102|B05BA0311|Glucos Fresenius Kabi|irl|200|mg/ml|1000|ml|9|plpok|Excel umbúðir|B05BA03|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|4014|5747|lyfsjukr|||00|9000|0|0|Icepharma hf|Fresenius Kabi|Kolvetni||4014||4014|5747 584276|B05BB0115|Ringer-acetat Fresenius Kabi|irl|0| |1000|ml|9|plpok|Excel umbúðir|B05BB01|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|2270|3250|lyfsjukr|||00|9000|0|9|Icepharma hf|Fresenius Kabi|Elektrólýtar||2270||2270|3250 584284|V07AB0003|Sterilt vatten Fresenius Kabi|leysir|0| |100|ml|30|pokar|excel umbúðir|V07AB00|01.02.2007||L|A|2|0|0|0|0|FRP|0|0|0|100|IKR|||lyflausa|||00|3000|0|0|Icepharma hf|Fresenius Kabi|||||| 584292|N06AG0201|Aurorix|töflur|300|mg|30|stk|1|þpakki||N06AG02|01.07.1995||R|A|5|0|0|B|0|MAS|0|1|0|100|SEK|3402|5457|lyfalmen|||64|30|0|30|Vistor hf|Meda AS|Móklóbemíð||3402||3402|5457 585646|B01AB0101|Heparin Leo|stl|25000|ae/ml|2|ml|10|hgl||B01AB01|01.11.1981||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|10162|14519|lyfsjukr|||02|20|0|50|Vistor hf|LEO Pharma A/S|Heparín||10162||10162|14519 585679|B01AB0101|Heparin Leo|stl|5000|ae/ml|5|ml|5|hgl||B01AB01|01.12.1972||R|A|3|0|0|0|1|LEP|0|0|0|100|DKK|3701|5299|lyfsjukr|||02|25|0|12|Vistor hf|LEO Pharma A/S|Heparín||3701||3701|5299 585844|J01DH5101|Tienam|irs|500|mg|12|hgl|1|pakki|monovial|J01DH51|01.04.1988||R|A|2|0|0|0|1|MSD|0|0|0|100|XEU|36375|47154|lyfsjukr|||00|12|0|3|Icepharma hf|M.S.D.|Imipenem og ensímhemill||36375||36375|47154 585869|J07BC0201|Havrix|bóluefni|1440|ein/ml|1|ml|1|dæla|einnota dæla|J07BC02|01.07.1994||R|K|3|0|0|0|0|GSK|0|0|0|100|GBP|3385|5434|lyfalmen|||02|1|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Lifrarbólga-A, dauð veira (inactiv­ated whole virus)||3385||3385|5434 586107|L04AD0102|Sandimmun Neoral|mixtúra|100|mg/ml|50|ml|1|glas||L04AD01|01.07.1994||R|A|3|0|0|*|0|NOH|0|0|0|100|DKK|35243|46063|lyfalmen|||00|50|0|20|Vistor hf|Novartis Healthcare A/S-|Ciklospórín||35243||35243|46063 586206|D07AB0201|Locoid|smyrsli|1|mg/g|100|g|1|túpa||D07AB02|01.03.1977||R|A|5|0|0|B|0|ASP|0|0|1|100|XEU|2681|4479|lyfalmen|||20|100|0|100|Vistor hf|Astellas Pharma A/S|Hýdrókortisón bútýrat||2681||2681|4479 587667|B05BB0210|Rehydrex m. gl. 25 mg/ml Fresenius Kabi|irl|0| |1000|ml|9|plpok|Excel umbúðir|B05BB02|01.11.2002||R|A|3|0|0|0|1|FRP|0|0|0|100|DKK|3154|4516|lyfsjukr|||00|9000|0|9|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||3154||3154|4516 588152|S01GX0401|Tilavist|augndr|20|mg/ml|5|ml|1|glas||S01GX04|01.10.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|1398|2738|lyfalmen|||06|5|0|0|Vistor hf|Sanofi-aventis Norge AS|Nedókrómíl||1398||1398|2738 588574|J01FF0101|Dalacin|hylki|300|mg|20|stk|1|þpakki||J01FF01|01.10.1995||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|2235|3873|lyfalmen|V0426|3811|43|20|0|5|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||2235||2235|3873 588608|B01AC0501|Ticlid|töflur|250|mg|100|stk|1|þpakki||B01AC05|01.04.1995||R|A|3|0|0|E|0|SNO|0|0|0|100|NOK|12338|17546|lyfalmen|||00|100|0|50|Vistor hf|Sanofi-aventis Norge AS|Tíklópídín||12338||12338|17546 588723|B03AA0702|Ferlen-R|forðatfl|100|mg|60|stk|1|glas||B03AA07|01.01.1994||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||10|60|0|30|Actavis Group hf|Actavis hf|Ferrósúlfat||||| 588772|H05BA0103|Miacalcic Nasal|nefúði|200|ae/sk|2|ml|1|úðagl|14 skammt|H05BA01|01.03.2002||R|K|3|0|0|E|0|NOH|0|0|0|100|DKK|8945|12979|lyfalmen|||23|2|0|14|Vistor hf|Novartis Healthcare A/S-|Samtengt laxakalsítónín||8945||8945|12979 589358|QP54AA0501|Stronghold vet.|bl.lausn|120|mg|1|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|6204|10736|vetorma|||16|3|0|0|Icepharma hf|Pfizer Animal Health|||6204||6204|10736 589366|QP54AA0501|Stronghold vet.|bl.lausn|15|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|2404|4160|vetorma|||16|1|0|0|Icepharma hf|Pfizer Animal Health|||2404||2404|4160 589374|QP54AA0501|Stronghold vet.|bl.lausn|240|mg|2|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|5985|10357|vetorma|||16|6|0|0|Icepharma hf|Pfizer Animal Health|||5985||5985|10357 589382|QP54AA0501|Stronghold vet.|bl.lausn|30|mg|0,25|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|3233|5595|vetorma|||16|1|0|0|Icepharma hf|Pfizer Animal Health|||3233||3233|5595 589390|QP54AA0501|Stronghold vet.|bl.lausn|60|mg|0,5|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|3358|5811|vetorma|||16|2|0|0|Icepharma hf|Pfizer Animal Health|||3358||3358|5811 589408|QP54AA0501|Stronghold vet.|bl.lausn|45|mg|0,75|ml|3|túpa||QP54AA05|01.04.2004||R|A|3|0|0|0|0|PFA|1|0|0|100|XEU|2601|4501|vetorma|||16|2|0|0|Icepharma hf|Pfizer Animal Health|||2601||2601|4501 589497|D11AF0102|Canthacur|lausn|0,7|%|7,5|ml|1|glas||D11AF01|01.01.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|2566|4323|lyfalmen|||00|8|1|8|Parlogis hf|Parlogis - óskráð lyf|||2566||2566|4323 589500|D11AF0103|Canthacur-PS|lausn|36|%|7,5|ml|1|glas|1%+30%+5%|D11AF01|01.01.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|5480|8277|lyfalmen|||00|8|1|8|Parlogis hf|Parlogis - óskráð lyf|||5480||5480|8277 589911|L01BB0501|Fludara|sts|50|mg/hgl|50|mg|5|hgl||L01BB05|01.01.1996||R|A|3|0|1|0|1|BAP|0|0|0|100|SEK|136817|172205|lyfsjukr|||00|250|0|0|Icepharma hf|Bayer Schering Pharma AG|Flúdarabín||136817||136817|172205 590315|J05AE0301|Norvir|hylki|100|mg|84|stk|4|glös|mjúk hylki|J05AE03|01.08.2003||R|K|2|0|1|0|1|ABL|0|0|0|100|DKK|87458|110753|lyfsjukr|||00|336|0|28|Vistor hf|Abbott Laboratories A/S|Ritonavír||87458||87458|110753 590497|D01AC0101|Canesten|krem|10|mg/g|20|g|1|túpa||D01AC01|01.12.1982||L|A|3|0|0|0|0|BAS|0|0|1|100|IKR|||lyflausa|||00|20|0|20|Vistor hf|Bayer A/S|Klótrímazól||||| 590539|A01AD1101|Bonjela|hlaup|0| |15|g|1|túpa|hlaup í munn|A01AD11|01.01.1996||L|A|3|0|0|0|0|REB|0|0|1|100|IKR|||lyflausa|||00|15|0|0|Icepharma hf|Reckitt Benckiser Healthcare Ltd.|Ýmis lyf||||| 590562|C01DA1403|Ismo|forðatfl|60|mg|98|stk|1|þpakki||C01DA14|01.10.1999||R|A|3|0|0|B|0|ACA|0|0|0|100|IKR|1404|2746|lyfalmen|V0139|2746|10|98|0|147|Actavis Group hf|Actavis hf|Ísósorbíð mónónítrat||1404||1404|2746 590752|N05AF0102|Fluanxol Depot|stl|100|mg/ml|1|ml|10|lykjur||N05AF01|01.03.1979||R|A|4|0|0|*|0|LBK|0|1|0|100|DKK|27009|35811|lyfalmen|||02|10|0|250|Lundbeck Export A/S|H. Lundbeck A/S|Flúpentixól||27009||27009|35811 590919|B01AD1101|Metalyse|sts/irs|10000|ein|1|stk|1|hgl|+ leysir áfyllt sprauta|B01AD11|01.07.2001||R|A|2|0|0|0|1|BOI|0|0|0|100|DKK|199181|249848|lyfsjukr|||00|1|0|1|Vistor hf|Boehringer Ingelheim|Tenekteplasi||199181||199181|249848 591131|V08AB0901|Visipaque|stl|270|mg J/ml|200|ml|6|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|31979|41681|lyfsjukr|||00|1200|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||31979||31979|41681 591149|V08AB0901|Visipaque|stl|320|mg J/ml|200|ml|6|fl||V08AB09|01.01.1996||R|A|3|0|0|0|1|GEH|0|0|0|100|IKR|36833|47725|lyfsjukr|||00|1200|0|0|Icepharma hf|GE Healthcare AS|Jódixanól||36833||36833|47725 592097|N01AF0301|Pentothal Natrium|sts|500|mg|1|stk|12|hgl||N01AF03|01.07.1990||R|A|4|0|0|0|1|HOS|0|0|0|100|DKK|3314|4745|lyfsjukr|||02|12|0|0|Vistor hf|Hospira Enterprises B.V.|Tíópentalnatríum||3314||3314|4745 592147|D05AX0301|Silkis|smyrsli|3|mcg/g|100|g|1|túpa||D05AX03|01.06.2001||R|A|3|0|0|B|0|GAN|0|0|0|100|XEU|6390|9512|lyfalmen|||00|100|0|0|Icepharma hf|Galderma Nordic AB|Kalcítríól||6390||6390|9512 592378|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|500|ml|1|glas||D08AC02|01.10.1976||L|A|3|0|0|0|0|REM|0|0|0|100|IKR|||lyflausa|||00|500|0|500|Vistor hf|Regent Medical Overseas Limited|Klórhexidín||||| 592469|N02BE0107|Paratabs|lausnart|160|mg|30|stk|1|þpakki||N02BE01|01.01.1995||L|A|2|0|0|0|0|ACA|0|0|1|100|IKR|||lyflausa|||09|30|0|2|Actavis Group hf|Actavis hf|Paracetamól||||| 593384|N03AE0101|Rivotril|töflur|0,5|mg|50|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|660|1736|lyfalmen|||00|50|0|3|Icepharma hf|Roche|Klónazepam||660||660|1736 593392|N03AE0101|Rivotril|töflur|0,5|mg|150|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|1031|2239|lyfalmen|||00|150|0|9|Icepharma hf|Roche|Klónazepam||1031||1031|2239 593434|N03AE0101|Rivotril|töflur|2|mg|100|stk|1|glas||N03AE01|01.01.1978||R|A|5|0|0|E|0|ROC|0|0|0|100|DKK|1751|3217|lyfalmen|||00|100|0|25|Icepharma hf|Roche|Klónazepam||1751||1751|3217 594325|H02AB0802|Lederspan|stl|20|mg/ml|1|ml|12|hgl|dreifa|H02AB08|01.12.2003||R|A|3|0|0|B|0|MAB|0|0|1|100|SEK|17833|24387|lyfalmen|||03|12|0|32|Vistor hf|Meda AB|Tríamcínólón||17833||17833|24387 594713|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|1|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|10|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||597 594721|QP52AF0201|Banminth, vet.|pasta|21,7|mg/g|10|g|10|spr||QP52AF02|01.07.1995||L|A|5|0|0|0|0|PAL|0|0|0|100|DKK|||vetorma|||16|100|0|0|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer Oy Animal Health||||||4958 594903|B05BB0209|Glucos 100 mg/ml med Na40 + K20 Fres|irl|0| |1000|ml|9|plpok|Exel umbúðir|B05BB02|01.04.2005||R|A|2|0|0|0|1|FRP|0|0|0|100|DKK|2908|4164|lyfsjukr|||02|9000|0|0|Icepharma hf|Fresenius Kabi|Elektrólýtar í blöndum með kol­vetnum||2908||2908|4164 594945|QA12CE9903|Selenevit, vet.|stl|26|mg/ml|100|ml|1|hgl|1+25 mg/ml|QA12CE99|01.09.1982||R|A|5|0|0|0|0|INI|0|0|0|100|DKK|1043|2058|vetalmen|||27|100|0|0|Icepharma hf|Intervet International B.V.|||1043||1043|2058 595066|H05BA0102|Miacalcic|stl|100|ae/ml|1|ml|5|lykjur||H05BA01|01.03.1979||R|K|5|0|0|0|1|NOH|0|0|0|100|DKK|8875|12707|lyfsjukr|||02|5|0|5|Vistor hf|Novartis Healthcare A/S-|Samtengt laxakalsítónín||8875||8875|12707 595991|J07BB0201|Fluarix|bóluefni|0| |0,5|ml|1|spr|einnotaspr|J07BB02|01.10.1994||R|K|1|0|0|0|0|GSK|0|0|0|100|GBP|577|1623|lyfalmen|||02|0|0|0|GlaxoSmithKline ehf|GlaxoSmithKline ehf|Inflúensa, hreinsaðir mótefnavakar||577||577|1623 596023|D08AC0201|Hibiscrub|lyf.sápa|40|mg/ml|250|ml|1|glas||D08AC02|01.06.1982||L|A|3|0|0|0|0|REM|0|0|0|100|IKR|||lyflausa|||00|250|0|250|Vistor hf|Regent Medical Overseas Limited|Klórhexidín||||| 597401|J01FF0101|Dalacin|hylki|150|mg|24|stk|1|þpakki||J01FF01|01.06.1979||R|A|5|0|0|0|0|PFI|0|0|1|100|DKK|3959|6213|lyfalmen|||43|24|0|3|Vistor hf (hum.)/Icepharma hf (vet.)|Pfizer ApS|Klindamýcín||3959||3959|6213 597567|D01AC0301|Pevaryl|krem|10|mg/g|30|g|1|túpa||D01AC03|01.05.1978||L|A|2|0|0|0|0|JAS|0|0|1|100|IKR|||lyflausa|||00|30|0|30|Vistor hf|Janssen-Cilag AB|Ekónazól||||| 597575|D01AC0301|Pevaryl|húðduft|10|mg/g|30|g|1|stauk||D01AC03|01.07.1991||L|A|5|0|0|0|0|JAS|0|0|1|100|IKR|||lyflausa|||00|30|0|30|Vistor hf|Janssen-Cilag AB|Ekónazól||||| 598094|R06AD0101|Vallergan|mixtúra|5|mg/ml|150|ml|1|glas||R06AD01|01.03.2004||R|A|5|0|0|0|0|SNO|0|0|1|100|NOK|931|2104|lyfalmen|||00|150|0|25|Vistor hf|Sanofi-aventis Norge AS|Alímemazín||931||931|2104 801120|A11HA0503|Biotin Bayer|töflur|5|mg|20|stk|1|glas||A11HA05|01.12.2005||R|A||0|0|0|0|PCO|0|0|0|100|IKR|1218|2493|lyfalmen|||00|20|1|0|Distica|Distica - óskráð lyf|||1218||1218|2493 907024|A04AD0501|Vogalene|eþ-stil|5|mg|10|stk|1|pakki||A04AD05|01.01.1998|31.03.2009|R|A||0|0|E|0|PCO|0|0|1|100|IKR|1597|3008|lyfalmen|||00|10|1|3|Distica|Distica - óskráð lyf|||1597||1597|3008 908048|J07AM5201|Immunoglob. mot tetanus|bóluefni|250|ae|1,2|ml|1|hgl||J07AM52|01.01.1998||R|K||0|0|0|0|LDR|0|0|1|100|IKR|9865|14228|lyfalmen|||00|1|1|0|Parlogis hf|Parlogis - óskráð lyf|||9865||9865|14228 912792|N07CA0301|Sibelium|hylki|5|mg|50|stk|1|glas||N07CA03|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|4276|6643|lyfalmen|||00|50|1|25|Distica|Distica - óskráð lyf|||4276||4276|6643 916827|A03FA0301|Motilium|töflur|10|mg|100|stk|1|glas||A03FA03|01.05.1998||R|A||0|0|0|0|PCO|0|0|1|100|IKR|2314|3981|lyfalmen|||00|100|1|33|Distica|Distica - óskráð lyf|||2314||2314|3981 922866|N05BA0602|Ativan|stl|4|mg/ml|1|ml|4|lykjur||N05BA06|01.11.2005||R|A||0|0|0|1|LDR|0|0|0|100|IKR|3294|4716|lyfsjukr|||00|4|1|0|Parlogis hf|Parlogis - óskráð lyf|||3294||3294|4716 923351|S01XA2006|Lacri - Lube|augnsm|0| |3,5|g|1|túpa||S01XA20|01.01.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|480|1492|lyfalmen|||00|4|1|0|Distica|Distica - óskráð lyf|Gervitár og aðrar óvirkar sam­setningar||480||480|1492 923608|C03BA0801|Metenix|töflur|5|mg|100|stk|1|þpakki||C03BA08|01.05.1998||R|A||0|0|0|0|PCO|0|0|0|100|IKR|4460|6893|lyfalmen|||00|100|1|100|Distica|Distica - óskráð lyf|||4460||4460|6893 924698|G03DA0402|Gestone|stl|50|mg/ml|2|ml|10|lykjur||G03DA04|01.11.2005||R|A||0|1|E|0|PCO|0|0|0|100|IKR|8792|12772|lyfalmen|||00|20|1|200|Distica|Distica - óskráð lyf|||8792||8792|12772 927361|A12AA1201|Phos-Ex|töflur|167|mg|180|stk|1|glas||A12AA12|01.01.1998||R|A||0|1|0|0|LDR|0|0|0|100|IKR|1768|3240|lyfalmen|||00|180|1|15|Parlogis hf|Parlogis - óskráð lyf|||1768||1768|3240 937980|C01CA2403|Adrenalin|stl|0,1|mg/ml|10|ml|1|spr||C01CA24|01.05.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|1461|2092|lyfsjukr|||02|10|1|2|Parlogis hf|Parlogis - óskráð lyf|Epínefrín (adrenalín)||1461||1461|2092 938376|N07BC0201|Metadon|hylki|40|mg|100|stk|1|glas||N07BC02|01.07.2000||R|A||1|0|0|0|LDR|0|0|0|100|IKR|8233|12013|lyfalmen|||00|100|1|160|Parlogis hf|Parlogis - óskráð lyf|||8233||8233|12013 938417|N07BC0201|Metadon|stl|10|mg/ml|1,1|ml|10|lykjur||N07BC02|01.07.2000||R|A||1|0|0|0|LDR|0|0|0|100|IKR|1770|3242|lyfalmen|||00|11|1|4|Parlogis hf|Parlogis - óskráð lyf|||1770||1770|3242 938483|M04AC0101|Colchicine|töflur|0,5|mg|100|stk|1|glas||M04AC01|01.01.1998||R|A||0|0|E|0|LDR|0|0|0|100|IKR|2510|4247|lyfalmen|||00|100|1|50|Parlogis hf|Parlogis - óskráð lyf|||2510||2510|4247 938524|G04BE0201|Papaverin|stl|40|mg/ml|1|ml|10|lykjur||G04BE02|01.01.1998||R|A||0|0|0|0|LDR|0|0|0|100|IKR|3002|4914|lyfalmen|||00|10|1|4|Parlogis hf|Parlogis - óskráð lyf|||3002||3002|4914 938649|C05BA0401|Elmiron|hylki|100|mg|100|stk|1|glas||C05BA04|01.05.1998||R|A||0|0|E|0|LDR|0|0|0|100|IKR|35415|46277|lyfalmen|||00|100|1|0|Parlogis hf|Parlogis - óskráð lyf|||35415||35415|46277 938665|A12CX0001|K-Phos Neutral|töflur|0| |100|stk|1|glas||A12CX00|01.03.2001||R|A||0|0|0|0|LDR|0|0|0|100|IKR|4071|6365|lyfalmen|||00|100|1|0|Parlogis hf|Parlogis - óskráð lyf|||4071||4071|6365 938780|C09AA0104|Captopril|hylki|1|mg|100|stk|1|glas||C09AA01|01.01.2000||R|A||0|0|E|0|LDR|0|0|0|100|IKR|7401|10884|lyfalmen|||00|100|1|2|Parlogis hf|Parlogis - óskráð lyf|Kaptópríl||7401||7401|10884 939366|G03DA0402|Gestone|stl|50|mg/ml|1|ml|10|lykjur||G03DA04|01.11.2005||R|A||0|1|E|0|PCO|0|0|0|100|IKR|11596|16577|lyfalmen|||00|10|1|100|Distica|Distica - óskráð lyf|||11596||11596|16577 940256|G03CA0313|Oestradiol|vefjatfl|25|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|2245|3887|lyfalmen|||00|1|1|83|Distica|Distica - óskráð lyf|Estradíól||2245||2245|3887 940264|G03CA0313|Oestradiol|vefjatfl|50|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|4490|6934|lyfalmen|||00|1|1|167|Distica|Distica - óskráð lyf|Estradíól||4490||4490|6934 940272|G03CA0313|Oestradiol|vefjatfl|100|mg|1|stk|1|pakki||G03CA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|8395|12233|lyfalmen|||00|1|1|333|Distica|Distica - óskráð lyf|Estradíól||8395||8395|12233 940313|G03BA0302|Testosteron|vefjatfl|100|mg|1|stk|1|pakki||G03BA03|01.04.1998||R|A||0|0|E|0|PCO|0|0|0|100|IKR|1837|3333|lyfalmen|||00|1|1|1|Distica|Distica - óskráð lyf|Testósterón||1837||1837|3333 942468|A04AD0501|Vogalene|hylki|15|mg|20|stk|1|glas||A04AD05|01.01.1998|31.03.2009|R|A||0|0|E|0|PCO|0|0|1|100|IKR|3163|5133|lyfalmen|||00|20|1|20|Distica|Distica - óskráð lyf|||3163||3163|5133 944505|H02AB1005|Cortisonacetat|töflur|5|mg|100|stk|1|glas||H02AB10|01.12.2002||R|A||0|0|E|0|PCO|0|0|1|100|IKR|4544|7007|lyfalmen|||00|100|1|13|Distica|Distica - óskráð lyf|||4544||4544|7007 944745|G03BA0302|Testosteron|vefjatfl|25|mg|1|stk|1|pakki||G03BA03|01.01.2002||R|A||0|0|E|0|PCO|0|0|0|100|IKR|1061|2280|lyfalmen|||00|1|1|8|Distica|Distica - óskráð lyf|Testósterón||1061||1061|2280 944852|A06AX0102|Glycerol infant|eþ-stil|0| |12|stk|1|pakki||A06AX01|01.10.1998||R|S||0|0|0|0|LDR|0|0|0|100|IKR|342|1304|lyfalmen|||00|12|1|0|Parlogis hf|Parlogis - óskráð lyf|||342||342|1304 944886|H02AB0601|Prednisolon|töflur|1|mg|28|stk|1|pakki||H02AB06|01.10.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|122|1006|lyfalmen|||00|28|1|3|Parlogis hf|Parlogis - óskráð lyf|Prednisólón||122||122|1006 944985|A06AX0103|Glycerol adult|eþ-stil|0| |12|stk|1|pakki||A06AX01|01.10.1998||R|S||0|0|0|0|LDR|0|0|0|100|IKR|342|1304|lyfalmen|||00|12|1|0|Parlogis hf|Parlogis - óskráð lyf|||342||342|1304 944993|V03AB1702|Methylen Blue|stl|10|mg/ml|10|ml|10|lykjur||V03AB17|01.11.1998||R|A||0|0|0|1|LDR|0|0|0|100|IKR|10030|14355|lyfsjukr|||00|100|1|0|Parlogis hf|Parlogis - óskráð lyf|||10030||10030|14355 945602|A11EA08|Vitamin B-komplex|stl|0| |2|ml|10|lykjur||A11EA|01.01.2000||R|A||0|0|0|0|LDR|0|0|0|100|IKR|1202|2472|lyfalmen|||00|20|1|0|Parlogis hf|Parlogis - óskráð lyf|||1202||1202|2472 945850|R06AD0202|Atosil|stl|25|mg/ml|2|ml|5|lykjur||R06AD02|01.03.2001||R|A||0|0|0|0|PCO|0|0|1|100|IKR|2293|3952|lyfalmen|||00|10|1|10|Distica|Distica - óskráð lyf|Prómetazín||2293||2293|3952 947236|N06BC0101|Koffein|töflur|200|mg|50|stk|1|glas||N06BC01|01.01.2000||R|A||0|0|0|0|LDR|0|0|0|100|IKR|1558|2955|lyfalmen|||00|50|1|25|Parlogis hf|Parlogis - óskráð lyf|||1558||1558|2955 947690|C01CA2403|Adrenalin|stl|1|mg/ml|1|ml|10|lykjur||C01CA24|01.07.2000||R|A||0|0|0|0|LDR|0|0|1|100|IKR|1301|2606|lyfalmen|||00|10|1|20|Parlogis hf|Parlogis - óskráð lyf|Epínefrín (adrenalín)||1301||1301|2606 947715|H02AB1004|Cortisone Acetat|töflur|25|mg|100|stk|1|glas||H02AB10|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|3625|5760|lyfalmen|||00|100|1|67|Parlogis hf|Parlogis - óskráð lyf|||3625||3625|5760 947822|H02AB0203|Dexamethason|töflur|4|mg|50|stk|1|glas||H02AB02|01.11.2001||R|A||0|0|E|0|LDR|0|0|1|100|IKR|8756|12723|lyfalmen|||00|50|1|133|Parlogis hf|Parlogis - óskráð lyf|||8756||8756|12723 947913|A11HA0203|Vitamin B6 Heve|stl|12,5|mg/ml|2|ml|10|lykjur||A11HA02|01.06.2000||R|A||0|0|0|0|LDR|0|0|0|100|IKR|582|1630|lyfalmen|||00|20|1|2|Parlogis hf|Parlogis - óskráð lyf|||582||582|1630 948242|H02AB0203|Dexamethason|töflur|0,5|mg|100|stk|1|pakki||H02AB02|01.04.2005||R|A||0|0|E|0|LDR|0|0|1|100|IKR|2071|3651|lyfalmen|||00|100|1|33|Parlogis hf|Parlogis - óskráð lyf|||2071||2071|3651 949620|G03DA0401|Utrogestan|hylki|100|mg|30|stk|1|pakki||G03DA04|01.01.1999||R|A||0|1|E|0|LDR|0|0|0|100|IKR|2001|3556|lyfalmen|||00|30|1|10|Parlogis hf|Parlogis - óskráð lyf|||2001||2001|3556 950742|H02AB0204|Dexa-Ratiopharm|stl|4|mg/ml|1|ml|10|hgl||H02AB02|01.01.2003||R|A||0|0|0|1|LDR|0|0|0|100|IKR|1307|1871|lyfsjukr|||55|10|1|0|Parlogis hf|Parlogis - óskráð lyf|||1307||1307|1871 951005|G03CA0102|Etinylestradiol|töflur|25|mcg|21|stk|1|pakki||G03CA01|01.09.2002||R|A||0|0|E|0|LDR|0|0|0|100|IKR|755|1865|lyfalmen|||00|21|1|21|Parlogis hf|Parlogis - óskráð lyf|||755||755|1865 951287|J01CA0101|Ampicillin|sts|0| |1|g|10|hgl||J01CA01|01.07.2003||R|A||0|0|0|1|LDR|0|0|0|100|IKR|4952|7090|lyfsjukr|||00|10|1|5|Parlogis hf|Parlogis - óskráð lyf|||4952||4952|7090 952251|J01CA0101|Ampicillin|sts|0| |500|mg|10|hgl||J01CA01|01.07.2003||R|A||0|0|0|1|LDR|0|0|0|100|IKR|4403|6304|lyfsjukr|||00|5000|1|2|Parlogis hf|Parlogis - óskráð lyf|||4403||4403|6304 952798|A03BA0101|Atropin|stl|1|mg/ml|1|ml|10|lykjur||A03BA01|01.07.2004||R|A||0|0|0|0|LDR|0|0|1|100|IKR|1315|2625|lyfalmen|||00|10|1|7|Parlogis hf|Parlogis - óskráð lyf|||1315||1315|2625 952855|N02AA0102|Morfin|eþ-stil|10|mg|12|stk|1|pakki||N02AA01|01.10.2004||R|S||1|0|E|0|LDR|0|0|0|100|IKR|3127|5084|lyfalmen|||00|12|1|4|Parlogis hf|Parlogis - óskráð lyf|Morfín||3127||3127|5084 953374|N05AB0602|Stelazine|töflur|1|mg|112|stk|1|glas||N05AB06|01.06.2007||R|A||0|0|*|0|LDR|0|0|0|100|IKR|1410|2754|lyfalmen|||00|112|1|6|Parlogis hf|Parlogis - óskráð lyf|||1410||1410|2754 953621|R03DA0504|Theofyllamin EDA Ratiopharm|stl|120|mg/ml|1|ml|5|lykja||R03DA05|01.09.2004||R|A||0|0|0|0|LDR|0|0|0|100|IKR|289|1233|lyfalmen|||00|5|1|1|Parlogis hf|Parlogis - óskráð lyf|||289||289|1233 955239|A11GA0108|Vitamin C 500|stl|100|mg/ml|5|ml|5|lykjur||A11GA01|01.01.2006||R|A||0|0|0|0|LDR|0|0|0|100|IKR|551|1588|lyfalmen|||00|25|1|12|Parlogis hf|Parlogis - óskráð lyf|||551||551|1588 956302|N07AA0101|Neostigmin|stl|0,5|mg/ml|1|ml|10|lykjur||N07AA01|01.01.2006||R|A||0|0|0|0|LDR|0|0|0|100|IKR|848|1991|lyfalmen|||00|10|1|2|Parlogis hf|Parlogis - óskráð lyf|||848||848|1991 958613|V03AB1503|Naloxon|stl|0,4|mg/ml|1|ml|10|lykjur||V03AB15|01.01.2009||R|A||0|0|0|1|LDR|0|0|0|100|IKR|12107|16941|lyfsjukr|||00|10|1|0|Parlogis hf|Parlogis - óskráð lyf|||12107||12107|16941 958829|A06AD0002|Miralax|lausnduf|0| |238|g|1|stauk||A06AD00|01.05.2007||R|A||0|0|0|0|LDR|0|0|0|100|IKR|2093|3681|lyfalmen|||00|238|1|0|Parlogis hf|Parlogis - óskráð lyf|||2093||2093|3681 960999|L02AB0101|Megace|töflur|160|mg|30|stk|1|glas||L02AB01|01.01.2009||R|A||0|1|0|1|PCO|0|0|0|100|IKR|12918|17950|lyfsjukr|||00|30|1|112|Distica|Distica - óskráð lyf|||12918||12918|17950 961393|A04AD0501|Vogalene|hylki|15|mg|20|stk|1|glas||A04AD05|01.01.1998||R|A||0|0|E|0|LDR|0|0|1|100|IKR|2108|3701|lyfalmen|||00|20|1|20|Parlogis hf|Parlogis - óskráð lyf|||||2108|3701 961658|H02AB0905|Hydrocortisone|töflur|20|mg|25|stk|1|glas||H02AB09|01.01.2009||R|A||0|0|E|0|LDR|0|0|1|100|IKR|4400|6811|lyfalmen|||00|25|1|17|Parlogis hf|Parlogis - óskráð lyf|Hýdrókortisón||4400||4400|6811 962523|B05BB0118|Natrium Bicarbonat|irl|50|mg/ml|100|ml|10|fl||B05BB01|01.05.2009||R|A||0|0|0|1|LDR|0|0|0|100|IKR|5430|7774|lyfsjukr|||0|1000|1|0|Parlogis hf|Parlogis - óskráð lyf|Elektrólýtar||5430||5430|7774